Clustering O 0 4.1907705963240005e-06
of O 0 1.0243028327749926e-06
missense O 0 4.774664148499141e-07
mutations O 0 1.3481282756799828e-08
in O 0 2.9351050478965135e-09
the O 0 3.279777160969388e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
gene O 0 1.9320042099479906e-07
in O 0 3.160412598290918e-09
a O 0 3.99474009427081e-09
sporadic B-Disease 0 3.3128710583696375e-06
T I-Disease 1 0.9999606609344482
- I-Disease 0 0.00038392937858588994
cell I-Disease 0 4.4938092287338804e-06
leukaemia I-Disease 0 0.00019979046192020178
. O 0 8.950400456342322e-07

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 3.2514071790501475e-05
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.5640523320925581e-09
is O 0 3.2607333499967694e-10
a O 0 4.856690605237191e-10
recessive B-Disease 0 2.902256568404482e-08
multi I-Disease 0 2.913072023602581e-07
- I-Disease 1 0.9999747276306152
system I-Disease 0 0.0008123263833113015
disorder I-Disease 0 1.073987914423924e-05
caused O 0 2.33469332755476e-09
by O 0 8.504573434375828e-11
mutations O 0 1.1843000191635866e-10
in O 0 1.3507626961395403e-10
the O 0 6.081986914097115e-09
ATM O 0 1.1124843695142772e-06
gene O 0 3.0512465887255757e-09
at O 0 3.9397463069690275e-08
11q22 O 0 3.950382051698398e-06
- O 0 2.1381410988396965e-06
q23 O 0 7.226250545500079e-06
( O 0 4.465779745999043e-09
ref O 0 4.189736841908598e-07
. O 0 2.226361095480911e-09
3 O 0 7.537232704635244e-08
) O 0 2.8439348653819252e-08
. O 0 3.192653252881428e-07

The O 0 2.1449082510116568e-07
risk O 0 4.7043354811648896e-07
of O 0 7.610169205918282e-08
cancer B-Disease 0 2.4289163775392808e-05
, O 0 3.603182863187726e-09
especially O 0 1.3317107416810359e-08
lymphoid B-Disease 0 9.311187341154437e-07
neoplasias I-Disease 1 0.9548887610435486
, O 0 7.330974494124121e-09
is O 0 7.002483592977171e-10
substantially O 0 7.579902927545845e-09
elevated O 0 2.5582744456187356e-07
in O 0 1.682720185414155e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 4.567214162420896e-08
and O 0 9.605843898086164e-10
has O 0 4.709896916921252e-10
long O 0 1.0010907658397628e-09
been O 0 1.8385495903494586e-10
associated O 0 7.34257210588396e-10
with O 0 9.774646869686876e-09
chromosomal O 1 1.0
instability O 1 1.0
. O 0 4.383532086649211e-06

By O 0 1.8814192870308943e-08
analysing O 0 2.6995492135029053e-06
tumour B-Disease 1 1.0
DNA O 0 9.858645455551596e-08
from O 0 9.987449756110323e-10
patients O 0 2.728303138965771e-10
with O 0 6.081215392361727e-11
sporadic B-Disease 0 5.48083392004628e-07
T I-Disease 0 0.025161607190966606
- I-Disease 0 5.078512913314626e-06
cell I-Disease 0 2.8654099537561706e-07
prolymphocytic I-Disease 1 0.9999046325683594
leukaemia I-Disease 0 0.3598380982875824
( O 0 5.983470163783977e-09
T B-Disease 0 0.0005144132883287966
- I-Disease 0 1.8870903659262694e-05
PLL I-Disease 0 8.993120718514547e-05
) O 0 1.1667784516333768e-09
, O 0 5.121446045031064e-10
a O 0 9.164299874520054e-10
rare O 0 1.7922793915658985e-08
clonal B-Disease 0 1.2713424268895324e-07
malignancy I-Disease 0 1.7643486671659048e-07
with O 0 2.001918075755782e-10
similarities O 0 9.27798671224167e-10
to O 0 2.5315016749516417e-10
a O 0 1.2987982911383256e-09
mature B-Disease 0 4.637111672423089e-08
T I-Disease 0 2.607866065318376e-07
- I-Disease 0 1.0390980520469384e-07
cell I-Disease 0 1.1080647510652852e-08
leukaemia I-Disease 0 2.3955672645570303e-07
seen O 0 3.5119298580355007e-09
in O 0 4.030417943834408e-10
A B-Disease 1 0.9999998807907104
- I-Disease 1 0.9993116855621338
T I-Disease 1 1.0
, O 0 1.1053391535398305e-09
we O 0 1.5534021291507827e-10
demonstrate O 0 1.7751106140551087e-10
a O 0 6.951591385861988e-11
high O 0 2.2805755062194066e-09
frequency O 0 1.3557422962051646e-09
of O 0 1.1213765915840668e-08
ATM O 0 4.703820650320267e-06
mutations O 0 6.21443803083821e-08
in O 0 9.931191868872702e-08
T B-Disease 1 0.9999804496765137
- I-Disease 0 0.21851657330989838
PLL I-Disease 0 0.0024836156517267227
. O 0 1.297877361139399e-06

In O 0 2.0097287389830853e-08
marked O 0 5.173285799742189e-09
contrast O 0 6.31018848284981e-10
to O 0 3.5986413848831944e-10
the O 0 4.109771634119852e-09
ATM O 0 6.701937991238083e-07
mutation O 0 1.1229019936109808e-09
pattern O 0 1.433969054609463e-09
in O 0 4.6473069836849845e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
, O 0 2.6933784091909274e-09
the O 0 1.850964048699666e-09
most O 0 2.1773430280980222e-10
frequent O 0 9.848675208701252e-10
nucleotide O 0 7.161163328994746e-10
changes O 0 3.330351827646183e-10
in O 0 8.685438479538732e-11
this O 0 4.675562714773207e-10
leukaemia B-Disease 0 2.7308291805638873e-07
were O 0 2.150837730141575e-08
missense O 0 1.894855813588947e-06
mutations O 0 5.498938548953447e-07
. O 0 3.3460855775047094e-07

These O 0 3.919494417914393e-08
clustered O 0 3.105618162635437e-08
in O 0 5.968990857141421e-10
the O 0 2.5125117542046382e-09
region O 0 3.7041969491724558e-09
corresponding O 0 8.655559602388507e-10
to O 0 6.583521505731937e-10
the O 0 6.478515057750656e-09
kinase O 0 3.149474281372022e-08
domain O 0 9.083626295591785e-09
, O 0 4.0943090584555364e-10
which O 0 6.126152363172821e-11
is O 0 1.1979517378080118e-10
highly O 0 1.4841176065871764e-09
conserved O 0 6.406275510073556e-09
in O 0 5.827228144461571e-10
ATM O 0 4.3773354718723567e-07
- O 0 5.557437887659944e-08
related O 0 1.070080113407812e-08
proteins O 0 2.347829985982486e-10
in O 0 2.580707314514541e-10
mouse O 0 3.305181905943755e-08
, O 0 3.0374034398761296e-09
yeast O 0 1.764788848390708e-08
and O 0 1.5217899829167436e-08
Drosophila O 0 5.282461756905832e-07
. O 0 1.7296638077368698e-07

The O 0 3.812278919212986e-07
resulting O 0 3.340062448842218e-08
amino O 0 4.3030623508855115e-09
- O 0 8.228001391330508e-09
acid O 0 3.760391553697673e-09
substitutions O 0 4.037590706218452e-09
are O 0 9.649930160504638e-11
predicted O 0 1.4237572232289608e-09
to O 0 1.130403770588373e-09
interfere O 0 2.2628634965826677e-08
with O 0 6.386633000232678e-09
ATP O 0 9.115123248193413e-05
binding O 0 8.284948904702105e-08
or O 0 4.938154329892086e-09
substrate O 0 1.430187239748193e-07
recognition O 0 2.2392774212676159e-07
. O 0 3.4468442322577175e-07

Two O 0 8.911879945117107e-08
of O 0 1.3867747838958167e-07
seventeen O 0 7.032203370727075e-07
mutated O 0 5.675257739312656e-07
T B-Disease 0 6.209607818163931e-06
- I-Disease 0 1.4119367506282288e-06
PLL I-Disease 0 5.392170805862406e-06
samples O 0 3.4800766712805853e-09
had O 0 1.0249248116878107e-09
a O 0 5.666156432937441e-10
previously O 0 9.230862296760733e-09
reported O 0 3.6811606207720615e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
allele O 0 5.718035254176357e-07
. O 0 2.841433683897776e-07

In O 0 1.5247186624378628e-08
contrast O 0 9.758440278062608e-09
, O 0 2.0521235821746586e-09
no O 0 1.288993467518651e-09
mutations O 0 1.3684951782888533e-10
were O 0 1.2005685334770533e-10
detected O 0 8.552630270663997e-10
in O 0 2.0618129425997722e-10
the O 0 4.3556704909519794e-09
p53 O 0 3.1267592959238755e-08
gene O 0 1.6203997033059636e-09
, O 0 6.697268295496883e-10
suggesting O 0 9.143051871163266e-10
that O 0 1.381089687058079e-10
this O 0 1.1087535334297627e-09
tumour B-Disease 1 1.0
suppressor O 0 0.025740938261151314
is O 0 1.079232081480086e-08
not O 0 4.3235617863679465e-10
frequently O 0 1.4085743682556995e-09
altered O 0 4.168062339715561e-09
in O 0 8.746871005271828e-10
this O 0 8.360475867164041e-09
leukaemia B-Disease 0 1.0867108358070254e-05
. O 0 8.301826142087521e-07

Occasional O 0 4.35592228313908e-05
missense O 0 1.386091412314272e-06
mutations O 0 2.2010036460073934e-08
in O 0 2.280366784290777e-09
ATM O 0 3.648013489510049e-06
were O 0 4.128942521219869e-09
also O 0 6.068379687640402e-10
found O 0 3.0315622234766693e-10
in O 0 3.360353939552141e-10
tumour B-Disease 1 1.0
DNA O 0 1.073989608357806e-08
from O 0 8.82088499465361e-11
patients O 0 2.0904975667201953e-11
with O 0 1.047006144977436e-11
B B-Disease 0 1.3146425317245303e-06
- I-Disease 0 4.821851717906611e-08
cell I-Disease 0 2.5994875585411137e-08
non I-Disease 0 0.4452296197414398
- I-Disease 1 0.9999978542327881
Hodgkins I-Disease 1 1.0
lymphomas I-Disease 0 0.045879095792770386
( O 0 6.948784880833614e-10
B B-Disease 0 8.669477438161266e-07
- I-Disease 0 7.284410230568028e-08
NHL I-Disease 1 0.9774630069732666
) O 0 1.6060662522132674e-10
and O 0 3.004845261500577e-10
a O 0 8.047029154134577e-10
B B-Disease 0 2.105235125782201e-06
- I-Disease 0 1.6046402606662014e-06
NHL I-Disease 1 0.9999818801879883
cell O 0 6.735359079357295e-07
line O 0 3.947105597035261e-06
. O 0 5.024233473704953e-07

The O 0 2.8257780115836795e-08
evidence O 0 2.4272988063955836e-09
of O 0 2.727784220724061e-09
a O 0 2.2277533984205178e-10
significant O 0 8.638588178122575e-10
proportion O 0 8.732569112268607e-10
of O 0 2.8793343265220983e-09
loss O 0 3.185529706684065e-08
- O 0 6.446973799256739e-08
of O 0 4.185591251371079e-08
- O 0 3.856800745438704e-08
function O 0 3.798205083782591e-10
mutations O 0 3.357123259939421e-11
and O 0 4.752406107533247e-11
a O 0 1.4060934361292965e-10
complete O 0 5.112564260834063e-10
absence O 0 2.3916002511725765e-09
of O 0 2.4227473360838303e-09
the O 0 9.905248843367076e-10
normal O 0 1.913649794182959e-10
copy O 0 1.168720675792656e-09
of O 0 3.3447915548379115e-09
ATM O 0 1.0055313737211691e-07
in O 0 3.9691125386376314e-10
the O 0 2.0381585308371086e-09
majority O 0 2.2250440379067982e-10
of O 0 1.283192663237287e-08
mutated O 0 3.8376489897018473e-07
tumours B-Disease 1 1.0
establishes O 0 4.174827665792691e-07
somatic O 0 4.1983202692108534e-08
inactivation O 0 3.4434273743499944e-07
of O 0 5.008290671071336e-09
this O 0 6.836876204063813e-11
gene O 0 5.831694849245395e-11
in O 0 8.974981868803411e-11
the O 0 2.0888215601644333e-09
pathogenesis O 0 9.172192676487612e-07
of O 0 7.575685856409109e-08
sporadic B-Disease 0 0.0041170381009578705
T I-Disease 1 1.0
- I-Disease 0 0.035908836871385574
PLL I-Disease 0 2.598073479020968e-05
and O 0 2.4247073238115036e-09
suggests O 0 5.965348770509138e-10
that O 0 4.770324066316611e-11
ATM O 0 3.855844852296286e-07
acts O 0 9.002491196952178e-09
as O 0 9.546250900882569e-09
a O 0 8.530140860329993e-08
tumour B-Disease 1 1.0
suppressor O 0 0.00979803130030632
. O 0 4.065020220878068e-06

As O 0 1.6919779000090784e-07
constitutional O 0 8.606214407791413e-08
DNA O 0 1.932224691358897e-08
was O 0 2.8164892640347716e-09
not O 0 5.273313036235905e-11
available O 0 3.000767412331129e-10
, O 0 5.368170907793512e-10
a O 0 6.075215441825321e-09
putative O 0 2.061919303741888e-06
hereditary O 0 0.0002619959122966975
predisposition O 0 0.00021512901003006846
to O 0 9.779756737771095e-07
T B-Disease 1 1.0
- I-Disease 1 0.9999923706054688
PLL I-Disease 0 0.3180740475654602
will O 0 1.1353396445201724e-08
require O 0 2.8245372707402794e-09
further O 0 6.7816086080085825e-09
investigation O 0 1.4143497040208786e-08
. O 0 9.987721760751356e-09
. O 0 2.1745694311903208e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
protein O 0 1.1051804904127494e-05
kinase O 0 2.9142336188670015e-07
is O 0 1.0825570440076149e-09
involved O 0 7.256941575439768e-11
in O 0 2.3589743006202646e-11
the O 0 1.8650143929210827e-10
modulation O 0 3.620805655302206e-09
of O 0 6.861247126010994e-09
the O 0 2.4473736814911717e-08
Ca2 O 0 3.687436276322842e-07
+ O 0 4.288054640255723e-07
homeostasis O 0 5.681669676960155e-07
in O 0 2.3798977011324496e-08
skeletal O 0 0.00015347631415352225
muscle O 0 1.1742170499928761e-05
cells O 0 1.1338588024045748e-07
. O 0 2.2683326506012236e-07

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 4.6583515711517975e-08
, O 0 1.7780120709076641e-09
the O 0 9.7617491867652e-10
most O 0 1.349645617487738e-09
prevalent O 0 6.250826345421956e-07
muscular B-Disease 1 1.0
disorder I-Disease 0 0.0329301692545414
in O 0 4.0260150768745007e-10
adults O 0 6.1273236484638e-10
, O 0 8.645556492936635e-11
is O 0 1.2336519306099802e-10
caused O 0 1.0265565064671023e-09
by O 0 2.975615587264002e-10
( O 0 2.781627372883122e-09
CTG O 0 1.6468669855385087e-05
) O 0 5.733209462732702e-10
n O 0 6.506671867967384e-10
- O 0 8.118627548014956e-09
repeat O 0 4.160032762712262e-09
expansion O 0 6.334575530786424e-09
in O 0 2.7785929113122165e-10
a O 0 5.277692172178661e-10
gene O 0 3.1291966240409863e-10
encoding O 0 1.805908311780513e-09
a O 0 4.745717152587758e-09
protein O 0 4.5424286554407445e-08
kinase O 0 2.871833544304536e-07
( O 0 1.713685726656422e-08
DM B-Disease 1 1.0
protein O 0 2.122279418870221e-08
kinase O 0 8.286400010604211e-09
; O 0 2.1101842495596657e-10
DMPK O 0 5.715613951906562e-05
) O 0 1.563663781789515e-10
and O 0 1.957245199246671e-10
involves O 0 3.017653071868409e-10
changes O 0 1.5134692110674308e-10
in O 0 3.50243584135157e-10
cytoarchitecture O 0 1.8242056967210374e-06
and O 0 6.371681848804656e-08
ion O 0 2.152859087800607e-05
homeostasis O 0 0.0001997763611143455
. O 0 3.0790113214607118e-06

To O 0 2.0786917076520695e-08
obtain O 0 6.755478842990215e-09
clues O 0 1.190990595034691e-08
to O 0 3.460258191090304e-10
the O 0 1.4198981990176662e-09
normal O 0 2.019838296618559e-09
biological O 0 3.5724434521711146e-09
role O 0 4.0381147314860755e-09
of O 0 3.3723512871119965e-08
DMPK O 1 1.0
in O 0 1.8552027469809218e-08
cellular O 0 2.45346818417147e-08
ion O 0 5.089583510198281e-07
homeostasis O 0 7.747124755042023e-07
, O 0 4.05631706001941e-09
we O 0 4.2344247552783543e-10
have O 0 3.0852095184163986e-11
compared O 0 2.052052000545146e-10
the O 0 1.6475129038795444e-09
resting O 0 9.720028515403101e-08
[ O 0 3.6683811543980482e-09
Ca2 O 0 1.5417611631818318e-09
+ O 0 1.0438745423613227e-09
] O 0 8.527448192019449e-10
i O 0 4.1498632308289984e-10
, O 0 5.4027230605990795e-11
the O 0 1.3268668108690207e-10
amplitude O 0 5.528991708914077e-10
and O 0 3.372682411129091e-10
shape O 0 4.894718852455071e-09
of O 0 9.226321040500807e-09
depolarization O 0 2.2076255490333097e-08
- O 0 1.725961311649371e-07
induced O 0 6.868398827464262e-08
Ca2 O 0 4.082255866677542e-09
+ O 0 9.087192109902276e-10
transients O 0 1.4715180185476129e-09
, O 0 4.60054459805459e-11
and O 0 7.310218402833968e-11
the O 0 2.4435278800361004e-10
content O 0 2.1699066987679316e-09
of O 0 4.288756016990192e-09
ATP O 0 6.594930164283141e-05
- O 0 1.0075738146042568e-06
driven O 0 4.380308737950145e-08
ion O 0 2.987430036682781e-08
pumps O 0 2.157765521815236e-08
in O 0 1.2034188090481734e-09
cultured O 0 8.028850473351667e-09
skeletal O 0 5.097808042364704e-08
muscle O 0 8.435727671951554e-09
cells O 0 1.3753510830216698e-10
of O 0 2.188410785919359e-09
wild O 0 1.3483289151849931e-08
- O 0 9.059903938180014e-09
type O 0 4.320167779070516e-09
and O 0 3.512284907358776e-09
DMPK O 1 1.0
[ O 0 4.8904382765613263e-08
- O 0 6.498293600998295e-07
/ O 0 6.581354909940274e-07
- O 0 3.4974170830537332e-06
] O 0 3.255188119055674e-07
knockout O 0 3.085838397964835e-05
mice O 0 1.4614695373893483e-06
. O 0 3.943099784464721e-07

In O 0 1.1830295676418245e-07
vitro O 0 1.9683893981436995e-07
- O 0 6.054974051039608e-07
differentiated O 0 9.426373139831412e-07
DMPK O 1 0.9999946355819702
[ O 0 1.275167278436129e-07
- O 0 9.680006769485772e-07
/ O 0 7.248423230521439e-07
- O 0 1.7960799141292227e-06
] O 0 9.542304724163841e-08
myotubes O 0 2.1099385776324198e-06
exhibit O 0 3.1972657410506145e-08
a O 0 1.1462117921468007e-09
higher O 0 4.681793619454311e-09
resting O 0 1.0570147424004972e-07
[ O 0 9.496690545063302e-09
Ca2 O 0 9.443891890725808e-09
+ O 0 6.2289013946781324e-09
] O 0 6.043779254838455e-09
i O 0 2.1408337325112825e-09
than O 0 2.901218709716602e-10
do O 0 1.3762649908599656e-09
wild O 0 3.403251014333364e-08
- O 0 1.7445410449568044e-08
type O 0 5.0519437522211774e-09
myotubes O 0 1.642444118488129e-07
because O 0 2.5124050062608205e-10
of O 0 1.1084447804066144e-09
an O 0 1.2594239540142382e-10
altered O 0 2.5450199725440825e-09
open O 0 2.9064375350884575e-09
probability O 0 3.513515589581573e-10
of O 0 1.4389445190943206e-09
voltage O 0 3.124702629975218e-08
- O 0 9.844495707511669e-08
dependent O 0 5.1192512451336825e-09
l O 0 1.02576380722752e-09
- O 0 1.0172791498064271e-08
type O 0 4.243870588283016e-09
Ca2 O 0 5.6968705308690915e-09
+ O 0 3.7008145437056328e-09
and O 0 3.0822244756478767e-09
Na O 0 8.331001481565181e-06
+ O 0 1.4121884817086539e-07
channels O 0 1.7411578312476195e-07
. O 0 2.388265443187265e-07

The O 0 3.956376986025134e-06
mutant O 0 4.262265065335669e-06
myotubes O 0 1.2220054486533627e-05
exhibit O 0 1.1688320000757813e-07
smaller O 0 1.9857198552131194e-08
and O 0 5.111397083368274e-09
slower O 0 1.7747602498729975e-08
Ca2 O 0 9.851423676821014e-09
+ O 0 2.130560172730611e-09
responses O 0 9.425113467464996e-11
upon O 0 4.745479564860489e-10
triggering O 0 4.7218264853654546e-09
by O 0 1.9814538898543788e-10
acetylcholine O 0 8.319739919215863e-08
or O 0 1.3982321078742643e-08
high O 0 3.7964093735354254e-07
external O 0 3.2210954259426217e-07
K O 0 4.01593297283398e-06
+ O 0 3.630503329077328e-07
. O 0 1.2744172295242606e-07

In O 0 1.8037059845710246e-08
addition O 0 1.558038675852913e-08
, O 0 2.0961452573686756e-09
we O 0 2.615873628819543e-10
observed O 0 1.1976318547990417e-10
that O 0 2.179602505425482e-11
these O 0 1.2228240642286892e-10
Ca2 O 0 6.4408380850977665e-09
+ O 0 9.166856607123464e-09
transients O 0 1.9259035255458912e-08
partially O 0 6.321551726529151e-09
result O 0 9.418787971782194e-11
from O 0 3.044209676006382e-11
an O 0 2.799358835015031e-11
influx O 0 6.619128578577715e-10
of O 0 1.6642710543024464e-09
extracellular O 0 2.5730413355518067e-09
Ca2 O 0 6.010556052871152e-09
+ O 0 1.4423077177028176e-09
through O 0 3.3307201441346024e-10
the O 0 1.3669358978063428e-09
l O 0 4.950706955497708e-09
- O 0 8.227973324892446e-08
type O 0 5.979126171951066e-08
Ca2 O 0 1.1041180414395058e-07
+ O 0 8.510639304404322e-08
channel O 0 2.1871939281936648e-07
. O 0 2.1763285928955156e-07

Neither O 0 8.005982863323879e-07
the O 0 3.920197499951428e-08
content O 0 5.564777794120346e-08
nor O 0 1.0274659345554937e-08
the O 0 3.012582627803795e-09
activity O 0 2.3821218331221417e-09
of O 0 2.6251376183950015e-08
Na O 0 2.9483449907274917e-05
+ O 0 1.838923679997606e-07
/ O 0 3.8322872342178016e-07
K O 0 3.527453316110041e-07
+ O 0 2.1184858312039978e-08
ATPase O 0 1.821014734559867e-07
and O 0 1.4100534961869471e-08
sarcoplasmic O 0 4.3346576603653375e-06
reticulum O 0 4.727037605789519e-07
Ca2 O 0 2.0592061389379523e-07
+ O 0 4.419996812998761e-08
- O 0 7.405631663459644e-08
ATPase O 0 7.871910412404759e-08
are O 0 1.6346192455163333e-10
affected O 0 9.880982698717844e-10
by O 0 1.4892671540422953e-09
DMPK O 1 1.0
absence O 0 7.318854841287248e-06
. O 0 7.694588362028298e-07

In O 0 8.542808416223124e-08
conclusion O 0 3.2207324807131954e-08
, O 0 2.1374961800546544e-09
our O 0 1.0969234409685669e-09
data O 0 5.249521928263334e-10
suggest O 0 3.5140118592735803e-10
that O 0 1.5159654087604224e-10
DMPK O 0 0.05691872909665108
is O 0 9.303610659650019e-10
involved O 0 8.306774018640439e-11
in O 0 7.99778507309945e-11
modulating O 0 7.0143846286896405e-09
the O 0 2.0193990923900174e-09
initial O 0 3.55844798072269e-09
events O 0 1.7105205030176762e-09
of O 0 9.34134725127933e-09
excitation O 0 2.2288313061835652e-07
- O 0 4.307968993089162e-06
contraction O 0 5.3682793321740974e-08
coupling O 0 6.325713286514656e-09
in O 0 1.9344805757270933e-09
skeletal O 0 1.945116991919349e-06
muscle O 0 2.5580547458048386e-07
. O 0 2.4257170494479396e-08
. O 0 1.7205249491780705e-07

Constitutional O 0 0.00025703880237415433
RB1 O 1 1.0
- O 0 0.00013031669368501753
gene O 0 6.052248835430873e-08
mutations O 0 6.014696296574584e-09
in O 0 4.57129722963856e-10
patients O 0 1.7200408874984419e-09
with O 0 1.5502388261978695e-09
isolated O 0 1.383945004818088e-06
unilateral B-Disease 0 0.00396313238888979
retinoblastoma I-Disease 1 1.0
. O 0 9.142594535660464e-06

In O 0 3.016482352791172e-08
most O 0 3.6528391422763207e-09
patients O 0 8.186232802742666e-10
with O 0 2.3767834922416853e-10
isolated O 0 1.6764525412327203e-07
unilateral B-Disease 0 0.035511065274477005
retinoblastoma I-Disease 1 1.0
, O 0 2.063247848127503e-07
tumor B-Disease 1 0.9999933242797852
development O 0 1.3872926807323438e-08
is O 0 1.6851989248500843e-10
initiated O 0 4.0324013572679007e-10
by O 0 1.8800030976429127e-11
somatic O 0 1.436076590977109e-09
inactivation O 0 4.59641178451875e-08
of O 0 2.3038739804803754e-09
both O 0 3.5674030396393164e-10
alleles O 0 3.8955069725510327e-10
of O 0 7.715498462346204e-09
the O 0 8.914889093603051e-08
RB1 O 0 0.04289601743221283
gene O 0 4.0924871314018674e-07
. O 0 4.1517762383591617e-07

However O 0 1.289479030219809e-07
, O 0 3.6373075662510246e-09
some O 0 4.1354980551133735e-10
of O 0 1.338350985591319e-09
these O 0 1.0292385832499917e-09
patients O 0 7.42668704312166e-10
can O 0 2.820261524316692e-10
transmit O 0 4.818265963990598e-08
retinoblastoma B-Disease 0 9.51500805967953e-06
predisposition O 0 4.364023880043533e-06
to O 0 3.88344076895919e-08
their O 0 9.644625720284239e-08
offspring O 0 4.3219586132181576e-07
. O 0 9.024603286889032e-08

To O 0 1.1025728774427535e-08
determine O 0 1.5251889751155545e-09
the O 0 4.689773014376897e-10
frequency O 0 1.2534167037614452e-09
and O 0 1.1353369355759924e-09
nature O 0 2.0716068860338055e-08
of O 0 1.900038348878752e-08
constitutional O 0 2.095676109092892e-06
RB1 O 1 1.0
- O 0 4.428657121025026e-06
gene O 0 6.005147490384388e-09
mutations O 0 5.053791829467968e-10
in O 0 5.064384328568039e-11
patients O 0 1.5642902251311597e-10
with O 0 1.3510202678812533e-10
isolated O 0 1.3367143480991217e-07
unilateral B-Disease 0 1.1122212526970543e-05
retinoblastoma I-Disease 1 0.999971866607666
, O 0 9.171018611198178e-09
we O 0 5.504789402088761e-10
analyzed O 0 9.741660811357633e-10
DNA O 0 2.0795394295447522e-09
from O 0 3.0451693944222313e-10
peripheral O 0 2.1974457922624424e-05
blood O 0 2.0607378914405672e-08
and O 0 1.0989302801078793e-08
from O 0 1.2758662570888646e-08
tumor B-Disease 1 0.9988800883293152
tissue O 0 2.712548166527995e-06
. O 0 3.0743322554371844e-07

The O 0 6.240164651671876e-08
analysis O 0 4.440299683494686e-09
of O 0 9.802020883853402e-08
tumors B-Disease 1 1.0
from O 0 1.00458787954949e-08
54 O 0 8.919668204043774e-08
( O 0 2.5951055193651484e-10
71 O 0 8.905860937602483e-09
% O 0 1.3048663538572924e-10
) O 0 6.920185952052904e-11
of O 0 1.9179917654099654e-09
76 O 0 4.4318660741282656e-08
informative O 0 1.874842148197331e-08
patients O 0 3.5154734678854993e-10
showed O 0 5.42786593449307e-10
loss O 0 1.2276065497474065e-08
of O 0 3.5538850085004015e-08
constitutional O 0 1.0946980637527304e-06
heterozygosity O 0 0.0006672689924016595
( O 0 7.271472668435308e-08
LOH O 1 1.0
) O 0 2.901359685836269e-08
at O 0 2.3072530552781245e-07
intragenic O 0 2.3490461899200454e-05
loci O 0 1.7792632434066036e-06
. O 0 4.5880733523517847e-07

Three O 0 1.5179901424744457e-07
of O 0 2.0761366670285497e-07
13 O 0 2.2313324166134407e-07
uninformative O 0 0.00010690050112316385
patients O 0 1.5145572263008944e-07
had O 0 7.017009551191222e-08
constitutional O 0 1.323581727774581e-06
deletions O 0 2.9877430733904475e-06
. O 0 1.1416193501645466e-06

For O 0 2.5011198090396647e-07
39 O 0 2.1368843761138123e-07
randomly O 0 4.804379116762902e-09
selected O 0 1.3433316325972555e-07
tumors B-Disease 1 1.0
, O 0 7.262242007755049e-08
SSCP O 1 1.0
, O 0 6.66255459691456e-08
hetero O 0 5.524042308024946e-07
- O 0 3.079240684655815e-08
duplex O 0 7.8305459894068e-09
analysis O 0 1.5684639698143599e-10
, O 0 6.387539802643616e-11
sequencing O 0 9.66620117281991e-10
, O 0 2.281196342934777e-10
and O 0 8.474137502822998e-10
Southern O 0 4.568704170537785e-08
blot O 0 1.4103071634963271e-06
analysis O 0 7.168706739335562e-10
were O 0 8.59724375024129e-11
used O 0 1.308065877836384e-10
to O 0 9.410263679399122e-10
identify O 0 1.7374480520970792e-08
mutations O 0 9.601712491758008e-08
. O 0 2.0042855908286583e-07

Mutations O 0 2.0866352201664995e-07
were O 0 6.528555029916561e-09
detected O 0 3.824026872933928e-09
in O 0 4.834666000874677e-10
21 O 0 1.694780671357421e-08
( O 0 2.583854519233597e-10
91 O 0 1.4111189550192194e-08
% O 0 1.7498047455433152e-10
) O 0 2.606515281389221e-10
of O 0 1.3861924053060193e-08
23 O 0 1.5642463040421717e-06
tumors B-Disease 1 1.0
with O 0 5.324813628249103e-06
LOH O 1 1.0
. O 0 1.9808849174296483e-05

In O 0 3.016027605440286e-08
6 O 0 9.813432200189709e-08
( O 0 6.188610734980671e-10
38 O 0 3.83977738493968e-09
% O 0 7.746161351240843e-11
) O 0 3.9906387222510276e-11
of O 0 1.199404020546524e-09
16 O 0 4.877350079368625e-08
tumors B-Disease 1 1.0
without O 0 3.801607917353067e-08
LOH O 1 1.0
, O 0 6.105127070554772e-09
one O 0 3.0523741867405363e-10
mutation O 0 1.934435250872113e-10
was O 0 3.0188793131991076e-10
detected O 0 5.516845869024678e-10
, O 0 1.0000902883611218e-10
and O 0 1.4137198356412028e-10
in O 0 1.9852633426076238e-10
9 O 0 9.81239889341623e-09
( O 0 1.1214459916253361e-10
56 O 0 1.1805275645926372e-09
% O 0 3.209113530466823e-11
) O 0 3.3835309554142157e-11
of O 0 8.119739325351816e-10
the O 0 1.0295453378716957e-08
tumors B-Disease 1 1.0
without O 0 2.5098984224314336e-07
LOH O 1 1.0
, O 0 1.7137281815848837e-08
both O 0 2.453373282307325e-09
mutations O 0 2.3575508212303475e-09
were O 0 9.248515842052996e-10
found O 0 4.121672336765414e-09
. O 0 3.481273225247605e-08

Thus O 0 1.1400924648796718e-07
, O 0 2.9127085188207502e-09
a O 0 7.284403080731749e-10
total O 0 6.010966169256449e-10
of O 0 1.91346094524647e-09
45 O 0 5.49621015366597e-09
mutations O 0 8.576725996078949e-10
were O 0 4.669271080892656e-10
identified O 0 1.6345047537669188e-09
in O 0 2.2115145270618086e-09
tumors B-Disease 1 1.0
of O 0 2.7265970857115462e-05
36 O 0 1.5443658867297927e-06
patients O 0 3.188873520798552e-08
. O 0 4.877610848552649e-08

Thirty O 0 8.320309348164301e-07
- O 0 8.657482908347447e-08
nine O 0 5.48797673971535e-09
of O 0 1.4317144136910542e-09
the O 0 7.157940906665772e-10
mutations O 0 1.3294962353249673e-10
- O 0 2.4478483684475805e-09
including O 0 5.760920629427346e-10
34 O 0 4.369341777277214e-09
small O 0 8.850853938646708e-10
mutations O 0 1.744126787439626e-10
, O 0 5.618671847229528e-11
2 O 0 8.530962047892388e-10
large O 0 1.3591469061324801e-09
structural O 0 6.846595113074727e-08
alterations O 0 8.782068761092887e-08
, O 0 9.682826762613672e-10
and O 0 1.3773573392938943e-09
hypermethylation O 0 3.222409077352495e-06
in O 0 2.969692047827266e-09
3 O 0 3.4562917790026404e-06
tumors O 1 1.0
- O 0 3.0963178687670734e-07
were O 0 6.620138881530124e-10
not O 0 3.6595022151475476e-11
detected O 0 3.732507081188885e-10
in O 0 1.1508685671124397e-10
the O 0 1.8255932321409318e-09
corresponding O 0 7.796655765446303e-09
peripheral O 0 2.455105232002097e-06
blood O 0 8.46960475087144e-08
DNA O 0 2.801548646402807e-07
. O 0 8.759200653685184e-08

In O 0 4.4183785519180674e-08
6 O 0 9.878917239802831e-08
( O 0 7.560782555593448e-10
17 O 0 2.509906060765843e-09
% O 0 5.0105593285554306e-11
) O 0 2.1054392604358263e-11
of O 0 3.084081046100806e-10
the O 0 7.77968744980484e-10
36 O 0 2.2739472527177895e-09
patients O 0 2.515109231993051e-10
, O 0 1.1197787835870443e-10
a O 0 3.288489758279667e-10
mutation O 0 9.015167501402743e-10
was O 0 2.3043178476456205e-09
detected O 0 4.696710242946267e-10
in O 0 9.492931440924224e-11
constitutional O 0 2.7593911600121146e-09
DNA O 0 6.474064617734143e-10
, O 0 4.019407029431932e-11
and O 0 5.53192110175349e-11
1 O 0 1.3107088747688067e-09
of O 0 8.804417195307224e-10
these O 0 1.6529509705431877e-10
mutations O 0 3.9886924318999206e-10
is O 0 6.542285463373432e-11
known O 0 2.238025736955862e-10
to O 0 2.0940663092439138e-10
be O 0 1.8753480712785375e-10
associated O 0 6.902472482472888e-10
with O 0 3.971136752767279e-09
reduced O 0 1.3338737971935188e-06
expressivity O 0 0.00012859089474659413
. O 0 1.5101970802788856e-06

The O 0 6.978117284006657e-08
presence O 0 3.365371537000783e-09
of O 0 1.2028479545733717e-08
a O 0 2.246537622596634e-09
constitutional O 0 2.6606759462310947e-08
mutation O 0 9.42608879839213e-10
was O 0 1.0079826973097283e-09
not O 0 2.6076973913546908e-11
associated O 0 3.348732749430816e-11
with O 0 3.013016225406062e-11
an O 0 1.8910015220363618e-10
early O 0 1.2951618666434683e-09
age O 0 5.562801330682987e-09
at O 0 1.1645778563718068e-08
treatment O 0 8.852416044646816e-08
. O 0 1.5775029282849573e-07

In O 0 5.0991108224707204e-08
1 O 0 1.688093504981225e-07
patient O 0 3.347811983189786e-08
, O 0 5.104499045671673e-09
somatic O 0 5.031310479353124e-07
mosaicism O 0 3.7573114241240546e-05
was O 0 5.2562299401870405e-08
demonstrated O 0 2.9069198159703546e-09
by O 0 5.013733525571773e-11
molecular O 0 4.520712137967564e-10
analysis O 0 5.0714696331333187e-11
of O 0 3.0239333259629575e-10
DNA O 0 8.168483667247983e-10
and O 0 5.291562188425303e-10
RNA O 0 8.555543473676153e-08
from O 0 8.3081124202522e-09
peripheral O 0 0.10433842986822128
blood O 0 7.639749242116523e-07
. O 0 2.9486756147889537e-07

In O 0 9.08210537886589e-08
2 O 0 3.9663095208197774e-07
patients O 0 9.9614663184866e-09
without O 0 1.6330151675347793e-09
a O 0 9.282518087516678e-10
detectable O 0 2.1336995814635884e-07
mutation O 0 1.2408309935096895e-09
in O 0 4.2625591945011365e-10
peripheral O 0 0.020712465047836304
blood O 0 4.259223373992427e-08
, O 0 4.325271252270113e-09
mosaicism O 0 4.098332283319905e-06
was O 0 1.1531285259991364e-08
suggested O 0 1.1391176890640509e-09
because O 0 3.042353868831782e-10
1 O 0 2.508585117411144e-09
of O 0 1.294139462260091e-09
the O 0 1.8170545068585398e-09
patients O 0 2.3841355556442068e-09
showed O 0 4.303507594727307e-08
multifocal O 1 1.0
tumors B-Disease 1 1.0
and O 0 4.7529755420328e-07
the O 0 4.318142998727126e-08
other O 0 1.6150987214302859e-09
later O 0 6.76434952495697e-09
developed O 0 3.351140520635454e-08
bilateral B-Disease 0 1.6643229173496366e-05
retinoblastoma I-Disease 1 0.9999758005142212
. O 0 4.7337957767012995e-06

In O 0 6.830551768644e-08
conclusion O 0 2.6840819344897682e-08
, O 0 1.433558827201864e-09
our O 0 5.223323995551254e-10
results O 0 1.4063293585220293e-10
emphasize O 0 3.548261240382544e-09
that O 0 4.458830527021007e-11
the O 0 1.080424083532705e-09
manifestation O 0 1.7752341818777495e-08
and O 0 1.4926454516839271e-09
transmissibility O 0 4.0070361251309805e-07
of O 0 2.1346290068890994e-08
retinoblastoma B-Disease 0 1.2228386481183406e-07
depend O 0 9.80852066234661e-10
on O 0 1.6600227858987182e-09
the O 0 1.439520946888706e-09
nature O 0 2.3533950344045707e-09
of O 0 1.4245802315571154e-09
the O 0 4.671301678804696e-10
first O 0 2.640027918499044e-10
mutation O 0 5.843910078073833e-11
, O 0 2.6585768309050906e-11
its O 0 5.206799921775307e-11
time O 0 3.5270501796969e-11
in O 0 1.4240300778844972e-11
development O 0 2.0392543209624137e-10
, O 0 1.0370315717267431e-10
and O 0 1.4843858087143502e-10
the O 0 2.288644412873353e-10
number O 0 4.92032387056085e-11
and O 0 1.4701455330889956e-10
types O 0 3.7354008775025704e-09
of O 0 2.9748168373089356e-09
cells O 0 1.079616049337595e-10
that O 0 6.293310317317946e-11
are O 0 1.0502267805412302e-10
affected O 0 2.0569199676856442e-09
. O 0 4.9600732410226556e-09
. O 0 1.2431182483396697e-07

Hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 0.9404631853103638
the I-Disease 0 3.5395848954067333e-06
fifth I-Disease 0 2.7430107252257585e-07
component I-Disease 0 1.3304152446380613e-07
of I-Disease 0 6.261517881966938e-08
complement I-Disease 0 4.469003300755503e-08
in O 0 1.9562021336128055e-08
man O 0 4.6833773126309097e-07
. O 0 3.2219833201452275e-07

I O 0 0.011951235122978687
. O 0 2.8044141799909994e-05

Clinical O 0 0.0009684759424999356
, O 0 4.801816189115016e-08
immunochemical O 0 2.3848428099881858e-05
, O 0 2.1967677454881596e-08
and O 0 1.736977672806006e-08
family O 0 1.560328577454584e-08
studies O 0 8.074988500084146e-08
. O 0 1.712619734917098e-07

The O 0 2.4679528110027604e-07
first O 0 7.269319812763797e-09
recognized O 0 5.417239279381647e-08
human O 0 1.0374696657322602e-08
kindred O 0 5.197686732572038e-06
with O 0 1.0872714284460017e-08
hereditary B-Disease 1 1.0
deficiency I-Disease 1 1.0
of I-Disease 1 1.0
the I-Disease 0 0.013981428928673267
fifth I-Disease 0 5.383628263189166e-07
component I-Disease 0 2.2506053198867448e-07
of I-Disease 0 5.597511787414078e-08
complement I-Disease 0 3.3593775583540264e-07
( O 0 7.536769430771528e-09
C5 O 1 1.0
) O 0 8.438012955025442e-09
is O 0 5.9069740210304644e-09
described O 0 6.594712687046922e-08
. O 0 3.133862094273354e-07

The O 0 1.2598908369909623e-06
proband O 0 3.6465455195866525e-05
, O 0 3.329414965946853e-08
a O 0 4.923248031474259e-09
20 O 0 1.2075627608965078e-08
- O 0 1.8174851845742523e-08
year O 0 4.073434090035022e-10
- O 0 2.3030226614650928e-08
old O 0 1.9098884251889103e-08
black O 0 7.192674789102682e-10
female O 0 2.1286744589232853e-10
with O 0 2.0812296330774416e-09
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 1.0
since O 0 3.911253315891372e-06
age O 0 9.811186174601971e-08
11 O 0 3.4603324650106515e-09
, O 0 7.386791733843268e-10
lacked O 0 6.48798987867849e-08
serum O 0 1.4742093412678514e-07
hemolytic O 0 1.0075574209622573e-05
complement O 0 2.887960270925305e-08
activity O 0 2.5992843433186863e-08
, O 0 2.5401896142085434e-09
even O 0 4.441138123922883e-09
during O 0 6.16306650158549e-08
remission O 0 1.600945779500762e-06
. O 0 2.287765710207168e-07

C5 O 1 1.0
was O 0 2.9672758046217496e-06
undetectable O 0 3.418844244151842e-06
in O 0 2.243279118019359e-09
her O 0 2.4234036999359887e-09
serum O 0 1.1971893476570017e-09
by O 0 1.7454779288605948e-10
both O 0 8.10655897964807e-09
immunodiffusion O 0 4.479972631088458e-05
and O 0 4.777771209774073e-07
hemolytic O 0 0.0012330038007348776
assays O 0 9.833095646172296e-06
. O 0 2.516653239581501e-06

Other O 0 2.0434377745459642e-08
complement O 0 8.29898993970346e-09
components O 0 9.503739129002042e-09
were O 0 4.227694028191564e-10
normal O 0 1.0640307523956949e-09
during O 0 3.9286965347606895e-10
remission O 0 5.216768172999764e-08
of O 0 2.1815521833445928e-08
lupus O 1 1.0
, O 0 5.486291865253179e-09
but O 0 4.48616699344484e-09
C1 O 1 0.9985452890396118
, O 0 2.3877911203840085e-08
C4 O 1 1.0
, O 0 1.0038259290467977e-07
C2 O 0 0.001633446547202766
, O 0 1.160374107911366e-08
and O 0 3.118046620897985e-08
C3 O 1 1.0
levels O 0 2.29733404921717e-06
fell O 0 4.59331886304426e-06
during O 0 1.5231977101848315e-07
exacerbations O 0 0.00014623146853409708
. O 0 1.5201819678622996e-06

A O 0 2.3604150101164123e-06
younger O 0 2.049491953926008e-08
half O 0 7.594636031171831e-09
- O 0 1.3178329538732214e-07
sister O 0 1.2496457202360034e-08
, O 0 1.1166610969226554e-09
who O 0 1.0556899798785935e-09
had O 0 1.962663143117993e-09
no O 0 6.71316868761096e-09
underlying O 1 0.9923257827758789
disease O 1 0.9921100735664368
, O 0 3.0626570168834633e-09
was O 0 4.4013628297534524e-08
also O 0 2.0138832823590747e-09
found O 0 7.652971034666223e-10
to O 0 1.6543144631953055e-09
lack O 0 3.5586370472628914e-07
immunochemically O 0 0.20193687081336975
detectable O 1 0.9867740869522095
C5 O 1 1.0
. O 0 3.7202335079200566e-06

By O 0 2.696551746339537e-07
hemolytic O 0 1.1081937373091932e-05
assay O 0 1.445481672135429e-07
, O 0 1.729549303775002e-08
she O 0 3.497724332390817e-09
exhibited O 0 7.035299898205949e-09
1 O 0 2.2823596346199793e-09
- O 0 3.1966667091154477e-09
2 O 0 2.3303556861975494e-09
% O 0 6.272302816023867e-11
of O 0 1.5963909361094153e-10
the O 0 3.3000382981818177e-10
normal O 0 1.4644928603146923e-09
serum O 0 2.625997863603402e-09
C5 O 0 3.490977906039916e-05
level O 0 1.1780314501663725e-08
and O 0 7.670419299721232e-10
normal O 0 9.972526138213311e-10
concentrations O 0 1.719460240856563e-09
of O 0 9.779098641971018e-10
other O 0 1.0005029027482237e-09
complement O 0 3.211647481293767e-08
components O 0 3.5258321418041305e-07
. O 0 1.94681547327491e-07

C5 O 0 0.0003601623175200075
levels O 0 6.867141166821966e-08
of O 0 7.445739136358043e-09
other O 0 3.1403957212461364e-10
family O 0 5.37771945030574e-11
members O 0 4.381118298008024e-12
were O 0 4.4763415196769074e-11
either O 0 1.7619886105713078e-10
normal O 0 4.856125501717656e-10
or O 0 6.24479981614634e-11
approximately O 0 2.0148811785691834e-10
half O 0 5.499017907695247e-10
- O 0 1.2960522433047572e-08
normal O 0 1.76545122965166e-09
, O 0 1.634622298629651e-10
consistent O 0 1.484318667976936e-09
with O 0 5.788058921041284e-10
autosomal O 0 9.635635223048666e-08
codominant O 0 1.5543646441074088e-06
inheritance O 0 6.357357307251732e-08
of O 0 1.3025203138283814e-08
the O 0 8.144125374087707e-09
gene O 0 3.739793896784249e-08
determining O 0 3.0660299671581015e-05
C5 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.9186355732235825e-06

Normal O 0 1.0640419532137457e-05
hemolytic O 0 5.480500840349123e-05
titers O 0 6.767423656128813e-06
were O 0 6.431606802692613e-09
restored O 0 2.0075219708814984e-08
to O 0 1.041295383252816e-09
both O 0 7.060626305843698e-09
homozygous O 0 1.5083292964845896e-05
C5 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
( O 0 1.3191922221267305e-07
C5D B-Disease 1 1.0
) O 0 1.3269314536046295e-08
sera O 0 9.935472462530015e-07
by O 0 9.474770967798918e-11
addition O 0 1.983591291221387e-09
of O 0 9.475394691094152e-09
highly O 0 1.8086278430473612e-07
purified O 0 5.869130177416082e-07
human O 0 1.201987345211819e-07
C5 O 1 0.9999949932098389
. O 0 1.015563270811981e-06

In O 0 7.66134675700414e-08
specific O 0 1.5379254136860254e-07
C5 O 0 0.03508017957210541
titrations O 0 9.601343435861054e-07
, O 0 3.6842704442818786e-09
however O 0 9.664118394425714e-10
, O 0 5.521772483696452e-10
it O 0 3.518062507978925e-10
was O 0 5.352796872415411e-09
noted O 0 1.3743762794504732e-09
that O 0 4.2906005137677283e-11
when O 0 1.1002043026620001e-10
limited O 0 5.21620580062887e-10
amounts O 0 2.1383483872483566e-09
of O 0 6.956360820709051e-09
C5 O 0 9.36141368583776e-05
were O 0 2.2523640730298666e-09
assayed O 0 1.693216589160329e-08
in O 0 2.0396043187709267e-10
the O 0 8.019632735667415e-10
presence O 0 3.6674210890375036e-10
of O 0 2.0868862193879067e-09
low O 0 2.3583794472870068e-08
dilutions O 0 3.5758955618803157e-07
of O 0 2.254910036469937e-08
either O 0 3.2578707731545364e-08
C5D B-Disease 1 1.0
serum O 0 1.4242554868815205e-07
, O 0 2.669163112756223e-09
curving O 0 3.034831763670809e-07
rather O 0 8.685824282039789e-10
than O 0 7.519560668578507e-11
linear O 0 8.819207031329768e-10
dose O 0 1.023682738576781e-08
- O 0 3.9506784510479065e-09
response O 0 2.087868627986822e-10
plots O 0 6.134144303615585e-09
were O 0 1.5176325751653508e-09
consistently O 0 5.595000907021586e-09
obtained O 0 6.664773732900642e-10
, O 0 4.5187292796455836e-10
suggesting O 0 1.3880833149571004e-09
some O 0 4.972489642263156e-10
inhibitory O 0 1.6354418619357602e-07
effect O 0 2.55734761367421e-07
. O 0 2.5783097612475103e-07

Further O 0 4.2710195202744217e-07
studies O 0 3.0044414955909815e-08
suggested O 0 3.731676301299558e-09
that O 0 1.9939573603355853e-10
low O 0 3.094838163519853e-08
dilutions O 0 1.3954353335066116e-06
of O 0 1.1746999462047825e-07
C5D B-Disease 1 1.0
serum O 0 3.231007639215022e-08
contain O 0 7.855378569843197e-09
a O 0 2.2231858021193318e-10
factor O 0 1.3478500537900118e-09
( O 0 2.571586346644672e-11
or O 0 7.044140964973522e-11
factors O 0 3.8924022338626685e-10
) O 0 4.285219401545248e-11
interfering O 0 9.24488263720491e-10
at O 0 1.6053505191848672e-09
some O 0 2.2772966845607812e-10
step O 0 3.621137167897359e-09
in O 0 4.3063280719124464e-10
the O 0 9.219565555440568e-09
hemolytic O 0 4.0051983773992106e-07
assay O 0 1.887202039085878e-08
of O 0 3.2606251920697105e-07
C5 O 1 1.0
, O 0 4.425402266861056e-09
rather O 0 1.0342409151320453e-09
than O 0 1.9020632291422146e-10
a O 0 1.8897763354175368e-09
true O 0 3.8711053917950267e-08
C5 O 0 0.00015179211914073676
inhibitor O 0 4.670905582315754e-07
or O 0 4.039410583800418e-08
inactivator O 0 2.409571607131511e-05
. O 0 7.367232797150791e-07

Of O 0 2.0973316168237943e-06
clinical O 0 6.322679382719798e-06
interest O 0 3.786822944107371e-08
are O 0 3.032452899898175e-10
( O 0 5.5656187991637296e-11
a O 0 5.818362458498427e-11
) O 0 2.9759375519411435e-11
the O 0 1.2080844657980094e-10
documentation O 0 1.1373574970718892e-08
of O 0 2.9307656745913846e-08
membranous O 1 1.0
glomerulonephritis B-Disease 1 1.0
, O 0 0.00011527901369845495
vasculitis B-Disease 1 1.0
, O 0 8.74381029802862e-08
and O 0 8.732790774956811e-07
arthritis B-Disease 1 1.0
in O 0 1.7306570621045125e-09
an O 0 3.4451902442000915e-10
individual O 0 2.1935039895559783e-10
lacking O 0 1.9454116539918687e-08
C5 O 1 1.0
( O 0 1.498789842235837e-10
and O 0 1.9531803951977622e-10
its O 0 3.64540370112465e-10
biologic O 0 2.521658970522367e-08
functions O 0 1.5933490637998204e-10
) O 0 2.374081833900199e-11
, O 0 6.435943444849102e-11
and O 0 1.9547828633559305e-10
( O 0 2.1359708446411219e-10
b O 0 3.999497177886724e-09
) O 0 1.6181626871780708e-10
a O 0 5.027410154845313e-10
remarkable O 0 1.7625542136912031e-09
propensity O 0 1.8421070890894953e-08
to O 0 6.02247640646425e-10
bacterial B-Disease 1 1.0
infections I-Disease 1 1.0
in O 0 2.3404347904154577e-10
the O 0 1.9297559106234985e-09
proband O 0 1.465566128899809e-06
, O 0 7.843337090918112e-10
even O 0 4.041741663574072e-10
during O 0 6.714651057393439e-10
periods O 0 4.865083447214147e-09
of O 0 1.0845245812518556e-09
low O 0 8.580035348870751e-09
- O 0 1.5090346749957462e-08
dose O 0 1.6697725868652924e-08
or O 0 3.462211906057888e-10
alternate O 0 1.7381632799740032e-09
- O 0 5.3413767631127484e-08
day O 0 2.122068920584752e-08
corticosteroid O 0 3.2052401365945116e-05
therapy O 0 1.0546198154770536e-06
. O 0 1.2200534627027082e-07

Other O 0 9.09850683683544e-08
observations O 0 1.0717019272021844e-08
indicate O 0 4.411780663016174e-10
that O 0 4.0651346872033756e-11
the O 0 3.279052362969992e-09
C5D B-Disease 1 1.0
state O 0 7.994895412366532e-09
is O 0 8.393449268950803e-10
compatible O 0 4.398213793166406e-09
with O 0 2.576924784669643e-10
normal O 0 2.6697841715161985e-09
coagulation O 0 1.2490571243972681e-08
function O 0 8.799280193372283e-10
and O 0 3.398499259787968e-10
the O 0 1.9829331510123893e-09
capacity O 0 6.147531816935725e-09
to O 0 9.036347670132727e-09
mount O 0 2.2813634132035077e-05
a O 0 6.614754965994507e-07
neutrophilic O 1 0.9769061207771301
leukocytosis O 0 0.0003040718729607761
during O 0 1.408732941854396e-06
pyogenic B-Disease 0 0.0185376163572073
infection I-Disease 0 9.905907063512132e-06
. O 0 5.129604474518601e-08
. O 0 3.9091361259124824e-07

Susceptibility O 0 9.055957343662158e-05
to O 0 2.059060307146865e-06
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 5.5466865887865424e-05
twins O 0 2.92613037800038e-07
: O 0 1.1066865479580912e-10
the O 0 1.4940916559513795e-10
role O 0 6.584174316870417e-10
of O 0 1.7556426312737017e-09
genes O 0 5.175751494057579e-10
, O 0 6.451088552239526e-10
HLA O 0 5.809671165479813e-06
, O 0 5.985285156384634e-09
and O 0 7.15199366396746e-09
the O 0 3.849143226375418e-08
environment O 0 3.712106888542621e-07
. O 0 2.7671040925270063e-07

OBJECTIVE O 0 1.7900209059007466e-05
To O 0 5.964555072068833e-09
determine O 0 2.044934221956396e-09
the O 0 5.437627015325575e-10
relative O 0 9.22117882051765e-10
effects O 0 6.108192707188209e-08
of O 0 1.781064362660345e-08
genetic O 0 6.967926680090386e-09
and O 0 4.80323114615544e-10
environmental O 0 1.2724630948923732e-07
factors O 0 1.994920895143082e-09
in O 0 1.0626754337605959e-10
susceptibility O 0 6.997416335252638e-08
to O 0 2.021144354102944e-07
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 1 0.9976704716682434
AS B-Disease 1 1.0
) O 0 9.592432093086245e-08
. O 0 2.6055940338665096e-07

METHODS O 0 3.0234866699174745e-06
Twins O 0 9.547419921318578e-08
with O 0 4.0903130882341543e-10
AS B-Disease 1 0.9999978542327881
were O 0 4.949259890807411e-10
identified O 0 1.2253642545090315e-10
from O 0 4.721569663024283e-11
the O 0 9.914188359161358e-10
Royal O 0 1.4254921154588374e-07
National O 0 7.2621205617906526e-06
Hospital O 0 0.004613582510501146
for O 0 2.5399157266292605e-07
Rheumatic B-Disease 1 1.0
Diseases I-Disease 1 1.0
database O 0 7.530248353759816e-07
. O 0 3.774593437810836e-07

Clinical O 0 1.2035078725602943e-05
and O 0 1.975369201545618e-08
radiographic O 0 1.4781244317418896e-06
examinations O 0 9.558826263855735e-08
were O 0 3.939697457155944e-10
performed O 0 9.26949628166085e-10
to O 0 1.6355891641062215e-10
establish O 0 1.7872160418264116e-09
diagnoses O 0 3.4380391866761784e-07
, O 0 2.7053590478942624e-09
and O 0 5.246724299468042e-08
disease O 1 0.9953972697257996
severity O 0 0.016495700925588608
was O 0 2.1017992679617237e-08
assessed O 0 3.4377041657762675e-08
using O 0 6.266960839163005e-10
a O 0 4.43798608973367e-10
combination O 0 1.8018208036707506e-09
of O 0 1.4606188258881048e-08
validated O 0 2.2498456075936701e-07
scoring O 0 4.680322831518424e-07
systems O 0 2.8161041427665623e-06
. O 0 4.468330132567644e-07

HLA O 0 9.80432887445204e-05
typing O 0 6.692829970234015e-07
for O 0 2.3666707704705914e-08
HLA O 0 1.3234504876891151e-05
- O 0 2.3442380552296527e-06
B27 O 0 5.3490048230742104e-06
, O 0 4.304441247882096e-09
HLA O 0 4.968778171132726e-07
- O 0 6.770173399672785e-08
B60 O 0 4.5942380211272393e-07
, O 0 6.163072829856731e-10
and O 0 9.866217842713354e-10
HLA O 0 1.9490646536723943e-06
- O 0 1.7775673768483102e-06
DR1 O 1 0.9999973773956299
was O 0 5.564958627246597e-08
performed O 0 5.368921307535857e-09
by O 0 2.606569682317428e-10
polymerase O 0 6.826354592703865e-09
chain O 0 7.561246739840044e-09
reaction O 0 5.1211111740112614e-11
with O 0 3.207399970617253e-11
sequence O 0 1.184252557129284e-10
- O 0 1.312920661078465e-09
specific O 0 3.730521447309343e-10
primers O 0 6.649603090380651e-09
, O 0 4.5338544030215644e-10
and O 0 2.1088011337155876e-09
zygosity O 0 3.5012019452551613e-06
was O 0 8.008390750546823e-08
assessed O 0 7.079669330778415e-07
using O 0 5.902899857801458e-08
microsatellite O 0 5.391918875830015e-06
markers O 0 7.193955752882175e-06
. O 0 6.345279643937829e-07

Genetic O 0 3.6731586305904784e-07
and O 0 9.218686258805064e-09
environmental O 0 4.3385512071836274e-08
variance O 0 4.634757022614622e-09
components O 0 2.0502377573450303e-09
were O 0 1.0162522212642244e-10
assessed O 0 5.65206237368443e-09
with O 0 1.1957192180833687e-10
the O 0 1.6502111899185934e-09
program O 0 2.2067192517738476e-09
Mx O 0 6.819948339398252e-06
, O 0 3.5748409787927926e-10
using O 0 5.544279618741044e-11
data O 0 5.3200169963796284e-11
from O 0 1.2092411273700865e-11
this O 0 1.0187765561719964e-11
and O 0 1.1572520025593391e-10
previous O 0 3.06102615477144e-10
studies O 0 3.841723605901848e-10
of O 0 1.0382096293781728e-09
twins O 0 4.445248613649255e-09
with O 0 1.0911225256649004e-09
AS B-Disease 1 1.0
. O 0 6.402808594430098e-07

RESULTS O 0 7.062042186589679e-07
Six O 0 1.6292048599098052e-08
of O 0 1.8678392166293634e-08
8 O 0 1.1749106221259353e-07
monozygotic O 0 1.2408634120220086e-06
( O 0 1.769291735342904e-08
MZ O 1 0.9999998807907104
) O 0 1.1120388165863915e-08
twin O 0 2.3569275242607546e-07
pairs O 0 1.0017899843006717e-09
were O 0 8.12829303864504e-10
disease O 0 4.674051368169785e-08
concordant O 0 4.6229644112827373e-07
, O 0 4.1016562368767495e-10
compared O 0 1.3238081464361784e-10
with O 0 5.762368707196153e-11
4 O 0 6.828282383963824e-09
of O 0 7.884649377842834e-09
15 O 0 7.460965179006962e-09
B27 O 0 2.958511799988628e-07
- O 0 8.016306907165927e-08
positive O 0 4.539230324951404e-09
dizygotic O 0 5.856175562257704e-07
( O 0 2.7120132806146557e-09
DZ O 0 0.0005211653769947588
) O 0 3.870475939748985e-09
twin O 0 6.029205223967438e-08
pairs O 0 1.9866308598182059e-10
( O 0 2.512614595551188e-11
27 O 0 6.76273370636693e-10
% O 0 1.5203661246632194e-11
) O 0 7.72199491849701e-12
and O 0 1.4062999376118768e-10
4 O 0 5.6417981397771655e-09
of O 0 1.305821140107355e-08
32 O 0 2.5377508450219466e-07
DZ O 1 0.9936330318450928
twin O 0 7.797876264703518e-07
pairs O 0 1.3997575321056388e-09
overall O 0 4.042330026265972e-09
( O 0 1.203278171546529e-10
12 O 0 1.3317558167358357e-09
. O 0 2.956149769417493e-10
5 O 0 1.4010565152489107e-08
% O 0 2.3491388834173677e-09
) O 0 5.9523044271259096e-09
. O 0 1.5161381838879606e-07

Nonsignificant O 0 1.704229180177208e-05
increases O 0 1.503283542092504e-08
in O 0 2.338801652346234e-10
similarity O 0 5.023748639310099e-10
with O 0 4.1601794925627544e-11
regard O 0 4.018061883215296e-09
to O 0 6.423915843711825e-10
age O 0 3.8211251940367674e-09
at O 0 6.3871814504068425e-09
disease O 0 3.46480589996645e-07
onset O 0 2.5133374492725125e-08
and O 0 8.267672657602532e-10
all O 0 7.115443234617658e-10
of O 0 3.4757512423766457e-09
the O 0 7.359513443105925e-09
disease O 0 5.6336499909548365e-08
severity O 0 7.625003206612746e-08
scores O 0 7.33980343170515e-09
assessed O 0 2.7480686171088564e-08
were O 0 5.554528503814993e-10
noted O 0 1.980612340801713e-09
in O 0 9.966250047455105e-10
disease O 0 5.933433726568182e-07
- O 0 6.29754913461511e-06
concordant O 0 0.0002784511889331043
MZ O 1 0.9999996423721313
twins O 0 1.1766070429075626e-07
compared O 0 2.0740056339008106e-09
with O 0 4.205723769246106e-09
concordant O 0 0.00021757531794719398
DZ O 1 1.0
twins O 0 9.75586681306595e-06
. O 0 4.6271807718767377e-07

HLA O 0 0.0002874530910048634
- O 0 6.82832433085423e-06
B27 O 0 3.916239620593842e-06
and O 0 8.472848200824501e-09
B60 O 0 4.195250369321002e-07
were O 0 2.288330080979506e-10
associated O 0 1.6188110574244519e-10
with O 0 8.64311608395063e-11
the O 0 5.837487826454435e-09
disease O 0 1.2844149921420467e-07
in O 0 3.8709169203343663e-10
probands O 1 0.7838876843452454
, O 0 1.6073542496997106e-09
and O 0 1.2103475999225566e-09
the O 0 2.1983257436630765e-09
rate O 0 2.624085171376578e-09
of O 0 6.3131295746643445e-09
disease O 0 1.6681846659594157e-07
concordance O 0 1.8556026049054708e-08
was O 0 5.170701644630071e-09
significantly O 0 6.240647443256364e-10
increased O 0 1.2210579214411155e-09
among O 0 1.989456599460482e-09
DZ O 0 0.0002685383951757103
twin O 0 6.644116012921586e-08
pairs O 0 1.2475701027803154e-10
in O 0 2.2611428354690766e-11
which O 0 2.5792739472008108e-11
the O 0 8.30272295360146e-10
co O 0 1.588859177559243e-08
- O 0 1.9169911524841154e-07
twin O 0 2.7579937977861846e-07
was O 0 8.343652879716501e-09
positive O 0 6.221370085768285e-10
for O 0 6.894393389522691e-10
both O 0 6.5396088544389386e-09
B27 O 0 8.00838097347878e-06
and O 0 3.674500703709782e-07
DR1 O 1 0.9999901056289673
. O 0 5.797428912046598e-06

Additive O 0 1.3630141211251612e-06
genetic O 0 4.877778181366921e-08
effects O 0 2.3054662179333718e-08
were O 0 3.188213304472498e-10
estimated O 0 2.1869160649057307e-10
to O 0 1.1208430017450866e-10
contribute O 0 5.943225356297432e-10
97 O 0 1.4185101981922799e-08
% O 0 1.2415431183132597e-10
of O 0 9.307800086233442e-10
the O 0 2.242718677436528e-09
population O 0 3.9466918622110825e-10
variance O 0 6.234608918020967e-08
. O 0 1.428536506864475e-07

CONCLUSION O 0 1.2678337952820584e-06
Susceptibility O 0 2.296071528462562e-07
to O 0 4.295468869486285e-09
AS B-Disease 1 1.0
is O 0 2.198057513780327e-09
largely O 0 2.1243844461338313e-09
genetically O 0 6.139233010848955e-10
determined O 0 2.632023765603009e-10
, O 0 1.447316988478775e-10
and O 0 4.707041423301916e-10
the O 0 3.694741845805538e-09
environmental O 0 5.671454346156679e-07
trigger O 0 3.6487048049593795e-08
for O 0 7.382651157072928e-10
the O 0 1.4401313919165659e-08
disease O 0 2.8622303034353536e-06
is O 0 1.0745633716169323e-08
probably O 0 4.8358330673181626e-08
ubiquitous O 0 2.966036618090584e-06
. O 0 8.075679716057493e-07

HLA O 0 0.0005276548909023404
- O 0 7.369555987679632e-06
B27 O 0 1.939082721946761e-06
accounts O 0 6.265730156940208e-10
for O 0 1.7581079647666087e-10
a O 0 2.086718020599676e-10
minority O 0 2.2240130570505556e-10
of O 0 1.2887352296431231e-09
the O 0 1.5570158495847863e-09
overall O 0 8.739537982194179e-09
genetic O 0 4.3629295731761886e-09
susceptibility O 0 3.611840426742674e-08
to O 0 1.6401957125822264e-08
AS B-Disease 1 1.0
. O 0 2.1842040496267145e-06

Cell O 0 4.565926701616263e-06
cycle O 0 1.688030693003384e-07
- O 0 9.857629379439459e-08
dependent O 0 1.1279469802616404e-08
colocalization O 0 5.421166520136467e-07
of O 0 5.907585531872428e-08
BARD1 O 1 0.9999921321868896
and O 0 4.0157502212423424e-08
BRCA1 O 0 1.9792160799170233e-08
proteins O 0 1.6408385761224054e-10
in O 0 2.3966861828483843e-10
discrete O 0 4.990842583652011e-08
nuclear O 0 1.334858779955539e-06
domains O 0 6.557497727044392e-07
. O 0 4.5997180109225155e-07

Germ O 0 4.2024119466077536e-05
- O 0 1.633809461054625e-06
line O 0 1.5111147888546839e-07
mutations O 0 2.636406426503868e-09
of O 0 1.0303783604115324e-08
the O 0 2.197924509061977e-08
BRCA1 O 0 1.9336188472607319e-07
gene O 0 4.85370144076569e-09
predispose O 0 2.6631790106534936e-08
women O 0 1.0544573894599729e-11
to O 0 1.0184773163723904e-11
early O 0 9.381929677587664e-10
- O 0 3.866129191010259e-05
onset O 0 0.00567985512316227
breast B-Disease 1 1.0
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
by O 0 6.684034437043351e-10
compromising O 0 1.9367971049177868e-07
the O 0 1.0363780056366068e-08
genes O 0 5.287871918113751e-09
presumptive O 0 3.186721357906208e-07
function O 0 8.186112232522191e-09
as O 0 4.136383680020117e-09
a O 0 2.7840068028694986e-08
tumor B-Disease 0 7.814179116394371e-05
suppressor O 0 0.00014449996524490416
. O 0 2.0557774860208156e-06

Although O 0 1.4854953178655705e-07
the O 0 2.69713229528179e-08
biochemical O 0 5.427085270071075e-08
properties O 0 4.2759019436289236e-08
of O 0 4.798080865953125e-08
BRCA1 O 0 2.2486480233396833e-08
polypeptides O 0 2.063214710190664e-09
are O 0 1.296035414405372e-11
not O 0 1.4886862576002358e-11
understood O 0 9.008463974780057e-10
, O 0 8.650158367373706e-11
their O 0 1.8842112592398763e-10
expression O 0 6.993887136097499e-10
pattern O 0 1.6463317376036457e-09
and O 0 6.351679737726101e-10
subcellular O 0 6.844440747499902e-08
localization O 0 2.8171138310995048e-08
suggest O 0 1.6681928061146323e-09
a O 0 5.973683214754999e-10
role O 0 2.5799162806094955e-09
in O 0 9.51008161109712e-10
cell O 0 5.567856931065762e-08
- O 0 4.019715106551303e-06
cycle O 0 4.931587227474665e-07
regulation O 0 8.913764872886532e-07
. O 0 3.2800932103782543e-07

When O 0 2.7820328796224203e-07
resting O 0 1.7613674572203308e-06
cells O 0 1.4685795912683375e-09
are O 0 2.1944705774767925e-10
induced O 0 4.997851021926181e-09
to O 0 2.868271731237826e-10
proliferate O 0 8.687551122932291e-09
, O 0 6.329306523333855e-10
the O 0 1.7975370081302344e-09
steady O 0 1.4380947988001935e-08
- O 0 5.028640615023505e-09
state O 0 5.064522135000971e-10
levels O 0 2.1644255276953572e-09
of O 0 1.3067049664527985e-09
BRCA1 O 0 8.802603645996498e-10
increase O 0 5.280700876575395e-11
in O 0 1.139054059406952e-10
late O 0 7.597852125229565e-09
G1 O 0 6.348632837216428e-07
and O 0 2.310320601495164e-09
reach O 0 1.6472363473241103e-09
a O 0 9.171748915903777e-10
maximum O 0 1.1638895180965392e-08
during O 0 1.7411636576980527e-08
S O 0 5.890544343856163e-06
phase O 0 1.153407538367901e-06
. O 0 3.246467201734049e-07

Moreover O 0 1.1012277809641091e-06
, O 0 1.7619836256699273e-08
in O 0 6.090112414369742e-09
S O 0 6.875187636978808e-07
phase O 0 4.254392749203362e-08
cells O 0 7.685004854707245e-10
, O 0 1.6615464559777138e-09
BRCA1 O 0 9.297938419194907e-09
polypeptides O 0 1.7896959469965168e-09
are O 0 1.5031671740661778e-10
hyperphosphorylated O 0 8.620441604989537e-08
and O 0 2.7849400563439985e-09
accumulate O 0 1.8145755120713147e-08
into O 0 3.1158156055255404e-09
discrete O 0 2.9189164862941652e-08
subnuclear O 0 4.029141109640477e-06
foci O 0 3.775324330490548e-06
termed O 0 5.516997703125526e-07
" O 0 4.1006171613844344e-07
BRCA1 O 0 2.1187865968386177e-06
nuclear O 0 4.4374501158017665e-06
dots O 0 9.191068784275558e-06
. O 0 1.1881927548529347e-06

" O 0 1.6340231013600715e-05
BRCA1 O 0 7.523862677771831e-06
associates O 0 2.6306972245038196e-07
in O 0 5.7495075367342e-09
vivo O 0 1.560561315727682e-07
with O 0 1.2401307758480584e-09
a O 0 6.6013927657593285e-09
structurally O 0 1.457389942061127e-07
related O 0 1.516596626061073e-07
protein O 0 2.423802811790665e-07
termed O 0 2.520558609830914e-06
BARD1 O 1 1.0
. O 0 2.484313199602184e-06

Here O 0 2.2120806519865255e-08
we O 0 1.403387961396163e-09
show O 0 1.2199871113338645e-09
that O 0 5.247136752872805e-11
the O 0 1.115667003226406e-09
steady O 0 6.038364031013543e-09
- O 0 2.796096021384642e-09
state O 0 3.155953554045965e-10
levels O 0 6.770128346822446e-10
of O 0 1.1738298111296785e-09
BARD1 O 0 0.3696487545967102
, O 0 3.7299166533166783e-10
unlike O 0 1.696091739278316e-10
those O 0 1.128514018344795e-10
of O 0 3.582610652586027e-09
BRCA1 O 0 5.741663855474144e-08
, O 0 1.427011508958742e-09
remain O 0 1.1473409777806864e-08
relatively O 0 1.9822601338148615e-09
constant O 0 9.304574000168486e-09
during O 0 8.23729706667109e-09
cell O 0 1.713817283643948e-07
cycle O 0 5.786387191619724e-07
progression O 0 1.3973156001156894e-06
. O 0 2.4371632889597095e-07

However O 0 5.389175612435793e-07
, O 0 5.76556544729101e-08
immunostaining O 0 6.596035746042617e-06
revealed O 0 2.745742300191978e-08
that O 0 2.401968623999551e-09
BARD1 O 1 0.9999760389328003
resides O 0 4.015708725546574e-07
within O 0 9.640851672543249e-09
BRCA1 O 0 6.953245446084111e-08
nuclear O 0 7.309434835178763e-08
dots O 0 2.956621081295907e-08
during O 0 6.0044831329264525e-09
S O 0 1.7449279710035626e-07
phase O 0 1.260487358933915e-08
of O 0 3.033721274192658e-09
the O 0 4.650803298034134e-09
cell O 0 3.6126794888957647e-09
cycle O 0 5.6026574490886105e-09
, O 0 1.3217088534744903e-10
but O 0 1.4347945054282718e-10
not O 0 1.2558065698442533e-10
during O 0 2.238842444768352e-09
the O 0 4.2682994916276584e-08
G1 O 0 2.9891118174418807e-05
phase O 0 2.5626507067499915e-06
. O 0 5.777277465313091e-07

Nevertheless O 0 6.21281833446119e-06
, O 0 1.1163469793018521e-07
BARD1 O 0 0.00017048495647031814
polypeptides O 0 3.960465377872424e-08
are O 0 1.2828732520731023e-10
found O 0 2.618667782616768e-11
exclusively O 0 2.5909019374381614e-10
in O 0 2.7581990511005294e-11
the O 0 5.159074834004684e-10
nuclear O 0 3.828084071955118e-09
fractions O 0 5.999878371909517e-10
of O 0 9.244001120123357e-10
both O 0 7.169609350654582e-10
G1 O 0 1.2345814184300252e-06
- O 0 1.1823550494227675e-07
and O 0 1.292107931760711e-08
S O 0 9.586302667230484e-07
- O 0 1.0638693481723749e-07
phase O 0 1.4457754105023923e-07
cells O 0 6.081128489654475e-09
. O 0 5.2045638909703484e-08

Therefore O 0 4.554869690309715e-07
, O 0 1.2953305095209089e-08
progression O 0 4.654461704944879e-08
to O 0 2.5759827604332486e-09
S O 0 4.23837633434232e-07
phase O 0 4.1814818274588106e-08
is O 0 5.144080161834097e-10
accompanied O 0 5.838642902489255e-10
by O 0 7.423199555045557e-11
the O 0 8.611033552874403e-10
aggregation O 0 1.8671340029641215e-08
of O 0 3.8747547392858905e-08
nuclear O 0 3.1316772037826013e-06
BARD1 O 1 0.9878337383270264
polypeptides O 0 2.9496712272703007e-07
into O 0 1.567503176147511e-07
BRCA1 O 0 1.378038177790586e-06
nuclear O 0 1.9478252397675533e-06
dots O 0 1.038549544318812e-05
. O 0 1.219312935063499e-06

This O 0 5.643716605163718e-08
cell O 0 4.8960473009174166e-08
cycle O 0 2.5902078704120868e-08
- O 0 2.4707780710286897e-08
dependent O 0 2.3166040197253324e-09
colocalization O 0 1.541636152069259e-07
of O 0 1.87654496386358e-08
BARD1 O 1 1.0
and O 0 4.507181827761997e-08
BRCA1 O 0 3.822059824187818e-08
indicates O 0 9.442734372200334e-10
a O 0 1.813968142361233e-10
role O 0 1.6210489617307644e-09
for O 0 2.4603086234975535e-09
BARD1 O 1 0.9999998807907104
in O 0 1.1909546770993984e-07
BRCA1 O 0 2.303509427292738e-05
- O 0 1.499664631410269e-05
mediated O 0 3.906161509803496e-06
tumor B-Disease 1 0.9240133166313171
suppression O 0 0.022684985771775246
. O 0 2.346172777833999e-06

Ethnic O 0 1.3379735719354358e-06
differences O 0 3.86179948463905e-07
in O 0 1.7372361327261387e-08
the O 0 2.0286002211378218e-07
HFE O 0 0.002142839366570115
codon O 0 5.671092822012724e-06
282 O 0 3.36372249876149e-06
( O 0 5.554925905926211e-07
Cys O 1 1.0
/ O 0 0.0008427041466347873
Tyr O 0 0.0025316504761576653
) O 0 1.0678846251721552e-07
polymorphism O 0 3.770966543470422e-07
. O 0 4.990290563000599e-07

Recent O 0 5.370900879597684e-08
studies O 0 1.99118010968391e-09
have O 0 3.282847604868522e-11
shown O 0 3.752608501716992e-10
that O 0 3.995974218184983e-09
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.18813489377498627
HH B-Disease 1 1.0
) O 0 7.415112968089943e-09
is O 0 5.697791127801111e-10
likely O 0 1.7741356994616098e-10
to O 0 1.113187944601357e-10
be O 0 1.680567074391348e-10
caused O 0 1.2592660247889853e-09
by O 0 2.467389625948613e-10
homozygosity O 0 1.302162104366289e-06
for O 0 3.846132301532634e-09
a O 0 1.1127708532399083e-08
Cys282Tyr O 0 4.724703103420325e-06
mutation O 0 3.0264393213741414e-09
in O 0 1.4387194768872291e-09
the O 0 5.0777590132611294e-08
HFE O 0 0.0001686278119450435
gene O 0 7.34658556211798e-08
located O 0 4.4115665787103353e-07
4 O 0 1.6031748373279697e-06
. O 0 5.137775929142663e-07

5 O 0 1.6902093193493783e-05
Mb O 0 0.0001545451086713001
telomeric O 0 6.0174555983394384e-05
to O 0 4.6663376451760996e-07
HLA O 1 0.9798177480697632
- O 0 0.00037937494926154613
A O 0 1.1372161679901183e-05
. O 0 6.357018378366774e-07

Population O 0 3.827113292942386e-09
studies O 0 2.9317368532844057e-09
of O 0 1.7420465070472346e-09
this O 0 3.6119593427308416e-11
polymorphism O 0 2.487657024818901e-10
are O 0 5.44912830136024e-11
facilitated O 0 2.0698355529535917e-10
by O 0 3.3226345286241354e-11
the O 0 4.5581327601240673e-10
fact O 0 3.052956498716952e-10
that O 0 7.115792677314658e-11
the O 0 4.9920583222728965e-09
Cys282Tyr O 0 4.216751767671667e-05
mutation O 0 1.185106199841357e-07
creates O 0 2.0773725850631308e-07
a O 0 5.483103748815665e-08
Rsal O 0 4.825876749237068e-05
restriction O 0 5.158106546332419e-07
site O 0 1.3754255405729054e-06
. O 0 4.377786524401017e-07

We O 0 1.6726228579955205e-07
have O 0 2.089287853834776e-09
studied O 0 6.072159663972343e-08
the O 0 2.349176142502074e-08
codon O 0 2.061699859723376e-07
282 O 0 3.523690850215644e-07
( O 0 5.967607563661659e-08
Cys O 1 1.0
/ O 0 2.7160449462826364e-05
Tyr O 0 5.4574909881921485e-05
) O 0 2.0867587657846798e-09
polymorphism O 0 9.347617124788599e-10
in O 0 2.209506189121413e-10
different O 0 1.7836632171253086e-10
ethnic O 0 3.740868947943454e-09
groups O 0 1.5066956571274659e-09
. O 0 5.0300819509629946e-08

In O 0 3.550070815094841e-08
agreement O 0 2.5337358877663974e-08
with O 0 1.265060500799109e-09
previous O 0 1.1629796681233984e-08
observations O 0 2.2362698359756905e-08
the O 0 8.29066770791087e-09
Tyr O 0 7.486636150133563e-06
allele O 0 3.7186806967071107e-09
appeared O 0 1.3880436799951212e-09
to O 0 2.4710206103506493e-10
be O 0 3.22006588060475e-10
rare O 0 3.578362717249206e-09
or O 0 1.6223419274652429e-09
absent O 0 8.905537640657712e-09
in O 0 6.631424298575439e-10
Asiatic O 0 1.0019778073910857e-06
( O 0 4.331088820919149e-10
Indian O 0 1.4820242810742457e-09
, O 0 8.749707625099745e-10
Chinese O 0 6.369686555984799e-09
) O 0 3.385399960365021e-09
populations O 0 2.6895397908788254e-08
. O 0 9.90894193364511e-08

The O 0 3.971949524839147e-07
highest O 0 1.399979083771541e-07
allele O 0 1.9702357523243563e-09
frequency O 0 3.7177303457980315e-09
( O 0 1.1700629354294279e-10
7 O 0 2.0762893626624646e-09
. O 0 1.2421257078454317e-10
5 O 0 1.5454414414861617e-09
% O 0 1.2342284139155169e-10
) O 0 9.263022987537894e-11
was O 0 2.371902674269677e-09
found O 0 6.100642213624496e-10
in O 0 2.8676825358786573e-09
Swedes O 0 2.217954488514806e-06
. O 0 3.3606144711484376e-07

Saamis O 0 0.0001338948932243511
( O 0 1.003412108957491e-08
2 O 0 2.088754769147272e-08
% O 0 4.1678696605096377e-10
) O 0 9.329764044663236e-11
and O 0 7.916229893822901e-10
Mordvinians O 0 7.341135983551794e-07
( O 0 1.5983592227541976e-10
1 O 0 2.1973280972531484e-09
. O 0 1.662008447533836e-10
8 O 0 1.798003301800577e-09
% O 0 1.211326317029915e-10
) O 0 1.346574796112776e-10
had O 0 4.702455647098702e-10
significantly O 0 3.7275268982561727e-10
lower O 0 1.215504474849638e-09
frequencies O 0 2.36491870531097e-09
of O 0 1.073903632686779e-08
the O 0 6.84859386979042e-08
Tyr O 0 0.0001354902924504131
allele O 0 5.801675797556527e-07
. O 0 6.085307973080489e-07

Comparisons O 0 8.096470196505834e-07
with O 0 6.259461837743174e-09
allele O 0 5.642906586444951e-09
frequencies O 0 4.229881778172739e-09
based O 0 7.243144972690629e-10
on O 0 2.692130296466644e-09
prevalence O 0 1.340456812215507e-08
estimates O 0 1.3988501468276127e-09
of O 0 1.2059032883371401e-08
HH B-Disease 1 1.0
showed O 0 3.04890370728117e-08
some O 0 8.47733772069148e-10
disagreements O 0 1.297182876669467e-07
with O 0 1.4011573012950862e-09
the O 0 1.2372678881433785e-08
RFLP O 0 8.810823715066363e-07
data O 0 4.784617146924575e-09
, O 0 1.1411575018271947e-09
particularly O 0 2.7822535386690106e-09
in O 0 1.0150269069697515e-08
Finns O 0 1.902797339425888e-05
. O 0 8.297282647617976e-07

The O 0 1.2928273918078048e-06
newly O 0 2.7114306249131914e-06
described O 0 5.865397270099493e-07
HFE O 1 0.5312013030052185
marker O 0 7.323428235395113e-06
provides O 0 7.292081161125452e-09
a O 0 3.9758862868666256e-10
new O 0 1.8203247242887244e-10
approach O 0 3.748602539488388e-10
to O 0 5.5860167186283505e-11
the O 0 1.7192397505638723e-10
screening O 0 3.5798508601914136e-09
of O 0 1.985371334001229e-08
HH B-Disease 1 1.0
as O 0 6.099551530525105e-09
well O 0 1.1548579870179765e-09
as O 0 8.246531929545498e-11
studies O 0 2.339497484626918e-10
of O 0 6.733400503833309e-10
the O 0 7.771323584648826e-10
relationship O 0 1.32014191245311e-10
between O 0 7.488277220524253e-10
the O 0 1.391246140514113e-08
HFE O 0 0.034573256969451904
Tyr O 0 4.6847908379277214e-05
allele O 0 1.2117550518553344e-08
and O 0 2.9789162248050616e-09
different O 0 1.1832784529985929e-08
disorders O 1 0.9975090026855469
including O 0 3.640089744294528e-06
cancer B-Disease 1 1.0

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 0.9999080896377563
associated O 0 6.834695653878953e-08
with O 0 7.399232782034915e-09
a O 0 1.274727878808335e-08
missense O 0 1.526800019746588e-07
mutation O 0 7.98130450618828e-09
encoding O 0 1.7760063641958368e-08
Gly23 O 0 0.0054435767233371735
- O 0 0.0002503752475604415
- O 0 1.911702929646708e-05
> O 0 3.218166284568724e-07
Val O 0 2.825018327712314e-06
in O 0 1.4378478851995169e-08
neurophysin O 0 8.10077108326368e-05
II O 1 1.0
. O 0 5.184657311474439e-06

Autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 6.777383532607928e-06
ADNDI B-Disease 1 1.0
) O 0 5.8535011504545764e-08
is O 0 3.8434189164604504e-09
an O 0 4.64868366023552e-09
inherited B-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 6.536992600558733e-07
by O 0 1.3321241887354063e-09
progressive O 1 0.708450436592102
degeneration O 1 1.0
of O 1 0.9999992847442627
the O 0 3.679101155285025e-06
magnocellular O 0 2.267706804559566e-05
neurons O 0 2.108826357982707e-08
of O 0 6.255764333218394e-07
the O 0 1.5961572898959275e-06
hypothalamus O 0 2.1785724584333366e-06
leading O 0 8.829179876101989e-08
to O 0 2.2315986836218826e-09
decreased O 0 1.0688765428312763e-08
ability O 0 5.402849834190704e-10
to O 0 3.768776679624608e-10
produce O 0 1.2831975482185953e-08
the O 0 4.682189214122445e-08
hormone O 0 2.9553225999734423e-07
arginine O 0 2.4867522370186634e-06
vasopressin O 0 8.763929145061411e-06
( O 0 1.4490565547475853e-07
AVP O 0 0.03526186943054199
) O 0 1.1406340405528681e-07
. O 0 2.9677124757654383e-07

Affected O 0 2.1635088387483847e-07
individuals O 0 3.816672533574206e-10
are O 0 5.915468809236657e-11
not O 0 6.769117905092159e-11
symptomatic O 0 3.4784321201186685e-08
at O 0 4.476183868007411e-09
birth O 0 2.228765838552249e-09
, O 0 3.007081250672172e-10
but O 0 3.7461581059439197e-10
usually O 0 9.809104639657562e-09
develop O 0 4.6137986942085263e-07
diabetes B-Disease 1 0.9955275654792786
insipidus I-Disease 0 2.184876757382881e-05
at O 0 4.211264226228195e-08
1 O 0 1.1262287102908886e-07
- O 0 6.893807267260854e-07
6 O 0 3.917353694760095e-07
yr O 0 7.282337719516363e-06
of O 0 9.763396491280218e-08
age O 0 1.0712813036661828e-07
. O 0 5.8329831631454e-08

The O 0 1.4405783588244958e-07
genetic O 0 5.3572932756651426e-08
locus O 0 6.614364167489839e-08
of O 0 2.9791564770675905e-08
the O 0 3.163526329785782e-08
disease O 0 0.00011867383727803826
is O 0 2.406751464789636e-09
the O 0 3.01892271181714e-08
AVP O 1 0.9999575614929199
- O 0 1.4693903722218238e-05
neurophysin O 1 0.9857569336891174
II O 1 1.0
( O 0 1.4434479389535682e-08
NPII O 1 1.0
) O 0 2.125255749163557e-09
gene O 0 8.167331255748422e-10
, O 0 4.5349962674023914e-10
and O 0 1.2789501679932869e-09
mutations O 0 8.235565007730372e-10
that O 0 1.2202774901659552e-10
cause O 0 5.716920714604612e-09
ADNDI B-Disease 1 1.0
have O 0 2.896750617153998e-10
been O 0 9.372069786905968e-11
found O 0 1.5911858636252774e-11
in O 0 1.0818829339342972e-11
both O 0 5.056701238292938e-11
the O 0 5.732017638315767e-10
signal O 0 1.668377325181325e-09
peptide O 0 2.246786090509545e-09
of O 0 1.2058066545250767e-08
the O 0 4.1298424235947095e-08
prepro O 0 0.14790235459804535
- O 1 0.9974047541618347
AVP O 1 0.9999998807907104
- O 0 0.00010982859384967014
NPII O 1 0.9999964237213135
precursor O 0 2.3039636687371967e-07
and O 0 1.728325749184023e-08
within O 0 3.649136459671354e-08
NPII O 1 0.9963055849075317
itself O 0 4.283191117337992e-07
. O 0 2.5398912839591503e-07

An O 0 6.45363016360534e-08
affected O 0 4.026257371947395e-08
girl O 0 2.3068826848771096e-08
who O 0 5.478279496706762e-10
presented O 0 1.0613290246652696e-09
at O 0 1.2965262197184302e-09
9 O 0 2.7060043095161745e-09
months O 0 2.1249911552612133e-10
of O 0 6.825335852056469e-10
age O 0 4.981403067816359e-10
and O 0 1.0344909651127665e-10
her O 0 2.329967885295048e-10
similarly O 0 1.5951856502383066e-10
affected O 0 2.877147964319704e-10
younger O 0 4.527442865054354e-10
brother O 0 1.0580081255540108e-09
and O 0 1.4146673832371448e-09
father O 0 1.936584892447968e-09
were O 0 3.9136638374515087e-10
all O 0 2.948930266644112e-10
found O 0 3.838770273878467e-11
to O 0 6.747307573773398e-11
have O 0 6.166644972438462e-11
a O 0 7.966137749448876e-10
novel O 0 1.1180922854236996e-07
missense O 0 1.1940342403704562e-07
mutation O 0 1.0590626153827998e-08
( O 0 5.278507630990248e-10
G1758 O 0 6.102242764427501e-07
- O 0 4.6584096935475827e-07
- O 0 5.861880367774575e-07
> O 0 4.1299369257785656e-08
T O 0 3.1365555486218e-08
) O 0 1.0915508080744374e-10
encoding O 0 6.013511355540402e-10
the O 0 8.551163110936955e-10
amino O 0 1.2794478809752263e-09
acid O 0 1.9051431543459785e-09
substitution O 0 1.110730973863383e-08
Gly23 O 0 2.6551444534561597e-05
- O 0 2.71432309091324e-05
- O 0 3.9011199987726286e-05
> O 0 2.030194309554645e-06
Val O 0 4.90227212139871e-05
within O 0 4.354801319550461e-07
NPII O 1 0.9999104738235474
. O 0 2.720594920901931e-06

The O 0 1.2988555226911558e-06
mutation O 0 1.1052262038901972e-07
was O 0 5.0873758539182745e-08
confirmed O 0 6.0911347077308164e-09
by O 0 1.602236454623096e-09
restriction O 0 1.8673659951673471e-07
endonuclease O 0 2.5457507035753224e-06
analysis O 0 9.001258405305634e-08
. O 0 3.6852355833616457e-07

A O 0 6.897559069329873e-05
T1 O 0 0.00015472530503757298
- O 0 2.3967311335582053e-06
weighted O 0 5.335054424904229e-07
magnetic O 0 3.391858527379554e-08
resonance O 0 2.2732978166573048e-08
imaging O 0 2.6802433694683714e-07
of O 0 1.42805973268878e-07
the O 0 2.809179022733588e-07
fathers O 0 6.171119366626954e-07
pituitary O 1 0.999897837638855
gland O 0 0.16143515706062317
demonstrates O 0 1.1437908398193031e-07
an O 0 7.2939725370702035e-09
attenuated O 0 1.5395558875752613e-05
posterior O 0 4.937850098940544e-05
pituitary O 1 1.0
bright O 0 0.002437023678794503
spot O 0 7.551885937573388e-05
. O 0 1.3328971135706524e-06

This O 0 1.374958991107178e-08
mutation O 0 3.72906505674564e-09
may O 0 1.9721597965816073e-10
be O 0 1.3053491620951263e-10
valuable O 0 8.878041635185241e-10
for O 0 4.079979062932004e-11
developing O 0 2.42515035830948e-10
models O 0 5.130851854495688e-10
of O 0 5.5906266283045625e-09
dominantly B-Disease 1 0.9943557977676392
inherited I-Disease 1 1.0
neurodegeneration I-Disease 1 1.0
, O 0 7.672940505187853e-09
as O 0 2.3439775120870365e-10
the O 0 1.751768313740243e-10
early O 0 2.3583229813439743e-10
age O 0 1.274420902142026e-09
of O 0 1.6805776770212333e-09
onset O 0 6.820162070653168e-07
of O 0 5.104989213577937e-07
symptoms O 1 0.9789861440658569
suggests O 0 1.257912107810455e-09
that O 0 2.515424674109923e-11
this O 0 3.7828108701010166e-11
mutation O 0 4.004242770694333e-10
may O 0 9.042683268845053e-11
be O 0 1.0612778017504709e-10
particularly O 0 9.38860655885776e-10
deleterious O 0 1.165471630315551e-07
to O 0 5.817524684204045e-09
the O 0 8.67095124590378e-08
magnocellular O 0 1.7987669707508758e-05
neuron O 0 5.354469294616138e-07
. O 0 5.642199241151502e-08
. O 0 4.6465405034723517e-07

Frequent O 0 3.88680837204447e-06
inactivation O 0 0.00012663350207731128
of O 0 3.289581582066603e-05
PTEN O 1 1.0
/ O 1 0.9999525547027588
MMAC1 O 1 1.0
in O 0 2.9115722099959385e-07
primary O 1 1.0
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.789476639009081e-06

Sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.00012798182433471084
the O 0 7.453656536426934e-08
most O 0 1.27637911351286e-09
common O 0 3.567853790187314e-09
male B-Disease 0 1.0516504334034948e-09
cancer I-Disease 0 1.1827904211614282e-09
in O 0 4.9503717097776345e-11
the O 0 1.7466444957037197e-09
Western O 0 2.776953245131608e-08
world O 0 3.5272268439356935e-10
, O 0 5.593757401722854e-11
yet O 0 3.636693376996014e-11
many O 0 1.3282866126451687e-11
of O 0 2.0574132675310608e-10
the O 0 5.241597711425072e-10
major O 0 1.0459578980714923e-08
genetic O 0 2.002476628959471e-09
events O 0 2.4958410338449255e-10
involved O 0 1.4279745441658775e-10
in O 0 9.637477621504686e-11
the O 0 1.3100390772180504e-09
progression O 0 5.4873798838173116e-09
of O 0 1.3013424782215566e-09
this O 0 3.361405320756461e-10
often O 0 2.3015781280832925e-08
fatal O 0 7.101181836333126e-05
cancer B-Disease 0 0.0002454944478813559
remain O 0 5.355556353947577e-08
to O 0 7.399853618750285e-09
be O 0 2.015090849738499e-08
elucidated O 0 9.473974387219641e-06
. O 0 8.518960044057167e-07

Numerous O 0 8.352098120667506e-06
cytogenetic O 0 0.00019014861027244478
and O 0 2.2050211612167914e-07
allelotype O 0 2.5205845304299146e-05
studies O 0 2.5032521833168175e-08
have O 0 4.82549000757615e-10
reported O 0 1.4715685336952333e-09
frequent O 0 2.238463459036666e-08
loss O 0 3.7374124417510757e-07
of O 0 4.112761757824046e-07
heterozygosity O 0 6.839155685156584e-05
on O 0 1.2556075716929627e-06
chromosomal O 0 2.9217877454357222e-05
arm O 0 4.895972324447939e-06
10q O 0 1.8276785340276547e-05
in O 0 5.077662024177698e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.070554384976276e-06

Deletion O 0 6.9514685492322315e-06
mapping O 0 5.619344989327146e-08
studies O 0 1.351320655373911e-08
have O 0 6.261213769676033e-10
unambiguously O 0 5.574764117000086e-08
identified O 0 1.203292687712576e-09
a O 0 5.713560180531374e-10
region O 0 1.798299109623258e-08
of O 0 4.440268241978629e-08
chromosome O 0 4.494228278417722e-08
10q23 O 0 1.391106110304463e-07
to O 0 4.911362982973344e-10
be O 0 2.120327108334763e-10
the O 0 8.342853075049561e-10
minimal O 0 4.240353135287478e-08
area O 0 1.469778823093293e-07
of O 0 2.1098026081745047e-07
loss O 0 1.3194053281040397e-05
. O 0 1.143567601502582e-06

A O 0 2.273062818858307e-06
new O 0 5.778005629508698e-08
tumor B-Disease 0 2.9338082185859093e-06
suppressor O 0 3.5333691812411416e-06
gene O 0 2.3573001328713872e-08
, O 0 3.2348925316227906e-08
PTEN O 1 1.0
/ O 1 0.9710965752601624
MMAC1 O 1 1.0
, O 0 5.298496219552362e-08
was O 0 1.4723418928497267e-07
isolated O 0 3.9549849617515065e-08
recently O 0 3.6511813572559504e-09
at O 0 1.5083115867398078e-09
this O 0 6.305746202972529e-11
region O 0 4.085168647804949e-09
of O 0 8.293563169559093e-09
chromosome O 0 1.0277677375825078e-08
10q23 O 0 1.3667821008311876e-07
and O 0 8.775847826214545e-10
found O 0 9.561493957699341e-11
to O 0 5.544301129312146e-11
be O 0 3.23709739569189e-11
inactivated O 0 9.878046824951525e-09
by O 0 5.1774466658383034e-11
mutation O 0 5.800968039260113e-10
in O 0 5.332433938853853e-10
three O 0 7.417096270501133e-08
prostate B-Disease 1 1.0
cancer I-Disease 1 1.0
cell O 0 2.656822516655666e-06
lines O 0 6.030286954228359e-07
. O 0 2.2563689583421365e-07

We O 0 2.8008273034174636e-07
screened O 0 2.321042757102987e-06
80 O 0 6.996721367613645e-06
prostate B-Disease 1 1.0
tumors I-Disease 1 1.0
by O 0 4.493977634467683e-09
microsatellite O 0 1.6039625450048334e-07
analysis O 0 7.321455108844077e-10
and O 0 8.268933870958506e-10
found O 0 9.86181469819769e-10
chromosome O 0 5.642691203178174e-09
10q23 O 0 9.071251128034419e-08
to O 0 6.320632350842459e-10
be O 0 6.939248620163596e-10
deleted O 0 1.7601664126232208e-08
in O 0 1.7078766179068339e-09
23 O 0 7.861181927637517e-08
cases O 0 1.449147113419258e-08
. O 0 1.1689234469258736e-07

We O 0 1.2235769020207954e-07
then O 0 7.268460500142737e-09
proceeded O 0 4.645075879494698e-09
with O 0 3.9988217598319054e-11
sequence O 0 5.662026750230531e-11
analysis O 0 8.450809496629574e-11
of O 0 9.365641595593388e-10
the O 0 8.712873977856361e-09
entire O 0 1.8036015489997226e-06
PTEN O 1 1.0
/ O 0 7.524425745941699e-05
MMAC1 O 1 1.0
coding O 0 3.847143261737074e-07
region O 0 4.5705693452191554e-08
and O 0 2.8406643703959844e-09
tested O 0 3.611535737135796e-09
for O 0 4.4595985237982916e-10
homozygous O 0 6.774084404526093e-09
deletion O 0 1.2827172657381425e-09
with O 0 3.737014170335229e-11
new O 0 1.2162280071947862e-09
intragenic O 0 5.146342800799175e-07
markers O 0 1.974220431577578e-08
in O 0 1.0610794881626973e-10
these O 0 5.761687307814789e-11
23 O 0 6.65594468429731e-10
cases O 0 7.632849213790038e-11
with O 0 1.985725334163746e-10
10q23 O 0 8.605526090832427e-06
loss O 0 3.0417240850511007e-06
of O 0 6.312069672276266e-06
heterozygosity O 0 0.0196547731757164
. O 0 2.353740910621127e-06

The O 0 2.241898755528382e-08
identification O 0 3.1412539236441717e-09
of O 0 9.408831935786566e-09
the O 0 7.0671202223593355e-09
second O 0 1.2462014531422483e-08
mutational O 0 7.21221567800967e-07
event O 0 4.615543502950459e-09
in O 0 7.44927231011161e-10
10 O 0 5.022390947573285e-09
( O 0 3.579712637424848e-10
43 O 0 1.3421017186487916e-08
% O 0 2.3526454118183437e-09
) O 0 3.181516206041124e-08
tumors B-Disease 1 1.0
establishes O 0 7.143836410250515e-05
PTEN O 1 1.0
/ O 0 4.4213258661329746e-05
MMAC1 O 1 0.9999998807907104
as O 0 4.76312855823835e-09
a O 0 4.700698164050721e-10
main O 0 8.18356760134975e-09
inactivation O 0 6.670183694268417e-08
target O 0 7.406970592427342e-09
of O 0 8.850926214165611e-09
10q O 0 6.966195087443339e-06
loss O 0 7.508620569751656e-07
in O 0 3.122963221358077e-08
sporadic B-Disease 1 1.0
prostate I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0496354008182607e-07
. O 0 1.8154710801354668e-07

Risk O 0 2.5991465008701198e-05
reversals O 0 7.464012696800637e-07
in O 0 4.927128038900719e-09
predictive O 0 1.5652774720820162e-07
testing O 0 4.219151250595132e-08
for O 0 8.477184110233793e-08
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.3085533510093228e-06

The O 0 7.848043281910577e-08
first O 0 1.1861928106426944e-09
predictive O 0 3.153849181813939e-09
testing O 0 9.018848445840888e-10
for O 0 2.6258275553914245e-09
Huntington B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 3.317647934153456e-09
HD B-Disease 1 1.0
) O 0 1.059195398056545e-09
was O 0 2.0878139217472835e-09
based O 0 3.342353616098137e-10
on O 0 1.3790503183841452e-09
analysis O 0 8.058088085682868e-10
of O 0 3.3661997633771534e-09
linked O 0 2.8550877217980997e-08
polymorphic O 0 4.3319523967966234e-08
DNA O 0 5.43152456344842e-09
markers O 0 2.251204556102948e-09
to O 0 7.917615174601877e-11
estimate O 0 2.910518770438131e-10
the O 0 6.362859128472564e-10
likelihood O 0 4.634509664924735e-09
of O 0 1.092847679018405e-08
inheriting O 0 6.818966369337431e-08
the O 0 1.137266369966028e-08
mutation O 0 2.9062154904835324e-09
for O 0 1.5819948018247487e-08
HD B-Disease 1 0.9999644756317139
. O 0 1.8668190477910684e-06

Limits O 0 7.556275818387803e-07
to O 0 4.13160528012213e-09
accuracy O 0 1.1128897803303062e-08
included O 0 1.2653429415365736e-09
recombination O 0 9.689620633634988e-11
between O 0 1.7499983406832342e-10
the O 0 3.985620444790783e-10
DNA O 0 1.361689871970384e-09
markers O 0 3.3700475743358993e-09
and O 0 5.52647205775969e-10
the O 0 1.749291711483636e-09
mutation O 0 6.217645287520668e-10
, O 0 1.923064069098146e-10
pedigree O 0 4.1362104852282755e-09
structure O 0 2.7050650608373417e-09
, O 0 3.938953607729445e-10
and O 0 1.9603163536885404e-10
whether O 0 7.340594104787712e-11
DNA O 0 1.7224366377632805e-10
samples O 0 3.4585275615617306e-11
were O 0 1.5477468265356897e-11
available O 0 6.445747408045932e-11
from O 0 2.6913279937978984e-10
family O 0 2.8086142300765005e-09
members O 0 8.112077121147365e-10
. O 0 1.2894531664642273e-07

With O 0 6.708483546447042e-09
direct O 0 1.9747692370231107e-09
tests O 0 1.5210513404362302e-10
for O 0 9.475529388902615e-11
the O 0 1.90937399224822e-09
HD B-Disease 1 0.9998500347137451
mutation O 0 9.5107344222356e-10
, O 0 2.6197832792007603e-10
we O 0 1.5043258305702523e-10
have O 0 2.3531322723702175e-11
assessed O 0 4.1966528030457084e-09
the O 0 4.538812381493784e-10
accuracy O 0 3.632662393115993e-09
of O 0 1.2361962564710893e-09
results O 0 1.663933713036414e-10
obtained O 0 5.208567604997327e-11
by O 0 4.077403692459569e-11
linkage O 0 4.097326922192224e-09
approaches O 0 2.6089237437076918e-09
when O 0 1.3466466830536206e-10
requested O 0 4.038759604529929e-10
to O 0 2.8923505257516524e-10
do O 0 6.492464899032768e-10
so O 0 9.365101055758274e-11
by O 0 6.680080100185393e-11
the O 0 2.176945512744055e-09
test O 0 3.746317478459105e-09
individuals O 0 5.511776035582727e-10
. O 0 4.470418346613769e-08

For O 0 4.29983195715522e-08
six O 0 2.59278643000016e-09
such O 0 8.519823735397836e-10
individuals O 0 6.453595990940642e-11
, O 0 1.502980795375919e-10
there O 0 2.360429074421688e-10
was O 0 4.59800508778585e-09
significant O 0 9.642434406487155e-09
disparity O 0 9.110524246125351e-08
between O 0 4.707779943657897e-09
the O 0 4.5569205298079396e-08
tests O 0 3.7825206078423435e-08
. O 0 1.7145693220754765e-07

Three O 0 1.23729662959704e-07
went O 0 5.16582474574534e-08
from O 0 6.108757943934506e-10
a O 0 1.0712354336916974e-09
decreased O 0 1.4070955067779778e-08
risk O 0 1.8216281816307855e-09
to O 0 9.008906814989004e-11
an O 0 4.600298961210392e-11
increased O 0 4.838383582672634e-10
risk O 0 4.949299636791693e-09
, O 0 9.355780733466545e-11
while O 0 1.9807018525330733e-10
in O 0 1.1247748565867965e-10
another O 0 3.146937155307228e-10
three O 0 3.1216138007827965e-10
the O 0 2.8865543288958406e-09
risk O 0 3.9477200175497273e-08
was O 0 5.069891173548058e-08
decreased O 0 4.959622401656816e-07
. O 0 3.0557623631466413e-07

Knowledge O 0 8.591749178776809e-08
of O 0 1.8849966920697625e-08
the O 0 2.182816372098273e-09
potential O 0 3.6280161097579366e-09
reasons O 0 1.2393361892293342e-09
for O 0 7.69582592097251e-11
these O 0 5.410426273666502e-11
changes O 0 6.215792464070446e-11
in O 0 2.5336354542160322e-11
results O 0 7.147036434895782e-11
and O 0 7.526304579563714e-11
impact O 0 2.1729216204136037e-09
of O 0 7.625112208309304e-10
these O 0 1.253325221384216e-10
risk O 0 7.339155949637188e-10
reversals O 0 1.4044858609452149e-09
on O 0 1.4123864300330524e-09
both O 0 4.726338209692926e-10
patients O 0 4.33695801493883e-10
and O 0 1.667091464874204e-10
the O 0 1.6384751333475833e-09
counseling O 0 6.282159792370123e-10
team O 0 8.643445681411066e-11
can O 0 9.01013898907399e-12
assist O 0 4.5750128685462244e-10
in O 0 5.870296609922221e-11
the O 0 4.309022860748968e-10
development O 0 1.6479582976014484e-10
of O 0 7.16616432860917e-10
strategies O 0 6.165659649504107e-10
for O 0 6.12902714691721e-11
the O 0 1.989664405455116e-10
prevention O 0 8.417565311447106e-09
and O 0 2.2213718364749724e-10
, O 0 8.832501396938142e-11
where O 0 8.499838333175802e-11
necessary O 0 6.626442727863946e-10
, O 0 1.000326835254306e-10
management O 0 2.7989399686845218e-09
of O 0 4.9479504937721686e-09
a O 0 3.677264048818074e-09
risk O 0 2.851484914856428e-08
reversal O 0 2.827221345924613e-09
in O 0 2.579649271972073e-10
any O 0 2.2410555633456397e-09
predictive O 0 1.0765778490906541e-08
testing O 0 4.672497944113729e-09
program O 0 6.033252120118959e-09
. O 0 4.087522764706364e-09
. O 0 1.0164881558694105e-07

A O 0 3.0643966510979226e-06
novel O 0 8.046589528021286e-07
common O 0 5.628097810017607e-08
missense O 0 2.3774529722686566e-07
mutation O 0 9.394951483443492e-09
G301C O 0 2.0572667835949687e-07
in O 0 1.0077307877054409e-09
the O 0 4.715004831012948e-09
N O 0 6.440165378762686e-08
- O 0 1.351950089656384e-07
acetylgalactosamine O 0 3.1213307920552325e-06
- O 0 4.863462095272553e-07
6 O 0 3.187177526342566e-07
- O 0 9.589062983650365e-07
sulfate O 0 7.498616696466343e-07
sulfatase O 0 9.18851037567947e-06
gene O 0 2.7449463146922426e-08
in O 0 2.3007615368442202e-08
mucopolysaccharidosis B-Disease 1 0.9725707173347473
IVA I-Disease 1 1.0
. O 0 1.6655454601277597e-05

Mucopolysaccharidosis B-Disease 1 1.0
IVA I-Disease 1 1.0
( O 1 0.9876983761787415
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 9.127271596298669e-07
is O 0 1.8655642364251435e-08
an O 0 1.212804789929578e-08
autosomal B-Disease 1 0.9999973773956299
recessive I-Disease 1 0.9999990463256836
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 1.485491054609156e-07
by O 0 3.515124580300011e-10
a O 0 9.618921659182433e-09
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
in O 0 3.6312768347812607e-09
N O 0 1.3261323772439937e-07
- O 0 1.0031120467601795e-07
acetylgalactosamine O 0 7.843455932743382e-06
- O 0 5.793930313302553e-07
6 O 0 3.113233901785861e-07
- O 0 2.4212993139371974e-06
sulfate O 0 2.3176942249847343e-06
sulfatase O 0 0.00012053694808855653
( O 0 3.227078337886269e-08
GALNS O 1 0.9999741315841675
) O 0 1.0877385392404904e-07
. O 0 3.296720478829229e-07

In O 0 4.22197707905525e-08
previous O 0 1.3498394402233771e-08
studies O 0 1.866798271521475e-09
, O 0 2.3080379274453833e-10
we O 0 1.5444563683519874e-10
have O 0 2.862236662959372e-11
found O 0 4.170125703084615e-11
two O 0 1.583033704122272e-11
common O 0 1.3626244577125135e-10
mutations O 0 5.5335881710139034e-11
in O 0 6.164763144411722e-11
Caucasians O 0 1.7226881254828186e-08
and O 0 1.6773303856965072e-09
Japanese O 0 2.2327841975311458e-07
, O 0 9.913021514762477e-09
respectively O 0 1.315181350491912e-07
. O 0 4.552372843136254e-07

To O 0 6.62893882008575e-08
characterize O 0 1.9936102546580514e-07
the O 0 3.340483090141788e-08
mutational O 0 7.901398930698633e-07
spectrum O 0 2.0574544734586198e-08
in O 0 1.2859674436427326e-10
various O 0 1.6560246229868625e-10
ethnic O 0 5.152574478195504e-10
groups O 0 3.5484202381974583e-11
, O 0 7.972578153214727e-11
mutations O 0 7.52535672665644e-11
in O 0 9.718050669738076e-11
the O 0 4.200512826457725e-09
GALNS O 1 0.9998764991760254
gene O 0 1.29132116111208e-09
in O 0 3.7771241689910084e-10
Colombian O 0 2.5150263809337048e-06
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 1.8520810272093513e-06
were O 0 1.2366867530033687e-09
investigated O 0 1.2730464682420006e-08
, O 0 3.5834218925501204e-10
and O 0 4.3894873846817006e-10
genetic O 0 1.2567178409028656e-09
backgrounds O 0 1.724635989575063e-10
were O 0 4.5439117746237656e-11
extensively O 0 4.6552026122803625e-10
analyzed O 0 6.89215851057412e-10
to O 0 1.0498982933038192e-10
identify O 0 1.926122039641598e-10
racial O 0 6.515402661833036e-10
origin O 0 3.5587564145567185e-11
, O 0 2.931823533947053e-11
based O 0 1.2492464007696213e-10
on O 0 2.827609701938627e-09
mitochondrial O 0 1.81062045356839e-08
DNA O 0 2.34781438734899e-08
( O 0 1.7288063203224624e-09
mtDNA O 0 6.710697775247354e-09
) O 0 3.973871898210746e-09
lineages O 0 3.725768138451713e-08
. O 0 9.197263750593265e-08

Three O 0 2.0741300943427632e-07
novel O 0 6.883204264340748e-07
missense O 0 3.7036201661067025e-07
mutations O 0 1.7673759344916107e-08
never O 0 8.506399140628673e-09
identified O 0 4.1118236593362667e-10
previously O 0 1.4750362042903475e-09
in O 0 5.029230157327369e-11
other O 0 9.787322341470173e-11
populations O 0 8.201826023901404e-11
and O 0 1.1399973326442492e-10
found O 0 1.3651113572876739e-10
in O 0 1.423395290522933e-10
16 O 0 1.4514976998114548e-09
out O 0 5.439909633864204e-10
of O 0 2.0929733501873216e-09
19 O 0 1.2182344910627307e-08
Colombian O 0 4.748671642573754e-07
MPS B-Disease 1 0.9999940395355225
IVA I-Disease 1 1.0
unrelated O 0 3.160066853524768e-06
alleles O 0 5.63683943965998e-09
account O 0 8.178492327814979e-10
for O 0 2.7314703832104215e-09
84 O 0 4.943981366523076e-07
. O 0 2.341256930549207e-07

2 O 0 1.7838019061855448e-07
% O 0 2.508786289823206e-09
of O 0 2.4989195157587574e-09
the O 0 2.949601229929044e-09
alleles O 0 5.00094743394186e-10
in O 0 3.68363617386791e-10
this O 0 8.973172205273272e-10
study O 0 4.086932392510789e-08
. O 0 2.0365010300338326e-07

The O 0 2.0936386135872453e-06
G301C O 0 1.9351797163835727e-05
and O 0 1.377128882040779e-07
S162F O 0 1.3079896234557964e-05
mutations O 0 5.646527156955017e-08
account O 0 4.016092791658821e-09
for O 0 1.583984499120561e-08
68 O 0 1.3398979490375496e-06
. O 0 3.597636464292009e-07

4 O 0 1.7874609739010339e-06
% O 0 2.0362868724532746e-08
and O 0 1.0749200640702838e-08
10 O 0 1.8658528233572724e-07
. O 0 4.278520577827294e-07

5 O 0 7.284799607987225e-08
% O 0 1.8015940961291221e-09
of O 0 3.065842246741113e-09
mutations O 0 5.570400807286546e-10
, O 0 5.201442054847405e-10
respectively O 0 1.801855220584514e-09
, O 0 3.6130978764425947e-10
whereas O 0 3.105958545912557e-10
the O 0 2.2602999472098873e-09
remaining O 0 6.748501135689366e-08
F69V O 1 0.9990000128746033
is O 0 2.3803776727504555e-09
limited O 0 1.094476287377688e-09
to O 0 9.268329992373481e-10
a O 0 2.8013753539113395e-09
single O 0 8.860588707193529e-09
allele O 0 8.443200982810595e-08
. O 0 3.502653953546542e-07

The O 0 3.309939131668216e-07
skewed O 0 7.20098611850517e-08
prevalence O 0 1.5723540514045453e-07
of O 0 3.880309051851327e-08
G301C O 0 1.0833373380592093e-06
in O 0 9.803694522858564e-10
only O 0 4.679684417752128e-10
Colombian O 0 2.2092809359719467e-08
patients O 0 1.6067749353254612e-09
and O 0 3.5842423473653184e-10
haplotype O 0 4.317268320619405e-09
analysis O 0 1.5382005391639808e-10
by O 0 6.453693829344687e-11
restriction O 0 1.3411056709600189e-09
fragment O 0 2.8825435371970798e-09
length O 0 9.626074382040883e-10
polymorphisms O 0 3.6263195224428557e-10
in O 0 6.310622024940926e-10
the O 0 2.22030660523842e-08
GALNS O 1 0.9998242259025574
gene O 0 5.874368547154063e-09
suggest O 0 1.7300828547561764e-09
that O 0 3.3679381505891115e-10
G301C O 0 3.1924463428367744e-07
originated O 0 9.610334750220773e-10
from O 0 3.488907218685e-10
a O 0 2.554698008694345e-09
common O 0 1.59614295114352e-08
ancestor O 0 1.2107400948480063e-07
. O 0 4.218475453399151e-07

Investigation O 0 3.94938098224884e-07
of O 0 8.717699273574908e-08
the O 0 5.511600065233324e-09
genetic O 0 1.4157822691984734e-09
background O 0 1.5790448115726718e-10
by O 0 4.0969005965507677e-11
means O 0 2.895382600343055e-09
of O 0 5.986552586989546e-09
mtDNA O 0 1.3246599372962464e-09
lineages O 0 1.1312250441930516e-10
indicate O 0 4.296316427621072e-11
that O 0 1.1534962221504408e-11
all O 0 5.853224155361048e-11
our O 0 1.1544697142706895e-10
patients O 0 4.408362910823804e-11
are O 0 9.008798915188798e-12
probably O 0 4.962806277042375e-10
of O 0 5.8483426990108e-09
native O 0 1.3433393064588017e-07
American O 0 4.5615641397489526e-07
descent O 0 1.5891612292762147e-06

Low O 0 5.326319865162077e-07
frequency O 0 4.434868117186852e-08
of O 0 1.0393399207941911e-07
BRCA1 O 0 7.222843123599887e-07
germline O 0 1.472099029342644e-07
mutations O 0 2.2100805630032028e-09
in O 0 3.4387173664107706e-10
45 O 0 1.3996248604541961e-08
German O 1 1.0
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 8.696934727936423e-09
. O 0 3.522235658692807e-08

In O 0 3.445785168310067e-08
this O 0 7.061605744596022e-10
study O 0 1.6353279841396784e-09
we O 0 2.820121636215589e-10
investigated O 0 5.237263067670028e-09
45 O 0 1.1513263231677229e-08
German O 1 0.9997054934501648
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.747536559904006e-10
for O 0 3.5457903280189385e-10
germline O 0 1.3334366499861972e-08
mutations O 0 1.1377865316575253e-09
in O 0 6.746410097235866e-10
the O 0 3.759016919957503e-08
BRCA1 O 0 5.62934189929365e-07
gene O 0 7.787266298464601e-08
. O 0 1.7867182577901985e-07

We O 0 4.025320521350295e-08
identified O 0 9.514948828837078e-09
four O 0 2.1724990695304314e-09
germline O 0 2.184987657471993e-08
mutations O 0 8.053784861239421e-10
in O 0 2.259574749530202e-10
three O 0 9.538893008809168e-10
breast B-Disease 0 1.4704670320497826e-05
cancer I-Disease 0 4.202221504101544e-08
families O 0 5.282067751938291e-12
and O 0 3.992557326415458e-11
in O 0 2.0382470711233225e-10
one O 0 7.801270385243697e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 2.4249005581289396e-10
. O 0 8.818542250599304e-12
among O 0 9.835150055481634e-12
these O 0 1.1969165242264879e-11
were O 0 8.116715632944249e-11
one O 0 7.094195231260869e-10
frameshift O 0 2.1372608571823548e-08
mutation O 0 1.2980058139433481e-09
, O 0 6.87669032828353e-10
one O 0 1.0318567111866628e-09
nonsense O 0 5.240003986273223e-08
mutation O 0 1.2698302409575035e-09
, O 0 4.725788649295737e-10
one O 0 8.640450577246384e-10
novel O 0 2.957314748641693e-08
splice O 0 1.4724191998993774e-07
site O 0 1.7187529621764952e-08
mutation O 0 1.1696550394901806e-09
, O 0 7.755331377090613e-10
and O 0 1.032485297258745e-08
one O 0 3.327345510228952e-08
missense O 0 4.56383713753894e-06
mutation O 0 4.883177666670235e-07
. O 0 3.5436579537417856e-07

The O 0 2.6598977456160355e-06
missense O 0 2.0882764601992676e-06
mutation O 0 5.932438540412477e-08
was O 0 4.440632039859338e-08
also O 0 2.4596096270812495e-09
found O 0 8.697561559856126e-10
in O 0 2.593562919983583e-09
2 O 0 7.490354505534924e-07
. O 0 4.359288539035333e-07

8 O 0 9.123235855668099e-08
% O 0 1.7858086120980943e-09
of O 0 1.8018037062361714e-09
the O 0 1.228669499475643e-09
general O 0 1.5087087135157162e-09
population O 0 1.524263493202227e-10
, O 0 1.4378628843125796e-10
suggesting O 0 5.527314717035381e-10
that O 0 4.1563329167271235e-11
it O 0 3.297408457392237e-10
is O 0 8.681931285003941e-10
not O 0 8.266078932450682e-10
disease O 0 7.487469844136285e-08
associated O 0 5.929180346697649e-08
. O 0 7.883913895057049e-07

The O 0 1.327590126720679e-07
average O 0 8.982765642429058e-09
age O 0 4.297681321929758e-09
of O 0 9.164758729696132e-09
disease O 0 7.278576390490343e-07
onset O 0 4.1046817500500765e-08
in O 0 2.73949363194248e-10
those O 0 7.105718791144966e-10
families O 0 1.230911345073693e-10
harbouring O 0 1.1962490020778205e-07
causative O 0 3.7797195773237036e-07
mutations O 0 2.3391873327227586e-08
was O 0 3.6236333045280844e-08
between O 0 1.7579790068111834e-08
32 O 0 1.0821095202118158e-06
. O 0 4.6509299522767833e-07

3 O 0 3.597674776756321e-06
and O 0 3.291122823156911e-07
37 O 0 3.305943437226233e-06
. O 0 9.023758025250572e-07

4 O 0 3.345269021792774e-07
years O 0 8.188985489709921e-09
, O 0 6.748211989204833e-10
whereas O 0 5.313204876067346e-10
the O 0 9.09253172753921e-10
family O 0 1.8008520230594627e-09
harbouring O 0 4.221606957344193e-07
the O 0 3.7789366302831695e-08
missense O 0 2.088394950305883e-07
mutation O 0 1.1744732297813698e-08
had O 0 1.501451518670649e-09
an O 0 1.5900762651011036e-10
average O 0 6.522949957954438e-10
age O 0 2.2561563728373812e-09
of O 0 7.84654297092402e-09
onset O 0 4.0961927538774034e-07
of O 0 1.016330656966602e-06
51 O 0 5.174274065211648e-06
. O 0 4.953297434440174e-07

2 O 0 1.60509989655111e-05
years O 0 1.5274146107913111e-06
. O 0 1.7188501715281745e-06

These O 0 3.069202492156364e-08
findings O 0 4.215762849923976e-09
show O 0 1.9530361772268634e-09
that O 0 9.354608199174663e-10
BRCA1 O 0 6.209378966559598e-08
is O 0 8.350463098771854e-10
implicated O 0 2.3531976367507923e-09
in O 0 3.5262784359169075e-10
a O 0 2.921776709463586e-10
small O 0 4.1309572429426566e-10
fraction O 0 2.4846662505240147e-09
of O 0 1.5833221311822854e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 3.7587100099045756e-11
suggesting O 0 9.175944032380201e-11
the O 0 1.0465474320486834e-10
involvement O 0 6.258515927726194e-10
of O 0 5.805443237250074e-09
another O 0 4.626887317726869e-09
susceptibility O 0 3.275042104178283e-07
gene O 0 7.236729970827582e-08
( O 0 4.4440806590273496e-08
s O 0 2.317097369086696e-06
) O 0 7.896027796050475e-07

Paternal O 0 0.0013496765168383718
transmission O 1 0.999832272529602
of O 1 0.9999996423721313
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 1 0.727671205997467

We O 0 1.7508439498215012e-07
report O 0 8.436290777069644e-09
a O 0 2.307106061749664e-09
rare O 0 5.942967451488812e-09
case O 0 4.79005013431788e-09
of O 0 1.3257442788017215e-07
paternally O 1 0.9999998807907104
transmitted O 1 1.0
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9998077750205994
DM B-Disease 1 1.0
) O 0 3.0213598734007974e-07
. O 0 3.925847238406277e-07

The O 0 7.08324876086408e-07
proband O 0 3.190473944414407e-05
is O 0 7.962374759529212e-09
a O 0 1.0645179182589004e-09
23 O 0 3.779669910386474e-09
year O 0 6.385082462756486e-10
old O 0 1.9940704021337297e-07
, O 0 4.177997681154011e-08
mentally B-Disease 1 1.0
retarded I-Disease 1 1.0
male O 0 1.4774464318634273e-07
who O 0 7.380827327096995e-08
suffers O 1 0.9999996423721313
severe O 1 1.0
muscular B-Disease 1 1.0
weakness I-Disease 1 1.0
. O 0 0.004521182272583246

He O 0 4.1278823914581153e-07
presented O 0 1.0242182924002918e-07
with O 0 4.223442928719123e-08
respiratory O 1 0.9999998807907104
and O 0 2.424441163384472e-07
feeding O 0 2.5097810066654347e-05
difficulties O 0 2.5484930574748432e-06
at O 0 4.3463492716000474e-07
birth O 0 7.119101042007969e-07
. O 0 3.237781811549212e-07

His O 0 4.4329922275210265e-06
two O 0 4.629378906884085e-07
sibs O 0 0.15284043550491333
suffer O 0 8.952407029028109e-07
from O 0 3.3888515105218175e-08
childhood O 0 0.016647396609187126
onset O 1 0.9999963045120239
DM B-Disease 1 1.0
. O 0 9.559676982462406e-06

Their O 0 3.148375427031169e-08
late O 0 1.8192608308709168e-08
father O 0 1.7464653723209267e-08
had O 0 1.3093045536649583e-09
the O 0 6.812772013198298e-10
adult O 0 1.5313950108009067e-09
type O 0 1.7380173966685675e-09
of O 0 7.87185001627222e-08
DM B-Disease 1 1.0
, O 0 1.5919683349352454e-08
with O 0 2.0842567671763845e-09
onset O 0 1.4584816199203487e-06
around O 0 2.2221707141056868e-08
30 O 0 4.287425170446113e-08
years O 0 1.189628395792397e-08
. O 0 1.0380442461155326e-07

Only O 0 3.12035517424647e-08
six O 0 5.547837189645577e-10
other O 0 3.608791737663708e-11
cases O 0 5.41509267981688e-11
of O 0 3.774330015193783e-10
paternal O 0 8.254632888338165e-08
transmission O 1 0.9070556163787842
of O 1 1.0
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 3.0972530566941714e-06
been O 0 1.0845912612467146e-08
reported O 0 1.6196342045304846e-08
recently O 0 1.5535836439539707e-07
. O 0 3.2545798944738635e-07

We O 0 6.730427770662573e-08
review O 0 2.0603842187938426e-08
the O 0 1.869007171251269e-09
sex O 0 6.578550482139178e-10
related O 0 1.2430126927753804e-09
effects O 0 2.1542659212059334e-08
on O 0 1.913206304493542e-08
transmission O 0 1.9003628040081821e-06
of O 0 0.00020643940661102533
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 3.336922236485407e-05

Decreased O 0 5.707689979317365e-06
fertility O 0 7.881525476705065e-08
of O 0 3.276045434930097e-09
males O 0 2.4431176526285014e-10
with O 0 6.479942277204387e-11
adult O 0 4.106662743197376e-08
onset O 0 2.5608158011891646e-06
DM B-Disease 1 1.0
and O 0 2.099295315360905e-08
contraction O 0 9.706852210911165e-09
of O 0 1.42670664171618e-09
the O 0 6.342865677133602e-10
repeat O 0 2.9312450244844968e-09
upon O 0 7.066564000623998e-10
male O 0 5.637008637648933e-10
transmission O 0 6.240564176529517e-10
contribute O 0 1.2697617957080354e-10
to O 0 1.4649306767644532e-10
the O 0 1.6200413233136146e-09
almost O 0 2.1135528882609833e-09
absent O 0 7.764393572529116e-09
occurrence O 0 3.4106442114989477e-09
of O 0 4.213704496436321e-09
paternal O 0 2.031500230259553e-07
transmission O 0 4.82252289657481e-06
of O 0 0.00047375858412124217
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 4.31405715062283e-05

Also O 0 7.842776028610388e-08
the O 0 1.2025498818957203e-08
fathers O 0 9.423073876746457e-09
of O 0 3.3101767993315434e-09
the O 0 3.2465734545183977e-09
reported O 0 1.0541050698975596e-08
congenitally O 0 2.0532272060336254e-07
affected O 0 5.311606710023398e-09
children O 0 7.161053972026821e-10
showed O 0 6.425031062740061e-10
, O 0 8.594275985318589e-11
on O 0 2.009854060958105e-09
average O 0 1.8948149715924956e-09
, O 0 9.250774035685083e-10
shorter O 0 1.7384169836986985e-07
CTG O 0 0.000252636760706082
repeat O 0 1.362389809855813e-07
lengths O 0 6.900951632360375e-08
and O 0 2.547506428030033e-09
hence O 0 9.43132771880073e-09
less O 0 2.7224720255958346e-09
severe O 0 1.7982431188556802e-07
clinical O 0 1.0440389814903028e-05
symptoms O 0 6.12107982078669e-08
than O 0 1.0917834344925659e-11
the O 0 1.544450539681108e-10
mothers O 0 9.518496407734389e-11
of O 0 2.065572157761153e-10
children O 0 1.3830674383541464e-09
with O 0 5.4452716113928545e-08
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 2.9717799407080747e-05

We O 0 4.8968505694801934e-08
conclude O 0 7.465349227686602e-09
that O 0 9.446656651368457e-11
paternal O 0 1.0218845858389614e-07
transmission O 0 4.635516233975068e-06
of O 1 0.9998277425765991
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 8.497611929669802e-07
rare O 0 7.3800077160512956e-09
and O 0 6.082517267635978e-10
preferentially O 0 6.786535222680357e-10
occurs O 0 1.3089711606295573e-11
with O 0 1.4286277022490523e-11
onset O 0 1.318663400695641e-08
of O 0 4.6572676382083955e-08
DM B-Disease 1 1.0
past O 0 1.6497455135322525e-07
30 O 0 4.406585318861289e-09
years O 0 2.1996585108929878e-10
in O 0 9.796736338829604e-11
the O 0 2.5260908920188285e-09
father O 0 8.838830112267715e-09
. O 0 1.0268410122193927e-08
. O 0 2.198432298428088e-07

The O 0 3.404034714549198e-06
RB1 O 0 0.05024779960513115
gene O 0 4.6014640986413724e-08
mutation O 0 2.9040712057337714e-09
in O 0 9.878174944688567e-10
a O 0 1.0870060407341953e-08
child O 0 2.2907435948127386e-07
with O 0 3.197900753093563e-07
ectopic B-Disease 1 0.9990252256393433
intracranial I-Disease 1 1.0
retinoblastoma I-Disease 1 1.0
. O 0 1.7644861145527102e-05

The O 0 6.352985110424925e-06
RB1 O 1 0.9987397789955139
gene O 0 1.948650663052831e-07
mutation O 0 4.4417586053668856e-08
was O 0 2.0582161752713546e-08
investigated O 0 1.512951186555256e-08
in O 0 1.2236365254381099e-09
a O 0 1.2624603584754368e-08
child O 0 2.2927936527139536e-07
with O 0 1.2655841885589325e-07
ectopic B-Disease 0 0.0014556491514667869
intracranial I-Disease 1 0.9999306201934814
retinoblastoma I-Disease 0 1.019432966131717e-05
using O 0 2.160202239309683e-09
DNA O 0 2.78086353944218e-09
obtained O 0 7.782503114173167e-11
from O 0 4.491633454062338e-11
both O 0 3.9297157194972954e-10
the O 0 4.789100227498011e-09
pineal B-Disease 0 0.0001253511436516419
and I-Disease 0 1.9711731624738604e-07
retinal I-Disease 1 1.0
tumours I-Disease 1 1.0
of O 1 0.9999984502792358
the O 0 1.337987578153843e-05
patient O 0 1.7062386632460402e-06
. O 0 1.3531678177969297e-07

A O 0 7.070991614455124e-06
nonsense O 0 1.513794700258586e-06
mutation O 0 9.512516108145519e-09
in O 0 5.343401721091823e-09
exon O 0 1.0576092108749435e-06
17 O 0 1.5896722516117734e-07
( O 0 1.8068110341218357e-09
codon O 0 1.9070419909894554e-08
556 O 0 1.037295582761999e-08
) O 0 2.0415270862716994e-10
of O 0 2.288863987232048e-09
the O 0 1.3246783225895342e-08
RB1 O 0 0.19628895819187164
gene O 0 3.7418752540929745e-09
was O 0 3.7316691958722e-09
found O 0 7.655712175314022e-11
to O 0 3.90424532981104e-11
be O 0 7.606573010354722e-11
present O 0 2.988429781414226e-10
homozygously O 0 2.658188407167472e-07
in O 0 5.594901764105487e-10
both O 0 1.8368400134249896e-09
the O 0 1.2816858685482657e-08
retinal B-Disease 0 2.475784185662633e-06
and I-Disease 0 4.1835201614048856e-07
the I-Disease 0 6.365453828038881e-06
pineal I-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 2.8282585844863206e-05

The O 0 5.840965400238929e-08
same O 0 1.3309254809357185e-09
mutation O 0 8.302849519026267e-10
was O 0 3.094464684494369e-09
present O 0 1.5331835800935778e-09
heterozygously O 0 2.6368937255938363e-07
in O 0 4.073231751888784e-10
the O 0 8.139711127341798e-10
DNA O 0 5.636471289705014e-10
from O 0 8.579225524441014e-11
the O 0 8.562048292581892e-10
constitutional O 0 7.464978857285587e-09
cells O 0 8.283894403771086e-11
of O 0 1.2124201642649268e-09
the O 0 2.8306856858506535e-09
patient O 0 4.344759663155173e-09
, O 0 2.9362012821110284e-10
proving O 0 7.91007526146359e-09
it O 0 1.253475934159809e-10
to O 0 2.0610109452423586e-10
be O 0 7.149753566970674e-10
of O 0 1.3535751186566358e-08
germline O 0 3.5643805063045875e-07
origin O 0 2.6854850787572104e-08
. O 0 1.055165483876408e-07

The O 0 1.3622624805975647e-07
initial O 0 2.8119496064960003e-08
mutation O 0 2.8982445332559337e-09
was O 0 3.3218143791202692e-09
shown O 0 3.563010164686631e-10
to O 0 5.103075184642591e-10
have O 0 1.5552699406118364e-10
occurred O 0 1.0035876574221447e-09
in O 0 4.538007192245175e-10
the O 0 1.9763188419119615e-08
paternally O 0 9.477039384364616e-07
derived O 0 2.377103811568304e-07
RB1 O 0 0.0004816655709873885
allele O 0 4.446421257853217e-07
. O 0 3.9671115814599034e-07

The O 0 1.1503303198878712e-07
mutation O 0 1.6406828118320504e-09
is O 0 1.7906920390942105e-10
in O 0 3.591884775722143e-11
an O 0 6.160272986166504e-11
area O 0 5.563713934009229e-09
of O 0 6.202203639560366e-09
the O 0 3.06459146948157e-09
gene O 0 2.0396666300381838e-10
that O 0 5.246706194506068e-11
encodes O 0 4.229807337718938e-10
the O 0 5.504642297537998e-10
protein O 0 4.671934505928732e-10
- O 0 3.077747834367983e-09
binding O 0 3.76795172840616e-09
region O 0 4.208885240331028e-09
known O 0 1.3469505510954605e-09
as O 0 4.197042713371957e-10
the O 0 2.1698569607764284e-09
pocket O 1 0.9999997615814209
region O 0 5.61039860258461e-06
and O 0 6.404164309969929e-08
has O 0 8.868754619584251e-09
been O 0 1.4480855403675719e-09
detected O 0 1.9928518835143905e-09
in O 0 1.328735732553099e-10
other O 0 2.8015609276899056e-10
cases O 0 7.074980046262169e-10
of O 0 1.4735634934481823e-08
retinoblastoma B-Disease 0 7.475820166291669e-05
. O 0 9.098923925421332e-08
. O 0 6.708140745104174e-07

Low O 0 4.0273485524267016e-07
levels O 0 8.687154107178685e-09
of O 0 9.628613462098201e-09
beta O 0 1.1044380698876921e-07
hexosaminidase O 0 4.4492817323771305e-06
A O 0 6.18208062519443e-08
in O 0 7.841930993457424e-10
healthy O 0 4.087974847521991e-09
individuals O 0 8.381634795939785e-12
with O 0 1.0651429738217644e-10
apparent O 0 1.6845072536852967e-07
deficiency O 0 1.3872439012629911e-05
of O 0 1.3358469459490152e-06
this O 0 1.3188496517102521e-08
enzyme O 0 1.1404980426732436e-07
. O 0 7.510998756288245e-08

Appreciable O 0 4.3253570765955374e-05
beta O 0 3.931725132133579e-06
hexosaminidase O 0 5.983078517601825e-05
A O 0 3.124088379991008e-06
( O 0 1.4413570781357521e-08
hex O 0 3.452226519584656e-05
A O 0 3.816385856225679e-07
) O 0 1.0717258192016743e-09
activity O 0 1.7954673303677282e-09
has O 0 5.510830125565747e-10
been O 0 2.443509006244682e-10
detected O 0 1.810098182453146e-09
in O 0 5.900586130813679e-10
cultured O 0 6.657166817802818e-09
skin O 0 6.323833758870023e-07
fibroblasts O 0 6.181099632129872e-09
and O 0 1.9806780926501233e-07
melanoma B-Disease 1 1.0
tissue O 0 3.4957965908688493e-06
from O 0 6.038340938374631e-09
healthy O 0 1.3768537421299243e-08
individuals O 0 5.174482804043423e-12
previously O 0 4.120208063618236e-10
reported O 0 1.5996767799286715e-10
as O 0 5.5618010197378e-10
having O 0 1.0013931017738287e-08
deficiency B-Disease 0 3.1811209737497848e-06
of I-Disease 0 2.4891653538361425e-06
hex I-Disease 1 0.9998990297317505
A I-Disease 0 2.609881448734086e-07
activity O 0 7.874455532075331e-10
indistinguishable O 0 4.097434336269856e-10
from O 0 6.8898905677960975e-12
that O 0 1.935518368842426e-12
of O 0 9.413993196094594e-11
patients O 0 5.7065654285315404e-11
with O 0 1.0366226765867737e-09
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.2731221943340643e-07
TSD B-Disease 1 1.0
) O 0 1.1998707805105369e-07
. O 0 2.8491098191807396e-07

Identification O 0 3.086944957431115e-07
and O 0 3.584375818377339e-08
quantitation O 0 1.0067660696222447e-05
of O 0 3.560382310752175e-06
hex O 1 0.5397025346755981
A O 0 5.294563834468136e-06
, O 0 1.8121509626212173e-08
amounting O 0 1.1540982569613334e-07
to O 0 2.1718951970228773e-08
3 O 0 1.0869396191992564e-06
. O 0 5.579789785770117e-07

5 O 0 1.9833084934361978e-06
% O 0 1.0024942298514361e-07
- O 0 9.752673122420674e-07
6 O 0 1.0427278311908594e-06
. O 0 3.2109497283272503e-07

9 O 0 2.0385976995385136e-07
% O 0 1.6011426628992353e-09
of O 0 2.080312810903706e-09
total O 0 1.778636127269806e-09
beta O 0 4.804427433668934e-08
hexosaminidase O 0 9.119302148974384e-07
activity O 0 2.250672093140338e-09
, O 0 5.614325115921304e-10
has O 0 1.8385284961119908e-10
been O 0 1.8210642716010028e-10
obtained O 0 1.2574676022669706e-10
by O 0 2.752850170040233e-10
cellulose O 0 9.442919690627605e-07
acetate O 0 7.895847602412687e-07
gel O 0 4.30606945656109e-07
electrophoresis O 0 2.8480931391072772e-08
, O 0 2.0200732198105698e-09
DEAE O 0 5.512589996214956e-05
- O 0 6.146549225150011e-08
cellulose O 0 2.0488887741976214e-07
ion O 0 2.0691986435394938e-07
- O 0 5.133392164680117e-07
exchange O 0 2.6328498492489416e-08
chromatography O 0 1.0618381196536575e-07
, O 0 2.0843522463565023e-09
radial O 0 4.982948098586348e-07
immunodiffusion O 0 6.665123692073394e-06
, O 0 2.048698632961532e-08
and O 0 7.290804404647133e-08
radioimmunoassay O 0 0.00018936084234155715
. O 0 2.212255139966146e-06

Previous O 0 3.549106850186945e-06
family O 0 1.6920802536901647e-08
studies O 0 2.509867869093796e-09
suggested O 0 8.722679800676758e-10
that O 0 2.375390856235171e-11
these O 0 7.692656234237205e-11
individuals O 0 1.9488105573728376e-11
may O 0 4.9500504389898836e-11
be O 0 9.266610395686214e-11
compound O 0 1.3273661059187702e-09
heterozygotes O 0 6.57872956111305e-09
for O 0 2.7598318075305883e-10
the O 0 2.6581181700180423e-09
common O 0 5.918816103900326e-09
mutant O 0 2.0227892605362285e-07
TSD B-Disease 0 5.925299774389714e-05
gene O 0 2.271285826083158e-09
and O 0 2.2064079452377428e-09
a O 0 5.414158454897233e-09
rare O 0 3.274985260759422e-08
( O 0 5.292836835479875e-09
allelic O 0 2.2989536319073522e-06
) O 0 2.595132997385008e-08
mutant O 0 8.081951250460406e-07
gene O 0 1.0816972917382373e-07
. O 0 1.5847300005589204e-07

Thus O 0 3.919390678674972e-07
, O 0 1.1712161018806455e-08
the O 0 1.4450290741763183e-08
postulated O 0 1.606129984565996e-07
rate O 0 1.166336272007129e-08
mutant O 0 2.164686740968591e-08
gene O 0 4.91014506831533e-10
appears O 0 4.659448937793798e-10
to O 0 6.466496782486786e-11
code O 0 1.2123479997683262e-10
for O 0 7.600511192640269e-11
the O 0 1.1108829411909937e-09
expression O 0 5.490245480466172e-10
of O 0 1.433400176331645e-09
low O 0 2.0729032712551998e-08
amounts O 0 1.2276112570930309e-08
of O 0 6.374040140144643e-08
hex O 0 0.00015287369024008512
A O 0 6.464307261921931e-06
. O 0 1.0963634622385143e-06

Heterozygotes O 0 4.2248957470292225e-06
for O 0 1.9318083133157415e-08
the O 0 3.026925554650006e-08
rare O 0 6.25831830802781e-08
mutant O 0 1.982416648615981e-07
may O 0 6.578977362892147e-10
be O 0 1.672926935869512e-10
indistinguishable O 0 2.5742585840760057e-09
from O 0 1.2961597073424258e-10
heterozygotes O 0 2.3628281553556008e-08
for O 0 8.513666993614777e-10
the O 0 1.611192068651235e-08
common O 0 8.39502618532606e-08
TSD B-Disease 0 0.0038537997752428055
mutant O 0 7.910673957667314e-06
. O 0 3.3794992759794695e-07

However O 0 1.37916217113343e-07
, O 0 9.719245852579661e-09
direct O 0 4.656750096643236e-09
visualization O 0 4.083005578081611e-08
and O 0 4.091883276657882e-09
quantitation O 0 1.8295107793164789e-06
of O 0 7.376843882411777e-07
hex O 0 0.007211744319647551
A O 0 7.633938281514929e-08
by O 0 1.1530327387321293e-10
the O 0 6.560306742287025e-10
methods O 0 2.368457652224265e-09
described O 0 6.176040789895865e-10
may O 0 2.642839558308907e-10
prevent O 0 8.030182740981218e-09
false O 0 2.6260680296985583e-09
- O 0 1.5425795751866644e-08
positive O 0 5.984676643144837e-10
prenatal O 0 5.543270731322991e-09
diagnosis O 0 6.261802631968294e-09
of O 0 7.708967686426149e-09
TSD B-Disease 1 0.9999549388885498
in O 0 7.1073626983775284e-09
fetuses O 0 1.3310657465126496e-08
having O 0 1.7965968990285575e-10
the O 0 5.366942446016765e-10
incomplete O 0 3.5707557799469214e-08
hex B-Disease 0 6.254261825233698e-05
A I-Disease 0 2.580686214059824e-06
deficiency I-Disease 0 2.417372570562293e-06
of O 0 9.399256839515147e-08
the O 0 2.840097046430401e-08
type O 0 3.3321978065714575e-08
described O 0 8.436077392204311e-10
in O 0 4.667810582503762e-10
the O 0 1.6573091343730084e-08
four O 0 4.286509280859718e-08
healthy O 0 5.465926733450033e-07
individuals O 0 3.5973823031554275e-08

The O 0 3.7278477975632995e-06
tumor B-Disease 0 0.00048163041356019676
suppressor O 0 0.0002070672926492989
gene O 0 1.4537616834786604e-06
Smad4 O 1 0.9999785423278809
/ O 0 3.814182127825916e-05
Dpc4 O 0 0.002637979108840227
is O 0 1.4361148936714585e-09
required O 0 3.085016408999053e-10
for O 0 1.3452039482331202e-10
gastrulation O 0 1.7486286196799483e-08
and O 0 4.669698516757137e-10
later O 0 1.4861940567101328e-09
for O 0 7.452853889589051e-10
anterior O 0 1.0650408910350961e-07
development O 0 6.650237249772317e-09
of O 0 6.473786839933382e-08
the O 0 1.235161590784628e-07
mouse O 0 1.6973934862107853e-06
embryo O 0 5.30042711943679e-07
. O 0 2.642041465605871e-07

Mutations O 0 2.6251987605974136e-07
in O 0 1.1280115508327526e-08
the O 0 1.624383827447673e-07
SMAD4 O 1 1.0
/ O 1 0.9971944093704224
DPC4 O 1 1.0
tumor B-Disease 0 0.022372907027602196
suppressor O 0 2.708644842641661e-06
gene O 0 3.4364240342199537e-09
, O 0 9.106173592954292e-10
a O 0 1.078735656356855e-09
key O 0 1.040583583744592e-07
signal O 0 1.1141555233962208e-08
transducer O 0 3.063108522383118e-08
in O 0 1.8010030133908117e-09
most O 0 3.2671596539302072e-09
TGFbeta O 0 4.972667375113815e-05
- O 0 2.495494300092105e-07
related O 0 4.679260356965642e-08
pathways O 0 2.8759534753675098e-09
, O 0 5.664349198020169e-11
are O 0 5.133430572984432e-12
involved O 0 1.8572287804885512e-11
in O 0 6.800927876415841e-11
50 O 0 2.817913236086156e-09
% O 0 8.717391253298956e-10
of O 0 4.5045524643683166e-08
pancreatic B-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 3.1410511383000994e-06

Homozygous O 0 0.0001374974672216922
Smad4 O 0 0.0011018472723662853
mutant O 0 1.1037163858418353e-05
mice O 0 6.773750556021696e-07
die O 0 1.3782259600247926e-07
before O 0 4.645466233910156e-09
day O 0 1.6333897789877483e-08
7 O 0 3.0566656050723395e-07
. O 0 2.1706740938043367e-07

5 O 0 7.700205060245935e-06
of O 0 3.1066601877682842e-06
embryogenesis O 0 1.654460902500432e-05
. O 0 4.022798293590313e-06

Mutant O 0 2.505151996956556e-06
embryos O 0 1.5626307359184466e-08
have O 0 1.016413134213856e-10
reduced O 0 9.42093070221972e-10
size O 0 1.50709800195159e-09
, O 0 5.685794612908524e-10
fail O 0 5.16756637480853e-09
to O 0 1.0069814981861214e-09
gastrulate O 0 3.4221388887090143e-06
or O 0 5.719559936778751e-09
express O 0 1.3236723939158423e-09
a O 0 9.320058058648328e-10
mesodermal O 0 1.143204144682386e-07
marker O 0 2.6656596219254425e-07
, O 0 1.9036792142657077e-09
and O 0 3.1526341537357894e-09
show O 0 6.137412356110872e-08
abnormal O 0 8.001107687505282e-08
visceral O 0 3.3042349514289526e-06
endoderm O 0 1.7102991478168406e-05
development O 0 4.222839038448001e-07
. O 0 4.826088684239949e-07

Growth B-Disease 1 1.0
retardation I-Disease 1 1.0
of O 0 4.625743258657167e-06
the O 0 2.116806285812345e-07
Smad4 O 0 0.17454281449317932
- O 0 2.980628551085829e-06
deficient O 0 1.202123769417085e-07
embryos O 0 1.2854309838772338e-09
results O 0 4.415549523240081e-11
from O 0 2.0378533929776843e-11
reduced O 0 1.025544649202459e-09
cell O 0 1.0882003076417845e-09
proliferation O 0 1.431555887165814e-07
rather O 0 1.3778250762541688e-09
than O 0 4.3242048830549606e-10
increased O 0 7.450512651274721e-09
apoptosis O 0 3.3519273756610346e-07
. O 0 3.737009990345541e-07

Aggregation O 0 3.2864038530533435e-06
of O 0 1.132752458943287e-06
mutant O 0 2.4991313694044948e-06
Smad4 O 0 0.00044759249431081116
ES O 0 0.0001045836615958251
cells O 0 1.2955867489949924e-09
with O 0 6.146133602058512e-10
wild O 0 2.8261939633011934e-07
- O 0 4.0822897062753327e-07
type O 0 1.504626396808817e-07
tetraploid O 0 3.619675510435627e-07
morulae O 0 7.3068522397079505e-06
rescues O 0 7.074756354086276e-07
the O 0 1.2332041876561561e-07
gastrulation B-Disease 0 1.2331905054452363e-05
defect I-Disease 0 1.5812027413630858e-05
. O 0 7.073312531247211e-07

These O 0 1.0256179905354657e-07
results O 0 5.620713672271904e-09
indicate O 0 9.858260874295866e-10
that O 0 1.8901215315114683e-10
Smad4 O 0 3.4297841011721175e-06
is O 0 7.568775606259237e-10
initially O 0 3.8799941037837016e-10
required O 0 6.238787264578605e-11
for O 0 5.608115014044124e-11
the O 0 3.6873198938636165e-10
differentiation O 0 9.053490734878267e-10
of O 0 3.2972717889379055e-09
the O 0 7.659049394703743e-09
visceral O 0 3.590876929138176e-07
endoderm O 0 3.406323685339885e-07
and O 0 5.186406415447209e-09
that O 0 3.968355644090593e-10
the O 0 5.413972381518306e-09
gastrulation B-Disease 0 1.3307946744589572e-07
defect I-Disease 0 1.9146446206264045e-08
in O 0 5.032130268034507e-10
the O 0 8.024441555676276e-09
epiblast O 0 1.649084538257739e-06
is O 0 2.046088853902006e-09
secondary O 0 4.888283910986502e-08
and O 0 2.8895674741846733e-09
non O 0 1.6191404483834049e-06
- O 0 1.0932730219792575e-05
cell O 0 2.3234413220052375e-06
autonomous O 0 5.958628753433004e-05
. O 0 1.404382828695816e-06

Rescued O 0 3.878336428897455e-06
embryos O 0 1.003050797976357e-07
show O 0 6.769282379082142e-08
severe O 0 3.6975891362089897e-06
anterior O 0 1.947422424564138e-05
truncations O 0 0.018224205821752548
, O 0 2.681277955218775e-08
indicating O 0 1.0146011142353473e-08
a O 0 7.672716351159181e-10
second O 0 1.6065573316126347e-09
important O 0 2.648280261752234e-09
role O 0 5.273468772770684e-09
for O 0 6.381762673868252e-09
Smad4 O 0 3.665128315333277e-05
in O 0 2.3768629731080182e-08
anterior O 0 1.164661534858169e-05
patterning O 0 3.655466116470052e-06
during O 0 6.261936391638301e-07
embryogenesis O 0 5.262216291157529e-06
. O 0 1.4248087154555833e-06

Prevalence O 0 1.4204795661498792e-05
of O 0 3.593158623971249e-07
p16 O 0 1.6552199895158992e-06
and O 0 1.1631365737230226e-07
CDK4 O 1 1.0
germline O 0 1.545647705825104e-06
mutations O 0 1.2930989612414123e-08
in O 0 2.147839905930482e-09
48 O 0 2.9272916890477063e-07
melanoma B-Disease 1 0.9999995231628418
- O 0 0.009777886793017387
prone O 0 3.2071197892946657e-06
families O 0 3.4579358820785444e-10
in O 0 2.208854210650202e-09
France O 0 1.3902895261708181e-06
. O 0 7.008622446846857e-07

The O 0 7.056265530991368e-06
French O 0 0.00035658679553307593
Familial B-Disease 1 0.9999992847442627
Melanoma I-Disease 1 1.0
Study O 0 3.397645514269243e-06
Group O 0 2.7945040415033873e-07
. O 0 2.1354522061756143e-07

Germline O 0 1.4098126484896056e-05
mutations O 0 2.7416550807402018e-08
in O 0 2.6008202258509527e-09
the O 0 1.3802589293732126e-08
p16 O 0 1.386588195373406e-07
and O 0 1.6090483612174467e-08
CDK4 O 1 1.0
genes O 0 3.673962023498234e-09
have O 0 1.481837014205567e-10
been O 0 1.594303578045242e-10
reported O 0 1.2617008826598664e-10
in O 0 7.403827551044628e-11
a O 0 9.37520283628146e-10
subset O 0 1.2382641578767561e-08
of O 0 2.4877923721078332e-08
melanoma B-Disease 1 0.5525147914886475
pedigrees O 0 4.0938683554259114e-08
, O 0 5.805550484794253e-10
but O 0 9.509151105424607e-11
their O 0 1.0960027330142452e-10
prevalence O 0 9.643978948759013e-09
is O 0 1.9690400698824106e-10
not O 0 1.326082438302123e-10
well O 0 3.5036935575050165e-09
known O 0 6.5873962284968e-08
. O 0 3.4915643709609867e-07

We O 0 2.6440520883852514e-08
searched O 0 9.486949892334451e-09
for O 0 3.1607125250410206e-10
such O 0 2.9505295984222357e-09
germline O 0 4.236448702954476e-08
mutations O 0 1.3379375385369485e-09
in O 0 5.021028037788255e-10
48 O 0 4.4757936024097944e-08
French O 0 1.1132420695503242e-05
melanoma B-Disease 1 1.0
- O 0 0.00013932112779002637
prone O 0 3.9296119780374283e-07
families O 0 5.8250800016868e-11
selected O 0 1.0128058808289708e-10
according O 0 4.625415502002017e-12
to O 0 3.128747261271769e-11
two O 0 2.5914886556122063e-11
major O 0 7.799225154592193e-10
criteria O 0 3.447663710076654e-09
families O 0 1.9907025246984622e-12
with O 0 5.1084943566981345e-12
at O 0 8.364841597163775e-10
least O 0 6.358148729734836e-11
three O 0 4.2104469216708296e-11
affected O 0 3.138730941820711e-10
members O 0 3.660570457864054e-11
( O 0 4.9975787397293914e-11
n O 0 4.1258071958871767e-10
= O 0 2.7059665619333373e-10
20 O 0 2.7480864805973226e-10
) O 0 1.9574310922143567e-11
or O 0 1.8331700740725765e-11
families O 0 3.4875647834074763e-13
with O 0 2.388592362095876e-12
two O 0 1.640981794892582e-11
affected O 0 1.1187732684714291e-10
members O 0 3.3497597057285944e-12
, O 0 3.2258796328621386e-11
one O 0 2.1203179836892794e-11
of O 0 1.8918384914190511e-10
them O 0 2.919290850722511e-11
affected O 0 4.037986958693729e-11
before O 0 4.186614943613165e-11
the O 0 2.3679147531652234e-10
age O 0 4.000593745168146e-10
of O 0 7.535659318769206e-10
50 O 0 1.3526092468296724e-09
( O 0 7.300144516664275e-11
n O 0 7.192125783817005e-10
= O 0 7.953399605575839e-10
28 O 0 2.070539295573326e-09
) O 0 1.277720568237939e-10
, O 0 1.266506066688322e-10
and O 0 2.1369651881375518e-10
one O 0 2.8709973287632806e-10
additional O 0 3.903333212207372e-09
minor O 0 1.0438471917950665e-06
criterion O 0 0.00018488131172489375
. O 0 8.078129098976206e-07

Sixteen O 0 8.592593985667918e-06
different O 0 1.3521740171995589e-08
p16 O 0 4.010515226582356e-07
germline O 0 2.915600205710689e-08
mutations O 0 2.3114213321129284e-10
were O 0 8.335532264425183e-11
found O 0 2.763897270774418e-11
in O 0 2.678145726020542e-11
21 O 0 7.305218097108934e-10
families O 0 5.753162703181491e-12
, O 0 4.1847227072455695e-11
while O 0 4.43801134730748e-10
one O 0 1.890072098831297e-09
germline O 0 2.5050050922459377e-08
mutation O 0 1.3931998887883879e-09
, O 0 1.616466960285834e-09
Arg24His O 0 0.00018436764366924763
, O 0 1.0238506931159463e-08
was O 0 2.6214152626380383e-08
detected O 0 6.003086028272264e-09
in O 0 1.4874502740624962e-09
the O 0 7.330097417934667e-08
CDK4 O 1 0.9999939203262329
gene O 0 5.211646794123226e-07
. O 0 4.766139056755492e-07

The O 0 1.0288626128840406e-07
frequency O 0 4.241048756625787e-08
of O 0 5.2825221530383715e-08
p16 O 0 2.834010217611649e-07
gene O 0 2.3800463821999074e-09
mutation O 0 6.773124838765909e-10
in O 0 1.451790493378624e-10
our O 0 3.263172232426115e-10
sample O 0 2.213150357421867e-10
( O 0 2.4675719800804075e-11
44 O 0 5.088185428547831e-10
% O 0 2.630527046187936e-11
) O 0 3.550783278516434e-11
is O 0 5.0717499644470365e-11
among O 0 3.171992182804395e-11
the O 0 2.21477197692721e-10
highest O 0 2.3121986547636197e-09
rates O 0 5.902860422679623e-10
yet O 0 2.5257046454285614e-10
reported O 0 4.794105668004534e-10
and O 0 9.99606397655839e-10
the O 0 8.281059393766554e-09
CDK4 O 1 0.9245314002037048
mutation O 0 3.379245550050314e-09
is O 0 4.5556469707719316e-10
the O 0 8.558636022115707e-10
second O 0 5.5219122607752524e-09
mutation O 0 1.0637548619740755e-09
detected O 0 2.208555116567368e-09
in O 0 3.984571284032512e-10
this O 0 7.564359139067278e-10
gene O 0 1.792778370202086e-08
worldwide O 0 7.366566023847554e-08
. O 0 4.921950562675192e-07

In O 0 8.570700771315387e-08
summary O 0 9.36656050498641e-08
, O 0 2.511769237045769e-09
our O 0 1.4336081211041574e-09
results O 0 1.9797501138452134e-10
show O 0 1.1157201829092855e-09
frequent O 0 2.115363662014147e-09
involvement O 0 3.9869756385257915e-09
of O 0 1.0789377391517974e-08
the O 0 1.193614984629221e-08
p16 O 0 9.227996145000361e-08
gene O 0 2.0102375319908106e-09
in O 0 1.291466600328306e-09
familial B-Disease 0 2.3714685539744096e-06
melanoma I-Disease 1 0.9976993203163147
and O 0 4.2498973229498915e-09
confirm O 0 6.766784910183787e-10
the O 0 1.4932149960955599e-09
role O 0 3.3751939021442467e-09
of O 0 1.2000019644631266e-08
the O 0 3.399177117557883e-08
CDK4 O 1 1.0
gene O 0 1.8872128748625983e-08
as O 0 8.735272061244359e-09
a O 0 3.704954920635828e-08
melanoma B-Disease 1 0.9999932050704956
- O 0 0.0003337454982101917
predisposing O 0 1.1653303772618528e-05
gene O 0 3.593397579493285e-08
. O 0 1.3281949762244949e-08
. O 0 1.6024382887280808e-07

Progression O 0 3.1435109121957794e-05
of O 0 1.3291563618622604e-06
somatic O 0 1.32267841763678e-05
CTG O 0 0.004906988237053156
repeat O 0 2.148230748844071e-07
length O 0 8.961649200500688e-09
heterogeneity O 0 2.5921451651811367e-08
in O 0 3.3636882168508464e-10
the O 0 1.148417583252126e-09
blood O 0 2.3753070621523875e-09
cells O 0 9.623870589337002e-10
of O 0 1.8422799996642425e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 2.768231752270367e-05
. O 0 2.888186827476602e-07

The O 0 7.734184492846907e-08
genetic O 0 1.693578433048515e-08
basis O 0 1.251613568342691e-08
of O 0 8.51417667036003e-07
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.5579832196235657
DM B-Disease 1 1.0
) O 0 2.37660335855594e-09
is O 0 1.1520434606282492e-10
the O 0 2.2996406168207528e-10
expansion O 0 1.003634064744574e-08
of O 0 7.532544366029015e-09
an O 0 1.9651205107606984e-09
unstable O 0 1.5686008225657133e-07
CTG O 0 7.485222158720717e-05
repeat O 0 4.7583725404365396e-08
in O 0 7.793172773773449e-10
the O 0 2.428215406524714e-09
34 O 0 2.0754907126274702e-08
UTR O 0 1.7407543055014685e-05
of O 0 8.379156923865594e-08
the O 0 1.670515388241256e-07
DM B-Disease 1 1.0
protein O 0 1.3915719421220274e-07
kinase O 0 6.757710480087553e-08
gene O 0 3.5854132995893906e-09
on O 0 2.8939924234805403e-08
chromosome O 0 1.0833800700993379e-07
19 O 0 2.0445165205273952e-07
. O 0 1.5750255499824561e-07

One O 0 2.1567943875311357e-08
of O 0 7.586238304213566e-09
the O 0 1.7225985082802708e-09
principal O 0 2.311696967183252e-08
features O 0 3.2228324453598134e-09
of O 0 1.2692980888573402e-08
the O 0 4.1535028572070587e-07
DM B-Disease 1 1.0
mutation O 0 2.281672983883709e-08
is O 0 4.332989245181551e-10
an O 0 1.4466657038969544e-10
extraordinarily O 0 9.256567956583694e-09
high O 0 5.445562578643148e-08
level O 0 3.312458574100674e-08
of O 0 6.804051366771091e-08
somatic O 0 6.753741672582692e-07
mosaicism O 0 1.2734668416669592e-05
, O 0 9.563340119811414e-10
due O 0 2.876995752743028e-09
to O 0 4.638477935081653e-10
an O 0 2.0221808949560938e-10
extremely O 0 8.576022114681336e-10
high O 0 9.641954790140517e-09
degree O 0 4.310249934746935e-09
of O 0 4.707887413246681e-09
somatic O 0 4.915294482543686e-08
instability O 0 2.713504976270542e-08
both O 0 2.9609012464071327e-10
within O 0 1.6946172243237356e-10
and O 0 1.399297760995566e-10
between O 0 3.576587082054772e-10
different O 0 2.0670314349047203e-09
tissues O 0 1.1400620536505812e-07
. O 0 1.009801948725908e-07

This O 0 8.247991445387015e-08
instability O 0 4.880323558609234e-07
appears O 0 2.4854434066412523e-09
to O 0 1.6118234524853392e-10
be O 0 4.6837717732062245e-11
biased O 0 1.3284425781634468e-09
towards O 0 6.907792671206892e-10
further O 0 3.738777620831968e-10
expansion O 0 2.493568018735459e-09
and O 0 2.458693804108236e-10
continuous O 0 6.495735060951802e-10
throughout O 0 1.8340419460916024e-10
the O 0 5.292571381154687e-10
life O 0 3.5382707874731523e-10
of O 0 3.8434899707340264e-10
an O 0 5.257234578226466e-11
individual O 0 2.4369823867220752e-11
, O 0 2.502852265717781e-11
features O 0 3.0158578412375903e-10
that O 0 1.497240352532625e-11
could O 0 4.2648912179643617e-11
be O 0 1.2568075920260657e-11
associated O 0 3.2468670113638964e-11
with O 0 1.0741482703302552e-10
the O 0 7.287547454382093e-09
progressive O 0 5.836143373016967e-07
nature O 0 7.448142724797435e-08
of O 0 1.3319360903096822e-07
the O 0 5.07904758251243e-07
disease O 0 0.00011098286631749943
. O 0 3.899785951944068e-07

Although O 0 8.551204189188866e-08
increasing O 0 1.2572651364450849e-08
measured O 0 5.833091343276919e-09
allele O 0 1.2824481476769733e-09
size O 0 1.6824699411444044e-09
between O 0 5.786801038354383e-10
patients O 0 2.432865464641054e-09
clearly O 0 5.950031023438385e-10
correlates O 0 2.164342927102325e-09
with O 0 5.533176694605402e-11
an O 0 5.741852132645775e-11
increased O 0 5.314066409134455e-10
severity O 0 1.119750479006143e-07
of O 0 1.8316489658332102e-08
symptoms O 0 2.1420240159386594e-07
and O 0 2.7328653229297117e-10
an O 0 4.1334772410417386e-11
earlier O 0 2.994221259822183e-10
age O 0 1.7439049093681547e-09
of O 0 2.267195320371229e-09
onset O 0 7.127239598503365e-08
, O 0 3.4788932845586373e-10
this O 0 3.5788913499423813e-11
correlation O 0 6.251202333551475e-10
is O 0 7.87009693525853e-11
not O 0 1.80565840057767e-11
precise O 0 1.0082441548320276e-09
and O 0 3.1943855893779016e-10
measured O 0 1.730455778670148e-09
allele O 0 4.896369421025781e-10
length O 0 1.3532466258681097e-09
cannot O 0 3.1831579039298674e-10
be O 0 4.864837352402951e-11
used O 0 1.0026802305107552e-10
as O 0 1.350332484717498e-10
an O 0 6.612967118346802e-11
accurate O 0 7.841187255053228e-09
predictor O 0 2.8071812607777247e-07
of O 0 2.9304136006658155e-08
age O 0 3.3433131818583206e-08
of O 0 7.833148174540838e-08
onset O 0 4.367912879388314e-06
. O 0 5.537872880267969e-07

In O 0 3.987281615991378e-08
order O 0 5.0937911666437685e-09
to O 0 6.844525501925602e-10
further O 0 3.273753268473456e-09
characterize O 0 2.1024728624752242e-08
the O 0 6.861076151665202e-09
dynamics O 0 5.25549772589784e-08
of O 0 5.60383000447473e-07
DM B-Disease 1 1.0
CTG O 1 0.9999994039535522
repeat O 0 5.790968771179905e-07
somatic O 0 1.776579807710732e-07
instability O 0 3.34007559388283e-08
, O 0 4.2380121634266743e-10
we O 0 1.341278893507436e-10
have O 0 1.8286651706778123e-11
studied O 0 1.5423730070907027e-09
repeat O 0 7.789546785375023e-10
length O 0 1.9769089143473195e-10
changes O 0 8.421668223901335e-11
over O 0 1.6843217098827523e-10
time O 0 2.103040241951959e-10
in O 0 6.19183426753267e-10
111 O 0 2.5947083486244082e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 0 5.189952290152178e-08
with O 0 3.3502553509201505e-10
varying O 0 3.875203713477049e-09
clinical O 0 6.520095041651075e-08
severity O 0 2.0329072469849052e-07
and O 0 5.080769138743335e-09
CTG O 0 1.2653488738578744e-05
repeat O 0 3.464710962575168e-09
size O 0 3.541701099063488e-10
over O 0 5.128885094407565e-10
time O 0 1.2281346772891055e-10
intervals O 0 2.6538918285190505e-10
of O 0 5.080466602969125e-10
1 O 0 1.2688672335059437e-08
- O 0 9.235655795691855e-08
7 O 0 6.977558086873614e-08
years O 0 2.3005290117339428e-08
. O 0 1.628315686730275e-07

We O 0 1.0407086392660858e-07
have O 0 1.0419312079790188e-09
found O 0 3.663065684111899e-10
a O 0 1.1338906896751766e-10
direct O 0 3.7644659611757447e-10
progression O 0 4.7529824520609054e-09
of O 0 1.9936730044634032e-09
the O 0 1.2090716206003549e-09
size O 0 2.5655189084261565e-09
heterogeneity O 0 1.9148016505710075e-08
over O 0 6.068892499655476e-09
time O 0 6.538246055676211e-10
related O 0 1.984355790796144e-09
to O 0 5.177469009076674e-10
initial O 0 6.8154268895170844e-09
CTG O 0 2.9199022719694767e-06
repeat O 0 2.63943533695965e-09
size O 0 7.702468107773086e-10
and O 0 3.566899553497649e-10
the O 0 1.2602270338391008e-09
time O 0 4.202818648657569e-10
interval O 0 3.688320315831106e-09
and O 0 1.7620835901510645e-09
always O 0 5.030290850527308e-09
biased O 0 2.5655690905068695e-08
towards O 0 1.4835749517772001e-08
further O 0 2.33532677640369e-08
expansion O 0 1.2833023674829747e-06
. O 0 6.686386200271954e-07

Attempts O 0 3.9284876152123616e-07
to O 0 2.9660349731841507e-09
mathematically O 0 6.0334941487383276e-09
model O 0 5.374379830058729e-10
the O 0 6.406162267325044e-10
dynamics O 0 8.273922880164264e-09
have O 0 3.4539540672007263e-10
proved O 0 1.164713392398653e-08
only O 0 4.795175923000272e-10
partially O 0 5.333944841368066e-08
successful O 0 3.5410543386404925e-09
suggesting O 0 6.489431769729492e-10
that O 0 2.986593611309374e-11
individual O 0 2.6111314499477345e-11
specific O 0 9.065028588883806e-11
genetic O 0 6.768630655962227e-10
and O 0 7.415787983688915e-10
/ O 0 1.3164398637854902e-07
or O 0 9.891711894027821e-10
environmental O 0 1.2085793343885598e-07
factors O 0 4.996335789542172e-09
also O 0 4.424285660054039e-10
play O 0 8.543554308459989e-09
a O 0 2.0615937845747112e-09
role O 0 1.674192517953088e-08
in O 0 1.4624141009278446e-08
somatic O 0 9.89566160569666e-07
mosaicism O 0 1.3496636711352039e-05
. O 0 7.677232360947528e-08
. O 0 5.12898850502097e-07

Aspartylglucosaminuria B-Disease 1 1.0
among O 0 7.495270892832195e-07
Palestinian O 0 5.674943963640544e-07
Arabs O 0 3.5839934753312264e-07
. O 0 3.65366389587507e-07

Aspartylglucosaminuria B-Disease 1 1.0
( O 1 0.999702513217926
AGU B-Disease 1 1.0
) O 0 1.1785837017441736e-07
is O 0 8.249089411549448e-09
a O 0 6.004803765335964e-09
rare O 0 1.3548740298574558e-06
disorder B-Disease 1 1.0
of I-Disease 1 0.9763715267181396
glycoprotein I-Disease 1 0.6010521054267883
metabolism I-Disease 0 1.526521941741521e-06
caused O 0 5.1898698671948296e-09
by O 0 9.737606554427458e-11
the O 0 1.376270919450917e-08
deficiency B-Disease 0 4.2177703107881825e-06
of I-Disease 0 5.687953148481029e-07
the I-Disease 0 2.1117573112405807e-07
lysosomal I-Disease 0 0.0002422887337161228
enzyme I-Disease 0 1.7085933734506398e-07
aspartylglucosaminidase I-Disease 0 1.8713017198024318e-05
( O 0 1.2513176272932469e-08
AGA O 0 0.0004056004690937698
) O 0 8.592895994752325e-08
. O 0 3.8266267665676423e-07

AGU B-Disease 1 1.0
is O 0 1.8620112314238213e-06
inherited O 0 1.586008511367254e-05
as O 0 2.734406656657029e-08
an O 0 2.7554900583481867e-08
autosomal O 0 9.409868653165177e-05
recessive O 0 1.2799607702618232e-06
trait O 0 1.214450975339787e-07
and O 0 1.3597745152083007e-09
occurs O 0 4.4781692243311966e-11
with O 0 1.472224078757911e-11
a O 0 1.7212969938285028e-10
high O 0 1.043689934476788e-08
frequency O 0 1.33410493763364e-09
in O 0 6.924123496787615e-10
Finland O 0 2.0998221827994712e-07
because O 0 6.556844844851639e-09
of O 0 4.2284241885681695e-08
a O 0 2.2370038266217307e-08
founder O 0 1.0374400289947516e-06
effect O 0 4.91177047479141e-07
. O 0 4.296503561818099e-07

While O 0 1.642544305013871e-07
very O 0 5.962507820811425e-09
few O 0 5.677930126068986e-09
patients O 0 3.6390699342803146e-09
with O 0 3.566343442784614e-09
AGU B-Disease 1 1.0
have O 0 1.0627778657124054e-08
been O 0 8.766596337750343e-10
reported O 0 2.0360985120149167e-10
from O 0 1.0438441777615992e-10
non O 0 3.663390657493437e-08
- O 0 2.6607978043102776e-08
Finnish O 0 8.400469937441812e-07
origin O 0 3.352524369226728e-10
, O 0 1.9050112876062286e-10
we O 0 7.570508664400677e-10
diagnosed O 0 2.519303734516143e-07
the O 0 1.0753670842689189e-08
disorder O 0 7.881763508521544e-07
in O 0 6.192826251805172e-10
8 O 0 1.5615551518521897e-08
patients O 0 1.3900565420943423e-10
originating O 0 2.19486286784365e-11
from O 0 2.5394604821760147e-11
3 O 0 1.0106335768256258e-09
unrelated O 0 1.0546515882836616e-09
families O 0 2.172172381201265e-12
, O 0 1.0577286442547962e-11
all O 0 2.6056191926304706e-11
Palestinian O 0 3.6258765434560303e-10
Arabs O 0 5.77572711879526e-11
from O 0 3.3239470204060595e-11
the O 0 6.167929500477953e-10
region O 0 1.5445285939108544e-08
of O 0 1.0150796470043133e-07
Jerusalem O 0 9.370396583108231e-06
. O 0 7.147298219933873e-07

The O 0 5.81820984280057e-07
clinical O 0 6.583504273294238e-06
diagnosis O 0 0.00011907920998055488
of O 0 0.3424956500530243
AGU B-Disease 1 1.0
is O 0 2.5214328402967112e-08
often O 0 4.132115483113097e-10
difficult O 0 3.3090769013810473e-10
, O 0 5.745993611472322e-11
in O 0 2.3375693741778392e-11
particular O 0 4.6357778726857646e-11
early O 0 5.275506073654235e-11
in O 0 2.0867210737129938e-11
the O 0 2.8885577263437767e-10
course O 0 1.4532457459637271e-09
of O 0 8.078570590264178e-10
the O 0 1.3108387708626879e-09
disease O 0 6.139659802784081e-08
, O 0 8.156989667051917e-11
and O 0 2.467478998902095e-10
most O 0 1.5865862790231944e-10
of O 0 6.004548525062603e-10
the O 0 6.135159047460093e-10
patients O 0 2.674635235511147e-10
are O 0 4.7285089038728856e-11
diagnosed O 0 2.2721826642424503e-09
after O 0 2.3320217978906044e-10
the O 0 2.0215880081053683e-09
age O 0 2.4341881843525925e-09
of O 0 5.4451652076181745e-09
5 O 0 4.638013706426136e-08
years O 0 2.6918852924495695e-08
. O 0 1.650204950465195e-07

However O 0 1.6637265787267097e-07
, O 0 1.1737834704206307e-08
since O 0 1.3172399837557691e-09
these O 0 9.769796083247684e-10
patients O 0 8.319431255010556e-10
excrete O 0 3.356296218726129e-08
early O 0 8.320668598571501e-10
large O 0 1.6151787685103614e-09
amounts O 0 4.306790035712993e-09
of O 0 1.0342236400617821e-08
aspartylglucosamine O 0 9.29735392674047e-07
in O 0 1.1720983073004732e-09
urine O 0 7.31981097956691e-09
, O 0 2.9123292666355383e-10
biochemical O 0 2.6883844039815585e-09
screening O 0 6.366553062520097e-09
is O 0 8.077276070217465e-10
easy O 0 2.179812330638242e-09
by O 0 5.988307627546874e-10
urine O 0 4.737209735594661e-08
chromatography O 0 7.356680384873471e-07
. O 0 3.0984118382093584e-08
. O 0 1.9264514605765726e-07

Detection O 0 1.4766379763386794e-06
of O 0 9.352457652767043e-08
heterozygous O 0 1.0040170472791488e-08
carriers O 0 5.722677887121108e-10
of O 0 2.828062672932674e-09
the O 0 1.4263501668665413e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.2056921150360722e-07
ATM O 0 7.818562880856916e-05
) O 0 2.82481726898709e-09
gene O 0 1.027324336710933e-09
by O 0 4.827018229569546e-10
G2 O 0 5.5664193496340886e-05
phase O 0 4.4370597152010305e-07
chromosomal O 0 8.2733254203049e-07
radiosensitivity O 0 1.4461477803706657e-05
of O 0 7.560499284409161e-07
peripheral O 1 0.9998717308044434
blood O 0 2.572545099610579e-06
lymphocytes O 0 9.368058044856298e-07
. O 0 2.0275498968658212e-07

In O 0 4.75789647680358e-06
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 2.0600994048436405e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.0998334465384119e-09
patients O 0 6.736946001062449e-10
, O 0 7.341979801900322e-11
mutations O 0 5.837571398492614e-11
in O 0 5.964799487667705e-11
a O 0 1.7851436995286463e-10
single O 0 1.1750590778181191e-10
gene O 0 1.4868029030168373e-10
, O 0 4.073535120330263e-10
ATM O 0 4.528588760877028e-06
, O 0 5.099057287516473e-10
result O 0 1.752099021423703e-10
in O 0 3.027026407309563e-10
an O 0 1.1781869346805252e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 5.104732636596054e-09
embraces O 0 2.9708038695730465e-08
a O 0 2.3077385835623687e-10
variety O 0 2.4414323895882717e-09
of O 0 1.2655601011601902e-09
clinical O 0 2.7810187930299435e-08
features O 0 2.4628910022528316e-09
and O 0 1.1794517584817754e-09
manifests O 0 6.620382020372517e-09
extreme O 0 3.6567310957025256e-08
radiosensitivity O 0 5.343995894691034e-07
and O 0 5.128036661972146e-09
a O 0 2.8222539860678353e-09
strong O 0 9.185444405090948e-09
pre O 0 1.8316231944481842e-06
- O 0 2.0233615032339003e-06
disposition O 0 3.8090443013061304e-06
to O 0 1.7121426765243086e-07
malignancy B-Disease 0 0.0003081799659412354
. O 0 9.213730436385958e-07

Heterozygotes O 0 3.898435807059286e-06
for O 0 1.7555731091078997e-08
the O 0 2.1450162535074924e-08
ATM O 0 8.271795195469167e-07
gene O 0 1.4898694500331544e-09
have O 0 1.4572169859672357e-10
no O 0 4.778941686822691e-10
clinical O 0 7.790234235471871e-09
expression O 0 2.6605107006361095e-10
of O 0 5.9774358796005345e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
but O 0 1.7774965943573307e-09
may O 0 4.816845811106418e-10
be O 0 7.980402449980772e-10
cancer B-Disease 0 7.747236452360085e-08
prone O 0 3.9140410024174344e-08
with O 0 7.536406498864778e-10
a O 0 4.396980557430652e-09
moderate O 0 1.1026465074337466e-08
increase O 0 7.118375333625693e-10
in O 0 1.789422832132459e-09
in O 0 9.61982049574317e-09
vitro O 0 3.6296344774200406e-07
radiosensitivity O 0 3.37530582328327e-05
. O 0 7.143843276935513e-07

We O 0 1.6267418345705664e-07
performed O 0 1.4993324271017627e-07
a O 0 2.3977127838747947e-08
blind O 0 1.1066965299733056e-07
chromosomal O 0 3.276640825333743e-08
analysis O 0 1.193463994297872e-09
on O 0 1.785761938322139e-08
G2 O 0 4.2452470552234445e-06
- O 0 4.403285558396419e-08
phase O 0 1.7996784507090524e-08
lymphocytes O 0 5.804222102945289e-10
from O 0 1.7188102330312205e-10
7 O 0 6.0577902694092245e-09
unrelated O 0 1.0952498286087575e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 1.0445582176998869e-08
, O 0 3.498656642175746e-10
13 O 0 3.8411616110067826e-09
obligate O 0 9.255035848809712e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 6.959136555906298e-08
( O 0 5.0507441978764334e-11
parents O 0 2.390065749480197e-11
of O 0 7.71003330624076e-11
the O 0 1.0367091213270285e-10
patients O 0 4.215324270195886e-11
) O 0 1.7129969318019356e-11
, O 0 1.1770914798425736e-10
and O 0 1.0372042114070723e-09
14 O 0 1.1850378456301769e-08
normal O 0 7.561491877083881e-09
controls O 0 3.078418586710541e-08
following O 0 4.566654610016485e-09
X O 0 1.5119624663384457e-07
- O 0 3.586543684264143e-08
irradiation O 0 3.409117610431167e-08
with O 0 5.057543273068177e-10
1 O 0 4.3973017227472155e-08
Gy O 0 5.9397571021690965e-06
in O 0 3.102335055515937e-10
order O 0 3.461987641006914e-10
to O 0 1.014747175176467e-10
evaluate O 0 1.6201648911362554e-09
this O 0 7.095679599444793e-11
cytogenetic O 0 9.410396728526393e-08
method O 0 8.33558444490734e-10
as O 0 2.3886131961248225e-10
a O 0 1.3851603197778672e-10
tool O 0 4.061093239471347e-09
for O 0 2.514696784139403e-10
detection O 0 9.421010815913178e-08
of O 0 3.050038230867358e-07
ATM O 0 0.00038119449163787067
carriers O 0 3.7442728739733866e-07
. O 0 4.634896697552904e-07

Both O 0 6.694910439364321e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
homozygotes O 0 1.421699289494427e-05
and O 0 3.5101834328088444e-08
heterozygotes O 0 1.0302883168833432e-07
showed O 0 1.575808261655709e-09
significantly O 0 2.7162053162221866e-10
increased O 0 2.411036925664689e-10
levels O 0 1.2401922822036227e-09
of O 0 1.8598680373571597e-09
radiation O 0 2.6232116852042964e-06
- O 0 1.6917790617299033e-06
induced O 0 7.046448331493593e-07
chromatid O 0 5.380086918194138e-07
damage O 0 2.1942095429494657e-07
relative O 0 2.202178217558526e-09
to O 0 1.9948970253480525e-10
that O 0 9.597909272907046e-11
of O 0 9.633003728026779e-09
normal O 0 8.24423338485758e-08
controls O 0 1.5815835467947181e-06
. O 0 5.703390115741058e-07

These O 0 2.3801700166359296e-08
results O 0 1.184768283479798e-09
show O 0 1.5630204908134715e-09
that O 0 1.401894433872286e-10
the O 0 1.2448332142867002e-08
G2 O 0 0.00019001089094672352
- O 0 2.255868594147614e-06
phase O 0 8.100888067019696e-07
chromosomal O 0 2.0157276026111504e-07
radiosensitivity O 0 2.404482302154065e-07
assay O 0 2.849210867239549e-09
can O 0 3.293434275297713e-11
be O 0 6.091729551349623e-12
used O 0 1.6555215531788292e-11
for O 0 4.314695128959656e-11
the O 0 1.8128440415488e-10
detection O 0 1.8063570195181455e-08
of O 0 1.6769769217717112e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.6168358342838474e-05
. O 0 7.659343737032032e-07

In O 0 1.6263167879060347e-07
combination O 0 6.205531377645457e-08
with O 0 1.0459074717417138e-09
molecular O 0 2.714198643616328e-08
genetic O 0 1.7482377767663593e-09
analyses O 0 1.671081162335497e-09
, O 0 1.309363867330049e-10
this O 0 1.1364883860387476e-11
test O 0 5.785495346688485e-11
may O 0 1.3280460064990507e-11
be O 0 1.1127543331213019e-11
of O 0 1.125161144810427e-10
value O 0 2.468156790058629e-10
in O 0 2.5133431794110983e-11
studies O 0 4.4076170491180733e-10
of O 0 9.84946457727176e-10
familial B-Disease 0 2.220408212849634e-08
and I-Disease 0 7.333142537646609e-09
sporadic I-Disease 0 5.59527450150199e-07
cancers I-Disease 0 4.801322120329132e-06
aimed O 0 2.17733706620038e-08
at O 0 8.143190011189461e-10
determination O 0 7.174561500455923e-10
of O 0 6.908741911892946e-10
the O 0 3.528909386929513e-10
potential O 0 2.530807785561251e-09
involvement O 0 1.081529199531417e-09
of O 0 3.9101458071399975e-08
ATM O 1 0.9482750296592712
mutations O 0 1.9550904895027088e-08
in O 0 2.293443657208627e-09
tumor B-Disease 1 0.9999994039535522
risk O 0 2.432816188502329e-07
or O 0 7.100177668029062e-10
development O 0 1.6362891042120964e-09
. O 0 3.771992940215796e-09
. O 0 7.328279849616592e-08

Ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
: O 0 1.5834951128113062e-08
identification O 0 4.11176293013682e-09
and O 0 7.014033243102347e-10
detection O 0 2.1158777485652536e-07
of O 0 1.8264061907302676e-07
founder O 0 1.515403766916279e-07
- O 0 1.3591365188858617e-07
effect O 0 2.082350647469866e-08
mutations O 0 3.443521856549836e-10
in O 0 9.170800230329235e-11
the O 0 2.7771265287412916e-09
ATM O 0 3.8392084888982936e-07
gene O 0 1.2697333184874537e-09
in O 0 1.1058579607592378e-09
ethnic O 0 4.426687283398678e-08
populations O 0 3.94690680138865e-08
. O 0 7.164011606164422e-08

To O 0 2.649888486416785e-08
facilitate O 0 4.983382595469266e-09
the O 0 2.267009691081512e-09
evaluation O 0 8.936898332478904e-09
of O 0 1.8380044153332165e-08
ATM O 0 0.0001539259683340788
heterozygotes O 0 1.5457818847153248e-07
for O 0 1.539234295577785e-09
susceptibility O 0 2.823181510791528e-08
to O 0 5.45017031505779e-10
other O 0 2.6110893447395256e-09
diseases O 1 0.9932509064674377
, O 0 3.8845704430912065e-10
such O 0 3.3303282354069097e-09
as O 0 2.3087139311428473e-08
breast B-Disease 1 0.9999994039535522
cancer I-Disease 0 6.886054052301915e-06
, O 0 2.0907217623822305e-10
we O 0 1.858888182271201e-10
have O 0 3.5420433946997676e-11
attempted O 0 1.2300388485542157e-09
to O 0 7.864470186191852e-11
define O 0 6.553902975880987e-10
the O 0 2.305741014785312e-10
most O 0 6.290046261625548e-11
common O 0 6.335463403894792e-11
mutations O 0 9.650293585072856e-12
and O 0 1.8848178226504864e-11
their O 0 3.7503028460506016e-11
frequencies O 0 1.1621631434977076e-09
in O 0 5.844294381773807e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.5476906507246895e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 3.6812641823757986e-09
homozygotes O 0 1.5456625135357172e-07
from O 0 3.351840471843559e-10
10 O 0 3.2942040206762613e-09
ethnic O 0 8.383629790387204e-09
populations O 0 1.1764147878068343e-08
. O 0 5.582648654467448e-08

Both O 0 1.31322494212327e-07
genomic O 0 6.397010565706296e-08
mutations O 0 1.159820239848841e-09
and O 0 5.832020422147366e-10
their O 0 3.003779724952693e-10
effects O 0 1.9022465380658105e-08
on O 0 1.1176930492240444e-08
cDNA O 0 2.8302117982548225e-08
were O 0 5.988356921449167e-09
characterized O 0 1.4748954413335014e-07
. O 0 2.689727693905297e-07

Protein O 0 2.0396400657318736e-07
- O 0 9.567909842189692e-08
truncation O 0 1.8735987339368876e-07
testing O 0 8.487923253142071e-09
of O 0 8.397712747409969e-09
the O 0 1.2009177652316794e-08
entire O 0 1.0968993535698246e-07
ATM O 0 1.0183340464209323e-06
cDNA O 0 8.75145218515172e-08
detected O 0 2.173445068365254e-08
92 O 0 1.1162021706923042e-07
( O 0 7.268789459224934e-10
66 O 0 5.6355844435529434e-08
% O 0 1.0161111951845214e-09
) O 0 1.1761629448159283e-09
truncating O 0 1.5179611523308267e-07
mutations O 0 4.917992679764893e-09
in O 0 1.0537506422991783e-09
140 O 0 4.771951367388283e-08
mutant O 0 1.675725087579849e-07
alleles O 0 9.235370690419131e-09
screened O 0 7.028502295725048e-07
. O 0 2.2776710295602243e-07

The O 0 6.476775524788536e-07
haplotyping O 0 2.6019040888058953e-05
of O 0 2.2370834074081358e-07
patients O 0 4.36221370136991e-09
with O 0 5.697650129476983e-10
identical O 0 4.550918220047606e-08
mutations O 0 1.618787215384998e-09
indicates O 0 4.637071282509453e-10
that O 0 1.1169285114853711e-11
almost O 0 4.850864848693348e-11
all O 0 3.28850037478734e-11
of O 0 1.3788602204467537e-10
these O 0 5.6844910722997355e-11
represent O 0 2.4599496051269654e-11
common O 0 2.0081364349167075e-10
ancestry O 0 3.977992935055852e-11
and O 0 8.273030871475129e-11
that O 0 6.088375636981169e-11
very O 0 5.980180795006618e-10
few O 0 6.862516332972746e-09
spontaneously O 0 2.304037671763126e-08
recurring O 0 1.723936111375224e-05
ATM O 0 0.00023902914836071432
mutations O 0 2.469414539518766e-07
exist O 0 2.2151360212774307e-07
. O 0 3.800107890583604e-07

Assays O 0 3.2694670153432526e-06
requiring O 0 2.550868316575361e-07
minimal O 0 2.1871649380500457e-07
amounts O 0 1.7015889142157903e-08
of O 0 5.157286597778921e-09
genomic O 0 3.1379423504063197e-09
DNA O 0 8.276097029913387e-10
were O 0 5.3605148098156974e-11
designed O 0 1.084191514344468e-09
to O 0 3.935108627839412e-10
allow O 0 4.17450490841631e-10
rapid O 0 8.632724535218017e-10
screening O 0 1.8481066677011881e-09
for O 0 3.662422864980641e-10
common O 0 3.035387940997225e-09
ethnic O 0 2.725897729760618e-08
mutations O 0 8.449064381466087e-08
. O 0 8.517703520283249e-08

These O 0 1.9844841858684958e-07
rapid O 0 2.2289590617674548e-07
assays O 0 1.1122260445972643e-07
detected O 0 7.012621239255168e-08
mutations O 0 3.557538708065522e-09
in O 0 5.277762671340724e-10
76 O 0 2.271425358912893e-08
% O 0 1.1328833010582073e-10
of O 0 5.118203638687646e-10
Costa O 0 6.985681011428824e-08
Rican O 0 3.958721492836048e-07
patients O 0 1.0545208040113607e-09
( O 0 1.029755881259975e-11
3 O 0 6.521594375641371e-10
) O 0 4.566667183292239e-11
, O 0 6.949098935171705e-11
50 O 0 3.437707341014118e-10
% O 0 4.267275421909744e-11
of O 0 3.931020509106986e-10
Norwegian O 0 2.5501522671333987e-08
patients O 0 4.069085346447565e-10
( O 0 1.5872513373094144e-11
1 O 0 1.0028585739618734e-09
) O 0 5.925180485144566e-11
, O 0 4.863389899134596e-11
25 O 0 2.872202475856511e-10
% O 0 1.7603888832762316e-11
of O 0 2.217883238175844e-10
Polish O 0 2.1452622434026125e-07
patients O 0 9.040428405882039e-10
( O 0 2.996979400760047e-11
4 O 0 1.5003064346430506e-09
) O 0 5.6340605791849185e-11
, O 0 5.784314693890735e-11
and O 0 1.0623592977543339e-10
14 O 0 7.890241238150963e-10
% O 0 3.868346268309786e-11
of O 0 1.7681631159227607e-10
Italian O 0 3.806854209642552e-08
patients O 0 7.495135623258875e-10
( O 0 2.293511387752023e-11
1 O 0 3.137816673159932e-09
) O 0 1.7856580103448039e-10
, O 0 2.1707334540987944e-10
as O 0 2.2108889718985836e-10
well O 0 2.751411876111831e-10
as O 0 1.783693887036364e-10
in O 0 1.300949764582171e-10
patients O 0 8.617507263330992e-10
of O 0 4.732248815031426e-09
Amish O 0 9.799328637427607e-08
/ O 0 1.2448371933260205e-07
Mennonite O 0 8.064122170026167e-08
and O 0 5.783052259289434e-09
Irish O 0 1.8871918427976198e-07
English O 0 7.691112102747866e-08
backgrounds O 0 6.208242098182382e-08
. O 0 8.290513164865843e-08

Additional O 0 3.142904176911543e-07
mutations O 0 8.402600393253579e-09
were O 0 1.462084231462768e-09
observed O 0 9.064307082695677e-10
in O 0 2.8124508277826976e-10
Japanese O 0 2.5508967382847914e-08
, O 0 2.2630177731741696e-09
Utah O 0 1.1895017593133161e-07
Mormon O 0 5.9830367327151635e-09
, O 0 2.9085545083518127e-10
and O 0 1.0395927452222509e-09
African O 0 3.635226786258272e-09
American O 0 3.206291765422975e-08
patients O 0 3.940498061183462e-08
. O 0 7.835060955585504e-08

These O 0 2.4200421222531077e-08
assays O 0 2.0882371387642706e-08
should O 0 4.69311034478892e-10
facilitate O 0 5.239159106551483e-10
screening O 0 1.5792505081435593e-09
for O 0 1.2672654037260145e-09
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
heterozygotes O 0 1.0820295415214787e-07
in O 0 6.759496851138636e-10
the O 0 1.8659225275996505e-09
populations O 0 6.972123989257284e-10
studied O 0 1.6155924598137972e-08
. O 0 4.931415276132611e-09
. O 0 1.0791420379518968e-07

The O 0 5.887668976356508e-06
von B-Disease 1 0.9999887943267822
Hippel I-Disease 1 1.0
- I-Disease 1 0.9999998807907104
Lindau I-Disease 1 0.9999998807907104
tumor I-Disease 1 0.99898761510849
suppressor O 0 1.3572013813245576e-05
gene O 0 1.1551405165732831e-08
is O 0 6.986088374461019e-10
required O 0 3.8472747210249736e-10
for O 0 6.454743961548104e-10
cell O 0 1.0104488801232492e-08
cycle O 0 2.3562842343949342e-08
exit O 0 2.672424592731204e-08
upon O 0 7.175112504143044e-09
serum O 0 7.728007034302209e-08
withdrawal O 0 3.985852856658312e-07
. O 0 3.771916112782492e-07

The O 0 1.9171740461843e-07
inactivation O 0 3.6352264487504726e-06
of O 0 1.703960634813484e-07
the O 0 9.166982550823377e-08
von B-Disease 1 0.9998838901519775
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( I-Disease 0 1.1146315728183254e-06
VHL I-Disease 1 1.0
) I-Disease 0 1.0707869080306409e-07
tumor I-Disease 0 0.0038247848860919476
suppressor O 0 0.00016887996753212065
gene O 0 7.806926305420347e-08
predisposes O 0 3.298944193375064e-07
affected O 0 3.9138599028376575e-09
individuals O 0 2.089293842100215e-11
to O 0 6.973636945684092e-11
the O 0 6.011828812546582e-09
human O 0 0.0991334319114685
VHL B-Disease 1 1.0
cancer I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 1.878635691454633e-09
is O 0 2.588338432474302e-10
associated O 0 2.87554591249517e-10
with O 0 4.282622867446406e-10
sporadic B-Disease 0 0.03139553964138031
renal I-Disease 1 1.0
cell I-Disease 1 1.0
carcinomas I-Disease 1 1.0
( O 0 0.3922629952430725
RCC B-Disease 1 1.0
) O 0 4.5296238226910646e-07
and O 0 1.5418700058944523e-06
brain B-Disease 1 0.995297372341156
hemangioblastomas I-Disease 1 0.9734225273132324
. O 0 2.1978253244014923e-06

VHL O 1 0.9999940395355225
- O 0 2.9607988835778087e-05
negative O 0 6.474539873124741e-07
786 O 0 1.3320241123437881e-06
- O 0 1.3373638694247347e-06
0 O 0 3.9892984204925597e-07
RCC B-Disease 0 0.02076559141278267
cells O 0 1.0113128112720915e-08
are O 0 8.165150222616546e-10
tumorigenic O 0 3.6175954392092535e-06
in O 0 8.778849647228526e-09
nude O 0 1.8354490975980298e-06
mice O 0 6.676494912483122e-09
which O 0 1.028815990733456e-10
is O 0 1.3034658075117278e-10
suppressed O 0 2.7935054269789816e-09
by O 0 5.723745089003529e-11
the O 0 3.821256200353673e-09
reintroduction O 0 1.1137825595142203e-06
of O 0 6.025630341355281e-07
VHL B-Disease 1 0.9998613595962524
. O 0 3.199122375008301e-06

Remarkably O 0 3.2595728498563403e-06
, O 0 7.406574908941366e-09
this O 0 8.672113027685668e-11
occurs O 0 8.882847929436721e-11
without O 0 1.5515604079308076e-10
affecting O 0 9.226756580993367e-10
the O 0 3.4612943067280355e-10
growth O 0 3.829039030289749e-10
rate O 0 4.829928124117089e-10
and O 0 2.305169527483386e-10
cell O 0 1.2260078507964067e-09
cycle O 0 2.4705835155458544e-09
profile O 0 1.7938106555703826e-09
of O 0 1.6961864135467408e-09
these O 0 2.9537491896824974e-10
cells O 0 1.4409597126618934e-10
in O 0 7.857082207074484e-10
culture O 0 4.995709090849232e-08
. O 0 1.7515471029128094e-07

The O 0 7.679926170567342e-07
786 O 0 1.054229642249993e-06
- O 0 1.3640982388096745e-07
0 O 0 1.8127940037970802e-08
cell O 0 5.04832176062564e-09
line O 0 1.1731773952305957e-07
, O 0 1.1795844301332181e-09
like O 0 1.3123196973552353e-09
many O 0 7.561705150926912e-10
cancer B-Disease 0 1.643120306482615e-08
cells O 0 5.870442326694203e-11
, O 0 1.9747493917865455e-10
fails O 0 1.4432984807299931e-09
to O 0 4.2262754407218495e-10
exit O 0 2.7057939888663896e-08
the O 0 5.276507231144478e-09
cell O 0 1.74390244467304e-08
cycle O 0 2.402065746309745e-08
upon O 0 8.69161187466716e-09
serum O 0 5.99299809778131e-08
withdrawal O 0 3.2001398153624905e-07
. O 0 2.419274380827119e-07

Here O 0 3.521167357689592e-08
, O 0 2.3267359150480615e-09
it O 0 1.9386239835661456e-10
is O 0 4.9768418552975646e-11
shown O 0 2.532504934926738e-11
that O 0 1.7435072482974157e-11
reintroduction O 0 4.9456794215529953e-08
of O 0 3.120442793047573e-09
the O 0 3.254012614917201e-09
wild O 0 1.1110237352340846e-07
- O 0 3.583094780879037e-07
type O 0 1.6116489121031918e-07
VHL B-Disease 0 0.0038779962342232466
gene O 0 4.190198410469748e-09
restores O 0 7.145326552659981e-09
the O 0 6.008833985937656e-10
ability O 0 8.92619589354382e-10
of O 0 1.238542868264858e-08
VHL O 1 1.0
- O 0 0.0029349990654736757
negative O 0 6.436947614929522e-07
RCC B-Disease 1 0.9997000694274902
cancer I-Disease 0 1.767093493754146e-07
cells O 0 7.164602244813523e-11
to O 0 1.3027474932147953e-10
exit O 0 6.625826998174489e-09
the O 0 1.7453989364923927e-09
cell O 0 4.162898026294215e-09
cycle O 0 1.762760248880113e-08
and O 0 6.0423501757611575e-09
enter O 0 1.1226375562500834e-07
G0 O 0 0.00015087956853676587
/ O 0 4.224388248985633e-06
quiescence O 0 1.3622278629554785e-06
in O 0 1.8942666102361727e-08
low O 0 6.637389446950692e-07
serum O 0 3.730838500359823e-07
. O 0 1.4741699772002903e-07

Both O 0 2.13220755540533e-06
VHL O 1 0.9999996423721313
- O 0 4.687060027208645e-06
positive O 0 2.8991745892881227e-08
and O 0 1.1970530344740382e-08
VHL O 1 0.9990437626838684
- O 0 1.4714057670062175e-06
negative O 0 1.4052548635845596e-07
RCC B-Disease 0 7.14488560333848e-05
cells O 0 5.062264385458093e-09
exit O 0 3.355342315103371e-08
the O 0 6.458368506656598e-09
cell O 0 1.1224742912929742e-08
cycle O 0 1.0572300368494325e-08
by O 0 7.052008976771162e-10
contact O 0 3.260301184582204e-08
inhibition O 0 9.951506854122272e-07
. O 0 8.996037763608911e-07

The O 0 3.0818137020105496e-06
cyclin O 0 2.2099857233115472e-05
- O 0 5.9954386415483896e-06
dependent O 0 1.7884772773868463e-07
kinase O 0 1.3909243534726556e-07
inhibitor O 0 6.357054616046298e-08
, O 0 4.497407335435355e-09
p27 O 0 5.280789423522947e-07
, O 0 2.1881436662596343e-09
accumulates O 0 8.888076941104828e-09
upon O 0 4.976493661601467e-10
serum O 0 1.386945447379162e-09
withdrawal O 0 1.5810648346104017e-09
, O 0 1.4233302036981144e-10
only O 0 2.3522572778489348e-11
in O 0 2.4844029611337248e-11
the O 0 4.79936645980672e-10
presence O 0 9.572903580945535e-10
of O 0 1.6424309023932437e-08
VHL B-Disease 1 0.9999991655349731
, O 0 3.071842114010792e-09
as O 0 5.821229054348009e-10
a O 0 1.584756492700734e-10
result O 0 1.8274178004151764e-10
of O 0 7.843426463871594e-10
the O 0 1.198080190611961e-09
stabilization O 0 8.83559820863411e-08
of O 0 5.043743200872086e-08
the O 0 4.106623663346909e-08
protein O 0 8.50108392569382e-08
. O 0 1.0554131790740939e-07

We O 0 5.088355692350888e-08
propose O 0 1.1751454920272408e-08
that O 0 1.4911366585934616e-10
the O 0 2.1240926795229598e-09
loss O 0 4.3589224674178695e-08
of O 0 1.053651175197956e-07
wild O 0 4.855444785789587e-06
- O 0 6.387289886333747e-06
type O 0 8.469505701214075e-07
VHL B-Disease 1 0.9944769740104675
gene O 0 1.1453112902515272e-09
results O 0 1.443297842351754e-10
in O 0 4.806564868342633e-11
a O 0 1.9710993948152122e-10
specific O 0 1.8550143643381034e-09
cellular O 0 2.114166619548996e-08
defect O 0 2.9716540339563835e-08
in O 0 8.07766131760701e-10
serum O 0 2.9958581393429995e-08
- O 0 4.0452172811455966e-07
dependent O 0 8.380927951634476e-09
growth O 0 2.3324677744795963e-09
control O 0 2.1796722649014555e-08
, O 0 1.1956193812778793e-09
which O 0 1.0479781487049422e-09
may O 0 3.2171698638450152e-09
initiate O 0 1.394406723420616e-07
tumor B-Disease 0 9.898334974423051e-05
formation O 0 1.939711637533037e-06
. O 0 7.321685302486003e-07

This O 0 1.4106183776618764e-08
is O 0 3.8419969428105105e-09
corrected O 0 9.439966142110734e-09
by O 0 9.928886879340126e-11
the O 0 3.4869600540332613e-09
reintroduction O 0 3.777222161716054e-07
of O 0 3.026683259577112e-08
wild O 0 1.579238301019359e-06
- O 0 4.755242571263807e-06
type O 0 4.890927357337205e-06
VHL B-Disease 1 1.0
, O 0 2.1287172913275754e-08
implicating O 0 7.916773029137403e-06
VHL B-Disease 1 1.0
as O 0 1.0123703653164284e-08
the O 0 7.491909315149314e-09
first O 0 3.4233595957999796e-09
tumor B-Disease 0 1.0668824188542203e-06
suppressor O 0 2.233193043821302e-07
involved O 0 1.7894945525398498e-09
in O 0 2.691307454671943e-10
the O 0 1.8853336669621967e-09
regulation O 0 2.1119177517903154e-08
of O 0 1.8995310213654193e-08
cell O 0 4.4432311163689064e-09
cycle O 0 5.152920756756885e-09
exit O 0 3.7450740286715245e-09
, O 0 1.4190391917079381e-10
which O 0 6.258345230936158e-11
is O 0 9.678963186487977e-11
consistent O 0 6.60316468170663e-10
with O 0 4.3867399296404486e-11
its O 0 2.1162231966798117e-09
gatekeeper O 0 5.171611761056738e-08
function O 0 8.739016732484117e-10
in O 0 5.56405033158569e-10
the O 0 4.530505037791954e-08
kidney O 0 0.00029115681536495686
. O 0 5.637315680928623e-08
. O 0 5.563546210396453e-07

Piebaldism B-Disease 1 1.0
with O 0 0.1598803550004959
deafness B-Disease 1 1.0
: O 0 1.1753611062204072e-07
molecular O 0 6.078973768808282e-08
evidence O 0 3.234681189567823e-09
for O 0 1.0190224219996935e-09
an O 0 4.52209425461092e-09
expanded O 0 2.86298254650319e-05
syndrome O 1 0.9999616146087646
. O 0 7.772944741191168e-07

In O 0 2.0766865560517545e-08
a O 0 4.806202991147757e-09
South O 0 1.3449334090864795e-08
African O 0 3.46525297345579e-09
girl O 0 9.720062088547365e-09
of O 0 4.088692495685109e-09
Xhosa O 0 5.849650506206672e-07
stock O 0 2.6019977283908702e-08
with O 0 6.87016110667571e-10
severe O 0 1.3531888498619082e-06
piebaldism B-Disease 1 0.9999074935913086
and O 0 0.00012983917258679867
profound O 1 1.0
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 7.254748925333843e-05
identified O 0 1.380553715790711e-08
a O 0 1.1912829611659959e-09
novel O 0 1.1864921489745939e-08
missense O 0 6.620130221790532e-09
substitution O 0 1.9148336249941167e-09
at O 0 4.085854765634167e-09
a O 0 6.310525435537784e-10
highly O 0 2.8938698104497007e-09
conserved O 0 1.7932983098489785e-08
residue O 0 4.7846381079352795e-08
in O 0 5.635245603485828e-10
the O 0 4.014576671096393e-09
intracellular O 0 4.638205819418317e-09
kinase O 0 1.3432875256569332e-08
domain O 0 3.888842581289964e-09
of O 0 1.0861106680692956e-08
the O 0 2.7004269043118256e-08
KIT O 0 0.0005774375167675316
proto O 0 0.00012584144133143127
- O 0 0.0005659954040311277
oncogene O 0 3.720227687153965e-05
, O 0 1.0772767211619794e-07
R796G O 0 3.122203270322643e-05
. O 0 9.113076657740748e-07

Though O 0 5.723076128560933e-07
auditory B-Disease 0 1.4086836927162949e-05
anomalies I-Disease 0 1.3362953723117243e-05
have O 0 2.0874435513462686e-09
been O 0 1.2449131725489337e-09
observed O 0 5.787728074579945e-10
in O 0 1.4350298727094923e-10
mice O 0 1.9784904825570493e-09
with O 0 2.7680030489918295e-10
dominant O 0 8.877830026676747e-08
white O 0 1.3700792500515035e-08
spotting O 0 1.1042070582334418e-05
( O 0 7.397412460363739e-09
W O 0 1.2428114132490009e-05
) O 0 3.833474648828883e-10
due O 0 2.7961974957690927e-09
to O 0 1.0240142067630131e-09
KIT O 1 0.9999998807907104
mutations O 0 7.14292980319442e-07
, O 0 7.120608813693252e-08
deafness B-Disease 1 1.0
is O 0 2.1819058559913174e-08
not O 0 7.831676973601986e-10
typical O 0 1.480104216966538e-08
in O 0 2.799682263798786e-09
human O 0 4.857204771724355e-08
piebaldism B-Disease 0 7.633994391653687e-05
. O 0 7.360736731243378e-07

Thus O 0 2.665985334715515e-07
, O 0 4.0111856058899775e-09
the O 0 1.9199171141792704e-09
occurrence O 0 7.646499255997696e-08
of O 0 3.8799939829914365e-06
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
in O 0 3.021445763806696e-06
this O 0 1.9920815219620636e-08
patient O 0 3.254088909443453e-08
extends O 0 3.1660842836345182e-09
considerably O 0 4.0477823870510576e-10
the O 0 3.7372802075275047e-10
phenotypic O 0 2.6329303182137664e-08
range O 0 1.5735864167254476e-08
of O 0 7.585920336339314e-09
piebaldism B-Disease 0 3.357225182298862e-07
due O 0 5.518290269179715e-09
to O 0 1.2115002334667224e-09
KIT O 0 2.1079989892314188e-05
gene O 0 5.718272966248605e-09
mutation O 0 1.2368801538542584e-09
in O 0 1.6032078442584918e-10
humans O 0 7.884765618193512e-10
and O 0 6.859110501800103e-10
tightens O 0 1.2625402234789362e-07
the O 0 3.4336200549489604e-09
clinical O 0 1.1781640552044337e-08
similarity O 0 9.412022272670129e-10
between O 0 2.862587666907501e-10
piebaldism B-Disease 0 3.786780382597499e-07
and O 0 7.708008120665966e-10
the O 0 5.766098709614198e-10
various O 0 4.0218861574459197e-10
forms O 0 3.2733662447270717e-09
of O 0 1.4273520037022536e-06
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 2.6715021306245035e-08
. O 0 1.7956570275146078e-07

Cycloheximide O 0 0.00015331631584558636
facilitates O 0 1.280137524872771e-07
the O 0 7.084111519617409e-09
identification O 0 5.476997078091017e-09
of O 0 2.1147071649352256e-08
aberrant O 0 7.405193969134416e-08
transcripts O 0 4.53541595391016e-08
resulting O 0 3.122415037637438e-08
from O 0 2.2053392445542386e-09
a O 0 3.2708884489807133e-09
novel O 0 6.453728218502874e-08
splice O 0 3.2401848670815525e-07
- O 0 1.0574058961765331e-07
site O 0 3.529693870518713e-08
mutation O 0 2.662695175459362e-09
in O 0 4.369489770006396e-10
COL17A1 O 1 0.9999667406082153
in O 0 3.6727076935250125e-09
a O 0 8.810704166251071e-09
patient O 0 1.994168563612675e-08
with O 0 1.4658852798277167e-08
generalized O 0 4.0875354898162186e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
. O 0 3.390345591469668e-05

Patients O 0 5.894220066693379e-06
with O 0 1.826399227411457e-07
generalized O 0 0.00015791798068676144
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
often O 0 3.941723036859912e-08
show O 0 1.3633824735848066e-08
decreased O 0 1.8416679736787955e-08
expression O 0 1.1876326588833308e-09
of O 0 3.9454746136868835e-09
type O 0 1.0390281204308849e-06
XVII O 1 1.0
collagen O 1 0.9999815225601196
, O 0 5.6887515142989287e-08
a O 0 2.1578973274927193e-08
transmembrane O 0 3.38064616300926e-08
hemidesmosomal O 0 1.0352439403504832e-06
protein O 0 2.4041961754761587e-09
encoded O 0 5.763360899635472e-10
by O 0 2.2757304929399425e-09
COL17A1 O 1 0.9999879598617554
. O 0 1.5375059092548327e-06

This O 0 3.388198877019022e-08
report O 0 1.4022809580183093e-08
documents O 0 3.633855882867465e-08
a O 0 1.312665887098774e-08
novel O 0 2.7140131919622945e-07
splice O 0 9.040864483722544e-07
- O 0 1.964610447657833e-07
site O 0 4.9606246221856054e-08
mutation O 0 4.48880310699451e-09
in O 0 7.26874782586151e-10
COL17A1 O 1 0.9999998807907104
in O 0 2.238428109535562e-09
a O 0 3.1069971040409428e-09
patient O 0 4.795800201407019e-09
with O 0 5.199817909584681e-09
generalized O 0 3.333270797156729e-05
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 7.96685881709891e-08
and O 0 1.5125040775387788e-08
applies O 0 9.03503671878525e-09
a O 0 2.719180713928182e-10
new O 0 2.8507371463426523e-10
methodology O 0 1.0226928193191043e-09
to O 0 2.2175195013574012e-10
define O 0 3.751007504604331e-09
and O 0 1.4882959309403532e-09
characterize O 0 1.3574332058396976e-07
the O 0 2.0868037964305586e-08
resulting O 0 3.520482394492319e-08
mRNA O 0 1.8689408420868858e-07
splice O 0 2.2640565475740004e-06
variants O 0 7.222416229524242e-07
. O 0 4.3816288552989135e-07

Mutational O 0 4.772004103870131e-05
analysis O 0 8.309906718295679e-08
of O 0 3.768223848510388e-07
COL17A1 O 1 0.9999984502792358
identified O 0 5.8033865713014166e-08
a O 0 1.3982053737038314e-08
maternally O 0 4.42603777628392e-07
inherited O 0 5.959327040727658e-07
G O 0 4.018555159746029e-07
- O 0 2.991912140259956e-08
to O 0 2.8311337718633922e-09
- O 0 1.965310957530164e-06
T O 0 1.3388275874604005e-06
transversion O 0 8.621869937996962e-07
at O 0 4.82396478318492e-09
the O 0 8.732119471943633e-10
- O 0 8.601615419934205e-09
1 O 0 1.2316992759053846e-08
position O 0 1.74121357332524e-08
of O 0 2.3289748796173626e-08
exon O 0 3.6384724353411e-06
32 O 0 2.1063599433546187e-06
. O 0 5.038897370468476e-07

This O 0 4.394015107322957e-08
acceptor O 0 7.730641904402091e-09
splice O 0 3.408715087971359e-07
- O 0 1.377771212673906e-07
site O 0 4.060715852460817e-08
mutation O 0 1.4567229644768531e-09
led O 0 1.3420269340258528e-09
to O 0 3.261915182406483e-10
the O 0 1.6724170937010285e-09
formation O 0 5.042528616883146e-09
of O 0 1.6406900726906315e-08
aberrant O 0 5.99720362259859e-09
transcripts O 0 8.045528687716796e-09
present O 0 2.5189030861128003e-09
at O 0 3.58065186389922e-08
extremely O 0 3.931594250161652e-08
low O 0 8.034359098019195e-07
levels O 0 4.1463709976596874e-07
. O 0 2.513443462248688e-07

Based O 0 1.4673993575797795e-07
on O 0 4.4366530005390814e-08
our O 0 4.655666518971202e-09
recent O 0 1.9766950298816255e-09
finding O 0 1.5711595358069985e-09
that O 0 3.876739484987013e-10
cycloheximide O 0 2.3358049929811386e-06
stabilized O 0 1.159891439783678e-06
mutant O 0 6.010272386447468e-07
COL17A1 O 0 7.683670992264524e-05
transcripts O 0 4.196950698087676e-08
in O 0 1.6209932285349282e-09
keratinocytes O 0 2.2824913514796208e-08
homozygous O 0 8.107424953607278e-09
for O 0 6.740339397737216e-10
a O 0 3.6034784045568813e-09
frameshift O 0 8.705087850557902e-08
mutation O 0 1.5274714826318814e-09
, O 0 2.5658600244504726e-10
the O 0 9.272326240150619e-10
effects O 0 4.471535319794384e-08
of O 0 1.1934464083651619e-08
the O 0 7.856382211457458e-09
splice O 0 1.1795991383678484e-07
- O 0 4.902485883917507e-08
site O 0 1.445412234346577e-08
mutation O 0 2.346679239817462e-10
on O 0 6.592304480079747e-10
splicing O 0 6.073083813618041e-09
of O 0 9.966864666921538e-09
COL17A1 O 0 7.23405901226215e-05
transcripts O 0 1.9036185960885632e-08
were O 0 1.07947661920349e-09
determined O 0 8.110375149250615e-10
using O 0 2.1150801943203845e-10
reverse O 0 9.553714486187914e-10
transcriptase O 0 6.009957531638577e-10
polymerase O 0 1.1253333820349098e-09
chain O 0 1.0768936853366995e-09
reaction O 0 1.2491273293502303e-10
of O 0 1.1380035802588395e-09
total O 0 3.0424932018213724e-10
RNA O 0 5.130051938806446e-09
from O 0 1.0332117383882178e-09
keratinocytes O 0 6.139540431604473e-09
incubated O 0 3.817817617601804e-09
for O 0 7.505120969142354e-10
2 O 0 1.215321248082546e-07
. O 0 1.629777557354828e-07

5 O 0 2.394747298239963e-07
h O 0 1.3782885055491079e-08
in O 0 5.392482016475242e-10
the O 0 2.744379612451553e-09
presence O 0 2.374890506473548e-09
or O 0 2.0235400022272643e-09
absence O 0 1.1176759961983862e-08
of O 0 2.4727487613063204e-08
10 O 0 6.871962909826834e-08
microg O 0 1.55128727783449e-05
cycloheximide O 0 1.6597517969785258e-05
per O 0 9.637692954811428e-08
ml O 0 6.246551947697299e-06
. O 0 5.53075835796335e-07

Using O 0 5.64396422930713e-08
this O 0 1.7175592059714972e-09
approach O 0 1.548519712457619e-08
, O 0 2.931161091623835e-09
an O 0 2.4235609075162756e-09
abnormally O 0 9.142815571294705e-08
spliced O 0 2.2115330011729384e-07
transcript O 0 3.948533233710805e-08
was O 0 3.028612027833333e-08
identified O 0 3.2822358719819533e-10
that O 0 2.7538360480861002e-11
contains O 0 3.745372068042485e-10
an O 0 7.392989692656116e-11
extra O 0 1.2843061059086835e-09
264 O 0 1.1138702182833526e-09
bases O 0 1.6849105444194379e-09
upstream O 0 1.3808091559042168e-08
from O 0 7.702468107773086e-10
exon O 0 8.769398363028813e-08
32 O 0 2.4174218182793084e-08
, O 0 5.78428471786907e-10
resulting O 0 1.61618951555198e-09
in O 0 9.174618842422433e-10
a O 0 1.122844750511831e-08
premature O 0 1.1165428759341012e-07
termination O 0 1.256383370673575e-07
codon O 0 2.8984487698835437e-07
27 O 0 1.2119367909235734e-07
bp O 0 8.053024913579065e-08
downstream O 0 1.9686370933413855e-07
from O 0 6.2735416861414706e-09
the O 0 5.8634906707766277e-08
cryptic O 0 3.6288251976657193e-06
splice O 0 1.0549403668846935e-05
site O 0 3.41924851454678e-06
. O 0 1.7346224012726452e-06

Three O 0 7.51656017428104e-08
other O 0 2.4103579132628283e-09
splice O 0 5.4490950418539796e-08
variants O 0 6.031733335021272e-09
, O 0 4.215294224785282e-10
including O 0 2.2543918121176176e-10
one O 0 1.2913231595135244e-10
derived O 0 2.6546953871275925e-11
from O 0 4.126088706812858e-11
the O 0 8.2533657685957e-10
skipping O 0 2.8931093964956744e-08
of O 0 1.6091680876684222e-08
exon O 0 1.3967517986657185e-07
32 O 0 3.0734494060880024e-08
, O 0 1.1051430881536817e-09
were O 0 1.548950190333187e-09
also O 0 3.230001821563633e-09
identified O 0 1.4845572771093885e-08
. O 0 1.3745243165885768e-07

These O 0 4.78336943388058e-08
results O 0 2.108921703936062e-09
indicate O 0 5.019811788464779e-10
the O 0 9.623357666299626e-10
usefulness O 0 4.704604705807469e-08
of O 0 1.5164065558792572e-08
cycloheximide O 0 1.6197845980059355e-06
treatment O 0 9.685195756503617e-09
in O 0 1.2770433321929175e-10
evaluating O 0 7.0845977973021945e-09
the O 0 1.6576687800196055e-09
abnormal O 0 5.984368556255504e-10
processing O 0 2.0599313366176375e-09
of O 0 2.4875066451102157e-09
mRNA O 0 6.198442648042146e-09
due O 0 5.237463351903671e-09
to O 0 8.136917251100328e-10
splice O 0 7.810203328517673e-08
- O 0 3.471896903306515e-08
site O 0 1.3052310343653062e-08
mutations O 0 1.5524431740132627e-09
, O 0 3.058225062080311e-10
because O 0 1.0131618877196047e-09
( O 0 4.940601816549872e-10
i O 0 6.3528213800623234e-09
) O 0 1.017395057090198e-09
aberrant O 0 7.098813981087915e-09
splicing O 0 4.410924514530734e-09
often O 0 3.80838971469899e-10
generates O 0 1.5564874944473672e-09
a O 0 7.658213507788503e-10
premature O 0 4.551793164608853e-09
termination O 0 5.283678383705137e-09
codon O 0 6.668172236601322e-09
, O 0 3.7800793051268045e-10
( O 0 1.725639492411446e-10
ii O 0 1.176261577029436e-07
) O 0 4.882892978841369e-10
transcripts O 0 3.669291093189031e-09
with O 0 1.4185149721512857e-09
premature O 0 4.83828692665611e-08
termination O 0 2.046183666948309e-08
codons O 0 2.4292452494023564e-08
can O 0 1.267047300412827e-10
occur O 0 7.338928076361384e-11
at O 0 1.1824926593462237e-09
low O 0 3.777560309004002e-08
or O 0 1.2458443165996869e-09
undetectable O 0 5.71592018161482e-08
levels O 0 7.835337378914176e-10
due O 0 9.031414505145108e-10
to O 0 4.488193150464781e-10
nonsense O 0 1.638357183253447e-08
- O 0 5.6697486705559186e-09
mediated O 0 1.584826825329344e-09
mRNA O 0 8.613234570020722e-10
decay O 0 4.185717106253151e-09
, O 0 8.123499095624709e-11
and O 0 2.1147857076631027e-10
( O 0 3.6482000753679245e-10
iii O 0 6.1042686638757e-07
) O 0 5.400005997913127e-10
the O 0 6.646099781626447e-10
levels O 0 6.359971438385514e-10
of O 0 5.142716807959857e-10
these O 0 6.475642244652136e-11
transcripts O 0 1.590246934135564e-09
can O 0 1.1318681408800657e-10
be O 0 9.112006288392038e-11
increased O 0 7.718350958363374e-10
by O 0 2.4993960234809265e-09
cycloheximide O 0 2.9382850698311813e-05
. O 0 1.0014676945502288e-06

A O 0 5.283618520479649e-06
deletion O 0 3.7275026443239767e-07
mutation O 0 9.570680248316421e-09
in O 0 1.4615544330354169e-09
COL17A1 O 1 0.9999988079071045
in O 0 3.7398346641737135e-09
five O 0 3.131156445235206e-09
Austrian O 0 7.548527491962886e-08
families O 0 1.1741159433587e-10
with O 0 1.7497387982956525e-09
generalized O 0 3.7316963243938517e-06
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999808073043823
represents O 0 2.21144858869593e-07
propagation O 0 7.779561173038019e-08
of O 0 8.790431138550048e-08
an O 0 1.1346014794355597e-08
ancestral O 0 1.323090828009299e-06
allele O 0 7.670133186366002e-07
. O 0 5.793035029455496e-07

Patients O 0 4.655412340071052e-06
with O 0 1.3105550067393779e-07
generalized O 0 0.0006093362462706864
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
, O 0 1.958674431534746e-07
a O 0 7.43366390665301e-09
usually O 0 2.4878006321671364e-09
nonlethal O 0 6.769527090000338e-07
form O 0 1.0449807241741382e-08
of O 0 3.1471722650167067e-07
junctional B-Disease 1 0.9999301433563232
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 0.9999992847442627
, O 0 1.195702594714021e-07
have O 0 7.289160386392268e-09
generalized O 0 1.806088789635396e-07
blistering B-Disease 0 2.1972093691147165e-06
, O 0 3.817579141696115e-08
nail B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 4.939710925100371e-05
patchy B-Disease 1 1.0
alopecia I-Disease 1 1.0
, O 0 1.698296955510159e-06
and O 0 7.74613545218017e-06
dental B-Disease 1 1.0
abnormalities I-Disease 1 1.0
. O 0 1.1011038623109926e-06

Skin B-Disease 1 1.0
fragility I-Disease 0 6.402324652299285e-05
in O 0 5.392855495500726e-09
most O 0 7.844593863381988e-10
cases O 0 2.971662360629068e-10
is O 0 7.001946245033253e-11
due O 0 9.719964833010408e-10
to O 0 8.072085777577342e-10
mutations O 0 5.316002638089401e-10
in O 0 2.4535407039394386e-10
the O 0 3.294417627586199e-09
gene O 0 2.3034740781469054e-09
encoding O 0 3.740393239581863e-08
type O 0 3.22462528856704e-06
XVII O 1 1.0
collagen O 1 1.0
( O 0 2.762684800927673e-07
COL17A1 O 1 1.0
) O 0 1.0128749039495233e-07
. O 0 2.207984124424911e-07

Recently O 0 1.5444777545781108e-06
, O 0 2.7437739191782384e-08
we O 0 3.4300591256197777e-09
reported O 0 5.498202337861358e-09
five O 0 1.8437337212517946e-09
Austrian O 0 9.053705696260295e-08
families O 0 2.8404192886632984e-10
with O 0 2.9640669918507e-09
generalized O 0 9.740972018335015e-06
atrophic B-Disease 1 1.0
benign I-Disease 1 1.0
epidermolysis I-Disease 1 1.0
bullosa I-Disease 1 1.0
who O 0 1.1909313570868107e-06
share O 0 6.358509807569135e-08
the O 0 3.7893951088108224e-08
same O 0 4.239326045762937e-08
COL17A1 O 1 0.9999998807907104
mutation O 0 1.1172154472660623e-06
. O 0 5.227819883657503e-07

Affected O 0 4.2287067003599077e-07
individuals O 0 3.6766872879567813e-10
in O 0 1.314393316409479e-10
three O 0 6.589020301595028e-11
families O 0 4.226681938473975e-12
are O 0 4.969801046389444e-12
homozygous O 0 4.0144748636450345e-10
for O 0 1.8718959715613437e-10
4003delTC O 0 8.262966133543159e-08
, O 0 4.003861131529618e-10
whereas O 0 2.1477937484082332e-10
those O 0 8.282820956884152e-11
in O 0 6.298714327890309e-11
two O 0 1.5835478761605515e-10
others O 0 1.332917221041896e-09
are O 0 7.014702152474683e-10
compound O 0 1.4844840734440368e-07
heterozygotes O 0 3.902017397194868e-06
. O 0 7.308123599614191e-07

To O 0 4.3555484552371126e-08
determine O 0 8.453735489410974e-09
if O 0 9.2443186439084e-10
the O 0 1.3447095659202546e-09
occurrence O 0 7.493839326855323e-09
of O 0 1.595920551267227e-08
4003delTC O 0 1.4963126204747823e-07
in O 0 3.7848119083250253e-10
these O 0 4.687921162371822e-10
unrelated O 0 4.416699894704834e-09
families O 0 1.7415298370071497e-11
signifies O 0 1.9902755832301722e-10
propagation O 0 1.2882216404719316e-09
of O 0 2.4517641250554334e-09
an O 0 7.836443161046702e-10
ancestral O 0 5.045071205245222e-08
allele O 0 1.6118004708687295e-08
or O 0 5.814485781741041e-09
a O 0 8.794317274407604e-09
mutational O 0 6.628384198847925e-06
hot O 0 1.3434353604679927e-05
spot O 0 7.661981271667173e-07
, O 0 3.0030076203502176e-09
haplotypes O 0 3.0678430906760923e-09
were O 0 2.0792766119992478e-10
determined O 0 5.024362037531205e-10
for O 0 2.8890922987301337e-10
polymorphisms O 0 1.3858427738711043e-09
both O 0 2.8557451958732827e-09
within O 0 5.109310752260399e-09
and O 0 2.2994806059273287e-08
flanking O 0 0.00037079674075357616
COL17A1 O 1 1.0
. O 0 5.6977919484779704e-06

Five O 0 1.401122744937311e-06
intragenic O 0 7.214951438072603e-06
polymorphisms O 0 3.0368028092198074e-08
were O 0 3.7139598063617996e-09
chosen O 0 1.956283357529287e-09
based O 0 4.2244538422941957e-10
on O 0 1.5546664400289956e-08
their O 0 2.0394351096797436e-08
informativeness O 0 2.732547727646306e-05
. O 0 1.130318082687154e-06

One O 0 1.8330819528955544e-08
of O 0 6.852863165818235e-09
these O 0 2.6186239288072954e-10
, O 0 1.2600702425924482e-10
not O 0 6.306239558329096e-11
previously O 0 2.176223201644234e-09
reported O 0 9.606448969634585e-10
, O 0 8.350940494672443e-10
was O 0 3.4170010820844254e-08
2988 O 0 3.019924633917981e-06
A O 0 1.168476586599354e-07
or O 0 2.352807060290729e-09
C O 0 4.672161679764031e-08
that O 0 2.685031641469493e-10
introduces O 0 1.4318762175946631e-08
a O 0 3.8681860492495446e-10
new O 0 4.3082176715003584e-10
restriction O 0 2.9687519109700133e-09
site O 0 6.646002415067187e-09
for O 0 4.943488285391595e-09
Eco0109 O 0 1.5046773114590906e-05
I O 0 1.916744622576516e-05
. O 0 1.2355508260952774e-06

All O 0 2.0133586531301262e-07
the O 0 3.8219869935574025e-08
4003delTC O 0 6.724974355165614e-07
alleles O 0 1.2938334847945043e-09
showed O 0 1.7501727844759785e-09
the O 0 1.1776354336134887e-09
same O 0 4.1492456692715507e-10
haplotype O 0 7.764097809115356e-09
for O 0 1.2868782706121351e-09
these O 0 2.35427055628179e-09
five O 0 5.211603593124892e-09
polymorphic O 0 7.874325547163608e-07
markers O 0 5.008932475902839e-06
. O 0 7.184591481745883e-07

Fourteen O 0 1.07234436654835e-05
microsatellite O 0 1.412491656083148e-06
polymorphisms O 0 1.4776360579560333e-08
were O 0 9.479348417329447e-10
selected O 0 5.151739035369474e-10
based O 0 4.359048885738126e-11
on O 0 4.995313052091888e-10
their O 0 2.6269281194757355e-10
high O 0 3.059009756611886e-08
heterozygosity O 0 2.1588508047898358e-07
and O 0 1.9408892271144396e-09
their O 0 1.1579700531783033e-09
location O 0 1.9537784723411278e-08
within O 0 6.726498025244609e-09
10q23 O 0 7.191897566372063e-06
- O 0 6.218864655238576e-06
q25 O 0 5.259080353425816e-05
near O 0 1.806657928682398e-05
COL17A1 O 1 0.9999630451202393
. O 0 4.86962562717963e-06

Three O 0 4.143286957969394e-08
families O 0 8.412393559531495e-10
shared O 0 2.5080446608427565e-09
microsatellite O 0 7.259180989649394e-08
polymorphisms O 0 5.914223333292057e-09
covering O 0 3.225392788408499e-07
at O 0 1.6075819786465217e-08
most O 0 1.5080584558901933e-09
19 O 0 4.590976487861553e-09
cM O 0 3.3029760260205876e-08
, O 0 4.5421638672493714e-10
whereas O 0 3.2607458400057965e-10
the O 0 5.539462777370829e-10
others O 0 2.2479769434813335e-10
shared O 0 2.484650540868216e-10
smaller O 0 1.0768567149099795e-09
regions O 0 3.567241613211536e-09
consistent O 0 2.446158831048706e-09
with O 0 1.0651104997982941e-10
cross O 0 1.0247201309709908e-08
- O 0 2.8917082062207555e-08
over O 0 5.950465009618711e-09
events O 0 1.4058044728315622e-09
during O 0 5.499206090497921e-10
passage O 0 9.916798493492252e-10
of O 0 5.549625758938248e-10
this O 0 6.378336053769473e-11
mutation O 0 4.687492061172804e-10
through O 0 2.827198475330306e-10
several O 0 7.813061309036584e-09
generations O 0 1.059309511219908e-07
. O 0 1.2368978730137314e-07

These O 0 1.3021444544847327e-07
results O 0 8.694646780327275e-09
indicate O 0 1.1800278532092534e-09
that O 0 3.2682173634057676e-10
4003delTC O 0 2.3021144102131075e-07
occurs O 0 1.8336922258388455e-10
on O 0 1.7601892166041466e-09
a O 0 8.296580644717721e-10
single O 0 1.1730979521118456e-09
ancestral O 0 3.001308712669015e-08
allele O 0 6.598610546859618e-09
. O 0 1.0898667746062074e-08
. O 0 1.6954312798134197e-07

The O 0 3.104747065663105e-06
haptoglobin O 0 2.3274278646567836e-05
- O 0 2.3016432351141702e-06
gene O 0 4.213417525988916e-08
deletion O 0 7.072368646277027e-08
responsible O 0 2.5894026478567866e-08
for O 0 2.04904253564564e-08
anhaptoglobinemia B-Disease 0 0.0026257780846208334
. O 0 1.5739669834147207e-06

We O 0 7.259914980295434e-08
have O 0 7.506867349960089e-10
found O 0 2.9131627665712756e-10
an O 0 2.0035835490705978e-10
allelic O 0 1.6377596523398097e-07
deletion O 0 2.912187824222201e-08
of O 0 3.9264829609919616e-08
the O 0 9.310577553378607e-08
haptoglobin O 0 1.9666567823151127e-05
( O 0 3.970621609283853e-09
Hp O 0 7.241991539785886e-08
) O 0 8.962703912374081e-10
gene O 0 3.104916046492434e-10
from O 0 2.377699426237001e-10
an O 0 5.016395077106495e-10
individual O 0 7.628516152102804e-10
with O 0 6.847375555452118e-09
anhaptoglobinemia B-Disease 0 0.00046040021697990596
. O 0 2.483512389517273e-06

The O 0 3.1184385989035945e-06
Hp O 0 1.8901885141531238e-06
gene O 0 1.1823580337022577e-08
cluster O 0 7.637637366997296e-08
consists O 0 4.567656031184697e-09
of O 0 2.642346785819427e-09
coding O 0 1.8406636215217986e-08
regions O 0 6.09061459044824e-08
of O 0 4.650291316465882e-07
the O 0 7.421228076509578e-08
alpha O 0 1.984091824169809e-08
chain O 0 1.2336288657266437e-09
and O 0 3.0871824541200965e-10
beta O 0 1.1654266884875142e-08
chain O 0 3.60123175724425e-09
of O 0 2.9529731992994357e-09
the O 0 4.467543668340568e-09
haptoglobin O 0 2.729066750362108e-07
gene O 0 9.120356692093878e-10
( O 0 1.3032097623266736e-10
Hp O 0 4.896296701417668e-09
) O 0 8.878782431498422e-11
and O 0 2.96717650449807e-10
of O 0 4.508934114966223e-09
the O 0 3.271437565288693e-09
alpha O 0 3.81534270843531e-09
chain O 0 1.0439681341622986e-09
and O 0 2.5941604420154363e-10
beta O 0 7.999441109518557e-09
chain O 0 3.1687847901196164e-09
of O 0 3.4670379900347825e-09
the O 0 3.2811735550808407e-09
haptoglobin O 0 1.356765295668083e-07
- O 0 4.435815625924988e-08
related O 0 1.3539289689390444e-08
gene O 0 1.446247122061095e-09
( O 0 4.039699408320274e-10
Hpr O 0 2.619723886709835e-07
) O 0 6.514632167053946e-10
, O 0 5.946990122573936e-10
in O 0 4.0710571025392994e-10
tandem O 0 1.0049098442266313e-08
from O 0 4.418466981181979e-10
the O 0 5.330341945608552e-09
5 O 0 5.671027736298129e-08
side O 0 6.940207413208554e-07
. O 0 4.328698821609578e-07

Southern O 0 1.3745175238000229e-05
blot O 0 4.986343265045434e-05
and O 0 3.747426546851784e-08
PCR O 0 3.0336302359046385e-08
analyses O 0 1.7650984673878156e-08
have O 0 1.0342009887365222e-10
indicated O 0 1.5341043713146263e-10
that O 0 9.803909420402768e-12
the O 0 9.460233985070232e-11
individual O 0 7.328125953276476e-12
with O 0 1.727229123615892e-11
anhaptoglobinemia B-Disease 0 4.6394114860959235e-07
was O 0 1.5731572489130485e-08
homozygous O 0 1.071378430417269e-09
for O 0 2.236382884435173e-10
the O 0 1.0103020642304728e-09
gene O 0 1.09189650376873e-10
deletion O 0 6.773835381501669e-10
and O 0 1.614598732491146e-10
that O 0 2.13061512877033e-11
the O 0 3.735384501712957e-10
gene O 0 1.393815757255723e-10
deletion O 0 9.99061278150748e-10
was O 0 1.8348300656612082e-09
included O 0 7.243752819796612e-10
at O 0 1.8790082823016974e-09
least O 0 9.816151363972736e-11
from O 0 1.9310511523151774e-10
the O 0 2.968281842541387e-09
promoter O 0 1.6451135707029607e-06
region O 0 5.22545235526195e-07
of O 0 8.511676696798531e-07
Hp O 0 1.0479795946594095e-06
to O 0 5.512938372476128e-08
Hpr O 0 3.805776259468985e-06
alpha O 0 4.024284194770189e-08
but O 0 6.258575324658011e-10
not O 0 2.2397853016720148e-10
to O 0 5.131852720552388e-09
Hpr O 0 9.226531801687088e-06
beta O 0 2.789838390526711e-06
( O 0 4.5953594707270895e-08
Hpdel O 0 0.00014250873937271535
) O 0 1.9181541688340076e-07
. O 0 6.457372592194588e-07

In O 0 1.7574391719676896e-08
addition O 0 8.055787148464333e-09
, O 0 9.125576960755666e-10
we O 0 1.4818257731974427e-10
found O 0 1.0625497703919962e-10
seven O 0 5.330519359247887e-11
individuals O 0 9.80573695158471e-13
with O 0 1.3859100499169497e-11
hypohaptoglobinemia B-Disease 0 6.557473142265735e-08
in O 0 1.2996154152844497e-10
three O 0 1.0179555115508165e-10
families O 0 3.695116695262568e-12
, O 0 1.2353323225466895e-11
and O 0 3.4512854379942226e-11
the O 0 2.636912910247702e-10
genotypes O 0 2.4517081698149923e-09
of O 0 4.57203164216935e-09
six O 0 6.292689147535668e-10
of O 0 4.751296245331105e-09
the O 0 5.9398739260529965e-09
seven O 0 9.528692279658912e-10
individuals O 0 1.6837267691194313e-11
were O 0 1.083911849164565e-10
found O 0 1.5828956201335842e-10
to O 0 1.416970873968637e-09
be O 0 3.539853921097347e-08
Hp2 O 1 0.9999967813491821
/ O 0 0.020383410155773163
Hpdel O 1 0.9996274709701538
. O 0 4.968852863385109e-06

The O 0 5.296207632454752e-07
phenotypes O 0 1.2505093138770462e-07
and O 0 4.609543413636175e-09
genotypes O 0 1.7144181185813068e-08
in O 0 1.4979953388838396e-10
one O 0 8.56385726222264e-11
of O 0 3.1140257039652397e-10
these O 0 3.7531935892509694e-11
three O 0 2.8832334089679e-11
families O 0 1.5410885458380652e-12
showed O 0 1.1429582974509245e-10
the O 0 1.1210637973491089e-09
father O 0 1.854901232611894e-09
to O 0 7.802200552298189e-10
be O 0 3.2320910392513724e-09
hypohaptoglobinemic B-Disease 0 7.459326297976077e-06
( O 0 3.966458272941509e-09
Hp2 O 0 2.805890835588798e-05
) O 0 2.307044333349495e-09
and O 0 4.89395324265729e-09
Hp2 O 0 0.00010739154095062986
/ O 0 3.6680481230177975e-07
Hpdel O 0 3.352893691044301e-05
, O 0 2.942863286392594e-09
the O 0 5.174026096455009e-09
mother O 0 8.389255956586794e-10
to O 0 2.23041057845208e-10
be O 0 3.5541727894106145e-10
Hp2 O 0 9.190773084810644e-07
- O 0 3.1228321262233294e-08
1 O 0 2.4287169608783188e-08
and O 0 3.8406047231376306e-09
Hp1 O 0 1.8283411918673664e-05
/ O 0 1.6003626512883784e-07
Hp2 O 0 5.023120593250496e-06
, O 0 5.819819626218248e-10
one O 0 1.267704829999161e-10
of O 0 4.537920594849254e-10
the O 0 2.848953850609348e-10
two O 0 5.0386205624475267e-11
children O 0 2.5151320262595256e-11
to O 0 2.050900595185201e-11
be O 0 3.3417416056558125e-10
hypohaptoglobinemic B-Disease 0 1.6677694247846375e-06
( O 0 1.7069321511797853e-09
Hp2 O 0 1.2901058653369546e-05
) O 0 1.319830245094522e-09
and O 0 4.7354453691639264e-09
Hp2 O 0 0.004895053803920746
/ O 0 6.333333431030042e-07
Hpdel O 0 0.00029050157172605395
, O 0 1.8204887597406127e-09
and O 0 4.5981607410539027e-10
the O 0 6.313318756667741e-10
other O 0 1.5547360621148698e-10
child O 0 5.112486545222339e-10
to O 0 1.1899403684623167e-10
be O 0 6.713984368467152e-10
Hp1 O 0 1.9258161046309397e-05
and O 0 5.215186504869962e-08
Hp1 O 1 0.9999864101409912
/ O 0 8.828790669213049e-06
Hpdel O 0 0.008605965413153172
, O 0 7.276283575663456e-09
showing O 0 1.8318027983355023e-08
an O 0 1.9836707831899503e-09
anomalous O 0 1.1776129582585781e-07
inheritance O 0 1.6764572308147763e-07
of O 0 4.48360310656426e-07
Hp O 0 7.331648816943925e-07
phenotypes O 0 5.469087227538694e-08
in O 0 6.374082928140012e-10
the O 0 9.190420868776528e-09
child O 0 1.6859978302363743e-08
with O 0 9.363538389095538e-09
Hp1 O 0 0.0335293747484684
. O 0 1.8481922552382457e-06

The O 0 3.479399310890585e-06
Hp2 O 1 0.9692891240119934
/ O 0 4.102449747733772e-05
Hpdel O 0 0.020941194146871567
individuals O 0 4.4785242181433205e-09
had O 0 3.3431204471412457e-09
an O 0 3.392288672188215e-10
extremely O 0 1.991947495838531e-09
low O 0 1.3601849424560442e-08
level O 0 3.3863575055192996e-08
of O 0 5.0524089800774163e-08
Hp O 0 3.808695794305095e-07
( O 0 2.3019104400390233e-09
mean O 0 1.8910322197029927e-08
+ O 0 8.475919521799824e-09
/ O 0 3.184460695138114e-08
- O 0 1.819740447217555e-07
SD O 0 3.0354643968166783e-05
= O 0 1.086831868946092e-08
0 O 0 4.9919632871819886e-09
. O 0 1.168107832683063e-09
049 O 0 1.5416787846334046e-06
+ O 0 9.792598731905855e-09
/ O 0 1.7442083333207847e-08
- O 0 2.9419670255492747e-08
0 O 0 5.486249676778243e-09
. O 0 8.799212469767781e-10
043 O 0 5.832860665577755e-07
mg O 0 2.3839237428546767e-07
/ O 0 2.4174125812237435e-08
ml O 0 1.7305291422076152e-08
; O 0 9.508370479860417e-11
n O 0 1.480407602061362e-10
= O 0 1.7375127725482997e-10
6 O 0 6.108082373224022e-10
) O 0 2.832994429324831e-11
, O 0 2.9404031293145394e-11
compared O 0 4.409859977183572e-11
with O 0 2.0360196167912292e-11
the O 0 6.55780429958952e-10
level O 0 3.4651075342395643e-09
( O 0 5.151166299066645e-11
1 O 0 1.9609380785823305e-09
. O 0 2.883212835147475e-10
64 O 0 1.0008584183651692e-08
+ O 0 1.18172605034772e-09
/ O 0 7.525795098217714e-09
- O 0 2.6607267500367016e-08
1 O 0 1.5584189938522286e-08
. O 0 1.2957103168176332e-09
07 O 0 1.0390459692644072e-06
mg O 0 2.5645326218182163e-07
/ O 0 5.211040132735434e-08
ml O 0 3.294966077760364e-08
) O 0 9.697497665994703e-11
obtained O 0 8.751940144824388e-11
from O 0 2.2485256712112545e-10
52 O 0 1.1009232636638444e-08
healthy O 0 3.490153943630503e-09
volunteers O 0 9.142825385666242e-10
having O 0 3.2754083889585672e-09
phenotype O 0 1.0712462028550362e-08
Hp2 O 0 4.0435070332023315e-06
, O 0 2.7775557409626117e-09
whereas O 0 2.755068173598829e-09
the O 0 2.690513145608975e-09
serum O 0 7.375645427742938e-09
Hp O 0 2.468620685647238e-08
level O 0 1.166004892638739e-08
of O 0 1.021147610913431e-08
an O 0 5.758415966283792e-10
individual O 0 2.8885632774589e-10
with O 0 1.9590689070980716e-09
Hp1 O 1 0.9493055939674377
/ O 0 1.2668726412812248e-05
Hpdel O 0 0.0008144841995090246
was O 0 8.298675311380066e-07
0 O 0 5.411641268437961e-07
. O 0 4.941040288031218e-07

50 O 0 1.589773660271021e-06
mg O 0 6.152453352115117e-06
/ O 0 8.284505383926444e-07
ml O 0 4.1030151010090776e-07
, O 0 1.0375523773475948e-09
which O 0 6.842146987873221e-11
was O 0 7.469561635886635e-10
approximately O 0 6.182779982433217e-11
half O 0 6.497354737566852e-11
the O 0 1.7516012251750368e-10
level O 0 2.288536249395179e-09
of O 0 7.623080833241147e-09
Hp O 0 3.007273718935721e-08
in O 0 9.243084631016529e-10
control O 0 1.9051883271004044e-07
sera O 0 1.2620370398508385e-05
from O 0 3.2501792368577753e-09
the O 0 1.3121902675550245e-08
Hp1 O 0 3.969945737480884e-06
phenotype O 0 2.8146742714341144e-09
( O 0 5.360045046698403e-11
1 O 0 1.5527304997320357e-09
. O 0 2.262986326106997e-10
26 O 0 7.297896509328439e-09
+ O 0 1.0799008354211992e-09
/ O 0 1.904670865471303e-09
- O 0 8.858020095203756e-09
0 O 0 2.2832216117762982e-09
. O 0 2.5580318419038406e-10
33 O 0 1.119758596956899e-08
mg O 0 5.611633469015942e-08
/ O 0 1.458592180370033e-08
ml O 0 1.7006350105930323e-08
; O 0 1.0311951292862886e-10
n O 0 2.962901035630239e-10
= O 0 3.164186967996585e-10
9 O 0 1.2434633323010758e-09
) O 0 2.525410713882792e-10
, O 0 5.429129368295094e-10
showing O 0 6.014971631884691e-09
a O 0 3.5052043489969265e-09
gene O 0 5.037818162634267e-09
- O 0 2.5787426238821354e-07
dosage O 0 1.5889188489381922e-06
effect O 0 2.0884488094452536e-07
. O 0 1.4914772350493877e-07

The O 0 9.402287304283163e-08
other O 0 4.079546922497457e-09
allele O 0 7.390488221403757e-09
( O 0 5.869381647372052e-10
Hp2 O 0 3.127540367131587e-06
) O 0 5.785145140713155e-10
of O 0 3.1676243850142782e-09
individuals O 0 4.6863096736515786e-11
with O 0 4.1251463356317686e-10
Hp2 O 1 0.9999994039535522
/ O 0 1.4519198884954676e-05
Hpdel O 1 0.8886641263961792
was O 0 1.4726362351780153e-08
found O 0 1.0009948425704351e-10
to O 0 5.858429019678368e-11
have O 0 2.2759452308895867e-11
, O 0 3.90864875188246e-11
in O 0 4.471563050389982e-11
all O 0 5.195185948103642e-10
exons O 0 1.4550964877457773e-08
, O 0 1.061561727411231e-09
no O 0 2.0564963065794473e-09
mutation O 0 7.725537987113285e-10
, O 0 2.0449097970498542e-10
by O 0 2.1431163788054874e-10
DNA O 0 1.204351729455766e-08
sequencing O 0 1.1377766639952824e-07
. O 0 1.7562371112944675e-07

On O 0 9.826730718032195e-08
the O 0 2.52197018824063e-09
basis O 0 1.2179388608757336e-09
of O 0 1.3835713685850237e-09
the O 0 1.4376825285822292e-09
present O 0 3.933045278348146e-10
study O 0 3.746486731959209e-10
, O 0 1.2202146237871858e-10
the O 0 1.3560752520902497e-10
mechanism O 0 9.917555665595046e-10
of O 0 1.8244341593032232e-09
anhaptoglobinemia B-Disease 0 3.5303742151882034e-07
and O 0 1.4097892853115468e-09
the O 0 1.89851934173646e-09
mechanism O 0 6.676392771964856e-09
of O 0 1.9331240608266853e-08
anomalous O 0 2.3410694893755135e-07
inheritance O 0 3.108308987975761e-07
of O 0 4.899218879472755e-07
Hp O 0 8.273261755675776e-07
phenotypes O 0 6.040600908363558e-08
were O 0 2.541478805184738e-09
well O 0 1.066268140448301e-08
explained O 0 1.6559685889205866e-07
. O 0 2.5945251991288387e-07

However O 0 1.6388484880280885e-07
, O 0 1.0130039029832005e-08
the O 0 7.356425246740628e-09
mechanism O 0 3.880634835695673e-08
of O 0 1.300429488537702e-07
hypohaptoglobinemia B-Disease 0 0.0006986436201259494
remains O 0 9.983912605093792e-06
unknown O 0 2.7640126063488424e-06

ATM O 0 0.000859081803355366
mutations O 0 2.9729673656220257e-07
and O 0 5.566316829686002e-08
phenotypes O 0 1.032613226925605e-06
in O 0 1.0037933151352263e-07
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
families O 0 2.3520800862542046e-09
in O 0 2.1110618808606318e-10
the O 0 1.2196055276803008e-09
British O 0 2.080078775890115e-09
Isles O 0 4.065334735514625e-08
: O 0 1.531774013185938e-10
expression O 0 1.2044813757494666e-10
of O 0 4.6264703179588196e-10
mutant O 0 2.6150017706783046e-09
ATM O 0 4.0308371751507366e-08
and O 0 2.188543374304075e-10
the O 0 2.5584417917556834e-10
risk O 0 2.003202492772971e-09
of O 0 4.2381271825320255e-09
leukemia B-Disease 1 1.0
, O 0 8.542365321773104e-07
lymphoma B-Disease 1 1.0
, O 0 1.20835977668321e-06
and O 0 4.308918050810462e-06
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999257326126099
. O 0 3.238868941934925e-07

We O 0 2.8555451336842452e-08
report O 0 1.5690332366702364e-09
the O 0 2.1547785777897843e-09
spectrum O 0 1.93254177105473e-08
of O 0 2.2811899924590762e-08
59 O 0 1.5913497009023558e-07
ATM O 0 3.302965524198953e-06
mutations O 0 6.223224602308619e-09
observed O 0 3.300688389273887e-09
in O 0 8.224801284484329e-09
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 1.668895947659621e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.724360432220351e-09
patients O 0 4.68022010036151e-10
in O 0 8.163479614520242e-11
the O 0 5.999114538468575e-09
British O 0 5.716400153232826e-08
Isles O 0 3.825619387498591e-06
. O 0 6.090011197557033e-07

Of O 0 8.147310836648103e-06
51 O 0 3.312861508675269e-06
ATM O 0 1.0622655281622428e-05
mutations O 0 4.132448605531636e-09
identified O 0 2.5140156623137955e-10
in O 0 4.3508256025726055e-11
families O 0 1.4990520977309352e-11
native O 0 7.363521598025002e-11
to O 0 4.726417174305553e-11
the O 0 6.345697856069421e-10
British O 0 7.988809058723234e-10
Isles O 0 4.208598269883623e-08
, O 0 5.646251799440449e-10
11 O 0 1.490682355331785e-09
were O 0 8.453441280309448e-10
founder O 0 1.0677476680598375e-08
mutations O 0 5.295014982031887e-10
, O 0 1.6717276174471607e-10
and O 0 2.8365426674170635e-10
2 O 0 9.353792407296169e-09
of O 0 4.601128367198726e-09
these O 0 7.503531684882603e-10
11 O 0 2.43360331886322e-09
conferred O 0 2.3628233591921344e-08
a O 0 2.9231828069242738e-09
milder O 0 2.7790548529083026e-07
clinical O 0 1.1043243830499705e-07
phenotype O 0 1.1633517482678712e-09
with O 0 3.611532253811056e-11
respect O 0 1.54745305458448e-09
to O 0 2.8764690629401457e-09
both O 0 1.9306375520500296e-07
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
and O 1 0.999541163444519
cellular O 0 1.4159945749270264e-05
features O 0 4.762631760968361e-06
. O 0 7.482008186343592e-07

We O 0 3.131743397943865e-08
report O 0 2.3517392477856447e-09
, O 0 3.0489644142761563e-10
in O 0 1.3091840112000597e-10
two O 0 2.2207786998240664e-10
A B-Disease 1 0.9999902248382568
- I-Disease 0 0.31577426195144653
T I-Disease 1 1.0
families O 0 2.2774879204767728e-10
, O 0 1.8104805155072512e-10
an O 0 3.06537323302436e-10
ATM O 0 1.2217666380820447e-06
mutation O 0 7.1145240809755705e-09
( O 0 8.241284321641729e-10
7271T O 0 5.099957434140379e-07
- O 0 2.2180806524829677e-07
- O 0 2.8145689157099696e-07
> O 0 1.8224282527512514e-08
G O 0 6.446715161700922e-08
) O 0 3.760172728739519e-11
that O 0 1.2049495949628675e-11
may O 0 2.860348589928119e-11
be O 0 1.128478994277815e-11
associated O 0 1.389112262717429e-11
with O 0 3.050963995332445e-11
an O 0 4.86848547587293e-11
increased O 0 1.0743824718772998e-09
risk O 0 2.0367608044580265e-08
of O 0 1.772777835640227e-08
breast B-Disease 1 0.7555287480354309
cancer I-Disease 0 1.2029414619973977e-07
in O 0 2.5463245401091683e-10
both O 0 1.114012659897412e-09
homozygotes O 0 2.2578112179871823e-07
and O 0 4.726990354697591e-09
heterozygotes O 0 3.2904630131724844e-08
( O 0 1.2937835525139718e-10
relative O 0 7.182119343696058e-10
risk O 0 7.850999850234075e-10
12 O 0 1.9226718828146971e-10
. O 0 2.3951037333991287e-11
7 O 0 2.1132826599767895e-09
; O 0 5.254029433743312e-10
P O 0 1.1043159986456885e-07
= O 0 1.4419557770040115e-09
. O 0 2.955045097507991e-10
0025 O 0 1.4657769042969448e-07
) O 0 3.0610960988219915e-10
, O 0 1.911431707357636e-10
although O 0 2.448421743128648e-10
there O 0 2.109222518864584e-10
is O 0 1.5592231672467705e-10
a O 0 2.3754057054681255e-10
less O 0 2.862316161866829e-09
severe O 0 0.0038935651537030935
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
phenotype O 0 2.3583919261938036e-09
in O 0 4.228385697135906e-11
terms O 0 2.580298752441479e-10
of O 0 3.721247476828893e-10
the O 0 1.0264312733099246e-09
degree O 0 2.187468872705267e-08
of O 0 1.7341380953439511e-07
cerebellar B-Disease 1 1.0
degeneration I-Disease 1 1.0
. O 0 0.00010479170305188745

This O 0 4.5940801385313534e-08
mutation O 0 1.9305522513946016e-08
( O 0 1.785951830868271e-09
7271T O 0 7.755263027320325e-07
- O 0 2.1618814116663998e-07
- O 0 2.9038852744633914e-07
> O 0 1.8861044281948125e-08
G O 0 7.128680579171487e-08
) O 0 9.351357188602805e-11
also O 0 7.859372180840651e-11
allows O 0 4.32921198889602e-11
expression O 0 2.5496329006391427e-11
of O 0 2.1620477630435175e-10
full O 0 3.4815750282746194e-10
- O 0 2.3133894799798327e-09
length O 0 8.867803158452148e-10
ATM O 0 6.876827285395848e-08
protein O 0 8.509121185440449e-10
at O 0 1.960205331386078e-09
a O 0 2.3073512545046526e-10
level O 0 9.554060875771597e-10
comparable O 0 1.0404138661712636e-09
with O 0 6.432201299366724e-11
that O 0 1.200756299946093e-10
in O 0 1.4154932781451635e-09
unaffected O 0 5.595658763013489e-07
individuals O 0 3.4792138059458466e-09
. O 0 1.0400061967175134e-07

In O 0 8.526542139009052e-09
addition O 0 4.0735290696147786e-09
, O 0 9.266455935907913e-10
we O 0 1.6720910767098474e-10
have O 0 1.6856160564571177e-11
studied O 0 2.3310624541750258e-09
18 O 0 5.072703590514038e-09
A B-Disease 1 0.9999562501907349
- I-Disease 1 0.9999910593032837
T I-Disease 1 1.0
patients O 0 1.5639478601059409e-09
, O 0 1.8130991499831772e-11
in O 0 5.239873205470369e-12
15 O 0 1.4485046495593679e-10
families O 0 3.2374660677986222e-12
, O 0 4.5690281419430434e-11
who O 0 1.7235966820461357e-10
developed O 0 3.049554919698494e-08
leukemia B-Disease 1 1.0
, O 0 1.3850421964889392e-06
lymphoma B-Disease 1 1.0
, O 0 3.2254973802992026e-07
preleukemic O 1 0.9999924898147583
T O 0 0.022159839048981667
- O 0 9.372222393722041e-07
cell O 0 9.904217534995041e-08
proliferation O 1 1.0
, O 0 9.1765830489976e-09
or O 0 5.171010570848011e-07
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 4.7879428421993e-08
mostly O 0 7.310756000578067e-09
in O 0 3.982096430377169e-09
childhood O 0 2.261717099827365e-06
. O 0 2.817493509610358e-07

A O 0 1.2860467677455745e-06
wide O 0 3.7592073454106867e-07
variety O 0 4.6768427353072184e-08
of O 0 5.08619173444913e-08
ATM O 0 2.1402854599728016e-06
mutation O 0 1.421594508776991e-09
types O 0 3.791815306186663e-09
, O 0 5.185909479621387e-10
including O 0 1.6915857603549966e-09
missense O 0 3.086973521249092e-08
mutations O 0 5.272561276470356e-10
and O 0 3.3839070434638074e-10
in O 0 3.618718935616272e-10
- O 0 5.368586286635946e-08
frame O 0 1.2249799397068273e-08
deletions O 0 8.999847089796731e-09
, O 0 8.454344446739981e-10
were O 0 4.832305666724324e-10
seen O 0 1.6623358245482223e-09
in O 0 5.063198749155617e-10
these O 0 3.885565202921271e-09
patients O 0 9.851272686489665e-09
. O 0 4.2991675996972845e-08

We O 0 3.4510801327769514e-08
also O 0 1.4749067522856762e-09
show O 0 6.408362174248339e-10
that O 0 2.1158901020168486e-11
25 O 0 2.660277276245182e-10
% O 0 2.681764706136125e-11
of O 0 2.468128479371501e-10
all O 0 5.51019951888776e-10
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 3.153139305211994e-09
carried O 0 3.460601250004913e-10
in O 0 1.0311990844558139e-10
- O 0 3.852279206739695e-08
frame O 0 2.853486869014432e-08
deletions O 0 2.65035353663734e-08
or O 0 3.268736614714385e-09
missense O 0 1.0559967122958369e-08
mutations O 0 1.8540653734522294e-10
, O 0 3.7928892665517466e-11
many O 0 1.3625458400445822e-11
of O 0 1.0181186449464974e-10
which O 0 1.1202440017288318e-11
were O 0 2.958308598088877e-11
also O 0 4.2026080532275856e-11
associated O 0 9.213948354291901e-11
with O 0 8.3735858524836e-11
expression O 0 1.1513785480588012e-09
of O 0 1.691670448167315e-08
mutant O 0 3.670091359708749e-07
ATM O 0 6.481449418060947e-06
protein O 0 2.3586005681863753e-07
. O 0 1.206888526894545e-07

The O 0 1.769205823620723e-06
DMPK O 1 1.0
gene O 0 1.8001081514285033e-07
of O 0 5.125379516357498e-07
severely O 1 1.0
affected O 1 0.9999998807907104
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.7294867634773254
is O 0 9.331535544276903e-09
hypermethylated O 0 4.572671514324611e-06
proximal O 0 5.842085215590487e-07
to O 0 4.5331995934816405e-09
the O 0 2.4756841909834293e-08
largely O 0 7.233487764324309e-08
expanded O 0 5.109645258016826e-07
CTG O 0 0.001564649399369955
repeat O 0 3.861213372147176e-06
. O 0 5.136869845046022e-07

Using O 0 6.877287006545885e-08
methylation O 0 2.4805129328342446e-07
- O 0 5.66570804494404e-07
sensitive O 0 4.193286429199361e-07
restriction O 0 7.693397918728806e-09
enzymes O 0 9.202800743679518e-10
, O 0 6.607296931804285e-10
we O 0 4.916780316222003e-10
characterized O 0 1.5645118534024505e-09
the O 0 8.974986864807022e-10
methylation O 0 3.817992144661275e-09
pattern O 0 4.0049630278815584e-09
on O 0 2.2450041825550215e-09
the O 0 8.524163597201095e-10
5 O 0 2.4065818227114733e-09
side O 0 7.68861596611714e-09
of O 0 9.637395770312196e-09
the O 0 1.2627879186766222e-08
CTG O 0 4.729093416244723e-05
repeat O 0 1.7400481056029093e-08
in O 0 3.7071778979935743e-10
the O 0 5.7637041805946865e-09
DMPK O 1 0.9933838248252869
gene O 0 1.3706091817056176e-09
of O 0 2.2051793724386926e-09
normal O 0 9.259600863842365e-10
individuals O 0 8.083479198506272e-12
and O 0 9.781444404444173e-11
of O 0 3.1589182380997727e-09
patients O 0 1.2859484588290115e-09
affected O 0 2.1453054888098677e-09
with O 0 2.9495351938635395e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
, O 0 7.302690363530928e-08
showing O 0 4.818045340471144e-08
expansions O 0 2.6013557885562477e-07
of O 0 8.83061090917181e-08
the O 0 4.24766284368161e-08
repetitive O 0 3.4495285490265815e-06
sequence O 0 8.144968433043687e-08
. O 0 9.108786969136418e-08

The O 0 2.1064240627310937e-06
gene O 0 5.0154149278114346e-08
segment O 0 1.188191092182933e-07
analyzed O 0 1.3840629975447882e-08
corresponds O 0 4.821996135717654e-09
to O 0 1.323657183860405e-09
the O 0 3.1223791552292823e-08
genomic O 0 4.81603365187766e-07
SacI O 0 1.3598807527159806e-05
- O 0 5.264276978778071e-07
HindIII O 0 4.7723706302349456e-06
fragment O 0 5.4248705083637105e-08
carrying O 0 1.1594448956486758e-08
exons O 0 1.5740810965780838e-07
11 O 0 2.8149116815257003e-08
- O 0 4.2110556819352496e-07
15 O 0 1.5466680736153648e-07
. O 0 1.3422136646568106e-07

There O 0 1.2035944507715612e-07
is O 0 1.0672428274460799e-08
constitutive O 0 6.639314875656055e-08
methylation O 0 4.632567751627903e-08
in O 0 1.5541298026278128e-08
intron O 0 2.1904722871113336e-06
12 O 0 4.7521325541310944e-08
at O 0 4.2924384047182684e-09
restriction O 0 2.7298141525022857e-09
sites O 0 1.4414057725176121e-09
of O 0 3.899776057636473e-09
SacII O 0 2.0362945178931113e-06
and O 0 1.0997437627224826e-08
HhaI O 0 2.295404192409478e-05
, O 0 4.33742375349766e-09
localized O 0 9.145780666131031e-08
1 O 0 3.5271096265887536e-08
, O 0 8.155500164086504e-10
159 O 0 3.114146274185714e-09
- O 0 1.1828654500334324e-08
1 O 0 1.998860099661215e-08
, O 0 1.3464265258278374e-09
232 O 0 7.166523374735334e-09
bp O 0 5.657649460033554e-09
upstream O 0 8.269569029550894e-09
of O 0 4.857091173704475e-09
the O 0 8.57275583854289e-09
CTG O 0 3.241734884795733e-05
repeat O 0 2.05851442558469e-08
, O 0 3.4801544979146115e-10
whereas O 0 1.139014993434273e-10
most O 0 4.114143747901977e-11
, O 0 1.8811832300236198e-11
if O 0 1.532074120347282e-11
not O 0 4.65571331487169e-12
all O 0 3.062963771505167e-11
, O 0 2.8688008565924683e-11
of O 0 2.5850180329634043e-10
the O 0 2.6683014131556604e-10
other O 0 4.467530512197726e-11
sites O 0 1.1168656000037913e-09
of O 0 7.211223174152792e-09
SacII O 0 4.562489630188793e-05
, O 0 8.106342264113664e-09
HhaI O 0 1.81239411176648e-05
, O 0 5.8555977844321205e-09
and O 0 4.4040313618154414e-09
HpaII O 0 2.029921461144113e-06
in O 0 5.334040986681998e-10
this O 0 1.122571688383367e-10
region O 0 4.581319767993364e-09
are O 0 1.842432179044451e-10
unmethylated O 0 1.5552321031009342e-07
, O 0 6.820494724557591e-10
in O 0 1.1923052822826463e-10
normal O 0 1.1506605668287762e-09
individuals O 0 7.92637483426617e-12
and O 0 8.375534293891818e-11
most O 0 2.2359776530311848e-10
of O 0 5.4466191556912236e-09
the O 0 4.369693940020625e-08
patients O 0 4.4067054005836326e-08
. O 0 1.3060034120826458e-07

In O 0 1.492697521143782e-08
a O 0 6.491425175170207e-10
number O 0 2.0112872478605937e-10
of O 0 4.612322523911416e-09
young O 0 3.0854947485892126e-09
and O 0 1.949533867673381e-09
severely O 0 1.3921641084380099e-06
affected O 0 9.757584074066017e-09
patients O 0 6.828383414259065e-10
, O 0 9.296865360886031e-11
however O 0 2.0177193249537595e-10
, O 0 2.486015837632749e-10
complete O 0 5.853819096124369e-10
methylation O 0 3.1663136557114058e-09
of O 0 5.6013855775916e-09
these O 0 3.9085687464357477e-10
restriction O 0 1.4250693958217653e-09
sites O 0 1.615320543990606e-09
was O 0 1.869884469485328e-09
found O 0 2.2860136006386256e-10
in O 0 2.2210668026989566e-10
the O 0 8.925995054198665e-09
mutated O 0 8.121079275724696e-08
allele O 0 7.860342066123849e-08
. O 0 1.7548173047998716e-07

In O 0 1.9041415555420826e-08
most O 0 1.211985511950786e-09
of O 0 1.1229877028284818e-09
these O 0 3.1565552949253117e-10
patients O 0 2.7285634862650454e-10
, O 0 7.707519344979374e-11
the O 0 8.012232544096776e-10
onset O 0 4.767384353954185e-08
of O 0 4.929574615175625e-08
the O 0 1.2962321989107295e-06
disease O 1 1.0
was O 1 0.9997807145118713
congenital O 1 1.0
. O 0 8.12907273939345e-06

Preliminary O 0 3.0220451208151644e-06
in O 0 9.247219168173615e-08
vivo O 0 2.0266677438485203e-06
footprinting O 0 5.394603704189649e-06
data O 0 7.491424369732158e-09
gave O 0 3.1121154542290697e-09
evidence O 0 1.6357648568998684e-09
for O 0 4.749952653426703e-10
protein O 0 1.0542834383286959e-09
- O 0 7.811272517699308e-09
DNA O 0 4.643180506747058e-09
contact O 0 4.5815445881558503e-10
in O 0 2.8604590918135386e-10
normal O 0 2.9106257404265534e-09
genes O 0 1.8986054395320195e-10
at O 0 2.3893753642312276e-09
an O 0 1.5830715627274117e-09
Sp1 O 0 1.0451108209963422e-05
consensus O 0 3.0661365002515595e-08
binding O 0 7.352890296630221e-09
site O 0 1.4078606724865494e-08
upstream O 0 2.197622706034963e-08
of O 0 5.6185061048097396e-09
the O 0 9.09812225557971e-09
CTG O 0 1.646901546337176e-05
repeat O 0 5.598042474019849e-09
and O 0 2.49113257799749e-10
for O 0 1.3107656626765163e-10
a O 0 6.24650331459975e-11
significant O 0 2.3148626071556322e-10
reduction O 0 3.338736176417001e-09
of O 0 2.463407700048492e-09
this O 0 2.648464607346579e-11
interaction O 0 1.1775472263941822e-10
in O 0 6.943720598506786e-11
cells O 0 7.675464430700885e-11
with O 0 5.332149166648037e-10
a O 0 2.803873400125667e-08
hypermethylated O 0 4.764428376802243e-05
DMPK O 1 0.9998021721839905
gene O 0 7.36111687160701e-08
. O 0 3.175326668269918e-08
. O 0 2.4938694309639686e-07

The O 0 8.234335837187245e-06
hemochromatosis B-Disease 1 0.9999934434890747
gene O 0 3.078606525264149e-08
product O 0 2.427647238789632e-08
complexes O 0 1.915045455547215e-09
with O 0 2.3745358457283317e-10
the O 0 8.229100068035677e-09
transferrin O 0 1.686125727928811e-07
receptor O 0 1.056879206373651e-08
and O 0 5.213423026617647e-09
lowers O 0 3.0682252827318734e-07
its O 0 1.335917931832853e-09
affinity O 0 8.781407268010355e-10
for O 0 8.614417512653461e-10
ligand O 0 3.412917237710644e-08
binding O 0 1.782614873491184e-07
. O 0 1.6051193085786508e-07

We O 0 2.4882913862711575e-07
recently O 0 6.19426074877083e-08
reported O 0 4.04005584542233e-09
the O 0 6.455683099204634e-09
positional O 0 1.7267235818962945e-07
cloning O 0 7.01269886604905e-09
of O 0 4.530753550113786e-09
a O 0 7.123944212317213e-10
candidate O 0 3.895806344189623e-09
gene O 0 1.1799653698574275e-08
for O 0 1.4589210195481428e-07
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 1.0
HFE O 1 1.0
. O 0 4.864343281951733e-06

The O 0 1.1669442301354138e-07
gene O 0 1.5973695699500468e-09
product O 0 4.34254765480091e-09
, O 0 6.813525854632019e-10
a O 0 4.191770541783768e-10
member O 0 1.9856495614423153e-10
of O 0 3.897218547876946e-09
the O 0 7.66963292875289e-09
major O 0 2.0848948167895287e-07
histocompatibility O 0 1.1077446288254578e-05
complex O 0 1.932888835654012e-07
class O 0 1.2784867609028083e-09
I O 0 1.938740368245817e-08
- O 0 1.3822427646914548e-08
like O 0 1.6730042906587528e-09
family O 0 4.284690102718258e-10
, O 0 2.0787253862675215e-10
was O 0 1.5809623610252288e-09
found O 0 5.281990123062741e-11
to O 0 1.3190494529968788e-10
have O 0 2.3862406495211985e-10
a O 0 2.0095858310753556e-09
mutation O 0 5.275299752582896e-09
, O 0 6.811125441430477e-09
Cys O 1 0.8106749057769775
- O 0 3.081381919400883e-06
282 O 0 4.201724834729248e-07
- O 0 4.293097845220473e-06
- O 0 4.888656803814229e-06
> O 0 2.71571394705461e-07
Tyr O 0 4.044307206640951e-05
( O 0 1.929851833892826e-09
C282Y O 0 3.807297446201119e-07
) O 0 3.819010108152554e-10
, O 0 3.3106614671929435e-10
in O 0 2.5476315501649083e-10
85 O 0 2.4148688382297223e-08
% O 0 1.253612769147594e-09
of O 0 9.616610618934374e-09
patient O 0 4.7083030807471005e-08
chromosomes O 0 1.6845836725565277e-08
. O 0 8.051873123804398e-08

This O 0 2.8319613321059478e-08
mutation O 0 8.649656102477365e-09
eliminates O 0 1.0607692502162536e-07
the O 0 3.7243239603412803e-09
ability O 0 4.422423316441382e-09
of O 0 4.4674347776663126e-08
HFE O 0 0.0002492213388904929
to O 0 9.660142907819136e-09
associate O 0 1.4869093512004383e-08
with O 0 1.376635250238678e-09
beta2 O 0 8.663602056913078e-05
- O 0 4.2753745219670236e-05
microglobulin O 0 0.008931397460401058
( O 0 1.0297987351748361e-08
beta2m O 0 9.605330888007302e-06
) O 0 2.9661482159326624e-09
and O 0 4.673924358655768e-09
prevents O 0 2.2306211988620817e-08
cell O 0 2.6857923884904267e-08
- O 0 5.929700250817405e-07
surface O 0 1.0703331554395845e-06
expression O 0 1.2141198624249228e-07
. O 0 1.0336798084153997e-07

A O 0 4.936904588248581e-06
second O 0 7.292987902474124e-08
mutation O 0 2.406008059452347e-09
that O 0 1.3274185917122594e-10
has O 0 3.480473131922679e-10
no O 0 4.3030107255148664e-10
effect O 0 1.3057184222731166e-09
on O 0 5.140659897762134e-09
beta2m O 0 1.4001876706970506e-06
association O 0 2.5202584463812627e-09
, O 0 2.3109552049760396e-09
H63D O 1 0.9999998807907104
, O 0 4.538373232776394e-09
was O 0 5.724274831919729e-09
found O 0 1.6555826154451836e-10
in O 0 9.623866287222782e-11
eight O 0 5.144806247692202e-10
out O 0 4.082409410521848e-10
of O 0 1.4757847166535498e-09
nine O 0 4.208676518402399e-09
patients O 0 3.003962634196e-10
heterozygous O 0 3.329437281429648e-10
for O 0 5.577949213630973e-10
the O 0 4.087649330131171e-08
C282Y O 0 2.468295133439824e-05
mutant O 0 5.085958036943339e-06
. O 0 4.1666822880870313e-07

In O 0 3.289352434876491e-08
this O 0 7.445068450628867e-10
report O 0 1.2604289834072802e-09
, O 0 8.12782730008621e-10
we O 0 6.066979141294837e-10
demonstrate O 0 9.962525249207488e-10
in O 0 1.2513264868729834e-09
cultured O 0 6.707178812348502e-09
293 O 0 3.549082094878031e-08
cells O 0 8.788327288122844e-10
overexpressing O 0 1.4913692325535521e-07
wild O 0 6.526963147734932e-08
- O 0 4.3212658340507915e-08
type O 0 8.9589491381048e-09
or O 0 8.834393216972103e-10
mutant O 0 2.4600518955253392e-08
HFE O 0 4.870518068855745e-07
proteins O 0 3.061112474611605e-11
that O 0 7.855095914000021e-12
both O 0 4.206056336553132e-11
the O 0 4.796090746772563e-10
wild O 0 2.437906587715588e-08
- O 0 2.7191990881192396e-08
type O 0 9.96990667800901e-09
and O 0 4.7535984037949675e-09
H63D O 1 0.9999973773956299
HFE O 0 1.8824022845365107e-05
proteins O 0 1.119967341089989e-09
form O 0 2.3464422072017044e-10
stable O 0 7.275974267528795e-10
complexes O 0 2.589434500155363e-10
with O 0 9.680606316564422e-11
the O 0 6.37777075596091e-09
transferrin O 0 4.0529170064473874e-07
receptor O 0 8.423319286521291e-08
( O 0 1.5140480869035855e-08
TfR O 0 4.850228833674919e-06
) O 0 2.2031793278642908e-08
. O 0 1.7725874101870431e-07

The O 0 2.53739790423424e-06
C282Y O 0 2.707970816118177e-05
mutation O 0 6.41920649968597e-08
nearly O 0 5.1261590527929e-09
completely O 0 1.461003407143835e-08
prevents O 0 3.864036646206159e-09
the O 0 3.420429273148784e-09
association O 0 1.1471740224422433e-09
of O 0 1.3786092267764616e-08
the O 0 2.7607507391280706e-08
mutant O 0 4.661489185764367e-07
HFE O 0 2.36151427088771e-05
protein O 0 1.562967533175197e-08
with O 0 1.3849152935563325e-09
the O 0 1.440174628442037e-07
TfR O 0 3.0050005079829134e-05
. O 0 4.1243174564442597e-07

Studies O 0 1.9268907180958195e-07
on O 0 4.071511483516588e-08
cell O 0 1.1067678329368391e-08
- O 0 6.85948364775868e-08
associated O 0 8.825454145267031e-09
transferrin O 0 1.9381255356165639e-07
at O 0 5.6522594604757614e-08
37 O 0 3.4692622108423166e-08
degrees O 0 2.5949301374339484e-08
C O 0 5.5332172621547215e-08
suggest O 0 8.841034571105411e-10
that O 0 1.152623760325433e-10
the O 0 5.684724246890482e-09
overexpressed O 0 2.4782741547824116e-06
wild O 0 1.1122764362880844e-06
- O 0 9.860541467787698e-07
type O 0 1.5744788584015623e-07
HFE O 0 1.0453640243213158e-05
protein O 0 3.862504094342967e-09
decreases O 0 1.969920004896153e-09
the O 0 1.9642236448458306e-10
affinity O 0 6.715867306716916e-10
of O 0 1.3278326882470992e-08
the O 0 3.4015634753359336e-08
TfR O 0 2.438103138047154e-06
for O 0 2.555752232069608e-08
transferrin O 0 4.9859986575029325e-06
. O 0 8.27990049856453e-07

The O 0 4.2396113713039085e-06
overexpressed O 0 7.991033635335043e-05
H63D O 1 0.9972761273384094
protein O 0 2.2488368500717115e-08
does O 0 3.8826297732441617e-10
not O 0 4.037525175304424e-11
have O 0 8.625227268521662e-12
this O 0 1.0451306486913836e-11
effect O 0 4.678649134781665e-10
, O 0 9.301548420381778e-11
providing O 0 1.937415089470207e-10
the O 0 2.331488058171516e-10
first O 0 1.6334381069960102e-10
direct O 0 1.2633478985168978e-10
evidence O 0 1.4971698880650308e-10
for O 0 2.076074728796229e-10
a O 0 6.606704627820648e-10
functional O 0 2.1311832298920308e-08
consequence O 0 1.4418190197318381e-08
of O 0 2.175361046852231e-08
the O 0 1.9295147524189815e-07
H63D O 1 0.9999994039535522
mutation O 0 7.078745056787739e-07
. O 0 2.7606671437752084e-07

Addition O 0 5.449250579658838e-07
of O 0 2.919574626503163e-07
soluble O 0 1.8454009023116669e-06
wild O 0 3.2539696803723928e-06
- O 0 5.0719886530714575e-06
type O 0 2.6101724870386533e-05
HFE O 1 1.0
/ O 1 0.7125246524810791
beta2m O 0 0.00048058186075650156
heterodimers O 0 1.5969063724696753e-06
to O 0 5.652235124387062e-09
cultured O 0 1.0944156692005436e-09
cells O 0 1.7121093431882173e-10
also O 0 1.605092447842793e-10
decreased O 0 1.5680549081409367e-09
the O 0 3.2426725193879236e-10
apparent O 0 6.631171167725824e-10
affinity O 0 2.2050940240436745e-10
of O 0 4.934312958226883e-09
the O 0 4.5683532512441616e-09
TfR O 0 3.804291992537401e-08
for O 0 7.183430933421775e-11
its O 0 1.4850343177386094e-10
ligand O 0 4.2373007880236457e-10
under O 0 7.019520520401556e-10
steady O 0 4.177932222404479e-09
- O 0 3.907221657328819e-09
state O 0 5.388647306148187e-10
conditions O 0 5.703502559128992e-09
, O 0 2.1705844066577384e-10
both O 0 1.6253420831446874e-10
in O 0 4.6137102471810465e-10
293 O 0 1.0019433283048329e-08
cells O 0 2.2407935229562526e-10
and O 0 2.1110466708051945e-09
in O 0 1.1646000608322993e-08
HeLa O 0 5.713506652682554e-06
cells O 0 2.067604221167585e-08
. O 0 1.2093356360765029e-07

Furthermore O 0 8.499549153384578e-07
, O 0 9.823278190879137e-09
at O 0 8.517115013262355e-09
4 O 0 1.0249213922008948e-08
degrees O 0 2.025131706773209e-08
C O 0 5.705028627289721e-08
, O 0 5.492790666750125e-10
the O 0 2.0568100556062063e-09
added O 0 1.3976828583395218e-08
soluble O 0 2.8577245458905054e-08
complex O 0 7.400365831244926e-08
of O 0 1.4482208143817843e-07
HFE O 1 0.9999537467956543
/ O 0 4.983754479326308e-06
beta2m O 0 3.0331179914355744e-06
inhibited O 0 1.9146007446124713e-08
binding O 0 9.179628612798751e-09
of O 0 1.8164662662911724e-08
transferrin O 0 2.8876692681478744e-07
to O 0 1.973346819283961e-08
HeLa O 0 8.804642675386276e-06
cell O 0 1.3530284093121736e-07
TfR O 0 4.3569528429543425e-07
in O 0 1.0872418521046257e-09
a O 0 1.8438253146513262e-09
concentration O 0 7.013236569264336e-08
- O 0 3.310867384698213e-07
dependent O 0 3.214552179997554e-08
manner O 0 3.430322692565824e-08
. O 0 6.770263638600227e-08

Scatchard O 0 5.625932681141421e-05
plots O 0 8.104705102596199e-07
of O 0 1.0678763828764204e-07
these O 0 1.5141687903508227e-09
data O 0 1.0483061085864165e-09
indicate O 0 4.2782549725117747e-10
that O 0 1.2006760863325638e-10
the O 0 7.503164312083754e-09
added O 0 5.50019834122395e-08
heterodimer O 0 1.0657542048875257e-07
substantially O 0 8.559195130430908e-09
reduced O 0 2.714891200739089e-09
the O 0 1.5754958448965795e-09
affinity O 0 8.434279941127443e-09
of O 0 6.203862312759156e-08
TfR O 0 5.377453362598317e-06
for O 0 2.9272795742940616e-08
transferrin O 0 9.264533218811266e-06
. O 0 9.556334816807066e-07

These O 0 5.789146939605416e-08
results O 0 4.990868163190498e-09
establish O 0 3.4121734326930664e-09
a O 0 9.603774442368262e-10
molecular O 0 6.899724791509243e-09
link O 0 6.629087945242418e-09
between O 0 2.3348580846516143e-09
HFE O 0 0.3684289753437042
and O 0 1.4844750317877242e-08
a O 0 3.485443933470833e-09
key O 0 3.9274869578775906e-08
protein O 0 1.1661510646021611e-09
involved O 0 3.2909117098078866e-10
in O 0 2.8763250115027006e-10
iron O 0 1.1285623031653813e-06
transport O 0 9.297441927458294e-09
, O 0 1.41916167706313e-09
the O 0 4.269787634569866e-09
TfR O 0 2.9783450372633524e-07
, O 0 4.0832040526517233e-10
and O 0 5.488455245838963e-10
raise O 0 4.468165837323568e-09
the O 0 2.8954429964755946e-09
possibility O 0 5.6735349751591e-09
that O 0 5.504597472283379e-11
alterations O 0 1.2549435268738307e-08
in O 0 4.27687607551519e-10
this O 0 1.0994070931413802e-10
regulatory O 0 5.5962598999315105e-09
mechanism O 0 5.173305783756632e-09
may O 0 2.4113772090217367e-10
play O 0 5.970155037005043e-09
a O 0 7.706876803403873e-10
role O 0 1.5855947665954773e-09
in O 0 3.8034536631315063e-10
the O 0 6.368253036015403e-09
pathogenesis O 0 0.0013047264656051993
of O 1 0.9995366334915161
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 7.735148392384872e-05
. O 0 1.5113785138964886e-06

Genomic O 0 9.763896287040552e-07
organization O 0 1.8830059289598466e-08
of O 0 6.83255763078705e-08
the O 0 1.3059835168860445e-07
UBE3A O 1 1.0
/ O 0 0.0005108066252432764
E6 O 1 1.0
- O 0 1.3667688108398579e-05
AP O 0 7.395817647193326e-06
gene O 0 1.3866206849399987e-08
and O 0 6.915179096012025e-09
related O 0 3.5017654909097473e-07
pseudogenes O 0 7.433846349158557e-06
. O 0 3.637302938841458e-07

The O 0 6.0770594245695975e-06
UBE3A O 0 0.0007633381173945963
gene O 0 6.897714399656252e-08
encodes O 0 2.8953836661571586e-08
the O 0 3.107040313921061e-08
E6 O 0 0.0008089534821920097
- O 0 1.910261971715954e-06
AP O 0 2.027564732998144e-06
ubiquitin O 0 1.0745104361831181e-07
- O 0 4.4076298166828565e-08
protein O 0 1.938968763326443e-09
ligase O 0 2.58718957368842e-09
and O 0 1.20240695178353e-09
has O 0 9.421901037143243e-10
recently O 0 1.9564325715037967e-09
been O 0 2.0928564437028285e-10
shown O 0 6.509325023440482e-11
to O 0 9.21927534314193e-11
be O 0 2.3348348254792484e-10
mutated O 0 5.999643093446139e-08
in O 0 1.2797003989817313e-07
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 3.7636448269040557e-07
who O 0 4.4896251161219425e-09
lack O 0 8.137499207805376e-08
15q11 O 0 2.012057666433975e-05
- O 0 7.000098321441328e-06
q13 O 0 1.0335134902561549e-05
deletions O 0 5.80087430535059e-07
or O 0 2.7643233480034723e-08
chromosome O 0 1.5333517922044848e-07
15 O 0 1.0875062628201704e-07
paternal O 0 3.125548346361029e-06
uniparental B-Disease 1 0.9973946809768677
disomy I-Disease 1 0.9938043355941772
. O 0 7.798123988322914e-06

Previous O 0 3.5756493161898106e-05
UBE3A O 0 0.000936339027248323
cDNA O 0 4.666827067012491e-07
analysis O 0 1.0628042446114705e-08
has O 0 1.1403633592976803e-09
shown O 0 2.157504175315239e-10
a O 0 4.086725402530078e-10
coding O 0 1.633408430734562e-08
region O 0 2.2421724921173336e-08
of O 0 5.256560342559169e-08
approximately O 0 1.0309248565931739e-08
2 O 0 2.1220128587629006e-07
. O 0 1.5361297300842125e-07

6 O 0 7.1416206992580555e-06
kb O 0 2.4328133804374374e-05
and O 0 4.204891723702531e-08
a O 0 7.235884780243396e-09
3 O 0 4.900980599131799e-08
- O 0 3.9297765397350304e-07
untranslated O 0 0.0006415147799998522
region O 0 1.6464102259305946e-07
( O 0 4.04784605834152e-09
UTR O 0 0.000578943407163024
) O 0 1.9599695200156475e-09
of O 0 1.9292935249382026e-08
< O 0 6.531646334906327e-08
50 O 0 1.2854709297016598e-08
bp O 0 2.2200440596975568e-08
, O 0 2.295807099983449e-09
whereas O 0 9.110064369544091e-10
Northern O 0 3.837222095626203e-09
analysis O 0 4.566861055987914e-10
has O 0 2.686445510491353e-10
indicated O 0 1.2916383240746399e-10
mRNA O 0 7.591126616190991e-10
sizes O 0 1.010772354703704e-09
of O 0 2.4202624349101143e-09
5 O 0 3.2751412248899214e-08
- O 0 5.203601176617667e-07
8 O 0 6.904617180225614e-07
kb O 0 2.9732002076343633e-05
. O 0 8.255331636064511e-07

We O 0 2.3921771230561717e-07
have O 0 1.5721156598758057e-09
analyzed O 0 5.926836799119428e-09
additional O 0 2.3442781049709538e-09
cDNA O 0 1.4059017061640589e-08
clones O 0 1.310364527995489e-08
and O 0 1.9089103908687122e-10
provide O 0 5.130066510483644e-11
evidence O 0 1.051329162615744e-10
for O 0 1.185803122361051e-10
an O 0 1.7154434817090447e-10
additional O 0 6.993730927717934e-09
0 O 0 1.7971544252759486e-07
. O 0 2.4348449301214714e-07

5 O 0 2.032644943028572e-06
kb O 0 1.1100278243247885e-05
of O 0 2.69041265710257e-07
5 O 0 2.448985298997286e-07
- O 0 1.1383740456949454e-06
UTR O 0 0.00023955116921570152
and O 0 2.226583006859073e-08
> O 0 6.495927351579667e-08
2 O 0 9.458406680096232e-08
kb O 0 1.4236215974960942e-06
of O 0 1.409014913633655e-07
3 O 0 1.3308317647897638e-06
- O 0 2.75500333373202e-05
UTR O 1 0.8988327980041504
. O 0 8.734015750633262e-07

We O 0 1.1864428017815953e-07
have O 0 1.166077567837931e-09
established O 0 3.2424889440108018e-09
the O 0 9.718796878388503e-10
genomic O 0 6.4001324240337e-09
organization O 0 4.5963013950434117e-10
of O 0 8.439348775368671e-09
UBE3A O 0 0.00026806927053257823
and O 0 8.507567983428999e-09
the O 0 7.130908752372989e-09
sequence O 0 2.158484946335193e-09
of O 0 2.8804127083503772e-08
intron O 0 1.4606707736675162e-05
- O 0 0.00037341006100177765
exon O 0 1.7247552023036405e-05
borders O 0 2.537722139095422e-06
. O 0 8.007884275684773e-07

We O 0 2.4305157353410323e-07
have O 0 3.458319852711611e-09
also O 0 4.08747613533933e-09
mapped O 0 3.504738188553347e-08
two O 0 5.571696992667796e-10
highly O 0 4.819173504699847e-09
homologous O 0 3.136510773327217e-10
processed O 0 2.8043907196462214e-09
pseudogenes O 0 2.735121107377836e-08
, O 0 1.0484619838990739e-09
UBE3AP1 O 0 0.01459143403917551
and O 0 3.1177254555814216e-08
UBE3AP2 O 1 0.9979033470153809
, O 0 1.797036408568431e-09
to O 0 2.3523435976890994e-10
chromosomes O 0 3.544192717086503e-11
2 O 0 4.848998980122587e-10
and O 0 2.4304291912358167e-10
21 O 0 2.839738222348842e-09
, O 0 2.2819054978917563e-10
respectively O 0 1.1912898445487485e-09
, O 0 4.305128753490095e-10
and O 0 8.580734456309358e-10
determined O 0 3.9844136878741665e-09
their O 0 1.0886050949565629e-09
genomic O 0 6.347906378323387e-08
organization O 0 2.1580783382546542e-08
. O 0 2.4879213356143737e-07

These O 0 5.706530714633118e-08
results O 0 2.355177608492909e-09
will O 0 4.126138042348515e-10
form O 0 1.0495539853883074e-10
the O 0 1.495990831212879e-10
basis O 0 2.59657129131341e-10
for O 0 3.44105126337535e-11
studies O 0 3.388053448905026e-10
of O 0 1.1208733941003857e-09
mutation O 0 9.030621805905525e-10
and O 0 3.3187683712299076e-09
imprinting O 0 2.377839109612978e-06
of O 0 1.7572283468325622e-06
UBE3A O 1 0.9999994039535522
. O 0 6.621270586038008e-06

Mutation O 0 1.681311573520361e-06
spectrum O 0 5.220272214501165e-07
and O 0 2.190508396893165e-08
genotype O 0 1.9399099926431518e-07
- O 0 3.1681884138379246e-07
phenotype O 0 1.696430018682804e-08
analyses O 0 8.092840175777383e-09
in O 0 2.275509114468832e-09
Cowden B-Disease 1 0.9999998807907104
disease I-Disease 0 0.0029492834582924843
and O 0 2.5894470567777716e-08
Bannayan B-Disease 1 1.0
- I-Disease 1 1.0
Zonana I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 1.9600079781412205e-08
two O 0 3.082907795715073e-08
hamartoma B-Disease 1 0.9994514584541321
syndromes I-Disease 0 0.00023889337899163365
with O 0 3.8125841683722683e-07
germline O 0 0.0004944135434925556
PTEN O 1 1.0
mutation O 0 5.4043257478042506e-06
. O 0 7.501478194171796e-07

The O 0 3.237354030716233e-05
tumour B-Disease 1 1.0
suppressor O 1 0.9997372031211853
gene O 0 1.3220793334767222e-05
PTEN O 1 0.9999386072158813
, O 0 4.1225391100851994e-08
which O 0 3.470557619067449e-09
maps O 0 5.2647482817747004e-08
to O 0 4.8647052608430386e-08
10q23 O 0 6.40625657979399e-05
. O 0 1.735141950121033e-06

3 O 0 1.1918198197236052e-06
and O 0 5.37693800595207e-08
encodes O 0 3.511147639301271e-08
a O 0 4.831957944873011e-09
403 O 0 1.387668469021719e-08
amino O 0 8.899271541906728e-09
acid O 0 2.5525077163024434e-08
dual O 0 8.049493516182338e-08
specificity O 0 1.7608859081974515e-07
phosphatase O 0 1.4316067790787201e-05
( O 0 1.1229068341833681e-08
protein O 0 6.066093760637159e-08
tyrosine O 0 1.3239512952623045e-07
phosphatase O 0 4.47139058223911e-07
; O 0 8.938973450334231e-10
PTPase O 0 2.4675155145814642e-06
) O 0 4.936080433282086e-10
, O 0 3.9529449158415275e-10
was O 0 1.964119977770906e-09
shown O 0 2.276923233290873e-10
recently O 0 1.3160595946359877e-09
to O 0 3.7925873552779876e-10
play O 0 1.1569396995980696e-08
a O 0 2.4723418867722557e-09
broad O 0 4.508531858959941e-08
role O 0 2.1698664198765982e-08
in O 0 6.262208085416887e-09
human O 0 2.1229965341262869e-07
malignancy B-Disease 0 0.00035655463580042124
. O 0 5.710983259632485e-07

Somatic O 0 0.00011956641537835822
PTEN O 0 0.00017156223475467414
deletions O 0 3.225832472253387e-07
and O 0 2.3250779079830863e-08
mutations O 0 3.4916187718891933e-09
were O 0 3.8746397756916906e-10
observed O 0 9.210737728082563e-10
in O 0 2.3867413601053045e-10
sporadic B-Disease 0 6.114065763540566e-05
breast I-Disease 1 1.0
, I-Disease 0 1.7707318420434603e-06
brain I-Disease 1 1.0
, I-Disease 0 7.622676889695867e-08
prostate I-Disease 1 1.0
and I-Disease 1 0.911655068397522
kidney I-Disease 1 1.0
cancer I-Disease 1 0.9999778270721436
cell O 0 3.417014227125037e-08
lines O 0 1.1584369019601581e-08
and O 0 1.0209912915115638e-09
in O 0 1.802644838955203e-10
several O 0 2.693501643946661e-09
primary O 0 1.4345437193696853e-06
tumours B-Disease 1 1.0
such O 0 1.3459847991725837e-07
as O 0 9.526371513857157e-07
endometrial B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 1 1.0
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 1.0
thyroid B-Disease 1 1.0
tumours I-Disease 1 1.0
. O 0 0.00010130414739251137

In O 0 2.347751681952559e-08
addition O 0 4.907247941332571e-08
, O 0 5.2858982968473356e-08
PTEN O 1 0.9575252532958984
was O 0 7.335075480341402e-08
identified O 0 2.0594990157718485e-09
as O 0 6.517378858816869e-10
the O 0 2.2664561338814337e-09
susceptibility O 0 3.5335872894393106e-08
gene O 0 1.1904585095479092e-09
for O 0 3.6999885377753117e-09
two O 0 6.250325412793245e-08
hamartoma B-Disease 1 1.0
syndromes I-Disease 1 1.0
Cowden B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 6.7035719197861e-09
CD B-Disease 1 1.0
; O 0 4.9542894231535684e-08
MIM O 1 0.9999558925628662
158350 O 0 2.781767079795827e-06
) O 0 1.9096326742129577e-09
and O 0 6.3954952445044455e-09
Bannayan B-Disease 0 0.0003429287171456963
- I-Disease 0 5.372751547838561e-05
Zonana I-Disease 1 0.6987661719322205
( I-Disease 0 1.0613724299446403e-07
BZS I-Disease 0 0.003944911994040012
) I-Disease 0 6.913174477318762e-09
or I-Disease 0 2.776067598020404e-09
Ruvalcaba I-Disease 0 7.371832907665521e-06
- I-Disease 0 6.612232255065464e-07
Riley I-Disease 0 1.3085035789117683e-05
- I-Disease 1 0.9999983310699463
Smith I-Disease 1 0.999971866607666
syndrome I-Disease 1 1.0
( O 0 4.2926128429598975e-08
MIM O 1 0.9999998807907104
153480 O 0 0.00011314091534586623
) O 0 1.1064685878636737e-07
. O 0 2.0770299613559473e-07

Constitutive O 0 2.502981033103424e-06
DNA O 0 5.897014787592525e-08
from O 0 9.102318343501281e-10
37 O 0 7.434032500697185e-09
CD B-Disease 0 2.612501248222543e-06
families O 0 1.3369318152545162e-10
and O 0 6.257047102664615e-10
seven O 0 3.4984184438258126e-09
BZS B-Disease 0 3.097499211435206e-05
families O 0 3.34583610817063e-10
was O 0 4.168507317103831e-09
screened O 0 7.38189740445705e-08
for O 0 6.306777322606649e-08
germline O 0 1.5891529983491637e-05
PTEN O 1 0.998902440071106
mutations O 0 5.2973718993598595e-06
. O 0 1.2279248267077492e-06

PTEN O 0 0.0007535837357863784
mutations O 0 3.803994275131117e-08
were O 0 3.2467466493102393e-09
identified O 0 1.0547842599351043e-09
in O 0 1.3039755386579088e-10
30 O 0 3.549973870420331e-09
of O 0 6.561861720655315e-09
37 O 0 2.853144209780112e-08
( O 0 2.1062436517116367e-10
81 O 0 1.3527002629132312e-08
% O 0 5.174386266681985e-11
) O 0 3.894256792036366e-11
CD B-Disease 0 1.505190539319301e-06
families O 0 1.1627922236190358e-10
, O 0 1.5618158155650264e-10
including O 0 4.5910622525902056e-10
missense O 0 2.8074909508291057e-08
and O 0 6.7286536342692216e-09
nonsense O 0 2.902905009705137e-07
point O 0 1.3858849001735507e-07
mutations O 0 3.26445648290985e-09
, O 0 7.915897382027026e-10
deletions O 0 2.643517582612276e-08
, O 0 4.5984962504519444e-09
insertions O 0 1.7915074579377688e-07
, O 0 1.1032691205059564e-08
a O 0 1.670804827824668e-08
deletion O 0 2.871959736694407e-07
/ O 0 5.00251701396337e-07
insertion O 0 1.3191444736548874e-07
and O 0 4.073251602676464e-08
splice O 0 2.8695772016362753e-06
site O 0 1.3619500123240869e-06
mutations O 0 2.7559903514884354e-07
. O 0 1.941734950605678e-07

These O 0 1.9230331105291043e-08
mutations O 0 2.7161755067339755e-09
were O 0 4.2197831340295977e-10
scattered O 0 2.308474966739027e-09
over O 0 1.110772807066951e-09
the O 0 1.5974334077739627e-09
entire O 0 3.8357295117918966e-09
length O 0 1.886254485938821e-09
of O 0 1.129796611820666e-08
PTEN O 0 1.832888665376231e-05
, O 0 4.1126080319031644e-10
with O 0 5.520190207719544e-11
the O 0 6.675409114365038e-10
exception O 0 1.1284715384363153e-09
of O 0 1.153673490073004e-09
the O 0 1.1097901486678552e-09
first O 0 1.8495031062215617e-09
, O 0 2.329986648064164e-09
fourth O 0 4.63790748028714e-08
and O 0 2.1962314633583446e-08
last O 0 2.3214182931496907e-07
exons O 0 1.1104598343081307e-05
. O 0 2.4970684080471983e-06

A O 0 1.3345684237719979e-05
hot O 0 1.306286776525667e-05
spot O 0 1.2393129509291612e-06
for O 0 3.8597001150719734e-08
PTEN O 0 3.260417724959552e-05
mutation O 0 4.600706926538578e-09
in O 0 7.881457708691642e-10
CD B-Disease 1 0.9999957084655762
was O 0 1.0954922657901989e-07
identified O 0 1.8179072691637543e-09
in O 0 5.439712014165821e-10
exon O 0 5.347248333009702e-08
5 O 0 5.077659626095965e-09
that O 0 1.1060365817661122e-10
contains O 0 2.2517370190655583e-09
the O 0 2.2441135616446672e-09
PTPase O 0 2.1649877908203052e-06
core O 0 2.97436230312087e-07
motif O 0 1.3169442425464695e-08
, O 0 1.2475130650724253e-10
with O 0 4.195528299777429e-11
13 O 0 2.2876940342086982e-09
of O 0 3.72308095464291e-09
30 O 0 4.830556843415934e-09
( O 0 1.7140795727232927e-10
43 O 0 6.76156330925437e-09
% O 0 1.934151172555687e-10
) O 0 6.446673195270591e-10
CD B-Disease 0 4.666269160225056e-05
mutations O 0 5.866329200188147e-09
identified O 0 9.752816332309067e-10
in O 0 3.968794459741076e-10
this O 0 3.876282850256985e-09
exon O 0 5.372414761950495e-06
. O 0 8.018735684345302e-07

Seven O 0 6.089626936045534e-08
of O 0 2.5294818684074016e-08
30 O 0 1.40087479394424e-08
( O 0 1.7406640018258202e-10
23 O 0 1.655488635066149e-09
% O 0 6.500342625281874e-11
) O 0 2.2820785192112503e-11
were O 0 7.910791466336775e-11
within O 0 1.0684902268520702e-10
the O 0 2.6764723770611454e-10
core O 0 1.8996432871176694e-08
motif O 0 2.3623401013139755e-09
, O 0 6.614657432901794e-11
the O 0 2.755634331830237e-10
majority O 0 2.8520460298997463e-11
( O 0 2.215975146435678e-11
five O 0 8.050080047006247e-11
of O 0 7.717997907441543e-10
seven O 0 1.7559564913227632e-10
) O 0 3.3534501564513874e-11
of O 0 3.757034683360416e-10
which O 0 1.6902529376139341e-10
were O 0 1.138455218985257e-09
missense O 0 6.661258566964534e-08
mutations O 0 2.668903542613066e-09
, O 0 4.454310809087758e-10
possibly O 0 1.1300956836990395e-09
pointing O 0 1.1148018508322366e-08
to O 0 3.9694381115396027e-10
the O 0 2.224459505484333e-09
functional O 0 8.507925031153718e-09
significance O 0 6.880842562395628e-08
of O 0 1.6759562626589286e-08
this O 0 3.783889646058469e-09
region O 0 4.3010911099372606e-07
. O 0 5.174769626137277e-07

Germline O 0 0.0003008489147759974
PTEN O 0 0.00046702256076969206
mutations O 0 2.666569365317173e-08
were O 0 1.6873289432339789e-09
identified O 0 4.82093642784065e-10
in O 0 7.123913264850401e-11
four O 0 2.3896201684081575e-10
of O 0 4.812459319936124e-09
seven O 0 2.084610706276635e-09
( O 0 2.577770219502895e-10
57 O 0 1.1997411064612606e-08
% O 0 6.112371164768149e-10
) O 0 2.4744837290313626e-09
BZS B-Disease 0 0.00029008256387896836
families O 0 3.676085880144342e-09
studied O 0 4.186373701031698e-07
. O 0 3.8943301206018077e-07

Interestingly O 0 6.171548534439353e-07
, O 0 1.129354920692549e-08
none O 0 3.993818165071161e-09
of O 0 1.8557151371112468e-09
these O 0 8.168888898651971e-10
mutations O 0 1.4790141333875795e-09
was O 0 5.918466161602964e-09
observed O 0 1.02939945456626e-09
in O 0 1.1400435040442858e-09
the O 0 5.510909417694165e-08
PTPase O 0 0.0004753046378027648
core O 0 0.0002308423281647265
motif O 0 7.261102382472018e-06
. O 0 7.859605375415413e-07

It O 0 2.5176843720942088e-08
is O 0 1.034854646420058e-09
also O 0 4.790312591040902e-10
worthy O 0 2.1838044261812684e-08
of O 0 3.5258163055829073e-09
note O 0 1.0114357129609175e-09
that O 0 6.412613495765385e-11
a O 0 3.075446008971028e-10
single O 0 6.438083399729067e-10
nonsense O 0 2.1071699052299664e-08
point O 0 2.4864357683895832e-08
mutation O 0 2.3918272917811123e-10
, O 0 2.8718299960317495e-10
R233X O 0 3.066151634811831e-07
, O 0 1.3310347268813416e-09
was O 0 4.624443494805064e-09
observed O 0 1.0837676311936661e-09
in O 0 1.7228013460268699e-10
the O 0 2.129739717915413e-09
germline O 0 3.045014018709935e-09
DNA O 0 1.008696237647655e-09
from O 0 4.2270711236858105e-11
two O 0 5.2480571971491585e-11
unrelated O 0 5.762462507163946e-09
CD B-Disease 0 1.4768951587029733e-05
families O 0 2.1868325206231276e-10
and O 0 1.8916876953767314e-09
one O 0 2.404986076953719e-08
BZS B-Disease 1 0.9917879700660706
family O 0 3.525805425397266e-07
. O 0 9.664961453381693e-07

Genotype O 0 2.0133156795054674e-06
- O 0 4.6903585371183e-07
phenotype O 0 3.096224165943795e-09
studies O 0 5.40751998734379e-10
were O 0 6.576465066965298e-11
not O 0 8.700173394216026e-12
performed O 0 2.9915495081134225e-10
on O 0 5.187333895761981e-10
this O 0 5.2344215767385904e-11
small O 0 1.939741922640792e-09
group O 0 1.4573064976985961e-09
of O 0 6.732764035177752e-08
BZS B-Disease 1 0.9841204285621643
families O 0 2.1003565109367628e-08
. O 0 2.3411743654833117e-07

However O 0 1.7533318441564916e-07
, O 0 1.897456058941316e-08
genotype O 0 3.606216836260501e-08
- O 0 6.54658762755389e-08
phenotype O 0 5.5368247764420175e-09
analysis O 0 4.564518485405955e-10
inthe O 0 1.161627416479405e-08
group O 0 6.908343341827106e-11
of O 0 9.783370780169776e-10
CD B-Disease 1 0.9405241012573242
families O 0 1.2859845133217362e-10
revealed O 0 5.159626059736411e-10
two O 0 2.2920332298781432e-11
possible O 0 1.2159444284787213e-10
associations O 0 6.386455947415826e-11
worthy O 0 1.9087886826696376e-08
of O 0 9.638425169100628e-09
follow O 0 3.316724228596968e-09
- O 0 4.352558491405034e-08
up O 0 2.4193408165729124e-08
in O 0 1.481148204085514e-09
independent O 0 1.2581958586110886e-08
analyses O 0 4.07061918394902e-07
. O 0 2.953274247374793e-07

The O 0 1.5489989380057523e-07
first O 0 7.07649494557927e-09
was O 0 2.5422897564908453e-08
an O 0 1.195959220545717e-09
association O 0 9.319701677057424e-10
noted O 0 2.6025024357778648e-09
in O 0 2.171988283672377e-10
the O 0 1.7290634479749656e-09
group O 0 1.2178894004399865e-10
of O 0 1.6550024684036657e-09
CD B-Disease 1 1.0
families O 0 6.518646733510991e-10
with O 0 1.68316720561279e-08
breast B-Disease 1 1.0
disease I-Disease 1 0.9999997615814209
. O 0 8.485869784635724e-07

A O 0 1.099777250601619e-06
correlation O 0 3.3978025726355554e-08
was O 0 6.060251855899423e-09
observed O 0 2.514903008066227e-10
between O 0 4.595344244018307e-11
the O 0 6.823943077272077e-10
presence O 0 1.7972593413517757e-09
/ O 0 9.584714177890419e-08
absence O 0 3.9065529477966265e-08
of O 0 3.4322990671853404e-08
a O 0 2.190211745300985e-08
PTEN O 0 5.2156330639263615e-05
mutation O 0 8.330164891212632e-10
and O 0 1.637786989361345e-10
the O 0 5.810768533009991e-10
type O 0 5.177412276680116e-09
of O 0 6.691068676900613e-08
breast O 1 0.9999974966049194
involvement O 0 8.561972322240763e-07
( O 0 1.300276419868851e-08
unaffected O 0 2.8599547476915177e-06
versus O 0 1.604252065590117e-05
benign O 1 0.938109815120697
versus O 0 0.0004016709281131625
malignant O 1 0.9999970197677612
) O 0 1.4017065552707209e-07
. O 0 4.1238180870095675e-07

Specifically O 0 1.0664394523018927e-07
and O 0 2.7613495934275534e-09
more O 0 9.012997292945357e-11
directly O 0 4.190763569500433e-10
, O 0 5.351507570416913e-10
an O 0 3.6490491184260065e-10
association O 0 8.935393536191327e-10
was O 0 1.1432080171402959e-08
also O 0 8.545325558273476e-10
observed O 0 3.6667144320823297e-10
between O 0 7.71182770420431e-11
the O 0 8.934541440019927e-10
presence O 0 1.3990743008562845e-09
of O 0 1.4273987325452708e-08
a O 0 4.576457612870399e-08
PTEN O 1 1.0
mutation O 0 1.6925279169299756e-06
and O 0 5.554270501306746e-06
malignant B-Disease 1 1.0
breast I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 9.162854439637158e-07

Secondly O 0 7.480916792701464e-07
, O 0 1.3063916171063283e-08
there O 0 1.45678413776551e-09
appeared O 0 9.293608105309659e-10
to O 0 2.944467725196631e-10
be O 0 4.4194697901289715e-10
an O 0 1.0746120659987923e-09
interdependent O 0 2.3328477993800334e-07
association O 0 2.534643384066726e-09
between O 0 4.192660441049156e-09
mutations O 0 3.380741242509089e-09
upstream O 0 1.23945502750189e-08
and O 0 1.0239771253139907e-09
within O 0 9.239453646614493e-10
the O 0 4.4794807863013375e-09
PTPase O 0 5.679406604031101e-05
core O 0 1.2903212336823344e-05
motif O 0 6.095844184983434e-08
, O 0 6.259936458086202e-10
the O 0 1.0212951595534037e-09
core O 0 4.222025395961282e-08
motif O 0 1.7375334504521334e-09
containing O 0 4.243431439565626e-10
the O 0 1.5672647901698866e-10
majority O 0 4.0503749659803745e-11
of O 0 1.8536632229171346e-09
missense O 0 1.09776125967187e-08
mutations O 0 3.0132477069066965e-10
, O 0 6.68954128202337e-11
and O 0 1.3412687627223363e-10
the O 0 4.868719871709004e-10
involvement O 0 6.151423259659339e-10
of O 0 6.071033897825373e-09
all O 0 6.449870637581512e-10
major O 0 1.0338276723587114e-07
organ O 1 0.9999998807907104
systems O 1 1.0
( O 0 1.0152787055517365e-08
central O 1 0.9999995231628418
nervous O 0 0.03190994635224342
system O 1 0.899722158908844
, O 0 2.494835200650414e-07
thyroid O 1 1.0
, O 0 2.691436520763091e-06
breast O 1 1.0
, O 0 2.0876323958418652e-07
skin O 1 1.0
and O 0 5.5914348195074126e-05
gastrointestinal O 1 1.0
tract O 1 1.0
) O 0 1.8331891737943806e-07
. O 0 4.871176884080342e-07

However O 0 1.282219415088548e-07
, O 0 4.50846959765272e-09
these O 0 2.1573023922805135e-10
observations O 0 2.1767130320426986e-09
would O 0 1.985558661932174e-10
need O 0 1.5154537347239483e-10
to O 0 1.1438088670656654e-10
be O 0 8.905546439175183e-11
confirmed O 0 5.058225366338931e-11
by O 0 1.8566337703362912e-11
studying O 0 7.994540585087861e-10
a O 0 1.3087096684127886e-10
larger O 0 4.3725076337430835e-10
number O 0 2.3355561928894986e-10
of O 0 4.4344430349951836e-09
CD B-Disease 1 0.5835522413253784
families O 0 6.9418999437687035e-09
. O 0 8.957823638411355e-08

Molecular O 1 0.9999852180480957
defects O 1 0.9986947178840637
leading O 0 5.502527500311771e-08
to O 0 7.730343032363862e-10
human O 0 3.575347573558929e-09
complement B-Disease 0 1.8312983911528136e-06
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 1.3861546355187215e-09
an O 0 2.6107244144313313e-10
African O 0 3.4538619186896824e-10
- O 0 3.0435526099381605e-08
American O 0 2.3152360029143892e-08
family O 0 6.165898014387494e-09
. O 0 4.9236547283726395e-08

Complement B-Disease 0 2.987658626807388e-05
component I-Disease 1 1.0
C6 I-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.8406605068198587e-08
C6D B-Disease 1 1.0
) O 0 7.422187753292064e-09
was O 0 6.478666136899847e-08
diagnosed O 0 5.048497797588425e-08
in O 0 3.7674971475887276e-10
a O 0 1.196500010181012e-09
16 O 0 3.0508975346066336e-09
- O 0 4.5747183818889425e-09
year O 0 2.7663088486562515e-10
- O 0 1.3282506650114101e-08
old O 0 1.9273514340056863e-08
African O 0 2.6585730839023825e-10
- O 0 3.1254998589247407e-09
American O 0 7.636552501466554e-10
male O 0 5.972315975100173e-10
with O 0 1.438362762229417e-09
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 1.095629727387859e-06

The O 0 1.1108966191386571e-07
patients O 0 1.0047870979690288e-08
father O 0 1.6287132753589617e-09
and O 0 1.3261767239924893e-09
two O 0 1.0657592586227338e-09
brothers O 0 2.6112251916288187e-08
also O 0 2.261852483087523e-09
had O 0 6.354869963587362e-09
C6D B-Disease 1 1.0
, O 0 1.6960667315046862e-09
but O 0 2.234489676622431e-10
gave O 0 4.514992379966998e-09
no O 0 1.6957820703211723e-09
history O 0 2.310787783343926e-09
of O 0 1.0499713987144332e-08
meningitis B-Disease 1 1.0
or O 0 1.6773249456036865e-08
other O 0 1.6186923801342346e-08
neisserial B-Disease 1 0.9286397695541382
infection I-Disease 0 3.311974796815775e-05
. O 0 4.3631982293845795e-07

By O 0 3.125036229789657e-08
using O 0 1.4544971449481636e-08
exon O 0 2.872507423035131e-07
- O 0 5.397869529133459e-08
specific O 0 3.698394035467345e-09
polymerase O 0 1.426374685031817e-09
chain O 0 1.804510318947905e-09
reaction O 0 1.4545899207352164e-10
( O 0 5.249979617705236e-11
PCR O 0 4.251178076231099e-09
) O 0 3.639637202734747e-10
/ O 0 5.7717901569276364e-09
single O 0 3.823835137417575e-10
- O 0 3.010692584126673e-09
strand O 0 6.150484566092018e-10
conformation O 0 6.88876386489845e-11
polymorphism O 0 6.261891699610445e-11
as O 0 8.594030348474391e-11
a O 0 3.778549001465237e-11
screening O 0 1.023022555557418e-09
step O 0 1.2083570810617061e-09
and O 0 6.969434751535886e-11
nucleotide O 0 3.855176594624865e-11
sequencing O 0 1.843078883956295e-10
of O 0 3.3933178489320426e-10
target O 0 3.0785110016751105e-09
exons O 0 2.0142184808946695e-08
, O 0 8.078108182374422e-10
we O 0 2.117453712369155e-10
determined O 0 2.598880277648874e-10
that O 0 3.2313048070609085e-11
the O 0 3.1268116984506378e-09
proband O 0 2.5855736112134764e-06
was O 0 6.342001057646485e-08
a O 0 2.221186568007738e-09
compound O 0 6.9673684599536045e-09
heterozygote O 0 1.1126096488567327e-08
for O 0 2.2425905576994865e-09
two O 0 1.2597543452841364e-08
C6 O 1 0.9999524354934692
gene O 0 2.9196360173955327e-07
mutations O 0 2.5651394253145554e-07
. O 0 2.1330930621843436e-07

The O 0 7.165049282775726e-07
first O 0 2.871904136725334e-08
, O 0 8.57553672517497e-09
1195delC O 0 3.5353269822735456e-07
located O 0 2.801296794530117e-08
in O 0 1.5382833895571935e-09
exon O 0 1.0297205932374709e-07
7 O 0 3.300217699120367e-08
, O 0 1.1835260549375448e-09
is O 0 3.4446254182363134e-10
a O 0 1.7881528202590147e-10
novel O 0 2.7373430189214787e-09
mutation O 0 6.143212327724967e-11
, O 0 4.079605403495279e-11
while O 0 7.706255078510083e-11
the O 0 5.314522710797576e-10
second O 0 2.640945906406955e-09
, O 0 9.670682032947298e-10
1936delG O 0 7.435821913759355e-08
in O 0 1.276359684609929e-09
exon O 0 8.916368443578904e-08
12 O 0 2.0468901240633386e-08
, O 0 1.4650656243730964e-09
has O 0 4.069962145081263e-10
been O 0 2.1559204421706113e-10
described O 0 1.4525826375066941e-10
before O 0 1.8391037304166247e-10
to O 0 4.32866104072005e-10
cause O 0 1.3982267788037461e-08
C6D B-Disease 1 0.9999996423721313
in O 0 3.431367634476601e-09
an O 0 1.8080312802482013e-09
unrelated O 0 6.178721179139757e-08
African O 0 6.147403031064869e-09
- O 0 2.414279833828914e-07
American O 0 4.714809520578456e-08
individual O 0 9.380448418028209e-09
. O 0 5.1089145358673704e-08

Both O 0 4.766857273352798e-07
mutations O 0 6.386696327354002e-08
result O 0 8.440749432736538e-09
in O 0 4.152113763922216e-09
premature O 0 1.0789671023303526e-07
termination O 0 7.163478699112602e-08
codons O 0 2.451469072184409e-07
and O 0 1.0273625150603038e-07
C6 O 1 0.9884048700332642
null O 0 8.153117050824221e-06
alleles O 0 9.025222880154615e-08
. O 0 1.6456866092084965e-07

Allele O 0 1.5310605760987528e-07
- O 0 3.573576279336521e-08
specific O 0 2.3345909649918895e-09
PCR O 0 4.2342973571862785e-09
indicated O 0 2.690984102216021e-10
that O 0 1.319723236942183e-11
the O 0 6.343059411051399e-10
probands O 0 6.448757403632044e-07
two O 0 2.0852628512813e-09
brothers O 0 2.8699382426111697e-08
also O 0 5.548612680428278e-09
inherited O 0 2.437553803247283e-07
the O 0 1.8541733481924894e-08
1195delC O 0 9.235937881157952e-08
mutation O 0 2.357999351332296e-10
from O 0 3.6908219536169184e-11
their O 0 1.737161525738884e-10
heterozygous O 0 1.1255824050593333e-09
mother O 0 5.694955063084706e-10
and O 0 3.4963085204786637e-10
the O 0 2.9925384392726073e-09
1936delG O 0 5.6685404814516005e-08
mutation O 0 3.682069649180164e-10
from O 0 6.679302944068155e-11
their O 0 8.926144268173175e-10
homozygous O 0 3.532576187126324e-08
father O 0 1.7267080210103813e-08
. O 0 1.428488261012717e-08
. O 0 2.214698753277844e-07

PAX6 O 1 0.9964377880096436
mutations O 0 4.5349926949711516e-05
reviewed O 0 2.828285505529493e-05
. O 0 6.008157015457982e-06

Mutations O 0 2.0720779048133409e-07
in O 0 7.912188237924056e-09
PAX6 O 0 0.0003429620701353997
are O 0 4.95000596067996e-10
responsible O 0 1.3153368394469567e-09
for O 0 6.416091546945779e-10
human O 0 1.3961906297765836e-08
aniridia B-Disease 1 1.0
and O 0 1.6488472454057046e-07
have O 0 7.801352897018887e-10
also O 0 5.087176235818447e-10
been O 0 1.8492940512260247e-10
found O 0 3.5403686926560596e-11
in O 0 1.879393689285802e-11
patients O 0 7.805635304780623e-11
with O 0 5.494842081343876e-11
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 7.818579916829549e-08
with O 1 0.9989069700241089
congenital B-Disease 1 1.0
cataracts I-Disease 1 1.0
, O 0 0.00024328271683771163
with O 0 2.2518690457218327e-05
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
keratitis I-Disease 1 1.0
, O 0 1.6137876812649665e-08
and O 0 2.3125791059896983e-08
with O 0 2.2461154003394768e-07
isolated B-Disease 1 0.9999997615814209
foveal I-Disease 1 1.0
hypoplasia I-Disease 1 1.0
. O 0 0.00021284390822984278

No O 0 7.979730867191392e-07
locus O 0 4.0073800278150884e-07
other O 0 3.5381311214166544e-09
than O 0 6.815917275027061e-10
chromosome O 0 1.20281136162248e-08
11p13 O 0 4.969361384610238e-07
has O 0 1.936326432527835e-09
been O 0 6.915359951342737e-10
implicated O 0 3.3074065708404987e-09
in O 0 9.27826981911295e-10
aniridia B-Disease 1 1.0
, O 0 6.1754548141834675e-09
and O 0 6.05522565422234e-09
PAX6 O 1 0.9999725818634033
is O 0 4.324240077124841e-09
clearly O 0 1.868850407760192e-09
the O 0 6.733478219445033e-10
major O 0 1.4830770389551162e-08
, O 0 9.53136347625616e-10
if O 0 2.4283441923955706e-10
not O 0 1.7369494731411805e-10
only O 0 6.008765152110129e-10
, O 0 3.841681639471517e-09
gene O 0 2.5198655606573084e-08
responsible O 0 3.4158060202571505e-07
. O 0 7.476758128177607e-07

Twenty O 0 1.2777045412804e-06
- O 0 1.7576411437403294e-07
eight O 0 7.149143499418642e-09
percent O 0 2.2657731246766843e-09
of O 0 2.5210034060307862e-09
identified O 0 3.613327193008331e-09
PAX6 O 0 5.7479115639580414e-05
mutations O 0 2.1056059118507164e-09
are O 0 1.4276314852512684e-10
C O 0 1.201358230673577e-07
- O 0 1.4554234439856373e-06
T O 0 7.640638273187506e-07
changes O 0 2.9707627469122144e-09
at O 0 5.679403169978059e-09
CpG O 0 1.379155492031714e-07
dinucleotides O 0 1.566424288057533e-07
, O 0 5.866818697519705e-10
20 O 0 6.750065506544445e-10
% O 0 1.7717811592876664e-11
are O 0 2.7184621741171977e-12
splicing O 0 3.7078709547166966e-10
errors O 0 1.0260754024216112e-08
, O 0 1.4427996297694534e-10
and O 0 1.9619472713117148e-10
more O 0 2.2906215119133932e-11
than O 0 4.112606089012871e-11
30 O 0 7.481880670567875e-10
% O 0 1.1097557595096674e-10
are O 0 3.168195220060177e-11
deletion O 0 9.710092285786232e-09
or O 0 2.5118025437365077e-09
insertion O 0 5.5897022122053386e-08
events O 0 4.5209407772972554e-08
. O 0 2.1407127803740877e-07

There O 0 8.294136222275483e-08
is O 0 6.614046199615586e-09
a O 0 2.4336404003122425e-09
noticeably O 0 5.223737886694835e-08
elevated O 0 1.7233658411441866e-07
level O 0 6.768066551643415e-09
of O 0 2.813600685769302e-09
mutation O 0 1.5904190464599566e-10
in O 0 8.25159870987413e-11
the O 0 1.2861077758330453e-09
paired O 0 2.8030910925735952e-09
domain O 0 6.951953457345894e-10
compared O 0 1.3820515565310387e-10
with O 0 2.625043758752721e-11
the O 0 1.8409296309584988e-09
rest O 0 6.783704264989865e-09
of O 0 7.601852480831894e-09
the O 0 3.3987880954100547e-08
gene O 0 7.805601853760891e-08
. O 0 2.512288403977436e-07

Increased O 0 2.9009734703322465e-07
mutation O 0 8.631165115957629e-09
in O 0 8.649024274554051e-10
the O 0 7.2509993565006425e-09
homeodomain O 0 8.267062980849005e-07
is O 0 1.5450052348597865e-09
accounted O 0 2.5985789076088395e-09
for O 0 1.396026766409264e-10
by O 0 3.367231771189694e-10
the O 0 3.9644859839427227e-08
hypermutable O 0 2.0423141904757358e-05
CpG O 0 1.691363831923809e-05
dinucleotide O 0 9.971247891371604e-06
in O 0 9.659280664209291e-08
codon O 0 2.633292751852423e-06
240 O 0 5.828128450957593e-07
. O 0 2.7662491675073397e-07

Very O 0 1.0643524461784182e-07
nearly O 0 6.354420989396203e-09
all O 0 8.41868630363507e-10
mutations O 0 8.056981193327317e-10
appear O 0 4.182865720459006e-10
to O 0 3.513153934431301e-10
cause O 0 3.81791931403086e-09
loss O 0 2.135427301652726e-08
of O 0 8.941774432003058e-09
function O 0 4.4367334806061365e-10
of O 0 2.4845239199322577e-09
the O 0 2.6617406057027893e-09
mutant O 0 7.997762452305324e-09
allele O 0 1.6220810805656072e-10
, O 0 8.093942877041016e-11
and O 0 8.386404071192288e-11
more O 0 1.2470794362451354e-11
than O 0 2.069206785082489e-11
80 O 0 1.2856590236864918e-09
% O 0 1.0468189509671433e-10
of O 0 1.1928086296464357e-09
exonic O 0 7.841457545509911e-07
substitutions O 0 3.938454185004048e-08
result O 0 2.7768460864052713e-09
in O 0 7.489423303752574e-09
nonsense O 0 2.1194211967667798e-06
codons O 0 5.423889888334088e-06
. O 0 5.649699232890271e-07

In O 0 1.0688096807598413e-07
a O 0 6.997173063183482e-09
gene O 0 5.15409770418529e-10
with O 0 2.2863012871798816e-10
such O 0 6.190691959062633e-09
extraordinarily O 0 8.02792001763919e-08
high O 0 1.7594321377600863e-07
sequence O 0 1.3708341128904067e-09
conservation O 0 7.972571047787369e-09
throughout O 0 1.782880926226582e-10
evolution O 0 2.0347201701298445e-10
, O 0 5.86972623284332e-11
there O 0 9.806606915407912e-11
are O 0 1.83782739027194e-10
presumed O 0 4.09101126308542e-08
undiscovered O 0 6.7016326283919625e-06
missense O 0 1.3554758027112257e-07
mutations O 0 2.444307201088236e-09
, O 0 2.6333946134826647e-10
these O 0 2.1254126236769366e-10
are O 0 3.7814328057717006e-11
hypothesized O 0 5.503844602294805e-10
to O 0 7.689091724438768e-11
exist O 0 9.375949322487642e-11
in O 0 1.1345072797874778e-10
as O 0 1.2564446150165054e-09
- O 0 1.0169127762083008e-07
yet O 0 5.908979971991357e-09
unidentified O 0 2.9494282571818076e-08
phenotypes O 0 5.7135007835995566e-08
. O 0 9.461199823590505e-09
. O 0 2.0911032549975062e-07

Genetic O 0 2.2138190161058446e-06
heterogeneity O 0 1.1856944865940022e-06
and O 0 2.2698490198536092e-08
penetrance O 0 4.547781884411961e-07
analysis O 0 2.5851965013146128e-09
of O 0 2.1785083959002804e-08
the O 0 7.494627851656332e-08
BRCA1 O 0 8.962452398009191e-07
and O 0 1.3547948185532732e-07
BRCA2 O 0 9.906038940243889e-06
genes O 0 7.69140218181974e-09
in O 0 6.420869613776858e-09
breast B-Disease 1 0.9999996423721313
cancer I-Disease 0 8.479243842884898e-05
families O 0 4.204423920128875e-09
. O 0 6.856762269080718e-08

The O 0 0.0003957234148401767
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 4.8395922931376845e-05
Consortium O 0 1.8858688690670533e-06
. O 0 3.2113663905875e-07

The O 0 5.281776438437191e-08
contribution O 0 5.982126083381445e-08
of O 0 1.4803447356825927e-07
BRCA1 O 0 6.397852416739624e-07
and O 0 6.610857639088863e-08
BRCA2 O 0 0.00014465021376963705
to O 0 1.1754709561273557e-07
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 2.3536796334155952e-07
assessed O 0 5.315592588317486e-08
by O 0 1.551672818012051e-10
linkage O 0 4.593464275615133e-09
and O 0 6.46661058034681e-10
mutation O 0 1.205672089943377e-10
analysis O 0 2.5715421111960346e-11
in O 0 2.406762809881169e-11
237 O 0 3.7588410162214814e-10
families O 0 3.411224644769839e-12
, O 0 8.436873595585315e-12
each O 0 2.956502230533342e-12
with O 0 9.666541005148854e-12
at O 0 1.0588722121340766e-09
least O 0 6.532883262133637e-11
four O 0 1.0450394716254863e-10
cases O 0 5.470479069735745e-10
of O 0 3.4013950767075585e-08
breast B-Disease 1 1.0
cancer I-Disease 0 0.006639181170612574
, O 0 4.133321740429352e-10
collected O 0 4.790476904048546e-10
by O 0 1.57147947432712e-10
the O 0 1.1910671560144692e-07
Breast B-Disease 1 1.0
Cancer I-Disease 1 1.0
Linkage O 0 5.399194833444199e-06
Consortium O 0 4.1736177536222385e-07
. O 0 1.0818479267982184e-07

Families O 0 6.594810919580141e-09
were O 0 3.2162233987165223e-10
included O 0 9.049467841748537e-10
without O 0 2.5634730449475285e-10
regard O 0 1.3670298226742261e-09
to O 0 2.5878299503290236e-10
the O 0 1.5918977247508792e-09
occurrence O 0 9.418172197683816e-08
of O 0 0.00018505450861994177
ovarian B-Disease 1 1.0
or I-Disease 0 6.682905109300918e-07
other I-Disease 0 7.756483455523266e-07
cancers I-Disease 1 1.0
. O 0 7.838421538508555e-07

Overall O 0 0.00016388919902965426
, O 0 2.371565130943054e-07
disease O 0 0.0001035539826261811
was O 0 4.208157022844716e-08
linked O 0 4.898074124071172e-08
to O 0 6.475031621988592e-09
BRCA1 O 0 1.3007526611374942e-08
in O 0 2.0652923815589475e-10
an O 0 8.815889684932188e-11
estimated O 0 2.713471114468291e-10
52 O 0 7.007026070482425e-10
% O 0 2.1002092426281038e-11
of O 0 1.7217961778559498e-10
families O 0 1.0652481501061128e-11
, O 0 8.369848564226956e-11
to O 0 9.720799720724926e-10
BRCA2 O 0 1.8229846077133516e-08
in O 0 1.5980054779429764e-10
32 O 0 1.9479058366300706e-09
% O 0 2.6487322751789222e-11
of O 0 2.2219989737060075e-10
families O 0 1.1839493795073874e-11
, O 0 2.8531234666506755e-11
and O 0 1.928283505092665e-10
to O 0 5.467099550848786e-10
neither O 0 2.6245956519233005e-09
gene O 0 1.259443105361413e-10
in O 0 2.466340465190342e-10
16 O 0 4.735355219054327e-09
% O 0 2.807043486541261e-10
( O 0 6.139593000664689e-11
95 O 0 1.478969657853213e-08
% O 0 6.787324591250865e-10
confidence O 0 4.8860071544254424e-09
interval O 0 1.6519566159445276e-08
[ O 0 7.17607306910395e-08
CI O 1 0.9993987083435059
] O 0 9.893678765138247e-09
6 O 0 5.234726430103365e-09
% O 0 1.0065431127470603e-10
- O 0 1.6196209928764915e-09
28 O 0 2.593562919983583e-09
% O 0 1.6472323505212216e-10
) O 0 1.6076109887741552e-10
, O 0 4.594811475744365e-10
suggesting O 0 2.9326820971675716e-09
other O 0 3.1031945901816016e-09
predisposition O 0 6.282914455368882e-07
genes O 0 1.1065107941021779e-07
. O 0 1.6209993702887004e-07

The O 0 1.4074664989038865e-07
majority O 0 4.56661064518471e-09
( O 0 3.5211569771043116e-10
81 O 0 1.257027637535657e-08
% O 0 6.438350547144367e-11
) O 0 3.295778233658453e-11
of O 0 1.1365415275577107e-09
the O 0 3.454893260368408e-08
breast B-Disease 1 1.0
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 7.586661333880418e-12
were O 0 5.517807998706159e-12
due O 0 1.334562460542088e-10
to O 0 1.642084662689669e-10
BRCA1 O 0 3.49875195482241e-09
, O 0 5.833186017545344e-11
with O 0 2.8582651870334708e-11
most O 0 3.083081290267131e-10
others O 0 4.3295111940011566e-10
( O 0 1.0811285894307687e-10
14 O 0 3.068521881033348e-09
% O 0 2.0921978038934697e-10
) O 0 2.694733602925936e-10
due O 0 4.103154793710928e-08
to O 0 2.2089275830694532e-07
BRCA2 O 0 6.226068217074499e-05
. O 0 8.577811740906327e-07

Conversely O 0 1.2766822976573167e-07
, O 0 2.3262034520854513e-09
the O 0 7.457603423688397e-10
majority O 0 1.2036913132895677e-10
of O 0 5.834089877865267e-10
families O 0 9.116035183664994e-12
with O 0 4.175314954890652e-11
male B-Disease 0 2.4765753892097564e-09
and I-Disease 0 2.5067772302378444e-09
female I-Disease 0 1.6131352253978548e-08
breast I-Disease 0 0.006286785937845707
cancer I-Disease 0 4.638810082724376e-07
were O 0 5.877369146922717e-10
due O 0 2.7026217708225886e-08
to O 0 5.305069095129511e-08
BRCA2 O 0 5.168652023712639e-06
( O 0 1.7003294328077345e-09
76 O 0 3.6597387520487246e-07
% O 0 4.165908507047789e-09
) O 0 6.340667546567147e-09
. O 0 1.4683891436106933e-07

The O 0 3.0185779564817494e-07
largest O 0 3.8762035359241054e-08
proportion O 0 6.028582077988176e-09
( O 0 1.5513323958771252e-10
67 O 0 2.8760192005705676e-09
% O 0 3.6361663680040124e-11
) O 0 1.7161558632516893e-11
of O 0 2.4349347538255017e-10
families O 0 3.656047253136618e-12
due O 0 1.5774012651625924e-10
to O 0 4.7673406888826264e-11
other O 0 1.251144465808096e-10
genes O 0 5.2920036408554694e-11
was O 0 7.023564507768754e-10
found O 0 4.789579496899954e-11
in O 0 1.4035150645852479e-11
families O 0 1.3986026963300202e-12
with O 0 1.2512417317533941e-11
four O 0 1.5304978118191315e-10
or O 0 1.5525312979658423e-10
five O 0 1.2453971187653678e-10
cases O 0 2.920105268700013e-10
of O 0 2.4094120476547687e-08
female O 0 1.966779308304467e-07
breast B-Disease 1 0.999998927116394
cancer I-Disease 0 0.0018485474865883589
only O 0 1.1159462687260202e-08
. O 0 1.1189862192395594e-07

These O 0 3.092171496632545e-08
estimates O 0 7.071125018853763e-09
were O 0 5.462283958479475e-10
not O 0 7.606776319946107e-11
substantially O 0 1.98142102725285e-09
affected O 0 4.882632076430582e-10
either O 0 9.923453031523977e-11
by O 0 3.205051848920171e-11
changing O 0 1.8665775591841793e-09
the O 0 1.2245354730211488e-09
assumed O 0 8.133507201080192e-09
penetrance O 0 2.7950525449682573e-08
model O 0 5.626020205262705e-10
for O 0 6.247650174984187e-10
BRCA1 O 0 6.798107854422142e-09
or O 0 1.0066007749554018e-10
by O 0 5.0083142494328214e-11
including O 0 4.3301660035410805e-09
or O 0 2.4183902880281494e-08
excluding O 0 2.1702799131162465e-06
BRCA1 O 0 5.169827090867329e-07
mutation O 0 1.7381308836661447e-08
data O 0 3.0085757884990016e-08
. O 0 2.517891459774546e-07

Among O 0 9.8970760475936e-09
those O 0 3.6932321090255016e-10
families O 0 1.138202119360665e-11
with O 0 6.133647062478431e-11
disease O 0 1.878945283806388e-07
due O 0 2.1841001895950285e-08
to O 0 6.222109050213476e-09
BRCA1 O 0 1.9064017919845355e-08
that O 0 6.575461702906793e-11
were O 0 1.8284498914944436e-10
tested O 0 1.3124241970974282e-10
by O 0 5.834718559000196e-12
one O 0 7.08345535005428e-11
of O 0 3.756805422305831e-10
the O 0 2.2756120598987906e-10
standard O 0 3.2567304408814834e-10
screening O 0 6.265956642437231e-10
methods O 0 6.465253887810718e-10
, O 0 2.386891517769385e-10
mutations O 0 1.891607565029929e-10
were O 0 1.2788567427257647e-10
detected O 0 3.868968201370393e-10
in O 0 6.78726935765539e-11
the O 0 7.477572450120817e-10
coding O 0 3.224818634350868e-09
sequence O 0 4.689656440959311e-10
or O 0 2.2986539061076172e-10
splice O 0 6.103380911781642e-09
sites O 0 9.861156335944088e-10
in O 0 1.508328045796148e-10
an O 0 1.6964023241694548e-10
estimated O 0 1.0625968993593915e-09
63 O 0 1.6728073148897238e-08
% O 0 6.705717647825793e-10
( O 0 3.832085759825077e-10
95 O 0 1.0467165623140318e-07
% O 0 8.71578276218088e-09
CI O 1 0.9995911717414856
51 O 0 1.0641393544119637e-07
% O 0 1.086329803889896e-09
- O 0 4.347779380964312e-08
77 O 0 5.883487474989124e-08
% O 0 2.6470734493244663e-09
) O 0 7.927929424056401e-09
. O 0 1.5715130530224997e-07

The O 0 7.868877816008535e-08
estimated O 0 5.237453137851844e-09
sensitivity O 0 2.125021758558887e-08
was O 0 9.344127249732992e-09
identical O 0 1.4280788773746167e-09
for O 0 1.6194225127552642e-10
direct O 0 4.82092699094494e-10
sequencing O 0 1.219884748770994e-09
and O 0 1.3138725662997786e-09
other O 0 1.9121328964644135e-09
techniques O 0 1.0445626230648486e-07
. O 0 1.2319722486608953e-07

The O 0 1.4694272749693482e-06
penetrance O 0 2.063746978819836e-05
of O 0 5.068903647043044e-06
BRCA2 O 0 7.474480298697017e-06
was O 0 1.2653098124815187e-08
estimated O 0 4.381992269042456e-10
by O 0 3.910856360977988e-11
maximizing O 0 7.219414044357109e-08
the O 0 6.524397466733944e-09
LOD O 1 0.9089328646659851
score O 0 6.871805879882231e-08
in O 0 5.915137268885928e-09
BRCA2 O 0 3.820609890681226e-07
- O 0 1.2931040238584046e-08
mutation O 0 5.445162098993706e-10
families O 0 1.1948089219393498e-11
, O 0 2.2607936356333624e-11
over O 0 2.632194462393045e-10
all O 0 1.1579768255387535e-09
possible O 0 6.573424027322972e-09
penetrance O 0 1.7325855878880247e-06
functions O 0 1.2431051743533317e-07
. O 0 2.962447354093456e-07

The O 0 6.529254648057758e-08
estimated O 0 4.194387948075473e-09
cumulative O 0 5.997915764055506e-08
risk O 0 4.9648274824676264e-08
of O 0 6.482720493750094e-08
breast B-Disease 1 0.999637246131897
cancer I-Disease 0 5.754497124144109e-06
reached O 0 6.1490799119212625e-09
28 O 0 1.0565930352868236e-08
% O 0 2.399265786046101e-10
( O 0 8.741930096478612e-11
95 O 0 2.7600874474842385e-08
% O 0 2.093532236457918e-09
CI O 0 0.0030998250003904104
9 O 0 7.55435625166001e-09
% O 0 5.610340664263802e-11
- O 0 5.135590841476301e-10
44 O 0 3.9024380948937676e-10
% O 0 8.059723895226245e-12
) O 0 3.5316528347595355e-12
by O 0 6.359686215151594e-12
age O 0 2.843693336362918e-10
50 O 0 1.978262970103728e-10
years O 0 1.135665519957918e-10
and O 0 5.15460896188813e-10
84 O 0 3.9324717704403156e-08
% O 0 4.3974984764716396e-10
( O 0 1.7013211672800566e-10
95 O 0 4.978197765126424e-08
% O 0 4.4478012384274734e-09
CI O 1 0.5827792882919312
43 O 0 1.549704542469499e-08
% O 0 1.2967332763125228e-10
- O 0 2.8443567501312828e-09
95 O 0 5.1947424140053045e-09
% O 0 7.148031472281602e-11
) O 0 1.7459166057332e-11
by O 0 5.40196047615904e-11
age O 0 4.044157453364505e-09
70 O 0 1.0681958428904181e-08
years O 0 5.643100653429656e-09
. O 0 1.302813927850366e-07

The O 0 1.4426133247980033e-06
corresponding O 0 0.0004263689916115254
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 0 0.0005364967510104179
were O 0 4.051476487632044e-09
0 O 0 6.378661510098027e-08
. O 0 4.605362136089752e-08

4 O 0 1.8081791495205835e-06
% O 0 3.2115799797338695e-08
( O 0 2.079015848366339e-09
95 O 0 1.8457583905728825e-07
% O 0 6.633932514432672e-09
CI O 0 8.02872673375532e-05
0 O 0 3.804180970234938e-09
% O 0 4.489706176280528e-11
- O 0 3.909366441678941e-10
1 O 0 7.881668095954808e-10
% O 0 1.987664546843071e-11
) O 0 3.1762227396814335e-12
by O 0 8.262524345270528e-12
age O 0 3.885844979123476e-10
50 O 0 1.9051567268224545e-10
years O 0 7.641443727779418e-11
and O 0 2.1748444711811032e-10
27 O 0 7.0444974298311536e-09
% O 0 3.4612479549167574e-10
( O 0 2.8194441226148115e-10
95 O 0 3.5478638693575704e-08
% O 0 2.9180242666626555e-09
CI O 0 6.556666630785912e-05
0 O 0 4.1674104167555015e-09
% O 0 1.0055491855842646e-10
- O 0 1.7953989406294113e-09
47 O 0 1.3704655188462311e-09
% O 0 4.5485077510010186e-11
) O 0 1.8377211211118016e-11
by O 0 5.4863173032382306e-11
age O 0 8.480900426377502e-09
70 O 0 2.1439076292040227e-08
years O 0 1.286501039032828e-08
. O 0 2.1244589731850283e-07

The O 0 4.022051598440157e-07
lifetime O 0 2.2984815473137132e-07
risk O 0 9.355683801004488e-07
of O 0 5.691289857168158e-07
breast B-Disease 1 1.0
cancer I-Disease 0 0.014731395058333874
appears O 0 8.896229863886163e-10
similar O 0 4.410869586246591e-11
to O 0 7.459818873734037e-11
the O 0 1.4107064405521896e-09
risk O 0 5.0643889082380156e-09
in O 0 3.910350931946027e-10
BRCA1 O 0 7.07314784520463e-09
carriers O 0 2.706926904849638e-10
, O 0 8.890000541272869e-11
but O 0 4.2661197491300484e-11
there O 0 8.20901055464951e-11
was O 0 7.459652340280343e-10
some O 0 1.194105508917076e-10
suggestion O 0 4.438589051858344e-09
of O 0 3.842671514320273e-09
a O 0 1.2008554151066164e-09
lower O 0 3.409189019976111e-08
risk O 0 2.0103687603523213e-08
in O 0 2.4433191025963197e-09
BRCA2 O 0 2.4412202037638053e-07
carriers O 0 1.954168826756586e-09
< O 0 1.2614638222885333e-08
50 O 0 2.845712998578165e-09
years O 0 1.4721636132364324e-09
of O 0 1.9073874923947187e-08
age O 0 1.3515324326363043e-07
. O 0 1.634227260183252e-07

Eye B-Disease 1 1.0
movement I-Disease 0 1.9811777747236192e-06
abnormalities I-Disease 0 1.7354630017507588e-06
correlate O 0 3.9035732868342166e-08
with O 0 1.957418005460454e-09
genotype O 0 3.7543088637903566e-08
in O 0 1.0005262396362014e-08
autosomal O 1 0.9978571534156799
dominant O 1 1.0
cerebellar B-Disease 1 1.0
ataxia I-Disease 1 1.0
type I-Disease 1 1.0
I I-Disease 1 1.0
. O 0 7.281809757841984e-06

We O 0 1.7471492697040958e-07
compared O 0 3.5812732335216424e-08
horizontal O 0 2.9653898536707857e-07
eye O 0 0.00013691422645933926
movements O 0 1.0391971727585769e-07
( O 0 5.128437674528641e-09
visually O 0 3.5530849373799356e-08
guided O 0 2.8165345611341763e-07
saccades O 0 1.0419256568638957e-06
, O 0 2.5163675587691614e-09
antisaccades O 0 3.0912400461602374e-07
, O 0 1.203526722726167e-09
and O 0 1.538277505375163e-09
smooth O 0 1.9361056757816186e-08
pursuit O 0 1.1025875323866785e-08
) O 0 1.4150579319416323e-10
in O 0 1.6336000607797274e-10
control O 0 2.5567420181005218e-08
subjects O 0 1.2380225200558925e-07
( O 0 5.042429807033955e-10
n O 0 2.4265209841445312e-09
= O 0 2.020554834558652e-09
14 O 0 9.463090311356837e-10
) O 0 1.0908223629924052e-10
and O 0 2.1253844517676868e-10
patients O 0 5.5965530820767384e-11
with O 0 4.996041774729676e-12
three O 0 5.899941646347884e-11
forms O 0 1.3156982170414722e-09
of O 0 1.160444256242954e-07
autosomal O 0 0.0035496153868734837
dominant O 1 0.9998435974121094
cerebellar B-Disease 1 1.0
ataxias I-Disease 1 0.9999991655349731
type I-Disease 0 0.028402522206306458
I I-Disease 0 0.0014832032611593604
spinocerebellar B-Disease 1 0.9999998807907104
ataxias I-Disease 0 9.574311843607575e-05
1 I-Disease 0 1.4572052009498293e-07
and I-Disease 0 4.01141520001147e-09
2 I-Disease 0 4.3951718708967746e-08
( O 0 8.899692094388456e-10
SCA1 B-Disease 0 0.00028992968145757914
, O 0 3.1880447171062087e-09
n O 0 9.249891963492018e-10
= O 0 5.399975466779949e-10
11 O 0 5.405251246592968e-10
; O 0 1.9343689150463916e-10
SCA2 B-Disease 0 1.2701072591880802e-05
, O 0 8.264235407118292e-10
n O 0 3.4833153028657193e-10
= O 0 2.4551088939617216e-10
10 O 0 1.9161332243111673e-10
) O 0 1.1517425207996368e-10
and O 0 2.8675073426853714e-09
SCA3 B-Disease 1 1.0
/ O 0 8.980454708762409e-07
Machado B-Disease 0 1.571129473632027e-06
- I-Disease 0 2.0387591348480782e-07
Joseph I-Disease 0 2.022632315856754e-06
disease I-Disease 0 0.0006152097485028207
( O 0 3.5671188225450123e-09
MJD B-Disease 1 1.0
) O 0 9.256249988709442e-09
( O 0 1.1080346640213179e-09
n O 0 8.240157001182524e-09
= O 0 9.650547916351115e-09
16 O 0 2.6883345327632924e-08
) O 0 9.832088032624142e-09
. O 0 1.7324605039448215e-07

In O 0 7.339231729019957e-07
SCA1 B-Disease 1 0.9365124702453613
, O 0 7.368112164840568e-08
saccade O 0 8.364910968339245e-07
amplitude O 0 7.110877220384282e-08
was O 0 1.727917187110961e-08
significantly O 0 2.6939384056845483e-09
increased O 0 3.983950058739083e-09
, O 0 3.252448976809319e-09
resulting O 0 2.2994454340619086e-08
in O 0 1.897014634266725e-08
hypermetria B-Disease 0 7.283440208993852e-05
. O 0 1.6639057776046684e-06

The O 0 4.07875904784305e-06
smooth O 0 4.879695097770309e-06
pursuit O 0 2.9143104711693013e-06
gain O 0 3.983892042924708e-07
was O 0 5.175791102374205e-07
decreased O 0 3.0969222279964015e-06
. O 0 9.345036460217671e-07

In O 0 1.8494881715014344e-06
SCA2 B-Disease 1 0.9999829530715942
, O 0 4.189952846900269e-07
saccade O 0 6.4770501921884716e-06
velocity O 0 7.386586844404519e-07
was O 0 3.459975062014564e-07
markedly O 0 5.187102374293318e-07
decreased O 0 2.9995885597600136e-06
. O 0 1.1020388228644151e-06

The O 0 9.947078893901562e-08
percentage O 0 1.7568828170055895e-08
of O 0 9.922214161406373e-09
errors O 0 1.7100262539315736e-07
in O 0 3.5948495291648896e-09
antisaccades O 1 0.6495237946510315
was O 0 5.074922171388607e-08
greatly O 0 7.203387220044988e-09
increased O 0 2.7666533508607927e-09
and O 0 2.3936903570387358e-09
was O 0 5.682566861509031e-09
significantly O 0 5.326558083496025e-10
correlated O 0 2.1580031095425056e-09
with O 0 4.5312781304929217e-10
age O 0 1.402492255664356e-08
at O 0 9.157283642480252e-08
disease O 0 5.192643129703356e-06
onset O 0 5.2216391850379296e-06
. O 0 8.13183362424752e-07

In O 0 3.049432706347943e-08
addition O 0 1.776989044799393e-08
, O 0 2.3124633319326904e-09
a O 0 4.12790107651162e-10
correlation O 0 8.568191156577143e-10
between O 0 7.61467666698934e-10
smooth O 0 2.7355698151154684e-08
pursuit O 0 1.980870045770189e-08
gain O 0 6.395601270803297e-10
and O 0 1.4038932516502456e-10
the O 0 7.070312113555133e-10
number O 0 7.875897156672806e-10
of O 0 2.6751990844786633e-08
trinucleotide O 0 8.826652447169181e-06
repeats O 0 9.875375894807803e-08
was O 0 1.2750493283419928e-07
found O 0 2.6743419923036527e-08
. O 0 1.4270236192714947e-07

In O 0 7.073608685459476e-07
SCA3 B-Disease 1 1.0
, O 0 4.5141425175643235e-07
gaze B-Disease 0 3.204216409358196e-05
- I-Disease 0 1.9875682482961565e-05
evoked I-Disease 0 1.7347547327517532e-06
nystagmus I-Disease 0 5.885782684345031e-06
was O 0 2.1265664784664295e-08
often O 0 5.89606419243438e-10
present O 0 2.7293078908030566e-10
as O 0 6.742293945372069e-10
was O 0 2.3229414836123397e-08
saccade O 0 5.423477773547347e-07
hypometria O 0 2.911699084506836e-06
and O 0 1.0704070518841036e-07
smooth O 0 1.959359678949113e-06
pursuit O 0 2.481973524481873e-06
gain O 0 2.4530149289603287e-07
was O 0 5.033066940995923e-07
markedly O 0 8.279577059511212e-07
decreased O 0 2.240981075374293e-06
. O 0 6.223690434126183e-07

Three O 0 9.404942602486699e-08
major O 0 1.431075418167893e-07
criteria O 0 2.6452082124706067e-07
, O 0 4.5834349648998796e-09
saccade O 0 1.9988378596735856e-07
amplitude O 0 1.7976098831695708e-08
, O 0 2.394667575345011e-09
saccade O 0 1.1847377123785918e-07
velocity O 0 8.36672864323873e-09
, O 0 4.1799705363665396e-10
and O 0 6.312957379073225e-10
presence O 0 2.8240414451374818e-09
of O 0 2.5029420314126583e-08
gaze B-Disease 0 1.1581579201447312e-05
- I-Disease 0 1.3613781447929796e-05
evoked I-Disease 0 1.2080463420716114e-06
nystagmus I-Disease 0 1.4881114793752204e-06
, O 0 1.6827459425883262e-09
permitted O 0 1.2992046327653384e-09
the O 0 6.585731959773966e-10
correct O 0 5.308808948001342e-10
assignment O 0 1.0094159952345194e-09
of O 0 6.28671503744016e-10
90 O 0 1.57078494655849e-09
% O 0 3.392073427699316e-11
of O 0 3.6241204481868294e-10
the O 0 3.66000851848014e-09
SCA1 B-Disease 1 0.9966235160827637
, O 0 1.2874037391696902e-09
90 O 0 1.9725483468846505e-09
% O 0 4.4585755226700385e-11
of O 0 2.5954521865045876e-10
the O 0 1.1460237203664292e-09
SCA2 B-Disease 1 0.9990589022636414
, O 0 7.188231676558132e-10
and O 0 3.5484828964094106e-10
93 O 0 5.1863664474183224e-09
% O 0 3.4452739272605726e-11
of O 0 1.380428688024793e-10
the O 0 5.224320975827368e-10
patients O 0 3.24340859725325e-10
with O 0 3.634531564600252e-10
SCA3 B-Disease 1 1.0
to O 0 1.9539946549684828e-08
their O 0 3.826186034672219e-09
genetically O 0 8.294464670655088e-09
confirmed O 0 3.0515243110151857e-10
patient O 0 5.564093075172138e-10
group O 0 2.0422970606337465e-11
and O 0 2.7071334063322183e-10
, O 0 3.6150352156205656e-10
therefore O 0 3.59724805498729e-10
, O 0 2.3594029507911785e-10
may O 0 1.7992442258307761e-10
help O 0 1.1227178076111954e-09
orient O 0 4.1528531369294797e-07
diagnoses O 0 6.602075330874868e-08
of O 0 4.5426538974879804e-08
SCA1 B-Disease 1 1.0
, O 0 1.5299798761247985e-08
SCA2 B-Disease 1 1.0
, O 0 8.452091471156109e-09
and O 0 2.0730141159219784e-08
SCA3 B-Disease 1 1.0
at O 0 6.077026171169564e-08
early O 0 4.086477822795587e-09
clinical O 0 4.2376122166842833e-08
stages O 0 1.9780459936669104e-08
of O 0 1.6247177825334802e-08
the O 0 3.305169471445879e-08
diseases O 0 1.0622514309943654e-05
. O 0 1.7451267098067547e-08
. O 0 2.3495350376379065e-07

Genetic O 0 6.301336838987481e-07
basis O 0 2.7039780192694707e-08
and O 0 1.9849917265446493e-09
molecular O 0 9.117129451396977e-08
mechanism O 0 3.4816292782124947e-07
for O 0 2.1126809315319406e-06
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
. O 0 7.251001807162538e-05

Ventricular B-Disease 1 1.0
fibrillation I-Disease 1 0.8334488868713379
causes O 0 2.581070077667391e-07
more O 0 5.719458795461208e-10
than O 0 1.2550857575455154e-10
300 O 0 1.5730334812502633e-09
, O 0 3.801683967630254e-10
000 O 0 1.1888207751553637e-08
sudden O 0 4.460774416514823e-09
deaths O 0 3.811383986196404e-10
each O 0 3.2035117614181985e-11
year O 0 1.9404364226538462e-10
in O 0 6.104122207695184e-10
the O 0 5.552670145902994e-08
USA O 0 5.597464678430697e-06
alone O 0 2.4979445356621e-07
. O 0 3.197022522272164e-07

In O 0 5.098031508055101e-08
approximately O 0 1.2902658497182529e-08
5 O 0 3.5728251468469807e-09
- O 0 7.528379697419041e-09
12 O 0 1.1770067143146434e-09
% O 0 3.065909678912071e-11
of O 0 3.4946798926904776e-11
these O 0 1.1796620971726846e-11
cases O 0 2.691223979778279e-11
, O 0 1.5336412695354795e-11
there O 0 1.3608316730417958e-11
are O 0 1.9521141647604878e-11
no O 0 1.2335865662294054e-09
demonstrable O 0 9.85487931757234e-05
cardiac O 1 0.9999480247497559
or O 0 3.807086557117145e-08
non O 1 0.9999998807907104
- O 1 0.9999754428863525
cardiac O 1 0.9927316308021545
causes O 0 2.1459931609513205e-09
to O 0 8.83319181688158e-11
account O 0 3.7221684068278194e-11
for O 0 7.126740170226853e-11
the O 0 1.671986549212079e-09
episode O 0 1.569450169824904e-08
, O 0 1.9966518716163506e-10
which O 0 2.907698734566644e-11
is O 0 3.6853842894091215e-11
therefore O 0 5.680393655449478e-11
classified O 0 1.2436987439912173e-08
as O 0 2.8807210128434235e-07
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 1.0
fibrillation I-Disease 1 1.0
( O 0 1.710229867057933e-06
IVF B-Disease 1 1.0
) O 0 7.524276668391394e-08
. O 0 2.528489062569861e-07

A O 0 1.2145176242484013e-06
distinct O 0 2.5391639013605527e-08
group O 0 1.063158450165247e-09
of O 0 3.714939467158729e-08
IVF B-Disease 1 1.0
patients O 0 2.4090537564802617e-08
has O 0 1.1901490903909462e-10
been O 0 7.791028239223508e-11
found O 0 1.734849416901163e-11
to O 0 2.985744984584926e-11
present O 0 8.754761499085717e-11
with O 0 2.086403549927951e-10
a O 0 1.1044629211198753e-08
characteristic O 0 1.7055554053513333e-06
electrocardiographic O 0 0.00012219078780617565
pattern O 0 3.959970399591839e-06
. O 0 7.93479784988449e-07

Because O 0 4.7531656832688896e-08
of O 0 2.2233324514786545e-08
the O 0 2.1216388645939332e-09
small O 0 4.301336786749488e-10
size O 0 7.14500958398645e-10
of O 0 1.8781700639181054e-09
most O 0 1.4333556563883576e-10
pedigrees O 0 9.475389362023634e-10
and O 0 2.045362212932389e-10
the O 0 4.653782359476111e-10
high O 0 1.8687302372200065e-08
incidence O 0 7.512661426289924e-08
of O 0 4.757456295578777e-08
sudden B-Disease 0 1.3241394469787338e-07
death I-Disease 0 5.621167531444371e-08
, O 0 1.9334072121068857e-09
however O 0 1.0028394781258498e-09
, O 0 6.972709076791261e-10
molecular O 0 4.3801557936262725e-09
genetic O 0 8.777237270329863e-10
studies O 0 6.699989452130239e-10
of O 0 4.833358602240878e-09
IVF B-Disease 1 0.9999997615814209
have O 0 2.366397633402073e-10
not O 0 1.0556975432729487e-10
yet O 0 8.44615655193337e-10
been O 0 1.3869057013948805e-09
done O 0 3.241896706640546e-08
. O 0 1.4808036041813466e-07

Because O 0 8.81947562447749e-06
IVF B-Disease 1 1.0
causes O 0 0.03662117198109627
cardiac O 1 1.0
rhythm O 1 0.9999998807907104
disturbance O 1 0.9999592304229736
, O 0 1.1308119773900671e-08
we O 0 1.5076557779991617e-09
investigated O 0 1.0362831481813828e-08
whether O 0 2.603917748089657e-09
malfunction O 0 3.112763579338207e-06
of O 0 1.069241584161773e-08
ion O 0 1.0238198200340776e-07
channels O 0 2.3567697127191423e-08
could O 0 4.724601598837808e-09
cause O 0 1.65350133585207e-08
the O 0 8.906183346368834e-09
disorder O 0 1.3953760813478766e-08
by O 0 6.353614856458023e-11
studying O 0 3.884483401606076e-09
mutations O 0 3.8582387285046593e-10
in O 0 1.7732561252703505e-10
the O 0 7.631241416561352e-09
cardiac O 0 4.2012482026621e-07
sodium O 0 9.890984387084245e-08
channel O 0 4.0658275679561484e-07
gene O 0 7.374086408162839e-07
SCN5A O 1 0.9999998807907104
. O 0 3.12172960548196e-06

We O 0 5.5933604414803995e-08
have O 0 8.732485290430247e-10
now O 0 2.454866532275446e-09
identified O 0 1.5394691077474931e-09
a O 0 2.357573247735445e-09
missense O 0 1.352632352791261e-07
mutation O 0 8.32597457645079e-09
, O 0 1.2133269944314407e-09
a O 0 6.696003751471835e-10
splice O 0 3.399086168087706e-08
- O 0 1.3072739335484584e-08
donor O 0 7.072847307831864e-10
mutation O 0 6.430965204806682e-10
, O 0 2.344169858226053e-10
and O 0 1.4856752494907255e-09
a O 0 5.444168227342061e-09
frameshift O 0 9.271573730984528e-08
mutation O 0 7.393022305457464e-10
in O 0 1.098916582731313e-10
the O 0 9.511677001583507e-10
coding O 0 8.792238048727086e-09
region O 0 2.400128629176379e-08
of O 0 1.456332654470316e-07
SCN5A O 1 1.0
in O 0 1.4570627371313094e-08
three O 0 1.620539613611527e-08
IVF B-Disease 0 0.0005198571016080678
families O 0 9.67200985968475e-10
. O 0 2.641425922433882e-08

We O 0 3.4636556733858015e-08
show O 0 2.7239004385393173e-09
that O 0 5.535045338733724e-11
sodium O 0 2.6530516672451654e-10
channels O 0 2.3915169844457296e-10
with O 0 1.1511539638187074e-10
the O 0 9.908862175223021e-09
missense O 0 1.3188714831358084e-07
mutation O 0 3.230815170951473e-09
recover O 0 2.4371149542901094e-09
from O 0 2.3003468574422925e-10
inactivation O 0 2.082114889390141e-07
more O 0 4.908944084558442e-11
rapidly O 0 1.8409077040537625e-10
than O 0 1.1029056140587912e-11
normal O 0 9.002448092543247e-11
and O 0 7.573103949498616e-11
that O 0 6.034316102354609e-11
the O 0 3.42697226152211e-09
frameshift O 0 1.340996931276095e-07
mutation O 0 3.0119620131330294e-09
causes O 0 1.6650140155505255e-09
the O 0 1.3544679822174999e-09
sodium O 0 3.8599043961085044e-09
channel O 0 1.0654808146881578e-09
to O 0 3.4152841665857636e-10
be O 0 1.1511368525063403e-09
non O 0 1.6609126873845526e-07
- O 0 7.848280461075774e-07
functional O 0 4.420764696533297e-07
. O 0 7.700462845150469e-08

Our O 0 4.2213289930259634e-07
results O 0 5.135152303381574e-09
indicate O 0 1.2348129185824064e-09
that O 0 1.2662210169267496e-10
mutations O 0 6.186828827026147e-10
in O 0 5.86337312036278e-10
cardiac O 0 1.8813659607985755e-07
ion O 0 7.896060338907773e-08
- O 0 6.360414204209519e-07
channel O 0 7.686064229517342e-09
genes O 0 1.2848543062826678e-10
contribute O 0 1.3313132540826444e-10
to O 0 5.940004044191483e-11
the O 0 7.307782157184306e-10
risk O 0 3.327762732041606e-09
of O 0 4.826431254656427e-09
developing O 0 5.033383487784704e-08
IVF B-Disease 1 0.9998654127120972
. O 0 1.459602305686758e-08
. O 0 1.3018724587254837e-07

Molecular O 0 2.6102973151864717e-06
heterogeneity O 0 2.301776930835331e-06
in O 0 3.219602362491969e-08
mucopolysaccharidosis B-Disease 1 0.8533701300621033
IVA I-Disease 1 1.0
in O 0 9.772670672703043e-09
Australia O 0 5.121270074681661e-10
and O 0 3.288339045504074e-10
Northern O 0 1.1634833541052103e-08
Ireland O 0 1.3498007156442782e-08
: O 0 3.934110537340274e-10
nine O 0 2.073906824051619e-09
novel O 0 8.060367484574726e-09
mutations O 0 5.55549273251188e-10
including O 0 8.300791165538612e-10
T312S O 0 1.8976678575199912e-06
, O 0 2.039356461480679e-09
a O 0 8.762267023065817e-10
common O 0 1.4038511464420367e-09
allele O 0 1.5846152168208505e-09
that O 0 4.836621103621042e-10
confers O 0 3.7744641190329276e-07
a O 0 1.1971401647770108e-07
mild O 0 2.0440036678337492e-05
phenotype O 0 9.452001563658996e-07
. O 0 4.121863810269133e-07

Mucopolysaccharidosis B-Disease 1 1.0
IVA I-Disease 1 1.0
( O 1 0.8632688522338867
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
) O 0 3.5914524687541416e-07
is O 0 6.316176470733126e-09
an O 0 6.340220348732828e-09
autosomal B-Disease 1 0.999998927116394
recessive I-Disease 1 0.9999994039535522
lysosomal I-Disease 1 1.0
storage I-Disease 1 1.0
disorder I-Disease 1 1.0
caused O 0 2.672986170182412e-07
by O 0 5.29390420389575e-10
a O 0 1.625464918220132e-08
genetic B-Disease 1 1.0
defect I-Disease 1 0.9999998807907104
in O 0 3.2621036982760643e-09
N O 0 1.7670564034233394e-07
- O 0 1.5954496745962388e-07
acetylgalactosamine O 0 5.697183496522484e-06
- O 0 6.599808557439246e-07
6 O 0 6.228416395970271e-07
- O 0 4.857825388171477e-06
sulfate O 0 5.089645583211677e-06
sulfatase O 0 0.00017036405915860087
( O 0 3.7424555898724066e-08
GALNS O 1 0.9999688863754272
) O 0 1.0123437732545426e-07
. O 0 2.1603685240734194e-07

Previous O 0 1.7266691543227353e-07
studies O 0 1.365578938816725e-08
of O 0 5.90307758230324e-09
patients O 0 7.567303450528584e-10
from O 0 4.59034199540298e-11
a O 0 1.3876776117083267e-10
British O 0 5.699367089384566e-10
- O 0 3.421148875304425e-08
Irish O 0 1.0099325820078775e-08
population O 0 1.4337487794224835e-11
showed O 0 3.730540876212274e-11
that O 0 6.38176447451122e-12
the O 0 4.3008446803938227e-10
I113F O 0 2.1004451866701856e-07
mutation O 0 6.161674503957215e-10
is O 0 1.047358241801355e-10
the O 0 1.0488575286071722e-10
most O 0 5.652768531039243e-11
common O 0 2.3355203881969544e-10
single O 0 2.7702637406257224e-10
mutation O 0 7.290463233111666e-10
among O 0 3.5103226991850534e-09
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 0.004076262004673481
and O 0 2.488077122109189e-08
produces O 0 2.548514430600335e-07
a O 0 2.9801228151882242e-08
severe O 0 7.63579646445578e-06
clinical O 0 1.9196349967387505e-05
phenotype O 0 2.03936181719655e-07
. O 0 7.10763643496648e-08

We O 0 1.581980342280076e-07
studied O 0 1.680972019357796e-07
mutations O 0 2.828062672932674e-09
in O 0 6.944491648397388e-10
the O 0 1.2993440989816918e-08
GALNS O 0 0.01558808796107769
gene O 0 9.619687268980215e-10
from O 0 1.618360306876454e-10
23 O 0 2.6282125364929243e-09
additional O 0 1.0960456542363772e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
patients O 0 5.187279725760163e-07
( O 0 1.0139424022614918e-10
15 O 0 4.4391965103862674e-10
from O 0 4.7660677487959546e-11
Australia O 0 7.716565580961898e-11
, O 0 3.8936329854744045e-11
8 O 0 1.389812570584681e-10
from O 0 1.1973160310430053e-11
Northern O 0 1.990276388141865e-09
Ireland O 0 2.2709001346044033e-09
) O 0 1.4727330466257627e-10
, O 0 4.731134581326124e-11
with O 0 1.4107830355325479e-11
various O 0 4.652095930701705e-10
clinical O 0 4.138714757573325e-07
phenotypes O 0 1.5416038934290555e-07
( O 0 6.713498090782366e-10
severe O 0 6.340949767036363e-05
, O 0 6.35243080360226e-10
16 O 0 6.689008791305184e-10
cases O 0 5.920910289836101e-11
; O 0 2.6267566247129004e-11
intermediate O 0 1.365883761650366e-08
, O 0 8.817655633430732e-11
4 O 0 1.9545824958555613e-09
cases O 0 2.969599843805071e-10
; O 0 6.86755430301389e-10
mild O 0 1.9342829205015732e-07
, O 0 1.7182832934281578e-09
3 O 0 2.141839594571593e-08
cases O 0 1.8190865480605112e-09
) O 0 6.2044751558687494e-09
. O 0 1.2876466826128308e-07

We O 0 6.238320082729842e-08
found O 0 2.1375778924692668e-09
two O 0 3.193952879954054e-10
common O 0 5.997818908198838e-10
mutations O 0 1.3625360562041777e-10
that O 0 1.5998131638883528e-11
together O 0 6.67378929897211e-11
accounted O 0 1.3950559596409562e-09
for O 0 1.7470368207650466e-10
32 O 0 3.370818957293409e-09
% O 0 7.206238383794528e-11
of O 0 6.968574051136045e-10
the O 0 3.251047431263032e-09
44 O 0 1.2441044638933363e-08
unrelated O 0 1.5599951552758284e-08
alleles O 0 4.862186764320597e-10
in O 0 3.5175926060837526e-10
these O 0 4.742676473767915e-09
patients O 0 1.132219118460398e-08
. O 0 8.715404931081139e-08

One O 0 1.0529661409464097e-07
is O 0 7.002246782406019e-09
the O 0 8.485899982701994e-09
T312S O 0 2.2492715743283043e-06
mutation O 0 1.5180908974343765e-08
, O 0 2.5134319070474476e-09
a O 0 4.213109860984332e-09
novel O 0 1.3756152839050628e-07
mutation O 0 5.795762092475343e-09
found O 0 1.2905406743257686e-09
exclusively O 0 1.6410655945264807e-08
in O 0 4.354964389108318e-09
milder O 0 5.367375251807971e-06
patients O 0 1.8241573229715868e-07
. O 0 2.335757471882971e-07

The O 0 1.2384134606691077e-07
other O 0 4.294698818796405e-09
is O 0 1.0228937696865614e-09
the O 0 2.2215085326848794e-09
previously O 0 2.5369468303892972e-08
described O 0 1.0253672577675843e-08
I113F O 0 1.306877265960793e-06
that O 0 2.3315871455764636e-09
produces O 0 1.7741214719535492e-07
a O 0 7.060022966243196e-08
severe O 0 8.421940037806053e-06
phenotype O 0 1.3611461326945573e-06
. O 0 6.495022830677044e-07

The O 0 1.3919981256549363e-06
I113F O 0 1.04848513728939e-05
and O 0 6.933909446615871e-08
T312S O 0 2.1218136225797934e-06
mutations O 0 3.565201023292275e-09
accounted O 0 2.5160558081438467e-09
for O 0 1.9417101260188474e-10
8 O 0 2.7888202858150635e-09
( O 0 6.421646547849491e-11
18 O 0 4.5045822627542975e-10
% O 0 2.690536161920054e-11
) O 0 1.4384546505319395e-11
and O 0 1.07168843244132e-10
6 O 0 5.066959296584628e-09
( O 0 1.0315610171618417e-10
14 O 0 1.0821854523612728e-09
% O 0 5.5005045657141594e-11
) O 0 4.0490003710980105e-11
of O 0 1.7131160934269474e-09
44 O 0 7.20536608156408e-09
unrelated O 0 2.469101012536612e-08
alleles O 0 1.7563861476332931e-09
, O 0 2.93502688819558e-09
respectively O 0 4.298331290897295e-08
. O 0 3.0235361236918834e-07

The O 0 5.497261099662865e-07
relatively O 0 9.685144419790959e-08
high O 0 7.615453228027036e-07
residual O 0 9.046998457051814e-05
GALNS O 1 0.9999402761459351
activity O 0 6.44803108684755e-08
seen O 0 9.345428431117853e-09
when O 0 1.1789569320797e-09
the O 0 5.9635771876287436e-09
T312S O 0 1.5211072650345159e-06
mutant O 0 9.880161400133147e-08
cDNA O 0 5.369313171854628e-08
is O 0 3.960184180584747e-09
overexpressed O 0 3.553173826276179e-07
in O 0 1.794878468075467e-09
mutant O 0 4.885711391011682e-08
cells O 0 1.1882257677786612e-10
provides O 0 4.9263149115574834e-11
an O 0 1.3263549980546685e-11
explanation O 0 7.362271209343518e-11
for O 0 1.4695426819866242e-10
the O 0 7.070410035225905e-09
mild O 0 5.165667289475095e-07
phenotype O 0 3.544885940343079e-09
in O 0 3.5952243959691543e-10
patients O 0 4.107488793536618e-10
with O 0 5.996877300296077e-11
this O 0 2.2925952247732084e-09
mutation O 0 6.780964412200774e-08
. O 0 1.5169278810844844e-07

The O 0 6.908629757162998e-08
distribution O 0 3.5698959344188097e-09
and O 0 7.830243120565683e-10
relative O 0 4.802370168199843e-10
frequencies O 0 8.394105410758357e-10
of O 0 2.335134308140141e-09
the O 0 7.445753347212758e-09
I113F O 0 1.1907427506230306e-06
and O 0 2.2924739440099984e-08
T312S O 0 2.082433638861403e-06
mutations O 0 1.904445712241909e-09
in O 0 3.404584947297451e-10
Australia O 0 2.3538743176843013e-10
corresponded O 0 5.875281511302788e-11
to O 0 3.776272350375365e-11
those O 0 3.69349793805096e-11
observed O 0 5.050166188014238e-11
in O 0 2.9409079338460486e-11
Northern O 0 4.98707164453549e-09
Ireland O 0 1.962906504004991e-09
and O 0 3.530848391442021e-10
are O 0 1.361428764862227e-11
unique O 0 2.316195325813286e-11
to O 0 9.439123094256985e-12
these O 0 2.3265115528525726e-11
two O 0 2.541859084326248e-11
populations O 0 1.671880689446681e-10
, O 0 7.137446189631191e-11
suggesting O 0 3.16526110877291e-10
that O 0 2.8170344529288016e-11
both O 0 1.6179467487997812e-10
mutations O 0 3.781586432882733e-10
were O 0 1.6817439107974508e-10
probably O 0 1.429817098053121e-10
introduced O 0 8.254431860255096e-11
to O 0 4.6893853383744855e-11
Australia O 0 5.891597626428435e-11
by O 0 2.1435938094005458e-11
Irish O 0 1.2893604406372106e-08
migrants O 0 3.089721534177414e-10
during O 0 5.320364149241641e-10
the O 0 2.8959790121518836e-09
19th O 0 7.101917987029083e-08
century O 0 3.0111826276879583e-07
. O 0 5.667340019499534e-07

Haplotype O 0 1.1913473827007692e-05
analysis O 0 5.4947875582911365e-08
using O 0 1.5867513525336108e-08
6 O 0 2.882067633436236e-07
RFLPs O 0 1.7240399756701663e-05
provides O 0 2.6193645030758717e-09
additional O 0 1.3515364383209771e-09
data O 0 3.709483831215721e-10
that O 0 1.1889171591672465e-10
the O 0 3.720951102792469e-09
I113F O 0 9.437463859285344e-07
mutation O 0 2.0660066990529913e-09
originated O 0 3.9777525717710205e-10
from O 0 2.7688162873573674e-10
a O 0 2.7386382051020064e-09
common O 0 1.552553641204213e-08
ancestor O 0 1.1280689449222336e-07
. O 0 2.5621565669098345e-07

The O 0 1.156335756036242e-07
other O 0 8.810166818307152e-09
9 O 0 4.103616646489172e-08
novel O 0 4.420275345751179e-08
mutations O 0 9.430278780087065e-10
identified O 0 2.5734767095109135e-10
in O 0 3.532800094130373e-11
these O 0 2.408486188265613e-10
23 O 0 2.6511814965601843e-09
patients O 0 1.2350691303009143e-10
were O 0 4.750385501628429e-11
each O 0 3.788905300616818e-11
limited O 0 4.251240748320839e-10
to O 0 8.024498843184347e-10
a O 0 4.475944948012511e-09
single O 0 1.2686397710126585e-08
family O 0 4.812810416865432e-08
. O 0 4.346784692188521e-07

These O 0 1.0472517431026063e-07
data O 0 5.110831313714925e-09
provide O 0 1.582808772937483e-09
further O 0 2.1649044779081805e-09
evidence O 0 9.89186288435917e-10
for O 0 6.578325106865179e-10
extensive O 0 7.686389835726004e-08
allelic O 0 6.064486797185964e-07
heterogeneity O 0 2.3780560809427698e-07
in O 0 4.024905919663979e-08
MPS B-Disease 1 1.0
IVA I-Disease 1 1.0
in O 0 4.075162962635659e-08
British O 0 2.5083089383315382e-08
- O 0 3.088717619448289e-07
Irish O 0 6.536581054206181e-08
patients O 0 4.472136827526896e-10
and O 0 2.3980841618032045e-11
provide O 0 1.4817232510400125e-11
evidence O 0 4.999447730802409e-11
for O 0 2.5003331002859674e-11
their O 0 3.576516860448464e-11
transmission O 0 3.652279867427666e-10
to O 0 1.19088031103054e-10
Australia O 0 1.1193475313309165e-10
by O 0 2.9640529614072264e-11
British O 0 1.910609004340813e-09
- O 0 7.419543379683091e-08
Irish O 0 4.016838062170791e-08
migrants O 0 8.748373137024146e-10
. O 0 8.689899910763188e-10
. O 0 3.233449064055094e-08

Identification O 0 3.479806878203817e-07
of O 0 5.469352117870585e-07
constitutional O 0 0.00010723231389420107
WT1 O 1 1.0
mutations O 0 4.341697206200479e-07
, O 0 2.0392940669466952e-09
in O 0 2.8498942095112056e-10
patients O 0 9.598298822410811e-10
with O 0 5.917255019305401e-10
isolated O 0 0.00019563274690881371
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 1.1296112489844745e-08
and O 0 8.568566967070979e-10
analysis O 0 1.44837264404174e-09
of O 0 1.1665075128064473e-08
genotype O 0 8.470299661667013e-08
/ O 0 1.0613764089839606e-07
phenotype O 0 2.706030066690346e-09
correlations O 0 1.0093409441580548e-09
by O 0 3.751848137723002e-11
use O 0 7.752107289427101e-10
of O 0 1.885457123762535e-08
a O 0 9.763597930145806e-09
computerized O 0 3.223269459340372e-06
mutation O 0 1.2029643414734892e-07
database O 0 3.1351234497378755e-07
. O 0 3.2581201026005147e-07

Constitutional O 0 8.749007065489423e-06
mutations O 0 5.9526929163666864e-08
of O 0 9.070004836075896e-08
the O 0 7.935496171285195e-08
WT1 O 0 0.00013309522182680666
gene O 0 3.751194022072468e-09
, O 0 1.2875682742219396e-09
encoding O 0 6.952368014623289e-09
a O 0 6.722598921982126e-09
zinc O 0 2.653555839060573e-06
- O 0 5.808945502394636e-07
finger O 0 5.187022793506912e-07
transcription O 0 4.3934281990232193e-08
factor O 0 7.185274597532043e-09
involved O 0 3.64754615400642e-10
in O 0 6.595109458551462e-10
renal O 1 1.0
and O 0 3.785971216530015e-07
gonadal O 1 1.0
development O 0 9.06379682419356e-08
, O 0 6.283142894858429e-10
are O 0 2.8766856952078257e-11
found O 0 4.930329061680894e-11
in O 0 1.479464120657248e-11
most O 0 3.02656302797466e-11
patients O 0 1.190443577048228e-11
with O 0 2.375259364195692e-11
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.7259028811954522e-08
DDS B-Disease 1 1.0
) O 0 5.91137006011877e-09
, O 0 1.7805098506684658e-09
or O 0 1.474660038525144e-08
diffuse B-Disease 1 1.0
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 2.3098620260952885e-07
DMS B-Disease 1 0.9999997615814209
) O 0 2.6013696752258397e-10
associated O 0 3.733233444602746e-10
with O 0 1.1506605668287762e-09
pseudohermaphroditism B-Disease 1 1.0
and O 0 2.89214483473188e-07
/ O 0 1.625146614969708e-05
or O 0 1.4092877620441868e-07
Wilms B-Disease 1 1.0
tumor I-Disease 1 1.0
( O 0 1.9895114178325457e-07
WT B-Disease 1 1.0
) O 0 4.836709166511355e-08
. O 0 2.714556615046604e-07

Most O 0 5.901132453800528e-07
mutations O 0 8.081290303607602e-08
in O 0 2.3721346664729026e-08
DDS B-Disease 1 1.0
patients O 0 8.876202173269121e-07
lie O 0 7.943947366584325e-08
in O 0 2.4871458226272125e-09
exon O 0 1.850739579367655e-07
8 O 0 5.506485933892691e-08
or O 0 1.6178797190846694e-09
exon O 0 2.619860772767879e-08
9 O 0 1.7843795774297178e-08
, O 0 1.058056642300187e-09
encoding O 0 1.5707376732621015e-08
zinc O 0 7.215834330054349e-07
finger O 0 1.3762441994913388e-06
2 O 0 2.493218005383824e-07
or O 0 5.37566391400901e-09
zinc O 0 2.861914367713325e-07
finger O 0 2.0078938689493953e-07
3 O 0 2.5280927573589906e-08
, O 0 3.6217018273276835e-10
respectively O 0 3.7529951368853176e-10
, O 0 1.9041904164573964e-10
with O 0 2.779886321135905e-10
a O 0 5.165743388602095e-09
hot O 0 1.033996795740677e-06
spot O 0 7.277521376636287e-07
( O 0 3.279596816341268e-09
R394W O 0 1.0066211189041496e-06
) O 0 2.6609994208115495e-09
in O 0 9.442414850013847e-09
exon O 0 4.333475317253033e-06
9 O 0 2.2144017748360056e-06
. O 0 6.924063313817896e-07

We O 0 4.225328353868463e-08
analyzed O 0 1.333540833314828e-08
a O 0 8.398317596913785e-10
series O 0 2.8507871618899117e-09
of O 0 3.80595199800382e-09
24 O 0 5.410400572003482e-09
patients O 0 4.034586553736119e-10
, O 0 4.2727973936784736e-11
10 O 0 4.0616801588733153e-10
with O 0 5.832120897331095e-10
isolated B-Disease 0 1.6310973478539381e-06
DMS I-Disease 1 1.0
( O 0 2.191118397831815e-08
IDMS B-Disease 1 1.0
) O 0 1.4776972978580716e-09
, O 0 3.4520047931252407e-10
10 O 0 5.707068706506391e-10
with O 0 5.871240160715274e-10
DDS B-Disease 1 1.0
, O 0 2.3743740307224925e-09
and O 0 5.864044250181166e-10
4 O 0 1.22439125505025e-08
with O 0 1.274182759303244e-09
urogenital B-Disease 1 1.0
abnormalities I-Disease 1 1.0
and O 0 1.105925889532955e-06
/ O 1 0.9441656470298767
or O 0 2.7461594527267152e-06
WT B-Disease 1 1.0
. O 0 1.0194738706559292e-06

We O 0 5.341499331734667e-07
report O 0 2.3690266459652776e-07
WT1 O 0 0.0024477981496602297
heterozygous O 0 2.293786707241452e-07
mutations O 0 2.6048763146491183e-09
in O 0 3.6734906783131294e-10
16 O 0 4.273975395818752e-09
patients O 0 3.834703388161387e-10
, O 0 1.000968058439966e-10
4 O 0 2.9775415466559707e-09
of O 0 6.1033222920059416e-09
whom O 0 4.767545913608728e-09
presented O 0 4.999903424618424e-08
with O 0 7.345337849073985e-08
IDMS B-Disease 1 1.0
. O 0 1.2608124052349012e-05

One O 0 8.881827540108134e-08
male O 0 6.51934684015032e-09
and O 0 6.751636472124289e-10
two O 0 1.0700571539956627e-09
female O 0 8.687336183754724e-09
IDMS B-Disease 1 1.0
patients O 0 3.482123389630942e-08
with O 0 1.5893258265009536e-08
WT1 O 1 1.0
mutations O 0 0.009512914344668388
underwent O 0 0.018082458525896072
normal O 0 2.019925886997953e-06
puberty O 0 3.5101418234262383e-06
. O 0 9.600137929055563e-08

Two O 0 1.453754521207884e-07
mutations O 0 1.6750293596601296e-08
associated O 0 3.907221657328819e-09
with O 0 5.073419462320317e-09
IDMS B-Disease 1 1.0
are O 0 4.698511024692209e-10
different O 0 3.4365059409235954e-11
from O 0 5.531182456497419e-11
those O 0 2.7547988890042063e-10
described O 0 1.7888802661403247e-09
in O 0 1.6763623378324155e-08
DDS B-Disease 1 1.0
patients O 0 4.55513190900092e-06
. O 0 4.7505648126389133e-07

No O 0 7.49449372960953e-06
WT1 O 1 0.9987785220146179
mutations O 0 1.6808901648346364e-07
were O 0 2.767508222589754e-09
detected O 0 4.110147777680595e-09
in O 0 2.0736447281510806e-10
the O 0 2.1821002782473897e-09
six O 0 2.3879811461569034e-09
other O 0 6.3564451480147e-09
IDMS B-Disease 1 1.0
patients O 0 9.224336139368461e-08
, O 0 1.849552400123855e-09
suggesting O 0 8.361608294649159e-09
genetic O 0 1.0496391311676234e-08
heterogeneity O 0 6.174444422413217e-08
of O 0 1.45821161368076e-07
this O 0 2.8886212533052458e-08
disease O 0 2.3750790205667727e-05
. O 0 4.0441523196932394e-07

We O 0 4.427928956829419e-07
analyzed O 0 7.459245239260781e-07
genotype O 0 2.2603836669077282e-07
/ O 0 2.8063408308298676e-07
phenotype O 0 5.298614436100024e-09
correlations O 0 6.798665186380504e-09
, O 0 1.6348343512273544e-10
on O 0 3.8569514249076065e-10
the O 0 2.0662459243592224e-10
basis O 0 1.8028786796797647e-10
of O 0 3.24767407411386e-10
the O 0 1.200422539149315e-09
constitution O 0 4.2665475596948e-09
of O 0 1.1373987085505632e-08
a O 0 1.269641991541448e-08
WT1 O 0 0.00016235295333899558
mutation O 0 5.9793401341323715e-09
database O 0 3.815589622035986e-09
of O 0 1.767321933243693e-08
84 O 0 1.276964809449055e-07
germ O 0 1.3049294693701086e-06
- O 0 4.437480129126925e-06
line O 0 4.260280093149049e-07
mutations O 0 8.27859170104972e-10
, O 0 3.9829358561283e-11
to O 0 2.8795622136756904e-11
compare O 0 2.04347094800994e-10
the O 0 1.0824820900756649e-10
distribution O 0 2.539946308832697e-10
and O 0 9.398778283431497e-11
type O 0 4.8287516207778935e-09
of O 0 1.5642976691765398e-08
mutations O 0 7.936579171641256e-10
, O 0 8.296228287685281e-11
according O 0 3.48957807094763e-11
to O 0 2.0601778616402555e-10
the O 0 1.8145054347940004e-09
different O 0 3.0642524073698496e-09
symptoms O 0 4.0228303532785503e-07
. O 0 1.1397879973173985e-07

This O 0 4.417862076167012e-09
demonstrated O 0 7.922578149077708e-09
( O 0 2.698843093451586e-10
1 O 0 6.410125763522956e-09
) O 0 4.316409452087555e-10
the O 0 1.5657716234684926e-09
association O 0 1.0132347738611713e-10
between O 0 8.323679939747919e-11
mutations O 0 8.045781402232777e-11
in O 0 5.862766522257701e-11
exons O 0 8.020661468322032e-09
8 O 0 1.755508516332327e-09
and O 0 4.789125207516065e-10
9 O 0 1.0144114881427413e-08
and O 0 4.200128245201995e-09
DMS B-Disease 0 0.0331866517663002
; O 0 6.734993118762134e-10
( O 0 1.7104771765641402e-10
2 O 0 3.86791532136499e-09
) O 0 2.3304433383053436e-10
among O 0 1.4673132153752988e-10
patients O 0 2.041215529935414e-10
with O 0 2.4483048921553063e-10
DMS B-Disease 1 0.9999849796295166
, O 0 1.3635560458524765e-09
a O 0 2.0615928408851403e-10
higher O 0 4.351334292884701e-10
frequency O 0 2.4644783436222895e-10
of O 0 1.8414564317836835e-09
exon O 0 9.605358286535193e-08
8 O 0 3.6197025821138595e-08
mutations O 0 9.287157709536586e-10
among O 0 3.1348121320995403e-10
46 O 0 9.083453100799943e-09
, O 0 3.6696130578661723e-09
XY O 0 4.355286728241481e-05
patients O 0 6.048065936958835e-10
with O 0 9.270569728547784e-11
female O 0 5.868117103347004e-10
phenotype O 0 3.317032759575511e-10
than O 0 2.4743113807845774e-11
among O 0 1.0886025414436062e-10
46 O 0 9.692237235015e-09
, O 0 3.79680153983486e-09
XY O 0 0.0003179316408932209
patients O 0 7.554353254057844e-10
with O 0 1.2190189135896645e-10
sexual O 0 3.2866915855578327e-09
ambiguity O 0 1.4078231025393961e-08
or O 0 5.45638034754603e-10
male O 0 3.3957972545017867e-10
phenotype O 0 5.852487938717843e-11
; O 0 1.2073789884547992e-11
and O 0 3.521486158231113e-10
( O 0 1.8984241956232495e-10
3 O 0 4.6010404375351754e-09
) O 0 1.2232952151247645e-10
statistically O 0 2.4348278948593816e-10
significant O 0 1.0372669390079636e-10
evidence O 0 2.3311769181688646e-10
that O 0 4.66325207615359e-11
mutations O 0 8.66131888432875e-11
in O 0 2.4830257294716773e-10
exons O 0 4.713227141905918e-08
8 O 0 1.3046486557755088e-08
and O 0 2.719337643952713e-09
9 O 0 1.1680437950190026e-08
preferentially O 0 3.1410860579228483e-09
affect O 0 4.992417590443665e-10
amino O 0 3.552600436051989e-10
acids O 0 3.550620561454387e-11
with O 0 6.929718517761918e-12
different O 0 2.6391052537766413e-11
functions O 0 1.1676822841977241e-09
. O 0 2.9188036432259423e-09
. O 0 1.1343854566803202e-07

The O 0 6.427331754821353e-06
185delAG O 0 6.0696595028275624e-05
BRCA1 O 0 4.138710778534005e-07
mutation O 0 2.842398760805054e-09
originated O 0 3.2839392316574845e-10
before O 0 8.431633863326127e-11
the O 0 7.157418407954808e-11
dispersion O 0 1.9414667651318496e-09
of O 0 8.507514692723817e-10
Jews O 0 3.3410915700748944e-10
in O 0 3.532193634803171e-11
the O 0 3.0911478932083014e-10
diaspora O 0 1.271480004616521e-10
and O 0 3.3969960178126257e-10
is O 0 3.299383821708801e-10
not O 0 2.2078380790269136e-10
limited O 0 4.0656891187040856e-09
to O 0 2.5970393835450523e-08
Ashkenazim O 0 2.186740493925754e-05
. O 0 8.897093266568845e-07

The O 0 1.4807756087975577e-06
185delAG O 0 1.1477784028102178e-05
mutation O 0 6.750406100763939e-08
in O 0 7.123512890672146e-09
BRCA1 O 0 1.2069990873442293e-07
is O 0 5.57909829446146e-10
detected O 0 5.26096832764722e-10
in O 0 5.843196759780511e-11
Ashkenazi O 0 2.176522073682463e-09
Jews O 0 7.947500990646006e-10
both O 0 1.4848870744099685e-10
in O 0 5.754375864697181e-10
familial B-Disease 0 0.2656310200691223
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 8.02641597630327e-09
in O 0 4.132202358064774e-10
the O 0 2.1690045315381212e-09
general O 0 2.9128970346903316e-09
population O 0 9.054734184665847e-10
. O 0 3.274997695257298e-08

All O 0 2.534630993977771e-07
tested O 0 6.160845344993504e-08
Ashkenazi O 0 3.6032943739883194e-08
mutation O 0 1.6742044417483726e-09
carriers O 0 6.512408390335622e-10
share O 0 5.844548178757236e-10
the O 0 2.3040980234867448e-09
same O 0 2.378643948475201e-09
allelic O 0 8.618524134362815e-07
pattern O 0 6.559549348139626e-08
at O 0 8.350550473323892e-08
the O 0 3.2896414836613985e-07
BRCA1 O 0 4.206362063996494e-06
locus O 0 7.62331046644249e-06
. O 0 9.112068823924346e-07

Our O 0 8.01746637080214e-07
previous O 0 2.4107359664071737e-08
study O 0 2.136566923383043e-09
showed O 0 5.948828096791203e-10
that O 0 2.5936397127224176e-11
this O 0 6.242263650424462e-11
Ashkenazi O 0 1.1521567699901425e-08
mutation O 0 2.100764229240326e-09
also O 0 2.8015503805711717e-10
occurs O 0 3.4348086874747e-11
in O 0 2.3976038168727065e-11
Iraqi O 0 9.193958372399891e-10
Jews O 0 6.349256675974857e-10
with O 0 1.4704736039927724e-10
a O 0 1.9256161110092762e-09
similar O 0 1.3067356086082782e-08
allelic O 0 7.716907020949293e-06
pattern O 0 2.68855046670069e-06
. O 0 7.355340585490922e-07

We O 0 1.442463144485373e-07
extended O 0 3.2051911347252826e-08
our O 0 7.903707688328154e-10
analysis O 0 8.416433522340228e-11
to O 0 1.5968720790127122e-10
other O 0 7.677035118724973e-10
non O 0 6.02538889893367e-08
- O 0 5.793786428398562e-08
Ashkenazi O 0 1.2532499482631465e-08
subsets O 0 4.381877083403651e-09
354 O 0 1.5514013407269545e-09
of O 0 6.82305822952145e-10
Moroccan O 0 3.137638771022466e-08
origin O 0 1.2850681629927863e-09
, O 0 6.729266033289605e-10
200 O 0 4.6882275839266185e-09
Yemenites O 0 6.938420824553759e-07
and O 0 6.636109439739357e-09
150 O 0 1.315452990979793e-08
Iranian O 0 2.8936007367974526e-08
Jews O 0 5.502296573922649e-08
. O 0 1.9813582241567929e-07

Heteroduplex O 0 8.370913565158844e-05
analysis O 0 2.6139359121657435e-08
complemented O 0 4.076640180983304e-08
by O 0 4.775616013752426e-10
direct O 0 1.826697459961224e-09
DNA O 0 1.7309179645152994e-09
sequencing O 0 2.9869897666401357e-09
of O 0 5.411938897026403e-09
abnormally O 0 1.5605250425210215e-08
migrating O 0 2.0756876217831177e-09
bands O 0 5.427436988725276e-08
were O 0 7.688762515556391e-09
employed O 0 6.354157022769868e-08
. O 0 1.588497724469562e-07

Four O 0 4.354020077812493e-08
of O 0 2.2116335429700484e-08
Moroccan O 0 3.871231157859256e-08
origin O 0 3.200056886143443e-10
( O 0 1.8797987472174427e-11
1 O 0 2.6770749506077607e-10
. O 0 1.4351660485023565e-11
1 O 0 5.656006774046318e-10
% O 0 1.8780390437234118e-11
) O 0 9.084999245956293e-12
and O 0 7.577524718804796e-11
none O 0 2.366862539293635e-10
of O 0 6.864777635229302e-10
the O 0 2.1077919409862034e-09
Yemenites O 0 2.7382824896449165e-07
or O 0 9.663749800381538e-10
Iranians O 0 1.2113893221865624e-09
was O 0 4.428128974609535e-09
a O 0 4.230840400243352e-10
carrier O 0 2.7518749501354023e-09
of O 0 1.779906178001056e-08
the O 0 9.888663754509253e-08
185delAG O 0 1.1720176189555787e-05
mutation O 0 4.813512646251183e-07
. O 0 3.7782021422572143e-07

BRCA1 O 0 7.3501696533639915e-06
allelic O 0 5.093968411529204e-07
patterns O 0 6.3392766591618965e-09
were O 0 2.152551054068752e-10
determined O 0 1.4176027018919513e-10
for O 0 3.072120335900763e-11
four O 0 3.123303699004154e-11
of O 0 1.3647730168209193e-10
these O 0 3.372050555450201e-11
individuals O 0 1.1024969999440248e-12
and O 0 1.275917826254469e-11
for O 0 4.349497845224093e-11
12 O 0 5.776567557624901e-10
additional O 0 8.099599879685115e-10
non O 0 4.082179927422658e-08
- O 0 7.781758171176989e-08
Ashkenazi O 0 4.5627647438095664e-08
185delAG O 0 1.4054357677650842e-07
mutation O 0 1.4866163855487002e-09
carriers O 0 6.761056714488234e-10
who O 0 1.226288515177032e-09
had O 0 4.716279988770111e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.8886441921495134e-06

Six O 0 4.011571093087696e-07
non O 0 9.017357456286845e-07
- O 0 1.661158108845484e-07
Ashkenazi O 0 1.4974656181721002e-08
individuals O 0 1.6008488978869195e-10
shared O 0 2.492206718773815e-10
the O 0 3.4547184557531807e-10
common O 0 1.0491542079549276e-09
Ashkenazi O 0 1.4290196581612236e-08
haplotype O 0 2.136739141178623e-08
, O 0 3.4195357656585657e-09
four O 0 2.5335702424911233e-09
had O 0 3.95745081149812e-09
a O 0 5.356613486107165e-10
closely O 0 2.3587548581005535e-10
related O 0 3.4909728441334664e-09
pattern O 0 5.096424615658179e-09
, O 0 1.620398953905422e-10
and O 0 3.514668833748402e-10
the O 0 5.975031136529196e-09
rest O 0 1.9660173933289116e-08
( O 0 8.663751938087216e-10
n O 0 4.107796769403649e-09
= O 0 2.9156599357094137e-09
6 O 0 5.781067180521404e-09
) O 0 5.683431503200609e-10
displayed O 0 2.1911352732217892e-08
a O 0 1.143382544199767e-08
distinct O 0 6.531683283128586e-08
BRCA1 O 0 7.677421649532334e-07
allelic O 0 9.538575795886572e-06
pattern O 0 2.5578599434084026e-06
. O 0 5.965593459222873e-07

We O 0 8.815683827378962e-08
conclude O 0 1.5950686105270506e-08
that O 0 3.896443445672304e-10
the O 0 1.1010639511255249e-08
185delAG O 0 8.584460374549963e-06
BRCA1 O 0 3.7343414760471205e-07
mutation O 0 2.249350261607219e-09
occurs O 0 1.2092232770655187e-10
in O 0 2.431494415533475e-11
some O 0 1.6243535683191368e-10
non O 0 4.779183626624217e-08
- O 0 1.4555912741798238e-07
Ashkenazi O 0 2.0027451697046672e-08
populations O 0 8.785847049885831e-10
at O 0 4.898153549426354e-10
rates O 0 2.6164273525530746e-10
comparable O 0 4.143156373537238e-10
with O 0 6.172881650279294e-11
that O 0 4.87096807333387e-10
of O 0 6.661818474640313e-08
Ashkenazim O 0 1.8249755157739855e-05
. O 0 7.310200658139365e-07

The O 0 1.6987895889997162e-07
majority O 0 5.3311346448481345e-09
of O 0 1.7790577899745585e-08
Jewish O 0 4.8314444001107404e-08
185delAG O 0 2.5655796775936324e-07
mutation O 0 1.2983376596054086e-09
carriers O 0 2.868293380586806e-10
have O 0 7.200591511935528e-11
a O 0 3.421823935312318e-10
common O 0 1.2365122259438976e-09
allelic O 0 5.807461533891001e-08
pattern O 0 1.1274221556334396e-08
, O 0 3.426160466446504e-10
supporting O 0 5.19549558930521e-09
the O 0 2.5410194837149902e-08
founder O 0 9.79480674345723e-08
effect O 0 1.339935362665301e-08
notion O 0 5.331724839408025e-09
, O 0 2.3787199987523877e-10
but O 0 1.398316046286041e-10
dating O 0 2.268141507943966e-10
the O 0 3.1594710181437335e-10
mutations O 0 7.199204427044137e-11
origin O 0 1.340812703920502e-11
to O 0 3.387095465212653e-11
an O 0 5.282383211402397e-11
earlier O 0 4.0030667669554987e-10
date O 0 5.518626888800782e-09
than O 0 8.268334350525208e-10
currently O 0 7.14035364168808e-09
estimated O 0 3.666746195563064e-08
. O 0 2.188283190207585e-07

However O 0 7.994654538379109e-08
, O 0 4.228051242449737e-09
the O 0 1.6845763672890257e-09
different O 0 1.436705893143042e-10
allelic O 0 1.2257703474460868e-07
pattern O 0 1.607027044769893e-08
at O 0 1.321906850648702e-08
the O 0 2.525601061620364e-08
BRCA1 O 0 5.7648179563329904e-08
locus O 0 7.980074911984048e-08
even O 0 1.178938946466701e-09
in O 0 1.9437369769281787e-10
some O 0 2.210138461133937e-10
Jewish O 0 2.1544170891729664e-09
mutation O 0 1.8387179279155674e-10
carriers O 0 1.5518740459352642e-10
, O 0 2.556690414934337e-10
might O 0 4.729142633053129e-10
suggest O 0 4.5391240766079477e-10
that O 0 9.409378831648496e-11
the O 0 2.8242139737955085e-09
mutation O 0 1.626043855118553e-09
arose O 0 1.1426951607163005e-09
independently O 0 2.4584698721241693e-09
. O 0 1.0258210281222091e-08
. O 0 2.9973213599987503e-07

Crystal O 0 1.149585750681581e-05
structure O 0 1.9747878354792192e-07
of O 0 4.3807014549201995e-07
the O 0 2.847477276191057e-07
hemochromatosis B-Disease 1 1.0
protein O 0 4.3812781314045424e-07
HFE O 0 0.000666955194901675
and O 0 1.3858857172976968e-08
characterization O 0 5.35572013404817e-08
of O 0 6.157192444788961e-08
its O 0 7.308092797586596e-09
interaction O 0 3.2389655402198514e-09
with O 0 3.1028042357661434e-09
transferrin O 0 1.6617411802144488e-06
receptor O 0 4.368602617432771e-07
. O 0 2.9709124760302075e-07

HFE O 1 0.9999988079071045
is O 0 4.2953851675520127e-07
an O 0 1.9146300545003214e-08
MHC O 0 4.419863671500934e-06
- O 0 3.59856301201944e-07
related O 0 4.448931534284384e-08
protein O 0 1.2324671283536759e-09
that O 0 3.562954098423887e-11
is O 0 1.3030680701131558e-10
mutated O 0 1.274143901497382e-09
in O 0 1.340890176670939e-10
the O 0 1.1369540864336614e-08
iron B-Disease 1 1.0
- I-Disease 1 1.0
overload I-Disease 1 1.0
disease I-Disease 1 1.0
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 1 0.696691632270813

HFE O 0 0.0009427637560293078
binds O 0 3.2695339768906706e-07
to O 0 3.240468871013036e-08
transferrin O 0 1.041812424773525e-06
receptor O 0 1.1613187922421275e-07
( O 0 3.3467313365065365e-09
TfR O 0 1.748539517620884e-07
) O 0 1.3647781516024082e-10
and O 0 1.773946267658033e-10
reduces O 0 2.1654908977097875e-09
its O 0 3.047487817653405e-10
affinity O 0 3.174584761733712e-10
for O 0 6.369416105656001e-10
iron O 0 5.486084546646453e-07
- O 0 1.866137608885765e-07
loaded O 0 4.2023980739713807e-08
transferrin O 0 2.4510694629498175e-07
, O 0 9.782443299855004e-09
implicating O 0 5.347974820324453e-06
HFE O 1 0.9999996423721313
in O 0 1.0298045935996925e-06
iron O 1 0.9999798536300659
metabolism O 0 5.775928366347216e-05
. O 0 1.1068311778217321e-06

The O 0 5.045609213993885e-06
2 O 0 1.1963146789639723e-05
. O 0 1.9046538000111468e-06

6 O 0 7.010212812019745e-06
A O 0 1.2037153283017687e-06
crystal O 0 1.6078786302387016e-06
structure O 0 1.5633706595963304e-07
of O 0 3.2990541853905597e-07
HFE O 1 0.9941679239273071
reveals O 0 2.9975669946225025e-08
the O 0 1.923839310080666e-09
locations O 0 3.328810338487642e-09
of O 0 1.1806671551539694e-07
hemochromatosis B-Disease 1 1.0
mutations O 0 3.7343763636954463e-08
and O 0 1.659703841028204e-08
a O 0 8.95157015179393e-09
patch O 1 0.8684853315353394
of O 0 0.010439892299473286
histidines O 0 0.29404398798942566
that O 0 6.447324341074534e-10
could O 0 3.816177374105223e-10
be O 0 1.7951171105146102e-10
involved O 0 3.977661533483001e-10
in O 0 1.106729374811266e-09
pH O 0 4.193585027678637e-06
- O 0 8.514403475601284e-07
dependent O 0 5.543611436564788e-08
interactions O 0 2.3083131850398786e-08
. O 0 8.316074939784812e-08

We O 0 1.4428029260216135e-07
also O 0 1.2891292477945626e-08
demonstrate O 0 4.707797707226291e-09
that O 0 5.885446019426865e-10
soluble O 0 2.4749152771619265e-07
TfR O 0 1.1737384966181708e-06
and O 0 1.9654398997204225e-08
HFE O 0 2.0537967429845594e-05
bind O 0 6.184460499270017e-09
tightly O 0 1.0449208609486504e-08
at O 0 4.543830200987031e-09
the O 0 1.2249629088856295e-09
basic O 0 1.144667738373073e-08
pH O 0 4.131434039322812e-08
of O 0 8.234642301374606e-09
the O 0 3.0470475032018385e-09
cell O 0 1.1247432984973216e-09
surface O 0 1.4162420569618916e-08
, O 0 5.146160719782245e-10
but O 0 1.4556557348388566e-10
not O 0 5.917263901089598e-11
at O 0 2.955768074741627e-09
the O 0 9.969221892447422e-09
acidic O 0 2.4493872388120508e-06
pH O 0 2.6072546006616903e-06
of O 0 2.315311604661474e-07
intracellular O 0 9.10782034679869e-07
vesicles O 0 1.079057346942136e-05
. O 0 2.357971425226424e-06

TfR O 0 0.002695695497095585
HFE O 0 0.002207063138484955
stoichiometry O 0 8.513075954397209e-06
( O 0 2.4723572522589166e-08
2 O 0 9.135825962403032e-08
1 O 0 4.119662122548107e-08
) O 0 8.657508043796724e-10
differs O 0 3.865267661495864e-09
from O 0 3.91900689677982e-09
TfR O 0 9.292354548051662e-07
transferrin O 0 6.648032524481096e-08
stoichiometry O 0 2.3248118097285442e-08
( O 0 1.8002054014143454e-10
2 O 0 3.216261701410872e-09
2 O 0 4.585533730505631e-09
) O 0 2.184664671389669e-10
, O 0 3.320317909505377e-10
implying O 0 1.9880379564796158e-09
a O 0 7.095774662291277e-11
different O 0 9.162123316974746e-12
mode O 0 8.497022530029597e-10
of O 0 1.9669155193469123e-10
binding O 0 1.5810769360413701e-09
for O 0 2.403214960366995e-09
HFE O 0 0.00012927112402394414
and O 0 2.7987651307626038e-08
transferrin O 0 1.7402962271262368e-07
to O 0 9.405638046189324e-09
TfR O 0 1.3312684359334526e-06
, O 0 8.020611952375134e-10
consistent O 0 6.101340543906986e-10
with O 0 5.292881757879009e-11
our O 0 8.512952565098431e-10
demonstration O 0 5.331683983200719e-09
that O 0 3.7525371698876597e-10
HFE O 0 0.00012161875929450616
, O 0 9.736910833169077e-09
transferrin O 0 1.968945042563064e-07
, O 0 8.935773010421144e-09
and O 0 1.7085747927580996e-08
TfR O 0 3.7335476008593105e-06
form O 0 6.0732689988185484e-09
a O 0 1.2009384597888584e-08
ternary O 0 2.207012357757776e-06
complex O 0 6.273918643273646e-06
. O 0 1.5951635532474029e-06

Identification O 0 1.2041707009302627e-07
of O 0 4.670647157922758e-08
three O 0 3.1422726642915677e-09
novel O 0 2.486430972226117e-08
mutations O 0 3.401015302717525e-10
and O 0 3.323111785746846e-10
a O 0 2.168498713928102e-10
high O 0 4.9306536631377185e-09
frequency O 0 7.666704493480836e-10
of O 0 2.2672947963542356e-09
the O 0 1.114465852936064e-08
Arg778Leu O 0 2.8742973881890066e-05
mutation O 0 5.34112976069423e-09
in O 0 8.660975825414141e-10
Korean O 0 3.8495437593155657e-07
patients O 0 2.883082439453233e-09
with O 0 2.533565357509815e-09
Wilson B-Disease 0 0.0002292811986990273
disease I-Disease 0 8.551985956728458e-05
. O 0 7.150072747208469e-07

Four O 0 2.470392246323172e-07
mutations O 0 1.3436718404591375e-08
- O 0 7.825293835139746e-08
- O 0 1.550700119423709e-07
R778L O 0 5.952170454293082e-07
, O 0 1.4447224527813773e-09
A874V O 0 2.1887716172841465e-07
, O 0 1.2732692677985824e-09
L1083F O 0 1.7188061463002668e-07
, O 0 9.434092396176652e-10
and O 0 7.235909649239147e-10
2304delC O 0 5.742244724160628e-08
- O 0 1.938862403960684e-08
- O 0 2.0023174229777396e-08
in O 0 7.061632389948613e-10
the O 0 4.3672008231965265e-09
copper O 0 3.354030653213158e-08
- O 0 1.222116452481714e-08
transporting O 0 6.650706652067129e-09
enzyme O 0 1.035057928255867e-09
, O 0 4.456443825073819e-10
P O 0 3.531201997475364e-08
- O 0 2.7116735523691204e-08
type O 0 3.3513959607489596e-08
ATPase O 0 1.462236127736105e-07
( O 0 6.509526806475208e-10
ATP7B O 1 1.0
) O 0 5.80541781314281e-10
, O 0 2.774081242495896e-10
were O 0 1.8830507986233869e-10
identified O 0 3.471065934679274e-10
in O 0 1.4732134956396692e-10
Korean O 0 1.4228788813852589e-07
Patients O 0 3.229897016510108e-09
with O 0 8.555273711685629e-10
Wilson B-Disease 0 0.00013914059672970325
disease I-Disease 0 0.00041567045263946056
. O 0 4.626360237125482e-07

Arg778Leu O 0 0.002546436619013548
, O 0 2.4955960853390025e-08
the O 0 4.719269419695138e-09
most O 0 7.642118604600512e-10
frequently O 0 3.978571916363194e-10
reported O 0 2.1875624922618186e-10
mutation O 0 4.9882462743733313e-11
of O 0 4.3537665139758985e-10
this O 0 1.88676001905419e-11
enzyme O 0 9.072258916331677e-11
, O 0 5.859457363754927e-11
was O 0 1.0196776756288273e-09
found O 0 9.980703069567554e-11
in O 0 6.03117486508431e-11
six O 0 5.114895729185776e-10
of O 0 2.1179031861606745e-09
eight O 0 3.483875188337038e-09
unrelated O 0 2.298673784650873e-08
patients O 0 2.233164764220419e-10
studied O 0 2.676953547720018e-09
, O 0 1.572180996500805e-10
an O 0 7.384675509980454e-11
allele O 0 4.637151218567226e-10
frequency O 0 5.213761422595553e-09
of O 0 8.603030465792472e-08
37 O 0 1.2605939900822705e-06
. O 0 8.299236924358411e-07

5 O 0 4.619905666913837e-07
% O 0 8.078806068567701e-09
, O 0 1.051558284892451e-09
which O 0 2.3758406353380224e-10
is O 0 2.1668945804353967e-10
considerably O 0 3.3240057928374256e-10
higher O 0 3.2533903349118987e-10
than O 0 2.4391402092538428e-11
those O 0 5.433757610529e-11
in O 0 1.179887576530092e-10
other O 0 2.1664328109238795e-09
Asian O 0 3.043296814553287e-08
populations O 0 1.9536553708121573e-08
. O 0 8.305739385150446e-08

The O 0 7.581987802041112e-07
novel O 0 2.1443089792683168e-07
single O 0 2.8094819803925475e-09
nucleotide O 0 3.894580213881227e-09
deletion O 0 1.3146804533903378e-08
, O 0 1.5791180585367215e-09
2304delC O 0 3.6198966313349956e-07
, O 0 4.575137602103041e-09
was O 0 1.7997608736664006e-08
found O 0 1.443392072530969e-09
in O 0 1.874762567410926e-09
one O 0 2.6409272990690624e-08
patient O 0 1.8472304930128303e-07
. O 0 2.4217072791543615e-07

Since O 0 1.4160697503484698e-07
a O 0 1.4174905693664641e-08
mutation O 0 2.3828126138880634e-09
at O 0 1.2158157147723614e-08
cDNA O 0 9.41948385957403e-08
nucleotide O 0 8.402972184740065e-08
2302 O 0 8.215604793804232e-06
( O 0 2.456177927712133e-09
2302insC O 0 2.7586145279201446e-07
) O 0 1.0820822016199827e-09
had O 0 1.3425901501662452e-09
been O 0 4.4601258797349885e-10
previously O 0 2.244644692339648e-09
described O 0 4.17772261229743e-10
, O 0 1.355940776326392e-10
this O 0 4.2197328964377334e-11
region O 0 4.636348638342724e-09
of O 0 1.212899647384802e-08
the O 0 3.4524692438253624e-08
ATP7B O 1 1.0
gene O 0 1.1857636650347558e-08
may O 0 6.147130027223113e-10
be O 0 2.534004117649147e-10
susceptible O 0 3.0807800754928394e-08
to O 0 3.4781655333659955e-09
gene O 0 6.77225244771762e-08
rearrangements O 1 0.9975976347923279
causing O 1 0.9999992847442627
Wilson B-Disease 1 0.999997615814209
disease I-Disease 1 0.997738242149353
. O 0 8.128359922920936e-07

Disruption O 0 4.816814453079132e-06
of O 0 3.105698453964578e-07
splicing O 0 4.6760845862081624e-08
regulated O 0 6.21750606555338e-09
by O 0 2.6747981607400106e-10
a O 0 5.9710205668750405e-09
CUG O 0 0.0011723920470103621
- O 0 3.011366516147973e-07
binding O 0 6.708435051905326e-08
protein O 0 4.34303863983132e-08
in O 0 4.501323047634287e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 5.2994357247371227e-05

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9999998807907104
DM B-Disease 1 1.0
) O 0 3.231106688872387e-07
is O 0 1.1386294573867417e-08
caused O 0 7.426633974461083e-09
by O 0 4.6314677093484136e-10
a O 0 1.4551130966822257e-08
CTG O 0 0.00013850018149241805
expansion O 0 8.855151634179492e-08
in O 0 6.978470024066041e-10
the O 0 1.1985831216421161e-09
3 O 0 1.1304798874789412e-08
untranslated O 0 4.795025688508758e-06
region O 0 5.28803596466787e-08
of O 0 1.2338675503542618e-07
the O 0 8.52164987463766e-07
DM B-Disease 1 1.0
gene O 0 1.2558256230477127e-06
. O 0 6.551047704306256e-07

One O 0 1.2616423816780298e-07
model O 0 3.773945067564455e-08
of O 0 4.0831776004779385e-07
DM B-Disease 1 1.0
pathogenesis O 1 0.7703662514686584
suggests O 0 1.23747083691228e-08
that O 0 7.364869825110532e-11
RNAs O 0 1.6703459948530508e-08
from O 0 3.6031810868308867e-10
the O 0 8.485005476011054e-10
expanded O 0 2.202859006317226e-09
allele O 0 5.195581742611921e-10
create O 0 1.3627915462777196e-09
a O 0 6.343869873859376e-10
gain O 0 1.911702574020069e-09
- O 0 1.9729668565560132e-08
of O 0 1.0468839128918717e-08
- O 0 3.336096199291205e-08
function O 0 4.1256026372948895e-10
mutation O 0 5.2370979081173274e-11
by O 0 8.762391853767149e-12
the O 0 4.787125140737203e-10
inappropriate O 0 1.0374890946351911e-09
binding O 0 1.4378251922408936e-09
of O 0 1.933447846269587e-09
proteins O 0 1.3967325906971695e-10
to O 0 8.971050569073213e-10
the O 0 7.248817723848333e-08
CUG O 1 0.9999998807907104
repeats O 0 1.9351864466443658e-06
. O 0 9.98595055534679e-07

Data O 0 1.524419843690339e-07
presented O 0 6.490725468211167e-08
here O 0 1.120484371952557e-09
indicate O 0 4.5145251426070843e-10
that O 0 7.235767540691995e-11
the O 0 1.4821542881904293e-09
conserved O 0 9.350727481205467e-08
heterogeneous O 0 9.93898154888484e-08
nuclear O 0 8.927137855607725e-07
ribonucleoprotein O 0 2.0916349967592396e-06
, O 0 1.542344207905444e-08
CUG O 0 3.569397813407704e-05
- O 0 3.082143607002763e-08
binding O 0 6.4495662144281596e-09
protein O 0 1.6966167359910855e-09
( O 0 1.973168017865845e-10
CUG O 1 0.999994158744812
- O 0 3.8066221463850525e-07
BP O 0 4.6923810259613674e-07
) O 0 9.131392308958652e-10
, O 0 9.201958084403827e-10
may O 0 1.0470670996909348e-09
mediate O 0 9.658521094024763e-09
the O 0 6.634210958367248e-09
trans O 0 6.761075610484113e-08
- O 0 1.2252515091404348e-07
dominant O 0 5.500460531493445e-08
effect O 0 8.07356848042673e-09
of O 0 8.597056400105885e-09
the O 0 1.1581628989176806e-08
RNA O 0 8.995763778330002e-07
. O 0 2.541735284466995e-07

CUG O 1 1.0
- O 0 0.0068001942709088326
BP O 0 1.6585239791311324e-05
was O 0 4.9443020344597244e-08
found O 0 3.231891698707301e-10
to O 0 1.2160232543134697e-10
bind O 0 1.2505362023684796e-10
to O 0 5.162223981614034e-10
the O 0 1.5622582338892244e-08
human O 0 7.453315475913769e-08
cardiac O 1 0.9999809265136719
troponin O 1 0.9999955892562866
T O 1 0.9999504089355469
( O 0 5.493904442488429e-09
cTNT O 0 1.93182859220542e-06
) O 0 1.0663062655069666e-09
pre O 0 1.6102494271308387e-07
- O 0 8.28502848548851e-08
messenger O 0 1.0790983218100791e-08
RNA O 0 1.0643804948529123e-08
and O 0 9.35771349297454e-10
regulate O 0 1.0057592980672325e-08
its O 0 1.4482318677622175e-09
alternative O 0 6.745692893161959e-09
splicing O 0 8.665842443633665e-08
. O 0 9.261057698495279e-08

Splicing O 0 7.508542125833628e-07
of O 0 3.987890977441566e-07
cTNT O 0 4.012295539723709e-05
was O 0 2.5743932496880007e-07
disrupted O 0 8.466727763334347e-07
in O 0 1.556408761871353e-07
DM B-Disease 1 1.0
striated O 1 0.9999998807907104
muscle O 0 8.269311365438625e-05
and O 0 2.7276401581843857e-08
in O 0 1.9009762652899553e-09
normal O 0 8.702013332140268e-09
cells O 0 4.075625392729876e-10
expressing O 0 5.986161011328761e-10
transcripts O 0 1.5196812697126916e-08
that O 0 2.0038941617173123e-09
contain O 0 5.570283292399836e-07
CUG O 1 0.9978182315826416
repeats O 0 1.049397724273149e-06
. O 0 4.0622774122311966e-07

Altered O 0 1.963583599717822e-06
expression O 0 4.686549104349069e-08
of O 0 3.3091307471977416e-08
genes O 0 3.1136710987311744e-09
regulated O 0 1.560280971091288e-08
posttranscriptionally O 0 9.14579572963703e-07
by O 0 3.737253173596855e-09
CUG O 1 1.0
- O 0 0.01163184829056263
BP O 0 5.506671641342109e-06
therefore O 0 2.884094296717876e-09
may O 0 2.309385321863644e-10
contribute O 0 2.2030268720385493e-09
to O 0 2.761235329273859e-08
DM B-Disease 1 1.0
pathogenesis O 1 0.9680734276771545
. O 0 1.1779712139059484e-07
. O 0 5.492413492902415e-07

Identification O 0 2.2588535841805424e-07
of O 0 1.3874506521460717e-07
a O 0 2.311679381250542e-08
novel O 0 2.4824441879900405e-07
nonsense O 0 2.05712950673842e-07
mutation O 0 1.8311766547540742e-09
and O 0 1.6358833176965959e-09
a O 0 1.4393589653494132e-09
missense O 0 5.104207279060802e-09
substitution O 0 1.8922001743248984e-09
in O 0 3.8876094010653617e-10
the O 0 5.946993120176103e-09
vasopressin O 0 1.2876762411906384e-07
- O 0 3.010200657627138e-07
neurophysin O 0 9.4901124612079e-06
II O 1 0.9999972581863403
gene O 0 2.265332366135908e-09
in O 0 1.765487339655536e-10
two O 0 3.0370891912490094e-10
Spanish O 0 5.4323667342259796e-08
kindreds O 0 2.9644133974215947e-06
with O 0 1.7546724961903237e-08
familial B-Disease 1 0.9986823201179504
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
. O 0 4.352855285105761e-06

Familial B-Disease 1 1.0
neurohypophyseal I-Disease 1 1.0
diabetes I-Disease 1 1.0
insipidus I-Disease 1 1.0
( O 0 0.21063244342803955
FNDI B-Disease 1 1.0
) O 0 1.3422788924799534e-07
is O 0 3.727230080130539e-09
an O 0 9.171736259361296e-09
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
caused O 0 6.364102489442303e-08
by O 0 1.3396127540588054e-09
deficiency O 0 0.019429711624979973
in O 0 1.1502375940608545e-08
the O 0 1.0588444183667889e-06
antidiuretic O 0 0.00015145266661420465
hormone O 0 7.236577630465035e-07
arginine O 0 5.12532153607026e-07
vasopressin O 0 4.958350245942711e-07
( O 0 5.7356408511566315e-09
AVP O 0 6.973871677473653e-06
) O 0 1.2535475435448973e-10
encoded O 0 3.7738673297482705e-11
by O 0 4.492310343162664e-11
the O 0 1.4888986932248827e-08
AVP O 0 0.0018954636761918664
- O 0 5.3093476708454546e-06
neurophysin O 1 0.5568447113037109
II O 1 1.0
( O 0 5.315845896802784e-07
AVP O 1 0.9999997615814209
- O 0 5.57304774702061e-05
NPII O 1 0.9999978542327881
) O 0 6.041105837795158e-09
gene O 0 6.456557510858829e-09
on O 0 5.57404113976645e-08
chromosome O 0 8.981662062979012e-07
20p13 O 0 1.657402935961727e-05
. O 0 7.162439032981638e-07

In O 0 2.5843895912203152e-08
this O 0 9.532381550769742e-10
study O 0 1.06730324578308e-09
, O 0 4.047566448672768e-10
we O 0 7.544097291312113e-11
analyzed O 0 3.2657501702892944e-10
two O 0 3.902272255329464e-11
families O 0 5.159994393572065e-12
with O 0 1.537912991400603e-10
FNDI B-Disease 1 1.0
using O 0 3.292344841199224e-09
direct O 0 2.7712057093509657e-09
automated O 0 1.3608442372969876e-08
fluorescent O 0 4.6479676996113994e-08
, O 0 2.2215254080748537e-09
solid O 0 1.1344889472297837e-08
phase O 0 1.1538457300730443e-08
, O 0 3.205212484314046e-10
single O 0 3.935904380192312e-10
- O 0 4.3223438161987815e-09
stranded O 0 1.4547127946684668e-09
DNA O 0 1.1996963145133321e-10
sequencing O 0 2.789723452245596e-10
of O 0 2.0203314576860976e-09
PCR O 0 1.5513377604747802e-07
- O 0 5.395900188887026e-06
amplified O 0 6.001496785756899e-06
AVP O 1 0.9447885155677795
- O 0 2.1549625671468675e-05
NPII O 0 0.004567657597362995
DNA O 0 1.3188769116823096e-06
. O 0 2.29767934456504e-07

In O 0 1.6242125866483548e-08
one O 0 1.2088733347681568e-09
of O 0 1.147204664597723e-09
the O 0 7.54505069533451e-10
families O 0 1.4382844741589462e-11
, O 0 4.7779641354495084e-11
affected O 0 2.2595186832674585e-10
individuals O 0 1.441437334076534e-11
presented O 0 9.196378103482061e-10
a O 0 9.866311101447423e-10
novel O 0 4.892257265964872e-08
nonsense O 0 1.5008625453560853e-08
mutation O 0 1.4289172622916624e-10
in O 0 7.57966467368476e-11
exon O 0 6.027248478090996e-09
3 O 0 2.186082870281325e-09
of O 0 1.9494186265234248e-09
the O 0 8.088700265140858e-10
gene O 0 6.860519791151987e-11
, O 0 7.197117901647232e-11
consisting O 0 1.0049605592143962e-10
in O 0 7.670971496898105e-11
a O 0 7.310487215583805e-10
G O 0 5.133128055945235e-08
to O 0 2.9442446258798327e-09
T O 0 5.761145871474582e-07
transition O 0 1.237900448813889e-08
at O 0 6.655414441780749e-09
nucleotide O 0 3.924953695388922e-09
2101 O 0 5.998899723635986e-07
, O 0 5.16512999038099e-10
which O 0 6.571235916519313e-11
produces O 0 7.765929566083685e-10
a O 0 3.8151803938291096e-10
stop O 0 3.142500260011616e-09
signal O 0 3.898660505541329e-09
in O 0 2.853866476471012e-09
codon O 0 2.4462775627398514e-07
82 O 0 4.4486438355306746e-07
( O 0 2.3571653073872767e-08
Glu O 1 0.997512698173523
) O 0 3.771361889448599e-08
of O 0 4.4119451558799483e-07
NPII O 1 0.999998927116394
. O 0 2.733502242335817e-06

The O 0 1.1655511116259731e-06
premature O 0 1.9758294911298435e-07
termination O 0 4.085825366928475e-08
eliminates O 0 1.2294266582557611e-07
part O 0 8.57615845006876e-09
of O 0 1.4309561535696957e-08
the O 0 3.219232214135559e-09
C O 0 3.594611186485963e-08
- O 0 1.682056804952481e-08
terminal O 0 6.280941100555992e-09
domain O 0 1.927968007464642e-09
of O 0 6.661282192510498e-09
NPII O 1 0.9999998807907104
, O 0 2.545053723324031e-09
including O 0 7.56687046354898e-10
a O 0 4.156802679844418e-10
cysteine O 0 5.369328315296684e-10
residue O 0 9.912906939746335e-09
in O 0 2.4261079256682194e-10
position O 0 2.9807123436143e-09
85 O 0 9.025047376098883e-09
, O 0 4.525992081116925e-10
which O 0 5.416135942515332e-11
could O 0 1.7661608286978492e-10
be O 0 7.143779318097288e-11
involved O 0 5.401033439933478e-11
in O 0 9.568079661903539e-11
the O 0 1.7249920380990602e-09
correct O 0 8.113179461588516e-09
folding O 0 2.2627583007306384e-07
of O 0 3.143359492696618e-07
the O 0 1.683419668552233e-06
prohormone O 0 0.006624924950301647
. O 0 3.152292492814013e-06

In O 0 3.1502736419497523e-08
the O 0 1.2674981952898179e-08
second O 0 9.079175633530667e-09
family O 0 8.620449909457761e-10
, O 0 5.894792987071185e-10
a O 0 6.653532724776312e-10
G279A O 0 6.015421405436427e-08
substitution O 0 8.381371152665906e-10
at O 0 1.6739553077016467e-09
position O 0 4.786586127458747e-10
- O 0 1.209694566739472e-09
1 O 0 1.9728154665443753e-09
of O 0 1.685264150452781e-09
the O 0 9.133935829908069e-10
signal O 0 2.577938973402638e-09
peptide O 0 3.8703209526147475e-09
was O 0 4.696532940329234e-09
observed O 0 5.659546165048823e-10
in O 0 3.2685915085650663e-10
all O 0 2.20126272765242e-09
affected O 0 9.80336345435262e-09
individuals O 0 1.1259215781933563e-09
. O 0 7.720463202076644e-08

This O 0 1.5044314238821244e-07
missense O 0 8.479543680550705e-07
mutation O 0 1.9490439484570743e-08
, O 0 2.6058206703538644e-09
which O 0 2.0381740739594534e-09
replaces O 0 1.920440126923495e-06
Ala O 0 8.161930963979103e-06
with O 0 1.190540821482955e-08
Thr O 1 0.9999935626983643
, O 0 1.733112320323471e-08
is O 0 1.5128697183897089e-09
frequent O 0 1.0644576775575842e-08
among O 0 1.2258353443428405e-08
FNDI B-Disease 1 1.0
patients O 0 7.996088413619873e-08
and O 0 1.9759638369976074e-09
is O 0 6.668626206796091e-10
thought O 0 5.624239407531206e-10
to O 0 5.171613831622679e-11
reduce O 0 8.679270635525427e-09
the O 0 1.8091592668412204e-09
efficiency O 0 1.2713139874165336e-08
of O 0 6.0894849163162235e-09
cleavage O 0 3.778754642524973e-09
by O 0 7.201322871353e-10
signal O 0 1.1533070676250645e-07
peptidases O 0 2.223554247393622e-06
. O 0 1.0539084627225748e-07
. O 0 6.686768756480888e-07

Genetic O 0 5.371216047933558e-06
heterogeneity O 0 3.487438789306907e-06
of O 0 1.8305649973626714e-06
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 2.3161887963141226e-09
due O 0 2.393855957905089e-08
to O 0 1.0651115545101675e-08
TWIST O 0 9.177247557090595e-05
and O 0 4.00760200136574e-07
FGFR O 1 1.0
mutations O 0 2.7530581974133383e-06
. O 0 8.073885737758246e-07

Thirty O 0 1.3263186701806262e-05
- O 0 1.8177922811446479e-06
two O 0 2.620134109676542e-09
unrelated O 0 4.282627230622893e-08
patients O 0 1.1668981059198558e-10
with O 0 5.920568289102812e-12
features O 0 4.57457849378784e-09
of O 0 2.00878830014517e-07
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.89361789873999e-10
a O 0 8.962464659312275e-10
common O 0 3.011564615462703e-07
autosomal B-Disease 1 0.5710287690162659
dominant I-Disease 0 0.115332692861557
condition I-Disease 0 4.4949743482902704e-07
of O 0 0.0036176268476992846
craniosynostosis B-Disease 1 1.0
and O 0 0.10035066306591034
limb B-Disease 1 1.0
anomalies I-Disease 1 0.9997822642326355
, O 0 1.820072093039471e-09
were O 0 2.3185300901396033e-10
screened O 0 7.015053427039675e-09
for O 0 6.897550308693212e-10
mutations O 0 2.395941223198861e-10
in O 0 1.8945864321828765e-10
TWIST O 0 3.018686356881517e-06
, O 0 7.326403927976344e-09
FGFR2 O 1 0.9999997615814209
, O 0 3.366515599623199e-08
and O 0 2.0851732074333995e-07
FGFR3 O 1 0.9999995231628418
. O 0 4.043869466840988e-06

Nine O 0 9.305852017860161e-07
novel O 0 2.2057005821807252e-07
and O 0 1.2010644923066138e-08
three O 0 7.024827386459265e-09
recurrent O 0 0.00019919413898605853
TWIST O 0 7.03853729646653e-05
mutations O 0 3.764137890271968e-09
were O 0 3.637138923373584e-10
found O 0 1.77922218624893e-10
in O 0 3.418112459740996e-10
12 O 0 2.3428624373877938e-08
families O 0 1.1935847865629512e-09
. O 0 7.039369620542857e-08

Seven O 0 7.482444175366254e-08
families O 0 1.1442146535811659e-10
were O 0 8.830446790453195e-11
found O 0 5.377678857776402e-11
to O 0 8.952892593949713e-11
have O 0 1.0241856668313787e-10
the O 0 3.997529418597878e-09
FGFR3 O 1 0.9999954700469971
P250R O 0 1.444918325432809e-06
mutation O 0 1.2677441318942329e-09
, O 0 2.646178554055467e-10
and O 0 4.1252881666231644e-10
one O 0 3.6221581289908045e-10
individual O 0 1.4826286032221248e-10
was O 0 1.322370324352562e-09
found O 0 1.7082470160634244e-10
to O 0 4.054976909806385e-10
have O 0 5.072748887613443e-10
an O 0 6.734868218671863e-09
FGFR2 O 1 0.9998892545700073
VV269 O 0 5.3536950872512534e-05
- O 0 7.554253443231573e-06
270 O 0 1.2758963521264377e-06
deletion O 0 1.950574642251013e-06
. O 0 4.4248307062844106e-07

To O 0 2.9403512513681562e-08
date O 0 2.8642073601758966e-08
, O 0 9.804068668017862e-10
our O 0 1.247622560818229e-10
detection O 0 2.3539965532393126e-09
rate O 0 2.494156270405057e-10
for O 0 9.458412525420457e-11
TWIST O 0 5.146529815647227e-07
or O 0 2.425132983319145e-09
FGFR O 1 0.5623942017555237
mutations O 0 1.0785504711563476e-09
is O 0 1.507186458971077e-10
68 O 0 2.8436080157234755e-09
% O 0 5.925293589115199e-11
in O 0 5.5861874154183866e-11
our O 0 2.370410090435371e-09
Saethre B-Disease 1 1.0
- I-Disease 1 1.0
Chotzen I-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 6.393860996212197e-09
, O 0 1.5732667946188883e-10
including O 0 3.525169045559551e-10
our O 0 2.955987898900503e-09
five O 0 7.430768222960182e-10
patients O 0 2.881145877431379e-10
elsewhere O 0 2.816273048100726e-10
reported O 0 1.3354848338309466e-09
with O 0 4.366392580834599e-09
TWIST O 0 0.00010708272748161107
mutations O 0 2.1082357193336065e-07
. O 0 2.1665707095053222e-07

More O 0 9.760096730815349e-09
than O 0 3.809290660683473e-10
35 O 0 2.54176968361719e-09
different O 0 6.32134067313217e-11
TWIST O 0 9.993251381956725e-08
mutations O 0 7.267721979786756e-10
are O 0 4.187852842285622e-11
now O 0 2.465201931478589e-10
known O 0 3.904046252944937e-10
in O 0 4.717430890366359e-10
the O 0 9.391368571698422e-09
literature O 0 7.009331426388599e-08
. O 0 9.295743552684144e-08

The O 0 2.1801676552968274e-07
most O 0 4.734433733943888e-09
common O 0 1.8280532643188963e-09
phenotypic O 0 2.9767480924647316e-08
features O 0 3.0939395490037214e-09
, O 0 2.759705519661537e-10
present O 0 1.272659200246551e-10
in O 0 2.764129203303156e-11
more O 0 1.804391532023164e-11
than O 0 3.031451131785268e-11
a O 0 8.794610872886466e-11
third O 0 5.597730057260719e-10
of O 0 1.060744159175897e-09
our O 0 3.4651850833178344e-10
patients O 0 4.852530530174981e-11
with O 0 4.949653881203275e-11
TWIST O 0 5.074054115539184e-06
mutations O 0 3.288591621242176e-09
, O 0 1.2018293027438176e-09
are O 0 1.0436694841686744e-09
coronal B-Disease 0 1.2318305380176753e-05
synostosis I-Disease 0 8.128148328978568e-05
, O 0 2.2620522344141136e-08
brachycephaly B-Disease 0 2.3251870516105555e-05
, O 0 4.337856296388054e-08
low B-Disease 0 5.8291487221140414e-05
frontal I-Disease 1 1.0
hairline I-Disease 1 1.0
, O 0 2.9805714802932926e-06
facial B-Disease 1 1.0
asymmetry I-Disease 0 0.4634549915790558
, O 0 1.0984381759726602e-07
ptosis B-Disease 1 1.0
, O 0 1.1933137500363955e-07
hypertelorism B-Disease 1 0.6140733361244202
, O 0 5.749159726065045e-08
broad B-Disease 0 3.826358079095371e-05
great I-Disease 0 5.739175685448572e-05
toes I-Disease 0 0.17551791667938232
, O 0 5.6154021876864135e-08
and O 0 3.0651955285065924e-07
clinodactyly B-Disease 0 0.0009738248190842569
. O 0 2.8593492515938124e-06

Significant O 0 1.421512115484802e-05
intra O 0 0.00010855290747713298
- O 0 4.678583536588121e-06
and O 0 7.61311582664348e-08
interfamilial O 0 1.5267580238287337e-05
phenotypic O 0 1.9002613953489345e-06
variability O 0 1.1244204500826527e-07
is O 0 2.4534002607268235e-10
present O 0 6.710371147633509e-11
for O 0 1.1798584331756956e-10
either O 0 5.402996716696862e-09
TWIST O 0 4.459434421733022e-06
mutations O 0 2.901122009291157e-08
or O 0 2.644213559221953e-08
FGFR O 1 0.9999997615814209
mutations O 0 9.398805786986486e-07
. O 0 3.3675055988169333e-07

The O 0 2.415516462406231e-07
overlap O 0 1.2174099062178811e-08
in O 0 5.574354311477236e-10
clinical O 0 1.2170407792666538e-08
features O 0 1.4022696337434581e-09
and O 0 3.4593869435717295e-10
the O 0 8.016757813145148e-10
presence O 0 5.07955566497742e-10
, O 0 1.3566806011944266e-10
in O 0 2.9608548252069156e-11
the O 0 1.6676765524081816e-10
same O 0 2.7135424116031537e-11
genes O 0 1.4130748654528347e-11
, O 0 3.61736439413729e-11
of O 0 3.857091035452953e-10
mutations O 0 4.809536102712286e-11
for O 0 3.407545773326248e-11
more O 0 1.3706287840808962e-11
than O 0 5.58350310431166e-11
one O 0 3.127501868593896e-10
craniosynostotic B-Disease 0 2.39645146393741e-07
condition I-Disease 0 2.741444626863654e-09
- O 0 1.1568625168933977e-08
such O 0 1.5210926962438975e-09
as O 0 2.853670633129468e-09
Saethre B-Disease 0 1.5100305063242558e-05
- I-Disease 0 5.432676744021592e-07
Chotzen I-Disease 0 0.00024185805523302406
, I-Disease 0 4.334123726579264e-09
Crouzon I-Disease 0 0.006994227878749371
, I-Disease 0 9.989702398627287e-09
and I-Disease 0 7.011818325963759e-08
Pfeiffer I-Disease 1 0.9985595345497131
syndromes I-Disease 0 1.2103618018954876e-06
- O 0 2.2189011517070867e-08
support O 0 5.412782444480513e-10
the O 0 1.5192602731417537e-09
hypothesis O 0 3.5067271308975023e-10
that O 0 9.89100294723766e-12
TWIST O 0 4.039857515181211e-08
and O 0 3.3220662332134054e-10
FGFRs O 0 5.200088821766258e-07
are O 0 3.465117082157576e-11
components O 0 7.567620974313627e-10
of O 0 1.3259920939034942e-09
the O 0 1.0172669373531562e-09
same O 0 2.5106947076913855e-10
molecular O 0 2.0147901125255885e-09
pathway O 0 7.821436276422844e-10
involved O 0 3.484217428462166e-11
in O 0 2.4467631046243277e-11
the O 0 3.69271085931544e-10
modulation O 0 6.51204175028397e-08
of O 0 1.2226513490531943e-06
craniofacial O 1 1.0
and O 1 0.9916326403617859
limb O 1 1.0
development O 0 8.533444173508542e-08
in O 0 6.331628110700649e-09
humans O 0 4.790808638688304e-09
. O 0 2.7355895326763857e-09
. O 0 6.501691274252153e-08

Mutation O 0 1.0827788798906113e-07
analysis O 0 8.43215630652594e-09
of O 0 5.541697944977386e-08
UBE3A O 1 1.0
in O 1 0.9571321606636047
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 0 4.2191892134724185e-05
. O 0 2.4745421001171053e-07

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 3.872076831612503e-06
AS B-Disease 1 1.0
) O 0 2.293825396293414e-08
is O 0 1.4112688795364647e-09
caused O 0 2.7565925098116395e-09
by O 0 8.258153050277883e-10
chromosome O 0 7.498989162968428e-08
15q11 O 0 1.4638437733083265e-06
- O 0 4.4986452962803014e-07
q13 O 0 1.1614266668402706e-06
deletions O 0 2.097806195422436e-08
of O 0 6.237056648927819e-09
maternal O 0 4.458817759456224e-09
origin O 0 5.964822386017588e-11
, O 0 6.217452247492261e-11
by O 0 2.5571245121369657e-10
paternal O 0 8.920695222514041e-07
uniparental B-Disease 1 0.9999959468841553
disomy I-Disease 1 1.0
( O 0 5.49234584923397e-07
UPD B-Disease 1 1.0
) O 0 6.06295680327662e-09
15 O 0 8.320371058800902e-09
, O 0 2.8362831527850574e-10
by O 0 1.7455645262565156e-10
imprinting O 0 4.31843318438041e-06
defects O 0 3.2255418318527518e-06
, O 0 7.101830790112729e-10
and O 0 4.17318346546125e-10
by O 0 1.8169564464098897e-10
mutations O 0 8.040186849633812e-10
in O 0 9.610718887387293e-10
the O 0 1.15553099533372e-07
UBE3A O 1 0.9998631477355957
gene O 0 8.248555900536303e-07
. O 0 7.199811875580053e-07

UBE3A O 0 0.04784243553876877
encodes O 0 3.1026631859276677e-06
a O 0 7.522741185539417e-08
ubiquitin O 0 2.7643343969430134e-07
- O 0 1.9770206449720718e-07
protein O 0 9.523627220175968e-09
ligase O 0 1.4844694362636801e-08
and O 0 4.296157207761553e-09
shows O 0 1.047793247721529e-07
brain O 0 1.271599671781587e-06
- O 0 8.221555276577419e-07
specific O 0 1.2413838135216793e-07
imprinting O 0 7.6149972301209345e-06
. O 0 3.540361035447859e-07

Here O 0 7.526889334030784e-08
we O 0 1.9467480072421495e-08
describe O 0 3.762761124903591e-08
UBE3A O 0 0.00402239803224802
coding O 0 6.0591432884393726e-06
- O 0 0.00041679132846184075
region O 0 6.639264142904722e-07
mutations O 0 6.666823981760217e-09
detected O 0 2.6992255097724183e-09
by O 0 1.0479236922655844e-10
SSCP O 0 2.8057247618562542e-05
analysis O 0 2.763582418463528e-10
in O 0 1.442697766806944e-10
13 O 0 6.326654755639538e-09
AS B-Disease 1 0.9999994039535522
individuals O 0 1.3169126900081096e-10
or O 0 1.2056979858954264e-09
families O 0 5.973819772187028e-10
. O 0 4.557259458692897e-08

Two O 0 1.4640249901276547e-07
identical O 0 9.99834171011571e-08
de O 0 4.341989097156329e-06
novo O 0 5.430882083601318e-06
5 O 0 3.041173783913109e-07
- O 0 3.8635749888271675e-07
bp O 0 1.195344623283745e-07
duplications O 0 5.098099791212007e-07
in O 0 5.668494118538092e-09
exon O 0 4.5138366999708524e-07
16 O 0 4.765021088815047e-08
were O 0 6.000316243870429e-09
found O 0 1.7405627161792836e-08
. O 0 1.2698750140316406e-07

Among O 0 2.5628107636066488e-08
the O 0 4.367258554793807e-09
other O 0 6.598392943146791e-10
11 O 0 2.0332431294178832e-09
unique O 0 6.867357793538531e-10
mutations O 0 2.394027198704407e-10
, O 0 2.4979079915610214e-10
8 O 0 3.379896806876559e-09
were O 0 6.29325369594369e-10
small O 0 4.4226342588160605e-09
deletions O 0 1.7138033214791903e-08
or O 0 3.630494349593505e-09
insertions O 0 5.4611437150242637e-08
predicted O 0 1.3709628099434212e-08
to O 0 2.3560133843858466e-09
cause O 0 1.2645812397238387e-08
frameshifts O 0 2.8657129860221175e-06
, O 0 2.1603672184511424e-09
1 O 0 1.4754928834292969e-08
was O 0 9.440920045733492e-09
a O 0 6.268885965887705e-10
mutation O 0 1.8003565305235725e-10
to O 0 2.226368533975176e-10
a O 0 1.0795301319532769e-09
stop O 0 5.2694870689151685e-09
codon O 0 4.82076423224953e-09
, O 0 3.934801096061591e-10
1 O 0 6.618601666730228e-09
was O 0 1.4929424807519354e-08
a O 0 1.7040565625237036e-09
missense O 0 1.4678970039483374e-08
mutation O 0 5.541639369610607e-10
, O 0 1.471096300331709e-10
and O 0 2.677350563473624e-10
1 O 0 1.124885518066776e-08
was O 0 1.0360182933766282e-08
predicted O 0 5.056455254504044e-09
to O 0 7.668561341489522e-10
cause O 0 3.796077674422804e-09
insertion O 0 2.6973625555370973e-09
of O 0 1.4064972297944678e-08
an O 0 3.494430300676754e-09
isoleucine O 0 1.352874051008257e-06
in O 0 3.510764567948854e-09
the O 0 2.5308379392185998e-08
hect O 0 1.1670661024254514e-06
domain O 0 1.3156285838533677e-08
of O 0 1.1316728887322824e-08
the O 0 1.9373283421941778e-08
UBE3A O 0 8.178577991202474e-05
protein O 0 8.317054600581741e-09
, O 0 4.217634852476948e-10
which O 0 1.0342542100527652e-10
functions O 0 5.600058194943358e-10
in O 0 5.335598074474035e-10
E2 O 0 1.5217833606584463e-06
binding O 0 1.2206069044395917e-08
and O 0 8.095635273264179e-09
ubiquitin O 0 4.6743815573790926e-07
transfer O 0 1.0052588095277315e-06
. O 0 7.161332860050607e-07

Eight O 0 1.0219215340612209e-07
of O 0 1.3722893044132434e-08
the O 0 1.2458443165996869e-09
cases O 0 4.453919733027334e-10
were O 0 3.9676137375543874e-10
familial O 0 5.9274164243561245e-08
, O 0 2.312639635349001e-09
and O 0 6.380460160215762e-09
five O 0 5.2878119660704215e-09
were O 0 3.859668584738074e-09
sporadic O 0 1.7908939753397135e-06
. O 0 8.60488228227041e-07

In O 0 6.25337790438607e-08
two O 0 7.025497961166138e-09
familial O 0 1.05161937824505e-07
cases O 0 3.946498239315588e-09
and O 0 1.7108825467460065e-09
one O 0 8.262154849170145e-10
sporadic O 0 5.6048726548851846e-08
case O 0 1.0029490127294594e-08
, O 0 1.5927845709029498e-09
mosaicism O 0 5.975147701064998e-07
for O 0 1.0252421134282486e-08
UBE3A O 1 0.9999994039535522
mutations O 0 3.4928178127557885e-09
was O 0 1.3653465025242895e-09
detected O 0 2.632505879951452e-10
in O 0 2.4026853423508854e-11
the O 0 2.1353437074100867e-10
mother O 0 1.5569676103943664e-10
of O 0 3.4804598092463834e-10
three O 0 2.192324377592314e-10
AS B-Disease 1 1.0
sons O 0 7.456981698794607e-09
, O 0 7.978129962227243e-11
in O 0 3.024001188345338e-11
the O 0 2.830770340356281e-10
maternal O 0 2.7594333484870504e-09
grandfather O 0 2.483827366006608e-09
of O 0 5.644693601425388e-09
two O 0 6.620568537840654e-10
AS B-Disease 1 1.0
first O 0 5.76215430925231e-09
cousins O 0 8.178402843839194e-09
, O 0 2.7658131340757564e-10
and O 0 3.8944000801954815e-10
in O 0 1.9948437346428705e-10
the O 0 3.245198998413912e-09
mother O 0 1.387823966858548e-09
of O 0 4.81412998354358e-09
an O 0 3.495950195997466e-09
AS B-Disease 1 1.0
daughter O 0 4.484377768676495e-06
. O 0 1.0649174555510399e-06

The O 0 2.921133024358369e-08
frequencies O 0 2.5406936554617232e-09
with O 0 1.933723320357572e-10
which O 0 1.7403917196290308e-10
we O 0 3.212924648554605e-10
detected O 0 7.963752435280469e-10
mutations O 0 1.4881731957849809e-10
were O 0 1.9119311689408391e-10
5 O 0 1.6323767892956198e-09
( O 0 4.582101711947395e-11
14 O 0 5.648567724669817e-10
% O 0 2.2712139460812075e-11
) O 0 1.974401891979838e-11
of O 0 3.831281958355248e-10
35 O 0 6.757640558241462e-10
in O 0 2.9502338072529e-11
sporadic O 0 3.047744945305908e-09
cases O 0 3.002307291666284e-10
and O 0 3.200685272375381e-10
8 O 0 4.283507326618974e-09
( O 0 8.487299751891442e-11
80 O 0 1.7200506574610586e-09
% O 0 5.766205568580318e-11
) O 0 5.581565071244299e-11
of O 0 1.3088949923911741e-09
10 O 0 2.442210211839324e-09
in O 0 7.737261387141814e-10
familial O 0 8.583297272934942e-08
cases O 0 9.312456583643325e-09
. O 0 6.592345780376263e-09
. O 0 1.5854118373681558e-07

The O 0 2.4680266506038606e-05
hemochromatosis B-Disease 1 1.0
845 O 0 5.51200209883973e-05
G O 0 8.917521881812718e-06
- O 0 8.215222919716325e-07
- O 0 3.636033625298296e-07
> O 0 2.1192091637090016e-08
A O 0 2.2712780989309067e-08
and O 0 6.267941166093749e-10
187 O 0 7.461761875049433e-09
C O 0 8.92429738996725e-08
- O 0 4.96527263749158e-07
- O 0 2.0686200059572e-06
> O 0 3.534828181273042e-07
G O 0 2.6329687443649163e-06
mutations O 0 4.872029446545412e-09
: O 0 1.673367278076654e-10
prevalence O 0 3.962572048266111e-09
in O 0 2.600933080021406e-10
non O 0 3.168429998368083e-07
- O 0 1.8829683767762617e-06
Caucasian O 0 1.3297077430252102e-06
populations O 0 5.2850008813720706e-08
. O 0 3.8770537003074423e-08

Hemochromatosis B-Disease 1 0.9955875873565674
, O 0 8.507961268833242e-08
the O 0 7.876518566263258e-07
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
of I-Disease 1 1.0
iron I-Disease 1 1.0
metabolism I-Disease 0 0.07995180040597916
, O 0 3.909689016978746e-09
leads O 0 1.3844748458780032e-08
, O 0 7.066078833162237e-10
if O 0 2.375098784312968e-09
untreated O 0 0.029195820912718773
, O 0 7.61932628101647e-10
to O 0 5.1982906867920065e-09
progressive O 1 0.9925368428230286
iron B-Disease 1 1.0
overload I-Disease 1 0.9986279010772705
and O 0 1.7795416624721838e-06
premature B-Disease 0 1.3182255315768998e-05
death I-Disease 0 1.8618052308738697e-06
. O 0 4.884010991190735e-07

The O 0 1.5429792256327346e-05
hemochromatosis B-Disease 1 1.0
gene O 0 3.671022454909689e-07
, O 0 1.3329514558790834e-07
HFE O 1 1.0
, O 0 4.0768732390006335e-08
recently O 0 2.7489649667700178e-08
has O 0 9.60219903589632e-10
been O 0 2.5621726962299363e-10
identified O 0 9.83926343178787e-11
, O 0 5.904985528326634e-11
and O 0 1.4176135265664414e-10
characterization O 0 7.305542393254427e-09
of O 0 1.1524599941026281e-08
this O 0 2.5046156815200504e-10
gene O 0 2.728677839236582e-10
has O 0 1.4419496152662248e-10
shown O 0 8.070619866851203e-11
that O 0 9.894795920117883e-12
it O 0 4.572515630019147e-11
contains O 0 4.3822595552356347e-10
two O 0 3.097001127772003e-11
mutations O 0 2.7566894947317344e-11
that O 0 1.379569809084602e-11
result O 0 1.3043935376266802e-10
in O 0 2.3039607721653255e-10
amino O 0 1.4161953831859364e-09
acid O 0 1.2945025051891434e-09
substitutions O 0 3.449650343156918e-09
- O 0 1.0483406143180218e-08
cDNA O 0 1.0628711244464739e-08
nucleotides O 0 2.4407897925016186e-09
845 O 0 5.9502635707531226e-08
G O 0 8.214519198190828e-08
- O 0 4.6374566409213e-08
- O 0 1.2154150397236663e-07
> O 0 1.784100511770248e-08
A O 0 4.1573219533574957e-08
( O 0 2.594541526068639e-10
C282Y O 0 7.471378182799526e-08
) O 0 7.629181314472433e-11
and O 0 1.571998087257498e-10
187 O 0 2.8562081588745514e-09
C O 0 5.3366111529840055e-08
- O 0 2.2154085854708683e-07
- O 0 1.5901892993497313e-06
> O 0 3.289742096512782e-07
G O 0 6.415463303710567e-06
( O 0 1.6863195284599897e-08
H63D O 1 0.9998795986175537
) O 0 1.656297001773055e-07
. O 0 3.7947987152620044e-07

Although O 0 1.4637565982411616e-05
hemochromatosis B-Disease 1 1.0
is O 0 5.315187223686735e-08
common O 0 7.101508714413285e-09
in O 0 8.68049077062949e-10
Caucasians O 0 5.35131960077706e-07
, O 0 7.471331997521702e-09
affecting O 0 1.1075179884301178e-07
> O 0 2.9672021284454786e-08
= O 0 2.744767080287147e-09
1 O 0 3.038811868805169e-09
/ O 0 3.29776250751479e-09
300 O 0 3.2729211008053483e-10
individuals O 0 2.4653311076622275e-12
of O 0 1.2860630616007285e-10
northern O 0 1.7782697536716796e-09
European O 0 1.6653125545218472e-09
origin O 0 7.932655227138596e-11
, O 0 4.3841468649885584e-11
it O 0 3.343238186293007e-11
has O 0 4.197329289690188e-11
not O 0 3.256045780219985e-11
been O 0 2.3954660477443213e-10
recognized O 0 1.3320098357638699e-09
in O 0 3.0731825417795733e-10
other O 0 2.1397561500435813e-09
populations O 0 1.936622773257568e-08
. O 0 6.65515074160794e-08

The O 0 2.418377107460401e-07
present O 0 6.157847565191332e-09
study O 0 1.365013213572297e-09
used O 0 4.0555414582144067e-10
PCR O 0 1.1339719385716762e-08
and O 0 1.4235643774895834e-09
restriction O 0 5.327617902395332e-09
- O 0 9.494969255285923e-09
enzyme O 0 1.8570099624692915e-10
digestion O 0 1.1455232318269282e-09
to O 0 4.303246647907599e-11
analyze O 0 5.739884123556749e-10
the O 0 1.5472928494020266e-10
frequency O 0 2.8764896020661013e-10
of O 0 1.6509952294185837e-09
the O 0 6.285603149080998e-09
845 O 0 1.8768284348880115e-07
G O 0 1.2630533774427022e-07
- O 0 5.5876235194318724e-08
- O 0 8.61702247334506e-08
> O 0 6.480987302381891e-09
A O 0 8.257117656285118e-09
and O 0 3.551285931990833e-10
187 O 0 1.594602450083471e-09
C O 0 1.508928093585382e-08
- O 0 3.83245470914062e-08
- O 0 1.641574982613747e-07
> O 0 5.0746315594096814e-08
G O 0 3.9603830259693495e-07
mutations O 0 1.1832619328799865e-09
in O 0 3.38638006525116e-10
HLA O 0 4.769481165567413e-07
- O 0 4.1133574768537073e-08
typed O 0 3.5086957783647676e-09
samples O 0 9.203146578151689e-11
from O 0 4.6380066454076996e-11
non O 0 9.743078344115474e-09
- O 0 4.082709637032167e-08
Caucasian O 0 2.9661386236057297e-08
populations O 0 3.221871935910059e-10
, O 0 7.919728761685008e-11
comprising O 0 1.956103334865844e-10
Australian O 0 1.1737268934552958e-09
Aboriginal O 0 8.891026581636652e-09
, O 0 2.7094473886712933e-10
Chinese O 0 1.8399641810162848e-09
, O 0 5.258289914600311e-10
and O 0 4.387380236892113e-09
Pacific O 0 2.0920069232488459e-07
Islanders O 0 3.988996468251571e-06
. O 0 4.458463536138879e-07

Results O 0 8.442169985301007e-08
showed O 0 7.711585148229005e-09
that O 0 3.383545665869292e-10
the O 0 3.3930991349961914e-09
845 O 0 2.9787909738843155e-07
G O 0 5.851558739777829e-07
- O 0 3.464356552740355e-07
- O 0 5.113954557600664e-07
> O 0 2.4135243137379803e-08
A O 0 2.2822606027261827e-08
mutation O 0 5.749252185438536e-10
was O 0 7.142311186925099e-10
present O 0 1.2202518162585108e-10
in O 0 4.1184618215783786e-11
these O 0 9.550830265547816e-11
populations O 0 8.47680051152544e-11
( O 0 1.2106119058608034e-11
allele O 0 1.2987029854305554e-11
frequency O 0 8.77812059152383e-11
0 O 0 1.4668878611789893e-10
. O 0 2.651224205452163e-11
32 O 0 6.568620647406931e-10
% O 0 1.89701171438017e-11
) O 0 2.0024822078301696e-11
, O 0 5.135754321816677e-11
and O 0 1.5509864226270764e-10
, O 0 1.1978351643904261e-10
furthermore O 0 3.5287342492473783e-10
, O 0 7.606370394652728e-11
it O 0 9.628328689892385e-11
was O 0 4.83720441479818e-09
always O 0 3.2379343650745795e-09
seen O 0 1.4357780520057872e-09
in O 0 1.9422287389492254e-10
conjunction O 0 6.140137287502512e-09
with O 0 3.1256190968775854e-09
HLA O 0 1.3460336049320176e-05
haplotypes O 0 5.810984760046267e-08
common O 0 3.6801690583843083e-09
in O 0 1.1052104786912764e-09
Caucasians O 0 1.0897237956442041e-07
, O 0 9.435281445036026e-10
suggesting O 0 2.1912092140752293e-09
that O 0 2.6052426882472446e-10
845 O 0 1.668092437512314e-07
G O 0 8.898832675185986e-07
- O 0 1.3137500900484156e-06
- O 0 3.0132966912788106e-06
> O 0 8.050982813756491e-08
A O 0 9.249971100189214e-08
may O 0 7.106383259625204e-10
have O 0 6.550488623746631e-11
been O 0 1.068390376168793e-10
introduced O 0 2.568553425508213e-10
into O 0 2.2636985341772942e-10
these O 0 9.273311285529218e-11
populations O 0 2.0675390566271545e-10
by O 0 6.86801282512306e-10
Caucasian O 0 1.7943577859114157e-06
admixture O 0 3.6575372632796643e-06
. O 0 8.566562996747962e-07

187 O 0 7.641512524969585e-07
C O 0 6.791176474507665e-07
- O 0 2.1076448319945484e-07
- O 0 2.340232470032788e-07
> O 0 2.9682720281698494e-08
G O 0 1.0485709367458185e-07
was O 0 2.8619122627304705e-09
present O 0 1.6211654241260476e-10
at O 0 5.838698413640486e-10
an O 0 7.449894173783278e-11
allele O 0 3.2435015784315624e-10
frequency O 0 3.042842644518373e-09
of O 0 3.69391237597938e-08
2 O 0 2.0756431240442907e-06
. O 0 9.852964240053552e-07

68 O 0 1.8511221924200072e-06
% O 0 4.750825066679454e-09
in O 0 7.25365156828417e-10
the O 0 2.7723847662031176e-09
two O 0 7.05385194699204e-10
populations O 0 6.684723330430131e-10
analyzed O 0 3.4978178131694904e-09
( O 0 3.5035715995057615e-10
Australian O 0 2.254015640801299e-08
Aboriginal O 0 3.142831772606769e-08
and O 0 2.305482915687662e-09
Chinese O 0 2.5593521968403365e-08
) O 0 9.465423111976179e-09
. O 0 1.4357422628563654e-07

In O 0 4.303277734152289e-08
the O 0 2.9247679833588336e-08
Australian O 0 1.2161589069137335e-08
Aboriginal O 0 1.8710617499806403e-09
samples O 0 1.6947400427458348e-10
, O 0 1.3090890871314542e-10
187 O 0 2.2735828775211075e-09
C O 0 2.835799151057472e-08
- O 0 1.06439102864897e-07
- O 0 3.666054624318349e-07
> O 0 4.349280402493605e-08
G O 0 4.824022425964358e-07
was O 0 2.149261879580422e-09
found O 0 7.49015849343948e-11
to O 0 6.308729233461818e-11
be O 0 7.419249936635453e-11
associated O 0 7.420145609060569e-10
with O 0 4.215505278182263e-09
HLA O 0 0.00010876034502871335
haplotypes O 0 4.69983341133684e-08
common O 0 2.2186121828582372e-09
in O 0 5.00646357703971e-10
Caucasians O 0 4.9160725268393435e-08
, O 0 5.234803701625879e-10
suggesting O 0 7.199317808570527e-10
that O 0 3.320607677714804e-11
it O 0 2.776812946247986e-10
was O 0 4.640223316698666e-09
introduced O 0 1.3999231773809129e-09
by O 0 3.8429037729770243e-10
recent O 0 2.959289524540054e-08
admixture O 0 1.2360670780253713e-06
. O 0 8.233168387050682e-07

In O 0 1.4062992192975798e-07
the O 0 3.841955020789101e-08
Chinese O 0 9.100221909363881e-09
samples O 0 4.221586136221589e-10
analyzed O 0 1.0161189667456938e-09
, O 0 1.956800971258943e-10
187 O 0 2.0796306898773764e-09
C O 0 1.7263193541339206e-08
- O 0 2.4855205893459242e-08
- O 0 7.927297218657259e-08
> O 0 1.480894784577913e-08
G O 0 1.1318244474978201e-07
was O 0 2.8505153792934834e-09
present O 0 1.0049509141518698e-10
in O 0 9.79909139942059e-11
association O 0 7.419207609382639e-11
with O 0 7.529491613533779e-11
a O 0 7.342124130893524e-10
wide O 0 5.97824723058693e-08
variety O 0 4.3457152543169286e-08
of O 0 8.271764784240077e-08
HLA O 0 1.8766741050058044e-05
haplotypes O 0 2.3218516886913676e-08
, O 0 7.085905195935993e-10
showing O 0 1.070124433510955e-09
this O 0 2.3772808374622478e-11
mutation O 0 5.5328710363289346e-11
to O 0 7.249181116497638e-11
be O 0 1.3164506984519875e-10
widespread O 0 2.408092614203383e-09
and O 0 2.480376126712258e-09
likely O 0 1.5682254383975192e-09
to O 0 1.1530311150309558e-09
predate O 0 7.448555550126912e-08
the O 0 5.9324691825679565e-09
more O 0 4.4540898747058577e-10
genetically O 0 2.9943538759624744e-09
restricted O 0 3.0958227092980906e-09
845 O 0 1.0818273210588814e-07
G O 0 1.0446109399708803e-06
- O 0 2.736520173129975e-06
- O 0 5.8097043620364275e-06
> O 0 3.8075373254287115e-07
A O 0 7.132746304705506e-07
mutation O 0 9.575541071171756e-08
. O 0 1.1302108759991825e-07

Genotype O 0 6.411891263269354e-06
- O 0 2.501384642528137e-06
phenotype O 0 4.320417090752926e-08
correlations O 0 1.6062111285464198e-07
in O 0 5.902607469465693e-08
attenuated B-Disease 1 0.9404510259628296
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
. O 0 5.5126431107055396e-05

Germ O 0 0.0004325240442994982
- O 0 1.0751376976259053e-05
line O 0 8.643125966045773e-07
mutations O 0 1.1117653464509658e-08
of O 0 1.760290757601979e-08
the O 0 2.661356290900585e-08
tumor B-Disease 0 7.964322867337614e-05
suppressor O 0 2.162777673220262e-05
APC O 0 1.0461512829351705e-06
are O 0 9.103637288454536e-10
implicated O 0 1.0235655878432226e-08
in O 0 5.219532361877555e-09
attenuated B-Disease 1 0.9999996423721313
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 0.005819002166390419
AAPC B-Disease 1 1.0
) O 0 1.5503550443440872e-08
, O 0 9.832120673181066e-10
a O 0 5.62611734977736e-10
variant O 0 1.5187617918854812e-07
of O 0 1.5002864302005037e-06
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 1.1904785424121656e-05
FAP B-Disease 1 1.0
) O 0 3.4842065588236437e-07
. O 0 4.787513603332627e-07

AAPC B-Disease 1 1.0
is O 0 2.1034320241142268e-07
recognized O 0 1.3721296987512233e-08
by O 0 2.174284502443058e-10
the O 0 3.422674366149181e-09
occurrence O 0 4.117070062648054e-08
of O 0 7.24323427903073e-08
< O 0 3.354120963194873e-07
100 O 0 5.1752234497826066e-08
colonic B-Disease 0 0.00249661598354578
adenomas I-Disease 0 0.000125769482110627
and O 0 1.2438079011189984e-08
a O 0 1.144656147644696e-09
later O 0 3.023935102319797e-09
onset O 0 1.1270088151604796e-07
of O 0 1.6978369785647374e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 4.143000609246883e-09
age O 0 4.374612228019714e-09
> O 0 4.586565349740113e-09
40 O 0 2.8019471187690215e-09
years O 0 2.6588280466199876e-09
) O 0 1.193555654310785e-08
. O 0 1.734799894848038e-07

The O 0 3.0629249181401974e-07
aim O 0 5.506684601641609e-07
of O 0 3.748070298570383e-08
this O 0 4.553440402510489e-10
study O 0 9.598445371850062e-10
was O 0 1.913292857480542e-09
to O 0 8.457972655584456e-10
assess O 0 5.2881876655419546e-08
genotype O 0 4.679260356965642e-08
- O 0 2.7162062110619445e-07
phenotype O 0 1.28975896629413e-08
correlations O 0 6.430455812278524e-08
in O 0 3.639780032926865e-08
AAPC B-Disease 1 1.0
families O 0 5.156580940024469e-08
. O 0 2.094484301551347e-07

By O 0 2.4315072622016487e-08
protein O 0 2.2938648314152488e-08
- O 0 9.224072528013494e-08
truncation O 0 4.2536788669167436e-07
test O 0 2.4111040275442974e-08
( O 0 2.2249857511980053e-09
PTT O 0 8.176741175702773e-06
) O 0 2.211310717870063e-10
assay O 0 1.335938359936506e-09
, O 0 1.9883632240702553e-10
the O 0 4.592428659577763e-10
entire O 0 3.051933150644004e-09
coding O 0 5.1143613788440234e-09
region O 0 7.78686182201227e-09
of O 0 1.615993028281082e-08
the O 0 2.2978934310913246e-08
APC B-Disease 0 2.38818785192052e-07
gene O 0 1.0958758345225306e-09
was O 0 1.2601357735064767e-09
screened O 0 5.089411114767017e-09
in O 0 2.4019855549006763e-10
affected O 0 1.273701699666674e-09
individuals O 0 2.2454600678845082e-11
from O 0 8.116549654602068e-10
11 O 0 1.4297344819169666e-07
AAPC B-Disease 1 1.0
kindreds O 0 9.580750884197187e-06
, O 0 4.083478444272259e-09
and O 0 1.7025946208448772e-09
their O 0 3.1091371699432102e-09
phenotypic O 0 1.8222829112346517e-07
differences O 0 6.551484688088749e-08
were O 0 5.440182082594447e-09
examined O 0 2.1965755081509997e-07
. O 0 1.3916289276494354e-07

Five O 0 7.429583774865023e-07
novel O 0 7.064629130582034e-07
germ O 0 3.768676378967939e-06
- O 0 2.932132701971568e-06
line O 0 1.3973863133287523e-06
APC B-Disease 0 5.317164095686167e-07
mutations O 0 2.8505262594791247e-09
were O 0 5.628757460129918e-10
identified O 0 5.076185027874658e-10
in O 0 1.0070737577194677e-09
seven O 0 5.845289763328765e-08
kindreds O 0 1.1055821232730523e-05
. O 0 5.229739485912432e-07

Mutations O 0 8.413701380050043e-08
were O 0 2.718507863264108e-09
located O 0 6.973963184719878e-09
in O 0 1.4158840766498315e-10
three O 0 4.267275421909744e-11
different O 0 9.331930193867688e-12
regions O 0 6.216400172398551e-10
of O 0 4.840038148046233e-09
the O 0 1.635491031493075e-08
APC B-Disease 0 1.0221535262644466e-07
gene O 0 5.386447954336404e-10
( O 0 3.817850202647577e-11
1 O 0 1.6588327378386225e-09
) O 0 4.914771020714248e-11
at O 0 5.073126363441816e-10
the O 0 6.079037828676803e-10
5 O 0 3.1108098319521105e-09
end O 0 1.9233843406851747e-09
spanning O 0 7.72324337816599e-09
exons O 0 6.909351757400373e-09
4 O 0 2.9965592229785898e-09
and O 0 4.200286229938399e-10
5 O 0 4.02415167854997e-09
, O 0 4.799055597359825e-10
( O 0 5.696212945771606e-11
2 O 0 2.052777281491558e-09
) O 0 1.345440009403731e-10
within O 0 1.649486658372723e-10
exon O 0 7.203524887700041e-09
9 O 0 3.5241420892617725e-09
, O 0 1.7072307456622582e-10
and O 0 3.303476936444838e-10
( O 0 5.372101721801137e-11
3 O 0 1.5613489390275959e-09
) O 0 4.2629639401825514e-11
at O 0 8.369661075313672e-10
the O 0 7.654255562705714e-10
3 O 0 1.1110742548225971e-08
distal O 0 1.4881995014093263e-07
end O 0 1.6099631849897378e-08
of O 0 4.528708075213217e-08
the O 0 7.589743944436123e-08
gene O 0 5.1367521791689796e-08
. O 0 1.885306488702554e-07

Variability O 0 1.0113534472111496e-06
in O 0 1.1586704928845393e-09
the O 0 1.2595590126451839e-09
number O 0 6.213353720418979e-10
of O 0 1.8998430562078283e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 0 5.776424586656503e-06
most O 0 1.4408174653368633e-09
apparent O 0 1.5408115894288699e-09
in O 0 6.03202626736632e-11
individuals O 0 6.674243623050469e-12
with O 0 2.518006983476262e-11
mutations O 0 2.4365839901285824e-10
in O 0 9.528195593633271e-11
region O 0 1.9631769987427106e-08
1 O 0 2.1441107378450397e-07
, O 0 1.1421068535355516e-09
and O 0 2.2119615028515227e-09
upper O 0 1.3801043223793386e-06
- O 0 0.05788008123636246
gastrointestinal O 1 0.9999998807907104
manifestations O 0 0.00015126995276659727
were O 0 2.2676063249349454e-09
more O 0 2.3096849433024147e-10
severe O 0 5.230617361462464e-08
in O 0 1.954757689048847e-09
them O 0 1.2058066545250767e-08
. O 0 1.574777712676223e-07

In O 0 1.4658769309505715e-08
individuals O 0 3.5603334169742595e-10
with O 0 1.524705500743906e-10
mutations O 0 2.985638403174562e-10
in O 0 1.255495291063724e-10
either O 0 5.867366592582357e-10
region O 0 5.255334833975667e-09
2 O 0 1.6222992726966368e-08
or O 0 3.8151004577713366e-10
region O 0 2.3076649480202605e-09
3 O 0 7.757288145171515e-09
, O 0 2.666317444610655e-10
the O 0 3.240286094996492e-10
average O 0 1.6444919037628125e-10
number O 0 2.1964387253436968e-10
of O 0 7.319196804189687e-09
adenomas B-Disease 0 6.446589395636693e-06
tended O 0 2.60791015449513e-08
to O 0 4.700715927619115e-10
be O 0 1.5252056562164995e-10
lower O 0 4.796913977145323e-10
than O 0 1.2372990652875782e-11
those O 0 9.797179560677716e-12
in O 0 1.327180032539843e-11
individuals O 0 3.2754469709433964e-12
with O 0 2.0964710870097214e-11
mutations O 0 1.132170468487459e-10
in O 0 8.225216341362085e-11
region O 0 5.440762951280931e-09
1 O 0 2.47297506916766e-08
, O 0 6.749086844948238e-10
although O 0 5.62530133585426e-10
age O 0 2.174339597260655e-09
at O 0 4.901464123463484e-09
diagnosis O 0 4.834818412291497e-08
was O 0 3.780933965913391e-08
similar O 0 8.871855072811741e-08
. O 0 2.541403318900848e-07

In O 0 2.992711642946233e-07
all O 0 5.828979396937939e-07
AAPC B-Disease 1 1.0
kindreds O 0 4.0768067265162244e-05
, O 0 2.3773118584813346e-08
a O 0 3.4024185691095e-09
predominance O 0 1.4976689044488012e-07
of O 0 2.9362442433011893e-07
right O 0 2.671959919098299e-05
- O 1 1.0
sided O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and O 1 0.9999996423721313
rectal B-Disease 1 1.0
polyp I-Disease 1 1.0
sparing O 0 2.055528966593556e-05
was O 0 5.033585352975933e-07
observed O 0 1.9555201902221597e-07
. O 0 1.713609663056559e-07

No O 0 2.8689490136457607e-05
desmoid B-Disease 1 0.9999994039535522
tumors I-Disease 1 1.0
were O 0 6.164395216501362e-08
found O 0 2.9220901254234377e-09
in O 0 1.5123965413366136e-09
these O 0 1.475841848730397e-08
kindreds O 0 9.509818482911214e-06
. O 0 2.926580009443569e-07

Our O 0 3.263042174239672e-07
data O 0 7.112556765775935e-09
suggest O 0 1.1726372095566262e-09
that O 0 8.501264969762445e-11
, O 0 8.811136820163767e-10
in O 0 2.6350590598411827e-09
AAPC B-Disease 1 1.0
families O 0 8.640747006793958e-10
, O 0 3.2534025473651695e-10
the O 0 3.1608329842391925e-10
location O 0 2.208571991957342e-09
of O 0 9.653161825440293e-09
the O 0 9.884308127539043e-08
APC B-Disease 0 2.780060276563745e-05
mutation O 0 1.1970294622187794e-07
may O 0 1.130350479883191e-08
partially O 0 4.307190977215214e-07
predict O 0 5.153533066959426e-08
specific O 0 1.6400674596184217e-08
phenotypic O 0 2.354710886720568e-06
expression O 0 1.1387754739189404e-07
. O 0 1.753764991008211e-07

This O 0 9.414127255524818e-09
should O 0 1.7826710108082011e-09
help O 0 9.065327377655308e-10
in O 0 2.428529322084927e-10
the O 0 1.3345426985722497e-09
design O 0 3.033329321056044e-08
of O 0 1.0332516175992623e-08
tailored O 0 5.78526169192628e-08
clinical O 0 1.2148987025284441e-06
- O 0 2.3887301381364523e-07
management O 0 1.956179929152313e-08
protocols O 0 1.9397427664102906e-08
in O 0 1.8185512817847638e-10
this O 0 1.0874362521562375e-10
subset O 0 5.247141832143143e-09
of O 0 9.857738625385082e-09
FAP B-Disease 1 0.9996187686920166
patients O 0 1.7283388942246347e-08
. O 0 4.368200468007899e-09
. O 0 9.247854393379384e-08

Wilms B-Disease 1 1.0
' I-Disease 0 5.103226794744842e-05
tumor I-Disease 0 9.616273018764332e-05
1 O 0 4.2987045389963896e-07
and O 0 3.970911421902201e-08
Dax O 1 0.9999849796295166
- O 0 2.790072812786093e-07
1 O 0 5.523632040649318e-08
modulate O 0 2.2470487692771712e-08
the O 0 1.0375925008077047e-08
orphan O 0 4.4663188702998013e-08
nuclear O 0 6.108123074000105e-08
receptor O 0 3.59432341667798e-08
SF O 1 1.0
- O 0 5.799104201287264e-07
1 O 0 4.391468166886625e-08
in O 0 4.45669001702953e-10
sex O 0 4.0527653455413315e-10
- O 0 2.213168537323895e-09
specific O 0 1.3762334605260662e-09
gene O 0 4.745898340985377e-09
expression O 0 9.056811300922618e-09
. O 0 4.626006955277262e-08

Products O 0 8.776096365181729e-07
of O 0 1.3968836753974756e-07
steroidogenic O 0 3.107531711066258e-06
factor O 0 4.330680170028245e-08
1 O 0 5.522631241206e-08
( O 0 1.099227375789269e-09
SF O 1 1.0
- O 0 3.647974722298386e-07
1 O 0 5.7188319857459646e-08
) O 0 8.773923809712869e-10
and O 0 8.831398723430084e-09
Wilms B-Disease 1 1.0
tumor I-Disease 1 0.9998385906219482
1 O 0 8.715103376744082e-07
( O 0 5.7609672587943805e-09
WT1 O 0 3.2203635782934725e-05
) O 0 2.5722499130687027e-10
genes O 0 5.651733595013475e-11
are O 0 7.978171942535361e-12
essential O 0 4.840238765346783e-10
for O 0 3.273714077600687e-10
mammalian O 0 4.597183078658418e-08
gonadogenesis O 0 1.532774263068859e-06
prior O 0 1.9233191039802477e-08
to O 0 1.1529392551778983e-08
sexual O 0 4.0952663482585194e-08
differentiation O 0 2.0357863661502051e-07
. O 0 2.802978542604251e-07

In O 0 7.775882693294989e-08
males O 0 2.2498019447425577e-08
, O 0 9.744044682236108e-09
SF O 1 1.0
- O 0 2.413166612313944e-06
1 O 0 1.1525957432922951e-07
participates O 0 1.4289760486008163e-08
in O 0 2.4046442614888974e-10
sexual O 0 3.497996059476094e-10
development O 0 4.2020789625674126e-11
by O 0 2.1161888213994118e-11
regulating O 0 3.0983525078909224e-08
expression O 0 1.511070157889094e-09
of O 0 3.0741633683106784e-09
the O 0 6.480962433386139e-09
polypeptide O 0 2.6508394057600526e-07
hormone O 0 6.818042663780943e-08
Mullerian O 0 8.395028999075294e-06
inhibiting O 0 7.377744282166532e-07
substance O 0 5.702275416297198e-07
( O 0 2.7913976907711913e-08
MIS O 1 0.9999984502792358
) O 0 8.900159542690744e-08
. O 0 3.6278731840866385e-07

Here O 0 6.759193382777084e-08
, O 0 1.1323767701298948e-08
we O 0 2.4766084738558902e-09
show O 0 1.1699657243013917e-08
that O 0 2.7356101828246437e-09
WT1 O 0 0.0046721710823476315
- O 0 4.160681419307366e-05
KTS O 0 0.0029787998646497726
isoforms O 0 2.3031281770613532e-08
associate O 0 2.9873046258899194e-08
and O 0 4.770747796811747e-09
synergize O 0 2.4896876311686356e-06
with O 0 2.1541387340562324e-08
SF O 1 1.0
- O 0 9.702996976557188e-06
1 O 0 3.3122094578175165e-07
to O 0 1.5707438905110394e-08
promote O 0 2.951949454654823e-06
MIS O 1 1.0
expression O 0 6.794428486500692e-07
. O 0 2.4309261448252073e-07

In O 0 6.683097097948121e-08
contrast O 0 8.419046793051166e-08
, O 0 1.2666987458942458e-07
WT1 O 1 0.9972364902496338
missense O 0 7.710513614256342e-07
mutations O 0 1.1266697796941116e-08
, O 0 6.647976613649575e-10
associated O 0 5.935555935643322e-10
with O 0 1.396749382820417e-09
male B-Disease 0 2.3882831712285224e-08
pseudohermaphroditism I-Disease 1 1.0
in O 0 4.248033036446941e-09
Denys B-Disease 1 1.0
- I-Disease 1 1.0
Drash I-Disease 1 1.0
syndrome I-Disease 1 1.0
, O 0 6.542666408648756e-09
fail O 0 2.3271276461400703e-08
to O 0 3.7316834067269156e-09
synergize O 0 1.57860395120224e-05
with O 0 1.3316757474512997e-07
SF O 1 1.0
- O 1 0.9999663829803467
1 O 0 1.9004599380423315e-05
. O 0 6.900187372593791e-07

Additionally O 0 1.2962718756170943e-06
, O 0 1.4021205529957115e-08
the O 0 4.692449984133873e-09
X O 0 4.0892490460464614e-07
- O 0 2.6585382784105605e-07
linked O 0 1.2272957405912166e-07
, O 0 1.2411955907509764e-09
candidate O 0 1.5449286294710873e-09
dosage O 0 7.06772951275525e-08
- O 0 2.859218461992441e-08
sensitive O 0 1.5510802597873408e-07
sex O 0 1.5958012689054613e-09
- O 0 6.758519965899268e-09
reversal O 0 2.0342942885775983e-09
gene O 0 3.131728210092888e-10
, O 0 9.589442573343376e-10
Dax O 1 0.997698962688446
- O 0 2.8665090212598443e-07
1 O 0 1.0876348000010694e-07
, O 0 4.915863716092872e-09
antagonizes O 0 1.1227804179725354e-06
synergy O 0 2.600393429474934e-07
between O 0 7.684510805461287e-09
SF O 1 1.0
- O 0 3.396611134576233e-07
1 O 0 6.014824549538389e-08
and O 0 8.232145631836829e-09
WT1 O 0 0.006594224367290735
, O 0 3.429417860800754e-09
most O 0 6.151117948327567e-10
likely O 0 2.5084642696349135e-10
through O 0 1.0423540502957351e-10
a O 0 2.654509390076498e-10
direct O 0 7.760984077620492e-10
interaction O 0 2.0907786613122425e-09
with O 0 1.3156913780676405e-08
SF O 1 1.0
- O 0 0.16662344336509705
1 O 0 9.717359716887586e-06
. O 0 6.675421104773704e-07

We O 0 1.984510618058266e-07
propose O 0 8.360542835816887e-08
that O 0 4.380506624102054e-09
WT1 O 0 0.11016826331615448
and O 0 3.695300847539329e-07
Dax O 1 0.9999996423721313
- O 0 7.517978133364522e-07
1 O 0 5.526741020389636e-08
functionally O 0 7.787916977974874e-09
oppose O 0 9.821925495145933e-10
each O 0 5.689111334805652e-11
other O 0 4.462906086355467e-11
in O 0 1.4822723604090982e-10
testis O 0 7.405193969134416e-08
development O 0 6.602308144643132e-10
by O 0 4.3679398986640194e-10
modulating O 0 1.6923438579397043e-06
SF O 1 1.0
- O 0 0.002009450690820813
1 O 0 3.2619238936604233e-06
- O 0 1.4625111361965537e-06
mediated O 0 3.2107476499732e-07
transactivation O 0 4.687086402554996e-06
. O 0 2.2000969934765635e-08
. O 0 1.5091590910287778e-07

A O 0 2.988042297147331e-06
mouse O 0 2.437925843423727e-07
model O 0 4.3228385315785545e-09
for O 0 1.0742313705236484e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
imprinting O 1 0.9813482761383057
- O 1 0.7633664011955261
centre O 0 2.5876708605210297e-05
mutations O 0 7.9105518580036e-07
. O 0 1.5699117739131907e-07

Imprinting O 0 1.0033155376731884e-05
in O 0 3.0635000314305216e-08
the O 0 4.067568326604487e-08
15q11 O 0 6.70089775667293e-06
- O 0 1.4531045735566295e-06
q13 O 0 4.060010724060703e-06
region O 0 4.655704444189723e-08
involves O 0 7.766288945276756e-09
an O 0 5.405220160348279e-10
imprinting O 0 4.509056736878847e-07
centre O 0 6.394259912667621e-07
( O 0 3.518507041277985e-09
IC O 0 4.950934908265481e-06
) O 0 8.821309793738408e-10
, O 0 2.4041260648921536e-10
mapping O 0 2.4601010117919486e-10
in O 0 6.385286743793017e-11
part O 0 4.378099272006608e-10
to O 0 3.117698599286456e-10
the O 0 2.3923849568063815e-09
promoter O 0 2.876523410577647e-07
and O 0 2.0241664344666788e-08
first O 0 4.0797051070740054e-08
exon O 0 2.5625968191889115e-06
of O 0 5.079152742837323e-06
SNRPN O 1 1.0
. O 0 5.778683771495707e-06

Deletion O 0 3.3756575703591807e-06
of O 0 1.9735922762720293e-07
this O 0 4.2385153165014344e-09
IC O 0 1.3327013220987283e-05
abolishes O 0 1.3396436315815663e-06
local O 0 6.398813923169655e-09
paternally O 0 6.065653934683723e-08
derived O 0 8.232282633358068e-10
gene O 0 3.8703706906062507e-10
expression O 0 1.5835266431452055e-10
and O 0 8.367646159301856e-11
results O 0 2.42515035830948e-10
in O 0 2.8883111458100075e-09
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 4.844131581194233e-06
PWS B-Disease 1 1.0
) O 0 3.270419597356522e-07
. O 0 6.779269483558892e-07

We O 0 1.463547505409224e-07
have O 0 2.3465327458893626e-09
created O 0 5.1345843132821756e-09
two O 0 1.4269897485874594e-09
deletion O 0 3.68414561080499e-08
mutations O 0 1.4085904664895565e-09
in O 0 3.2667840654809766e-10
mice O 0 8.400692586008063e-09
to O 0 2.266706822240394e-09
understand O 0 7.5203743676866e-08
PWS B-Disease 1 1.0
and O 0 2.7913976907711913e-08
the O 0 1.5604417313852537e-08
mechanism O 0 1.508594316135259e-08
of O 0 1.0171238962186635e-08
this O 0 1.1958436019199326e-08
IC O 0 0.00043846730841323733
. O 0 1.4683248537039617e-06

Mice O 0 0.00013292653602547944
harbouring O 0 0.00011134708620375022
an O 0 5.11441307082805e-08
intragenic O 0 1.2636339306482114e-05
deletion O 0 2.140492512126002e-07
in O 0 3.6898262223417078e-09
Snrpn O 1 0.9627218842506409
are O 0 5.591064056176265e-09
phenotypically O 0 3.2445203146380663e-07
normal O 0 3.6978651252184136e-09
, O 0 2.356164985339859e-10
suggesting O 0 2.3266016890843844e-10
that O 0 4.5788168395732853e-11
mutations O 0 4.3924688886143315e-10
of O 0 3.752810950885532e-09
SNRPN O 1 0.9999046325683594
are O 0 3.136061965669512e-10
not O 0 1.4073758825006166e-10
sufficient O 0 3.929657932388864e-09
to O 0 2.2118191722597658e-08
induce O 0 1.1191499652341008e-05
PWS B-Disease 1 1.0
. O 0 1.558117764943745e-05

Mice O 0 1.2846174968217383e-06
with O 0 5.25402210627135e-09
a O 0 7.793712342163417e-09
larger O 0 2.7927129053750832e-08
deletion O 0 4.1495503921851196e-08
involving O 0 3.9192831202683465e-09
both O 0 2.102820584326537e-09
Snrpn O 0 1.3113319255353417e-05
and O 0 3.900817890922781e-09
the O 0 1.7715676037255434e-08
putative O 0 1.7506913536635693e-06
PWS O 1 1.0
- O 0 1.5834906662348658e-05
IC O 0 8.909723692340776e-05
lack O 0 6.733599633435006e-08
expression O 0 2.8743902813488376e-09
of O 0 4.235258810325604e-09
the O 0 3.3828246870371004e-09
imprinted O 0 3.370235646116271e-08
genes O 0 5.580186535070197e-09
Zfp127 O 0 3.286601213403628e-06
( O 0 9.643496001743301e-10
mouse O 0 2.9456334260657968e-08
homologue O 0 1.0312988507621412e-07
of O 0 1.2297813434258842e-08
ZNF127 O 1 1.0
) O 0 6.14224582307088e-09
, O 0 6.850955358572719e-09
Ndn O 0 1.0065068636322394e-05
and O 0 2.27705587718674e-08
Ipw O 0 1.938494733622065e-06
, O 0 3.0618978463792246e-09
and O 0 1.8347775521121434e-09
manifest O 0 6.791200046762924e-09
several O 0 8.925139516335889e-10
phenotypes O 0 3.34853353933795e-08
common O 0 4.3060506271785925e-09
to O 0 4.5537753123880975e-08
PWS B-Disease 1 1.0
infants O 0 0.006847671698778868
. O 0 4.325546001382463e-07

These O 0 1.7746890179637376e-08
data O 0 1.867147325640417e-09
demonstrate O 0 4.465667280406649e-10
that O 0 3.005646079246027e-11
both O 0 1.1375820424541772e-10
the O 0 5.506994860127179e-10
position O 0 1.0355791779659285e-09
of O 0 1.096383872578599e-09
the O 0 1.0051622867379706e-09
IC O 0 4.979779646419047e-07
and O 0 5.569816274864081e-10
its O 0 6.239123662155066e-10
role O 0 1.1477605532661528e-09
in O 0 1.4039816531585814e-10
the O 0 6.464785373694326e-10
coordinate O 0 8.670827389423152e-10
expression O 0 9.160280312059399e-10
of O 0 3.2950333572756563e-09
genes O 0 2.795470521732568e-10
is O 0 1.2043367692005091e-10
conserved O 0 2.248423891515472e-09
between O 0 3.4409478044672426e-10
mouse O 0 1.4847128859685199e-08
and O 0 1.5335316350117978e-09
human O 0 1.8770347498531237e-09
, O 0 3.203061149648079e-10
and O 0 4.1340628142982894e-10
indicate O 0 3.1739549877229933e-10
that O 0 3.653602073661055e-11
the O 0 1.6183981932371694e-09
mouse O 0 3.927172187445649e-08
is O 0 5.001357661349459e-10
a O 0 1.4966815287120738e-10
suitable O 0 1.391049164745084e-09
model O 0 2.6540639130878674e-10
system O 0 2.6474508696416876e-10
in O 0 3.695484890320344e-11
which O 0 6.95498658664917e-11
to O 0 1.3696391243378514e-10
investigate O 0 1.5601967495726399e-09
the O 0 1.06486730544475e-09
molecular O 0 2.621898920196486e-09
mechanisms O 0 2.2133459509632303e-09
of O 0 3.2477500688798955e-09
imprinting O 0 4.022189514785168e-08
in O 0 4.530102959421356e-10
this O 0 1.0564388253087031e-10
region O 0 5.821165771635606e-09
of O 0 1.449688991073117e-08
the O 0 1.2439739016656404e-08
genome O 0 1.0187353183255254e-08
. O 0 4.573375012029146e-09
. O 0 1.033865117960886e-07

Mutations O 0 1.4533925707382878e-07
of O 0 1.3269509224755893e-07
the O 0 1.1759598095295587e-07
ATM O 0 0.00021610059775412083
gene O 0 4.3845215458304665e-08
detected O 0 1.878668776100767e-08
in O 0 4.035281442327232e-09
Japanese O 1 0.9816038608551025
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 5.367807034417638e-07
: O 0 8.917410559972083e-11
possible O 0 3.318076646774415e-10
preponderance O 0 2.913032126627968e-08
of O 0 1.1730047155822376e-08
the O 0 6.5208638488911674e-09
two O 0 2.4825581590448564e-09
founder O 0 1.754049350211062e-07
mutations O 0 3.710152540747913e-08
4612del165 O 0 2.346459041291382e-06
and O 0 1.2632376922283584e-07
7883del5 O 0 5.794559183414094e-05
. O 0 1.560059899929911e-06

The O 0 1.1493777947180206e-06
ATM O 0 0.0008991657523438334
( O 0 8.948056517965597e-08
A O 1 1.0
- O 1 1.0
T O 1 1.0
, O 0 1.0619997325989061e-08
mutated O 0 1.340270205929528e-08
) O 0 5.938443625730372e-10
gene O 0 1.1504455166289063e-09
on O 0 2.2803547494731902e-08
human O 0 2.854521241602015e-08
chromosome O 0 2.696345973163261e-07
11q22 O 0 2.1858855689060874e-05
. O 0 8.152721875376301e-07

3 O 0 1.9844153484882554e-06
has O 0 1.4900122913275027e-08
recently O 0 6.678787300984368e-09
been O 0 4.823097476958083e-10
identified O 0 1.7705355237485065e-10
as O 0 8.512883453715148e-11
the O 0 1.9719414989793904e-10
gene O 0 9.534704276115136e-11
responsible O 0 1.6772720712321387e-10
for O 0 1.4015576199621904e-10
the O 0 5.708138850479827e-09
human O 0 2.4504149109816353e-07
recessive B-Disease 1 0.9999895095825195
disease I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 0.0010402471525594592
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 1.1849208192415972e-07
. O 0 2.400855123596557e-07

In O 0 1.722284004301855e-08
order O 0 4.243077444954224e-09
to O 0 4.2731582161614767e-10
define O 0 2.385568409479788e-09
the O 0 4.65842697749963e-10
types O 0 2.736424420390904e-09
of O 0 1.050285902692849e-08
disease O 0 0.0029755360446870327
- O 0 6.762229168089107e-05
causing O 0 1.8936183323603473e-06
ATM O 0 1.3264781955513172e-05
mutations O 0 2.1598520749677164e-09
in O 0 3.776051138437708e-10
Japanese O 0 5.598808456852566e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 5.052791518522781e-09
as O 0 1.5312744128248568e-10
well O 0 1.3338193050049796e-10
as O 0 9.406454087867999e-11
to O 0 1.449151215693334e-10
look O 0 6.996022094973853e-10
for O 0 4.216757776287494e-10
possible O 0 8.419107189183705e-09
mutational O 0 2.4313835638167802e-06
hotspots O 0 4.126394799186528e-07
, O 0 2.849080305011853e-09
reverse O 0 7.099314913716626e-09
- O 0 1.2919896263952069e-08
transcribed O 0 2.1846573439177064e-09
RNA O 0 2.7669171398514436e-09
derived O 0 7.95761373462156e-11
from O 0 1.1386624282350155e-11
ten O 0 6.685934583749997e-10
patients O 0 4.7102721029146366e-11
belonging O 0 1.9959615557563204e-11
to O 0 1.9467756573465778e-10
eight O 0 1.929093551567007e-09
unrelated O 0 2.82324066347428e-08
Japanese O 0 1.9116967564514198e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
families O 0 5.597602381612887e-10
was O 0 1.766714330386776e-09
analyzed O 0 9.532381550769742e-10
for O 0 2.770580709299253e-10
mutations O 0 2.8943097918343597e-10
by O 0 8.625362923897484e-11
the O 0 8.628432190960211e-09
restriction O 0 2.7025961912841012e-08
endonuclease O 0 3.5983981661047437e-07
fingerprinting O 0 2.390940778695949e-07
method O 0 6.002172625585445e-08
. O 0 9.490862851180282e-08

As O 0 1.818980450707386e-07
has O 0 3.732950393242618e-09
been O 0 2.648733732346642e-10
reported O 0 8.860376321528918e-11
by O 0 2.0624729354934423e-11
others O 0 4.2184472581752175e-10
, O 0 4.0870917761282044e-10
mutations O 0 3.974294227049313e-10
that O 0 1.0664318039754761e-10
lead O 0 8.640916426827516e-09
to O 0 7.954253256059474e-09
exon O 0 1.1492134035506751e-06
skipping O 0 6.369992888721754e-07
or O 0 1.2579702612924848e-08
premature O 0 1.592730747290716e-08
protein O 0 1.0528687921507185e-09
truncation O 0 1.9995541222783686e-08
were O 0 9.619099961000188e-10
also O 0 1.7127959051066455e-09
predominant O 0 5.099325051105552e-08
in O 0 2.601728166240491e-09
our O 0 3.709041607180552e-08
mutants O 0 2.003666423888717e-07
. O 0 1.3918864283368748e-07

Six O 0 9.182714677535841e-08
different O 0 1.0143297313192079e-09
mutations O 0 4.2386749665723755e-10
were O 0 5.41274872145614e-11
identified O 0 4.9405615015762905e-11
on O 0 6.919502748559125e-10
12 O 0 2.3360207102030017e-09
of O 0 3.980919593971066e-09
the O 0 9.579958160088609e-09
16 O 0 7.783672373307127e-08
alleles O 0 1.242150737823522e-08
examined O 0 3.7175908573772176e-07
. O 0 3.442869171976781e-07

Four O 0 1.0469602074181239e-07
were O 0 3.3882423533526662e-09
deletions O 0 2.9458526284997788e-08
involving O 0 8.616180657838868e-09
a O 0 2.4469335446752893e-09
loss O 0 5.8766801203091745e-08
of O 0 9.252600108311526e-08
a O 0 8.469099199714947e-09
single O 0 5.654197554605389e-09
exon O 0 2.517151926895167e-07
exon O 0 2.5700143169160583e-07
7 O 0 9.968237435487026e-08
, O 0 6.059615920150918e-09
exon O 0 1.3509564666946972e-07
16 O 0 4.7045507045595514e-08
, O 0 8.686557251280647e-09
exon O 0 7.000513164712174e-07
33 O 0 2.4219662009272724e-07
or O 0 2.5595280561674372e-08
exon O 0 2.3445129500032635e-06
35 O 0 1.0548532145548961e-06
. O 0 5.31738749032229e-07

The O 0 1.43027321541922e-07
others O 0 8.491226388684936e-09
were O 0 1.231700963444382e-09
minute O 0 1.0671698902342541e-07
deletions O 0 6.297786114828341e-08
, O 0 1.0049443055493157e-08
4649delA O 0 4.599130249971495e-07
in O 0 6.990890089042523e-09
exon O 0 7.729295248282142e-07
33 O 0 1.2086772471775475e-07
and O 0 2.0599912886609673e-08
7883del5 O 0 3.660859647425241e-06
in O 0 3.000678816533764e-08
exon O 0 5.25075665791519e-06
55 O 0 2.2026367787475465e-06
. O 0 6.44353178813617e-07

The O 0 9.864811545412522e-07
mutations O 0 4.8482082348755284e-08
4612del165 O 0 5.306384878167592e-07
and O 0 1.0000893446715509e-08
7883del5 O 0 5.370429221329687e-07
were O 0 6.965743537534763e-10
found O 0 9.995372585169804e-11
in O 0 1.7464961768465237e-11
more O 0 5.4859797260498055e-12
than O 0 8.976690051010205e-12
two O 0 1.3835751988544587e-11
unrelated O 0 5.327411845001961e-10
families O 0 1.3994245215767642e-12
; O 0 4.53978608178085e-12
44 O 0 3.2194272248098343e-10
% O 0 3.4996026909706046e-11
( O 0 1.7086861439641332e-11
7 O 0 1.0854018794859144e-09
of O 0 8.903716652852722e-10
16 O 0 1.1343671557639823e-09
) O 0 7.691071390869553e-11
of O 0 9.33001786940224e-10
the O 0 9.559510960599482e-10
mutant O 0 6.747803649176376e-09
alleles O 0 6.157806209383665e-11
had O 0 2.3798635284677516e-10
one O 0 1.5485977777895954e-10
of O 0 2.5779292034400214e-09
the O 0 7.733089724126785e-09
two O 0 6.646192485249003e-09
mutations O 0 4.825771071637064e-08
. O 0 1.9211218216241832e-07

The O 0 1.0981381137753488e-06
4612del165 O 0 5.984499239275465e-06
mutations O 0 2.1151658202711587e-09
in O 0 2.1262601401783598e-10
three O 0 4.5919181651532526e-11
different O 0 4.671510574205673e-12
families O 0 1.2743509589588364e-12
were O 0 9.242581526514027e-12
all O 0 3.634668607754854e-11
ascribed O 0 2.9513738120101607e-09
to O 0 2.7951721492947e-10
the O 0 2.317819491892692e-09
same O 0 1.3642531548896386e-09
T O 0 4.5728191366833926e-07
- O 0 2.5425012495361443e-07
- O 0 1.386909644907064e-07
> O 0 7.315163141896619e-09
A O 0 4.462723524056855e-09
substitution O 0 1.1021077384043565e-09
at O 0 2.9711084703620827e-09
the O 0 3.081648491942701e-09
splice O 0 1.2224153067563748e-07
donor O 0 1.6433104876867333e-09
site O 0 3.3164351265213554e-08
in O 0 2.3693628392607025e-08
intron O 0 2.2739453925169073e-05
33 O 0 1.0159983503399417e-05
. O 0 1.0412809388071764e-06

Microsatellite O 0 6.4785112044774e-05
genotyping O 0 7.786234164086636e-06
around O 0 7.521263967191771e-08
the O 0 6.973753130523619e-08
ATM O 0 5.0622311391634867e-05
locus O 0 8.163131042238092e-07
also O 0 4.74218841972629e-09
indicated O 0 1.4136235515493922e-09
that O 0 1.182586806258712e-10
a O 0 7.249724154334558e-10
common O 0 2.7954667469742844e-09
haplotype O 0 4.664593333814082e-08
was O 0 9.291007074807567e-09
shared O 0 7.148076019980465e-10
by O 0 1.0919527088093517e-10
the O 0 4.82008388758004e-09
mutant O 0 3.620980493224124e-08
alleles O 0 4.288704669175303e-10
in O 0 7.993427586505675e-10
both O 0 1.8514803912239586e-08
mutations O 0 3.805925246069819e-07
. O 0 3.2072955491457833e-07

This O 0 1.600303889404131e-08
suggests O 0 3.338729959168063e-09
that O 0 7.4508746394919e-11
these O 0 4.458611813085156e-10
two O 0 5.518887569166964e-10
founder O 0 3.8687360870426346e-08
mutations O 0 2.9075295504554788e-09
may O 0 2.197838439021993e-10
be O 0 1.1960475665429016e-10
predominant O 0 1.9579191601337698e-08
among O 0 7.904340515452191e-10
Japanese O 0 5.592037410906414e-08
ATM O 0 6.561390819115331e-06
mutant O 0 1.7845450202003121e-06
alleles O 0 3.269686033036123e-08
. O 0 1.353002687665139e-07

W474C O 0 5.874500493519008e-05
amino O 0 9.837250303235123e-08
acid O 0 6.149314835113273e-09
substitution O 0 1.0902487801445204e-09
affects O 0 5.008011227936038e-10
early O 0 9.961342167796872e-11
processing O 0 8.761431580239787e-10
of O 0 1.6543396652579645e-09
the O 0 3.064766662674856e-09
alpha O 0 1.70676284216853e-09
- O 0 1.7559206311190678e-09
subunit O 0 3.49300227631133e-10
of O 0 8.387031624756958e-10
beta O 0 1.607986810370221e-08
- O 0 3.572894868852927e-08
hexosaminidase O 0 4.519664855706651e-07
A O 0 6.828438703365691e-09
and O 0 2.707711554972292e-10
is O 0 1.522020703914606e-10
associated O 0 3.585582386556041e-10
with O 0 5.9099267701867575e-09
subacute O 1 0.9999842643737793
G B-Disease 1 0.9993411898612976
( I-Disease 0 4.378279072625446e-08
M2 I-Disease 1 1.0
) I-Disease 0 2.51850650556662e-07
gangliosidosis I-Disease 0 6.356915400829166e-05
. O 0 8.192346285795793e-07

Mutations O 0 4.45949240202026e-07
in O 0 2.3919119129800492e-08
the O 0 1.0013208395776019e-07
HEXA O 0 2.988795495184604e-05
gene O 0 1.0810528028315503e-09
, O 0 3.283125160624678e-10
encoding O 0 4.466289005300439e-10
the O 0 9.351290852777083e-10
alpha O 0 1.3098341300477045e-09
- O 0 1.2387383341305735e-09
subunit O 0 2.5125296287953347e-10
of O 0 1.417619688304228e-09
beta O 0 1.2913244695766934e-08
- O 0 6.841438704441316e-08
hexosaminidase O 0 1.7197946817759657e-06
A O 0 1.4441175721913169e-07
( O 0 8.305668930397303e-10
Hex O 0 2.9782245292153675e-06
A O 0 4.202053105473169e-08
) O 0 2.347435856808744e-10
, O 0 2.166481161136602e-10
that O 0 1.693234441546565e-10
abolish O 0 4.85670454963838e-07
Hex O 0 5.80296000407543e-06
A O 0 3.459984299070129e-08
enzyme O 0 7.145568026167837e-10
activity O 0 8.708749832386786e-10
cause O 0 2.0220716123731108e-07
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 1.1965280322101535e-08
TSD B-Disease 1 1.0
) O 0 1.7408042785049815e-09
, O 0 8.526309658307696e-10
the O 0 1.2075512145770517e-08
fatal O 0 1.0001429018302588e-06
infantile B-Disease 0 5.568684287027281e-07
form I-Disease 0 1.907419333591065e-09
of I-Disease 0 1.2117070014028286e-07
G I-Disease 0 0.0006094541749916971
( I-Disease 0 2.316409730696023e-09
M2 I-Disease 1 0.9999991655349731
) I-Disease 0 7.065354523660972e-09
gangliosidosis I-Disease 0 9.622913239581976e-07
, I-Disease 0 5.433897332096649e-09
Type I-Disease 0 9.936099587548597e-08
1 I-Disease 0 5.283771997710573e-07
. O 0 2.8523993478302145e-07

Less O 0 1.4702725366078084e-06
severe O 1 0.9717419147491455
, O 0 1.3296656220518344e-07
subacute O 1 1.0
( O 0 2.6426858923400687e-08
juvenile O 1 1.0
- O 1 0.8597370982170105
onset O 0 2.0454930563573726e-05
) O 0 1.427449825008864e-09
and O 0 1.5584429746695605e-08
chronic O 1 1.0
( O 0 2.369144658231903e-09
adult O 0 5.479862466017948e-07
- O 0 1.545871896269091e-06
onset O 0 1.1107101727247937e-07
) O 0 1.548716016541718e-10
variants O 0 1.6091333820966724e-09
are O 0 3.8634210414167924e-11
characterized O 0 1.6929115054242772e-10
by O 0 2.414971174424796e-11
a O 0 4.3532849547389674e-10
broad O 0 2.223328010586556e-08
spectrum O 0 1.1405770550254601e-08
of O 0 3.6197975727958465e-09
clinical O 0 5.1235517162240285e-08
manifestations O 0 1.0205771339144576e-08
and O 0 1.7985236910877944e-10
are O 0 2.054651414284958e-11
associated O 0 1.1850434522564512e-10
with O 0 1.1899493890243917e-10
residual O 0 4.250250185577897e-06
levels O 0 7.172296534463385e-08
of O 0 6.877352376477575e-08
Hex O 0 5.305018203216605e-05
A O 0 4.6798677999504434e-07
enzyme O 0 3.0272950368726015e-08
activity O 0 3.4322663822194954e-08
. O 0 9.411456147745412e-08

We O 0 1.5762381622153043e-07
identified O 0 1.5147818999139417e-08
a O 0 1.1112479825214905e-08
1422 O 0 4.0784554585115984e-05
G O 0 3.600076161092147e-05
- O 0 1.399554093950428e-05
- O 0 5.651112132909475e-06
> O 0 1.6322833573667594e-07
C O 0 4.1297568031950505e-07
( O 0 3.315520913371728e-10
amino O 0 5.612462716797495e-10
acid O 0 8.824794228701194e-10
W474C O 0 6.4320233583714526e-09
) O 0 5.01967304528117e-12
substitution O 0 7.290849868279992e-11
in O 0 1.5278370582572087e-11
the O 0 2.694157952287668e-10
first O 0 1.2479128841391685e-10
position O 0 1.2008530836382647e-09
of O 0 4.14836920370476e-09
exon O 0 9.066079087460821e-08
13 O 0 3.105049728446829e-08
of O 0 4.6561307698311794e-08
HEXA O 1 0.9994008541107178
of O 0 1.4182700169840246e-07
a O 0 6.806956331928404e-09
non O 0 2.2858378656565037e-07
- O 0 1.7709416511024756e-07
Jewish O 0 4.793534813529732e-08
proband O 0 6.132098405942088e-06
who O 0 1.0809605655026644e-08
manifested O 0 6.56320366942964e-08
a O 0 4.616441451332776e-09
subacute O 0 9.777596460480709e-06
variant O 0 3.331508651172044e-07
of O 0 6.156579729577061e-06
G B-Disease 1 0.9996638298034668
( I-Disease 0 2.853552238946122e-08
M2 I-Disease 1 1.0
) I-Disease 0 2.452196383728733e-07
gangliosidosis I-Disease 0 7.670150807825848e-05
. O 0 1.1988142887275899e-06

On O 0 2.4608456783425936e-07
the O 0 2.312411417904059e-08
second O 0 5.322927876250105e-08
maternally O 0 3.1771202202435234e-07
inherited O 0 3.4488829214751604e-07
allele O 0 6.3933240923574886e-09
, O 0 6.136762764619164e-10
we O 0 3.203427800801961e-10
identified O 0 4.5686995853166934e-10
the O 0 1.3745335980530626e-09
common O 0 1.6192889518151787e-07
infantile O 1 0.9999998807907104
disease O 1 1.0
- O 1 0.9815114140510559
causing O 0 0.0011757983593270183
4 O 0 9.66471361607546e-07
- O 0 4.1851802734527155e-07
bp O 0 3.9642969795750105e-08
insertion O 0 2.50721345906868e-08
, O 0 6.096271931710362e-09
+ O 0 1.2512835212419304e-07
TATC O 0 0.059078097343444824
1278 O 0 0.00011459052620921284
, O 0 3.5266182862869755e-08
in O 0 2.307476698604205e-08
exon O 0 4.550729045149637e-06
11 O 0 1.0441497124702437e-06
. O 0 6.783441222069087e-07

Pulse O 0 0.00014921520778443664
- O 0 4.466840437089559e-06
chase O 0 1.1844169023333961e-07
analysis O 0 1.2999333831587023e-09
using O 0 2.9360907038977757e-09
proband O 0 2.439861646053032e-06
fibroblasts O 0 1.796036741552598e-08
revealed O 0 1.1874747407603081e-08
that O 0 4.0846215298984134e-10
the O 0 3.7228535809674668e-09
W474C O 0 1.662589284023852e-07
- O 0 1.761288181967302e-08
containing O 0 5.8663967017480445e-09
alpha O 0 3.3585998426843844e-09
- O 0 5.457642338058122e-09
subunit O 0 2.170941648671487e-09
precursor O 0 1.3663996156765279e-08
was O 0 3.2616058742718224e-09
normally O 0 1.5241094497575602e-10
synthesized O 0 8.201079260139466e-10
, O 0 9.619755686474107e-11
but O 0 5.2287937868378265e-11
not O 0 1.7677508762359295e-11
phosphorylated O 0 5.136648884018769e-10
or O 0 2.211546917818552e-10
secreted O 0 7.204922769510347e-10
, O 0 3.706131512792865e-10
and O 0 1.2699659102111127e-09
the O 0 1.4802396641755422e-08
mature O 0 1.0733531041751121e-07
lysosomal O 0 4.5619341904057364e-07
alpha O 0 4.6905377359962586e-08
- O 0 5.7924165020040164e-08
subunit O 0 1.2271055283008536e-08
was O 0 1.8458353068240285e-08
not O 0 1.303752328318808e-09
detected O 0 9.902650077719954e-08
. O 0 1.5825115440293303e-07

When O 0 1.4310849394405523e-07
the O 0 3.7565655475191306e-08
W474C O 0 4.3946815253548266e-07
- O 0 3.712382223852728e-08
containing O 0 5.677940784210023e-09
alpha O 0 2.807703403107098e-09
- O 0 3.894060629505702e-09
subunit O 0 2.8904549864705587e-09
was O 0 1.727508447402215e-08
transiently O 0 2.8306004651312833e-08
co O 0 9.103295006696044e-09
- O 0 7.332316975805497e-09
expressed O 0 4.607413894852641e-10
with O 0 1.8525102285504857e-10
the O 0 1.6219736664879747e-09
beta O 0 3.6244054424372507e-09
- O 0 2.3598136777991385e-09
subunit O 0 2.060280002158521e-10
to O 0 1.1228928897821788e-10
produce O 0 5.6087410271743465e-09
Hex O 0 2.0375868189148605e-05
A O 0 3.1999536531657213e-07
( O 0 1.3844160262621585e-09
alphabeta O 0 9.749400078362669e-07
) O 0 6.685564324371285e-10
in O 0 7.571518967353086e-10
COS O 0 6.163717443996575e-06
- O 0 3.0787592919523377e-08
7 O 0 5.027930516376955e-09
cells O 0 2.4595507921998383e-11
, O 0 7.508954569246384e-11
the O 0 2.7103055910693286e-10
mature O 0 1.0579153109091521e-09
alpha O 0 4.130200903507131e-10
- O 0 5.548916326425513e-10
subunit O 0 1.6466951413551811e-10
was O 0 4.1371706060999713e-10
present O 0 8.944188445436652e-11
, O 0 4.514419740808684e-11
but O 0 1.194043475205575e-11
its O 0 9.912368148512485e-11
level O 0 1.0912828418696563e-09
was O 0 2.349806793588982e-09
much O 0 6.878710379076836e-10
lower O 0 3.844034424105303e-09
than O 0 7.242864641376912e-11
that O 0 2.7344388905947703e-11
from O 0 3.0908356429826256e-10
normal O 0 1.7437884469728715e-09
alpha O 0 4.2524921362030454e-09
- O 0 1.552864681286792e-08
subunit O 0 5.830299354414592e-09
transfections O 0 3.5737613757191866e-07
, O 0 4.480230353376413e-10
although O 0 1.3799072995368533e-10
higher O 0 2.366298268441369e-10
than O 0 2.1549612788662742e-11
in O 0 5.123280272245623e-11
those O 0 1.739475785633715e-10
cells O 0 7.365824616911709e-11
transfected O 0 3.7108445205547014e-09
with O 0 8.862675177079282e-11
an O 0 4.5506531876071676e-10
alpha O 0 1.2353908118711843e-08
- O 0 4.3651954939605275e-08
subunit O 0 1.536334259810701e-08
associated O 0 2.5198174213869606e-08
with O 0 1.5581997558911098e-07
infantile O 1 0.8839062452316284
TSD B-Disease 1 0.9999995231628418
. O 0 4.373464889795287e-06

Furthermore O 0 6.132146950221795e-07
, O 0 9.826013780411813e-09
the O 0 5.560945037785814e-09
precursor O 0 9.329594874429858e-09
level O 0 1.3119750619239312e-08
of O 0 9.532568512327089e-09
the O 0 1.1591971826874214e-08
W474C O 0 2.5723758767526306e-07
alpha O 0 7.314451710982439e-09
- O 0 8.283018715360413e-09
subunit O 0 1.6770361765949815e-09
was O 0 1.784940306670535e-09
found O 0 6.10150055480041e-11
to O 0 8.071034812706657e-11
accumulate O 0 1.5235579464700777e-09
in O 0 8.694637371187142e-11
comparison O 0 5.660053536971077e-10
to O 0 4.214988635897754e-10
the O 0 4.261480501810411e-09
normal O 0 4.98393326608948e-09
alpha O 0 1.2216410105736486e-08
- O 0 6.03500325269124e-08
subunit O 0 2.932935316835028e-08
precursor O 0 1.31009883830302e-07
levels O 0 1.2174986352420092e-07
. O 0 1.1164811297703636e-07

We O 0 7.917400068890856e-08
conclude O 0 1.6907188538084483e-08
that O 0 3.7151198784002304e-10
the O 0 4.985245549704587e-09
1422 O 0 1.684315429884009e-05
G O 0 1.2602689821505919e-05
- O 0 3.689895493153017e-06
- O 0 1.3503153013516567e-06
> O 0 4.6691503996498795e-08
C O 0 1.1565111179834275e-07
mutation O 0 4.867271585773381e-10
is O 0 8.180406352309433e-11
the O 0 1.660978576900618e-10
cause O 0 9.722208593743176e-10
of O 0 2.5407723924786296e-08
Hex B-Disease 1 0.9999998807907104
A I-Disease 0 0.0004505865217652172
enzyme I-Disease 1 0.9999995231628418
deficiency I-Disease 1 1.0
in O 0 8.449447364000662e-09
the O 0 1.412142722756471e-07
proband O 0 8.685704960953444e-05
. O 0 7.694397368140926e-07

The O 0 8.394848123316478e-07
resulting O 0 2.0121531463246356e-07
W474C O 0 1.2966797839908395e-06
substitution O 0 4.8524082529866064e-08
clearly O 0 2.1885037781999017e-08
interferes O 0 1.5045024781557004e-08
with O 0 7.481980590640092e-10
alpha O 0 5.479588338630492e-09
- O 0 2.6262683139322007e-09
subunit O 0 2.6021737542514245e-10
processing O 0 1.4616937660250073e-09
, O 0 6.902468874248058e-11
but O 0 2.0209304715801402e-11
because O 0 5.976803080232074e-11
the O 0 1.3989134850511675e-10
base O 0 6.147024556035774e-10
substitution O 0 3.3648579478295915e-09
falls O 0 5.396366731247326e-08
at O 0 1.632367463422213e-09
the O 0 1.3306284962766313e-09
first O 0 1.0756598944894336e-09
position O 0 7.41301953155471e-09
of O 0 1.5250153140300426e-08
exon O 0 3.264134704750177e-07
13 O 0 6.696341614542689e-08
, O 0 3.861347241951307e-09
aberrant O 0 6.083065162698631e-09
splicing O 0 1.6823776149976766e-08
may O 0 4.818573318132735e-10
also O 0 3.878558585412861e-10
contribute O 0 1.5096067729203355e-09
to O 0 2.2646411412807765e-09
Hex B-Disease 1 0.9999997615814209
A I-Disease 0 6.920083978911862e-05
deficiency I-Disease 0 1.9876483747793827e-06
in O 0 3.0727622668536014e-09
this O 0 3.5760430172615543e-09
proband O 0 6.605503585888073e-06
. O 0 3.9709490806671965e-08
. O 0 3.1664666266806307e-07

Two O 0 3.2203644195760717e-07
frequent O 0 8.212653597183817e-07
missense O 0 3.0745600270165596e-06
mutations O 0 4.692917912052508e-07
in O 0 3.742213152690965e-07
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.214040356804617e-06

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 2.0358136509912583e-07
an O 0 1.942607013916131e-06
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 1.8599205304781208e-06
by O 0 8.672150220156993e-10
early O 0 8.939459661405635e-08
childhood O 1 1.0
deafness B-Disease 1 1.0
and O 1 1.0
goiter B-Disease 1 1.0
. O 0 0.00010281581489834934

A O 0 5.691963451681659e-07
century O 0 6.202960367573951e-09
after O 0 4.3617956468899877e-10
its O 0 2.3662033443727637e-10
recognition O 0 1.0490160962106643e-09
as O 0 2.0940873479702304e-09
a O 0 1.6464927199422164e-08
syndrome O 0 1.157946257990261e-06
by O 0 4.578644408059773e-10
Vaughan O 0 2.117413032465265e-06
Pendred O 1 0.9999388456344604
, O 0 7.611123287176724e-09
the O 0 1.24598287243316e-08
disease O 0 3.600118589019985e-06
gene O 0 3.069811072009543e-08
( O 0 1.0342808387520108e-08
PDS O 1 1.0
) O 0 7.061097484495349e-09
was O 0 4.971782985307982e-08
mapped O 0 4.927506580543195e-08
to O 0 1.1865373572561566e-08
chromosome O 0 3.141564661746088e-07
7q22 O 0 2.3053795302985236e-05
- O 0 2.906170266214758e-05
q31 O 0 9.84797443379648e-05
. O 0 1.1746197969841887e-06

1 O 0 5.95469089148537e-07
and O 0 3.688540317625666e-08
, O 0 7.749362040954111e-09
recently O 0 1.7804563157142184e-08
, O 0 1.40567046891249e-09
found O 0 3.7578659628501043e-10
to O 0 6.449538680897149e-10
encode O 0 6.985265255110562e-09
a O 0 2.611792915274691e-08
putative O 0 2.9166405965952436e-06
sulfate O 0 2.685559820747585e-06
transporter O 0 9.695255357655697e-06
. O 0 7.726944204478059e-07

We O 0 7.832655768424956e-08
performed O 0 1.1013726819442127e-08
mutation O 0 3.1232816333215396e-10
analysis O 0 1.3162271272904036e-10
of O 0 3.4989520170114474e-09
the O 0 1.876598787475814e-08
PDS B-Disease 1 0.9999990463256836
gene O 0 2.314042513162917e-09
in O 0 5.608503106380169e-10
patients O 0 7.367303989092022e-10
from O 0 1.8280034430606662e-10
14 O 0 4.022616906240728e-09
Pendred B-Disease 0 5.570043981606432e-07
families O 0 1.955818840215784e-11
originating O 0 3.6234827638370604e-11
from O 0 1.6266843774759288e-11
seven O 0 4.556096472319027e-11
countries O 0 5.2930910522663854e-12
and O 0 3.312411178679753e-10
identified O 0 2.036681934214357e-09
all O 0 7.154286052468706e-09
mutations O 0 7.472618079873428e-08
. O 0 1.9324538413911796e-07

The O 0 3.5856174918080796e-07
mutations O 0 1.5669375130755725e-08
include O 0 5.386851409383553e-09
three O 0 1.72808756193632e-09
single O 0 9.572903580945535e-10
base O 0 1.323405474096262e-08
deletions O 0 7.818191960495824e-08
, O 0 9.78852732202995e-09
one O 0 1.1545479239316592e-08
splice O 0 3.821141945081763e-07
site O 0 1.203744801614448e-07
mutation O 0 1.4740526133039111e-08
and O 0 8.675199225649521e-09
10 O 0 2.3773735335907986e-07
missense O 0 6.212160769791808e-06
mutations O 0 8.612534543317452e-07
. O 0 6.100404448261543e-07

One O 0 9.122085202761809e-07
missense O 0 1.220879084939952e-06
mutation O 0 2.2723398274138162e-08
( O 0 1.160931351051886e-09
L236P O 0 3.4121563885491923e-07
) O 0 6.244910144559412e-10
was O 0 2.2144648337274475e-09
found O 0 1.574443631024991e-10
in O 0 9.850999876936939e-11
a O 0 5.046836837330204e-10
homozygous O 0 1.7613713820807675e-09
state O 0 2.385435182716833e-10
in O 0 1.5566262168142941e-10
two O 0 1.6157510052128288e-10
consanguineous O 0 1.1284032375158404e-08
families O 0 1.7151939590842602e-11
and O 0 4.6992167102022364e-11
in O 0 1.271082267217949e-10
a O 0 7.290227310718933e-10
heterozygous O 0 4.2617301354574977e-10
state O 0 1.399393795287196e-10
in O 0 8.247004468220354e-11
five O 0 2.7656285594979124e-10
additional O 0 4.425114941142283e-09
non O 0 3.395795147298486e-07
- O 0 1.2583826674017473e-06
consanguineous O 0 3.7857437291677343e-06
families O 0 3.7225555971076574e-09
. O 0 5.770505140390014e-08

Another O 0 2.1371993170760106e-06
missense O 0 2.4191206193791004e-06
mutation O 0 3.065750675546042e-08
( O 0 3.2436890951004216e-09
T416P O 0 8.682160910211678e-07
) O 0 1.3973249224363826e-09
was O 0 5.970473893057715e-09
found O 0 3.216382993276312e-10
in O 0 1.9571930187645137e-10
a O 0 7.68018371122281e-10
homozygous O 0 3.42826034227528e-09
state O 0 4.104833972728983e-10
in O 0 1.3250307795420468e-10
one O 0 2.425585010623621e-10
family O 0 3.7733129121253484e-11
and O 0 1.8836364412688766e-10
in O 0 2.232074525210237e-10
a O 0 1.1620788775701385e-09
heterozygous O 0 1.854695952374641e-09
state O 0 7.061363160865142e-10
in O 0 6.622235537712129e-10
four O 0 2.408868882142201e-09
families O 0 5.434558358885511e-10
. O 0 3.9360060100079863e-08

Pendred B-Disease 0 0.09151415526866913
patients O 0 2.2929401666260674e-07
in O 0 1.8702697168748728e-09
three O 0 3.367554457511801e-09
non O 0 1.4275055093548872e-07
- O 0 1.4607643095132516e-07
consanguineous O 0 2.4999201286846073e-07
families O 0 7.109470651078809e-11
were O 0 4.5309651863778555e-11
shown O 0 8.075715790534232e-11
to O 0 2.2997151405412808e-10
be O 0 5.388051116383963e-10
compound O 0 1.1262637045206247e-08
heterozygotes O 0 7.953073577482428e-08
for O 0 1.1107140096555668e-08
L236P O 0 6.7312116698303726e-06
and O 0 2.521996123050485e-07
T416P O 0 8.973588410299271e-05
. O 0 1.2633366850423045e-06

In O 0 5.918217471645448e-09
total O 0 2.5967656913650217e-09
, O 0 3.888677435615051e-10
one O 0 8.718933214302282e-11
or O 0 6.165151028580951e-11
both O 0 4.538031062040204e-11
of O 0 7.94887988764259e-10
these O 0 6.205794211844307e-11
mutations O 0 2.2191472617838492e-11
were O 0 3.618937788330001e-11
found O 0 2.654123448797563e-11
in O 0 4.3720048414908064e-11
nine O 0 1.3804951626283923e-09
of O 0 3.3802836085783383e-09
the O 0 6.260429064042228e-09
14 O 0 2.5593474006768702e-08
families O 0 5.493105414977606e-10
analyzed O 0 1.3568467238656012e-07
. O 0 2.407107047019963e-07

The O 0 2.7593820561833127e-08
identification O 0 6.551907016927316e-09
of O 0 1.289498197110106e-08
two O 0 1.4852106211549199e-09
frequent O 0 1.952761863321939e-07
PDS B-Disease 1 1.0
mutations O 0 1.2507497260116907e-08
will O 0 5.065005082016683e-10
facilitate O 0 2.5176110085567416e-09
the O 0 1.1709720970642934e-09
molecular O 0 7.439879823323281e-08
diagnosis O 0 3.5641627960103506e-07
of O 0 0.01406477764248848
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 5.555764801101759e-06

Insertional O 0 7.581657700939104e-05
mutation O 0 2.4412102561655047e-08
by O 0 8.214762203806458e-10
transposable O 0 5.447390094559523e-07
element O 0 6.2869602857063e-08
, O 0 6.062228496972466e-09
L1 O 0 7.466415991075337e-05
, O 0 4.139493192667487e-09
in O 0 1.33555622117143e-09
the O 0 7.680674940502286e-08
DMD B-Disease 1 1.0
gene O 0 1.121139181492481e-08
results O 0 8.337794898949369e-10
in O 0 1.2074492516944701e-09
X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 0.9999983310699463
dilated I-Disease 0 0.0001867786340881139
cardiomyopathy I-Disease 1 1.0
. O 0 1.2769054364980548e-06

X B-Disease 1 1.0
- I-Disease 1 1.0
linked I-Disease 1 1.0
dilated I-Disease 1 0.9999916553497314
cardiomyopathy I-Disease 1 1.0
( O 0 2.1655792181718425e-07
XLDCM B-Disease 1 1.0
) O 0 1.3607948545768522e-08
is O 0 2.126727682849605e-09
a O 0 1.2034738761101949e-09
clinical O 0 1.6088695531379926e-07
phenotype O 0 6.229400106860794e-09
of O 0 1.0363483404773888e-08
dystrophinopathy B-Disease 0 0.0013628489105030894
which O 0 1.168818819508033e-09
is O 0 2.840803703385575e-10
characterized O 0 6.800048857336094e-10
by O 0 2.2665198884386228e-10
preferential O 0 3.5238289797234756e-07
myocardial B-Disease 0 5.934751698077889e-06
involvement I-Disease 0 4.2130636757065076e-08
without O 0 2.447008151662544e-09
any O 0 2.845034874354724e-09
overt O 0 1.0087008917025742e-07
clinical O 0 6.856761842755077e-07
signs O 0 4.042196451337077e-06
of O 0 5.954913285677321e-05
skeletal B-Disease 1 1.0
myopathy I-Disease 1 1.0
. O 0 9.870180656434968e-05

To O 0 2.0384085530622542e-08
date O 0 2.0318717375289452e-08
, O 0 1.2264124160665801e-09
several O 0 6.357485093921866e-10
mutations O 0 1.1215791628771399e-09
in O 0 7.266530155369821e-10
the O 0 3.4111835134353896e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
gene O 0 6.897420826135203e-05
, O 0 2.071943470127735e-07
DMD O 1 1.0
, O 0 1.2350186651133299e-08
have O 0 1.3465080439534205e-10
been O 0 1.3382124575134213e-10
identified O 0 7.420991599005333e-11
in O 0 2.4212295363090774e-11
patients O 0 1.4679010784668378e-10
with O 0 1.30733757153223e-10
XLDCM B-Disease 1 1.0
, O 0 4.948186305142599e-09
but O 0 4.469118408678696e-10
a O 0 1.8906264054319166e-10
pathogenic O 0 2.8574613786247482e-09
correlation O 0 1.1221354956347795e-09
of O 0 2.7325541829270605e-09
these O 0 1.2541938598786828e-09
cardiospecific O 0 4.512575344506331e-07
mutations O 0 1.84168125194617e-09
in O 0 7.987179251323084e-10
DMD O 1 1.0
with O 0 7.49731299265477e-09
the O 0 1.2545312699785427e-07
XLDCM B-Disease 1 1.0
phenotype O 0 7.308681659878857e-08
has O 0 3.765918243914257e-09
remained O 0 4.553184496103313e-08
to O 0 3.527861336394267e-09
be O 0 1.2628167844752625e-08
elucidated O 0 1.604080716788303e-05
. O 0 1.1150259524583817e-06

We O 0 5.541222591887163e-08
report O 0 1.0401718375518954e-09
here O 0 1.1379509140541089e-10
the O 0 2.277140281892187e-10
identification O 0 9.003002232610413e-10
of O 0 3.3905633856079476e-09
a O 0 2.5526767366557124e-09
unique O 0 9.886020002625173e-09
de O 0 4.892677225143416e-06
novo O 0 1.6206242435146123e-05
L1 O 0 1.7153462977148592e-05
insertion O 0 1.174558406091819e-08
in O 0 4.6051645830047505e-10
the O 0 3.171487517050764e-09
muscle O 0 2.04445154139421e-08
exon O 0 1.0719516296830989e-07
1 O 0 5.7473723558132406e-08
in O 0 7.6542594484863e-09
DMD O 1 1.0
in O 0 7.942792201731663e-09
three O 0 8.007470242432646e-09
XLDCM B-Disease 1 0.9999992847442627
patients O 0 1.9481511959185127e-09
from O 0 1.2174666830233605e-10
two O 0 2.2009595534999704e-10
unrelated O 0 2.5470509257274898e-08
Japanese O 0 3.915578972168987e-08
families O 0 7.809421442850351e-10
. O 0 2.071504212608488e-08

The O 0 3.472699177109462e-07
insertion O 0 1.1170669012017242e-07
was O 0 3.4971122886418016e-08
a O 0 1.5105111605961952e-09
5 O 0 6.181913203562317e-09
- O 0 1.9239173809637578e-08
truncated O 0 9.664566036349242e-09
form O 0 8.904191828307262e-10
of O 0 1.0626481916631292e-08
human O 0 7.186343520260152e-09
L1 O 0 5.269789198791841e-06
inversely O 0 6.129889129624644e-08
integrated O 0 7.377474631198311e-09
in O 0 1.2619534583979686e-10
the O 0 8.349666513751686e-10
5 O 0 4.5804022796858135e-09
- O 0 4.219883820155701e-08
untranslated O 0 8.207679456972983e-06
region O 0 3.941204695934175e-08
in O 0 1.2550266381694541e-09
the O 0 5.548834280943993e-09
muscle O 0 1.3222549277713824e-08
exon O 0 3.4602084753032614e-08
1 O 0 1.7160799004045657e-08
, O 0 1.6838366811988692e-10
which O 0 2.7433824309475163e-11
affected O 0 1.4690998417776768e-10
the O 0 1.2593566467433703e-10
transcription O 0 1.628443047074768e-09
or O 0 1.3552814426276427e-10
the O 0 8.179880661707273e-10
stability O 0 2.4914678320442363e-08
of O 0 8.886449798239937e-09
the O 0 6.687761455737018e-09
muscle O 0 2.2424845980140162e-08
form O 0 8.770995041373908e-10
of O 0 1.5994221058690528e-08
dystrophin O 0 5.563631688687565e-08
transcripts O 0 3.912359769486784e-09
but O 0 1.2008066763158354e-10
not O 0 2.7155095880249114e-11
that O 0 9.440923737225049e-12
of O 0 1.1597030002974407e-09
the O 0 9.357860264458395e-09
brain O 0 5.351227514438506e-07
or O 0 4.460621205737425e-09
Purkinje O 0 7.315498351090355e-06
cell O 0 2.8014676800580673e-08
form O 0 1.2351051292824877e-09
, O 0 6.042992217736298e-10
probably O 0 4.0667574863206823e-10
due O 0 9.197553829665139e-10
to O 0 1.7298081023131573e-10
its O 0 6.152010012527853e-10
unique O 0 1.015933004389069e-09
site O 0 1.1618356943188246e-08
of O 0 2.6401416164389957e-08
integration O 0 1.867088172957665e-07
. O 0 3.5728751868191466e-07

We O 0 1.3026908618485322e-07
speculate O 0 3.52200721920326e-08
that O 0 9.679793772088274e-11
this O 0 7.960270637097366e-11
insertion O 0 3.175918639186648e-09
of O 0 4.8512767136799084e-09
an O 0 2.306591362355448e-09
L1 O 0 9.985675205825828e-06
sequence O 0 2.842686086523827e-09
in O 0 2.2161508184126433e-09
DMD O 1 1.0
is O 0 1.5239211004214326e-09
responsible O 0 2.1167953501155523e-10
for O 0 2.793449152549421e-11
some O 0 2.6111314499477345e-11
of O 0 3.71925323872091e-10
the O 0 2.3855123432170444e-10
population O 0 7.536355220438828e-12
of O 0 2.3185832420669072e-10
Japanese O 0 1.5583804469088136e-08
patients O 0 6.726443291249495e-10
with O 0 1.1814399458742741e-09
XLDCM B-Disease 1 1.0
. O 0 1.2332512255852635e-07
. O 0 4.99668146858312e-07

Severe O 1 0.9999666213989258
early O 0 4.978919605491683e-07
- O 1 0.9999401569366455
onset O 1 0.9922001957893372
obesity B-Disease 1 1.0
, O 0 1.291807762981989e-07
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 2.161437350878259e-06
red O 1 0.9926422238349915
hair O 0 0.00010065601236419752
pigmentation O 1 0.8525055050849915
caused O 0 3.443046523443627e-07
by O 0 2.1758548740535844e-08
POMC O 1 0.9999903440475464
mutations O 0 3.780357005211954e-08
in O 0 7.994742645678343e-09
humans O 0 8.541993423705208e-08
. O 0 8.909857029948398e-08

Sequential O 0 1.1660870313789928e-06
cleavage O 0 8.195098644137033e-08
of O 0 1.2573363505907764e-07
the O 0 1.4459940800293225e-08
precursor O 0 1.741841337832284e-08
protein O 0 3.0368823011883705e-09
pre O 0 1.6457116203127953e-07
- O 0 2.105164867316489e-06
pro O 0 1.3100219803163782e-05
- O 0 7.783740329614375e-06
opiomelanocortin O 0 2.0608125851140358e-05
( O 0 7.2581669563476225e-09
POMC O 0 6.099070105847204e-06
) O 0 1.0878973277783643e-09
generates O 0 1.706730201611606e-09
the O 0 1.9349086777253888e-09
melanocortin O 0 2.6272375635016942e-06
peptides O 0 1.82659043446165e-08
adrenocorticotrophin O 0 1.6327222738254932e-06
( O 0 5.214298326450262e-09
ACTH O 0 2.908596115958062e-06
) O 0 2.1345789580351493e-09
, O 0 2.8436621946070773e-09
melanocyte O 0 1.9824783521471545e-06
- O 0 1.136529931500263e-06
stimulating O 0 1.0787957762659062e-06
hormones O 0 1.0514187209764714e-07
( O 0 1.401702642844782e-09
MSH O 0 8.33874219097197e-05
) O 0 8.733151979356535e-10
alpha O 0 3.77790421168811e-09
, O 0 2.2369119057064069e-10
beta O 0 2.9783708832553657e-09
and O 0 2.3011104133274785e-10
gamma O 0 7.071354168886046e-09
as O 0 2.3229612677866385e-10
well O 0 1.8136050994321806e-10
as O 0 1.8703186221991075e-10
the O 0 1.0248935033985163e-09
opioid O 0 1.7352218151245324e-07
- O 0 8.800731166047626e-08
receptor O 0 6.120797646502751e-09
ligand O 0 6.140913200169962e-08
beta O 0 8.340376780324732e-07
- O 0 3.6469834867602913e-06
endorphin O 0 8.166839688783512e-05
. O 0 8.463780432066415e-07

While O 0 1.7124791895639646e-07
a O 0 3.3752132200248752e-09
few O 0 1.9798191974729207e-09
cases O 0 8.11896494479214e-10
of O 0 2.2434129220982868e-08
isolated O 1 0.966891884803772
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9999674558639526
have O 0 1.2569383311955562e-09
been O 0 1.068929056380341e-09
reported O 0 5.0726258749023145e-09
( O 0 6.364416105242299e-09
OMIM O 1 0.9998486042022705
201400 O 0 7.256727258209139e-06
) O 0 1.8649513044977084e-09
, O 0 1.3968558532084785e-09
an O 0 7.4370674063573006e-09
inherited O 1 0.9999676942825317
POMC O 1 1.0
defect O 1 0.5213872194290161
has O 0 1.62832591854567e-08
not O 0 1.0865868205200968e-09
been O 0 2.4798982867224595e-09
described O 0 6.501539751013752e-09
so O 0 4.831552047335208e-09
far O 0 4.2774601638484455e-08
. O 0 2.7435604010861425e-07

Recent O 0 2.55619397648843e-07
studies O 0 2.0555011914780152e-08
in O 0 5.752268661396442e-10
animal O 0 6.9636483246426906e-09
models O 0 1.1092358143116599e-09
elucidated O 0 4.3235164781663116e-08
a O 0 2.83725709593341e-10
central O 0 3.735300957430354e-09
role O 0 4.9441859495402696e-09
of O 0 1.5991231450129817e-08
alpha O 0 8.68848388790866e-08
- O 0 1.2433142728696112e-06
MSH O 1 0.9980504512786865
in O 0 1.2236225366279996e-09
the O 0 1.4065179021471863e-09
regulation O 0 2.991876302260721e-09
of O 0 7.820869507568773e-10
food O 0 1.9063853273770803e-10
intake O 0 3.99456821786881e-11
by O 0 2.0016564360875178e-12
activation O 0 1.441842867322407e-09
of O 0 6.3072800315921995e-09
the O 0 4.5783522750753036e-08
brain O 0 1.6120533530283865e-07
melanocortin O 0 2.3893276193120982e-06
- O 0 1.2487883793710353e-07
4 O 0 3.137818183063246e-08
- O 0 1.9145495855354966e-08
receptor O 0 2.1999364552272027e-09
( O 0 4.4810849475496184e-10
MC4 O 0 5.782752123195678e-05
- O 0 1.853003652740881e-07
R O 0 1.4877296905524418e-07
; O 0 1.7839013599640907e-10
refs O 0 4.324471003513963e-09
3 O 0 7.806502111407099e-10
- O 0 8.899589953870191e-10
5 O 0 5.006683401198586e-10
) O 0 3.619006830324345e-11
and O 0 1.1296338170430076e-10
the O 0 8.098889336949355e-10
linkage O 0 1.9323351807543077e-08
of O 0 1.2416555783545391e-08
human O 0 2.1549110940100036e-08
obesity B-Disease 1 1.0
to O 0 2.4385562458206778e-09
chromosome O 0 3.679375693010911e-09
2 O 0 3.1079747664364277e-09
in O 0 1.7769533067202303e-10
close O 0 1.7248407147008038e-09
proximity O 0 5.772835987016833e-09
to O 0 1.3155174727330632e-09
the O 0 1.4983539742274843e-08
POMC O 0 5.544333180296235e-05
locus O 0 2.6684676868171664e-07
, O 0 1.9357984104573234e-09
led O 0 1.1384030385030997e-09
to O 0 1.7702957155751875e-10
the O 0 5.311918127581805e-10
proposal O 0 1.493818957420956e-09
of O 0 3.387395919318692e-09
an O 0 3.7000996711000766e-10
association O 0 1.2597224374744087e-09
of O 0 5.709448203106149e-08
POMC O 1 0.9999995231628418
with O 0 1.2730785670100886e-07
human O 0 1.1370015272404999e-05
obesity B-Disease 1 1.0
. O 0 1.4635102161264513e-06

The O 0 1.4212798760127043e-07
dual O 0 9.160672931329827e-08
role O 0 3.9105039206788206e-08
of O 0 1.3626524264509499e-07
alpha O 0 1.914237600431079e-06
- O 0 0.0007758536958135664
MSH O 1 1.0
in O 0 9.819513202558028e-09
regulating O 0 1.3233541551471717e-07
food O 0 7.959868320028818e-09
intake O 0 5.079654918915821e-09
and O 0 7.955159864181383e-10
influencing O 0 1.1455877313437668e-07
hair O 0 5.767764719166735e-07
pigmentation O 0 4.533238097792491e-06
predicts O 0 2.9992943240131353e-08
that O 0 1.3869976001057438e-10
the O 0 1.0793159699318267e-09
phenotype O 0 7.885487263159519e-10
associated O 0 1.3685631794491115e-10
with O 0 3.6139732872975117e-10
a O 0 5.1545621104764905e-09
defect O 0 6.955328046842624e-08
in O 0 3.3393476872589645e-09
POMC O 1 0.9999374151229858
function O 0 5.667067259906844e-09
would O 0 1.2835249529885573e-09
include O 0 1.42081503895497e-07
obesity B-Disease 1 1.0
, O 0 1.706307983795341e-08
alteration O 0 3.3089386874962656e-07
in O 0 8.548753704928913e-09
pigmentation O 1 0.998056948184967
and O 0 6.463842146331444e-05
ACTH B-Disease 1 1.0
deficiency I-Disease 1 0.9998111128807068
. O 0 1.1680838269967353e-06

The O 0 2.437347177419724e-07
observation O 0 2.0041747461618797e-07
of O 0 3.460855779735539e-08
these O 0 9.879252971245478e-09
symptoms O 0 7.415277991640323e-07
in O 0 1.0710862197171878e-09
two O 0 4.520033236588006e-09
probands O 0 7.617002665938344e-06
prompted O 0 1.7977537680735622e-08
us O 0 3.915694435363548e-10
to O 0 5.558470905775437e-10
search O 0 1.7208776625921018e-09
for O 0 1.3741665583211216e-09
mutations O 0 3.005219184615271e-09
within O 0 3.0564306641167605e-09
their O 0 1.4498272804530643e-08
POMC O 0 0.0003321267431601882
genes O 0 2.584084768386674e-07
. O 0 2.7839436711474264e-07

Patient O 0 8.199636795325205e-06
1 O 0 2.5063536668312736e-07
was O 0 2.255081987811991e-08
found O 0 2.250645225743142e-10
to O 0 1.840072122449854e-10
be O 0 1.7948090236252767e-10
a O 0 2.01763480922601e-10
compound O 0 1.682752381881869e-09
heterozygote O 0 5.728731267140574e-09
for O 0 2.146024746796371e-10
two O 0 2.615579142162261e-10
mutations O 0 2.3338372900916227e-10
in O 0 2.9066132833932556e-10
exon O 0 7.678521996012933e-08
3 O 0 7.661054013397006e-08
( O 0 1.1837247848589527e-09
G7013T O 0 8.93376409294433e-07
, O 0 2.8578375221854913e-09
C7133delta O 0 8.413731507062039e-07
) O 0 3.0667648975857276e-10
which O 0 6.321847212387155e-11
interfere O 0 5.859505103344986e-10
with O 0 6.159544402306594e-11
appropriate O 0 6.117935047456058e-10
synthesis O 0 7.679641922386793e-10
of O 0 1.3423142597446258e-08
ACTH O 0 8.92129901330918e-06
and O 0 6.859522727609146e-08
alpha O 0 8.919155334297102e-06
- O 0 0.00019895858713425696
MSH O 1 0.9999992847442627
. O 0 2.4719104203541065e-06

Patient O 0 2.42457599597401e-06
2 O 0 1.900861690273814e-07
was O 0 4.151307919642022e-08
homozygous O 0 1.7977846766825678e-08
for O 0 1.0578266040894846e-09
a O 0 1.5529052488361117e-09
mutation O 0 7.196791496077992e-10
in O 0 7.401910750992613e-10
exon O 0 1.6536377245301992e-07
2 O 0 2.4085881022983813e-07
( O 0 2.918369323978709e-09
C3804A O 0 8.009380962903379e-07
) O 0 2.6365221117430337e-09
which O 0 7.023327253108391e-09
abolishes O 0 1.264830007130513e-05
POMC O 0 0.00040564878145232797
translation O 0 1.085236817743862e-06
. O 0 1.0247825912301778e-06

These O 0 2.0214654838923707e-08
findings O 0 2.3861235209921006e-09
represent O 0 1.6349591125397467e-10
the O 0 2.4019947142406295e-10
first O 0 1.0540476824694167e-10
examples O 0 9.875310569285034e-10
of O 0 1.420058737267027e-08
a O 0 1.678182570685749e-08
genetic B-Disease 1 1.0
defect I-Disease 1 1.0
within O 0 8.644443383332145e-09
the O 0 3.531485148755564e-08
POMC O 0 6.771973858121783e-05
gene O 0 1.6646964917654827e-09
and O 0 7.290004711002496e-10
define O 0 2.3668771387264087e-09
a O 0 3.1886510098999565e-10
new O 0 6.920113815311879e-09
monogenic B-Disease 1 1.0
endocrine I-Disease 1 1.0
disorder I-Disease 1 0.9999842643737793
resulting O 0 1.3020111211403673e-08
in O 0 1.16351546453064e-10
early O 0 2.6778319561771013e-09
- O 0 3.571423440007493e-05
onset O 0 0.02665584720671177
obesity B-Disease 1 1.0
, O 0 7.552343816996654e-08
adrenal B-Disease 1 1.0
insufficiency I-Disease 1 1.0
and O 0 1.1064333875765442e-06
red O 0 0.00026783678913488984
hair O 0 8.034497113840189e-06
pigmentation O 0 6.06467729085125e-05
. O 0 8.760704872656788e-08
. O 0 3.792273446379113e-07

A O 0 5.144358965480933e-06
European O 0 3.6030064620717894e-07
multicenter O 0 5.35516574018402e-06
study O 0 2.2590080916984334e-08
of O 0 4.673409819133667e-07
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 4.266319297840937e-09
classification O 0 6.2081091378729525e-09
of O 0 8.279985586057137e-09
105 O 0 3.5089922079123426e-08
mutations O 0 6.729523049919806e-10
and O 0 6.653101403131245e-10
a O 0 6.072038982729566e-10
general O 0 6.218961456916361e-10
system O 0 1.403024030288691e-09
for O 0 7.302139448661649e-10
genotype O 0 3.703271689303733e-09
- O 0 1.3221741923530317e-08
based O 0 4.418654331317384e-09
prediction O 0 2.0684569790319074e-07
of O 0 2.441904882743984e-07
metabolic O 0 0.0056788260117173195
phenotype O 0 5.742188591284503e-07
. O 0 1.52142490605911e-07

Phenylketonuria B-Disease 1 0.9999996423721313
( O 0 1.487058852944756e-06
PKU B-Disease 1 1.0
) O 0 3.201183318424228e-08
and O 0 2.8318911660107915e-08
mild B-Disease 1 0.9999910593032837
hyperphenylalaninemia I-Disease 1 1.0
( O 0 1.0729047971835826e-05
MHP B-Disease 1 1.0
) O 0 2.271789334429286e-08
are O 0 2.9204743068333983e-09
allelic B-Disease 1 0.9998956918716431
disorders I-Disease 1 0.9999973773956299
caused O 0 3.2926712467684638e-09
by O 0 1.0704607339429018e-10
mutations O 0 2.1141081940623252e-10
in O 0 7.160968346076046e-11
the O 0 2.148417665992497e-09
gene O 0 3.057048392207662e-09
encoding O 0 5.078146259052119e-08
phenylalanine O 0 4.957294095220277e-06
hydroxylase O 0 0.0002295386657351628
( O 0 1.0911214332054442e-07
PAH O 1 1.0
) O 0 3.261371546159353e-07
. O 0 5.283131940814201e-07

Previous O 0 7.185365689110768e-07
studies O 0 4.9475097796403134e-08
have O 0 2.6728960711430716e-10
suggested O 0 5.363156585502793e-10
that O 0 2.1298756161525212e-11
the O 0 2.983372715537058e-10
highly O 0 1.40909106605136e-08
variable O 0 5.5633986306702354e-08
metabolic O 0 8.450403583992738e-06
phenotypes O 0 1.468573884721991e-07
of O 0 3.0554028853657655e-06
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
correlate O 0 1.5563477973046247e-06
with O 0 5.090316790301586e-07
PAH O 1 1.0
genotypes O 1 0.6959676146507263
. O 0 1.8292561207999825e-06

We O 0 1.2707023699931597e-07
identified O 0 1.2246972325158367e-08
both O 0 7.025122261694605e-09
causative O 0 4.6443258838735346e-07
mutations O 0 1.2890014389199678e-08
in O 0 2.926876074837992e-09
686 O 0 1.019318347061926e-06
patients O 0 7.04453784194925e-09
from O 0 1.1410072886519629e-09
seven O 0 4.641497852730936e-09
European O 0 5.622496956902978e-08
centers O 0 2.1169272201859712e-07
. O 0 1.9025338815481518e-07

On O 0 2.075649803146007e-07
the O 0 6.7031882267087894e-09
basis O 0 1.4773506862297836e-09
of O 0 1.0179540543830967e-09
the O 0 1.52688306442883e-09
phenotypic O 0 1.4388346869509405e-07
characteristics O 0 1.985155506645242e-08
of O 0 1.6824095894207858e-08
297 O 0 1.312811690468152e-07
functionally O 0 3.8308476746351516e-07
hemizygous O 0 3.469041985226795e-06
patients O 0 3.036940254830256e-09
, O 0 1.1121119997126172e-10
105 O 0 7.47193062977658e-09
of O 0 3.47674600220671e-09
the O 0 1.7766966786680882e-09
mutations O 0 2.3466928400495135e-10
were O 0 6.660944712466588e-11
assigned O 0 3.720863894773885e-10
to O 0 1.3833015288788886e-10
one O 0 3.4310912444546204e-10
of O 0 2.1039079367568547e-09
four O 0 9.271936551868976e-10
arbitrary O 0 6.511393646491115e-09
phenotype O 0 1.566405671837856e-08
categories O 0 7.256509348962936e-08
. O 0 6.395595164576662e-08

We O 0 7.064980422910594e-08
proposed O 0 3.4032638041026075e-08
and O 0 3.963456229882922e-09
tested O 0 5.8422102711119805e-09
a O 0 1.7808417240861019e-10
simple O 0 1.5732579128346913e-10
model O 0 4.066832981486357e-11
for O 0 3.603275663954797e-11
correlation O 0 3.2336985866798784e-10
between O 0 3.646739021867518e-10
genotype O 0 1.6064164443108098e-09
and O 0 2.6596191915473355e-09
phenotypic O 0 5.312891744324588e-07
outcome O 0 2.299020707141608e-07
. O 0 2.263790008782962e-07

The O 0 6.040797302375722e-07
observed O 0 4.045995538604075e-08
phenotype O 0 8.312994737025292e-09
matched O 0 6.751897263512774e-09
the O 0 4.977122269878009e-09
predicted O 0 1.60506345991962e-08
phenotype O 0 1.3379962693349512e-09
in O 0 1.9120151295570764e-10
79 O 0 4.306757173111464e-09
% O 0 4.2326135651915564e-11
of O 0 2.0256010757613296e-10
the O 0 1.8840244642159831e-10
cases O 0 1.661669274399813e-10
, O 0 8.946952206878578e-11
and O 0 2.2547487488200346e-10
in O 0 1.3573638046882053e-10
only O 0 7.208438013162066e-11
5 O 0 1.30515320773128e-09
of O 0 1.2555629869126506e-09
184 O 0 4.472403336563957e-09
patients O 0 7.874665364226985e-10
was O 0 2.1169175301594123e-09
the O 0 1.034809238298351e-09
observed O 0 5.609187558874851e-10
phenotype O 0 1.0522097776410888e-10
more O 0 4.678394390639218e-12
than O 0 1.2282604620883486e-11
one O 0 4.310894696768486e-11
category O 0 3.638478129897038e-10
away O 0 1.6052035256564068e-09
from O 0 2.867276138740493e-10
that O 0 1.6166726291011457e-10
expected O 0 2.4744803539533677e-08
. O 0 2.3693993966844573e-07

Among O 0 8.327900502536068e-08
the O 0 1.500164259482517e-08
seven O 0 2.503867113645697e-09
contributing O 0 2.3322366260458693e-09
centers O 0 8.011010188546663e-10
, O 0 6.221652359972296e-11
the O 0 8.620001934467325e-11
proportion O 0 2.140142646434029e-10
of O 0 3.4255592806786694e-10
patients O 0 6.405633662387444e-11
for O 0 5.441691541818727e-11
whom O 0 5.500307986849862e-10
the O 0 1.403066773875139e-09
observed O 0 1.0497346325522017e-09
phenotype O 0 1.9223637959253637e-10
did O 0 9.248352778046254e-11
not O 0 4.599316066888903e-11
match O 0 2.596602266535797e-09
the O 0 2.922859287934898e-09
predicted O 0 4.659273411533604e-09
phenotype O 0 4.981687840022175e-10
was O 0 1.9418815444538495e-09
4 O 0 2.929283260399984e-09
% O 0 1.912664332470726e-10
- O 0 5.607328823487023e-09
23 O 0 1.5208033943281407e-08
% O 0 1.0462964938895425e-09
( O 0 7.821779890448965e-10
P O 0 1.8233397724998213e-07
< O 0 2.2364321949908117e-08
. O 0 8.70008287634505e-10
0001 O 0 6.062762736291916e-08
) O 0 5.564549376835259e-10
, O 0 2.986993707931873e-10
suggesting O 0 3.1156535684750963e-10
that O 0 3.0075272133833764e-11
differences O 0 1.13512899080348e-09
in O 0 3.753122465588454e-11
methods O 0 1.9563493880436766e-10
used O 0 9.38045682796762e-11
for O 0 2.3097113110992495e-10
mutation O 0 1.7162558041405873e-09
detection O 0 1.6703720007171796e-07
or O 0 7.062969764604077e-09
phenotype O 0 9.12137121389378e-09
classification O 0 7.039850036250073e-09
may O 0 1.2966640261513618e-10
account O 0 4.795173633165284e-11
for O 0 7.663659290502167e-11
a O 0 1.757799600321519e-10
considerable O 0 3.2099862767864806e-09
proportion O 0 2.681834310180875e-09
of O 0 1.0765778490906541e-08
genotype O 0 1.300125660463891e-07
- O 0 2.0639104150177445e-06
phenotype O 0 4.021047175228887e-07
inconsistencies O 0 3.909888164344011e-06
. O 0 1.1619152928687981e-06

Our O 0 4.524227392721514e-07
data O 0 9.631258457432068e-09
indicate O 0 3.5745545412524393e-10
that O 0 1.1634489205381016e-10
the O 0 8.589188915664181e-09
PAH O 1 1.0
- O 0 6.798823960707523e-06
mutation O 0 4.637453976386041e-09
genotype O 0 5.234743749582549e-10
is O 0 3.543692422836031e-11
the O 0 4.3033944463477525e-11
main O 0 1.441082098097013e-08
determinant O 0 2.303067390130309e-07
of O 0 5.1959741398377446e-08
metabolic O 0 0.0023048906587064266
phenotype O 0 7.948915303757076e-09
in O 0 2.1174172137872205e-10
most O 0 1.4173735518596686e-09
patients O 0 4.165360500962834e-09
with O 0 1.7420896369912953e-07
PAH B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 2.1468358681886457e-05

In O 0 2.441084667736959e-08
the O 0 1.2175004115988486e-08
present O 0 1.6976073879959586e-09
study O 0 8.139027785070141e-10
, O 0 3.2850794307037745e-10
the O 0 6.61131871471099e-10
classification O 0 7.366478982362423e-09
of O 0 1.0995172772254591e-08
105 O 0 2.473127096891403e-06
PAH O 1 1.0
mutations O 0 3.7026307353471566e-08
may O 0 3.4082689448489134e-10
allow O 0 9.361493524817632e-11
the O 0 3.2535144023349005e-10
prediction O 0 1.1561279933403057e-08
of O 0 7.13901915361248e-09
the O 0 1.0969825936513189e-08
biochemical O 0 5.8519049161986914e-08
phenotype O 0 2.085505546034483e-09
in O 0 3.0898747449548125e-10
> O 0 9.825265046004006e-09
10 O 0 2.5845459106221824e-09
, O 0 5.697606830779023e-10
000 O 0 1.2600618326530366e-08
genotypes O 0 2.4846910307019243e-08
, O 0 3.7338598879443907e-10
which O 0 7.071630087063241e-11
may O 0 4.474429854406381e-11
be O 0 1.4656090577269687e-11
useful O 0 6.5365469981149e-11
for O 0 5.400322550253023e-11
the O 0 6.146825271002854e-10
management O 0 1.3299947809741752e-08
of O 0 7.002061863659037e-08
hyperphenylalaninemia B-Disease 1 1.0
in O 0 2.3540837901236955e-07
newborns O 0 1.4366794403031236e-06
. O 0 1.4969833728173398e-07

Somatic O 0 2.9577900932054035e-05
instability O 0 2.463852069922723e-06
of O 0 7.314510526157392e-07
the O 0 6.210859169186733e-07
CTG O 1 0.9999765157699585
repeat O 0 2.3036604090975743e-07
in O 0 2.222406925156406e-09
mice O 0 9.253849242440992e-09
transgenic O 0 3.43243655720471e-08
for O 0 6.303993438372402e-10
the O 0 7.15987269472862e-08
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
region O 0 0.0002904902212321758
is O 0 3.644335055952297e-09
age O 0 1.3674862353596495e-09
dependent O 0 1.4603332432194804e-10
but O 0 3.0093746938852917e-11
not O 0 3.269095064095673e-11
correlated O 0 9.253138810727535e-10
to O 0 3.485388921919963e-10
the O 0 6.2079785756452566e-09
relative O 0 1.632492896419535e-08
intertissue O 0 1.0589898238322348e-06
transcription O 0 1.2739505450554134e-07
levels O 0 6.225482707122865e-08
and O 0 4.8698854726580976e-08
proliferative O 0 0.007282324600964785
capacities O 0 4.2654624849092215e-05
. O 0 3.921389634342631e-06

A O 0 3.958910019719042e-05
( O 0 2.6242824446853774e-07
CTG O 0 0.0011028313310816884
) O 0 2.9199076934105506e-08
nexpansion O 0 1.1789404652517987e-06
in O 0 1.3052278147185348e-09
the O 0 2.2344610606239712e-09
3 O 0 1.3440666357666942e-08
- O 0 1.2140642979829863e-07
untranslated O 0 6.3474421040155e-05
region O 0 1.0250449378190751e-07
( O 0 2.6586455259547392e-09
UTR O 0 6.08947520959191e-05
) O 0 9.948739609910717e-10
of O 0 8.217210911709572e-09
the O 0 3.2508506109252266e-08
DM O 1 1.0
protein O 0 1.3384492092427536e-07
kinase O 0 1.0482629164698665e-07
gene O 0 7.507515498161865e-09
( O 0 6.866415214190624e-10
DMPK O 1 0.9999994039535522
) O 0 8.383673200107467e-10
is O 0 2.2344173733479522e-10
responsible O 0 8.221737735070178e-10
for O 0 2.091672390847066e-09
causing O 0 0.039750389754772186
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.17352792620658875
DM B-Disease 1 1.0
) O 0 3.7294086041583796e-07
. O 0 6.327404662442859e-07

Major O 0 0.0001142701439675875
instability O 0 2.996320517922868e-06
, O 0 5.080837528481652e-09
with O 0 6.462961277264867e-10
very O 0 4.664730823833452e-10
large O 0 3.3136449140158675e-09
expansions O 0 5.5347157967844396e-08
between O 0 1.0941694217336817e-09
generations O 0 8.997268485799736e-10
and O 0 1.808244387557778e-10
high O 0 5.8714113571056714e-09
levels O 0 2.055700276670791e-09
of O 0 5.331175501055441e-09
somatic O 0 2.072996920787773e-07
mosaicism O 0 6.854428647784516e-06
, O 0 6.35457908515491e-09
is O 0 2.25143637067049e-09
observed O 0 4.870914338539478e-09
in O 0 5.087809729076298e-09
patients O 0 2.9527607026125224e-08
. O 0 1.0945774420179077e-07

There O 0 7.568551296799342e-08
is O 0 5.580867767918107e-09
a O 0 8.523220462741676e-10
good O 0 1.5246596207774132e-09
correlation O 0 1.025280638167203e-09
between O 0 4.843609402449545e-10
repeat O 0 6.05407057818752e-09
size O 0 5.078163223259935e-09
( O 0 1.9972193343598121e-10
at O 0 2.5919411061892106e-09
least O 0 1.3332190906822916e-10
in O 0 2.705006774128549e-10
leucocytes O 0 1.037151150740101e-06
) O 0 1.5116351503863257e-09
, O 0 7.030694915144409e-10
clinical O 0 9.91842963316003e-09
severity O 0 4.23124788540008e-08
and O 0 4.531738539981234e-09
age O 0 3.446902852033418e-08
of O 0 6.278356323718981e-08
onset O 0 2.6242673811793793e-06
. O 0 5.455614768834494e-07

The O 0 2.773063670247211e-06
trinucleotide O 0 0.00016056250024121255
repeat O 0 1.4198657254382852e-06
instability O 0 5.920026637795672e-07
mechanisms O 0 1.4362230160713807e-07
involved O 0 5.683000736667054e-09
in O 0 7.919013000901032e-09
DM B-Disease 1 1.0
and O 0 9.800805145232516e-08
other O 0 1.907671176581971e-08
human O 0 2.352194172772215e-07
genetic B-Disease 1 1.0
diseases I-Disease 1 1.0
are O 0 1.7084761383401315e-09
unknown O 0 1.074282618418465e-08
. O 0 1.9505986159629174e-08

We O 0 8.95714080684229e-08
studied O 0 2.3306508012410632e-07
somatic O 0 1.1083103856890375e-07
instability O 0 1.4651417856725857e-08
by O 0 1.9644261217699466e-10
measuring O 0 4.480072277601721e-07
the O 0 3.9591814271489056e-08
CTG O 0 0.00016060676716733724
repeat O 0 1.3946044319368411e-08
length O 0 1.0669877203994815e-09
at O 0 1.5225178895406088e-09
several O 0 5.724806739770827e-10
ages O 0 4.856681168341481e-10
in O 0 5.6671046327894103e-11
various O 0 8.120637495778738e-10
tissues O 0 6.7364998024288525e-09
of O 0 8.445419474867322e-09
transgenic O 0 1.455949387718647e-07
mice O 0 3.810724180652869e-09
carrying O 0 1.5958803167848146e-09
a O 0 5.425444538076363e-10
( O 0 1.0078192724805035e-09
CTG O 0 5.950849299551919e-05
) O 0 2.8028559473369796e-09
55expansion O 0 3.460902462393278e-07
surrounded O 0 3.294764994166144e-08
by O 0 1.5557563570745003e-10
45 O 0 4.4519685715727064e-09
kb O 0 1.46237709941488e-07
of O 0 1.490029344353161e-08
the O 0 2.1424279239568023e-08
human O 0 2.1786587467431673e-07
DM B-Disease 1 1.0
region O 0 2.9460209134413162e-06
, O 0 3.328410436154172e-09
using O 0 2.3995416764677202e-09
small O 0 3.008254623182438e-08
- O 0 7.839408908694168e-07
pool O 0 4.1720900867403543e-07
PCR O 0 5.117408932164835e-07
. O 0 1.3795408904115902e-07

These O 0 1.290413962351522e-07
mice O 0 3.149041916117312e-08
have O 0 1.1829950907760178e-10
been O 0 7.062114087963423e-11
shown O 0 5.6774477480425745e-11
to O 0 6.317917716769372e-11
reproduce O 0 1.231179602712018e-09
the O 0 4.92994589595952e-10
intergenerational O 0 4.042568946260872e-09
and O 0 1.1666249077890711e-09
somatic O 0 3.1426935720446636e-08
instability O 0 2.9705431003890226e-08
of O 0 2.1144408890449995e-08
the O 0 3.051853525448678e-08
55 O 0 1.4542757753588376e-07
CTG O 0 0.00018309996812604368
repeat O 0 6.914588368545083e-08
suggesting O 0 3.3511513564121742e-09
that O 0 7.099375254338014e-11
surrounding O 0 3.943985138477046e-09
sequences O 0 4.73744821150035e-10
and O 0 3.924023606050042e-10
the O 0 7.810345148406839e-10
chromatin O 0 5.789044799087151e-09
environment O 0 1.1795192600416726e-09
are O 0 7.229669640729242e-11
involved O 0 2.0121160293484763e-10
in O 0 1.107979707981599e-09
instability O 0 4.545630929442268e-07
mechanisms O 0 9.364833886138513e-07
. O 0 6.102824841036636e-07

As O 0 7.239381005774703e-08
observed O 0 3.369109213835486e-09
in O 0 1.1452540304990322e-10
some O 0 6.036331157144303e-11
of O 0 8.113422711453211e-10
the O 0 1.2808689664467465e-09
tissues O 0 1.79944841249835e-08
of O 0 3.5957498312200187e-07
DM B-Disease 1 1.0
patients O 0 1.0204276890135588e-07
, O 0 1.4609573273371979e-10
there O 0 1.525170822969102e-10
is O 0 1.728614196228051e-10
a O 0 1.353896578182301e-10
tendency O 0 5.78289471864224e-10
for O 0 1.2010815952923082e-10
repeat O 0 2.3220896316900053e-09
length O 0 1.0842226005891575e-09
and O 0 1.9039516629959508e-09
somatic O 0 3.233757439602414e-08
mosaicism O 0 1.0452423282458767e-07
to O 0 1.4442341766951472e-10
increase O 0 4.9742703012167766e-11
with O 0 7.704638316230472e-11
the O 0 1.8805714763203696e-09
age O 0 4.363387429151544e-09
of O 0 7.563295767454292e-09
the O 0 2.7888322762237294e-08
mouse O 0 2.4583480353612686e-06
. O 0 5.306354182721407e-07

Furthermore O 0 5.959435043223493e-07
, O 0 1.3805247611742288e-08
we O 0 1.6385407475283387e-09
observed O 0 1.0880384371247942e-09
no O 0 3.636279055641012e-10
correlation O 0 1.9985417487600188e-10
between O 0 1.5194043245791988e-10
the O 0 2.7528199719739632e-09
somatic O 0 1.3775946605676381e-08
mutation O 0 8.62309723625998e-10
rate O 0 7.713832350653149e-10
and O 0 1.8223543785111929e-09
tissue O 0 1.3959676437025337e-07
proliferation O 0 2.9045744668110274e-05
capacity O 0 1.1879637895617634e-06
. O 0 4.587434148106695e-07

The O 0 1.1751205875043524e-06
somatic O 0 6.789285293962166e-07
mutation O 0 3.5893683580923152e-09
rates O 0 7.574220139971999e-10
in O 0 3.2659850518479416e-11
different O 0 1.9832640738015606e-11
tissues O 0 4.934838093717531e-10
were O 0 6.973623761785674e-11
also O 0 7.909524424309922e-11
not O 0 6.8530884092532496e-12
correlated O 0 1.8232608478552237e-10
to O 0 6.344726133367118e-11
the O 0 9.821812252397422e-10
relative O 0 1.7079221370508435e-09
inter O 0 2.7542350267140137e-07
- O 0 1.592391214444433e-07
tissue O 0 6.525716411687199e-09
difference O 0 8.237512894027077e-10
in O 0 1.4638016493373485e-11
transcriptional O 0 7.295621051728318e-11
levels O 0 1.697949697510026e-10
of O 0 2.575706037344361e-10
the O 0 3.1424149393721734e-10
three O 0 1.2575468444353533e-10
genes O 0 1.9610305046491305e-10
( O 0 2.1029279706485937e-10
DMAHP O 1 0.9999955892562866
, O 0 6.222133031030808e-09
DMPK O 1 0.993902325630188
and O 0 1.280405470538426e-08
59 O 0 7.060710061068676e-08
) O 0 1.2875486232744038e-09
surrounding O 0 1.2253963177499827e-07
the O 0 3.007508908581258e-08
repeat O 0 1.4449732077537192e-07
. O 0 1.684390760203769e-08
. O 0 2.8902204007863475e-07

A O 0 1.3015404874749947e-05
novel O 0 5.691600563295651e-06
missense O 0 1.6738656540837837e-06
mutation O 0 1.7290743059561464e-08
in O 0 9.174933035538402e-10
patients O 0 1.7347485670171636e-09
from O 0 3.3037478308628465e-10
a O 0 2.900163220687091e-09
retinoblastoma B-Disease 0 2.2672240902466e-06
pedigree O 0 2.81355994502519e-07
showing O 0 2.4442341484132157e-08
only O 0 1.5612326986769176e-09
mild O 0 1.0897071689441873e-07
expression O 0 3.7779472883414655e-09
of O 0 1.0024919561146817e-08
the O 0 4.721036717114657e-08
tumor B-Disease 0 3.691041638376191e-05
phenotype O 0 4.639836390651908e-07
. O 0 1.9205081969175808e-07

We O 0 1.7433096388685954e-07
have O 0 1.3663676856623397e-09
used O 0 1.982350950058276e-09
single O 0 1.319830245094522e-09
strand O 0 2.8857782830016276e-09
conformation O 0 7.081432662481291e-10
polymorphism O 0 1.8564859372016684e-10
analysis O 0 6.08683173308755e-11
to O 0 9.86950660086805e-11
study O 0 1.9156801145392421e-10
the O 0 2.779070029657049e-10
27 O 0 5.1667679024092195e-09
exons O 0 1.4480916910031283e-08
of O 0 1.1795738608100237e-08
the O 0 3.412767313193399e-08
RB1 O 0 0.0007842211634851992
gene O 0 6.5230248980086e-10
in O 0 1.4528209191233543e-10
individuals O 0 2.184871901456109e-11
from O 0 8.742863377708687e-11
a O 0 4.993817581677717e-10
family O 0 7.021127013118189e-10
showing O 0 1.0304255226856185e-08
mild O 0 4.5377828428172506e-07
expression O 0 6.729026225116286e-09
of O 0 2.7583611839077093e-08
the O 0 6.397498708565763e-08
retinoblastoma B-Disease 0 8.12895450508222e-05
phenotype O 0 9.240868621418485e-07
. O 0 2.1595405996777117e-07

In O 0 1.091864287872113e-08
this O 0 5.420169313374856e-10
family O 0 7.927939971175135e-10
affected O 0 7.721207562205734e-10
individuals O 0 1.64577743794192e-11
developed O 0 4.847604540003658e-09
unilateral B-Disease 0 0.43034669756889343
tumors I-Disease 1 1.0
and O 0 8.322422218043357e-08
, O 0 9.035653336653127e-10
as O 0 3.6689393190236785e-10
a O 0 2.052646941308467e-10
result O 0 5.412503778501332e-10
of O 0 2.5106148271447637e-09
linkage O 0 1.0917684534206273e-08
analysis O 0 1.5991407087412313e-09
, O 0 1.7775644289841352e-09
unaffected O 0 3.9937969376069304e-08
mutation O 0 1.0118216264842772e-09
carriers O 0 4.816156917719638e-10
were O 0 2.613858574029848e-10
also O 0 7.806234547658164e-10
identified O 0 1.21274401632121e-09
within O 0 1.6944241565397533e-09
the O 0 1.9277777596471424e-08
pedigree O 0 3.2513394216948655e-06
. O 0 6.246654606911761e-07

A O 0 3.0360902201209683e-06
single O 0 4.5007137572383726e-08
band O 0 8.617515590003677e-08
shift O 0 1.045943864852461e-08
using O 0 4.773123229995235e-09
SSCP O 1 0.9989492297172546
was O 0 8.376760263217875e-08
identified O 0 1.8131978141155969e-09
in O 0 1.2894876277869116e-09
exon O 0 1.9861674616095115e-07
21 O 0 2.8140529906295342e-08
which O 0 2.445775248993698e-10
resulted O 0 4.674495013290425e-09
in O 0 8.256813566198673e-10
a O 0 5.761429111572625e-09
missense O 0 1.29463444409339e-07
mutation O 0 7.2950299134788565e-09
converting O 0 6.34691375012153e-08
a O 0 1.830426654692019e-08
cys O 0 0.0003942917101085186
- O 0 7.701203685428482e-06
- O 0 1.763555928846472e-06
> O 0 5.997377883204535e-08
arg O 0 3.9766987924849673e-07
at O 0 1.6620512965914713e-08
nucleotide O 0 3.0133180395353065e-09
position O 0 4.183075219543753e-09
28 O 0 6.517904438396727e-09
in O 0 1.6475064645860016e-09
the O 0 8.997945855071521e-08
exon O 0 1.2681768566835672e-05
. O 0 1.8880896277551074e-06

The O 0 1.174965973405051e-06
mutation O 0 1.6395910051869578e-07
destroyed O 0 7.686521144023573e-07
an O 0 3.0092188296748645e-08
NdeI O 0 4.531249214778654e-05
restriction O 0 8.845400998325204e-07
enzyme O 0 8.796300932090162e-08
site O 0 5.093186246085679e-07
. O 0 3.4915277069558215e-07

Analysis O 0 1.2175423336202584e-08
of O 0 1.6901642752031876e-08
all O 0 6.099757920985382e-10
family O 0 1.8948140279029246e-10
members O 0 1.1466260232961822e-11
demonstrated O 0 9.302630193941397e-11
that O 0 4.23809910776729e-11
the O 0 3.7007508169040193e-09
missense O 0 1.3776725893421826e-07
mutation O 0 1.0088524682316802e-08
co O 0 1.2230048973549401e-08
- O 0 4.279344878455049e-08
segregated O 0 3.753555688490451e-09
with O 0 5.0665485695766677e-11
patients O 0 2.526350240117381e-10
with O 0 3.1722360849251174e-10
tumors B-Disease 1 1.0
or O 0 7.276939584244246e-08
who O 0 2.320902803276681e-09
, O 0 2.2946325395345468e-10
as O 0 2.7501317889644383e-10
a O 0 4.5096026912716525e-10
result O 0 1.4374851309284509e-09
of O 0 7.807877011600795e-09
linkage O 0 9.144469181876502e-09
analysis O 0 1.3287061451094928e-09
had O 0 2.1020307716668185e-09
been O 0 1.0000412720145846e-09
predicted O 0 2.980701019339449e-09
to O 0 1.2559030482250932e-09
carry O 0 6.168344501844558e-09
the O 0 3.954411553763748e-08
predisposing O 0 6.4295877564291e-06
mutation O 0 2.5972903472393227e-07
. O 0 2.0124987543113093e-07

These O 0 3.81484994704806e-08
observations O 0 4.708680023668421e-08
point O 0 2.4100739182131292e-08
to O 0 7.763323317533377e-10
another O 0 7.727822826097963e-10
region O 0 6.434698995860799e-09
of O 0 1.5829304089720608e-08
the O 0 4.536938646992894e-08
RB1 O 0 0.0012825672747567296
gene O 0 2.2914934394435704e-09
where O 0 1.3260275100179797e-09
mutations O 0 2.9836400017302367e-10
only O 0 3.4296957635016057e-11
modify O 0 1.182542175293122e-09
the O 0 1.9943872942018714e-10
function O 0 1.081004868952462e-10
of O 0 4.855847390849988e-10
the O 0 1.1633873864269617e-09
gene O 0 1.0347257772824747e-10
and O 0 2.959817113623586e-10
raise O 0 6.880813252507778e-09
important O 0 2.1319628284999226e-09
questions O 0 1.7237817839799163e-09
for O 0 1.9454024502429945e-10
genetic O 0 1.068800603576392e-09
counseling O 0 1.4937755199451175e-10
in O 0 1.4774619028212754e-11
families O 0 2.2122787542849798e-12
with O 0 2.4292970413064552e-11
these O 0 8.89465223696817e-10
distinctive O 0 7.688384329185283e-08
phenotypes O 0 1.3403690957147774e-07
. O 0 1.8018285530274625e-08
. O 0 2.3007535787655797e-07

Maternal B-Disease 0 5.433074329630472e-05
disomy I-Disease 0 0.0002653615374583751
and O 0 1.080079709936399e-05
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 2.3168013285612687e-06
with O 0 7.071259577884348e-09
gamete O 0 4.790061893800157e-07
complementation O 0 9.305443882112741e-07
in O 0 6.29109320193777e-10
a O 0 1.0911350711850787e-09
case O 0 3.6229816924304714e-09
of O 0 3.666074732677771e-08
familial O 0 4.5365320033852186e-07
translocation O 0 8.603326051570548e-08
( O 0 1.8036973303825476e-10
3 O 0 2.632582374317849e-09
; O 0 1.197028864918792e-10
15 O 0 1.6261586521792992e-09
) O 0 4.1697620356551113e-10
( O 0 5.209911391190758e-10
p25 O 0 3.374430264102557e-07
; O 0 1.0538311334684636e-09
q11 O 0 2.9222374564596976e-07
. O 0 8.520327776651015e-10
2 O 0 6.980300781833648e-08
) O 0 3.2050078146994565e-08
. O 0 2.590089991372224e-07

Maternal B-Disease 0 0.10894898325204849
uniparental I-Disease 1 1.0
disomy I-Disease 1 1.0
( I-Disease 0 1.368101584375836e-05
UPD I-Disease 1 1.0
) I-Disease 0 2.103291052435452e-08
for I-Disease 0 4.427783029115062e-09
chromosome I-Disease 0 2.0205250805815922e-08
15 I-Disease 0 2.0213952733882934e-09
is O 0 1.4034515216643229e-10
responsible O 0 2.2965679358222246e-10
for O 0 1.0318187970703718e-10
an O 0 8.536980844464637e-11
estimated O 0 1.7835338761429398e-10
30 O 0 5.787971213422338e-10
% O 0 2.6511078055069248e-11
of O 0 4.793024657723244e-11
cases O 0 1.530713750197421e-10
of O 0 3.9666343099042933e-08
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.952662261028308e-06
PWS B-Disease 1 1.0
) O 0 4.3578006625466514e-07
. O 0 5.642866085509013e-07

We O 0 5.7856368584907614e-08
report O 0 2.4466253467636534e-09
on O 0 4.068319015004818e-09
an O 0 3.313321006448433e-10
unusual O 0 1.2776456559393523e-09
case O 0 1.8507169130543843e-09
of O 0 2.1047920739647452e-08
maternal B-Disease 0 2.1707133157633507e-07
disomy I-Disease 0 2.2648451704299077e-05
15 I-Disease 0 3.243300739086408e-08
in O 0 4.926949515038359e-09
PWS B-Disease 1 1.0
that O 0 8.993854549999014e-10
is O 0 3.6581224160947556e-10
most O 0 4.961468735853458e-11
consistent O 0 2.920272357265219e-10
with O 0 3.174571022723782e-11
adjacent O 0 4.05033295791668e-09
- O 0 9.352079999302987e-09
1 O 0 1.13486118280548e-08
segregation O 0 1.8990782280070562e-08
of O 0 1.8465280415824736e-09
a O 0 4.150100541000512e-10
paternal O 0 7.115623645859159e-09
t O 0 1.9449581944996908e-09
( O 0 4.548333931708726e-11
3 O 0 1.3722546432504146e-09
; O 0 6.901270527270853e-11
15 O 0 1.1766991825368223e-09
) O 0 3.823193706065098e-10
( O 0 3.6005431969243773e-10
p25 O 0 1.463278209712371e-07
; O 0 3.2235439317851444e-10
q11 O 0 6.584519240959708e-08
. O 0 1.5805454167683308e-10
2 O 0 2.5003592529770913e-09
) O 0 2.0569894398914101e-10
with O 0 4.05418004723046e-10
simultaneous O 0 3.137076021175744e-08
maternal O 0 2.7906423838430783e-07
meiotic O 0 6.2294657254824415e-06
nondisjunction O 0 3.9781731175025925e-05
for O 0 7.821070369118388e-08
chromosome O 0 2.7844166083923483e-07
15 O 0 1.2862659559687017e-07
. O 0 1.746666100643779e-07

The O 0 7.969561579557194e-07
patient O 0 1.1936597843487107e-07
( O 0 5.949270520666516e-10
J O 0 1.1012974709956325e-07
. O 0 2.3793961245743844e-10
B O 0 1.4442602669362259e-08
. O 0 2.9063569259579758e-11
) O 0 3.4748461053002444e-11
, O 0 1.431454260680809e-10
a O 0 2.9977353932508777e-10
17 O 0 1.9559176500649755e-09
- O 0 2.574479518457906e-09
year O 0 2.758316075546219e-10
- O 0 1.143805672398912e-08
old O 0 1.8419560987581463e-08
white O 0 9.540749301706342e-10
male O 0 5.375774270177658e-10
with O 0 3.7298597543866663e-10
PWS B-Disease 1 1.0
, O 0 9.342701723369373e-09
was O 0 1.2757446654632076e-08
found O 0 2.8309324329178764e-10
to O 0 3.4718269925626544e-10
have O 0 2.9310420757155953e-10
47 O 0 3.7270453390192415e-09
chromosomes O 0 8.157860498236857e-11
with O 0 5.3688033185839146e-11
a O 0 1.2490611878135383e-09
supernumerary O 0 4.05437788231211e-07
, O 0 4.7807495739959904e-09
paternal O 0 1.88570936643373e-07
der O 1 0.9840714931488037
( O 0 6.406772889988588e-10
15 O 0 8.029183429236753e-10
) O 0 1.7058174317519104e-11
consisting O 0 5.6704241996330396e-11
of O 0 2.856032355058602e-10
the O 0 5.038949812963267e-10
short O 0 2.6547537501642182e-09
arm O 0 1.7679086639077468e-08
and O 0 1.9241144233461682e-09
the O 0 2.176871838344141e-08
proximal O 0 9.855890311882831e-06
long O 0 6.24103364543771e-08
arm O 0 1.905846147565171e-07
of O 0 7.013932190602645e-08
chromosome O 0 2.971892065772863e-08
15 O 0 6.9249197487408765e-09
, O 0 1.9593155986541433e-09
and O 0 2.784654640208828e-08
distal O 0 0.47550538182258606
chromosome O 0 8.769729174673557e-05
arm O 0 8.885152783477679e-05
3p O 0 0.0008935919613577425
. O 0 4.8292422434315085e-06

The O 0 5.090452646072663e-07
t O 0 3.6419049109781554e-08
( O 0 2.971990986644357e-10
3 O 0 1.6206779251959347e-09
; O 0 3.991963010152588e-11
15 O 0 3.7885963810602163e-10
) O 0 4.5702660406155005e-11
was O 0 7.729753503937786e-10
present O 0 7.597873025178004e-11
in O 0 3.83612065724126e-11
the O 0 4.82131334855751e-10
balanced O 0 2.710063951028019e-09
state O 0 2.338792493006281e-10
in O 0 1.3397040421470052e-10
the O 0 1.6697270233123618e-09
patients O 0 9.843117432239978e-10
father O 0 1.929608917095038e-09
and O 0 1.1695017398949403e-08
a O 0 7.014146063966109e-08
sister O 0 2.0656905235227896e-06
. O 0 1.2631066965695936e-06

Fluorescent O 0 1.838404750742484e-05
in O 0 8.92530138685288e-08
situ O 0 2.283171852468513e-06
hybridization O 0 8.528851402900273e-09
analysis O 0 6.457785972635577e-10
demonstrated O 0 4.930434949201867e-10
that O 0 8.017517899583382e-11
the O 0 5.832791138971061e-09
PWS B-Disease 1 1.0
critical O 0 1.898091454677342e-06
region O 0 1.4196002950939146e-07
resided O 0 6.500476246174003e-08
on O 0 1.0614590983948347e-08
the O 0 4.3050816245227e-09
derivative O 0 1.1731970950279447e-08
chromosome O 0 5.799263846917313e-10
3 O 0 5.923895263215684e-10
and O 0 7.142784280711467e-11
that O 0 2.2945352215475445e-11
there O 0 8.775173643282841e-11
was O 0 1.1988117165628864e-09
no O 0 5.729252627872938e-10
deletion O 0 2.1351735934871385e-09
of O 0 3.594561315267697e-09
the O 0 4.8468400848378224e-08
PWS B-Disease 1 1.0
region O 0 2.093737379027516e-07
on O 0 2.6777923878285037e-08
the O 0 7.37798133698675e-09
normal O 0 2.4894240002737433e-09
pair O 0 1.2901666401887724e-09
of O 0 3.6031486683185676e-09
15s O 0 3.4894841860477754e-07
present O 0 8.384684946349807e-09
in O 0 2.2242060637722716e-08
J O 0 0.0003715646162163466
. O 0 9.379143079968344e-07

B O 0 0.024119144305586815
. O 0 8.36764411360491e-06

Methylation O 0 3.0822883445580374e-07
analysis O 0 1.9525639771700298e-08
at O 0 2.8490873660302896e-08
exon O 0 7.072045349332257e-08
alpha O 0 1.326939003121197e-08
of O 0 9.495657593561191e-09
the O 0 3.135495418860046e-09
small O 0 5.435162098166302e-09
nuclear O 0 1.703216554460596e-07
ribonucleoprotein O 0 3.447067911110935e-07
- O 0 3.9890160508093686e-08
associated O 0 5.733792107776026e-09
polypeptide O 0 7.793313727688655e-08
N O 0 1.1949228451157978e-07
( O 0 9.659842925557882e-10
SNRPN O 1 0.9561625123023987
) O 0 1.6227503785160025e-09
gene O 0 7.952216107831589e-10
showed O 0 8.696134923269483e-10
a O 0 1.7268149410387679e-10
pattern O 0 7.311100613804911e-10
characteristic O 0 6.657725037939599e-09
of O 0 2.781760155556867e-09
only O 0 4.699488020953879e-10
the O 0 2.8683715402877397e-09
maternal O 0 2.1545496053931856e-08
chromosome O 0 2.723481173916298e-08
15 O 0 2.379271535346561e-08
in O 0 1.4087255806316534e-08
J O 0 0.0003255742194596678
. O 0 9.96370999928331e-07

B O 0 0.03625447675585747
. O 0 8.160615834640339e-06

Maternal B-Disease 0 0.0002484405704308301
disomy I-Disease 0 0.0005540617858059704
was O 0 3.417298444219341e-07
confirmed O 0 7.422867209783135e-09
by O 0 3.3751537675819065e-10
polymerase O 0 2.9065592155319564e-09
chain O 0 7.094658194262138e-09
reaction O 0 1.4254901425925226e-10
analysis O 0 1.8121457112663109e-10
of O 0 5.440036865422826e-09
microsatellite O 0 1.664098050468965e-07
repeats O 0 5.2375228598577905e-09
at O 0 5.26983923165858e-09
the O 0 5.854480455980138e-09
gamma O 0 2.2795312304424442e-07
- O 0 3.7028152632956335e-07
aminobutyric O 0 2.121358420481556e-06
acid O 0 1.9798200412424194e-08
receptor O 0 2.089598716281671e-09
beta3 O 0 3.863862332309509e-07
subunit O 0 3.568263906572611e-08
( O 0 8.501241488545475e-09
GABRB3 O 1 0.9511415362358093
) O 0 1.2249780922957143e-07
locus O 0 6.635075351368869e-06
. O 0 5.642725682264427e-07

A O 0 1.789307498256676e-05
niece O 0 3.7462662021425785e-06
( O 0 3.3950544597871612e-09
B O 0 1.086527632310208e-07
. O 0 1.1491356477488779e-10
B O 0 1.0233411451565644e-08
. O 0 1.7448580774681588e-11
) O 0 1.3968118328655521e-11
with O 0 7.044221456142807e-11
45 O 0 9.224310204558606e-10
chromosomes O 0 2.5702917225145505e-11
and O 0 7.115466549301175e-11
the O 0 2.4935570275275154e-10
derivative O 0 7.557495185217533e-10
3 O 0 2.40154118813507e-10
but O 0 2.2390663975691005e-11
without O 0 7.874616930747536e-11
the O 0 7.576025917721552e-10
der O 0 0.00012127435184083879
( O 0 6.62238708315499e-10
15 O 0 2.8966751219883236e-09
) O 0 2.818631994472298e-10
demonstrated O 0 1.4899319555894408e-09
a O 0 7.685151959258008e-10
phenotype O 0 1.5975065714712855e-09
consistent O 0 4.716441681651418e-10
with O 0 3.579915877627293e-11
that O 0 4.567102598884709e-11
reported O 0 5.125491697732798e-10
for O 0 1.1540960409561762e-09
haploinsufficiency O 0 4.6953405217209365e-06
of O 0 3.392283076664171e-07
distal O 0 0.0002448814921081066
3 O 0 2.130923530785367e-05
p O 0 1.977070724024088e-06
. O 0 2.6883145665124175e-07

Uniparental B-Disease 1 1.0
disomy I-Disease 1 1.0
associated O 0 2.3804477677913383e-07
with O 0 1.4604934150952431e-08
unbalanced O 0 9.645616501074983e-07
segregation O 0 2.9054035621811636e-07
of O 0 1.5679441389693238e-07
non O 0 2.152836532332003e-05
- O 0 7.816945981176104e-06
Robertsonian O 0 0.04231301322579384
translocations O 0 2.2962773016388383e-07
has O 0 1.921037773300327e-09
been O 0 2.9723257188862817e-10
reported O 0 2.1255099069694694e-10
previously O 0 1.3571419543723096e-09
but O 0 7.174229266215804e-11
has O 0 1.2411002781043123e-10
not O 0 4.6926424551729795e-11
, O 0 8.121159994489702e-11
to O 0 1.4886557264670586e-10
our O 0 1.8118287981039316e-09
knowledge O 0 3.568793260910752e-09
, O 0 9.905041231661471e-10
been O 0 1.3278650401460368e-09
observed O 0 1.3016205890892252e-09
in O 0 5.874208897083122e-10
a O 0 2.780258911982969e-09
case O 0 1.232157487152108e-08
of O 0 3.620321251673886e-07
PWS B-Disease 1 1.0
. O 0 9.132390005106572e-06

Furthermore O 0 1.965078581633861e-06
, O 0 3.033942519437005e-08
our O 0 4.619912008507754e-09
findings O 0 6.836045063352003e-10
are O 0 7.17663845017924e-11
best O 0 1.9294543740500103e-09
interpreted O 0 2.8732558554622756e-09
as O 0 2.209119775997692e-09
true O 0 1.2568238894061778e-08
gamete O 0 1.5721232671239704e-07
complementation O 0 5.959804525446089e-07
resulting O 0 2.802333476381591e-08
in O 0 1.0977340814122272e-08
maternal B-Disease 0 6.9597072069882415e-06
UPD I-Disease 1 1.0
15 I-Disease 0 2.557836523919832e-05
and O 0 9.095259883906692e-06
PWS B-Disease 1 1.0

Schwartz B-Disease 1 0.9999761581420898
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
type I-Disease 0 6.821620246455495e-08
2 I-Disease 0 8.966303255419916e-08
and O 0 6.055618229083848e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
: O 0 7.713817917753829e-10
a O 0 3.2008196093613606e-10
case O 0 6.436978727819564e-10
for O 0 5.485891740875104e-10
" O 0 1.2627686452049147e-08
lumping O 0 8.182024089364859e-07
" O 0 1.885916134369836e-07
. O 0 2.245549950430359e-07

Recent O 0 1.1371171382279499e-07
studies O 0 6.319683887312522e-09
demonstrated O 0 2.5192969932419373e-09
the O 0 9.707866732711068e-10
existence O 0 8.793709649346226e-10
of O 0 1.6717601747373578e-09
a O 0 7.370972721076896e-10
genetically O 0 3.317958352511141e-09
distinct O 0 3.0592986477451234e-10
, O 0 3.967082218281348e-11
usually O 0 3.757964425754601e-11
lethal O 0 1.7078496949984867e-10
form O 0 1.0681412351831732e-11
of O 0 2.788680675269717e-10
the O 0 8.658333494615533e-10
Schwartz B-Disease 0 0.0019943935330957174
- I-Disease 1 1.0
Jampel I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.649780726064591e-09
SJS B-Disease 1 1.0
) O 0 6.8239596195951435e-09
of O 0 1.4425290828512516e-07
myotonia B-Disease 1 1.0
and O 0 3.021123120561242e-06
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 6.513878325620226e-09
which O 0 8.780570159849788e-10
we O 0 2.735771831297029e-09
called O 0 3.9664829643015764e-08
SJS B-Disease 1 1.0
type I-Disease 0 8.651259122416377e-06
2 I-Disease 0 9.024316568684299e-06
. O 0 5.772095050815551e-07

This O 0 7.79912809889538e-08
disorder O 0 2.1423851649160497e-05
is O 0 2.6882562842445168e-09
reminiscent O 0 5.832727367760526e-08
of O 0 3.324604946897125e-08
another O 0 3.758211963855729e-09
rare O 0 7.632537268875694e-09
condition O 0 1.799623561282715e-08
, O 0 5.704848815568653e-10
the O 0 2.676453281225122e-09
Stuve B-Disease 1 1.0
- I-Disease 1 1.0
Wiedemann I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 6.652371098425647e-08
SWS B-Disease 1 1.0
) O 0 3.036552120860847e-09
, O 0 4.693862520888104e-10
which O 0 2.2678214861571178e-10
comprises O 0 6.755865200602784e-09
campomelia B-Disease 0 4.3376783764870197e-07
at O 0 6.256943407834115e-09
birth O 0 3.6405833903074836e-09
with O 0 1.7736357937891967e-09
skeletal B-Disease 1 1.0
dysplasia I-Disease 1 1.0
, O 0 2.0559841118483746e-07
contractures B-Disease 1 0.9999984502792358
, O 0 1.7794750561961337e-08
and O 0 1.3273668386659665e-08
early B-Disease 0 8.861437095220026e-08
death I-Disease 0 6.313884455266816e-07
. O 0 5.237905611465976e-07

To O 0 1.411374572768409e-08
test O 0 1.6394879898129489e-09
for O 0 3.3462893567204333e-10
possible O 0 5.995351326504306e-09
nosologic O 0 1.7066779491869966e-06
identity O 0 8.590707589739566e-10
between O 0 2.623723460715155e-10
these O 0 1.7508705596469554e-09
disorders O 0 7.190664632616972e-07
, O 0 2.4951840593701036e-10
we O 0 9.903410730371931e-11
reviewed O 0 7.490533748821804e-10
the O 0 4.3023132278996457e-10
literature O 0 2.274804927759888e-10
and O 0 8.901130527094736e-11
obtained O 0 1.7695531151495913e-10
a O 0 4.866414909932004e-11
follow O 0 9.921333893325723e-11
- O 0 6.488206638621818e-10
up O 0 5.587021401076697e-10
of O 0 3.439609430611057e-10
the O 0 1.632958351871494e-10
only O 0 3.0250395938180574e-11
two O 0 4.3656137732606126e-11
surviving O 0 3.972007611707795e-09
patients O 0 3.6150488158526173e-10
, O 0 1.4425106942272947e-10
one O 0 2.2183571646294808e-10
with O 0 7.047948336058596e-10
SJS B-Disease 1 0.9924654960632324
type I-Disease 0 4.170641076939319e-08
2 I-Disease 0 1.7475050739790277e-08
at O 0 2.1852408771394494e-09
age O 0 5.549519732639396e-10
10 O 0 7.60715379577448e-11
years O 0 4.5363868911296734e-11
and O 0 1.3539275256491123e-10
another O 0 5.312597028961363e-10
with O 0 1.2371444979564217e-09
SWS B-Disease 0 0.0003806753666140139
at O 0 1.9781147386765952e-07
age O 0 7.245693467439196e-08
7 O 0 6.75970852626051e-08
years O 0 3.954592742161367e-08
. O 0 2.669730463367159e-07

Patients O 0 1.4994425328040961e-06
reported O 0 1.0071625311525167e-08
as O 0 3.6125831215372273e-09
having O 0 1.1429595048184638e-08
either O 0 5.15039850768062e-08
neonatal O 1 1.0
SJS B-Disease 1 1.0
or O 0 2.104425584548153e-05
SWS B-Disease 1 0.9999970197677612
presented O 0 2.627221462603302e-08
a O 0 6.342115721480468e-10
combination O 0 2.072807481212635e-09
of O 0 4.289393729095536e-09
a O 0 2.5434183648087583e-09
severe O 0 2.414368054814986e-06
, O 0 2.965130141419081e-09
prenatal O 0 4.495249868341489e-06
- O 1 0.999748170375824
onset O 1 0.9999997615814209
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 1.6214987397233926e-07
with O 0 0.007871942594647408
congenital B-Disease 1 1.0
joint I-Disease 1 1.0
contractures I-Disease 1 1.0
, O 1 0.9112499356269836
respiratory O 1 1.0
and O 0 1.5492101113068202e-07
feeding O 0 0.0038114474155008793
difficulties O 0 8.906482435122598e-06
, O 0 1.1392675691723753e-09
tendency O 0 7.487109598969255e-09
to O 0 2.5435251682637272e-09
hyperthermia B-Disease 0 0.00020922454132232815
, O 0 1.0869950495262515e-09
and O 0 1.2734077126097532e-09
frequent O 0 1.3220128103341722e-08
death O 0 2.8806487861743335e-08
in O 0 1.2588313724748446e-09
infancy O 0 1.5088589933043295e-08
) O 0 1.089799153697335e-10
with O 0 1.5933825092684373e-10
a O 0 2.3924122682927873e-09
distinct O 0 4.377076479045172e-08
campomelic B-Disease 0 0.16089943051338196
- I-Disease 1 0.9998766183853149
metaphyseal I-Disease 1 0.9999973773956299
skeletal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 1.192605668620672e-05

The O 0 1.0831590202542429e-07
similarity O 0 5.404287506394212e-08
of O 0 2.2974814939402677e-08
the O 0 9.443495763150622e-09
clinical O 0 2.923932527210127e-07
and O 0 5.2486033297327594e-09
radiographic O 0 0.004394503775984049
findings O 0 3.97638331151029e-08
is O 0 6.699453214409345e-10
so O 0 3.890218355784292e-11
extensive O 0 2.6119510998512396e-09
that O 0 2.0834689529181105e-10
these O 0 1.5791300489453874e-09
disorders O 0 5.613693474515458e-07
appear O 0 6.562884680150205e-10
to O 0 4.3084966150352955e-10
be O 0 8.473571289080439e-10
a O 0 4.307143086634824e-09
single O 0 3.3278531930136523e-08
entity O 0 4.1806765693763737e-07
. O 0 4.251557470524858e-07

The O 0 1.6846566097683535e-07
follow O 0 1.6244294798184455e-08
- O 0 2.780122443368782e-08
up O 0 4.672872311317633e-09
observation O 0 9.282858925985238e-09
of O 0 1.6915115974569517e-09
an O 0 6.097393423498687e-11
identical O 0 2.2890984940904247e-10
and O 0 2.452586189694017e-10
unique O 0 5.35214039754095e-10
pattern O 0 6.251611228691445e-09
of O 0 8.941402285245204e-08
progressive O 1 1.0
bone B-Disease 1 1.0
dysplasia I-Disease 1 1.0
in O 0 4.311326851080821e-09
the O 0 1.9350496316405952e-08
two O 0 5.967806804285658e-10
patients O 0 5.536420766283356e-10
( O 0 2.1247590492601276e-11
one O 0 2.1672086347734876e-10
with O 0 6.27341900649725e-10
SJS B-Disease 1 1.0
type I-Disease 0 2.906151621573372e-07
2 I-Disease 0 1.3039276325343963e-07
, O 0 5.022196547521673e-10
one O 0 3.064788700601895e-10
with O 0 8.69580296658512e-10
SWS B-Disease 1 0.6287719011306763
) O 0 1.2806791183095356e-08
surviving O 0 2.1516713388791686e-07
beyond O 0 5.6248030233518875e-08
infancy O 0 5.21628784611039e-09
adds O 0 1.5022728894198423e-10
to O 0 4.6493794925162035e-11
the O 0 1.820578132694095e-10
evidence O 0 1.9830494191186432e-10
in O 0 1.1878585615132664e-10
favor O 0 7.417659375619223e-09
of O 0 2.2130260290964543e-08
identity O 0 3.8504794019900146e-08
. O 0 1.1428923585299344e-07

The O 0 2.2934563048693235e-07
hypothesis O 0 4.0871739770409476e-08
that O 0 2.503155682731517e-09
SWS B-Disease 1 0.9969214797019958
and O 0 2.2219550999125204e-07
SJS B-Disease 1 1.0
type I-Disease 0 2.034689714491833e-07
2 I-Disease 0 4.0255894617757804e-08
are O 0 5.904737115924874e-11
the O 0 4.965636790643657e-10
same O 0 1.1769124563798528e-09
disorder O 0 1.5525912999692082e-07
should O 0 7.036061178133934e-10
be O 0 3.463136721837401e-10
testable O 0 1.584283637612316e-08
by O 0 1.5969330025011885e-10
molecular O 0 6.080907777317179e-09
methods O 0 4.637781270133701e-09
. O 0 5.425240257039832e-09
. O 0 1.1552390333235962e-07

A O 0 4.440227712620981e-06
mouse O 0 2.9856815331186226e-07
model O 0 6.6311622859416275e-09
of O 0 1.5248030393877343e-08
severe O 1 0.9930141568183899
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.0005746731185354292
defects O 1 0.9999984502792358
in O 0 5.964444227402055e-08
hemostasis O 1 1.0
and O 0 5.626494385069236e-06
thrombosis B-Disease 0 0.007192241959273815
. O 0 1.1319092436679057e-06

von B-Disease 1 0.9979968667030334
Willebrand I-Disease 1 1.0
factor I-Disease 1 0.9948462247848511
( I-Disease 0 2.194043418057845e-06
vWf I-Disease 1 1.0
) I-Disease 0 0.42131370306015015
deficiency I-Disease 1 1.0
causes O 0 0.10721547156572342
severe O 1 1.0
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
in O 0 2.41629390984599e-06
humans O 0 4.524011671946937e-07
. O 0 1.665012234752794e-07

We O 0 1.2287173944969254e-07
generated O 0 1.3166327583746806e-08
a O 0 2.762935435995928e-09
mouse O 0 1.9993329658518633e-08
model O 0 5.111989165307307e-10
for O 0 1.7650832184745724e-10
this O 0 1.1269567223859411e-10
disease O 0 1.5490003724139e-09
by O 0 8.432533837865464e-11
using O 0 3.0716547083642354e-09
gene O 0 7.623705222670196e-09
targeting O 0 1.3023468170558772e-07
. O 0 2.947978430256626e-07

vWf B-Disease 0 0.0037006190977990627
- I-Disease 1 0.9540550112724304
deficient I-Disease 0 0.0003681729140225798
mice O 0 5.130054887558799e-07
appeared O 0 1.9786121185916272e-08
normal O 0 3.820090022088607e-09
at O 0 1.5830261546057045e-09
birth O 0 2.748463956425695e-10
; O 0 2.5634813716202132e-11
they O 0 7.194660839315858e-11
were O 0 3.6658753810314693e-10
viable O 0 2.0589386195979387e-08
and O 0 8.248585814385478e-09
fertile O 0 1.452375840926834e-06
. O 0 4.2379599562991643e-07

Neither O 0 6.0588914493564516e-05
vWf O 0 0.0010277340188622475
nor O 0 1.611054722161498e-05
vWf O 0 0.0004112468450330198
propolypeptide O 0 0.0001474853343097493
( O 0 1.1042970271546437e-07
von B-Disease 0 6.504460179712623e-05
Willebrand I-Disease 1 0.9853362441062927
antigen O 0 2.2086546778155025e-06
II O 1 1.0
) O 0 3.861597708265663e-09
were O 0 1.0662187799326261e-09
detectable O 0 7.107325217248217e-08
in O 0 3.3490030193483733e-10
plasma O 0 1.4692863814502743e-08
, O 0 3.6158073757341924e-10
platelets O 0 2.885524930107408e-09
, O 0 3.2049801701461433e-10
or O 0 6.88563789319474e-11
endothelial O 0 3.121601865885282e-10
cells O 0 3.4926141839752844e-11
of O 0 3.2045903708421974e-09
the O 0 1.9603632495091006e-08
homozygous O 0 2.4249035845969047e-07
mutant O 0 1.0837557056220248e-06
mice O 0 3.8308914440676745e-07
. O 0 8.761439573845564e-08

The O 0 1.7803174614527961e-06
mutant O 0 1.0604396265989635e-05
mice O 0 1.9034099523196346e-06
exhibited O 0 1.7925959809872438e-06
defects O 0 8.49453681439627e-06
in O 0 1.3435481616141942e-09
hemostasis O 0 1.2926503586641047e-05
with O 0 8.714532429010546e-10
a O 0 5.639699818260624e-09
highly O 0 1.4668511312265764e-06
prolonged O 0 0.0003306689905002713
bleeding O 1 0.9999912977218628
time O 0 5.9570286481402945e-09
and O 0 2.396935450121873e-08
spontaneous O 0 1.4565756600859459e-07
bleeding O 0 3.3502317364764167e-06
events O 0 2.05798333929863e-09
in O 0 2.27341256930913e-10
approximately O 0 2.7992269613363874e-10
10 O 0 7.657058875842893e-10
% O 0 4.038166467879023e-10
of O 0 8.275690355219467e-09
neonates O 0 1.3079595646559028e-06
. O 0 2.312667817250258e-07

As O 0 4.438413725438295e-08
in O 0 1.40410016946646e-09
the O 0 3.753870991829444e-09
human O 0 3.0579758725224337e-09
disease O 0 4.3630482338130605e-08
, O 0 1.875698762976441e-10
the O 0 1.1960117340947818e-09
factor O 0 6.282330655693613e-09
VIII O 0 5.873486225027591e-05
level O 0 3.311883745027444e-08
in O 0 3.2766064861355915e-10
these O 0 4.891711480325966e-10
mice O 0 4.0263472556034685e-09
was O 0 1.2518087677548806e-09
reduced O 0 1.889606915383979e-09
strongly O 0 4.0187728145291146e-10
as O 0 1.9610044144080518e-10
a O 0 8.189540018355146e-11
result O 0 1.5171601475127972e-10
of O 0 8.295077402742379e-10
the O 0 8.523123318227022e-10
lack O 0 6.351961623352054e-09
of O 0 5.517174272995362e-09
protection O 0 7.339414054285953e-08
provided O 0 3.151906735610055e-09
by O 0 8.836217979535377e-09
vWf O 0 0.00014209854998625815
. O 0 3.0117796541162534e-06

Defective O 1 0.9999996423721313
thrombosis B-Disease 0 7.435068255290389e-05
in O 0 3.8480273190089065e-08
mutant O 0 1.184807160825585e-06
mice O 0 6.235917027197502e-08
was O 0 6.818157149979243e-09
also O 0 8.488825753438789e-10
evident O 0 4.6364192485270905e-09
in O 0 1.0912343945124192e-10
an O 0 1.3180635749510117e-10
in O 0 4.35802033349475e-10
vivo O 0 5.442094774821271e-08
model O 0 7.907178911636947e-09
of O 0 2.38317809930777e-07
vascular B-Disease 1 1.0
injury I-Disease 1 1.0
. O 0 6.385578672052361e-06

In O 0 1.4932556524627216e-08
this O 0 6.299126220632445e-10
model O 0 1.417662875979886e-09
, O 0 9.460364713831382e-10
the O 0 5.285814896893726e-09
exteriorized O 0 3.541256091921241e-06
mesentery O 0 2.404299084446393e-05
was O 0 1.7483743874890934e-07
superfused O 0 3.921505594917107e-06
with O 0 1.865873677786567e-08
ferric O 0 3.152787758153863e-05
chloride O 0 1.4810846948876133e-07
and O 0 2.8769644444537334e-08
the O 0 3.3837039836726035e-08
accumulation O 0 3.706634288391797e-07
of O 0 2.046199938376958e-07
fluorescently O 0 1.2205159691802692e-05
labeled O 0 9.473985187469225e-07
platelets O 0 4.297388898066856e-07
was O 0 4.762767247257216e-08
observed O 0 3.081207289312715e-09
by O 0 1.981145247853533e-09
intravital O 0 6.944941560504958e-06
microscopy O 0 1.8057701822726813e-07
. O 0 6.315540304058231e-07

We O 0 1.8801821966007992e-07
conclude O 0 4.040334999899642e-08
that O 0 3.5462363601190816e-10
these O 0 1.514717573591895e-09
mice O 0 2.0720809956742414e-08
very O 0 5.760503185570087e-10
closely O 0 6.264430307822977e-09
mimic O 0 1.8978646039613523e-05
severe O 1 0.6430627107620239
human O 0 1.489152873546118e-05
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
and O 0 2.3723434594558057e-07
will O 0 8.426718212106721e-10
be O 0 9.410582035851434e-11
very O 0 2.296671880452905e-11
useful O 0 8.803438533711017e-11
for O 0 3.032410780812178e-11
investigating O 0 3.5639208251225796e-10
the O 0 6.730729862347573e-10
role O 0 2.8869893142768888e-09
of O 0 1.704714058803347e-08
vWf O 0 2.107115278704441e-06
in O 0 6.090309589978915e-09
normal O 0 2.8905777327281612e-08
physiology O 0 3.096651113310145e-08
and O 0 9.372486120540202e-10
in O 0 1.2722326525604899e-09
disease O 0 9.023089120319128e-08
models O 0 6.143570097094653e-09
. O 0 7.242512811700408e-09
. O 0 1.2989642073080176e-07

Oral O 0 0.0001950817386386916
contraceptives O 0 1.4486791769741103e-05
and O 0 1.4771822876014085e-08
the O 0 1.6686964698919837e-08
risk O 0 1.6508722637809115e-06
of O 0 9.731973841553554e-05
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.16643364992342e-06

Hereditary B-Disease 1 1.0
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 1.0
Clinical O 1 0.9999957084655762
Study O 0 5.57544353796402e-07
Group O 0 9.98303946175838e-08
. O 0 9.415280999292008e-08

BACKGROUND O 0 8.040429747779854e-06
Women O 0 2.368430784827069e-09
with O 0 9.153149765905866e-11
mutations O 0 2.2991406001260373e-10
in O 0 1.0953590812157188e-10
either O 0 6.888846715291663e-10
the O 0 4.76991068865118e-09
BRCA1 O 0 2.7325244289500006e-08
or O 0 1.0341857370477214e-09
the O 0 1.3940192999939427e-08
BRCA2 O 0 1.3029928425112303e-07
gene O 0 1.7484769188058635e-10
have O 0 2.2937039420578564e-11
a O 0 1.1635842983581668e-10
high O 0 4.510037143745649e-08
lifetime O 0 1.0523757509872667e-07
risk O 0 7.288460892596049e-07
of O 0 4.749214349430986e-05
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.2229160120114102e-06

Oral O 0 0.013479025103151798
contraceptives O 1 0.9821441173553467
protect O 1 0.7036013007164001
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.0714203685656685e-09
general O 0 1.507923230725794e-09
, O 0 1.4947187931824146e-10
but O 0 3.095489142790342e-11
it O 0 6.962631859952495e-11
is O 0 5.139958250688359e-11
not O 0 1.1826087852051526e-11
known O 0 9.923358662566883e-11
whether O 0 9.712936011041506e-11
they O 0 8.225310016429788e-11
also O 0 4.137186426778072e-10
protect O 0 1.0805276673409026e-08
against O 0 6.638656913082741e-08
hereditary B-Disease 1 0.9995855689048767
forms I-Disease 0 0.2892313003540039
of I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.3711533028981648e-06

METHODS O 0 1.9116471321467543e-06
We O 0 1.3965022915840564e-08
enrolled O 0 1.360475643252812e-08
207 O 0 2.9955078417742698e-09
women O 0 8.494555059357367e-11
with O 0 3.856283736780597e-09
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.5435236422334242e-09
161 O 0 9.364427011604448e-10
of O 0 1.070593946828069e-09
their O 0 9.626111019400696e-10
sisters O 0 1.030527663203884e-08
as O 0 8.631934611535996e-10
controls O 0 6.304733091155867e-08
in O 0 1.9410075768888646e-09
a O 0 5.043683248828756e-09
case O 0 1.375646263568342e-08
- O 0 9.825378128880402e-07
control O 0 8.325039857481897e-07
study O 0 1.2157501316778507e-07
. O 0 1.1824621282130465e-07

All O 0 9.594756278374916e-08
the O 0 1.7559147025281163e-08
patients O 0 1.9558354935611533e-09
carried O 0 6.924322226709023e-10
a O 0 1.747589989387066e-10
pathogenic O 0 3.6131067027156405e-09
mutation O 0 2.8976904209443433e-10
in O 0 2.231819035136695e-10
either O 0 5.856111151558707e-09
BRCA1 O 0 2.7820162173952667e-08
( O 0 1.1834509761055045e-10
179 O 0 2.987069480653304e-09
women O 0 1.92110181929106e-11
) O 0 9.293213421024404e-11
or O 0 2.8258519968460405e-09
BRCA2 O 0 6.139484867162537e-07
( O 0 7.682733338398862e-10
28 O 0 4.797248465138182e-08
women O 0 4.059999558769789e-10
) O 0 2.6723316892685034e-09
. O 0 7.051975359217977e-08

The O 0 2.436749753087497e-07
control O 0 1.78547821860775e-07
women O 0 1.8128960832530794e-10
were O 0 7.511676003435497e-11
enrolled O 0 3.5979275114783604e-10
regardless O 0 8.252731831248639e-11
of O 0 1.623034207032248e-10
whether O 0 9.1941988744626e-11
or O 0 8.297335735152345e-11
not O 0 5.403156047578683e-11
they O 0 2.2177648606458433e-10
had O 0 4.084202753773525e-09
either O 0 2.9965892878180966e-08
mutation O 0 6.569039356918438e-08
. O 0 1.8883798702518106e-07

Lifetime O 0 1.0872437087527942e-05
histories O 0 5.141212113812799e-07
of O 0 1.844804558004398e-07
oral O 0 6.58757187466108e-07
- O 0 1.4988019358952442e-07
contraceptive O 0 8.6625835393761e-09
use O 0 7.171287869089937e-11
were O 0 3.5925290520211206e-11
obtained O 0 2.0271846701280793e-11
by O 0 1.2774227856060527e-11
interview O 0 1.7433894328178212e-09
or O 0 1.0434679509341294e-10
by O 0 2.4221350619635373e-11
written O 0 1.2552246742014717e-10
questionnaire O 0 9.925497229668068e-11
and O 0 3.281026145218746e-11
were O 0 4.251182045278412e-11
compared O 0 5.608693023906319e-11
between O 0 6.177263561779611e-11
patients O 0 1.3910803065009247e-10
and O 0 1.9538808071484226e-10
control O 0 1.119750479006143e-07
women O 0 5.79247413923234e-11
, O 0 2.6483785650621705e-11
after O 0 9.663431166373471e-11
adjustment O 0 6.773710037322189e-09
for O 0 2.0011697854371846e-10
year O 0 4.064338310350024e-10
of O 0 4.966861588684424e-09
birth O 0 1.3456056713323505e-08
and O 0 2.2529926368974884e-08
parity O 0 1.9344613519933773e-06
. O 0 4.687076682330371e-07

RESULTS O 0 1.0050747505374602e-06
The O 0 3.273192916708467e-08
adjusted O 0 5.783187617680596e-08
odds O 0 3.486309907430041e-08
ratio O 0 2.6449198387012984e-08
for O 0 5.653046386555616e-08
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
associated O 0 4.3327907928158993e-10
with O 0 7.933366463763747e-11
any O 0 5.96507565564508e-10
past O 0 1.1478723527247325e-09
use O 0 3.1937030797735133e-10
of O 0 2.829810830107249e-09
oral O 0 1.8230616660730448e-07
contraceptives O 0 4.83568499021203e-07
was O 0 3.256895553249706e-08
0 O 0 6.512401995451e-08
. O 0 8.859662870008833e-08

5 O 0 9.530178886052454e-07
( O 0 1.1027831980925384e-08
95 O 0 1.6614116304936033e-07
percent O 0 1.4588897201406326e-08
confidence O 0 1.8417233293988033e-09
interval O 0 2.0288655200317862e-09
, O 0 1.652093739590299e-10
0 O 0 3.4135844151350625e-10
. O 0 3.8588254119842347e-11
3 O 0 6.151446574342856e-10
to O 0 1.903097540667531e-10
0 O 0 1.3426105782698983e-09
. O 0 5.111647771727235e-10
8 O 0 3.073267507147648e-08
) O 0 1.8043184724092498e-08
. O 0 2.1904212132994871e-07

The O 0 3.839054443233181e-07
risk O 0 9.772227116400245e-08
decreased O 0 2.20899343261749e-09
with O 0 5.2663470806457724e-11
increasing O 0 1.265120785909346e-09
duration O 0 2.9256648215181258e-09
of O 0 1.2495711132487486e-09
use O 0 9.53550904903011e-10
( O 0 5.519592560787601e-10
P O 0 3.626973210657525e-08
for O 0 3.91907950536563e-10
trend O 0 6.3836003150186116e-09
, O 0 2.528548481706139e-10
< O 0 1.2973424556861346e-09
0 O 0 3.490072120193588e-10
. O 0 5.6806975790024694e-11
001 O 0 2.0790276167304e-09
) O 0 9.05296410752543e-12
; O 0 3.2054170515799507e-12
use O 0 1.5960613039545102e-11
for O 0 2.3630857687306772e-11
six O 0 5.965072186198128e-11
or O 0 2.351162840807941e-11
more O 0 7.672782548207024e-12
years O 0 6.16355230742549e-11
was O 0 4.930030828020904e-10
associated O 0 1.1100436542177405e-10
with O 0 9.14969419674172e-11
a O 0 1.1084277939943377e-09
60 O 0 3.910501700232771e-09
percent O 0 1.6476195963122109e-09
reduction O 0 2.9231062015355747e-08
in O 0 7.483111907902185e-09
risk O 0 8.798983230917656e-07
. O 0 1.7941302132840065e-07

Oral O 0 7.57672096369788e-05
- O 0 1.6574979326833272e-06
contraceptive O 0 9.479067841766664e-08
use O 0 4.858137891972092e-09
protected O 1 0.9966276288032532
against O 1 1.0
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
both O 0 1.4707653150924926e-10
for O 0 5.771080141547813e-11
carriers O 0 9.459241723241973e-11
of O 0 6.440711852739867e-10
the O 0 5.6969682304952585e-09
BRCA1 O 0 2.8133445795219814e-08
mutation O 0 6.906791805150192e-10
( O 0 8.196102824209461e-11
odds O 0 2.199215920484221e-08
ratio O 0 1.2660719139745424e-09
, O 0 5.844143918798395e-11
0 O 0 1.4611774290518298e-10
. O 0 2.3458948325560947e-11
5 O 0 3.992955410758725e-10
; O 0 8.476994106665359e-11
95 O 0 7.549603608936195e-09
percent O 0 2.167209744996512e-09
confidence O 0 6.114271866586307e-10
interval O 0 7.322865647196863e-10
, O 0 1.0435834141286904e-10
0 O 0 1.6860476903524102e-10
. O 0 1.990434032872468e-11
3 O 0 1.6540832592504273e-10
to O 0 2.6166855141007694e-11
0 O 0 2.296760559516997e-10
. O 0 2.7101284758024313e-11
9 O 0 4.2609499262269424e-10
) O 0 1.2615485912859103e-11
and O 0 3.246248062027668e-11
for O 0 5.263686014833624e-11
carriers O 0 1.2137338356588145e-10
of O 0 2.1199886290901304e-09
the O 0 1.4650495039347788e-08
BRCA2 O 0 3.805834580816736e-07
mutation O 0 8.572620946445397e-10
( O 0 8.033039511357032e-11
odds O 0 1.2523012848930648e-08
ratio O 0 6.386203232899845e-10
, O 0 3.5867982195458836e-11
0 O 0 1.1665954313677673e-10
. O 0 2.2381442185692713e-11
4 O 0 9.722875837780975e-10
; O 0 1.0709325093394284e-10
95 O 0 1.0950489404137898e-08
percent O 0 3.9391507833386186e-09
confidence O 0 9.495472186316078e-10
interval O 0 8.443579169181703e-10
, O 0 9.364457820293381e-11
0 O 0 2.3297722084869577e-10
. O 0 4.260590144578025e-11
2 O 0 5.546503811793002e-10
to O 0 1.7598927870565717e-10
1 O 0 2.557564826588532e-09
. O 0 5.225326837887678e-10
1 O 0 5.111341039309991e-08
) O 0 2.6657302143462402e-08
. O 0 1.994153961959455e-07

CONCLUSIONS O 0 2.1130974346306175e-05
Oral O 0 3.0253553632064722e-05
- O 0 1.0122527100975276e-06
contraceptive O 0 4.185319824046019e-08
use O 0 1.9575886744949145e-10
may O 0 1.5511217310582026e-11
reduce O 0 7.112512245832647e-10
the O 0 6.535902374871227e-10
risk O 0 6.840121358209217e-08
of O 0 0.02433081343770027
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 1.5603038860945162e-09
women O 0 1.8269290594230547e-11
with O 0 5.625639277334615e-12
pathogenic O 0 1.5224975724592582e-09
mutations O 0 4.141118281619782e-10
in O 0 2.450752933924605e-10
the O 0 2.044365743358867e-08
BRCA1 O 0 1.1352821047694306e-06
or O 0 3.012205240793264e-07
BRCA2 O 0 6.125889194663614e-05
gene O 0 4.991184141545091e-06

A O 0 3.6860899399471236e-06
Japanese O 0 6.390047246895847e-07
family O 0 1.8707272175788603e-08
with O 0 2.171066881828665e-08
adrenoleukodystrophy B-Disease 1 1.0
with O 0 4.6926228236543466e-08
a O 0 3.9841115295757845e-08
codon O 0 6.587445966488303e-08
291 O 0 1.3438307355784218e-08
deletion O 0 7.279823410755171e-09
: O 0 1.9527035544086857e-10
a O 0 2.7016708314953064e-10
clinical O 0 2.6587077428530392e-08
, O 0 3.603002340923922e-10
biochemical O 0 1.3904132067921182e-08
, O 0 1.3538171694804646e-09
pathological O 0 1.455563619856548e-06
, O 0 1.6059629182052504e-09
and O 0 6.8220078475178525e-09
genetic O 0 7.859757999995054e-08
report O 0 1.729836363040249e-08
. O 0 1.97681515601289e-07

We O 0 4.604255821050174e-08
report O 0 3.946498239315588e-09
a O 0 7.292410564296858e-10
Japanese O 0 1.739172184045401e-08
family O 0 1.730511955955194e-09
with O 0 2.889657224613984e-08
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.0001823233178583905
ALD B-Disease 1 1.0
) O 0 3.3265699084239486e-09
with O 0 5.240498035519181e-10
a O 0 1.4729922837020126e-09
three O 0 4.6018894250821063e-10
base O 0 2.010736999125129e-08
pair O 0 1.2876892441227028e-08
deletion O 0 3.669586945420633e-08
( O 0 1.2522720638230567e-09
delGAG O 0 7.162220754253212e-07
291 O 0 1.0041146580874738e-08
) O 0 2.1455498488975877e-10
in O 0 8.383465588401862e-10
the O 0 8.017346431188344e-08
ALD B-Disease 1 1.0
gene O 0 1.3238721976449597e-06
. O 0 5.956832751508045e-07

A O 0 4.610829478224332e-07
variety O 0 5.120660162560853e-08
of O 0 2.6559403565329376e-08
phenotypes O 0 4.133073261414211e-08
were O 0 1.0409657580368048e-09
observed O 0 1.698216234302663e-09
within O 0 4.5275894144936046e-10
this O 0 2.7288546422532534e-10
family O 0 1.209069999674739e-08
. O 0 1.7230898663456173e-07

While O 0 1.435000456240232e-07
the O 0 4.419027632707184e-08
proband O 0 3.160334381391294e-05
( O 0 3.5265561582065175e-09
patient O 0 8.04012945110344e-09
1 O 0 2.1429837460118506e-08
) O 0 4.487012150722336e-10
was O 0 3.45481265817682e-09
classified O 0 7.97582622169557e-09
as O 0 8.442098131666853e-10
having O 0 1.2549404848627432e-09
a O 0 5.256786117513457e-10
rare O 0 3.03666225498489e-09
intermediate O 0 7.766736587200285e-08
type O 0 5.6615356847089515e-09
of O 0 2.639879603805184e-08
adult O 0 5.371325073610933e-07
cerebral O 0 2.449214093758201e-07
and O 0 1.3079075600330725e-08
cerebello O 1 0.9999973773956299
- O 0 0.026128370314836502
brain O 0 2.8308335231486126e-07
stem O 0 6.096759985751987e-09
forms O 0 2.9935987022611243e-10
, O 0 3.461008910021768e-11
his O 0 1.101586488694295e-09
younger O 0 5.900240740430718e-09
brother O 0 8.481611857291682e-09
( O 0 3.0277655382882074e-10
patient O 0 1.0916846315822681e-09
2 O 0 5.5010342947525714e-09
) O 0 4.995923119643919e-10
and O 0 8.594629008484844e-09
nephew O 0 2.7531684736459283e-06
( O 0 2.2187391923722544e-09
patient O 0 1.0360539093312582e-08
3 O 0 1.9497431225090622e-08
) O 0 1.4797421066248262e-09
had O 0 8.002584372945876e-09
a O 0 3.474811904879971e-08
childhood O 0 0.00026076732319779694
ALD B-Disease 1 1.0
type O 0 0.00020790014241356403
. O 0 7.754944704174704e-07

Another O 0 4.045049536216538e-06
nephew O 0 1.893645094241947e-05
( O 0 1.9806549289569375e-08
patient O 0 3.886249189122282e-08
4 O 0 1.8185810191084784e-08
) O 0 5.408871128764758e-10
of O 0 6.5627885348362724e-09
patient O 0 6.09139005902648e-09
1 O 0 1.9910901372099943e-08
was O 0 6.884397052431268e-09
classified O 0 1.2565554818877445e-08
as O 0 2.894250616947147e-09
having O 0 6.955338971437186e-09
an O 0 3.3452889347529435e-09
adolescent O 0 7.420555903081549e-07
form O 0 3.378312740665024e-08
. O 0 1.9734756051548175e-07

The O 0 6.614452559006168e-07
tau O 0 6.12723624726641e-07
level O 0 2.587793090924606e-08
in O 0 1.1693539470059022e-09
the O 0 3.214092458847517e-08
cerebrospinal O 0 9.093647008739936e-07
fluid O 0 6.074836278457951e-07
( O 0 1.24086483310748e-08
CSF O 1 1.0
) O 0 5.554168791555014e-10
in O 0 1.1723838566624067e-10
patient O 0 1.3210694760346087e-09
1 O 0 3.818676930222864e-09
was O 0 3.4019578265542805e-09
as O 0 3.223728228807232e-10
high O 0 1.3079324290288241e-08
as O 0 1.2151746275890218e-10
that O 0 1.5074242201706944e-11
of O 0 7.315034133981158e-10
patients O 0 9.803713396649982e-10
with O 0 4.113787088755316e-09
Alzheimers B-Disease 1 1.0
disease I-Disease 1 1.0
( O 0 4.470714909388107e-09
AD B-Disease 0 1.8132749346477794e-06
) O 0 2.350242844784134e-08
. O 0 1.4745256748938118e-07

His O 0 3.213350646547042e-05
brain O 0 2.5549306883476675e-05
magnetic O 0 4.039711711811833e-07
resonance O 0 2.2222708651042922e-07
image O 0 7.422402745760337e-07
( O 0 3.422125915975016e-09
MRI O 1 0.9999618530273438
) O 0 1.0681301398918208e-09
showed O 0 3.106256141194308e-09
abnormalities B-Disease 0 5.969656768911591e-08
in I-Disease 0 1.5704545996975128e-10
the I-Disease 0 3.863491304656463e-09
bilateral I-Disease 0 5.534492083825171e-05
cerebellar I-Disease 1 1.0
hemispheres I-Disease 0 0.0005259682075120509
and O 0 7.983668126598786e-08
brain O 0 9.221853360941168e-07
stem O 0 1.3363111506237146e-08
, O 0 8.272226653671666e-11
but O 0 1.4322291616575278e-11
not O 0 1.3453623631809464e-11
in O 0 4.3521040937744004e-11
the O 0 1.6521701784455445e-09
cerebral O 0 3.4668545367821935e-08
white O 0 2.850732760961705e-09
matter O 0 2.4833821665737332e-09
, O 0 9.464186379037898e-11
where O 0 9.789825200501312e-11
marked O 0 2.998364334594328e-10
reductions O 0 6.853451584021286e-09
of O 0 3.3907703311797377e-09
the O 0 5.331012520315426e-09
cerebral O 0 5.9322232459635416e-08
blood O 0 3.882942856137106e-09
flow O 0 7.232629162245985e-09
and O 0 1.9375601123527986e-09
oxygen O 0 1.294494955672576e-09
metabolism O 0 1.6026643345767866e-09
were O 0 3.0770067049878946e-10
clearly O 0 1.1214166262263348e-09
demonstrated O 0 9.620935159659894e-10
by O 0 3.2244601433362163e-10
positron O 0 3.111900639396481e-07
emission O 0 1.730891085571784e-06
tomography O 0 4.1677077433632803e-07
( O 0 1.1519413867233652e-08
PET O 0 0.00023327794042415917
) O 0 2.3997076326054412e-08
. O 0 1.748462779005422e-07

In O 0 3.214264054918203e-08
patients O 0 6.461608581531664e-09
2 O 0 7.275715141474848e-09
and O 0 6.890659709490876e-10
3 O 0 1.555879691750306e-08
, O 0 6.695722865046605e-10
the O 0 1.1489083018290103e-09
autopsy O 0 3.038853790826579e-08
findings O 0 1.2745910993317011e-09
showed O 0 3.916391211333803e-09
massive O 0 1.1864534599226317e-06
demyelination B-Disease 1 1.0
of I-Disease 1 0.9973854422569275
the I-Disease 0 1.7659120885582524e-06
cerebral I-Disease 0 3.608432734836242e-07
white I-Disease 0 2.529697562536626e-09
matter I-Disease 0 8.27642898659775e-10
with O 0 4.8386118028931335e-11
sparing O 0 8.638279425099427e-09
of O 0 1.735745769337882e-08
the O 0 3.2622605061760623e-08
U O 0 3.130742334178649e-05
- O 0 2.393081103946315e-06
fibers O 0 1.9719441013421601e-07
, O 0 1.1777612218821787e-09
compatible O 0 4.272834530638647e-09
with O 0 1.991042469784432e-10
the O 0 3.3748721595117104e-09
findings O 0 4.420188659537416e-09
of O 0 7.028783954865503e-08
childhood O 0 0.14156819880008698
ALD B-Disease 1 1.0
. O 0 8.603253263572697e-06

Oleic O 0 0.004918154329061508
and O 0 1.0772330369945848e-06
erucic O 0 0.0020998530089855194
acids O 0 2.54704218605184e-07
( O 0 2.977144086813155e-09
Lorenzos O 0 2.481878709659213e-06
Oil O 0 3.502258749676912e-08
) O 0 3.145653182379249e-10
were O 0 1.1657480536442222e-10
administered O 0 2.0963000779694596e-10
to O 0 5.50328532744615e-11
patients O 0 8.925578331986372e-11
1 O 0 6.248150330456781e-10
and O 0 2.990539760272526e-10
4 O 0 4.593736058211562e-09
, O 0 1.6045537121200937e-10
but O 0 5.832317961917965e-11
sufficient O 0 6.799037999272173e-10
effectiveness O 0 4.090205507623068e-09
was O 0 8.288455255467397e-09
not O 0 7.827256620629441e-10
obtained O 0 1.2699035600860498e-08
. O 0 1.53930187707374e-07

The O 0 3.618798700699699e-07
findings O 0 1.2179858011052147e-08
in O 0 6.826924026093195e-10
this O 0 2.9512259303032806e-10
family O 0 4.666777519979348e-10
suggest O 0 3.220391175950965e-10
that O 0 4.3307562397343347e-11
delGAG291 O 0 5.786673895613603e-08
is O 0 3.009904547823794e-10
part O 0 1.4398011671801214e-09
of O 0 5.320387685969763e-09
the O 0 5.306513450875627e-09
cause O 0 8.308667531764513e-09
of O 0 3.5940146858592925e-08
Japanese O 0 7.504464065277716e-06
ALD B-Disease 1 1.0
with O 0 1.1599738769518808e-07
phenotypic O 0 2.6521078325458802e-05
variations O 0 3.5828561522066593e-06
. O 0 3.0764704206376337e-07

Moreover O 0 2.654851982697437e-07
, O 0 3.2589568821350667e-09
although O 0 2.7692070858620355e-10
the O 0 3.4706354457014754e-10
scale O 0 8.849171173608283e-09
of O 0 4.564050914979134e-09
the O 0 1.799118298784208e-09
study O 0 3.9079200986336105e-10
is O 0 1.1094298396630009e-10
limited O 0 7.343440855400729e-10
, O 0 2.272281113269159e-10
there O 0 3.5858216396178477e-10
is O 0 6.647520311986455e-10
a O 0 1.0332117383882178e-09
possibility O 0 7.054824280317007e-09
that O 0 8.646715010662831e-10
PET O 0 0.00015100679593160748
can O 0 2.156793410534874e-09
detect O 0 5.902607469465693e-08
an O 0 5.280625270387418e-09
insidious B-Disease 0 6.9172588155197445e-06
lesion I-Disease 0 0.0003808826731983572
which O 0 6.8401702080223e-09
is O 0 2.6067650260586106e-09
undetectable O 0 1.0325369004249296e-07
by O 0 1.9941209794538395e-10
computed O 0 3.5408465492992036e-08
tomogram O 0 1.4591031685995404e-05
( O 0 7.283045277972633e-09
CT O 0 0.16223300993442535
) O 0 2.068486715245399e-09
or O 0 3.022353478598916e-10
MRI O 0 1.443602712924985e-07
analysis O 0 2.2300829238819375e-10
, O 0 7.475230157094614e-11
and O 0 8.790686234494416e-11
that O 0 3.284989988361353e-11
the O 0 3.0168015308085216e-10
higher O 0 6.108688554995467e-10
level O 0 1.8129763246221842e-09
of O 0 1.8837700288543147e-09
tau O 0 4.5092974687577225e-08
reflects O 0 1.0116691928629962e-09
the O 0 5.392410407090154e-10
process O 0 6.617172365608326e-10
of O 0 1.083689671332877e-08
neuronal B-Disease 0 8.486763363180216e-06
degeneration I-Disease 1 1.0
in O 0 0.00015956144488882273
ALD B-Disease 1 1.0
. O 0 6.0132286307634786e-05

Lorenzos O 0 9.435719402972609e-05
Oil O 0 1.4511364554437023e-07
should O 0 4.801729014403122e-10
be O 0 2.9626735092991296e-11
given O 0 1.2978287715348369e-11
in O 0 2.4550842261938932e-11
the O 0 5.112886225511204e-10
early O 0 1.7203001245746918e-09
stage O 0 5.300578465039507e-08
. O 0 1.6100123900741892e-08
. O 0 2.2651310871424357e-07

Nonsense O 0 1.5916359188850038e-05
mutation O 0 6.046906264600693e-08
in O 0 2.5347690613131135e-09
exon O 0 2.336635134270182e-07
4 O 0 9.725147265271517e-08
of O 0 2.525769637884423e-08
human O 0 5.5224806949638605e-09
complement O 0 6.570957111762254e-08
C9 O 1 0.99998939037323
gene O 0 1.1142235578631698e-08
is O 0 8.24208645777702e-10
the O 0 1.1029867019729522e-09
major O 0 1.9073402413027907e-08
cause O 0 1.1873932059813797e-08
of O 0 2.8237845839385045e-08
Japanese O 0 8.726796636437939e-07
complement B-Disease 0 6.997735454206122e-06
C9 I-Disease 1 1.0
deficiency I-Disease 1 0.9997069239616394
. O 0 1.577865305080195e-06

Deficiency B-Disease 1 0.999904990196228
of I-Disease 0 2.7208907340536825e-06
the I-Disease 0 2.143065955806378e-07
ninth I-Disease 0 2.1918798154274555e-07
component I-Disease 0 7.155789916168942e-08
of I-Disease 0 2.313267266629282e-08
human I-Disease 0 2.076083527313699e-09
complement I-Disease 0 2.958691247556544e-08
( O 0 2.742966742630415e-09
C9 O 1 1.0
) O 0 9.5536056843315e-10
is O 0 9.481206791894792e-11
the O 0 8.653772143318861e-11
most O 0 5.029901495312572e-11
common O 0 7.687291914137973e-10
complement B-Disease 1 0.9999988079071045
deficiency I-Disease 1 1.0
in O 0 8.188575373324625e-10
Japan O 0 1.3645739649348343e-08
but O 0 4.1838310593789174e-10
is O 0 4.777920836751548e-10
rare O 0 6.670433094768669e-10
in O 0 1.6919721179675662e-10
other O 0 1.214609857136395e-09
countries O 0 8.101361248513683e-10
. O 0 1.1981636305335996e-07

We O 0 1.0687750062743362e-07
studied O 0 7.926858813789295e-08
the O 0 2.692417622185417e-09
molecular O 0 2.667605691897279e-09
basis O 0 1.0878267175939982e-09
of O 0 2.7173429728577503e-08
C9 B-Disease 1 1.0
deficiency I-Disease 1 0.9999359846115112
in O 0 7.491252063118736e-09
four O 0 3.322556008100719e-09
Japanese O 0 1.5155484334172797e-07
C9 B-Disease 1 1.0
- I-Disease 1 0.999980092048645
deficient I-Disease 0 0.42046940326690674
patients O 0 1.0154417395824566e-07
who O 0 5.611994424725708e-09
had O 0 3.636643342019852e-08
suffered O 0 7.89383102528518e-06
from O 0 1.402561053964746e-07
meningococcal B-Disease 1 1.0
meningitis I-Disease 1 1.0
. O 0 9.371007081426797e-07

Direct O 0 2.990172447425721e-07
sequencing O 0 1.6447938833152875e-07
of O 0 2.0303768621943163e-07
amplified O 0 1.5436561398018966e-06
C9 O 0 0.0001483261730754748
cDNA O 0 6.938500973774353e-08
and O 0 6.597175694622592e-09
DNA O 0 1.720681730432716e-08
revealed O 0 7.177411998071648e-09
a O 0 1.2537083593500142e-09
nonsense O 0 2.3750139632738865e-08
substitution O 0 1.2513129199476225e-08
( O 0 2.5952553439623216e-09
CGA O 0 1.6840278476593085e-05
- O 0 7.99877852841746e-06
- O 0 3.2709858714952134e-06
> O 0 3.826042984655942e-07
TGA O 0 8.452806468994822e-06
) O 0 1.732510024332612e-09
at O 0 8.399555717630847e-09
codon O 0 1.510981562091729e-08
95 O 0 8.608361135031828e-09
in O 0 3.2176714070963897e-10
exon O 0 3.8231387833320696e-08
4 O 0 1.1978637637355405e-08
in O 0 6.412604891536944e-10
the O 0 5.6158704353492794e-09
four O 0 7.455558836966247e-09
C9 B-Disease 1 0.9999983310699463
- I-Disease 0 5.27203555975575e-05
deficient I-Disease 0 2.744847506619408e-06
individuals O 0 5.840706585047428e-09
. O 0 6.432713206550034e-08

An O 0 9.84134160830763e-08
allele O 0 3.4933655967961386e-08
- O 0 6.105373984155449e-08
specific O 0 7.67212071650647e-09
polymerase O 0 5.215611054154579e-09
chain O 0 1.1519281528649117e-08
reaction O 0 2.0894859453779446e-10
system O 0 5.656805579512536e-10
designed O 0 2.7905711075248973e-09
to O 0 4.783246021489163e-10
detect O 0 3.136643833556718e-09
exclusively O 0 1.5305394729381305e-09
only O 0 4.220135005339465e-11
one O 0 3.956246788505702e-11
of O 0 6.388408135826751e-10
the O 0 6.044041378494569e-10
normal O 0 1.0641586500881317e-09
and O 0 4.898629835103918e-10
mutant O 0 1.0373034875499343e-08
alleles O 0 4.480689430597096e-11
indicated O 0 2.6562248928163612e-11
that O 0 4.584792181322461e-12
all O 0 3.877920554118397e-11
the O 0 8.520518318677617e-11
four O 0 5.665515973030111e-11
patients O 0 3.551751601160724e-11
were O 0 3.268471604478407e-11
homozygous O 0 4.0139541690464853e-10
for O 0 1.0810791151172339e-10
the O 0 9.716016879934841e-10
mutation O 0 7.361274784178917e-11
in O 0 1.094102031196087e-10
exon O 0 1.3736850767998021e-08
4 O 0 4.9903254861760615e-09
and O 0 2.878103033676638e-10
that O 0 2.954609473748704e-11
the O 0 3.360289824172469e-10
parents O 0 6.93704885201818e-11
of O 0 8.214401936434967e-10
patient O 0 1.3638602469612238e-09
2 O 0 1.7931718332420132e-08
were O 0 1.0706660447112881e-08
heterozygous O 0 1.1022053314491131e-07
. O 0 8.998031120199812e-08

The O 0 6.55080953038123e-07
common O 0 6.071186930967087e-08
mutation O 0 1.3392505771037122e-08
at O 0 2.0446035975396626e-08
codon O 0 5.100492117549038e-08
95 O 0 2.239283247718049e-08
in O 0 1.1789704768006004e-09
exon O 0 9.124941868776659e-08
4 O 0 1.993803522282178e-08
might O 0 4.3713571651338157e-10
be O 0 4.798091784996572e-11
responsible O 0 2.757490347171654e-10
for O 0 1.5778857387349632e-10
most O 0 1.5281184095883305e-09
Japanese O 0 5.686516146852227e-07
C9 B-Disease 1 1.0
deficiency I-Disease 0 0.007375488989055157
. O 0 8.091469538840101e-08
. O 0 3.596401541017258e-07

BRCA1 O 0 1.6129649793583667e-06
required O 0 1.410429995019058e-08
for O 0 3.184374097742193e-09
transcription O 0 2.3099808288407075e-07
- O 0 6.897319053678075e-07
coupled O 0 8.313378430102603e-08
repair O 0 3.6453036500461167e-07
of O 0 2.1368049374359543e-07
oxidative O 0 8.299292630908894e-07
DNA O 0 2.512562105039251e-06
damage O 0 0.0002688847598619759
. O 0 1.2941570730617968e-06

The O 0 6.653483069385402e-06
breast B-Disease 1 1.0
and I-Disease 1 0.9999995231628418
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
susceptibility O 0 4.286450348445214e-05
gene O 0 1.1960698031998618e-07
BRCA1 O 0 5.979308639325609e-07
encodes O 0 3.088793576466742e-08
a O 0 6.5553069639179284e-09
zinc O 0 1.472405301683466e-06
finger O 0 7.39934819193877e-07
protein O 0 9.218440233382807e-09
of O 0 1.7162633980660758e-08
unknown O 0 2.0885158491523725e-08
function O 0 9.391440514150418e-09
. O 0 4.599445802000446e-08

Association O 0 1.8688125180688075e-07
of O 0 2.0673682854521758e-07
the O 0 3.8551679182319276e-08
BRCA1 O 0 1.596794518832212e-08
protein O 0 2.757727102231655e-10
with O 0 4.700238462329587e-11
the O 0 1.5080757753693774e-09
DNA O 0 3.176160667806016e-09
repair O 0 2.152857092596605e-08
protein O 0 2.9878617358036763e-09
Rad51 O 0 1.6876796848919184e-07
and O 0 1.3335325066421433e-09
changes O 0 5.87640491822583e-10
in O 0 6.644600841765325e-11
the O 0 2.397559373257252e-10
phosphorylation O 0 7.804593082916256e-11
and O 0 2.242516727868349e-10
cellular O 0 3.1327918037504787e-10
localization O 0 5.373449685208698e-09
of O 0 5.892188070788507e-09
the O 0 1.9117243343913515e-09
protein O 0 5.600165331465234e-10
after O 0 2.7264251967196174e-10
exposure O 0 1.2298094986817887e-08
to O 0 3.238302959118755e-10
DNA O 0 8.842826915156365e-09
- O 0 5.323638774257233e-08
damaging O 0 6.793910500846323e-08
agents O 0 2.2140962674388476e-10
are O 0 1.7201145022238684e-11
consistent O 0 3.366473766419631e-10
with O 0 2.966162385154014e-11
a O 0 2.381702612908043e-10
role O 0 3.1769971098327687e-09
for O 0 4.818998977640376e-09
BRCA1 O 0 5.3991051629509457e-08
in O 0 2.9708364657210495e-09
DNA O 0 2.2135351684937632e-07
repair O 0 3.784768978221109e-06
. O 0 8.39711390199227e-07

Here O 0 3.592541020225326e-08
, O 0 5.704438255094146e-09
it O 0 6.128422214146667e-10
is O 0 4.432681721677767e-10
shown O 0 5.210458176030386e-10
that O 0 3.995012098911843e-10
mouse O 0 1.3134126675140578e-07
embryonic O 0 8.827630182395296e-08
stem O 0 2.7915518785448512e-08
cells O 0 5.921454993007558e-10
deficient B-Disease 0 1.781876335371635e-08
in I-Disease 0 1.0346552503648354e-09
BRCA1 I-Disease 0 1.0549257467573625e-08
are O 0 6.320327594622199e-11
defective O 0 2.2304584845755926e-09
in O 0 1.314338082814004e-10
the O 0 5.364261812523807e-10
ability O 0 9.375681481182951e-11
to O 0 5.315716269937987e-11
carry O 0 5.186304719018153e-10
out O 0 4.5281506322325527e-10
transcription O 0 1.8504566767774122e-08
- O 0 5.639186539951879e-08
coupled O 0 7.150711578418623e-09
repair O 0 1.4270749026934482e-08
of O 0 6.834979693337573e-09
oxidative O 0 6.52168496984018e-09
DNA O 0 1.2185690678734318e-08
damage O 0 3.0487180424643157e-07
, O 0 5.20275156290495e-10
and O 0 8.722364497337765e-10
are O 0 7.54923956680642e-10
hypersensitive O 0 6.291386398515897e-07
to O 0 1.251909687027819e-08
ionizing O 0 3.942961120628752e-05
radiation O 0 1.3076229151920415e-05
and O 0 2.0223717811518327e-08
hydrogen O 0 2.9388488087533915e-08
peroxide O 0 1.8404290358375874e-07
. O 0 1.0282407458817033e-07

These O 0 1.4567257267117384e-07
results O 0 7.50921991254927e-09
suggest O 0 3.4704583651290477e-09
that O 0 7.633348952928998e-10
BRCA1 O 0 4.766602401673481e-08
participates O 0 8.788767935641317e-09
, O 0 8.98224772338807e-10
directly O 0 1.0476663980796275e-09
or O 0 4.894212257688935e-10
indirectly O 0 2.35101271783833e-09
, O 0 3.368233747469418e-10
in O 0 3.4683059202400557e-10
transcription O 0 5.4424994289092865e-08
- O 0 2.0355884089440224e-07
coupled O 0 2.7404263747143887e-08
repair O 0 6.952741671284457e-08
of O 0 5.276590897551614e-08
oxidative O 0 1.2365251222945517e-07
DNA O 0 1.5449094803443586e-07
damage O 0 2.353805939492304e-06
. O 0 2.9396840517392775e-08
. O 0 2.5199045694535016e-07

Truncation O 0 1.6301306459354237e-05
mutations O 0 4.543840859128068e-08
in O 0 2.0260813027306313e-09
the O 0 7.164978388374266e-09
transactivation O 0 1.831151621445315e-06
region O 0 1.1403186306324642e-07
of O 0 2.3462661147277686e-07
PAX6 O 1 0.999998927116394
result O 0 3.1768351504979364e-08
in O 0 4.593026403654221e-09
dominant O 0 1.3652361303684302e-06
- O 0 1.9283572783024283e-06
negative O 0 3.112354818313179e-07
mutants O 0 2.8725293077513925e-07
. O 0 7.305197868845426e-08

PAX6 O 1 0.9996509552001953
is O 0 9.364398323441492e-08
a O 0 6.28669383218039e-09
transcription O 0 2.398408049941736e-08
factor O 0 2.1816008999309133e-09
with O 0 1.198390553458495e-10
two O 0 1.4749566845662088e-10
DNA O 0 2.4524002828485436e-09
- O 0 1.4634688128012385e-08
binding O 0 1.0967713848231142e-08
domains O 0 1.4395272529554859e-08
( O 0 2.59181620609894e-10
paired O 0 9.177703041984842e-09
box O 0 1.2167568286258756e-07
and O 0 7.432671367268995e-09
homeobox O 0 2.557103471190203e-07
) O 0 8.043561372517161e-10
and O 0 1.7153395370783642e-09
a O 0 3.364216238921358e-09
proline O 0 2.611387515116803e-07
- O 0 9.536572065371729e-08
serine O 0 6.547736575157614e-08
- O 0 2.7819453407573747e-07
threonine O 0 4.900083467873628e-07
( O 0 4.378685414252459e-09
PST O 1 1.0
) O 0 5.027942862056989e-08
- O 0 1.436228785678395e-06
rich O 0 1.1907548014278291e-07
transactivation O 0 1.7526812371215783e-05
domain O 0 1.1052869695049594e-06
. O 0 3.823314500550623e-07

PAX6 O 1 1.0
regulates O 0 0.0003914569679182023
eye O 1 0.9999840259552002
development O 0 2.4444864266115474e-07
in O 0 6.1552283270316366e-09
animals O 0 1.4432276707054825e-08
ranging O 0 3.177144236587992e-08
from O 0 7.860679884785782e-10
jellyfish O 0 5.519658508035263e-09
to O 0 1.4714253149250567e-09
Drosophila O 0 2.0881573803421816e-08
to O 0 4.803609066073022e-09
humans O 0 1.9014665397776298e-08
. O 0 8.418757602157712e-08

Heterozygous O 0 9.053806593328773e-07
mutations O 0 1.6363395971552563e-08
in O 0 1.0456600030295249e-09
the O 0 6.466367441504417e-09
human O 0 2.1651779036346852e-08
PAX6 O 0 0.31271204352378845
gene O 0 4.609455483972624e-09
result O 0 1.1227392349155707e-09
in O 0 2.144743965759588e-10
various O 0 1.3648621122186455e-09
phenotypes O 0 1.8255176925663363e-08
, O 0 3.823981131745313e-10
including O 0 2.606953986017402e-09
aniridia B-Disease 1 1.0
, O 0 6.0391492695544e-08
Peters B-Disease 1 1.0
anomaly I-Disease 1 1.0
, O 0 2.429129892789206e-07
autosomal B-Disease 0 0.14458344876766205
dominant I-Disease 1 0.6075740456581116
keratitis I-Disease 1 0.9999797344207764
, O 0 1.9125174333112227e-07
and O 0 1.0381852462160168e-06
familial B-Disease 1 1.0
foveal I-Disease 1 1.0
dysplasia I-Disease 1 1.0
. O 0 5.881524702999741e-05

It O 0 8.209428870031843e-08
is O 0 4.274953724348052e-09
believed O 0 4.841605449890096e-10
that O 0 2.8738339832856674e-11
the O 0 7.116542910523549e-10
mutated O 0 5.866955810063246e-09
allele O 0 3.5887524063582532e-09
of O 0 3.86260161633345e-08
PAX6 O 1 0.9999973773956299
produces O 0 7.99552424268768e-08
an O 0 8.706424470261709e-10
inactive O 0 6.148050601950672e-08
protein O 0 5.491054722028821e-09
and O 0 1.2229092405391384e-08
aniridia B-Disease 1 1.0
is O 0 2.948618238463041e-08
caused O 0 2.070417792765511e-08
due O 0 4.737706404966957e-08
to O 0 2.842709179162739e-08
genetic O 0 1.2845587207266362e-06
haploinsufficiency O 0 0.0001443928194930777
. O 0 2.0240968297002837e-06

However O 0 1.3411681720754132e-07
, O 0 1.0640922809557196e-08
several O 0 7.2392674077548236e-09
truncation O 0 1.9419033492340532e-07
mutations O 0 1.6524915880111735e-09
have O 0 1.8658362355150615e-10
been O 0 2.588856629071046e-10
found O 0 5.774162745164624e-11
to O 0 7.083644781857856e-11
occur O 0 2.7271362251779507e-11
in O 0 5.462948149403957e-11
the O 0 6.968242094451682e-10
C O 0 2.6127047192403552e-08
- O 0 2.147484678971523e-08
terminal O 0 1.3025053036130885e-08
half O 0 1.5585371881954302e-09
of O 0 6.191164025892704e-09
PAX6 O 0 0.00026501339743845165
in O 0 1.0660174964982616e-09
patients O 0 6.578876887708418e-10
with O 0 2.2276853972602595e-10
Aniridia B-Disease 1 1.0
resulting O 0 1.4224035282950354e-08
in O 0 3.607086851431518e-10
mutant O 0 4.565914313303665e-09
proteins O 0 1.5021775490176026e-11
that O 0 1.059820807502998e-11
retain O 0 2.22534213278891e-09
the O 0 7.071957464077627e-10
DNA O 0 1.2007981275985458e-09
- O 0 2.775638607843689e-09
binding O 0 1.140176286718031e-09
domains O 0 4.1091735569764865e-10
but O 0 8.12373154857049e-11
have O 0 7.094813625485585e-11
lost O 0 4.848585088979007e-09
most O 0 3.358021916088916e-10
of O 0 6.919202988342477e-09
the O 0 4.7439275618899046e-08
transactivation O 0 1.3726049473916646e-05
domain O 0 2.576024144218536e-06
. O 0 1.044693590301904e-06

It O 0 2.4742773163666243e-08
is O 0 9.46805522872296e-10
not O 0 8.271974077933564e-11
clear O 0 8.563175168951886e-10
whether O 0 1.7006138164354923e-10
such O 0 1.478393518716814e-09
mutants O 0 1.6144804604323326e-08
really O 0 1.6457791796042898e-09
behave O 0 9.820964180784486e-11
as O 0 2.093135942349278e-10
loss O 0 1.500822399691515e-08
- O 0 2.1946569006559002e-08
of O 0 2.3726821396508058e-08
- O 0 6.52052989380536e-08
function O 0 1.4772688627928687e-09
mutants O 0 3.5036402667998345e-09
as O 0 1.0971830111117242e-09
predicted O 0 1.3326814318759261e-08
by O 0 8.088210989853906e-09
haploinsufficiency O 0 0.0001051746221492067
. O 0 1.4033935258339625e-06

Contrary O 0 2.8438870458558085e-07
to O 0 3.135531168041439e-09
this O 0 3.5622760297115974e-10
theory O 0 3.2437632579984665e-09
, O 0 3.719402286161966e-10
our O 0 3.6016761795210073e-10
data O 0 1.8465975970549664e-10
showed O 0 1.2515885550179462e-10
that O 0 1.518908089581661e-11
these O 0 7.458993839248862e-11
mutants O 0 6.404989316699528e-10
are O 0 7.375314942104083e-11
dominant O 0 5.9529847717954e-09
- O 0 1.6975336691871235e-08
negative O 0 2.9170728055305517e-09
in O 0 2.507273277885247e-10
transient O 0 2.1125452498438335e-09
transfection O 0 1.3854092317799882e-09
assays O 0 6.213543013444678e-10
when O 0 2.556354294913632e-10
they O 0 1.0366933700378667e-10
are O 0 4.9198169843611694e-11
coexpressed O 0 8.719744215568426e-08
with O 0 1.0928553617617354e-09
wild O 0 1.0643499308571336e-06
- O 0 5.17725538884406e-06
type O 0 3.00209262604767e-06
PAX6 O 1 0.9999972581863403
. O 0 1.9780609363806434e-06

We O 0 1.354833134570299e-08
found O 0 3.463321573971001e-10
that O 0 4.803924966156892e-11
the O 0 8.13260403464966e-10
dominant O 0 2.971427193187992e-08
- O 0 3.0663350969462044e-08
negative O 0 5.739898334411464e-09
effects O 0 2.4876406712337484e-08
result O 0 1.6368593980242707e-10
from O 0 4.851919560566742e-11
the O 0 1.663917892358313e-10
enhanced O 0 1.3855361302717029e-09
DNA O 0 7.217025865813298e-10
binding O 0 6.83603229578722e-10
ability O 0 2.692518985547565e-10
of O 0 2.658397058041828e-09
these O 0 2.7630249199717127e-09
mutants O 0 7.27351192608694e-08
. O 0 5.91353774836989e-08

Kinetic O 0 1.5359495364464237e-06
studies O 0 1.3155407430076593e-08
of O 0 4.309353762721457e-09
binding O 0 2.6721380663730088e-09
and O 0 1.2899206147665154e-09
dissociation O 0 7.98773136523323e-09
revealed O 0 1.243157354835489e-09
that O 0 3.373330434430777e-11
various O 0 5.772448075092029e-10
truncation O 0 1.0773753444937029e-07
mutants O 0 6.65872867955386e-09
have O 0 6.996178636420325e-11
3 O 0 2.9217446240181744e-09
- O 0 1.0899083413562494e-08
5 O 0 4.961076438547707e-09
- O 0 7.4007289185828995e-09
fold O 0 1.2194846243929192e-09
higher O 0 1.8488215125511687e-10
affinity O 0 4.247640086885163e-11
to O 0 4.690637808724141e-11
various O 0 1.3540696341962644e-10
DNA O 0 3.1927407939669195e-10
- O 0 1.0933390859335645e-09
binding O 0 5.863082241930329e-10
sites O 0 4.363859551492766e-10
when O 0 3.849563029456604e-11
compared O 0 9.665367117772661e-11
with O 0 9.666731304314169e-11
the O 0 6.615497483153376e-09
wild O 0 9.17301406389015e-07
- O 0 8.159168828569818e-06
type O 0 4.611516033037333e-06
PAX6 O 1 0.9999887943267822
. O 0 2.0474856228247518e-06

These O 0 2.742172888758887e-08
results O 0 1.3484748873082708e-09
provide O 0 4.336660197612474e-10
a O 0 4.782670925962407e-10
new O 0 1.3451224578631127e-09
insight O 0 2.9207749552284668e-09
into O 0 2.4440216517263025e-10
the O 0 6.129334817472909e-10
role O 0 3.798743097860324e-09
of O 0 2.932286413681595e-08
mutant O 0 8.792356425146863e-07
PAX6 O 1 0.9959327578544617
in O 0 4.509443485289921e-08
causing O 0 6.266198852244997e-06
aniridia B-Disease 1 1.0
. O 0 1.8992851380517095e-07
. O 0 6.614325798182108e-07

Reversal O 0 3.0300504931801697e-06
of O 0 2.5052306682482595e-06
severe O 1 1.0
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
and O 0 1.575343958393205e-06
excellent O 0 1.5204806231849943e-06
neuropsychologic O 0 7.4565950853866525e-06
outcome O 0 2.617533212401213e-08
in O 0 6.491722159829294e-10
very B-Disease 0 8.036200038752384e-10
- I-Disease 0 3.0965040309638425e-07
long I-Disease 0 6.533166185818118e-08
- I-Disease 0 5.221895094109641e-07
chain I-Disease 0 4.839865397343601e-08
acyl I-Disease 0 7.20715505053704e-08
- I-Disease 0 9.130042144533945e-08
coenzyme I-Disease 0 1.3768433504424138e-08
A I-Disease 0 6.214841050677933e-07
dehydrogenase I-Disease 0 1.2624488590518013e-05
deficiency I-Disease 0 2.9464559702319093e-05
. O 0 3.204886240837368e-07

Very B-Disease 0 3.16864770866232e-07
- I-Disease 0 1.7907044593812316e-06
long I-Disease 0 1.7043717548403947e-07
- I-Disease 0 4.883046926806855e-07
chain I-Disease 0 6.501058891217326e-08
acyl I-Disease 0 3.701331507954819e-08
- I-Disease 0 4.180014556709466e-08
coenzyme I-Disease 0 2.130068565975307e-09
A I-Disease 0 4.473523418369041e-08
dehydrogenase I-Disease 0 7.801686763286853e-08
( I-Disease 0 2.3672295235144247e-09
VLCAD I-Disease 1 1.0
) I-Disease 0 1.1901859409135795e-07
deficiency I-Disease 0 0.00593139510601759
is O 0 3.3799869569861585e-09
a O 0 8.809594831404866e-09
disorder O 0 0.009918740019202232
of O 0 4.973168188371346e-07
fatty O 0 2.8499680411187e-06
acid O 0 1.6745758557590307e-08
beta O 0 2.034084900515154e-09
oxidation O 0 4.044648782564053e-10
that O 0 5.144234691001337e-11
reportedly O 0 4.814809440034651e-09
has O 0 3.0715885390719677e-10
high O 0 9.548964285954753e-09
rates O 0 2.3161090823009545e-09
of O 0 5.737752939438678e-09
morbidity O 0 3.831304184132023e-06
and O 0 1.3320745040346083e-07
mortality O 0 1.2932248864672147e-05
. O 0 5.28285454493016e-07

We O 0 3.970032835809434e-08
describe O 0 3.391184222323318e-09
the O 0 7.787526179470206e-10
outcome O 0 1.219135792318582e-09
of O 0 2.2330977067497315e-09
a O 0 4.792341523618404e-10
5 O 0 2.4425970135411035e-09
- O 0 3.9586813826986145e-09
year O 0 3.204546072943515e-10
- O 0 1.0521646665040407e-08
old O 0 1.8576743698872633e-08
girl O 0 1.2977632302124675e-09
with O 0 3.802655690332557e-10
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
who O 0 1.1785461495605887e-08
was O 0 1.3632029727261852e-08
first O 0 7.265393842104118e-10
seen O 0 1.5714262113775135e-09
at O 0 1.383194114801256e-09
5 O 0 2.19921902910869e-09
months O 0 2.1231517932651656e-10
of O 0 8.279018026691176e-10
age O 0 1.5328736058251025e-09
with O 0 6.710963451617147e-10
severe O 1 0.999968409538269
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.9999983310699463
hepatomegaly B-Disease 1 1.0
, O 1 1.0
encephalopathy B-Disease 1 1.0
, O 0 9.79364855879794e-08
and O 0 8.395008421757666e-07
hypotonia B-Disease 1 0.9999868869781494
. O 0 6.6630773289944045e-06

Biochemical O 0 3.893735083693173e-06
studies O 0 1.7137305974301853e-07
indicated O 0 4.496554538491182e-05
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 1.2958342949787038e-06
by O 0 3.815771698612025e-09
a O 0 2.6024743249308813e-08
stable O 0 1.929836770386828e-07
yet O 0 4.190336255760485e-08
inactive O 0 1.1152247907375568e-06
enzyme O 0 1.0245953774301597e-07
. O 0 1.1923047793516162e-07

Molecular O 0 1.1274371445324505e-06
genetic O 0 1.7899630222473206e-08
analysis O 0 2.9430093917426348e-09
of O 0 1.9561573694204526e-08
her O 0 5.390626611756488e-08
VLCAD O 1 1.0
gene O 0 6.848227940281504e-08
revealed O 0 4.530574315708691e-08
a O 0 1.3538488552455874e-08
T1372C O 0 3.161127779094386e-06
( O 0 8.777810478477477e-09
F458L O 0 4.331789568823297e-06
) O 0 1.5776675965639697e-08
missense O 0 5.626465622299293e-07
mutation O 0 9.836440106880673e-09
and O 0 5.592994511971483e-09
a O 0 6.90130761427099e-08
1668 O 0 0.00013452323037199676
ACAG O 1 0.9999359846115112
1669 O 0 0.0001342620817013085
splice O 0 3.033132088603452e-05
site O 0 3.017690687556751e-06
mutation O 0 7.871277603044291e-07
. O 0 2.9463984674293897e-07

After O 0 9.680675105983028e-08
initial O 0 1.5034354206022726e-08
treatment O 0 2.7764871290969495e-08
with O 0 4.0983799687310807e-10
intravenous O 0 5.039214201474351e-08
glucose O 0 1.0208520251353548e-07
and O 0 7.004677726740738e-09
carnitine O 0 1.9508761397446506e-06
, O 0 1.9537997886232006e-09
the O 0 8.148010266495476e-09
patient O 0 2.017459799219523e-08
has O 0 1.8430306170102995e-09
thrived O 0 3.7899372529182074e-08
on O 0 9.453551719218467e-09
a O 0 2.0761705687988297e-09
low O 0 7.837033422219974e-08
- O 0 2.3308196261950798e-07
fat O 0 3.181929457696242e-07
diet O 0 2.5115452828572415e-08
supplemented O 0 1.5327831226485955e-09
with O 0 1.0003840811290132e-10
medium O 0 1.365959860777366e-07
- O 0 1.0194024469001306e-07
chain O 0 2.6401718145052655e-08
triglyceride O 0 3.0338846102040407e-08
oil O 0 1.2495885215457747e-08
and O 0 1.4774239609494089e-09
carnitine O 0 2.5815600679379713e-07
and O 0 8.023339326257428e-09
avoidance O 0 1.2503281141107436e-05
of O 0 9.569951089360984e-07
fasting O 0 1.5130327710721758e-06
. O 0 2.814273898366082e-07

Her O 0 7.482595538021997e-05
ventricular O 1 0.9999985694885254
hypertrophy O 0 0.0005001294193789363
resolved O 0 1.633054154126512e-07
significantly O 0 1.2879439736934728e-09
over O 0 7.586726802344401e-10
1 O 0 4.4538372989677555e-09
year O 0 2.409106247824866e-10
, O 0 1.4261890279865241e-10
and O 0 7.102643473366754e-10
cognitively O 0 9.515677845683967e-08
, O 0 4.301632106074038e-10
she O 0 4.400292352713109e-10
is O 0 7.507049842869762e-11
in O 0 4.397630523622631e-11
the O 0 9.042152582239282e-10
superior O 0 7.892928266528543e-08
range O 0 1.728043059756601e-07
for O 0 1.2798806459102252e-08
age O 0 1.1176188507988627e-07
. O 0 1.1107229624940373e-07

Clinical O 0 2.0601542928488925e-05
recognition O 0 3.059663811200153e-07
of O 1 0.9999662637710571
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 2.8647974659179454e-08
important O 0 2.4738229242871057e-09
because O 0 2.1007470762945957e-10
it O 0 7.263006862601173e-11
is O 0 7.167144655539914e-11
one O 0 5.527575619446168e-11
of O 0 7.135394497481684e-10
the O 0 1.214014555550591e-09
few O 0 4.184807167462168e-09
directly O 0 1.2037063790160119e-08
treatable O 1 0.9809908866882324
causes O 0 1.1246906694850622e-07
of O 0 3.690754283525166e-06
cardiomyopathy B-Disease 1 1.0
in O 0 3.852124663694667e-08
children O 0 1.0860092380937658e-08
. O 0 5.443835604523883e-09
. O 0 1.0688055596119739e-07

Cloning O 0 2.333557773681605e-07
of O 0 4.264677855303489e-08
a O 0 2.659137354754648e-09
novel O 0 2.6439058942173688e-08
member O 0 1.0594459753932028e-09
of O 0 3.834631723265147e-09
the O 0 3.523107139358217e-09
low O 0 3.778922419428454e-08
- O 0 5.127080626721181e-08
density O 0 5.725148355395504e-09
lipoprotein O 0 2.8373358418321004e-06
receptor O 0 1.6794898272110004e-07
family O 0 4.340984816053606e-08
. O 0 1.2904533264190832e-07

A O 0 1.2402068705341662e-06
gene O 0 2.5665369829397378e-09
encoding O 0 3.811785553864411e-09
a O 0 3.281336091731646e-09
novel O 0 5.6946788618006394e-08
transmembrane O 0 2.9713009830345527e-09
protein O 0 2.6162938482343634e-09
was O 0 1.7092974813337491e-09
identified O 0 5.974796352115064e-11
by O 0 8.757913665113914e-12
DNA O 0 2.6460775237602263e-10
sequence O 0 4.6533096820233766e-11
analysis O 0 2.5666664973944542e-11
within O 0 3.518490013232345e-11
the O 0 5.78216752256111e-10
insulin B-Disease 0 5.158586645848118e-06
- I-Disease 1 0.9999995231628418
dependent I-Disease 1 0.88490891456604
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
( O 0 1.5187076485290163e-08
IDDM B-Disease 1 1.0
) O 0 9.850821491852457e-09
locus O 0 9.798933433557977e-07
IDDM4 O 0 0.000714554509613663
on O 0 6.023228706908412e-07
chromosome O 0 1.798184598555963e-06
11q13 O 0 1.703569432720542e-05
. O 0 5.432220859802328e-07

Based O 0 3.8021809700694575e-08
on O 0 1.6917253375936525e-08
its O 0 7.025189763254502e-09
chromosomal O 0 2.54411418154632e-07
position O 0 2.983967561931422e-08
, O 0 8.727206735059667e-10
this O 0 7.861245682194706e-11
gene O 0 8.092898018396966e-10
is O 0 4.678791798440329e-10
a O 0 5.825382953794644e-10
candidate O 0 1.6255632395711928e-09
for O 0 1.1339020833389668e-09
conferring O 0 8.830409115034854e-08
susceptibility O 0 1.7396736211594543e-06
to O 0 4.6922556862227793e-07
diabetes B-Disease 1 1.0
. O 0 3.1884710551821627e-06

The O 0 7.924384703983378e-07
gene O 0 3.1332131555927845e-08
, O 0 8.618235014523634e-09
termed O 0 1.1007850986288759e-07
low O 0 1.667826978746234e-07
- O 0 1.3335515802737063e-07
density O 0 9.284063295922351e-09
lipoprotein O 0 3.3324141668344964e-07
receptor O 0 4.762692462634277e-09
related O 0 6.1834697362428415e-09
protein O 0 5.124650703791644e-10
5 O 0 2.808180354918477e-09
( O 0 3.0701535758126397e-10
LRP5 O 1 0.9998832941055298
) O 0 1.112814840276144e-09
, O 0 6.256880569210921e-10
encodes O 0 9.26066057171937e-10
a O 0 4.1636427638991336e-10
protein O 0 1.480541134135649e-09
of O 0 4.998394587119037e-09
1615 O 0 1.5499460914725205e-07
amino O 0 3.4785037072992964e-09
acids O 0 2.9448160576706073e-10
that O 0 6.072912138443964e-12
contains O 0 1.9066907774867303e-10
conserved O 0 1.4032327522173205e-09
modules O 0 3.578661256220528e-10
which O 0 7.616587048564494e-12
are O 0 3.822198200303939e-12
characteristic O 0 1.2913138336401175e-09
of O 0 9.685228175015936e-10
the O 0 8.301170861813034e-10
low O 0 9.952635160459522e-09
- O 0 4.066482262032878e-08
density O 0 7.985644145946935e-09
lipoprotein O 0 1.4406253285415005e-05
( O 0 1.0965935715034902e-08
LDL O 1 1.0
) O 0 1.4522572477915219e-08
receptor O 0 5.7435041611597626e-08
family O 0 1.4706938777919731e-08
. O 0 9.228718056419893e-08

These O 0 6.809803210217069e-08
modules O 0 1.2032477059165103e-07
include O 0 1.6917672596150624e-08
a O 0 7.703118143354004e-09
putative O 0 9.602958073173795e-08
signal O 0 5.604206876341777e-09
peptide O 0 1.2234312452008567e-09
for O 0 2.183015157530832e-10
protein O 0 2.775235041774238e-10
export O 0 4.161278877035102e-09
, O 0 6.397516960632288e-10
four O 0 4.419082044737621e-10
epidermal O 0 1.8199382623151905e-07
growth O 0 1.1926409193563359e-08
factor O 0 2.0424325342105476e-08
( O 0 1.3966268141984983e-09
EGF O 0 5.493579465110088e-06
) O 0 7.345177799322755e-10
repeats O 0 8.639889914618948e-10
with O 0 1.438263258490835e-10
associated O 0 2.9709723570192637e-09
spacer O 0 6.876722125070955e-08
domains O 0 1.400789262362423e-08
, O 0 1.0658345317438034e-09
three O 0 7.595500339796502e-10
LDL O 1 1.0
- O 0 5.790035629615886e-06
receptor O 0 1.3805721899018408e-08
( O 0 4.998134683908972e-10
LDLR O 1 0.9999861717224121
) O 0 5.564538829716525e-10
repeats O 0 9.706089265648643e-10
, O 0 2.3200784349253212e-10
a O 0 5.005556524828592e-10
single O 0 2.8881237401634507e-09
transmembrane O 0 8.663508133111009e-09
spanning O 0 2.7796771107091445e-08
domain O 0 3.073971299727418e-08
, O 0 2.4986621660616493e-09
and O 0 4.584606472235464e-09
a O 0 1.3243372620763694e-08
cytoplasmic O 0 8.108802376227686e-07
domain O 0 7.963134862620791e-07
. O 0 6.647994723607553e-07

The O 0 2.3088644240942813e-07
encoded O 0 4.1687937546441844e-09
protein O 0 3.03909009069514e-09
has O 0 4.2992942539399337e-10
a O 0 2.027123885417481e-10
unique O 0 3.3059729953599515e-10
organization O 0 1.3600383319545273e-10
of O 0 9.732788797123249e-09
EGF O 0 0.00447803596034646
and O 0 6.759606208106561e-08
LDLR O 1 0.9999997615814209
repeats O 0 1.4795960900926275e-08
; O 0 4.521134577828434e-10
therefore O 0 9.36155153397067e-10
, O 0 1.391893156288404e-09
LRP5 O 0 0.0005391360027715564
likely O 0 4.883016213597102e-09
represents O 0 2.3884766386927936e-10
a O 0 5.928707524915922e-11
new O 0 1.650424519272775e-10
category O 0 1.704492103016264e-09
of O 0 4.755448479443203e-09
the O 0 4.3978552355383727e-08
LDLR O 1 0.9999996423721313
family O 0 7.747265726720798e-07
. O 0 8.99433928225335e-07

Both O 0 3.655964349036367e-07
human O 0 6.319469036952796e-08
and O 0 3.166206852256437e-08
mouse O 0 4.5957285692566074e-06
LRP5 O 1 1.0
cDNAs O 0 0.0034642035607248545
have O 0 1.879338240584616e-09
been O 0 2.208643712364733e-09
isolated O 0 3.1516000920106535e-09
and O 0 4.5037745755038827e-10
the O 0 9.932207278851024e-10
encoded O 0 2.879256000287711e-10
mature O 0 8.429386633146407e-10
proteins O 0 1.043644597825688e-11
are O 0 9.68447978061393e-12
95 O 0 1.753497458345521e-09
% O 0 4.29774271726302e-11
identical O 0 3.3323915848981756e-10
, O 0 1.2343202848708046e-10
indicating O 0 1.138459548855053e-09
a O 0 3.446761209779936e-10
high O 0 1.656140113936999e-08
degree O 0 8.133879347838047e-09
of O 0 4.823155208555363e-09
evolutionary O 0 1.7661628604059842e-08
conservation O 0 3.8014700720623296e-08
. O 0 7.081207176184989e-09
. O 0 1.0390662907866499e-07

The O 0 1.4999802715465194e-06
APC B-Disease 0 1.4948992657082272e-06
variants O 0 1.422176154619592e-07
I1307K O 0 6.547930979650118e-07
and O 0 4.275092280181525e-09
E1317Q O 0 2.881473903926235e-07
are O 0 8.602476370134227e-11
associated O 0 9.653654542418622e-10
with O 0 1.4430742112381267e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 2.3829866080404827e-08
but O 0 2.0004219114522215e-10
not O 0 5.2827353602680205e-11
always O 0 3.852032859352761e-10
with O 0 1.375791841562446e-10
a O 0 2.763509865388869e-09
family O 0 8.2888025332295e-09
history O 0 1.5199994152226282e-07
. O 0 3.0904146797183785e-07

Classical O 0 0.0013289920752868056
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.0018727624556049705
FAP B-Disease 1 1.0
) O 0 1.7223300119439955e-08
is O 0 1.7811619956731306e-09
a O 0 1.1204801531050634e-09
high O 0 0.04412300884723663
- O 1 1.0
penetrance O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 0.9995071887969971
that O 0 6.6983285584854e-10
predisposes O 0 2.8411914598791554e-08
to O 0 2.610784366474661e-10
hundreds O 0 6.64247601367407e-10
or O 0 1.7431224519359745e-10
thousands O 0 8.787941485621786e-10
of O 0 6.027078711667855e-07
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
and O 0 2.8526762889669044e-06
that O 0 1.088981016472701e-09
results O 0 3.9458789014013007e-10
from O 0 2.4126611819497157e-10
truncating O 0 3.0857314925469836e-08
mutations O 0 6.100014382504071e-10
in O 0 4.489058014200964e-10
the O 0 2.1452699172641587e-08
APC B-Disease 0 3.466386715444969e-06
gene O 0 2.1252876081234717e-07
. O 0 3.453227463978692e-07

A O 0 1.3405509662334225e-06
variant O 0 4.5927836822556856e-07
of O 0 2.1075541667414655e-07
FAP B-Disease 1 0.9999953508377075
is O 0 2.8349455760690034e-07
attenuated B-Disease 1 0.9986057877540588
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
, O 0 3.945401161331574e-08
which O 0 5.313549600316492e-10
results O 0 2.835915113852394e-10
from O 0 1.662715520822644e-10
germ O 0 9.633172481926522e-08
- O 0 5.484630705154814e-08
line O 0 4.2112723974696564e-08
mutations O 0 3.8513275901763677e-10
in O 0 4.395668204426606e-11
the O 0 2.9844426929770407e-10
5 O 0 1.0144013407042962e-09
and O 0 2.157306694394734e-10
3 O 0 3.3745759520087404e-09
regions O 0 4.82902784426642e-09
of O 0 1.677030603275398e-08
the O 0 3.476760923604161e-08
APC B-Disease 0 3.323015789646888e-06
gene O 0 1.3593543712886458e-07
. O 0 2.325624137711202e-07

Attenuated B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
patients O 0 0.00025134635507129133
have O 0 1.2134705462685247e-09
" O 0 7.563756732054117e-09
multiple O 0 2.6438561917530023e-07
" O 1 0.9999724626541138
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
( O 0 2.4632353046172284e-08
typically O 0 9.107493648130571e-10
fewer O 0 3.6211492138171764e-10
than O 0 2.5978778156465765e-11
100 O 0 2.843107693717428e-10
) O 0 4.787990143251264e-11
without O 0 2.8029936705031844e-10
the O 0 1.7020393983102622e-09
florid O 0 1.1533779797900934e-06
phenotype O 0 1.8885595309825476e-08
of O 0 3.2595735888207855e-08
classical O 0 1.2013414334433037e-06
FAP B-Disease 0 0.0007235689554363489
. O 0 9.72785301200929e-07

Another O 0 2.5170319872813707e-07
group O 0 7.633134124773733e-09
of O 0 1.3761868977724134e-08
patients O 0 2.4919228902575696e-09
with O 0 3.649940072403268e-10
multiple O 0 3.1529370403404755e-07
adenomas B-Disease 1 1.0
has O 0 2.7168866267857084e-08
no O 0 4.946298926000736e-09
mutations O 0 3.2015953776998174e-10
in O 0 1.1794039356249897e-10
the O 0 4.701175448929007e-09
APC B-Disease 0 9.318003435510036e-08
gene O 0 4.372791295725875e-10
, O 0 1.9899870640216477e-10
and O 0 2.235107793291391e-10
their O 0 2.625765993524709e-10
phenotype O 0 3.768215739441416e-10
probably O 0 6.83365586340301e-11
results O 0 2.8013032865592535e-11
from O 0 5.021389901105344e-11
variation O 0 5.874099873182104e-09
at O 0 4.736439240815571e-09
a O 0 1.1505179031701118e-09
locus O 0 4.325875480049035e-08
, O 0 1.052348763685984e-09
or O 0 4.5338371945646827e-10
loci O 0 3.4122968894934047e-09
, O 0 5.939043701275182e-10
elsewhere O 0 1.5039794964977204e-09
in O 0 1.0503615754942075e-09
the O 0 2.419451661239691e-08
genome O 0 8.501829285023632e-08
. O 0 1.6748863629345578e-07

Recently O 0 5.560204385801626e-07
, O 0 1.3099696438700903e-08
however O 0 2.6040916090153132e-09
, O 0 1.5256370611282932e-09
a O 0 1.5602147351856388e-09
missense O 0 6.610580527421916e-08
variant O 0 5.883499198944264e-08
of O 0 7.478220140910707e-07
APC B-Disease 0 6.40266589471139e-05
( O 0 3.2755080869861786e-09
I1307K O 0 2.0175962163193617e-06
) O 0 7.580853722544134e-10
was O 0 5.664214430822767e-09
described O 0 2.847145297302234e-10
that O 0 5.193093177702224e-11
confers O 0 6.747945313634318e-09
an O 0 8.708695570236458e-11
increased O 0 9.04230801346273e-10
risk O 0 5.150201687342815e-08
of O 0 6.2580838857684284e-06
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 3.5233045991844847e-07
including O 0 6.13362018953012e-08
multiple O 0 6.218522798917547e-07
adenomas B-Disease 1 0.9994853734970093
, O 0 1.799754123510411e-08
in O 0 4.1471608369647583e-08
Ashkenazim O 0 5.7801269576884806e-05
. O 0 7.817690743650019e-07

We O 0 1.3212041949373088e-07
have O 0 2.094091344773119e-09
studied O 0 2.0802900735361618e-08
a O 0 7.994037098946194e-10
set O 0 1.1674150535156969e-09
of O 0 1.1074937633637205e-09
164 O 0 7.57802354200976e-09
patients O 0 4.392418651022467e-10
with O 0 4.731867675467072e-10
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
/ I-Disease 1 1.0
or I-Disease 0 1.9221264665247872e-05
carcinoma I-Disease 1 1.0
and O 0 4.272439582564402e-06
analyzed O 0 1.1501606422825716e-06
codons O 0 1.0592141279630596e-06
1263 O 0 5.277202490105992e-06
- O 0 7.046676842037414e-07
1377 O 0 2.491706482032896e-06
( O 0 7.749864749939661e-09
exon O 0 4.1930587713068235e-07
15G O 0 1.0530660574659123e-06
) O 0 5.882640485843638e-10
of O 0 5.015173165645592e-09
the O 0 9.838541537021683e-09
APC B-Disease 0 1.4958247618324094e-07
gene O 0 2.075157157221952e-09
for O 0 1.535721105838661e-09
germ O 0 1.7148092865681974e-06
- O 0 1.548548425489571e-06
line O 0 9.766587254489423e-07
variants O 0 3.7532143437601917e-07
. O 0 1.7098632554279902e-07

Three O 0 5.176012862762036e-08
patients O 0 2.683865796271334e-09
with O 0 1.0966427071990026e-10
the O 0 4.338714720830694e-09
I1307K O 0 4.855070301346132e-07
allele O 0 2.3410386962297025e-09
were O 0 6.272438124454993e-10
detected O 0 2.363917728231968e-09
, O 0 3.0420402308273253e-10
each O 0 1.0459846183641375e-10
of O 0 8.443921117873288e-09
Ashkenazi O 0 2.1959931473247707e-07
descent O 0 9.93420528061506e-08
. O 0 1.5285600341030658e-07

Four O 0 9.331643013865687e-07
patients O 0 1.1060761551107134e-07
had O 0 1.1047052161927695e-08
a O 0 6.448656275637177e-09
germ O 0 3.336113877594471e-06
- O 0 5.9479198171175085e-06
line O 0 1.244331997440895e-06
E1317Q O 0 1.9616293229773873e-06
missense O 0 3.493512323871073e-08
variant O 0 1.0640476055812087e-08
of O 0 3.134432446927349e-08
APC O 0 4.023601007929756e-08
that O 0 8.477398644179956e-11
was O 0 6.699018562095205e-10
not O 0 1.3031146474384858e-11
present O 0 3.2340609357195405e-11
in O 0 2.954716332714824e-11
controls O 0 5.639559930159521e-09
; O 0 8.53652495913515e-11
one O 0 8.712400245691754e-11
of O 0 2.352424643969897e-10
these O 0 9.825310703925894e-11
individuals O 0 1.0074357147116242e-11
had O 0 2.6506138950388447e-10
an O 0 8.835501080772801e-11
unusually O 0 1.8214683095152395e-09
large O 0 1.6343238984362074e-09
number O 0 1.3972929480132734e-09
of O 0 2.3605892351952207e-08
metaplastic B-Disease 0 0.0001051963772624731
polyps I-Disease 0 4.913241355097853e-06
of I-Disease 0 5.767258812738874e-07
the I-Disease 0 6.580789886356797e-07
colorectum I-Disease 0 0.0003733983321581036
. O 0 1.2182435966678895e-06

There O 0 7.684631242454998e-08
is O 0 1.2643320834726524e-09
increasing O 0 6.685819675666949e-10
evidence O 0 5.002407377219242e-10
that O 0 3.462593406444725e-11
there O 0 1.731379345448758e-10
exist O 0 4.4436523904956005e-10
germ O 0 3.854035668382494e-08
- O 0 1.8841664228830268e-08
line O 0 1.492395718116768e-08
variants O 0 4.543535325751691e-09
of O 0 1.361379009523489e-08
the O 0 1.6453908457947364e-08
APC B-Disease 0 2.270284795713451e-07
gene O 0 1.0097240821238529e-09
that O 0 7.214889102824529e-11
predispose O 0 4.701830036424326e-09
to O 0 1.4060451414277253e-10
the O 0 4.464278946514355e-10
development O 0 6.648420702859426e-10
of O 0 3.720697350217961e-08
multiple O 1 1.0
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 1.0
carcinoma I-Disease 1 1.0
, O 0 6.335206137464411e-08
but O 0 6.389480611268539e-10
without O 0 6.137148567120221e-10
the O 0 1.1220071538531329e-09
florid O 0 2.1915558079399489e-07
phenotype O 0 1.896905077458655e-09
of O 0 1.4200715048318102e-09
classical O 0 1.6420800719174622e-08
FAP B-Disease 0 6.451519584516063e-05
, O 0 4.421349952821174e-10
and O 0 1.2090341228176982e-10
possibly O 0 6.727415152729677e-11
with O 0 1.7369286564594688e-11
importance O 0 2.5407819848055624e-08
for O 0 1.3898370809783955e-07
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 5.325990173332684e-07
in O 0 7.555357728339374e-11
the O 0 3.9776462679164126e-10
general O 0 2.6403401687247197e-10
population O 0 4.511699694398352e-11
. O 0 6.021086407237419e-10
. O 0 4.216818183522264e-08

Genomic O 0 4.232741446230648e-07
structure O 0 2.0746515616565375e-08
of O 0 1.7993352585676803e-08
the O 0 6.819486486620008e-08
human O 1 0.9999911785125732
congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 8.655138117319439e-06
CLD B-Disease 1 1.0
) O 0 1.3204370929997822e-07
gene O 0 1.6462013263662811e-07
. O 0 2.6860953994400916e-07

Congenital B-Disease 1 1.0
chloride I-Disease 1 1.0
diarrhea I-Disease 1 1.0
( O 0 0.12713207304477692
CLD B-Disease 1 1.0
) O 0 3.6459919527942475e-08
is O 0 9.861381711218087e-10
caused O 0 1.1373113562029857e-09
by O 0 8.73226491115986e-11
mutations O 0 7.856003625406061e-10
in O 0 3.9830591602729726e-10
a O 0 1.2268827065398114e-09
gene O 0 6.504959904063412e-10
which O 0 4.055989710760599e-10
encodes O 0 1.67710734189086e-08
an O 0 7.307618954399686e-09
intestinal O 0 7.413601997541264e-05
anion O 0 1.100409008358838e-05
transporter O 0 2.5300561901531182e-05
. O 0 1.5892659348537563e-06

We O 0 5.339298780882018e-08
report O 0 3.30019123140346e-09
here O 0 2.572446144988305e-10
the O 0 1.9470887124839464e-09
complete O 0 1.92274618449062e-09
genomic O 0 4.2440002623322926e-09
organization O 0 5.847134998404613e-10
of O 0 8.537347717663124e-09
the O 0 2.0836457892414728e-08
human O 0 3.0670253892139954e-08
CLD B-Disease 1 0.9965986609458923
gene O 0 3.429261097309677e-09
which O 0 4.077351511977412e-10
spans O 0 1.3004400223337598e-08
approximately O 0 7.250940958769547e-10
39kb O 0 1.9191826083897467e-07
, O 0 1.0011766971018687e-09
and O 0 5.316878048944318e-09
comprises O 0 8.376440518986783e-08
21 O 0 2.1923500526099815e-07
exons O 0 4.009167696494842e-06
. O 0 4.893806817563018e-07

All O 0 3.3853648346848786e-06
exon O 0 1.686715222604107e-05
/ O 0 3.7091099329700228e-06
intron O 0 4.0024515328696e-06
boundaries O 0 3.8006582769867236e-08
conform O 0 4.3034233954131196e-09
to O 0 2.216776318064717e-09
the O 0 6.667131202675591e-08
GT O 1 0.9999514818191528
/ O 1 0.9894891381263733
AG O 1 1.0
rule O 0 5.3329954425862525e-06
. O 0 1.3231930324764107e-06

An O 0 1.978076369368864e-08
analysis O 0 2.939744225827212e-09
of O 0 9.553827950981031e-09
the O 0 2.783221120239432e-08
putative O 0 4.953590746481495e-07
promoter O 0 3.3964988688239828e-06
region O 0 1.5533095165665145e-07
sequence O 0 9.6330587950888e-09
shows O 0 7.565171600276699e-09
a O 0 4.345853454879034e-09
putative O 0 3.793083749314974e-07
TATA O 0 1.7188311176141724e-05
box O 0 2.4248211047961377e-06
and O 0 3.956992244980029e-08
predicts O 0 5.5076093019579275e-08
multiple O 0 4.0328189676586135e-09
transcription O 0 3.0729161437648145e-08
factor O 0 2.9417538627285467e-08
binding O 0 7.38206651362816e-08
sites O 0 4.114625653528492e-07
. O 0 3.421136511860823e-07

The O 0 2.750161343101354e-07
genomic O 0 8.135342000059609e-08
structure O 0 1.4531106096171698e-08
was O 0 6.132307994732855e-09
determined O 0 2.569797985518818e-10
using O 0 6.151748555005554e-11
DNA O 0 4.2889009010949053e-10
from O 0 3.4545193094981386e-11
several O 0 6.65434166102763e-11
sources O 0 1.4558222682925503e-10
including O 0 2.605282656276131e-10
multiple O 0 1.404475091781876e-09
large O 0 3.947207716237244e-08
- O 0 3.0954047360864934e-06
insert O 0 4.247719971317565e-07
libaries O 0 2.1121288682479644e-06
and O 0 3.6559200111696555e-09
genomic O 0 2.503013618593286e-08
DNA O 0 9.877425100057735e-09
from O 0 2.0242774123602203e-09
Finnish O 0 0.0427272692322731
CLD B-Disease 1 1.0
patients O 0 2.738011062319856e-07
and O 0 4.982833701205891e-08
controls O 0 4.0352417272515595e-05
. O 0 1.135833258558705e-06

Exon O 0 4.213881038594991e-05
- O 0 8.568400744479732e-07
specific O 0 4.103742057282034e-08
primers O 0 1.154681683601666e-07
developed O 0 4.707043643747966e-09
in O 0 2.564470580335154e-10
this O 0 4.4826642398021477e-11
study O 0 3.2651523151905337e-10
will O 0 5.518453055630701e-11
facilitate O 0 4.994998858975919e-10
mutation O 0 5.5538795784570993e-11
screening O 0 2.4545424026634066e-10
studies O 0 3.7212899428595847e-10
of O 0 8.822925168239237e-10
patients O 0 2.0390170107909e-10
with O 0 8.326633826882812e-11
the O 0 5.488879750714659e-08
disease O 0 2.840037086571101e-05
. O 0 3.590644155337941e-07

Genomic O 0 6.219726742529019e-07
sequencing O 0 1.602407593281896e-07
of O 0 1.1748321782079074e-07
a O 0 1.1838250912887816e-07
BAC O 1 1.0
clone O 0 2.598586434032768e-05
H O 1 1.0
_ O 0 1.4153698657537461e-08
RG364P16 O 0 2.489464066002256e-07
revealed O 0 1.8334938012287694e-09
the O 0 3.9648828664695657e-10
presence O 0 2.355059758318845e-10
of O 0 3.302540019234357e-09
another O 0 9.939560285943116e-10
, O 0 5.650356849074001e-10
highly O 0 2.491880035648819e-09
homologous O 0 2.1544568906683992e-10
gene O 0 1.6810385028431796e-10
3 O 0 1.8791230793624436e-09
of O 0 4.880157611353297e-09
the O 0 1.393562065743481e-08
CLD B-Disease 0 0.0012963790213689208
gene O 0 2.518951047747464e-09
, O 0 2.933838727514626e-10
with O 0 9.777582909986648e-11
a O 0 2.410522059737019e-10
similar O 0 1.4460393993331877e-10
genomic O 0 1.9015200525274167e-09
structure O 0 1.5457892743597768e-09
, O 0 1.496898577313388e-10
recently O 0 2.8688515452124363e-10
identified O 0 5.455305304713498e-11
as O 0 1.0469567574000749e-10
the O 0 8.294938957931208e-09
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 2.1214057710494671e-07
( O 0 9.921873989071628e-09
PDS B-Disease 1 0.9999929666519165
) O 0 5.9772076177466715e-09
. O 0 1.2628481371734779e-08
. O 0 2.06927367685239e-07

The O 0 6.419120950340584e-07
APCI1307K O 1 0.9999966621398926
allele O 0 1.2154197293057223e-07
and O 0 4.424644473033368e-08
cancer B-Disease 0 0.00025661810650490224
risk O 0 2.985818241540983e-07
in O 0 8.182736710438121e-10
a O 0 1.4755736632565686e-09
community O 0 4.2335687733263683e-10
- O 0 2.69445199485574e-09
based O 0 3.85990961415672e-10
study O 0 1.958731649098766e-10
of O 0 7.816813307748305e-10
Ashkenazi O 0 2.4109292340313004e-08
Jews O 0 3.8847002059583247e-08
. O 0 9.072651607766602e-08

Mutations O 0 7.834528332750779e-07
in O 0 1.6321129336915874e-08
APC O 0 7.148259442146809e-07
are O 0 7.814070501765968e-10
classically O 0 3.7810636399626674e-08
associated O 0 2.760064843343457e-09
with O 0 2.521581698999853e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 0.0001928741403389722
FAP B-Disease 1 1.0
) O 0 4.661620423007662e-09
, O 0 3.765995848503678e-10
a O 0 1.0992231569417754e-09
highly O 1 0.9692140817642212
penetrant O 1 1.0
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 0 3.9524596218143415e-07
by O 0 7.869005447247446e-10
multiple O 0 1.0441159474794404e-06
intestinal O 1 1.0
polyps B-Disease 1 0.9988051652908325
and O 0 1.785966396994354e-08
, O 0 6.442235633841165e-10
without O 0 1.7403459784404163e-09
surgical O 0 1.27857665574993e-05
intervention O 0 8.443937993263262e-09
, O 0 2.5859844821063405e-10
the O 0 5.96846738698531e-10
development O 0 3.550447935651846e-09
of O 0 2.0332987332949415e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 1.0814497386490984e-07
CRC B-Disease 1 0.9999997615814209
) O 0 5.430947780382667e-08
. O 0 1.3484785199580074e-07

APC B-Disease 0 0.00011045053543057293
is O 0 1.3706589641060418e-07
a O 0 5.300315564227276e-08
tumour O 1 1.0
- O 0 1.9713888832484372e-05
suppressor O 0 4.877796982327709e-06
gene O 0 4.902576566934158e-09
, O 0 1.2060291654236721e-09
and O 0 5.453646423347891e-09
somatic O 0 1.4066521316635772e-06
loss O 0 2.0826780655625043e-06
occurs O 0 1.0759373836322084e-08
in O 0 2.4981488877529046e-08
tumours B-Disease 1 1.0
. O 0 3.1854622193350224e-06

The O 0 2.446207872708328e-06
germline O 0 7.27517601717409e-07
T O 0 9.873950830296963e-07
- O 0 4.151782917460878e-08
to O 0 2.5772899370224422e-09
- O 0 7.148628355935216e-08
A O 0 6.316769685099644e-08
transversion O 0 4.982149448551354e-07
responsible O 0 5.026770555360827e-09
for O 0 8.170851772959509e-10
the O 0 1.163392404635033e-08
APC O 0 5.589616307588585e-07
I1307K O 0 9.476389095652848e-07
allele O 0 4.297648903417439e-09
converts O 0 1.5311293344311139e-09
the O 0 1.8755137443093872e-09
wild O 0 4.8733515001231353e-08
- O 0 2.1833006513816144e-08
type O 0 2.9514302113398116e-09
sequence O 0 4.5787404423514033e-10
to O 0 2.773615503937066e-10
a O 0 5.645856226976775e-09
homopolymer O 1 1.0
tract O 1 1.0
( O 0 6.610076042079527e-08
A8 O 1 1.0
) O 0 5.114709766829151e-10
that O 0 1.8139993673838006e-10
is O 0 1.3263209419633881e-09
genetically O 0 2.9351177488479152e-08
unstable O 0 2.8981794741866906e-08
and O 0 6.486614356759901e-09
prone O 0 6.681656259388546e-07
to O 0 6.294327192790661e-08
somatic O 0 3.5987523006042466e-06
mutation O 0 4.0613051055515825e-07
. O 0 2.739698459208739e-07

The O 0 1.4153071106193238e-06
I1307K O 0 1.312142558163032e-05
allele O 0 3.857197938827994e-08
was O 0 3.2499325897106246e-08
found O 0 3.6305634054656366e-09
in O 0 4.657327856705251e-09
6 O 0 1.2592446410053526e-06
. O 0 5.309806851983012e-07

1 O 0 5.482486358232563e-07
% O 0 1.2138507976544588e-08
of O 0 1.9338765255838553e-08
unselected O 0 2.732537359406706e-05
Ashkenazi O 0 7.657942546757113e-08
Jews O 0 5.020206916839243e-09
and O 0 4.682702559044571e-10
higher O 0 9.255433641719435e-10
proportions O 0 1.3806926713044732e-09
of O 0 2.8591515821574376e-09
Ashkenazim O 0 1.0185317478317302e-07
with O 0 7.112403443976234e-10
family O 0 3.4129870041255117e-09
or O 0 3.150073757396399e-09
personal O 0 3.384510804949059e-08
histories O 0 2.866294757097876e-08
of O 0 1.5141200492507778e-05
CRC B-Disease 1 1.0
( O 0 1.536905713805936e-08
ref O 0 5.300345833347819e-07
. O 0 2.4519652974674955e-09
2 O 0 1.073211848279243e-07
) O 0 2.002905397091581e-08
. O 0 1.5886628546013526e-07

To O 0 1.1694370805059862e-08
evaluate O 0 1.6570279370853314e-08
the O 0 3.0140998585892476e-09
role O 0 4.0766923170565406e-09
of O 0 3.387630442830414e-08
I1307K O 0 2.9775544589938363e-06
in O 0 3.9560243969560815e-09
cancer B-Disease 0 1.522822799415735e-06
, O 0 4.347577853280882e-09
we O 0 3.857622665748295e-09
genotyped O 0 1.959139126483933e-06
5 O 0 1.17708744085121e-07
, O 0 2.002103371978592e-08
081 O 0 7.710294084972702e-06
Ashkenazi O 0 1.325028762266811e-07
volunteers O 0 1.941219629486568e-08
in O 0 3.1112132869992593e-09
a O 0 1.724052189899794e-08
community O 0 2.4757596861491038e-08
survey O 0 4.07332940710603e-08
. O 0 1.3620210381759534e-07

Risk O 0 7.26243206372601e-06
of O 0 1.942008935884587e-07
developing O 0 0.46007969975471497
colorectal B-Disease 1 1.0
, I-Disease 0 0.00013355469855014235
breast I-Disease 1 1.0
and I-Disease 0 1.9876713608368846e-08
other I-Disease 0 4.917120488556748e-09
cancers I-Disease 0 0.001196816097944975
were O 0 2.0196831707064433e-10
compared O 0 2.8155694442588697e-10
between O 0 4.873216830070248e-10
genotyped O 0 2.2005058326612925e-06
I1307K O 0 1.584846387459038e-07
carriers O 0 6.289497256339871e-10
and O 0 2.976484059225015e-10
non O 0 5.096657762493351e-09
- O 0 3.062020415001143e-09
carriers O 0 2.408058752401132e-10
and O 0 7.663104178989855e-11
their O 0 1.5054740787334708e-10
first O 0 9.151444047006407e-10
- O 0 5.1002395196064754e-08
degree O 0 7.751064146077624e-08
relatives O 0 2.7138415958916084e-08
. O 0 9.141089662989543e-08

Sperm O 0 6.292479071134949e-08
DNA O 0 1.0725198507088862e-08
analysis O 0 2.4067470238975375e-09
in O 0 1.9317520916217745e-09
a O 0 7.608934993186267e-08
Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
premutation O 1 0.9999992847442627
carrier O 0 2.689827738322492e-07
suggests O 0 3.2457947440889257e-08
both O 0 3.3019162959391224e-09
meiotic O 0 4.845508669859555e-07
and O 0 2.8149116815257003e-08
mitotic O 0 2.8308166477586383e-08
expansion O 0 9.728746164228141e-08
in O 0 3.102005319277623e-09
the O 0 5.449011908353896e-08
FRDA B-Disease 1 0.9965943694114685
gene O 0 4.915257250104332e-07
. O 0 5.287078579385707e-07

Friedreich B-Disease 1 1.0
ataxia I-Disease 1 1.0
is O 0 1.4550580999639351e-05
usually O 0 2.674142862701956e-08
caused O 0 6.585860745644823e-09
by O 0 1.5190913804641326e-10
an O 0 7.116230382742117e-10
expansion O 0 9.91026425367636e-08
of O 0 1.0958412133277307e-07
a O 0 6.274454023014187e-08
GAA O 0 8.55034013511613e-05
trinucleotide O 0 1.1489654752949718e-05
repeat O 0 1.0588751564455379e-07
in O 0 2.480480265631968e-09
intron O 0 1.5816408449609298e-07
1 O 0 4.9514934374883524e-08
of O 0 3.831548767152526e-08
the O 0 8.278836105546361e-08
FRDA B-Disease 1 0.998982846736908
gene O 0 2.2132037713618047e-07
. O 0 2.7901555199605355e-07

Occasionally O 0 1.8073482124236762e-06
, O 0 2.593480452617314e-08
a O 0 6.118871631599632e-09
fully O 0 2.1799467120331428e-08
expanded O 0 5.56012791363969e-09
allele O 0 1.3096492779141045e-09
has O 0 2.486518491107148e-10
been O 0 2.1196963628788978e-10
found O 0 3.438532097943536e-11
to O 0 8.660278050243164e-11
arise O 0 4.692107813397683e-10
from O 0 1.0537421629708277e-10
a O 0 1.5051963009327096e-09
premutation O 0 1.148544924944872e-06
of O 0 8.26080750471192e-08
100 O 0 6.686093456664821e-08
or O 0 7.768807819275025e-09
less O 0 2.733509596453132e-08
triplet O 0 4.097808414371684e-06
repeats O 0 4.605621768405399e-07
. O 0 4.733506386855879e-07

We O 0 2.847110636139405e-07
have O 0 2.478824923102252e-09
examined O 0 8.895878700343474e-09
the O 0 1.483908218524732e-09
sperm O 0 1.4738936460201302e-10
DNA O 0 1.5518512030965326e-09
of O 0 5.624274379556482e-09
a O 0 1.4490532329602956e-08
premutation O 0 2.4590897737652995e-05
carrier O 0 7.289635277629714e-07
. O 0 7.390716518784757e-07

This O 0 9.11467878950134e-08
mans O 0 5.054152552474989e-06
leucocyte O 0 2.764885493888869e-06
DNA O 0 2.1424360951982635e-08
showed O 0 2.222356076941878e-09
one O 0 3.570479745196309e-10
normal O 0 6.061022794767723e-10
allele O 0 1.4817860827243123e-10
and O 0 2.396677023508431e-10
one O 0 5.774716815842851e-10
allele O 0 8.117880812008593e-10
of O 0 1.2798439641414916e-08
approximately O 0 1.4216711363701506e-08
100 O 0 3.417411775785695e-08
repeats O 0 7.672182533724481e-08
. O 0 1.5012953724635736e-07

His O 0 1.2417240213835612e-06
sperm O 0 7.959473968810471e-09
showed O 0 4.700494216081097e-09
an O 0 2.874811222408624e-10
expanded O 0 2.4803572529208395e-09
allele O 0 1.3329655157434672e-09
in O 0 6.391467355371105e-10
a O 0 8.516285454618355e-09
tight O 0 3.337305827244563e-07
range O 0 1.4691973149183468e-07
centering O 0 1.0269059202983044e-07
on O 0 9.52166523404685e-09
a O 0 1.7439214516912216e-09
size O 0 4.7177306505830074e-09
of O 0 1.8682454694385342e-08
approximately O 0 1.731344667632584e-08
320 O 0 3.077664700867899e-07
trinucleotide O 0 2.890683572331909e-05
repeats O 0 1.0483354344614781e-06
. O 0 8.823234338706243e-07

His O 0 4.9303125706501305e-06
affected O 0 1.3698281691176817e-06
son O 0 1.1851744829982636e-06
has O 0 1.269692706529213e-08
repeat O 0 2.6685025744654922e-08
sizes O 0 8.360427017350958e-09
of O 0 2.2361250628932794e-08
1040 O 0 3.083231945311127e-07
and O 0 3.917282143106604e-08
540 O 0 1.9600063296820736e-06
. O 0 4.158877402460348e-07

These O 0 4.0451162419685716e-08
data O 0 5.530850444301905e-09
suggest O 0 9.701017766872155e-10
that O 0 6.270879648884176e-11
expansion O 0 5.516521905946092e-09
occurs O 0 7.832046816647065e-11
in O 0 1.9735961129252466e-11
two O 0 5.3563861679428726e-11
stages O 0 1.7794979934038224e-09
, O 0 2.159715045690902e-10
the O 0 8.098703929704243e-10
first O 0 1.0459593191569638e-09
during O 0 2.577211111187694e-09
meiosis O 0 3.437617301926821e-09
followed O 0 1.1173514335993673e-09
by O 0 4.2466946625907553e-10
a O 0 6.413427566798191e-09
second O 0 4.958108590358279e-08
mitotic O 0 2.090532973397785e-07
expansion O 0 5.744622285419609e-06
. O 0 1.4154907148622442e-06

We O 0 3.2187120524440616e-08
also O 0 1.0704838127040261e-09
show O 0 5.526418767054508e-10
that O 0 2.184276023942111e-11
in O 0 4.158862490499793e-11
all O 0 1.1997879079128637e-10
informative O 0 4.311277557178528e-09
carrier O 0 1.8716541649865803e-09
father O 0 1.1661133170193239e-09
to O 0 1.550247014092676e-10
affected O 0 2.1938688643530213e-09
child O 0 1.2546150784942256e-09
transmissions O 0 8.720085209468209e-10
, O 0 4.7034133532353195e-11
with O 0 1.7866654336562426e-11
the O 0 5.896682031547584e-10
notable O 0 3.276970472754215e-09
exception O 0 3.0785698434954156e-09
of O 0 8.663260331331912e-09
the O 0 1.3145800892289117e-08
premutation O 0 3.0675603284180397e-06
carrier O 0 1.1042586400833443e-08
, O 0 2.0789048260638765e-09
the O 0 7.461790296758863e-09
expansion O 0 1.0175550357871543e-07
size O 0 3.7222022797323007e-08
decreases O 0 8.253310568306915e-08
. O 0 2.6887549964271784e-08
. O 0 3.451304451118631e-07

The O 0 1.3380833934206748e-06
R496H O 0 1.151200649474049e-05
mutation O 0 2.6778588235742973e-08
of O 0 4.51215349528411e-08
arylsulfatase O 0 0.00017029403534252197
A O 0 2.96110738418065e-06
does O 0 1.9788686245192366e-08
not O 0 1.5314864043602938e-08
cause O 0 1.8606407365950872e-06
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
. O 0 1.67928865266731e-05

Deficiency B-Disease 1 0.9999926090240479
of I-Disease 0 3.16050645778887e-05
arylsulfatase I-Disease 1 0.9999997615814209
A I-Disease 1 0.5791807770729065
( O 0 1.3953366817531787e-07
ARSA O 1 0.9999998807907104
) O 0 1.450737308061889e-08
enzyme O 0 1.259569248901471e-08
activity O 0 1.3020483358161528e-08
causes O 0 1.267970191065615e-07
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 1.3513820249499986e-06
MLD B-Disease 1 1.0
) O 0 7.182700301200384e-07
. O 0 8.452012139059661e-07

A O 0 6.760687938367482e-07
number O 0 1.6628503018978336e-08
of O 0 1.4320228558517556e-07
ARSA O 1 0.9999977350234985
gene O 0 8.986608435179733e-08
mutations O 0 1.2842333418916496e-08
responsible O 0 1.6418889359215427e-08
for O 0 2.3230210643987448e-08
MLD B-Disease 1 1.0
have O 0 2.510098973118602e-08
been O 0 1.3830074863108166e-08
identified O 0 1.3348285143877092e-08
. O 0 7.289622772077564e-08

Recently O 0 1.0225820687992382e-06
, O 0 2.2843728686439135e-08
the O 0 2.0732157324232503e-08
R496H O 0 1.7362046946800547e-06
mutation O 0 1.2913885072407538e-08
of O 0 6.07146475317677e-08
ARSA O 1 0.9999959468841553
was O 0 7.179742311791415e-08
proposed O 0 5.4218882716838834e-09
to O 0 6.116814832424211e-10
be O 0 3.877597132273536e-10
a O 0 5.794686952498296e-10
cause O 0 1.7642435068410123e-08
of O 0 3.467794442713057e-07
MLD B-Disease 1 1.0
( O 0 5.155017390734429e-08
Draghia O 0 2.1139418095117435e-05
et O 0 1.0320860610590898e-07
al O 0 2.8363725590452304e-08
. O 0 2.4250774721679136e-09
, O 0 6.2956697632898795e-09
1997 O 0 9.106111775736281e-08
) O 0 3.3838460922197555e-08
. O 0 3.143923379411717e-07

We O 0 2.972748802676506e-07
have O 0 4.927861230186181e-09
investigated O 0 2.392860842803657e-08
the O 0 6.323928047891059e-09
R496H O 0 7.08276274963282e-07
mutation O 0 1.044545783202011e-09
and O 0 4.313627788299357e-10
found O 0 1.5571992306728788e-10
this O 0 4.920286400533769e-11
mutation O 0 2.058127557269529e-10
at O 0 1.495500945303263e-09
a O 0 5.319776286150102e-10
relatively O 0 3.8466438367912303e-10
high O 0 1.6246581857615183e-09
frequency O 0 1.1819283052272311e-10
in O 0 3.624395228385424e-11
an O 0 6.913365713234754e-11
African O 0 1.1865068649807853e-10
American O 0 1.6036970362787173e-10
population O 0 6.570731805877195e-12
( O 0 1.0987944061569e-11
f O 0 2.348673033836235e-09
= O 0 7.61662344306302e-10
0 O 0 1.1120531162589486e-09
. O 0 2.5091054234316346e-10
09 O 0 3.671768240565143e-07
, O 0 3.609882837096734e-09
n O 0 9.064294204108592e-09
= O 0 1.8520172062608253e-08
61 O 0 6.257482709770557e-08
subjects O 0 1.375635179101664e-07
) O 0 2.1960387286412697e-08
. O 0 1.934581774776234e-07

The O 0 5.1715810513996985e-06
ARSA O 0 0.0009393856162205338
enzyme O 0 1.4932670211464938e-08
activity O 0 1.055331710908547e-09
in O 0 6.500292665245766e-11
subjects O 0 1.1447304215650433e-09
with O 0 1.689368957225046e-11
and O 0 1.4619551402805797e-10
without O 0 3.4023714401421046e-10
the O 0 2.1287080986809315e-09
R496H O 0 2.6944385922433867e-07
mutation O 0 1.0445617704135657e-09
was O 0 1.974999053189208e-09
determined O 0 1.2234451229886645e-09
and O 0 8.47381387281132e-10
found O 0 5.328367191914651e-10
to O 0 1.6656397372472043e-09
be O 0 5.040471151573911e-09
normal O 0 1.7172857269542874e-07
. O 0 2.6667225938581396e-07

It O 0 1.3720935498895415e-07
is O 0 1.3287980493714713e-08
therefore O 0 1.394896309570015e-09
concluded O 0 1.5343567527636992e-09
that O 0 4.85617865364496e-11
the O 0 1.5775886152979979e-09
R496H O 0 2.7846394345942826e-07
mutation O 0 3.587787178460644e-09
of O 0 2.6397387387078197e-08
ARSA O 1 0.9666976928710938
does O 0 2.7105653277459396e-09
not O 0 2.1760726554020948e-10
negatively O 0 7.953248060132978e-10
influence O 0 1.4022026872950732e-09
the O 0 1.1645906461410505e-09
activity O 0 8.707504162153157e-10
of O 0 4.760512872792333e-09
ARSA O 1 0.9863654375076294
and O 0 1.5010686027494557e-08
is O 0 2.1366728386595923e-09
not O 0 4.537055453557315e-10
a O 0 5.446193274138977e-09
cause O 0 2.4749033400439657e-07
of O 0 9.347183549834881e-06
MLD B-Disease 1 1.0

Down O 0 1.0335459592170082e-05
- O 0 5.647075909109844e-07
regulation O 0 1.0090627000636232e-07
of O 0 4.995613522851272e-08
transmembrane O 0 3.784809052831406e-07
carbonic O 0 1.3906241292716004e-05
anhydrases O 0 0.000235270825214684
in O 0 4.820839905050889e-08
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 4.912327767669922e-06
by O 0 4.137172826546021e-09
wild O 0 8.330469427164644e-06
- O 0 3.743858997040661e-06
type O 0 1.1648021427390631e-06
von B-Disease 1 0.999998927116394
Hippel I-Disease 1 1.0
- I-Disease 1 0.9953662157058716
Lindau I-Disease 0 0.10175276547670364
transgenes O 0 0.00031275508808903396
. O 0 2.514920879548299e-06

To O 0 3.368224952282617e-07
discover O 0 3.48979583009168e-08
genes O 0 1.6987280471170152e-09
involved O 0 7.71187613768376e-10
in O 0 1.1738365834901288e-09
von B-Disease 1 0.9999240636825562
Hippel I-Disease 1 1.0
- I-Disease 1 1.0
Lindau I-Disease 1 1.0
( O 0 3.5905688378079503e-07
VHL B-Disease 1 1.0
) O 0 3.9061205825419165e-08
- O 0 1.5511852780036861e-06
mediated O 0 1.4692547267713962e-07
carcinogenesis O 1 0.9917575716972351
, O 0 1.680058425712616e-09
we O 0 5.837240135697641e-10
used O 0 7.440699612004664e-09
renal B-Disease 1 1.0
cell I-Disease 1 0.9999998807907104
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 0 0.007604382932186127
stably O 0 1.1021955288015306e-05
transfected O 0 1.440888866000023e-07
with O 0 1.3764173134589441e-09
wild O 0 9.200068689096952e-07
- O 0 4.750922926177736e-06
type O 0 3.7711645290983142e-06
VHL O 1 1.0
- O 0 2.609480361570604e-05
expressing O 0 5.077653213447775e-07
transgenes O 0 1.5612682545906864e-05
. O 0 3.856484909192659e-07

Large O 0 6.763880264770705e-07
- O 0 2.7535261892808194e-07
scale O 0 2.037849355929211e-07
RNA O 0 1.1180112124975494e-07
differential O 0 2.334707893680843e-08
display O 0 1.4545803672660895e-08
technology O 0 5.588963958302884e-09
applied O 0 1.9830921349495156e-09
to O 0 1.600146543045966e-10
these O 0 1.6727290386153726e-10
cell O 0 6.432069321604672e-10
lines O 0 3.03273761659284e-09
identified O 0 4.800740360799693e-10
several O 0 4.4369108387343204e-10
differentially O 0 1.78903469816305e-08
expressed O 0 1.0204657119317062e-09
genes O 0 4.773148543080197e-10
, O 0 3.1744754047657864e-10
including O 0 6.03621874706306e-10
an O 0 2.6069142400331202e-09
alpha O 0 3.1203376238408964e-07
carbonic O 0 6.581520665349672e-06
anhydrase O 0 1.966154195542913e-05
gene O 0 1.003133078825158e-07
, O 0 7.247352584727196e-08
termed O 0 8.972579053079244e-06
CA12 O 1 0.9999996423721313
. O 0 9.772413250175305e-06

The O 0 8.292868756143434e-07
deduced O 0 7.782737299066866e-08
protein O 0 3.5153877586679982e-09
sequence O 0 9.204380591043559e-10
was O 0 2.6845310419076895e-09
classified O 0 6.699686139199912e-09
as O 0 8.63073279511184e-10
a O 0 6.826755272193452e-10
one O 0 4.620649973752222e-10
- O 0 1.0183006082797874e-07
pass O 0 2.3237197410708177e-07
transmembrane O 0 1.8616653107983439e-07
CA O 0 0.0008550810161978006
possessing O 0 2.5931768732334604e-07
an O 0 3.0544664575415936e-09
apparently O 0 1.037159069738891e-08
intact O 0 2.387353958965832e-08
catalytic O 0 3.056227981801385e-08
domain O 0 4.756972593611408e-09
in O 0 6.527318685556338e-10
the O 0 1.3646285879076459e-08
extracellular O 0 1.697309130577196e-06
CA O 1 0.9707367420196533
module O 0 8.346341019205283e-06
. O 0 1.0941824939436628e-06

Reintroduced O 0 7.889811968198046e-05
wild O 0 2.6622794393915683e-05
- O 0 1.856733979366254e-05
type O 0 3.0296287150122225e-06
VHL B-Disease 0 0.029023880138993263
strongly O 0 5.6451483487762744e-08
inhibited O 0 2.18968132514874e-08
the O 0 5.588643769982582e-09
overexpression O 0 1.948553318698032e-08
of O 0 1.930986925913203e-08
the O 0 1.5000324538050336e-08
CA12 O 1 0.9999364614486694
gene O 0 1.196376664402976e-09
in O 0 2.730479176094036e-10
the O 0 5.150896598138388e-09
parental O 0 9.748203410708811e-06
renal B-Disease 1 1.0
cell I-Disease 1 1.0
carcinoma I-Disease 1 1.0
cell O 1 1.0
lines O 1 0.9998726844787598
. O 0 3.4507295367802726e-06

Similar O 0 4.553827182007808e-08
results O 0 2.3651982594685705e-09
were O 0 3.3401295618240567e-10
obtained O 0 2.643656127343519e-10
with O 0 5.603028596645743e-10
CA9 O 0 5.039794268668629e-05
, O 0 3.380586477419456e-09
encoding O 0 3.5776188678227072e-09
another O 0 3.342144783147205e-09
transmembrane O 0 2.839338897331345e-08
CA O 0 4.022388111479813e-06
with O 0 3.99681310270239e-09
an O 0 9.481794016608092e-09
intact O 0 5.94927598740469e-07
catalytic O 0 3.852474492305191e-06
domain O 0 1.0612717460389831e-06
. O 0 3.9206838664540555e-07

Although O 0 6.738005708939454e-08
both O 0 9.672015188755267e-09
domains O 0 3.629436662322405e-08
of O 0 4.829214717005925e-08
the O 0 4.645211504339386e-08
VHL B-Disease 0 0.00016184165724553168
protein O 0 5.0875863522037434e-09
contribute O 0 1.0025469343588611e-09
to O 0 1.9175590282305421e-10
regulation O 0 2.3140263039067577e-08
of O 0 1.701606038295722e-07
CA12 O 1 1.0
expression O 0 1.4636251322031057e-08
, O 0 1.5915364581786662e-09
the O 0 5.35377697730155e-09
elongin O 0 1.0287305940437363e-06
binding O 0 3.619384969510975e-08
domain O 0 5.285313520175805e-08
alone O 0 8.71400462898464e-09
could O 0 6.2954415014360166e-09
effectively O 0 3.7371916050688014e-07
regulate O 0 5.7402521633775905e-06
CA9 O 1 0.9906631708145142
expression O 0 4.011856162833283e-06
. O 0 1.1757192623917945e-06

We O 0 1.069908648787532e-06
mapped O 0 6.114410552982008e-06
CA12 O 1 0.9999934434890747
and O 0 1.94905737771478e-06
CA9 O 0 0.0017923127161338925
loci O 0 6.062682018637133e-07
to O 0 2.8284203423822873e-08
chromosome O 0 5.812049153064436e-08
bands O 0 5.228961299508228e-07
15q22 O 0 1.4484484381682705e-05
and O 0 2.3180601260719413e-07
17q21 O 0 7.117296627257019e-05
. O 0 1.8441131715007941e-06

2 O 0 7.556563446087239e-07
respectively O 0 5.938279556971793e-08
, O 0 1.1414322820257894e-08
regions O 0 7.389405709545827e-08
prone O 0 2.1345196898892027e-07
to O 0 1.898809109945887e-09
amplification O 0 3.1097791008960485e-08
in O 0 2.3250588121470628e-09
some O 0 1.0214476375836057e-08
human O 0 1.4406622028673155e-07
cancers B-Disease 1 0.9996755123138428
. O 0 7.282908995875914e-07

Additional O 0 9.971108028139497e-08
experiments O 0 7.973224747104268e-09
are O 0 3.5598021058680374e-11
needed O 0 1.2339861077403924e-10
to O 0 3.908052353951419e-11
define O 0 4.787398810712773e-10
the O 0 1.753212297561646e-10
role O 0 5.154707216625809e-10
of O 0 7.001151658414528e-09
CA O 0 1.2230080756125972e-05
IX O 1 0.9999996423721313
and O 0 5.590992202542111e-08
CA O 0 2.25806452363031e-05
XII O 1 0.998023271560669
enzymes O 0 2.3980775143428446e-09
in O 0 3.863791508962322e-10
the O 0 1.4623101618482792e-09
regulation O 0 1.3712871727022957e-08
of O 0 4.080496829317326e-09
pH O 0 3.270353232665002e-08
in O 0 2.35415242855197e-10
the O 0 1.4020662408853468e-09
extracellular O 0 7.441863569823681e-09
microenvironment O 0 6.875974634112936e-08
and O 0 1.4113038515617404e-09
its O 0 2.2152801815167322e-09
potential O 0 9.570571890549218e-09
impact O 0 3.6793213809005465e-08
on O 0 1.6345529729733244e-07
cancer B-Disease 0 5.481385414896067e-06
cell O 0 1.8958540692892711e-07
growth O 0 4.71743618390974e-07
. O 0 3.666131362933811e-07

A O 0 1.935387672347133e-06
gene O 0 1.178287600822614e-08
encoding O 0 7.21535329262224e-08
a O 0 1.3855103730975316e-08
transmembrane O 0 5.418397108769568e-08
protein O 0 5.229560073871653e-08
is O 0 1.45687295560748e-09
mutated O 0 8.566153120170839e-09
in O 0 1.549877309825476e-10
patients O 0 1.0495504465524164e-09
with O 0 7.366956822352222e-09
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
( O 1 0.9999998807907104
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 4.300389733202792e-08
. O 0 1.5507370676459686e-07

Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 2.485441291355528e-05
WFS B-Disease 1 1.0
; O 0 4.899233090327471e-07
OMIM O 1 0.9999998807907104
222300 O 0 2.4475135433021933e-05
) O 0 5.8480749132172605e-09
is O 0 1.2102667756863639e-09
an O 0 1.0458340859997861e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
neurodegenerative I-Disease 1 1.0
disorder I-Disease 1 1.0
defined O 0 5.654790857789749e-09
by O 0 9.483196172777042e-11
young O 0 8.437224252588749e-09
- O 0 1.2580381962834508e-06
onset O 0 0.0002867463626898825
non O 1 0.9972201585769653
- O 1 0.5636281371116638
immune O 0 6.354370270855725e-05
insulin B-Disease 1 0.9999964237213135
- I-Disease 1 1.0
dependent I-Disease 1 0.8068483471870422
diabetes I-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9649096727371216
progressive O 1 1.0
optic B-Disease 1 1.0
atrophy I-Disease 1 1.0
. O 0 4.1076440538745373e-05

Linkage O 0 1.1648104191408493e-05
to O 0 8.245348936952723e-08
markers O 0 5.261029514258553e-07
on O 0 2.4473882831443916e-07
chromosome O 0 5.393166020439821e-07
4p O 0 5.288982265483355e-06
was O 0 3.4431835160830815e-08
confirmed O 0 3.686126071045237e-09
in O 0 1.419275474923154e-09
five O 0 7.494039166999755e-09
families O 0 4.746810167155502e-10
. O 0 4.058067659684639e-08

On O 0 1.7218347636571707e-07
the O 0 1.003530769594363e-08
basis O 0 3.3493494644432076e-09
of O 0 1.45469130075071e-08
meiotic O 0 8.333846380992327e-06
recombinants O 1 0.9999983310699463
and O 0 5.012794304093404e-07
disease O 0 0.07123524695634842
- O 0 1.6052602802574256e-07
associated O 0 6.707792987725725e-09
haplotypes O 0 3.113286695111128e-08
, O 0 1.863187826245394e-09
the O 0 4.0066456818976803e-08
WFS B-Disease 1 0.9996520280838013
gene O 0 4.002147235837583e-08
was O 0 4.406167519732662e-08
localized O 0 1.6244625840045046e-06
to O 0 3.505286017002618e-08
a O 0 3.539219903814228e-07
BAC O 1 1.0
/ O 0 3.8655281969113275e-05
P1 O 0 0.0014019166119396687
contig O 0 1.2373995559755713e-05
of O 0 9.130565103987465e-08
less O 0 7.351123709753438e-09
than O 0 2.5377198120679623e-09
250 O 0 1.1830870505491475e-07
kb O 0 2.5963914595195092e-05
. O 0 1.195733830172685e-06

Mutations O 0 1.358684329488824e-07
in O 0 5.376412648416817e-09
a O 0 8.890179259424258e-09
novel O 0 1.373083193811908e-07
gene O 0 3.223828315412902e-09
( O 0 9.32798949193625e-10
WFS1 O 0 0.3109190762042999
) O 0 1.2467453736064726e-09
encoding O 0 3.6159883975983576e-09
a O 0 2.1658377313826804e-09
putative O 0 2.0836457892414728e-08
transmembrane O 0 1.3393137709982739e-09
protein O 0 3.6209560350108916e-10
were O 0 6.033751970280221e-11
found O 0 1.5614426418508742e-11
in O 0 1.4793341898688972e-11
all O 0 7.850037980761115e-11
affected O 0 2.257498354918397e-10
individuals O 0 7.911934996052139e-12
in O 0 7.215398417637076e-11
six O 0 4.35593650038868e-09
WFS B-Disease 0 0.00035079088411293924
families O 0 8.678931184835648e-11
, O 0 8.949990054629708e-11
and O 0 1.3391751596536494e-10
these O 0 1.811689687158946e-10
mutations O 0 9.425239755334047e-11
were O 0 3.156843189633385e-11
associated O 0 1.0122246096866405e-10
with O 0 4.1035030928782135e-10
the O 0 1.1766946528268818e-07
disease O 0 3.337119778734632e-05
phenotype O 0 3.124858096725802e-07
. O 0 2.0969986280761077e-07

WFS1 O 1 0.9999992847442627
appears O 0 1.6496635169005458e-07
to O 0 1.6552675896619462e-09
function O 0 1.5723765622865926e-09
in O 0 4.32537616834594e-10
survival O 0 7.152092251772046e-08
of O 0 2.9285862623851244e-08
islet O 0 7.618208201165544e-06
beta O 0 1.6019156134916557e-07
- O 0 2.185675924692987e-07
cells O 0 5.010065140531594e-10
and O 0 1.6892095500153914e-09
neurons O 0 1.945070238207336e-08
. O 0 1.0959118945663704e-08
. O 0 1.561402456218275e-07

Stable O 0 1.6170001799764577e-06
interaction O 0 4.29284785496975e-09
between O 0 4.0173395166043235e-10
the O 0 7.698796045119138e-10
products O 0 3.416960492330645e-09
of O 0 4.9466386542462715e-09
the O 0 3.358870515057788e-08
BRCA1 O 0 4.913152906738105e-07
and O 0 1.2141383365360525e-07
BRCA2 O 0 8.246170182246715e-06
tumor B-Disease 0 4.3520044528122526e-06
suppressor O 0 5.639982418870204e-07
genes O 0 3.989859109765348e-09
in O 0 1.3452867708707572e-09
mitotic O 0 2.262673604036536e-08
and O 0 2.5103574330387346e-08
meiotic O 0 1.067505763785448e-05
cells O 0 1.1414676492904618e-07
. O 0 2.7321004836267093e-07

BRCA1 O 0 3.339828981552273e-05
and O 0 2.5427584660064895e-07
BRCA2 O 0 7.618569384248985e-07
account O 0 2.9829005931958363e-10
for O 0 5.435716807222768e-11
most O 0 5.314864867655977e-11
cases O 0 6.834972865465971e-11
of O 0 1.1865662896681783e-09
familial O 0 2.7964449600403896e-07
, O 0 1.4465119102524682e-09
early O 0 4.268240427762748e-09
onset O 0 9.091279025597032e-06
breast B-Disease 1 1.0
and I-Disease 0 0.00017677176219876856
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 1.0412695150563422e-09
encode O 0 1.9162209319301127e-10
products O 0 1.269384597435419e-09
that O 0 3.249475341582375e-11
each O 0 8.220934349933984e-11
interact O 0 4.659377883520222e-10
with O 0 2.721366243463308e-09
hRAD51 O 0 8.203343895729631e-06
. O 0 5.414640327217057e-07

Results O 0 3.126950431919795e-08
presented O 0 1.2250663594670641e-08
here O 0 2.7613061837072905e-10
show O 0 1.369153901364939e-09
that O 0 3.1204472339396716e-10
BRCA1 O 0 4.096680328302682e-08
and O 0 1.8695750725328253e-08
BRCA2 O 0 5.618593945655448e-07
coexist O 0 6.596899027044856e-09
in O 0 2.3263975468257314e-10
a O 0 6.048042622275318e-10
biochemical O 0 7.0904917492953246e-09
complex O 0 1.0990916621267388e-08
and O 0 2.5361521771571915e-09
colocalize O 0 1.4669867596239783e-06
in O 0 7.21970083716883e-09
subnuclear O 0 1.162096577900229e-05
foci O 0 8.298374609694292e-07
in O 0 1.5413377241202397e-09
somatic O 0 9.582334037361306e-09
cells O 0 1.004008404192902e-10
and O 0 1.770900232012096e-10
on O 0 1.670306781775821e-09
the O 0 1.005480698701433e-09
axial O 0 1.436970631374379e-08
elements O 0 3.824530026008688e-09
of O 0 1.1130723009955545e-08
developing O 0 3.648391810884277e-08
synaptonemal O 0 1.1347505278536119e-05
complexes O 0 7.316980372706894e-07
. O 0 3.7017665022176516e-07

Like O 0 3.5781167753157206e-06
BRCA1 O 0 3.0641365356132155e-06
and O 0 1.6515714662546088e-07
RAD51 O 1 1.0
, O 0 6.377372301358264e-07
BRCA2 O 0 2.7819580736831995e-06
relocates O 0 1.209212285857575e-07
to O 0 5.555103932408656e-09
PCNA O 0 2.7059828425990418e-05
+ O 0 1.787008940823398e-08
replication O 0 1.6229732002770447e-09
sites O 0 8.250186089853173e-10
following O 0 6.711987077245851e-10
exposure O 0 5.3091582685738103e-08
of O 0 2.177150193460875e-08
S O 0 3.8499288734783477e-07
phase O 0 1.6446879413933857e-08
cells O 0 4.717629065176254e-10
to O 0 4.890127858203641e-09
hydroxyurea O 0 6.5549738792469725e-06
or O 0 1.1448351955323233e-07
UV O 1 0.9999997615814209
irradiation O 0 1.9296086975373328e-05
. O 0 6.50290644443885e-07

Thus O 0 4.623387610536156e-07
, O 0 4.959612454058515e-08
BRCA1 O 0 8.689908526093859e-08
and O 0 1.6090021759396222e-08
BRCA2 O 0 1.0857549170850689e-07
participate O 0 6.756673553987014e-10
, O 0 1.4783138602147972e-10
together O 0 7.680077407368202e-11
, O 0 1.251975190186272e-10
in O 0 1.1158601126437517e-10
a O 0 8.092450043406529e-10
pathway O 0 3.838217299545477e-09
( O 0 1.922609432769562e-10
s O 0 1.3380601071588671e-09
) O 0 1.6391861826225984e-11
associated O 0 4.5506598489453154e-11
with O 0 3.220506500367648e-11
the O 0 2.29579272259528e-10
activation O 0 5.735572017329105e-10
of O 0 2.9061213435710442e-09
double O 0 1.3825215416929382e-09
- O 0 2.5362888678159834e-08
strand O 0 6.57135545978349e-09
break O 0 1.4946062165677176e-08
repair O 0 5.951727999331524e-08
and O 0 1.5668538466684367e-08
/ O 0 2.5119146584984264e-07
or O 0 4.155187305343588e-09
homologous O 0 5.896730659316063e-09
recombination O 0 2.4813237686771572e-08
. O 0 1.5805628095222346e-07

Dysfunction O 0 0.03384191542863846
of O 0 3.339578995564807e-07
this O 0 1.2383910563684708e-09
pathway O 0 7.38482341944291e-09
may O 0 1.2782226666008256e-10
be O 0 1.0069195477413473e-10
a O 0 1.4778402113169165e-10
general O 0 3.065338260999084e-10
phenomenon O 0 3.5935998621283716e-10
in O 0 2.4727168229654595e-11
the O 0 1.5529577623851765e-10
majority O 0 1.7656816980737844e-11
of O 0 1.9624186997635462e-10
cases O 0 5.766011001995253e-10
of O 0 1.242575393689549e-07
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
/ I-Disease 1 1.0
or I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.636251750232077e-08
. O 0 6.508688699113918e-08

A O 0 6.1734713199257385e-06
novel O 0 1.208159233101469e-06
Arg362Ser O 0 9.573580427968409e-06
mutation O 0 4.264464337211393e-09
in O 0 5.447052808804642e-10
the O 0 6.229020410586372e-09
sterol O 0 7.527305001531204e-07
27 O 0 1.6960683524303022e-07
- O 0 4.20018636759778e-07
hydroxylase O 0 5.98705128140864e-06
gene O 0 2.2072887517765594e-08
( O 0 2.018367029066326e-09
CYP27 O 1 0.9999840259552002
) O 0 1.2343467359343663e-09
: O 0 7.663030626714473e-11
its O 0 2.8710575583623665e-10
effects O 0 9.06607500184009e-09
on O 0 5.437090777604681e-09
pre O 0 5.151764170818751e-08
- O 0 1.2318896125407264e-08
mRNA O 0 3.5124052555346452e-09
splicing O 0 2.644272800722547e-09
and O 0 1.070696198368637e-09
enzyme O 0 4.8388932860632394e-09
activity O 0 1.511964597966653e-08
. O 0 5.268706360084252e-08

A O 0 2.4741439119679853e-06
novel O 0 2.61575223703403e-07
C O 0 7.747768648869169e-08
to O 0 8.192230782633203e-10
A O 0 2.7307946126597926e-08
mutation O 0 3.6351277543644755e-10
in O 0 2.21914431275394e-10
the O 0 2.8895288384234163e-09
sterol O 0 2.8693204967567e-07
27 O 0 4.9020183467973766e-08
- O 0 1.1895709661757792e-07
hydroxylase O 0 1.5889582982708816e-06
gene O 0 9.937441980412132e-09
( O 0 1.0480580847627152e-09
CYP27 O 1 0.9999061822891235
) O 0 6.998157608961719e-10
was O 0 3.226233724618055e-09
identified O 0 1.9582684085417412e-10
by O 0 4.413141727055425e-11
sequencing O 0 1.3667385445614855e-08
amplified O 0 1.44678097058204e-07
CYP27 O 1 0.9999462366104126
gene O 0 2.141086863360897e-09
products O 0 4.545312126680301e-09
from O 0 1.5263988684122154e-10
a O 0 3.833606210257301e-10
patient O 0 1.7134560437170876e-09
with O 0 1.1550562728501745e-09
cerebrotendinous B-Disease 1 1.0
xanthomatosis I-Disease 1 1.0
( O 0 1.0451719845150365e-06
CTX B-Disease 1 1.0
) O 0 1.4292233174728608e-07
. O 0 4.626624843240279e-07

The O 0 7.534903261330328e-07
mutation O 0 5.01523302887108e-08
changed O 0 1.331464360987411e-08
the O 0 1.4173229700986667e-08
adrenodoxin O 0 1.6916886806939146e-06
cofactor O 0 2.1008132122801726e-08
binding O 0 1.654864334454942e-08
residue O 0 5.696600737792323e-07
362Arg O 0 6.206536795616557e-07
to O 0 1.868159849038875e-08
362Ser O 0 6.278395630943123e-06
( O 0 2.680122435094745e-08
CGT O 0 0.002543897135183215
362Arg O 0 3.909131464752136e-06
to O 0 4.9414172309525384e-08
AGT O 1 1.0
362Ser O 0 4.791666015080409e-06
) O 0 1.6877924613467599e-09
, O 0 5.381641798862802e-10
and O 0 3.9786704486566293e-10
was O 0 4.943092601905619e-09
responsible O 0 2.35194552722362e-09
for O 0 2.9354187969232726e-09
deficiency O 0 3.7457692769748974e-07
in O 0 2.1282047235615664e-09
the O 0 4.2883002038252016e-08
sterol O 0 1.6453772104796371e-06
27 O 0 1.6570965044593322e-07
- O 0 2.4417184363301203e-07
hydroxylase O 0 1.1535857993294485e-06
activity O 0 6.392568252522324e-09
, O 0 2.544858490605151e-10
as O 0 6.245979428110005e-11
confirmed O 0 6.487856779591183e-11
by O 0 4.458940855434079e-11
expression O 0 1.50076717719827e-09
of O 0 1.6363271626573805e-08
mutant O 0 7.683429004146092e-08
cDNA O 0 5.530494817662657e-08
into O 0 2.0949073586962186e-08
COS O 0 2.6873591195908375e-05
- O 0 3.804814809882373e-07
1 O 0 1.9144114560276648e-07
cells O 0 1.0402319006175276e-08
. O 0 8.239532434117791e-08

Quantitative O 0 3.217325570403773e-07
analysis O 0 3.0302804709947395e-09
showed O 0 1.904798097029925e-09
that O 0 4.24704889312455e-11
the O 0 8.001664886236881e-10
expression O 0 1.0352158019699687e-09
of O 0 1.1524204701629515e-08
CYP27 O 0 7.277607801370323e-05
gene O 0 1.4515310065021936e-09
mRNA O 0 4.9946677904699754e-09
in O 0 7.063329920953265e-10
the O 0 9.114170751445272e-09
patient O 0 1.910813907102238e-08
represented O 0 7.3639223607813165e-09
52 O 0 2.7952930281571753e-07
. O 0 2.7870783014805056e-07

5 O 0 3.794881706653541e-07
% O 0 7.620768904814668e-09
of O 0 9.908143638881484e-09
the O 0 3.185293095953057e-08
normal O 0 1.5341591108608554e-07
level O 0 6.135984449429088e-07
. O 0 4.7329015728792e-07

As O 0 1.1183076509269085e-07
the O 0 1.895755730174642e-08
mutation O 0 1.5311087953051583e-09
occurred O 0 9.646585752420833e-10
at O 0 1.7111730921115509e-09
the O 0 1.6252996726251467e-09
penultimate O 0 1.670960969590851e-08
nucleotide O 0 1.2716285802127913e-09
of O 0 6.784869110987302e-09
exon O 0 5.2718828413844676e-08
6 O 0 3.986483321227752e-08
( O 0 2.2457141701792693e-10
- O 0 8.464835943300386e-09
2 O 0 1.0322254162531408e-08
position O 0 7.557008352421235e-09
of O 0 1.1838834801380926e-08
exon O 0 1.1096810936805923e-07
6 O 0 1.0175821785196604e-07
- O 0 1.5041845813357213e-07
intron O 0 3.737819156413025e-07
6 O 0 1.9577251819669073e-08
splice O 0 1.9638736858951233e-08
site O 0 1.8620934794100208e-09
) O 0 1.032726543170881e-10
of O 0 6.902222127180835e-10
the O 0 1.205980870722101e-09
gene O 0 8.791076755443328e-10
, O 0 5.967215055413533e-10
we O 0 5.018730431238794e-10
hypothesized O 0 2.8424149700612134e-09
that O 0 3.6443178336176274e-11
the O 0 9.393513744626603e-10
mutation O 0 1.9866697176240677e-09
may O 0 3.602150244752522e-10
partially O 0 1.7450270561880643e-08
affect O 0 9.132472555961613e-10
the O 0 3.8608743979651194e-10
normal O 0 2.364728135528793e-10
splicing O 0 1.879580935337799e-10
efficiency O 0 1.1284757572838089e-09
in O 0 2.687070566054217e-10
exon O 0 3.835314288380687e-08
6 O 0 1.202728761029448e-08
and O 0 7.608376151324592e-10
cause O 0 7.851629346689037e-10
alternative O 0 4.735054570659258e-10
splicing O 0 5.107534950532511e-10
elsewhere O 0 4.61819138486419e-10
, O 0 1.4549146609699193e-10
which O 0 1.0077610967940132e-10
resulted O 0 3.986686536450179e-09
in O 0 5.509474543252679e-10
decreased O 0 2.3574260765713007e-08
transcript O 0 1.2546491845455421e-08
in O 0 3.5039475765330508e-09
the O 0 1.0295752161937344e-07
patient O 0 1.6133022029407584e-07
. O 0 1.9272196993824764e-07

Transfection O 0 2.491345412636292e-06
of O 0 1.4442387907820375e-07
constructed O 0 1.5632231509243866e-07
minigenes O 0 2.012315690080868e-06
, O 0 9.944907120029711e-10
with O 0 1.2651443781486194e-10
or O 0 2.487951233920427e-10
without O 0 2.7888669151820977e-10
the O 0 5.456265439462982e-10
mutation O 0 3.5292796463082254e-10
, O 0 3.702937956262531e-10
into O 0 2.7437621064052564e-09
COS O 0 8.336533028341364e-06
- O 0 3.00677456266385e-08
1 O 0 6.491255533092044e-09
cells O 0 2.0107108686384656e-11
confirmed O 0 5.782991099878565e-11
that O 0 1.631531541812503e-11
the O 0 1.0792624571820397e-09
mutant O 0 7.897144627122543e-08
minigene O 0 1.2548618997243466e-06
was O 0 1.489756584760471e-08
responsible O 0 3.472226284273461e-09
for O 0 7.805326385224021e-10
a O 0 1.4304233353357176e-09
mRNA O 0 1.1270825162057463e-08
species O 0 7.438226146128102e-10
alternatively O 0 3.4364504575279398e-09
spliced O 0 4.8696069399056796e-08
at O 0 2.5725029217937845e-08
an O 0 5.090148746944578e-09
activated O 0 5.80232381253154e-07
cryptic O 0 8.758521516938345e-07
5 O 0 9.406682721646575e-08
splice O 0 6.601823088203673e-07
site O 0 1.9935646378144156e-07
88 O 0 1.9744055634873803e-07
bp O 0 2.420411604475703e-08
upstream O 0 1.7383232631118517e-08
from O 0 3.031845607903705e-10
the O 0 1.3226174599978435e-09
3 O 0 9.16556253116596e-09
end O 0 6.4418212986083745e-09
of O 0 4.780733675602278e-08
exon O 0 2.3920133571664337e-06
6 O 0 2.1548944459937047e-06
. O 0 8.164688551914878e-07

Our O 0 3.352675435053243e-07
data O 0 8.6986604586059e-09
suggest O 0 1.0952593276769562e-09
that O 0 4.9298776866324445e-11
the O 0 7.719336836409241e-10
C O 0 2.1262462013282857e-08
to O 0 6.974917310387241e-10
A O 0 2.340187066351973e-08
mutation O 0 4.4706441326702873e-10
at O 0 1.8789509947936267e-09
the O 0 1.1428977764182946e-09
penultimate O 0 1.1389639453796008e-08
nucleotide O 0 3.030134199111245e-10
of O 0 2.685391464751774e-09
exon O 0 2.1069006095331133e-08
6 O 0 1.4129126313378038e-08
of O 0 8.170669474338865e-09
the O 0 1.0842520659082311e-08
CYP27 O 1 0.9992057681083679
gene O 0 7.574018079381517e-10
not O 0 4.102749737167066e-11
only O 0 5.500944838532362e-11
causes O 0 6.985221845390299e-10
the O 0 2.9084781250077185e-09
deficiency B-Disease 0 8.13878742178531e-08
in I-Disease 0 2.3596562481742467e-09
the I-Disease 0 3.460815989342336e-08
sterol I-Disease 0 1.5402519011331606e-06
27 I-Disease 0 1.015155106642851e-07
- I-Disease 0 9.922084842628465e-08
hydroxylase I-Disease 0 3.632221421412396e-07
activity I-Disease 0 5.356984189575087e-09
, O 0 4.4028866663659016e-10
but O 0 3.062135822684553e-10
also O 0 1.4802896686205713e-09
partially O 0 5.281856729766332e-08
leads O 0 2.151210098944034e-09
to O 0 1.7112734840285526e-10
alternative O 0 9.043445992062971e-10
pre O 0 4.80506656685975e-09
- O 0 2.826617606643822e-09
mRNA O 0 1.2307147523316075e-09
splicing O 0 4.263854602726269e-09
of O 0 6.1206226753540705e-09
the O 0 1.2958124351314382e-08
gene O 0 4.7688487825325865e-08
. O 0 2.0776103326625162e-07

To O 0 5.8269005620559255e-08
our O 0 1.1308896041839489e-08
knowledge O 0 1.629542945025264e-09
, O 0 1.6284762427432042e-10
this O 0 1.2478170406671207e-11
is O 0 8.24319848491406e-11
the O 0 2.5875684928067244e-10
first O 0 2.5933194480742827e-10
report O 0 2.4374902096724327e-10
regarding O 0 2.264373355487237e-09
effects O 0 1.5151199406204796e-08
on O 0 4.280714449578227e-09
pre O 0 2.4184364733059738e-08
- O 0 1.9233110659655495e-09
mRNA O 0 2.412564314990817e-10
splicing O 0 2.358430950533119e-10
of O 0 3.561175798694194e-10
a O 0 1.1501158359017438e-10
mutation O 0 8.915607141446458e-11
at O 0 5.301057925954922e-10
the O 0 7.633567111753337e-10
- O 0 1.5152124888118124e-08
2 O 0 1.706574970228303e-08
position O 0 1.3145601052144684e-08
of O 0 1.1358659790516867e-08
a O 0 7.97026000753931e-09
5 O 0 1.2919680614231766e-07
splice O 0 2.021444288402563e-06
site O 0 1.3084872989566065e-06
. O 0 8.461900051770499e-07

ATM O 0 0.001064833952113986
germline O 0 1.0201498298556544e-05
mutations O 0 1.2450652775441995e-07
in O 0 1.0525741167555225e-08
classical O 1 0.9996980428695679
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
patients O 0 1.9965680166933453e-06
in O 0 1.039913932743275e-09
the O 0 5.817968773413895e-09
Dutch O 0 1.5143853033805499e-06
population O 0 3.745931564935745e-09
. O 0 2.5458076535755936e-08

Germline O 0 1.1793097655754536e-05
mutations O 0 3.8645396216452355e-08
in O 0 3.045885321739661e-09
the O 0 1.6431453531140505e-08
ATM O 0 9.744975386638544e-07
gene O 0 1.2116572190024044e-09
are O 0 2.6449460677202552e-11
responsible O 0 2.0202146899794826e-10
for O 0 1.9468278378287351e-10
the O 0 6.250564297261008e-07
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 1.0
telangiectasia I-Disease 1 1.0
( O 0 4.94453752253321e-06
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
) O 0 8.535267426168502e-08
. O 0 2.772426341834944e-07

In O 0 5.496821131600882e-08
our O 0 7.059750561921874e-09
study O 0 8.650508642737975e-10
, O 0 1.6922528656149183e-10
we O 0 4.865226971295655e-11
have O 0 8.457980843479262e-12
determined O 0 1.9055165778603111e-10
the O 0 5.003056302577136e-10
ATM O 0 9.881989626592258e-08
mutation O 0 4.348695570310923e-10
spectrum O 0 2.987827318889913e-09
in O 0 3.0846339371670695e-10
19 O 0 5.2375228598577905e-09
classical O 0 2.1975470332336045e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
patients O 0 2.6771884709120286e-09
, O 0 3.7888255033369234e-11
including O 0 4.786255072830592e-11
some O 0 3.386785296655148e-11
immigrant O 0 3.2310831094006787e-11
populations O 0 3.4015651406704706e-11
, O 0 2.3030808163349015e-11
as O 0 5.792495996748137e-11
well O 0 1.5617977744408762e-10
as O 0 1.7129715701447168e-10
12 O 0 1.1826595258668249e-09
of O 0 2.28105401234302e-09
Dutch O 0 3.7239212247186515e-07
ethnic O 0 2.2627340001690754e-08
origin O 0 7.0888690473225324e-09
. O 0 4.641819373318867e-08

Both O 0 9.674196377318367e-08
the O 0 3.081802546489598e-08
protein O 0 6.118311191016801e-09
truncation O 0 1.356505237026795e-07
test O 0 1.533538274145485e-08
( O 0 2.5229611733124102e-09
PTT O 0 9.179671906167641e-05
) O 0 2.40379272042901e-09
and O 0 2.6794719776290776e-09
the O 0 3.7683038911495714e-09
restriction O 0 4.074446113833119e-09
endonuclease O 0 5.579997619520327e-08
fingerprinting O 0 8.831773357087513e-08
( O 0 3.119782210347921e-09
REF O 0 1.20499714739708e-06
) O 0 7.896711062826967e-11
method O 0 6.260649637601645e-11
were O 0 8.367211437598776e-12
used O 0 1.9137582144002074e-11
and O 0 4.7893602278525904e-11
compared O 0 5.2710905085184834e-11
for O 0 2.589438038991254e-11
their O 0 1.7445118266623538e-11
detection O 0 4.864459390852005e-10
efficiency O 0 1.9222987646116962e-09
, O 0 1.2876903709990728e-10
identifying O 0 1.1100208530123723e-09
76 O 0 5.0856847622071655e-09
% O 0 2.9751544977640876e-11
and O 0 5.395020541421047e-11
60 O 0 3.575004736688925e-10
% O 0 3.316050559143413e-11
of O 0 3.3259592302492536e-10
the O 0 2.6040616329936483e-09
mutations O 0 2.4189794611828574e-09
, O 0 4.312198598199757e-09
respectively O 0 6.176752975761701e-08
. O 0 3.629198488397378e-07

Most O 0 1.392133412991825e-07
patients O 0 7.179958405600928e-09
were O 0 3.184396635269593e-10
found O 0 9.985844096060958e-11
to O 0 5.468517860762745e-10
be O 0 2.0286565760585518e-09
compound O 0 1.2913471891806694e-07
heterozygote O 0 3.4055090054607717e-06
. O 0 3.4266938087057497e-07

Seventeen O 0 2.5573381208232604e-06
mutations O 0 4.265318320761935e-09
were O 0 5.554104953731098e-10
distinct O 0 5.828272864327744e-10
, O 0 1.2308642993730246e-10
of O 0 8.563338926848019e-10
which O 0 8.8533659570178e-11
10 O 0 6.568018906527584e-10
were O 0 2.791863129569805e-10
not O 0 3.5021149868974533e-10
reported O 0 1.746645317268758e-08
previously O 0 6.244117685128003e-07
. O 0 5.490114745043684e-07

Mutations O 0 5.614555220745387e-07
are O 0 4.585953394808939e-09
small O 0 1.2888269118604967e-08
deletions O 0 2.2907566687990766e-07
or O 0 3.6063269703845435e-08
point O 0 6.5233172108492e-07
mutations O 0 4.312760282232375e-08
frequently O 0 3.004831228281546e-08
affecting O 0 3.274005280218262e-07
splice O 0 2.9189111501182197e-06
sites O 0 6.188038810250873e-07
. O 0 4.6189890667847067e-07

Moreover O 0 3.5354692045075353e-06
, O 0 1.4249022228796093e-07
a O 0 7.662822554266313e-08
16 O 0 7.418213385790295e-07
. O 0 5.690725970453059e-07

7 O 0 3.458121909716283e-06
- O 0 1.867869627858454e-06
kb O 0 3.1218783078656998e-06
genomic O 0 5.681854631234273e-08
deletion O 0 6.961709431152485e-09
of O 0 2.020643652400622e-09
the O 0 6.962635468177325e-10
3 O 0 1.7435821675348961e-09
end O 0 1.2395017234823058e-09
of O 0 1.3840675272547287e-09
the O 0 8.220154557037063e-10
gene O 0 8.767445103252669e-11
, O 0 8.341417140345087e-11
most O 0 1.2750182853960013e-10
likely O 0 5.736510572118547e-11
a O 0 5.354547361058337e-11
result O 0 1.0664114036273986e-10
of O 0 4.5468792619907106e-10
recombination O 0 1.1921932191460982e-11
between O 0 6.270209351733058e-11
two O 0 1.177401232066444e-10
LINE O 0 4.684114003339346e-07
elements O 0 7.709569871394706e-09
, O 0 1.5075465320535386e-09
was O 0 3.79955622520356e-08
identified O 0 4.941247411238692e-08
. O 0 2.0247114207450068e-07

The O 0 2.8805948204535525e-07
most O 0 5.596377139482911e-09
frequently O 0 3.733128473015768e-09
found O 0 3.684704485973356e-10
mutation O 0 1.7734251567258497e-10
, O 0 1.208151356735243e-10
identified O 0 7.426796677645342e-11
in O 0 6.900639087925597e-11
three O 0 2.0311645421156044e-10
unrelated O 0 3.305980822432275e-09
Turkish O 0 2.184608582922465e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
individuals O 0 4.1709791176458566e-10
, O 0 3.951075300268059e-10
was O 0 7.546119284995711e-09
previously O 0 1.0229644686887696e-08
described O 0 7.1429379078225e-10
to O 0 2.3959001449469497e-10
be O 0 3.8521208445274624e-10
a O 0 8.620926750246838e-10
Turkish O 0 3.016287166701659e-07
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
founder O 0 0.00011800547508755699
mutation O 0 1.6101248547784053e-06
. O 0 2.9422653824440204e-07

The O 0 2.744120024544827e-07
presence O 0 1.757881840092068e-08
of O 0 9.741687989617276e-08
a O 0 2.551286115703988e-08
founder O 0 2.149040199128649e-07
mutation O 0 3.811189586144792e-09
among O 0 3.0547506191247464e-10
relatively O 0 3.080712351888337e-10
small O 0 3.268392223532146e-10
ethnic O 0 3.2295008334237707e-10
population O 0 3.5089515928315995e-12
groups O 0 1.4702420053983034e-12
in O 0 1.8379912175570112e-11
Western O 0 6.263928487015846e-09
Europe O 0 3.093090006345278e-09
could O 0 9.799993039294463e-10
indicate O 0 3.1467692340747533e-10
a O 0 2.213116773175372e-10
high O 0 8.060597522785429e-09
carrier O 0 8.27390378432824e-10
frequency O 0 2.370039275945146e-09
in O 0 6.784011130633871e-10
such O 0 2.2874511174109102e-08
communities O 0 7.550758596153173e-08
. O 0 2.130302050318278e-07

In O 0 1.6314096740188688e-08
patients O 0 3.1106910380884756e-09
of O 0 1.979830521747772e-09
Dutch O 0 8.316201416391777e-08
ethnic O 0 6.872415969638723e-10
origin O 0 2.749789458633689e-11
, O 0 1.4369519463208746e-11
however O 0 5.8031343619369125e-11
, O 0 2.3094998136130584e-10
no O 0 1.921822256889527e-09
significant O 0 2.3649379343737564e-08
founder O 0 1.0892230051240404e-07
effect O 0 3.7903131300254245e-08
could O 0 3.944308435421817e-09
be O 0 2.9837952109090793e-09
identified O 0 1.7969414400909045e-08
. O 0 1.17538242250248e-07

The O 0 2.875177074201929e-07
observed O 0 2.009552346748933e-08
genetic O 0 4.82008388758004e-09
heterogeneity O 0 1.7806328855840547e-08
including O 0 1.8255724709703713e-09
the O 0 4.7862140917231955e-09
relative O 0 4.066263326052422e-09
high O 0 4.145310583680839e-08
percentage O 0 9.624243624273277e-09
of O 0 8.189767086719257e-09
splice O 0 1.1645705910723336e-07
- O 0 1.0627134372498404e-07
site O 0 2.877474791773693e-08
mutations O 0 1.6148213877187345e-09
had O 0 1.883931899371305e-09
no O 0 1.2658690762279434e-09
reflection O 0 3.6302933992260478e-09
on O 0 1.4540588288980416e-08
the O 0 2.8659997042268515e-08
phenotype O 0 9.540211465264292e-08
. O 0 1.1016841483524331e-07

All O 0 2.5297188699369144e-07
patients O 0 1.5655693630378664e-08
manifested O 0 1.650690606425087e-08
classical O 0 8.755292668638504e-08
A B-Disease 1 1.0
- I-Disease 1 1.0
T I-Disease 1 1.0
and O 0 2.2380705289037905e-08
increased O 0 3.64453853762825e-08
cellular O 0 5.2776172765334195e-08
radioresistant O 0 1.8434976709613693e-06
DNA O 0 5.4969678586758164e-08
synthesis O 0 5.6745765419918826e-08
. O 0 9.209340134930244e-08

Determination O 0 2.1382656996138394e-06
of O 0 1.6432760219231568e-07
the O 0 1.0342334988422408e-08
genomic O 0 1.8364939791126744e-08
structure O 0 3.797612890821256e-09
of O 0 1.2575959829064232e-08
the O 0 1.6810144387591208e-08
COL4A4 O 1 0.9999961853027344
gene O 0 1.2196103016393067e-09
and O 0 5.153409921021535e-10
of O 0 1.4309534002165947e-08
novel O 0 2.316054633411113e-06
mutations O 0 4.329029081873159e-07
causing O 0 5.3778672736370936e-05
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 7.690561687923037e-06

Autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 5.86084070164361e-07
a O 0 9.887946816888871e-08
progressive O 1 0.9998674392700195
hematuric B-Disease 1 1.0
glomerulonephritis I-Disease 1 1.0
characterized O 0 7.352090506174136e-06
by O 0 5.055664331621301e-09
glomerular B-Disease 1 1.0
basement I-Disease 1 1.0
membrane I-Disease 0 0.008113948628306389
abnormalities I-Disease 1 0.9991233944892883
and O 0 1.7157747445040172e-09
associated O 0 6.903920768408511e-10
with O 0 3.169333129271479e-10
mutations O 0 3.465522036005808e-10
in O 0 1.4880909005032805e-10
either O 0 7.267777490937988e-10
the O 0 4.074399040376875e-09
COL4A3 O 1 1.0
or O 0 4.483395432686166e-09
the O 0 8.16677392379006e-09
COL4A4 O 1 0.9983048439025879
gene O 0 6.171165800594736e-10
, O 0 1.3438755663841562e-10
which O 0 3.168122708618881e-11
encode O 0 3.1610020156946916e-10
the O 0 1.949184369465229e-09
alpha3 O 0 1.4405951560547692e-06
and O 0 1.258378201640653e-08
alpha4 O 0 1.337038520432543e-05
type O 0 4.526801149040693e-06
IV O 1 1.0
collagen O 1 1.0
chains O 0 0.01845156028866768
, O 0 5.0977007504116045e-08
respectively O 0 8.804995843547658e-08
. O 0 3.0364151371031767e-07

To O 0 2.5845078965858193e-08
date O 0 2.308815183482693e-08
, O 0 8.701909193220558e-10
mutation O 0 3.5786592439412956e-11
screening O 0 3.7286290721638693e-10
in O 0 1.4405419912488782e-10
the O 0 1.2908361046726213e-09
two O 0 4.582916823814287e-10
genes O 0 7.584469718935338e-10
has O 0 4.647980889060932e-10
been O 0 5.187235085912789e-10
hampered O 0 4.13331804338668e-08
by O 0 2.3393725845366475e-10
the O 0 2.726483705473015e-09
lack O 0 1.1896919005494055e-08
of O 0 2.6077211501274178e-08
genomic O 0 1.0912108905358764e-07
structure O 0 1.0359890723066201e-07
information O 0 2.1886290113570794e-08
. O 0 2.3095425660812907e-07

We O 0 4.957995258791925e-08
report O 0 2.0569788095059494e-09
here O 0 1.444283581619743e-10
the O 0 6.313030098681338e-10
complete O 0 1.0785278226066453e-09
characterization O 0 3.775440404751862e-09
of O 0 7.325593465168367e-09
the O 0 6.647422168271078e-09
48 O 0 1.6755599574480584e-08
exons O 0 1.6028790739142096e-08
of O 0 3.124225855799523e-08
the O 0 7.464925033673353e-08
COL4A4 O 1 1.0
gene O 0 7.434258986194209e-09
, O 0 9.654905763767374e-10
a O 0 5.028254479455541e-10
comprehensive O 0 5.045915241197463e-09
gene O 0 2.8528313045228515e-10
screen O 0 4.956281163259746e-09
, O 0 3.34978239591166e-10
and O 0 2.2023115275882077e-10
the O 0 3.4392289016693667e-10
subsequent O 0 4.0819581048623377e-10
detection O 0 4.549900900485682e-09
of O 0 3.8870999752305124e-09
10 O 0 9.205824547109387e-09
novel O 0 4.77836366030715e-08
mutations O 0 1.8191629314046054e-09
in O 0 1.6852472195516555e-10
eight O 0 4.81528683593524e-09
patients O 0 3.344153398643357e-09
diagnosed O 0 8.366189518937972e-08
with O 0 5.887888576694422e-08
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 7.279767942236504e-06

Furthermore O 0 1.243895439984044e-06
, O 0 2.3092290746262734e-08
we O 0 3.6199565567329728e-09
identified O 0 2.3087700640189723e-09
a O 0 1.052828602077227e-09
glycine O 0 3.77162567843925e-09
to O 0 1.6682087933261869e-09
alanine O 0 1.9647053761673305e-08
substitution O 0 6.262709906224018e-09
in O 0 1.1386593889994856e-09
the O 0 1.0499975111599724e-08
collagenous O 0 8.254757517534017e-07
domain O 0 7.060505069489409e-09
that O 0 1.2814693750584638e-10
is O 0 4.97067831339848e-10
apparently O 0 1.3986474201033161e-09
silent O 0 2.4472802451214193e-08
in O 0 4.306918988117303e-10
the O 0 5.28660137888437e-09
heterozygous O 0 7.953707026331358e-09
carriers O 0 1.0962499796818292e-09
, O 0 9.34209154479504e-10
in O 0 3.8013014957982705e-09
11 O 0 2.1230513880254875e-07
. O 0 2.9251762612148013e-07

5 O 0 4.982120671570556e-08
% O 0 5.916408474249124e-10
of O 0 6.959342546686287e-10
all O 0 2.0500645625531888e-10
control O 0 2.684275024478211e-09
individuals O 0 1.0566780957177446e-11
, O 0 6.087678972033217e-11
and O 0 1.5286540089309852e-10
in O 0 2.291098977202921e-10
one O 0 7.405794311132752e-10
control O 0 8.974545551154733e-09
individual O 0 2.233582208077678e-10
homozygous O 0 1.3679584132120226e-09
for O 0 2.06955910742046e-10
this O 0 2.295368062288361e-10
glycine O 0 1.2988881969988597e-08
substitution O 0 6.365292648524701e-08
. O 0 1.9922302385566582e-07

There O 0 1.2628666468117444e-07
has O 0 5.363752553222412e-09
been O 0 9.934253419885408e-10
no O 0 5.480484399633667e-10
previous O 0 1.311579067575508e-09
finding O 0 1.0837055697265896e-09
of O 0 1.2202709953612612e-09
a O 0 2.518133201956374e-10
glycine O 0 3.64689195508916e-10
substitution O 0 5.209265796501938e-10
that O 0 5.598368643666696e-11
is O 0 5.2315572013350575e-11
not O 0 4.874476256661042e-12
associated O 0 2.0879234105541933e-11
with O 0 8.666457829153984e-11
any O 0 3.174259077809438e-09
obvious O 0 2.5922785695797756e-08
phenotype O 0 2.5614410592567083e-09
in O 0 2.4566417788918216e-09
homozygous O 0 2.524818967231113e-07
individuals O 0 7.003528867954856e-09
. O 0 1.5071282177814282e-07

Founder O 0 0.0003554238355718553
BRCA1 O 0 1.1943994650209788e-05
and O 0 3.46667007988799e-07
BRCA2 O 0 4.572584657580592e-06
mutations O 0 3.2465237165268945e-09
in O 0 4.1810391260277413e-10
French O 0 8.715751391719095e-07
Canadian O 0 1.4439386177400593e-05
breast B-Disease 1 1.0
and I-Disease 1 0.9999996423721313
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.859832175048041e-09
. O 0 3.271576431984613e-08

We O 0 2.3497317869214385e-08
have O 0 3.662898040435181e-10
identified O 0 1.9717083521442191e-10
four O 0 7.652704858696069e-11
mutations O 0 1.3249189072250811e-11
in O 0 2.6344131737188192e-11
each O 0 4.38931772872575e-11
of O 0 4.347677329263888e-09
the O 0 4.590339841570312e-08
breast B-Disease 1 0.999990701675415
cancer I-Disease 0 4.358043042884674e-06
- O 0 8.481680424665683e-08
susceptibility O 0 2.0438198689021192e-08
genes O 0 5.430734750788702e-10
, O 0 4.901536398982387e-10
BRCA1 O 0 1.0789789506304714e-08
and O 0 4.140093157189995e-09
BRCA2 O 0 4.039819998524763e-07
, O 0 2.597859150021975e-10
in O 0 2.1727382393255112e-10
French O 0 4.678654192957765e-07
Canadian O 0 3.993752102360304e-07
breast B-Disease 1 0.9999552965164185
cancer I-Disease 0 0.0076064555905759335
and O 0 9.243124736713071e-07
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 1.2019462092283106e-09
from O 0 3.6829916894021153e-09
Quebec O 0 1.4565213859896176e-05
. O 0 3.299375066490029e-07

To O 0 1.9272711426765454e-07
identify O 0 3.9462750578422856e-07
founder O 0 1.132440388573741e-06
effects O 0 0.0003961642796639353
, O 0 1.2871194776664652e-08
we O 0 2.097201079465094e-09
examined O 0 4.065573211420315e-09
independently O 0 5.664913538261374e-10
ascertained O 0 1.1348005202194145e-08
French O 0 4.836127942553503e-08
Canadian O 0 2.7002466040926265e-08
cancer B-Disease 0 6.441870148421458e-09
families O 0 4.380249635227429e-12
for O 0 8.67899242057435e-12
the O 0 9.189132094133967e-11
distribution O 0 3.246249657973266e-10
of O 0 1.0455384336083284e-09
these O 0 1.2257996839792895e-09
eight O 0 1.4987113772235716e-08
mutations O 0 5.187260043726383e-08
. O 0 1.2310010788496584e-07

Mutations O 0 2.678531245692284e-07
were O 0 7.621161479676175e-09
found O 0 7.941182156301352e-10
in O 0 5.976965589127303e-10
41 O 0 2.1197953614660037e-08
of O 0 2.556288514199423e-08
97 O 0 5.514967256203818e-07
families O 0 2.3125954484726208e-09
. O 0 1.1273409228351738e-07

Six O 0 8.214817626139848e-08
of O 0 3.67433514725235e-08
eight O 0 8.25352763911269e-09
mutations O 0 9.042859239194456e-10
were O 0 4.187870883409772e-10
observed O 0 2.5328648067812765e-09
at O 0 1.1726958959457079e-08
least O 0 3.386614322309356e-09
twice O 0 6.145189956896502e-08
. O 0 2.809511272516829e-07

The O 0 7.165963324951008e-06
BRCA1 O 0 6.481462150986772e-06
C4446T O 0 8.273867933894508e-06
mutation O 0 1.635843460690012e-08
was O 0 8.254975369936801e-09
the O 0 1.5315966273021786e-09
most O 0 6.54000520405873e-10
common O 0 8.752344959894742e-10
mutation O 0 3.050453500907935e-10
found O 0 2.886899885812255e-10
, O 0 2.1286503115724997e-10
followed O 0 4.490633698228663e-10
by O 0 7.375937083331507e-10
the O 0 2.398582523710502e-07
BRCA2 O 0 1.1733596693375148e-05
8765delAG O 0 1.0700917300709989e-05
mutation O 0 5.402055762715463e-07
. O 0 4.2036725744765135e-07

Together O 0 3.529936165591607e-08
, O 0 2.8309663502312787e-09
these O 0 6.815474851151748e-10
mutations O 0 3.6679875803358186e-10
were O 0 1.1835661617443094e-10
found O 0 7.218289160837443e-11
in O 0 8.858179467718941e-11
28 O 0 4.763300864851772e-09
of O 0 4.366492500906816e-09
41 O 0 5.032843475305526e-09
families O 0 1.7500107266088527e-11
identified O 0 5.653102985725411e-11
to O 0 2.8789923223193625e-10
have O 0 7.414741598488206e-10
a O 0 1.6726987794868364e-08
mutation O 0 1.1762715956820102e-07
. O 0 1.9322031619140034e-07

The O 0 2.4839809498189425e-07
odds O 0 4.0050571215033415e-07
of O 0 9.529605549118969e-09
detection O 0 2.278906663377711e-08
of O 0 1.240098157495595e-08
any O 0 3.231363621125638e-09
of O 0 1.1427458090906839e-08
the O 0 1.3973362911201548e-08
four O 0 7.3399433198062525e-09
BRCA1 O 0 8.42865546246685e-08
mutations O 0 4.66435068346982e-09
was O 0 4.211634063722158e-08
18 O 0 1.0470201061707485e-07
. O 0 1.3404573451225588e-07

7x O 0 0.0003861376317217946
greater O 0 2.771398328604846e-07
if O 0 5.0559925135473804e-09
one O 0 4.722220392494592e-10
or O 0 7.873626056698058e-11
more O 0 8.353529673543747e-12
cases O 0 3.742901544256938e-10
of O 0 6.276707608776633e-06
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
were O 0 1.673942651159166e-09
also O 0 1.8649752575594647e-10
present O 0 7.61630064571861e-11
in O 0 1.6040917205639715e-10
the O 0 1.0131468997087723e-08
family O 0 2.0826524504968802e-08
. O 0 1.5214496329463145e-07

The O 0 1.6162834981514607e-07
odds O 0 1.626484333883127e-07
of O 0 5.172417605336932e-09
detection O 0 1.440782515516048e-08
of O 0 5.940236302848234e-09
any O 0 1.3268421916734496e-09
of O 0 5.544782855082531e-09
the O 0 1.1174671854519147e-08
four O 0 1.3006087762335028e-08
BRCA2 O 0 4.742987016470579e-07
mutations O 0 8.556453323649293e-09
was O 0 3.221186872792714e-08
5 O 0 2.757775519057759e-07
. O 0 2.6030707545032783e-07

3x O 0 2.9555909350165166e-05
greater O 0 2.3044009367367835e-07
if O 0 2.1493276047834797e-09
there O 0 2.7032429072981756e-10
were O 0 1.6757371879005944e-10
at O 0 7.581822947244632e-10
least O 0 5.309778311479718e-11
five O 0 3.565238035352358e-11
cases O 0 1.7363398219227832e-10
of O 0 1.526770176951686e-08
breast B-Disease 1 0.9992884397506714
cancer I-Disease 0 8.631709533801768e-07
in O 0 2.5427782102127594e-09
the O 0 1.2839277019338624e-07
family O 0 8.32204136713699e-08
. O 0 2.0258201516298868e-07

Interestingly O 0 6.456066898863355e-07
, O 0 6.512933747870875e-09
the O 0 2.040414504023147e-09
presence O 0 3.2733911137228233e-09
of O 0 3.245769875093174e-08
a O 0 3.692798955512444e-08
breast B-Disease 1 0.999268114566803
cancer I-Disease 0 2.6006787265941966e-06
case O 0 6.344780700828778e-09
< O 0 4.015013210789675e-09
36 O 0 1.3828326261844381e-09
years O 0 1.0674167105761967e-10
of O 0 8.492632153078716e-10
age O 0 6.318571221797242e-10
was O 0 2.780257690737642e-10
strongly O 0 1.0649053860944946e-10
predictive O 0 1.402874039158064e-09
of O 0 6.383889528116526e-10
the O 0 2.274058719109462e-10
presence O 0 1.4233682288367078e-10
of O 0 7.18990422754473e-10
any O 0 6.615367698081798e-10
of O 0 2.472323012980837e-09
the O 0 5.44861400442187e-09
eight O 0 2.531455933763027e-08
mutations O 0 1.2646655278558683e-08
screened O 0 7.230424330373353e-07
. O 0 3.3538586308168306e-07

Carriers O 0 5.80777168579516e-08
of O 0 2.707089663545048e-08
the O 0 3.167328399555913e-09
same O 0 4.642443374169858e-10
mutation O 0 2.2132051746837078e-10
, O 0 3.689442501508822e-11
from O 0 1.2350920633452667e-11
different O 0 1.2893977552330682e-11
families O 0 3.4031531932765535e-12
, O 0 6.022760068447042e-11
shared O 0 2.9597663209202096e-10
similar O 0 4.5353162891892396e-10
haplotypes O 0 2.61015808966647e-09
, O 0 3.454758146226311e-10
indicating O 0 1.0232039659996417e-09
that O 0 4.287394050894733e-11
the O 0 1.1982334013893592e-09
mutant O 0 7.171308880060678e-09
alleles O 0 4.279926413275348e-11
were O 0 3.744713220066309e-11
likely O 0 2.6819081677675882e-11
to O 0 1.9096451850386664e-11
be O 0 1.5316884913185724e-11
identical O 0 6.201345686962512e-11
by O 0 1.189835209525203e-11
descent O 0 2.102839707918136e-10
for O 0 1.0684922391313023e-10
a O 0 6.807173713596626e-10
mutation O 0 3.325045794255743e-10
in O 0 6.661558527021327e-10
the O 0 3.142142190881714e-08
founder O 0 4.229125920574006e-07
population O 0 4.939680664506341e-09
. O 0 8.20271424117891e-08

The O 0 1.5800829089585022e-08
identification O 0 5.8862914542601175e-09
of O 0 1.2156927908790749e-08
common O 0 5.562931448821473e-08
BRCA1 O 0 7.483656645490555e-07
and O 0 1.3851067137693462e-07
BRCA2 O 0 2.0061072518728906e-06
mutations O 0 1.1744591965623385e-09
will O 0 1.1064755361944734e-10
facilitate O 0 4.829697752839479e-10
carrier O 0 6.984102740581477e-10
detection O 0 1.327794763028578e-08
in O 0 1.2098975155083735e-09
French O 0 3.5000068692170316e-06
Canadian O 0 2.1742428089055466e-06
breast B-Disease 1 1.0
cancer I-Disease 1 0.9999825954437256
and O 0 0.0002617806603666395
breast B-Disease 1 1.0
/ I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
families O 0 5.34708233246306e-09
. O 0 2.6452777746044376e-08

Are O 0 1.9568260256619396e-07
Dp71 O 0 0.0002881778054870665
and O 0 3.844367029159912e-07
Dp140 O 0 0.0006241650553420186
brain O 0 1.0811483662109822e-05
dystrophin O 0 1.7509100871393457e-06
isoforms O 0 2.9663194567319806e-08
related O 0 4.647488793807497e-08
to O 0 5.496451294106919e-09
cognitive B-Disease 0 0.001939469133503735
impairment I-Disease 1 0.99996018409729
in O 0 9.15014084057475e-07
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
? O 0 0.00014865437697153538

Molecular O 0 1.104891794057039e-06
study O 0 1.1016374479311253e-08
and O 0 2.13250372915752e-09
neuropsychological O 0 1.79354174179025e-07
analysis O 0 1.0826850527223542e-09
were O 0 2.771917972932414e-10
performed O 0 1.4553288574248313e-09
concurrently O 0 2.0744805873107452e-09
on O 0 2.267186882676242e-09
49 O 0 3.6986499196700606e-08
patients O 0 1.1573143554599596e-09
with O 0 2.713567148759921e-08
Duchenne B-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.000748557795304805
DMD B-Disease 1 1.0
) O 0 8.666627415720995e-10
in O 0 1.1467797544906233e-10
order O 0 2.767696904992789e-10
to O 0 2.1773181868578462e-10
find O 0 2.939114784883401e-10
a O 0 1.3203130255767803e-10
molecular O 0 1.474783073440733e-09
explanation O 0 2.2283143386037096e-10
for O 0 1.2251726022594056e-10
the O 0 6.610350933300424e-09
cognitive B-Disease 0 2.2999931843514787e-06
impairment I-Disease 0 2.278847432535258e-06
observed O 0 3.384683422424928e-09
in O 0 1.0668576022609955e-09
most O 0 3.800107251095142e-08
DMD B-Disease 1 1.0
patients O 0 6.331914050861087e-07
. O 0 1.7266691543227353e-07

Complete O 0 7.577796168334316e-08
analysis O 0 3.3383222852734207e-09
of O 0 8.945971075036141e-09
the O 0 1.1666499766249672e-08
dystrophin O 0 3.138147803838365e-07
gene O 0 3.0537616879655616e-09
was O 0 5.565496952186777e-09
performed O 0 1.8406206558907456e-09
to O 0 3.3118296993706053e-10
define O 0 1.3669855247755436e-09
the O 0 9.458560601416366e-10
localization O 0 1.944202487891289e-08
of O 0 1.936641069733014e-08
deletions O 0 2.93742541401798e-08
and O 0 6.118918705055876e-09
duplications O 0 2.1392455096247431e-07
in O 0 1.99831795555383e-09
relation O 0 3.008551408001381e-09
to O 0 6.949885111851017e-10
the O 0 1.2352824541039809e-08
different O 0 3.549529026258824e-08
DMD B-Disease 1 1.0
promoters O 0 7.572668982902542e-05
. O 0 2.4459839096380165e-06

Qualitative O 0 7.939263468870195e-07
analysis O 0 8.354147595923678e-09
of O 0 2.001545951202388e-08
the O 0 1.0585516463379463e-08
Dp71 O 0 5.587235591519857e-06
transcript O 0 5.489086518650765e-09
and O 0 8.778995863600869e-10
testing O 0 3.0546512541640425e-10
for O 0 3.795349798330072e-11
the O 0 1.3504741769310158e-10
specific O 0 1.38458966514321e-10
first O 0 6.528825258200754e-10
exon O 0 3.088528544026303e-08
of O 0 5.844542627642113e-08
Dp140 O 0 1.3053762586423545e-06
were O 0 2.2519559550460144e-09
also O 0 1.9426076303119544e-09
carried O 0 8.761301018012091e-09
out O 0 2.9464256812161693e-08
. O 0 1.4129078351743374e-07

Neuropsychological O 0 7.113395258784294e-05
analysis O 0 4.5129283421374566e-08
assessed O 0 4.570464966491272e-07
verbal O 0 1.4645026169546327e-07
and O 0 1.1572443447960268e-08
visuospatial O 0 1.1810346904894686e-06
intelligence O 0 7.396495416145399e-09
, O 0 1.2369351765073588e-08
verbal O 0 1.405498892381729e-06
memory O 1 0.9980447292327881
, O 0 2.7565096871740025e-08
and O 0 6.731082180522208e-08
reading O 0 1.0152853974432219e-05
skills O 0 3.067782699872623e-06
. O 0 4.1213135659745603e-07

Comparison O 0 2.2184517547430005e-06
of O 0 3.8953405123720586e-07
molecular O 0 1.1786656983758803e-07
and O 0 1.9063072898006794e-08
psychometric O 0 6.373152814376226e-07
findings O 0 7.098259313664812e-09
demonstrated O 0 1.4346202004134057e-09
that O 0 1.2719336694999583e-10
deletions O 0 5.365185185013388e-09
and O 0 1.951606209971146e-09
duplications O 0 3.6547856296920145e-08
that O 0 1.7530517315567096e-10
were O 0 1.8027686288224487e-10
localized O 0 1.8891972430878923e-08
in O 0 3.91016441447789e-10
the O 0 4.830796651589253e-09
distal O 0 6.678222916889354e-07
part O 0 4.926473096134032e-08
of O 0 5.515551038115518e-07
the O 0 1.8625549103035155e-07
gene O 0 4.445782408879495e-09
seemed O 0 3.8497871557297e-09
to O 0 1.9793575112281303e-10
be O 0 1.7863495405112673e-10
preferentially O 0 3.617091959284835e-09
associated O 0 1.5570932321296027e-09
with O 0 2.556522460395172e-08
cognitive B-Disease 0 0.06755909323692322
impairment I-Disease 1 0.9999151229858398
. O 0 1.0416921440992155e-06

Two O 0 1.8416703539969603e-07
altered O 0 2.3806430249351251e-07
Dp71 O 0 4.9088762352766935e-06
transcripts O 0 3.6945746018091086e-08
and O 0 1.1258879162312496e-08
two O 0 2.571544754914612e-09
deleted O 0 3.02663671902792e-08
Dp140 O 0 1.0947131556804379e-07
DNA O 0 1.1555497669846204e-09
sequences O 0 1.5564509403542814e-10
were O 0 5.367635849684582e-11
found O 0 3.599071735083115e-11
in O 0 5.894711108123118e-11
four O 0 6.021431131486565e-10
patients O 0 1.3690625300100123e-09
with O 0 4.744214798790836e-09
severe O 1 1.0
cerebral B-Disease 1 1.0
dysfunction I-Disease 1 1.0
. O 0 2.4402431790804258e-06

These O 0 1.7006894381665916e-07
findings O 0 7.900093912383e-09
suggest O 0 7.766107201767625e-10
that O 0 1.7331627452654708e-11
some O 0 1.4129698279463643e-11
sequences O 0 4.817725732242373e-11
located O 0 4.845485124249649e-10
in O 0 7.12114187062518e-11
the O 0 7.626858034015527e-10
distal O 0 9.842843695651027e-08
part O 0 7.926825418280714e-09
of O 0 4.2328139215896954e-08
the O 0 5.4682498529246004e-09
gene O 0 8.011342284008904e-11
and O 0 3.0660865513176816e-10
, O 0 1.5682186105259177e-10
in O 0 5.636146063747738e-11
particular O 0 2.8223978709718267e-10
, O 0 1.6723079865332835e-10
some O 0 9.253562360811429e-10
DMD B-Disease 1 1.0
isoforms O 0 4.862523272919361e-09
expressed O 0 1.2134265814367495e-09
in O 0 6.91079748982304e-10
the O 0 4.3792645953999454e-08
brain O 0 2.571071263446356e-06
may O 0 2.642340235503582e-10
be O 0 5.0248194494173504e-11
related O 0 4.831817168593489e-10
to O 0 2.8438668087105157e-10
the O 0 8.117157612730352e-09
cognitive B-Disease 0 6.570394816662883e-06
impairment I-Disease 0 1.6375708582927473e-05
associated O 0 1.5785948548341366e-08
with O 0 9.146112489588631e-08
DMD B-Disease 1 1.0
. O 0 2.2595432369598711e-07
. O 0 5.515798875421751e-07

I1307K O 0 7.506236579502001e-05
APC O 0 5.3548083087662235e-06
and O 0 7.294198667295859e-08
hMLH1 O 0 1.097937115446257e-06
mutations O 0 4.454635771367066e-09
in O 0 3.599252007546738e-10
a O 0 8.231859083274173e-10
non O 0 3.975693019242499e-08
- O 0 2.5545046966612972e-08
Jewish O 0 1.921682812877634e-09
family O 0 7.533629275968678e-11
with O 0 3.292920935926702e-10
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 2.0483823391259648e-05

We O 0 1.6010115189146745e-07
describe O 0 2.9063725648370564e-08
a O 0 5.1446815696465364e-09
French O 0 2.644960943598562e-07
Canadian O 0 6.478246064034465e-07
hereditary B-Disease 1 1.0
non I-Disease 1 1.0
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 3.441901571932249e-05
HNPCC B-Disease 1 1.0
) O 0 1.4060304920349154e-08
kindred O 0 3.4004941085186147e-07
which O 0 4.1392858585176384e-10
carries O 0 1.7617486136600746e-08
a O 0 1.2698688767187605e-09
novel O 0 7.06667862004906e-08
truncating O 0 1.1789495601988165e-06
mutation O 0 1.6777216060859246e-08
in O 0 1.1255529841491807e-08
hMLH1 O 0 1.7669515727902763e-05
. O 0 1.202672251565673e-06

Interestingly O 0 1.5890915392446914e-06
, O 0 2.5412765225496514e-08
the O 0 2.073077176589777e-08
I1307K O 0 2.673225935723167e-06
APC O 0 1.4883342203120264e-07
polymorphism O 0 3.033605588953492e-09
, O 0 5.21586718260636e-10
associated O 0 2.604328697142222e-10
with O 0 9.550174540073897e-11
an O 0 7.181896050090231e-11
increased O 0 6.173390687536084e-10
risk O 0 3.143089344348482e-08
of O 0 8.90758656169055e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 8.308049359584402e-09
is O 0 3.9845560184659234e-10
also O 0 1.649555908533884e-10
present O 0 1.651035280714197e-10
in O 0 2.0454637983391422e-10
this O 0 4.896490435335465e-10
family O 0 7.742565699686565e-09
. O 0 1.3777371066225896e-07

The O 0 6.102208089941996e-07
I1307K O 0 3.320342102597351e-06
polymorphism O 0 1.5483573534424977e-08
has O 0 3.2312588160721134e-09
previously O 0 6.2781384535526286e-09
only O 0 1.52487994453665e-10
been O 0 1.960159257130556e-10
identified O 0 4.582433738020697e-11
in O 0 3.7739825153870754e-11
individuals O 0 2.7839706234766837e-11
of O 0 4.079111270982594e-09
self O 0 2.001989400923776e-07
- O 0 2.628350159739057e-07
reported O 0 7.61418750272469e-09
Ashkenazi O 0 7.175251681701411e-08
Jewish O 0 5.7895224614412655e-08
origins O 0 5.398754865382216e-08
. O 0 5.8173725392407505e-08

In O 0 9.018938484928185e-09
addition O 0 5.4602762311617425e-09
, O 0 3.5238648110613724e-10
in O 0 1.0092267993533355e-10
this O 0 9.330902717152867e-11
family O 0 1.8941781476655706e-10
, O 0 2.047922942338687e-10
there O 0 1.3722198377585926e-10
appears O 0 4.095590255825954e-10
to O 0 6.26355217692165e-11
be O 0 1.6146049774956595e-10
no O 0 3.367899847894762e-10
relationship O 0 2.960809375451845e-11
between O 0 1.0933928068501686e-10
the O 0 1.3330112569320818e-09
I1307K O 0 3.0064708056443123e-08
polymorphism O 0 1.3313793123526096e-10
and O 0 2.678872679240385e-10
the O 0 1.3439992452290994e-09
presence O 0 1.9580566057442184e-09
or O 0 1.7233707794162e-09
absence O 0 4.0056143291167245e-08
of O 0 9.188619287670008e-08
cancer B-Disease 0 2.458359631418716e-06
. O 0 2.0473548190125257e-08
. O 0 2.243683354663517e-07

Identification O 0 2.971779622384929e-07
of O 0 1.4776141199490667e-07
a O 0 7.423235359738101e-09
novel O 0 4.253694996236845e-08
mutation O 0 1.19972665135748e-09
of O 0 8.406527030047073e-09
the O 0 2.1988805443129422e-08
CPO O 1 0.9418688416481018
gene O 0 4.107123086072306e-09
in O 0 1.2442841201831811e-09
a O 0 1.1199294824848494e-08
Japanese O 0 1.3468275028571952e-06
hereditary B-Disease 1 0.9940593242645264
coproporphyria I-Disease 1 0.9994407296180725
family O 0 1.1744125458790222e-06
. O 0 1.1011070455424488e-06

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 3.953756095143035e-05
HCP B-Disease 1 1.0
) O 0 2.003756236490517e-07
is O 0 1.5562804378532746e-08
an O 0 3.3833750023859466e-08
autosomal B-Disease 1 1.0
dominant I-Disease 1 1.0
disease I-Disease 1 1.0
characterized O 0 5.770139033245414e-09
by O 0 1.380402320227958e-10
a O 0 4.434468348080145e-09
deficiency B-Disease 0 3.507302244543098e-05
of I-Disease 0 0.0001220798003487289
coproporphyrinogen I-Disease 1 0.9999996423721313
oxidase I-Disease 0 5.9136056052011554e-08
( O 0 8.820233432516034e-10
CPO O 1 0.9997628331184387
) O 0 7.689257008891559e-10
caused O 0 1.1887567596957638e-09
by O 0 8.637842524583661e-11
a O 0 8.011560304055365e-10
mutation O 0 4.4190398562626854e-10
in O 0 5.575290229486995e-10
the O 0 2.97871327603616e-08
CPO O 1 0.8491448163986206
gene O 0 3.091086568929313e-07
. O 0 4.3625365719890397e-07

Only O 0 1.817613437538057e-08
11 O 0 5.818057147166655e-09
mutations O 0 6.583998346521014e-10
of O 0 6.087069515103849e-09
the O 0 5.8820264214887175e-09
gene O 0 1.8091420583843387e-09
have O 0 2.3858673370291683e-10
been O 0 1.176122532697832e-09
reported O 0 4.7038306583147005e-09
in O 0 1.687233286418177e-08
HCP B-Disease 1 1.0
patients O 0 1.8350816617385135e-06
. O 0 3.0667098371850443e-07

We O 0 1.5956155152707652e-07
report O 0 2.1791235482737648e-08
another O 0 4.852618751272075e-09
mutation O 0 1.6678873837605579e-09
in O 0 8.476659374423434e-10
a O 0 7.193652784565074e-09
Japanese O 0 3.6118134971729887e-07
family O 0 6.536506447218926e-08
. O 0 3.5288260846755293e-07

Polymerase O 0 8.665121526973962e-07
chain O 0 2.0056374694377155e-07
reaction O 0 2.542264176952358e-09
- O 0 4.24503845408708e-08
single O 0 1.6477486042276723e-09
strand O 0 1.4393947145308061e-09
conformational O 0 2.2883082928526477e-10
polymorphism O 0 2.0656508448180233e-10
and O 0 4.926054564258209e-10
direct O 0 5.929570168206055e-10
sequence O 0 2.086073258578125e-10
analyses O 0 1.5101511152693092e-09
demonstrated O 0 1.310423769496083e-09
a O 0 5.005738046293118e-10
C O 0 1.0525380567116827e-08
to O 0 5.229175426002541e-10
T O 0 7.450953631860102e-09
substitution O 0 3.993930464130102e-10
in O 0 2.1167832764401595e-10
exon O 0 1.2781168123865427e-08
1 O 0 8.863292322303096e-09
of O 0 6.78750966542907e-09
the O 0 7.770408316787325e-09
CPO O 0 1.143652480095625e-05
gene O 0 4.5207806942393347e-10
at O 0 2.0683723622738626e-09
nucleotide O 0 1.4088967770220506e-09
position O 0 2.3374022717348453e-09
85 O 0 7.799274115427579e-09
, O 0 2.1540542960440945e-10
which O 0 1.1530547350258047e-10
lies O 0 1.1015869993968863e-08
in O 0 4.073931192394298e-10
the O 0 1.0835408126297352e-08
putative O 0 1.6213627418437682e-07
presequence O 0 6.353684511850588e-07
for O 0 6.930297669072161e-09
targeting O 0 3.879672405560086e-08
to O 0 1.9813539253732415e-08
mitochondria O 0 2.2631273566275922e-07
. O 0 5.854125788573583e-07

This O 0 2.554158662348982e-08
mutation O 0 8.83955575403661e-09
changes O 0 3.1092437513535742e-09
the O 0 3.3294262902217042e-09
codon O 0 9.262643096974443e-09
for O 0 7.299800208748763e-10
glutamine O 0 8.412365026799762e-09
to O 0 2.878236315950744e-09
a O 0 8.542103913100618e-09
termination O 0 6.230662563666556e-08
codon O 0 5.028691063557744e-08
at O 0 2.7917488765183407e-08
amino O 0 2.9779291921272488e-08
acid O 0 4.323261038052806e-08
position O 0 6.188781753735384e-08
29 O 0 4.855611450693686e-07
. O 0 3.444704930188891e-07

MaeI O 0 0.0001135912534664385
restriction O 0 1.005397152198384e-07
analysis O 0 3.6557665783476523e-09
showed O 0 1.7874102198334185e-09
two O 0 8.792128136647648e-11
other O 0 8.276235252679953e-11
carriers O 0 1.1650833076082279e-10
in O 0 2.745247085211844e-10
the O 0 1.6770082211792214e-08
family O 0 1.94303844125443e-08
. O 0 2.1128127514202788e-07

The O 0 6.763873443560442e-07
C O 0 0.00010205509897787124
- O 0 0.20677241683006287
T O 0 2.682544982235413e-05
mutation O 0 1.3387218444904647e-08
is O 0 1.0302049213706255e-09
located O 0 6.2392939703670436e-09
within O 0 1.3331638015756653e-09
a O 0 7.343692320915807e-10
recently O 0 4.406719877891874e-09
proposed O 0 1.148168493614321e-08
putative O 0 3.598006514948793e-08
alternative O 0 4.8439074973316565e-09
translation O 0 2.251616892934294e-09
initiation O 0 9.17119358234686e-09
codon O 0 1.321619524929929e-08
( O 0 1.8127473133677796e-10
TIC O 0 4.8625256710010945e-08
- O 0 6.836531341036789e-09
1 O 0 2.1332522415207222e-09
) O 0 5.5261632075920275e-11
, O 0 5.582288797878476e-11
supporting O 0 3.3853919667592436e-10
that O 0 6.717465472760864e-11
TIC O 0 1.2720566644475184e-07
- O 0 1.3193679038181472e-08
1 O 0 1.2580518848892552e-08
is O 0 3.6631217503746427e-10
the O 0 1.1891604367875175e-09
real O 0 9.057229277686929e-08
TIC O 0 3.127671561742318e-06
rather O 0 6.674088393054944e-09
than O 0 1.8933843382029636e-09
TIC O 0 1.9677484033309156e-06
- O 0 3.732137656697887e-07
2 O 0 2.414086281987693e-07
. O 0 1.747605082869086e-08
. O 0 1.4547195803515933e-07

Human B-Disease 0 1.9966448405739357e-07
complement I-Disease 0 3.161219694902684e-07
factor I-Disease 0 3.9553404349135235e-05
H I-Disease 1 1.0
deficiency I-Disease 1 0.6570157408714294
associated O 0 2.1151916484996036e-07
with O 1 0.9976389408111572
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 1.867333412519656e-05

This O 0 1.3727735392876639e-08
study O 0 2.983419733482151e-09
reports O 0 9.018142899108739e-10
on O 0 1.5393722962997458e-09
six O 0 2.5396315606052156e-10
cases O 0 2.2716745151640794e-10
of O 0 6.522580697776448e-09
deficiency B-Disease 0 7.652838576177601e-07
in I-Disease 0 1.5330695601889488e-09
the I-Disease 0 1.2131379456548075e-08
human I-Disease 0 7.314950312142798e-10
complement I-Disease 0 1.5220735782861539e-09
regulatory I-Disease 0 2.4091997286035394e-09
protein I-Disease 0 2.8215541014731116e-09
Factor I-Disease 0 3.19098205636692e-07
H I-Disease 1 1.0
( O 0 1.5078168713600348e-09
FH O 1 0.9786116480827332
) O 0 1.1309531783298965e-10
in O 0 4.7762967192443995e-11
the O 0 3.6586247920133985e-10
context O 0 5.182587137220196e-10
of O 0 3.663058745217995e-10
an O 0 1.893391443630321e-09
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 9.374812179885339e-06

Five O 0 6.644394545674004e-08
of O 0 1.1220889994945082e-08
the O 0 1.871957699961513e-09
cases O 0 3.788249436365021e-10
were O 0 4.3583837927574365e-11
observed O 0 1.3001336118811935e-10
in O 0 2.7226771184829524e-11
children O 0 4.2065861211026956e-11
presenting O 0 2.146639976885467e-09
with O 0 1.745706157407767e-08
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.0012707483256235719
HUS B-Disease 1 1.0
) O 0 2.2052054191590287e-06
. O 0 1.290686213906156e-06

Two O 0 9.21612031135055e-09
of O 0 1.5517187534896948e-08
the O 0 3.609924359437855e-09
children O 0 9.5219154783166e-10
exhibited O 0 3.045410679192173e-08
a O 0 7.907329901968296e-09
homozygous O 0 1.192629270008183e-06
deficiency O 0 3.324546469229972e-06
characterized O 0 1.6009046310827557e-09
by O 0 6.490530335412359e-11
the O 0 2.5974442596776726e-09
absence O 0 1.1872481664454426e-08
of O 0 7.334541418657636e-09
the O 0 1.2909296964735972e-09
150 O 0 3.265413772712833e-10
- O 0 2.071187221730497e-09
kD O 0 1.1537614597045831e-07
form O 0 1.0803452576979566e-10
of O 0 7.343356478450858e-10
Factor O 0 7.997426720862677e-09
H O 0 0.0002210883394582197
and O 0 1.7412084274415207e-10
the O 0 5.201798991549822e-10
presence O 0 3.939832626809192e-10
, O 0 1.633276014434415e-10
upon O 0 7.567678150799395e-10
immunoblotting O 0 1.8494939979518676e-07
, O 0 7.567274584729944e-10
of O 0 3.980289431382289e-09
the O 0 5.664862356979938e-09
42 O 0 9.249332855176817e-09
- O 0 2.4767137674075457e-08
kD O 0 3.888232186000096e-06
Factor O 0 1.3206272342358716e-07
H O 0 2.0601170035661198e-05
- O 0 1.913366887151824e-08
like O 0 6.835523813641942e-10
protein O 0 7.476403385275887e-10
1 O 0 6.142374608941736e-09
( O 0 4.720311364003749e-10
FHL O 0 1.5416997484862804e-05
- O 0 2.2601804872124376e-08
1 O 0 6.729680812611605e-09
) O 0 7.174023874956248e-11
and O 0 1.9635719439303756e-10
other O 0 8.420323882596392e-10
FH O 0 4.539561632554978e-05
- O 0 2.7177367911690453e-08
related O 0 2.2981039293767935e-08
protein O 0 7.1152026492882214e-09
( O 0 1.0415377449390917e-09
FHR O 1 0.998745322227478
) O 0 1.8005128055165187e-08
bands O 0 2.1588705294561805e-06
. O 0 5.050337676948402e-07

Southern O 0 6.52878952678293e-06
blot O 0 4.0319569961866364e-05
and O 0 1.0778806291966703e-08
PCR O 0 6.735215496433966e-09
analysis O 0 1.231749702235163e-10
of O 0 3.034541506963251e-10
DNA O 0 7.702687931931962e-10
of O 0 1.522398873632369e-09
one O 0 3.1323016402851067e-10
patient O 0 8.379245075573749e-10
with O 0 4.389822116923625e-10
homozygous O 0 7.047537451398966e-07
deficiency O 0 5.340243205864681e-06
ruled O 0 7.331170781554874e-09
out O 0 6.076429359680446e-10
the O 0 3.02860875267541e-10
presence O 0 1.8528351075630667e-10
of O 0 7.227605736126463e-10
a O 0 2.0177848281122124e-10
large O 0 2.021861789103241e-09
deletion O 0 3.958741778831154e-09
of O 0 5.156175042486666e-09
the O 0 1.0297809716064421e-08
FH O 1 0.9999163150787354
gene O 0 8.436914500364878e-10
as O 0 2.1938093008877502e-10
the O 0 1.4889148802765817e-09
underlying O 0 4.889729439128132e-07
defect O 0 2.5324700558826407e-08
for O 0 3.839433215802046e-09
the O 0 5.628274379887444e-07
deficiency O 1 0.9998457431793213
. O 0 2.669109335329267e-06

The O 0 6.583728406894807e-08
other O 0 2.0529924427137303e-09
four O 0 2.421152445197805e-10
children O 0 1.1398038762822083e-10
presented O 0 6.283634168546826e-10
with O 0 8.704930110070563e-10
heterozygous O 0 3.4489485756239446e-07
deficiency O 0 1.5671814253437333e-05
and O 0 7.446123273524563e-09
exhibited O 0 3.2356857104787196e-07
a O 0 4.04603994752506e-09
normal O 0 4.5978296725479595e-09
immunoblotting O 0 5.400073277428419e-08
pattern O 0 1.1571421598688403e-09
of O 0 6.051711909371704e-10
proteins O 0 5.954818582676324e-11
of O 0 3.415070670698128e-09
the O 0 6.246940387200084e-08
FH O 1 0.9999998807907104
family O 0 7.77247208816334e-08
. O 0 3.1889044294075575e-07

Factor B-Disease 1 1.0
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999979734420776
is O 0 4.057802538426358e-09
the O 0 2.3754431754952066e-09
only O 0 3.0969566910954427e-09
complement B-Disease 1 1.0
deficiency I-Disease 1 1.0
associated O 0 1.0707052666703021e-07
with O 0 1.7226000181835843e-07
HUS B-Disease 1 1.0
. O 0 1.0950720934488345e-05

These O 0 9.749309271001039e-08
observations O 0 6.501331739627858e-08
suggest O 0 5.196466368317942e-09
a O 0 5.225745391967962e-10
role O 0 1.920059888860237e-09
for O 0 2.1813431061445954e-09
FH O 1 1.0
and O 0 4.196126468514194e-08
/ O 0 3.3904730116773862e-06
or O 0 2.4940732146205846e-08
FH O 0 0.011288675479590893
receptors O 0 6.851778255878571e-09
in O 0 5.296711957925027e-10
the O 0 1.2100967339279123e-08
pathogenesis O 0 2.4627319362480193e-05
of O 0 1.3732785646425327e-06
idiopathic O 1 1.0
HUS B-Disease 1 1.0
. O 0 9.088861361306044e-07
. O 0 1.2370717286103172e-06

Further O 0 2.0799497235657327e-07
evidence O 0 1.6533940438989703e-08
for O 0 9.930198885399477e-10
a O 0 7.938152912778662e-10
major O 0 1.2806253835151438e-08
ancient O 0 2.0947220491507323e-07
mutation O 0 5.934033424637164e-07
underlying O 1 0.9946311712265015
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
from O 0 3.631965057593334e-07
linkage O 0 6.857429184492503e-07
disequilibrium O 0 2.289155816015409e-07
studies O 0 6.052130796518895e-09
in O 0 4.2093969976342294e-10
the O 0 2.5168380712869975e-09
Japanese O 0 5.941939207332325e-08
population O 0 6.186179346556742e-10
. O 0 2.7595032037197598e-08

The O 0 0.00016638745728414506
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.9998553991317749
DM B-Disease 1 1.0
) O 0 2.881962224421386e-08
mutation O 0 4.734741043677104e-09
is O 0 3.700064421519045e-10
an O 0 7.10559722172377e-10
unstable O 0 1.1668318222746166e-07
( O 0 4.8189807699827725e-09
CTG O 0 4.63247524749022e-05
) O 0 1.3242431595728021e-09
n O 0 9.232935527236918e-10
repeat O 0 3.4731004738830507e-09
, O 0 2.268747134603899e-10
present O 0 1.2585113506879964e-10
at O 0 8.923540240068917e-10
a O 0 1.8086097897107578e-10
copy O 0 1.1903222851827877e-09
number O 0 2.5916035983897245e-10
of O 0 7.349479358431665e-10
5 O 0 5.215491594157129e-09
- O 0 3.580521834578576e-08
37 O 0 1.7747805003409667e-08
repeats O 0 7.107250898918949e-10
on O 0 3.2923197501588675e-09
normal O 0 1.5742550596442584e-09
chromosomes O 0 8.011708657607031e-11
but O 0 5.3897750845743886e-11
amplified O 0 4.987565915826053e-09
to O 0 6.96709911984783e-10
50 O 0 8.971054121786892e-09
- O 0 2.260081188865115e-08
3000 O 0 6.539359720392213e-09
copies O 0 4.773187178841454e-09
on O 0 1.519799326388238e-07
DM B-Disease 1 1.0
chromosomes O 0 2.0785101639830827e-07
. O 0 1.0906283165468267e-07

Previous O 0 6.666304557256808e-07
findings O 0 8.078497870656065e-09
in O 0 8.666694029102473e-10
Caucasian O 0 5.82077959165872e-08
populations O 0 1.0471948863610692e-09
of O 0 6.689624409972339e-09
a O 0 8.076883517560418e-08
DM B-Disease 1 1.0
founder O 0 1.0185402061324567e-05
chromosome O 0 1.3733706616392283e-08
raise O 0 7.2910375514823045e-09
a O 0 9.236916231891712e-10
question O 0 1.3262526632473737e-09
about O 0 1.9914413174060286e-10
the O 0 1.1388829879166451e-09
molecular O 0 3.2454836595974257e-09
events O 0 3.207414056571878e-10
involved O 0 4.390508789864356e-10
in O 0 6.671667107660539e-10
the O 0 2.1789198001442855e-08
expansion O 0 1.629635789868189e-06
mutation O 0 1.8699856241255475e-07
. O 0 1.857607543342965e-07

To O 0 7.745670416170469e-08
investigate O 0 7.64365637451192e-08
whether O 0 1.6249749990038254e-08
a O 0 1.894245116318416e-08
founder O 0 1.434230227914668e-07
chromosome O 0 5.677063708020569e-09
for O 0 1.0068489375569811e-09
the O 0 6.999925972195342e-08
DM B-Disease 1 1.0
mutation O 0 6.728756662965907e-09
exists O 0 2.6711377554278215e-10
in O 0 5.128011903998697e-11
the O 0 4.607044745696953e-10
Japanese O 0 4.285272581228128e-09
population O 0 3.7463136759452453e-11
, O 0 9.207747064809979e-11
we O 0 3.0340668866202236e-10
genotyped O 0 1.7226756199306692e-07
families O 0 3.928410027831397e-11
using O 0 1.7538810681561046e-10
polymorphic O 0 1.612403188744338e-08
markers O 0 8.648768101693349e-08
near O 0 1.6633602228921518e-07
the O 0 2.7380545830624214e-08
( O 0 6.395824314608944e-09
CTG O 0 9.323870472144336e-05
) O 0 4.096795347408033e-09
n O 0 6.57609522392022e-09
repeat O 0 4.507921858021291e-08
region O 0 2.3898232726082824e-08
and O 0 1.7762298298862333e-08
constructed O 0 1.3070466593489982e-06
haplotypes O 0 1.2827738373744069e-06
. O 0 4.960407409271284e-07

Six O 0 1.886986495946985e-07
different O 0 1.044390463000866e-09
haplotypes O 0 4.5289909600398914e-09
were O 0 2.462687831439325e-10
found O 0 3.1348837414846287e-10
and O 0 5.9602451862872385e-09
DM B-Disease 1 1.0
alleles O 0 4.726602220728182e-09
were O 0 2.17872342389569e-09
always O 0 2.425814216167055e-08
haplotype O 0 1.1888409972016234e-06
A O 0 2.065091621261672e-06
. O 0 1.1505161410241271e-06

To O 0 1.9672553364102896e-08
find O 0 1.5012567855521297e-09
an O 0 3.59722564235998e-11
origin O 0 4.600000588772524e-11
of O 0 5.688409188131516e-10
the O 0 3.120603553341539e-09
( O 0 3.1226992103228213e-09
CTG O 0 5.686668009730056e-05
) O 0 1.5422906285422755e-09
n O 0 2.3988093733606775e-09
repeat O 0 2.3687740657862832e-09
mutation O 0 8.229782827440246e-11
and O 0 7.107762295399667e-11
to O 0 1.0348442242014144e-10
investigate O 0 3.7037289901675763e-10
the O 0 3.4839001128439406e-10
mechanism O 0 5.822939352917444e-10
of O 0 5.834423499884167e-10
the O 0 1.4008473270266109e-09
expansion O 0 1.2961065998240429e-08
mutation O 0 1.2642832614151445e-10
in O 0 5.983475520610071e-11
the O 0 4.198796310639352e-10
Japanese O 0 4.46348069615965e-09
population O 0 2.341094332281024e-11
we O 0 4.5091961414778226e-11
have O 0 3.158987307849692e-11
studied O 0 9.296874381448106e-09
90 O 0 1.016127271213918e-08
Japanese O 0 7.328028317488133e-08
DM B-Disease 1 1.0
families O 0 3.7264749619403403e-10
comprising O 0 5.615353182442107e-10
190 O 0 1.8949632973885855e-09
affected O 0 1.2467524790338302e-09
and O 0 4.149026011646129e-09
130 O 0 9.741297901655344e-08
unaffected O 0 8.504057404934429e-07
members O 0 9.904251641046358e-09
. O 0 2.145172146583718e-07

The O 0 5.597543122348725e-07
results O 0 1.1074795303045448e-08
suggest O 0 1.1047510684036865e-09
that O 0 6.529519286369023e-11
a O 0 2.5417054572152153e-10
few O 0 1.92923343966811e-09
common O 0 2.2800272780898467e-09
ancestral O 0 2.5454969687643825e-08
mutations O 0 7.426757542283724e-10
in O 0 1.7482100489463193e-10
both O 0 1.630233059657371e-09
Caucasian O 0 8.135248918961224e-08
and O 0 1.7721479839138965e-09
Japanese O 0 1.5038770229125475e-08
populations O 0 1.484946471341786e-10
have O 0 1.0757634366642677e-11
originated O 0 2.061678432141445e-11
by O 0 1.3278636003255517e-11
expansion O 0 9.751761176346463e-09
of O 0 4.383139629027255e-09
an O 0 6.827848841872708e-10
ancestral O 0 2.1083156553913796e-08
n O 0 3.732017805901933e-09
= O 0 2.6661610696976368e-09
5 O 0 5.3402331445795426e-09
repeat O 0 9.14560249754004e-09
to O 0 2.669178433833963e-09
n O 0 1.6181706641305027e-08
= O 0 1.6603719288355023e-08
19 O 0 3.943430115782576e-08
- O 0 1.2653718783894874e-07
37 O 0 9.154263125310536e-08
copies O 0 6.861550616577006e-08
. O 0 1.7241352168184676e-07

These O 0 3.789192604131131e-08
data O 0 2.295973411392538e-09
support O 0 3.124616121397139e-10
multistep O 0 8.062427170330011e-09
models O 0 4.169318668090227e-09
of O 0 1.8975574889168456e-08
triplet O 0 3.2472536304339883e-07
repeat O 0 1.7118955142336745e-08
expansion O 0 1.7237695715266454e-08
that O 0 4.804172337724566e-11
have O 0 8.923343834676967e-12
been O 0 2.1580586276326308e-11
proposed O 0 1.752242795305392e-10
for O 0 8.26779408824585e-11
both O 0 5.0924406913566145e-09
DM B-Disease 1 1.0
and O 0 6.740602316313016e-07
Friedreichs B-Disease 1 0.9999998807907104
ataxia I-Disease 1 0.9999994039535522
. O 0 4.872952104051365e-07
. O 0 1.5750121065138956e-06

The O 0 1.4935298509044515e-07
molecular O 0 2.806805454724781e-08
basis O 0 1.69342673217443e-08
of O 0 4.156238446739735e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
in O 0 4.056293523291288e-09
the O 0 5.64581359441263e-09
western O 0 1.3662744713371922e-08
Cape O 0 4.800676833838224e-07
, O 0 2.3099813173388384e-09
South O 0 3.811576831935781e-08
Africa O 0 1.5489746374441893e-08
. O 0 9.221855634677922e-08

Deficiency B-Disease 1 0.9998537302017212
of I-Disease 0 2.3248530851560645e-06
the I-Disease 0 3.144240849906055e-07
sixth I-Disease 0 4.0542465740145417e-07
component I-Disease 0 1.655453871762802e-07
of I-Disease 0 4.393772101707327e-08
human I-Disease 0 6.16733286662452e-09
complement I-Disease 0 1.0467724109730625e-07
( O 0 8.834835973914323e-09
C6 O 1 1.0
) O 0 1.7028609633484848e-09
has O 0 6.73875844015015e-10
been O 0 1.9041032639499633e-10
reported O 0 7.666042106668769e-11
in O 0 2.6102750169676447e-11
a O 0 3.675184809259768e-11
number O 0 2.5198617498167764e-11
of O 0 1.5219218940654144e-10
families O 0 2.4700237515051793e-12
from O 0 6.25657555278214e-12
the O 0 1.4753112620446984e-10
western O 0 3.91462151583255e-09
Cape O 0 1.977356447468992e-07
, O 0 2.5025828076508105e-09
South O 0 5.509669165348896e-08
Africa O 0 1.5706360656508878e-08
. O 0 1.5402224562421907e-07

Meningococcal B-Disease 1 0.9999943971633911
disease I-Disease 1 0.9980598092079163
is O 0 6.158658027999309e-09
endemic O 0 1.2691576678491856e-08
in O 0 1.811758659764351e-10
the O 0 1.8193154760481889e-09
Cape O 0 1.6544989023259404e-07
and O 0 4.71158612125322e-10
almost O 0 5.969420097118316e-11
all O 0 1.9459432329393955e-11
pedigrees O 0 1.0465759370248406e-09
of O 0 1.4261707370621934e-09
total O 0 1.4471178246822092e-06
C6 B-Disease 1 1.0
deficiency I-Disease 1 1.0
( O 0 2.772851459553749e-08
C6Q0 O 1 1.0
) O 0 1.7083914283233526e-09
have O 0 1.1501114643985844e-10
been O 0 2.1984002118724533e-10
ascertained O 0 1.60559636697144e-08
because O 0 1.197541066311203e-09
of O 0 2.7277492264943248e-08
recurrent O 1 1.0
disease O 1 0.9999622106552124
. O 0 1.3043347735219868e-06

We O 0 5.465624397515967e-08
have O 0 5.470124353479378e-10
sequenced O 0 1.942081606642887e-09
the O 0 5.755484422387269e-10
expressed O 0 3.34206023966388e-10
exons O 0 2.270974874818421e-08
of O 0 5.7715620727094574e-08
the O 0 1.0841966258112734e-07
C6 O 1 0.9984986782073975
gene O 0 4.3920247994044814e-10
from O 0 1.0189947496908047e-10
selected O 0 6.308888966799486e-10
cases O 0 8.278950441864552e-11
and O 0 1.026260396108647e-10
have O 0 4.74306982578554e-11
found O 0 1.6597528906814318e-10
three O 0 3.4114625013792477e-10
molecular O 0 1.231083729180682e-06
defects O 0 0.00039136072155088186
leading O 0 3.491660294230314e-08
to O 0 3.5721710034408716e-09
total O 0 9.24067478536017e-07
deficiency O 1 0.9999998807907104
879delG O 0 0.11115193367004395
, O 0 3.3296676527072577e-09
which O 0 4.4373513197193404e-10
is O 0 3.080765087482007e-10
the O 0 8.782412574959153e-10
common O 0 1.7559104170672413e-09
defect O 0 3.5973461987026667e-09
in O 0 1.1076960182432316e-10
the O 0 4.213150273102428e-09
Cape O 0 1.0333767477277433e-06
and O 0 7.2520092153638416e-09
hitherto O 0 9.38694881824631e-08
unreported O 0 8.876729395979055e-08
, O 0 4.735325465077267e-10
and O 0 6.638182226126332e-10
1195delC O 0 9.187094462959067e-08
and O 0 2.1187354093399335e-09
1936delG O 0 2.4476076987411943e-07
, O 0 7.630582832263144e-10
which O 0 1.240045011119406e-10
have O 0 3.58771484743059e-11
been O 0 2.0696894198479754e-10
previously O 0 1.5324908009262117e-09
reported O 0 4.25044638374672e-10
in O 0 3.03155639480579e-10
African O 0 3.168984186174839e-09
- O 0 2.4416439714514127e-07
Americans O 0 1.2140615623934536e-08
. O 0 7.539777868714737e-08

We O 0 7.387390610347211e-08
also O 0 4.932920294464793e-09
show O 0 2.8644571159475163e-09
that O 0 1.3518502983700387e-10
the O 0 2.2659201182051447e-09
879delG O 0 2.783731360977981e-07
and O 0 1.4956215821371188e-08
1195delC O 0 7.926002581370994e-06
defects O 0 1.0298928145857644e-06
are O 0 7.601178020344435e-11
associated O 0 2.458646897185446e-10
with O 0 1.371859403853648e-09
characteristic O 1 1.0
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
region O 0 1.4626589290855918e-06
DNA O 0 2.4228879169641004e-07
marker O 0 3.1124619681577315e-07
haplotypes O 0 5.138111269786805e-09
, O 0 3.324709396679282e-10
although O 0 4.142524101524714e-10
small O 0 2.567090096050606e-09
variations O 0 3.323514619069101e-08
were O 0 4.183450030836866e-09
observed O 0 4.373179507410896e-08
. O 0 1.347822831121448e-07

The O 0 1.1772203833970707e-06
1936delG O 0 2.8087231839890592e-05
defect O 0 3.323922101117205e-06
was O 0 5.105631473156791e-08
observed O 0 3.741275733659677e-09
only O 0 2.175778029966935e-10
once O 0 3.2680555483999285e-10
in O 0 3.724952291062067e-11
the O 0 6.124543094898627e-10
Cape O 0 1.3710877055927995e-07
, O 0 4.2421044454954426e-10
but O 0 1.3134310306028851e-10
its O 0 4.618359028540908e-10
associated O 0 1.6064592989195603e-09
haplotype O 0 6.343246639062272e-08
could O 0 1.082324274648272e-08
be O 0 9.494606878490686e-09
deduced O 0 1.9367267611869465e-07
. O 0 2.1459354115904716e-07

The O 0 3.5121868791065936e-07
data O 0 1.6981132944238198e-08
from O 0 1.57130342071099e-09
the O 0 4.978005119227191e-09
haplotypes O 0 1.0116985471597673e-08
indicate O 0 2.4486690453073834e-10
that O 0 2.0701029432301787e-11
these O 0 8.303620985250504e-11
three O 0 7.570417209779023e-11
molecular O 0 1.198590648954223e-08
defects O 0 1.6512196054918604e-08
account O 0 6.520831791201331e-11
for O 0 2.129291742924977e-10
the O 0 7.594186612891463e-09
defects O 0 1.0875746880856241e-07
in O 0 3.4937086557107477e-10
all O 0 1.597564525113171e-09
the O 0 5.102591238426157e-09
38 O 0 4.145428889046343e-08
unrelated O 0 1.9171868359535438e-07
C6Q0 O 1 0.9999998807907104
individuals O 0 5.480150222503255e-10
we O 0 5.424595772574037e-10
have O 0 1.2396476900544684e-10
studied O 0 8.518674654567349e-09
from O 0 1.6106749267663645e-09
the O 0 2.0001644784883865e-08
Cape O 0 6.313292033155449e-06
. O 0 5.246254204394063e-07

We O 0 1.5959655286224006e-07
have O 0 2.3351565126006335e-09
also O 0 1.099399238313481e-09
observed O 0 2.2690687107029817e-09
the O 0 4.418351018387057e-09
879delG O 0 3.238313013298466e-07
defect O 0 1.8583371286240435e-08
in O 0 5.56804213847073e-10
two O 0 3.1268594380406967e-09
Dutch O 1 1.0
C6 B-Disease 1 1.0
- I-Disease 1 1.0
deficient I-Disease 1 1.0
kindreds O 0 2.6669091312214732e-05
, O 0 2.065198900780274e-09
but O 0 4.1945219519945454e-10
the O 0 4.768055283932426e-09
879delG O 0 4.940352482663002e-07
defect O 0 1.3195138315325039e-08
in O 0 3.250425484324637e-10
the O 0 6.14085227113037e-09
Cape O 0 6.781662023058743e-07
probably O 0 6.97771118662871e-10
did O 0 1.2761813827921742e-10
not O 0 3.085467992214319e-11
come O 0 7.854111805372099e-11
from O 0 9.570671338776648e-11
The O 0 3.2607225808334306e-09
Netherlands O 0 1.5611776404966804e-07
. O 0 2.507687213437748e-08
. O 0 1.8534456103225239e-07

Complement B-Disease 1 1.0
C7 I-Disease 1 1.0
deficiency I-Disease 1 1.0
: O 0 1.1267992050534303e-07
seven O 0 7.473170526850481e-09
further O 0 1.191467635663912e-08
molecular O 0 3.301543642919569e-07
defects O 0 3.195961539859127e-07
and O 0 1.5168512002006196e-09
their O 0 1.948701200404912e-09
associated O 0 1.4253910052275387e-08
marker O 0 1.2606152267835569e-05
haplotypes O 0 2.2027188606443815e-06
. O 0 7.349065072048688e-07

Seven O 0 2.0190539373743377e-07
further O 0 1.5670391206867862e-08
molecular O 0 3.807572923619773e-08
bases O 0 1.0183801890661925e-07
of O 0 0.00021201629715505987
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.286925551852619e-08
described O 0 1.6295584259751195e-07
. O 0 2.3781468883044e-07

All O 0 3.538861648166858e-08
these O 0 1.3863159509241996e-09
new O 0 2.587974279322225e-09
molecular O 0 1.2323953058057668e-07
defects O 0 8.72538450380489e-08
involve O 0 2.2428128243490164e-09
single O 0 5.069489272813144e-10
- O 0 3.7874783309632676e-09
nucleotide O 0 1.2389816950175714e-09
events O 0 6.32382757270733e-10
, O 0 2.3133177318168663e-10
deletions O 0 3.0704305764572837e-09
and O 0 9.419492963402831e-10
substitutions O 0 1.1854810466616073e-08
, O 0 3.858356689701026e-10
some O 0 1.1539854488651358e-10
of O 0 1.1446212866417227e-09
which O 0 3.315173136009264e-10
alter O 0 3.1284240975537614e-08
splice O 0 4.0551896063334425e-08
sites O 0 8.27049895235632e-09
, O 0 1.6811996239596283e-09
and O 0 5.239821021518765e-09
others O 0 1.759458356787036e-08
codons O 0 2.2053752672945848e-06
. O 0 4.045325283641432e-07

They O 0 6.119536877235987e-09
are O 0 8.04337291215873e-11
distributed O 0 5.50340086002965e-11
along O 0 1.7398482654584768e-09
the O 0 9.309367499099608e-09
C7 O 0 0.19850699603557587
gene O 0 1.1350078654714935e-09
, O 0 3.473111798157902e-10
but O 0 1.4646485413383203e-10
predominantly O 0 6.204164404444157e-10
towards O 0 1.098171220625943e-09
the O 0 1.6222428955714463e-09
3 O 0 7.83583757879569e-08
end O 0 3.112402566785022e-07
. O 0 5.656044663737703e-07

All O 0 6.570192567778577e-08
were O 0 2.9424480629813843e-09
found O 0 8.370236170840428e-10
in O 0 7.695389880879588e-10
compound O 0 5.5625601902420385e-08
heterozygous O 0 9.028804015542846e-08
individuals O 0 2.2410511224535412e-09
. O 0 6.098437665968959e-08

The O 0 7.058176561258733e-05
C6 O 1 1.0
/ O 1 1.0
C7 O 1 1.0
marker O 0 2.0414554455783218e-05
haplotypes O 0 1.2148680639256781e-07
associated O 0 4.653180951663671e-09
with O 0 5.4023163720273715e-09
most O 0 9.832801879383624e-07
C7 B-Disease 1 1.0
defects I-Disease 1 0.9999713897705078
are O 0 5.1560280489582055e-09
tabulated O 0 8.155600994541601e-08
. O 0 5.931292346161854e-09
. O 0 6.585712952755784e-08

A O 0 7.29562771084602e-06
genome O 0 9.134222977991158e-08
- O 0 2.1395209159891238e-07
wide O 0 1.1070702043980418e-07
search O 0 2.4112867258452297e-09
for O 0 6.180141398637318e-10
chromosomal O 0 2.0630490382700373e-07
loci O 0 1.6124700152886362e-07
linked O 0 9.061687933353824e-08
to O 0 4.282657783960531e-09
mental O 1 0.9987668991088867
health O 0 1.9173105556546943e-06
wellness O 0 7.087438689268311e-07
in O 0 2.1803603367231972e-10
relatives O 0 2.0573898140696656e-10
at O 0 3.238685986062251e-10
high O 0 6.612156511209832e-08
risk O 0 7.531786394565643e-08
for O 0 1.646414204969915e-08
bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
among O 0 1.3597310832835774e-08
the O 0 2.4271797016695018e-08
Old O 0 9.126522968472273e-07
Order O 0 9.980716697555181e-08
Amish O 0 6.549622639795416e-07
. O 0 1.285755786284426e-07

Bipolar B-Disease 1 1.0
affective I-Disease 1 1.0
disorder I-Disease 1 1.0
( O 0 0.05432949960231781
BPAD B-Disease 1 1.0
; O 0 0.4140101373195648
manic B-Disease 1 1.0
- I-Disease 1 1.0
depressive I-Disease 1 1.0
illness I-Disease 1 1.0
) O 0 2.888774108811276e-09
is O 0 2.5227386846182753e-10
characterized O 0 4.675437814682937e-10
by O 0 2.7345847808391e-11
episodes O 0 2.736723203611291e-08
of O 0 1.0039311604259638e-07
mania B-Disease 0 0.4634968042373657
and O 0 4.048434831815939e-08
/ O 0 8.61074950080365e-05
or O 0 2.2851658343370218e-08
hypomania B-Disease 0 5.613106168311788e-06
interspersed O 0 1.047275759447075e-07
with O 0 2.9676252566446237e-09
periods O 0 1.0381352666399835e-07
of O 0 1.9302399323350983e-07
depression B-Disease 0 1.0679109436750878e-05
. O 0 2.9456120387294504e-07

Compelling O 0 1.829650386753201e-06
evidence O 0 1.2735374355088425e-07
supports O 0 1.4020781691215234e-07
a O 0 5.705177663628547e-09
significant O 0 1.2040118235745467e-08
genetic O 0 5.8399152180754754e-09
component O 0 1.3878061366767724e-08
in O 0 5.554380289041205e-10
the O 0 9.792486821424973e-09
susceptibility O 0 2.4132762632689264e-07
to O 0 5.4492197421041055e-08
develop O 0 0.0003540123288985342
BPAD B-Disease 1 1.0
. O 0 3.081239992752671e-05

To O 0 3.098045198157706e-08
date O 0 3.737996934205512e-08
, O 0 2.877078131291455e-09
however O 0 1.7405054064667524e-09
, O 0 2.159769696419289e-09
linkage O 0 1.3400580201050616e-08
studies O 0 2.457063663641179e-09
have O 0 9.89259368866513e-11
attempted O 0 3.778120483133307e-09
only O 0 8.173654114651541e-11
to O 0 1.8937518220241145e-10
identify O 0 2.875854665518318e-09
chromosomal O 0 1.0819552187513182e-07
loci O 0 3.449915197961673e-08
that O 0 9.338706474792957e-10
cause O 0 5.271769243364588e-09
or O 0 1.810936400836738e-10
increase O 0 2.6178997858394837e-10
the O 0 2.9324305206301915e-09
risk O 0 1.6218908882592586e-08
of O 0 4.351637272748121e-08
developing O 0 7.584564627904911e-06
BPAD B-Disease 1 1.0
. O 0 8.09256289358018e-06

To O 0 1.2808207827674778e-08
determine O 0 2.4209643179062823e-09
whether O 0 4.665407504766961e-10
there O 0 1.2898461465571387e-10
could O 0 2.0350889029518981e-10
be O 0 1.2525867842949623e-10
protective O 0 2.1679840145338858e-08
alleles O 0 7.378142541369925e-11
that O 0 1.165816228276828e-11
prevent O 0 8.432007314596035e-10
or O 0 5.7736562059096386e-11
reduce O 0 1.3220928796187081e-09
the O 0 4.2057457516619934e-10
risk O 0 1.3459899861345548e-09
of O 0 1.208131150676195e-09
developing O 0 3.959982208812107e-08
BPAD B-Disease 1 1.0
, O 0 1.0553518059452927e-09
similar O 0 7.17436596242571e-11
to O 0 8.395814599104767e-11
what O 0 1.0435734915104078e-10
is O 0 5.731742164227782e-11
observed O 0 7.375314942104083e-11
in O 0 4.2232353031357306e-11
other O 0 8.861467115650612e-09
genetic B-Disease 1 1.0
disorders I-Disease 1 1.0
, O 0 1.3867151871238548e-09
we O 0 6.659500173533672e-10
used O 0 3.1683315970809645e-09
mental O 0 0.0022639536764472723
health O 0 8.153794510690204e-07
wellness O 0 1.0452085007273126e-05
( O 0 8.934230438795154e-11
absence O 0 6.730036528068695e-10
of O 0 1.2083155587205852e-09
any O 0 3.7249279216666764e-09
psychiatric B-Disease 1 0.9999946355819702
disorder I-Disease 0 1.8727283759290003e-06
) O 0 8.210122165452916e-11
as O 0 1.8857285177809047e-10
the O 0 1.4598382502839513e-09
phenotype O 0 8.328862044493235e-10
in O 0 1.8714890748228186e-10
our O 0 1.1271635846910044e-09
genome O 0 3.929073510988701e-09
- O 0 1.2058599452302587e-07
wide O 0 4.965518769495247e-07
linkage O 0 6.437451105512082e-08
scan O 0 7.46532435869085e-08
of O 0 2.0674306711043755e-08
several O 0 3.387925939790648e-09
large O 0 2.9225709852198634e-08
multigeneration O 0 3.2587679470452713e-06
Old O 0 2.3838281038024434e-07
Order O 0 1.0051858900794741e-08
Amish O 0 2.1027656060823574e-08
pedigrees O 0 1.521685533134587e-08
exhibiting O 0 1.0362120050899648e-08
an O 0 5.539642078389306e-10
extremely O 0 1.1975005875797251e-08
high O 0 2.778795362701203e-07
incidence O 0 2.4922412649175385e-06
of O 0 6.853664217487676e-06
BPAD B-Disease 1 1.0
. O 0 1.3888031389797106e-05

We O 0 9.569187398028589e-08
have O 0 6.709427458062578e-10
found O 0 1.3222384298572365e-10
strong O 0 1.354919648699493e-10
evidence O 0 1.909551405887555e-10
for O 0 1.8060589135338034e-10
a O 0 8.135194740077623e-10
locus O 0 5.0659764383453876e-08
on O 0 5.657361512589887e-08
chromosome O 0 1.706779215737697e-07
4p O 0 2.3768641312926775e-06
at O 0 8.929779937716376e-08
D4S2949 O 0 1.8808219692800776e-06
( O 0 2.2561221779682228e-09
maximum O 0 5.119498069916517e-08
GENEHUNTER O 0 6.986057269386947e-05
- O 0 5.200421355766593e-07
PLUS O 0 5.874505859537749e-07
nonparametric O 0 1.446954769335207e-07
linkage O 0 9.300848091697844e-09
score O 0 8.452123445579218e-09
= O 0 5.543405179331273e-10
4 O 0 1.0551143292403253e-09
. O 0 2.73633948832952e-10
05 O 0 6.321114369711722e-07
, O 0 7.3431922764655155e-09
P O 0 5.6154021876864135e-08
= O 0 4.497816841197988e-10
5 O 0 4.1712971965424117e-10
. O 0 8.91513182721404e-11
22 O 0 1.162025697887259e-09
x O 0 6.505629368547261e-10
10 O 0 1.2631437007470936e-09
( O 0 1.1138229921714426e-10
- O 0 1.0881821665975622e-08
4 O 0 8.758494374205839e-09
) O 0 3.911126422728728e-10
; O 0 1.0239341596829377e-09
SIBPAL O 0 4.187187005300075e-05
Pempirical O 0 1.6185832691917312e-06
value O 0 6.052200518524842e-09
< O 0 3.273004089976439e-09
3 O 0 1.4784612423213161e-09
x O 0 1.337707944415456e-09
10 O 0 9.335180406466748e-10
( O 0 7.060578510742488e-11
- O 0 1.0804844130518632e-08
5 O 0 3.6993959007247668e-09
) O 0 1.7569280752471883e-10
) O 0 1.6543609537844617e-10
and O 0 4.20544848944715e-10
suggestive O 0 9.069914597148454e-09
evidence O 0 3.450964791706923e-10
for O 0 1.568083995984182e-10
a O 0 8.112602811749525e-10
locus O 0 4.337177728075403e-08
on O 0 6.297113230857576e-08
chromosome O 0 3.5134900144839776e-07
4q O 0 3.935168479074491e-06
at O 0 7.165363768990574e-08
D4S397 O 0 1.3763911965725129e-06
( O 0 2.457129166799632e-09
maximum O 0 5.9284001707737843e-08
GENEHUNTER O 0 6.0404647229006514e-05
- O 0 4.1335354694638227e-07
PLUS O 0 3.0518654625666386e-07
nonparametric O 0 5.8602928731943393e-08
linkage O 0 4.47390524627167e-09
score O 0 4.4139709665103055e-09
= O 0 2.728428039056041e-10
3 O 0 3.5352554217382703e-10
. O 0 7.942814461703307e-11
29 O 0 8.16197776032368e-09
, O 0 1.394034554458301e-09
P O 0 3.679173943282876e-08
= O 0 4.142381992977562e-10
2 O 0 1.0863691057849678e-09
. O 0 1.4863774100426497e-10
57 O 0 3.350704158577855e-09
x O 0 1.1284694290125685e-09
10 O 0 1.3869003723243623e-09
( O 0 7.931157119944743e-11
- O 0 8.22370260777916e-09
3 O 0 6.922344475412956e-09
) O 0 4.807722553401561e-10
; O 0 1.2702177087930977e-09
SIBPAL O 0 4.6418233978329226e-05
Pempirical O 0 1.125799713008746e-06
value O 0 1.038023977883995e-08
< O 0 3.4702665185903925e-09
1 O 0 2.8634739024369082e-09
x O 0 1.739542954126705e-09
10 O 0 2.2198820559538035e-09
( O 0 1.6062133567640302e-10
- O 0 1.3509804830391658e-08
3 O 0 3.80740416972003e-09
) O 0 1.379178438121187e-10
) O 0 5.706195238541767e-11
that O 0 3.420360522587984e-11
are O 0 1.1991747872475145e-10
linked O 0 2.575576196761631e-08
to O 0 2.088117589948979e-08
mental O 1 0.9067450761795044
health O 0 2.0808174667763524e-05
wellness O 0 0.00014131887292023748
. O 0 3.3388849374205165e-07

These O 0 8.483071667342301e-08
findings O 0 5.963895155502996e-09
are O 0 6.503864807827497e-11
consistent O 0 3.784306756848821e-10
with O 0 1.948944478025183e-11
the O 0 3.413571370014523e-10
hypothesis O 0 2.1120606652491603e-10
that O 0 1.3380331564949444e-11
certain O 0 4.323429669828016e-10
alleles O 0 2.0651466647869654e-10
could O 0 2.3943283466998366e-10
prevent O 0 3.1274201006681324e-09
or O 0 6.496466142813517e-10
modify O 0 5.937767166841468e-09
the O 0 1.639319013868601e-09
clinical O 0 5.608508857335437e-08
manifestations O 0 1.428729916597149e-07
of O 0 3.9522481642961793e-07
BPAD B-Disease 1 1.0
and O 0 1.400848645971564e-07
perhaps O 0 7.4108852388121704e-09
other O 0 4.881210102780642e-09
related O 0 0.0003164468798786402
affective B-Disease 1 1.0
disorders I-Disease 1 1.0
. O 0 1.4306375533124083e-06

Segregation O 0 0.00030528136994689703
distortion O 1 0.6323286294937134
in O 0 5.634865829051705e-06
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.00023653690004721284

Myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 1.0
DM B-Disease 1 1.0
) O 0 2.4136397769325413e-07
is O 0 5.766035648946399e-09
an O 0 3.825901817577915e-09
autosomal B-Disease 1 0.9984049201011658
dominant I-Disease 1 0.9999997615814209
disease I-Disease 1 0.9995743632316589
which O 0 2.667258358624025e-10
, O 0 7.228980608564584e-11
in O 0 5.4226168694215815e-11
the O 0 7.220564701704291e-10
typical O 0 3.733206632716701e-09
pedigree O 0 1.3256007846962348e-08
, O 0 3.5861569269712845e-10
shows O 0 1.169840224690688e-09
a O 0 1.4025370864700903e-09
three O 0 2.6384183726690935e-09
generation O 0 4.924142871232107e-08
anticipation O 0 1.624010337764048e-06
cascade O 0 0.0001373129925923422
. O 0 1.4369288692250848e-06

This O 0 8.830893349909275e-09
results O 0 2.3913446778323078e-09
in O 0 2.28829644122186e-09
infertility B-Disease 1 0.8251093029975891
and O 1 0.9850746393203735
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.6068915442701837e-07
CDM B-Disease 1 0.9996902942657471
) O 0 1.0876997219577689e-10
with O 0 4.215083143632725e-11
the O 0 3.411333882041845e-09
disappearance O 0 3.142004345590976e-08
of O 0 1.2316338882101263e-07
DM B-Disease 1 1.0
in O 0 2.4687054178684775e-08
that O 0 9.204701001408466e-09
pedigree O 0 1.5094929040060379e-06
. O 0 3.72370124068766e-07

The O 0 1.4275069304403587e-07
concept O 0 2.64463722032815e-08
of O 0 2.1107299019718084e-08
segregation O 0 2.0592061389379523e-07
distortion O 0 1.5358880318672163e-06
, O 0 6.395381446644421e-10
where O 0 1.364195145736602e-10
there O 0 2.3127210216355998e-11
is O 0 2.4639693063654988e-11
preferential O 0 1.2187824083298437e-09
transmission O 0 5.921725887425566e-10
of O 0 1.1100018681986512e-09
the O 0 5.842876182882151e-10
larger O 0 1.161409746153197e-09
allele O 0 1.8262158452131416e-10
at O 0 1.436665675313975e-09
the O 0 1.7009400110623574e-08
DM B-Disease 1 1.0
locus O 0 1.1338797776261345e-06
, O 0 2.8610500635295466e-09
has O 0 7.583240146935566e-10
been O 0 5.773417299792527e-10
put O 0 6.2838045877811055e-09
forward O 0 9.142097745495903e-09
to O 0 1.009620165248748e-09
explain O 0 2.726223913285253e-09
partially O 0 3.423616234954352e-08
the O 0 1.039434094352032e-09
maintenance O 0 1.3643636975757545e-07
of O 0 3.864680309106916e-07
DM B-Disease 1 1.0
in O 0 2.0865051908458554e-08
the O 0 5.959372728625567e-08
population O 0 4.25706936368897e-09
. O 0 5.001286496053581e-08

In O 0 1.0078931467205621e-07
a O 0 8.055725864153374e-09
survey O 0 2.529374265591855e-09
of O 0 1.4530717962202289e-08
DM B-Disease 1 1.0
in O 0 9.888245777744942e-09
Northern O 0 1.356006350761163e-06
Ireland O 0 1.3184200042815064e-07
, O 0 9.652259436165878e-09
59 O 0 7.253949263485993e-08
pedigrees O 0 1.3965440359697823e-07
were O 0 1.607643262957481e-08
ascertained O 0 2.013924358834629e-06
. O 0 2.507458134459739e-07

Sibships O 0 1.5188317775027826e-05
where O 0 1.0713748999080508e-08
the O 0 9.762511909983118e-10
status O 0 7.969100934701601e-10
of O 0 5.019457627319923e-10
all O 0 9.320657440303748e-11
the O 0 3.756389643783109e-10
members O 0 2.3488410869076937e-11
had O 0 5.614967935052562e-10
been O 0 4.2073580730495053e-10
identified O 0 1.802115540128213e-10
were O 0 7.527711787247426e-11
examined O 0 5.474216080436634e-10
to O 0 3.91027418777945e-11
determine O 0 7.241925115142323e-11
the O 0 2.6141028230952656e-10
transmission O 0 2.0134338640787064e-09
of O 0 1.83214172722046e-08
the O 0 1.035787136061117e-06
DM B-Disease 1 1.0
expansion O 0 7.715685569564812e-06
from O 0 1.4034950979180394e-09
affected O 0 1.416706085777264e-09
parents O 0 5.013666218300905e-11
to O 0 1.3188129754926337e-10
their O 0 3.123437952723407e-09
offspring O 0 4.861412605805526e-08
. O 0 7.383685840522958e-08

Where O 0 1.2135758709064248e-07
the O 0 3.0902668868293404e-08
transmitting O 0 1.572682549522142e-06
parent O 0 4.5718248742332435e-08
was O 0 1.1914318065464613e-07
male O 0 3.905926959646422e-08
, O 0 1.3024283873619424e-08
58 O 0 4.6982964363451174e-07
. O 0 3.5735703818318143e-07

3 O 0 7.41944461424282e-08
% O 0 1.0228625724195695e-09
of O 0 1.8103433196969831e-09
the O 0 1.1620611140017445e-09
offspring O 0 5.39405631272416e-10
were O 0 7.799860757273791e-11
affected O 0 2.0056023508630005e-10
, O 0 6.482117620443262e-11
and O 0 9.210381762825293e-11
in O 0 5.791899598817096e-11
the O 0 4.867865555091555e-10
case O 0 3.3279767830407536e-10
of O 0 2.4146140642500313e-09
a O 0 1.8211452346150736e-09
female O 0 3.2173417263692272e-09
transmitting O 0 2.9062431394777377e-07
parent O 0 4.611629833561892e-08
, O 0 2.9303631521315765e-08
68 O 0 2.599699200800387e-06
. O 0 7.562799737570458e-07

7 O 0 2.4930425297498005e-06
% O 0 3.6346182952229356e-08
were O 0 7.4246515602283125e-09
affected O 0 1.8487074271433812e-07
. O 0 6.625392643400119e-07

Studies O 0 1.3470736348608625e-07
on O 0 5.413490100636409e-08
meiotic O 0 7.983513796716579e-07
drive O 0 2.304447122014608e-07
in O 0 9.3699883407794e-09
DM B-Disease 1 1.0
have O 0 4.4694337120176897e-10
shown O 0 1.027839272027542e-10
increased O 0 1.2931741788513307e-10
transmission O 0 6.673894215047937e-10
of O 0 3.9811678953505236e-10
the O 0 3.1383837195697595e-10
larger O 0 1.2917079628138595e-09
allele O 0 2.1330720523238256e-10
at O 0 2.4944621923594923e-09
the O 0 1.5551023579973844e-08
DM B-Disease 1 1.0
locus O 0 5.743503379562753e-07
in O 0 7.622339204260697e-09
non O 0 2.154050162062049e-05
- O 0 0.04619625210762024
DM O 1 1.0
heterozygotes O 0 3.981548161391402e-06
for O 0 1.0622574109220295e-07
CTGn O 0 0.0003800413978751749
. O 0 7.500633500967524e-07

This O 0 4.2362547247876137e-08
study O 0 9.940626988225176e-09
provides O 0 8.09947608981787e-10
further O 0 5.172089978522365e-10
evidence O 0 6.503346750008632e-10
that O 0 2.4131902032209496e-10
the O 0 4.060003533368217e-08
DM B-Disease 1 1.0
expansion O 0 5.490389412443619e-06
tends O 0 8.171513599108948e-08
to O 0 3.7910270478391794e-09
be O 0 2.851537894699163e-09
transmitted O 0 1.0075237533158088e-08
preferentially O 0 1.846600099497664e-07
. O 0 2.1195292276843247e-07

Diagnosis O 1 0.9999927282333374
of O 0 0.24561487138271332
hemochromatosis B-Disease 1 1.0
. O 0 0.00016681302804499865

If O 0 4.583508598443586e-06
untreated O 1 1.0
, O 0 3.935815016120614e-07
hemochromatosis B-Disease 1 1.0
can O 0 2.0390817212501133e-07
cause O 0 2.7297504857415333e-05
serious O 1 1.0
illness O 1 0.982511579990387
and O 0 1.0314671339273218e-09
early B-Disease 0 1.3048295777196017e-09
death I-Disease 0 6.304393451728174e-09
, O 0 2.5633897782206816e-10
but O 0 2.4594723480042546e-10
the O 0 5.222539734006659e-09
disease O 0 1.0514434052311117e-06
is O 0 1.7736628832309975e-09
still O 0 2.03377048535458e-09
substantially O 0 2.345133509606967e-08
under O 0 8.572269649675945e-08
- O 1 0.9952496290206909
diagnosed O 0 3.360463961143978e-05
. O 0 6.435302566387691e-07

The O 0 3.073280083754071e-07
cornerstone O 0 7.4336408033559565e-06
of O 0 3.05251681709251e-08
screening O 0 2.3582625630069742e-08
and O 0 1.799204008001709e-09
case O 0 5.359270804916605e-10
detection O 0 2.6391850482809787e-08
is O 0 5.116720380726747e-10
the O 0 8.905703396955289e-10
measurement O 0 1.224767309793151e-08
of O 0 1.837632801482414e-08
serum O 0 2.5020208127557453e-08
transferrin O 0 1.660082915577732e-07
saturation O 0 1.2689572770341329e-07
and O 0 1.0414487938703587e-08
the O 0 2.9799295475640974e-08
serum O 0 1.2061498466664489e-07
ferritin O 0 1.5978234841895755e-06
level O 0 4.976508307663607e-07
. O 0 2.635578937315586e-07

Once O 0 8.891215088624449e-07
the O 0 2.5375999967991447e-08
diagnosis O 0 8.495650831719104e-07
is O 0 2.3348003530543338e-09
suspected O 0 2.625488271235099e-08
, O 0 3.865599396135622e-09
physicians O 0 5.8546145709215125e-09
must O 0 6.5890742861896e-10
use O 0 1.2051138975621711e-09
serum O 0 1.614520428461219e-08
ferritin O 0 6.473774760706874e-07
levels O 0 3.966354995554866e-07
and O 0 1.0597722877037086e-07
hepatic O 1 1.0
iron O 1 1.0
stores O 0 2.8782605454580334e-07
on O 0 1.280672279335704e-07
liver O 0 1.2889967365481425e-05
biopsy O 0 3.719335381902056e-07
specimens O 0 6.538174890380333e-09
to O 0 2.3808396920621533e-10
assess O 0 7.2176078447228065e-09
patients O 0 1.277511013642041e-10
for O 0 5.242014808337636e-11
the O 0 1.5008674303373937e-09
presence O 0 6.795657370162189e-09
of O 0 3.7883262393734185e-07
iron B-Disease 1 0.9999996423721313
overload I-Disease 0 0.00012144028733018786
. O 0 1.1458711242084973e-06

Liver O 1 1.0
biopsy O 1 0.7085133194923401
is O 0 1.6707282668448897e-08
also O 0 5.43751321746555e-10
used O 0 1.6428208793328736e-10
to O 0 2.342761540319316e-10
establish O 0 9.018848445840888e-10
the O 0 7.943908864049831e-10
presence O 0 1.702263330294329e-09
or O 0 2.3589992181882735e-09
absence O 0 3.695575401252427e-08
of O 0 1.2669089244354836e-07
cirrhosis B-Disease 1 1.0
, O 0 5.008471859468955e-09
which O 0 5.114358936353369e-10
can O 0 3.0770008763170154e-10
affect O 0 1.6047298601051807e-08
prognosis O 0 5.331764896254754e-06
and O 0 6.3077877143769e-08
management O 0 1.2396865258779144e-06
. O 0 7.759280151731218e-07

A O 0 4.372186879209039e-07
DNA O 0 5.4411577465884875e-09
- O 0 4.338317705077088e-09
based O 0 3.175589791126754e-10
test O 0 6.480831843402868e-11
for O 0 7.028867765601632e-11
the O 0 3.584032182146757e-09
HFE O 0 0.00013276591198518872
gene O 0 9.953067259260706e-10
is O 0 1.0110610265678943e-10
commercially O 0 4.5985815155802356e-10
available O 0 5.407444630955993e-11
, O 0 4.4195605508612346e-11
but O 0 1.1267927563229918e-11
its O 0 5.084748941341921e-11
place O 0 1.8536411294789445e-10
in O 0 5.375586781264374e-11
the O 0 1.0322642740590027e-09
diagnosis O 0 7.53573843326194e-08
of O 0 1.6485816445310775e-07
hemochromatosis B-Disease 1 1.0
is O 0 2.3540522420262278e-07
still O 0 2.3052596276329496e-08
being O 0 1.4918779100980828e-08
evaluated O 0 1.5462536850918696e-07
. O 0 9.421262348041637e-08

Currently O 0 3.8045243400119944e-07
, O 0 2.767824858196377e-09
the O 0 7.235053667287161e-10
most O 0 2.089215050959936e-10
useful O 0 2.888089489783141e-10
role O 0 2.0406160095021164e-10
for O 0 6.287743242738841e-11
this O 0 1.1985863690444631e-11
test O 0 6.843190597516369e-11
is O 0 1.778573295585506e-11
in O 0 7.2371717993457985e-12
the O 0 4.89144766357974e-11
detection O 0 9.60077528588954e-09
of O 0 5.4644047509100346e-08
hemochromatosis B-Disease 1 1.0
in O 0 4.5774939394505054e-09
the O 0 1.840466978819677e-08
family O 0 3.093784672891786e-10
members O 0 1.1229009042046378e-11
of O 0 6.471521096784727e-10
patients O 0 1.7195840584793842e-10
with O 0 6.507413358169956e-11
a O 0 1.1319378767638e-09
proven O 0 1.637788571429155e-08
case O 0 3.656756897285618e-09
of O 0 3.212063859336922e-08
the O 0 4.640974111680407e-07
disease O 0 0.00012435371172614396
. O 0 4.980259404874232e-07

It O 0 1.1141433020611657e-07
is O 0 9.453947846793653e-09
crucial O 0 1.0554795437656139e-07
to O 0 3.977703144641964e-08
diagnose O 1 1.0
hemochromatosis B-Disease 1 1.0
before O 1 0.9999994039535522
hepatic B-Disease 1 1.0
cirrhosis I-Disease 1 1.0
develops O 1 0.9999953508377075
because O 0 2.4462588044116274e-07
phlebotomy O 1 0.9999957084655762
therapy O 0 6.214407903826213e-07
can O 0 1.095957324892538e-09
avert O 0 2.4653186301293317e-06
serious O 1 1.0
chronic O 1 1.0
disease O 1 1.0
and O 0 2.82878565016631e-09
can O 0 9.791355920496514e-11
even O 0 4.383848006828117e-10
lead O 0 3.0191862343542653e-09
to O 0 2.1370274438936576e-09
normal O 0 4.981921364333175e-08
life O 0 1.0596727939571338e-08
expectancy O 0 1.3086785877192142e-08
. O 0 2.0289738777989896e-09
. O 0 7.238897836714386e-08

Prevalence O 0 1.572994005982764e-05
of O 0 5.201051180847571e-07
the O 0 3.2338320465896686e-07
I1307K O 0 3.569946056813933e-05
APC B-Disease 0 1.5035205933600082e-06
gene O 0 3.951755811471003e-09
variant O 0 2.7765070242935508e-09
in O 0 1.8190994544031724e-10
Israeli O 0 2.3806683291383024e-09
Jews O 0 2.2632279383927312e-10
of O 0 1.1305262281879891e-10
differing O 0 3.929009548264695e-11
ethnic O 0 8.139831170206335e-11
origin O 0 1.6919358275524488e-11
and O 0 8.625494068992268e-11
risk O 0 2.457730374771927e-08
for O 0 6.829522192219883e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 6.752582976332633e-06

BACKGROUND O 0 1.0031136298493948e-05
& O 0 1.3865329719919828e-06
AIMS O 0 1.2077906603735755e-06
Israeli O 0 1.0006445450017054e-08
Jews O 0 1.9034398501815986e-09
of O 0 2.1873758360158035e-09
European O 0 2.1981119147085337e-09
birth O 0 1.3487269079348607e-09
, O 0 2.0023113722622554e-10
i O 0 2.7331781282669e-10
. O 0 5.840578021221177e-11
e O 0 4.485506133189432e-10
. O 0 2.3453683439811357e-10
, O 0 1.3913887819683168e-09
Ashkenazim O 0 1.8527528311551578e-07
, O 0 7.575289284744713e-10
have O 0 6.88528262182686e-11
the O 0 1.964292062339723e-09
highest O 0 2.2042353521101177e-05
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 6.945988570805639e-05
of O 0 6.87706318558412e-08
any O 0 6.875539249051599e-09
Israeli O 0 2.4192759795482743e-08
ethnic O 0 2.1513956838248305e-08
group O 0 6.923321915763836e-09
. O 0 5.168012862100113e-08

The O 0 6.2241988416644745e-06
I1307K O 0 0.00012512842658907175
APC B-Disease 0 5.718336069548968e-06
gene O 0 3.7452903001167215e-08
variant O 0 9.848177029425642e-08
was O 0 5.843216399625817e-08
found O 0 2.4713093793593544e-09
in O 0 3.286183769546369e-09
6 O 0 1.0637187415341032e-06
. O 0 4.4606025539906113e-07

1 O 0 6.250015616160454e-08
% O 0 5.474852793341256e-10
of O 0 5.029079375162837e-10
American O 0 3.7941644270844677e-10
Jews O 0 3.352013111523888e-10
, O 0 7.497033549519472e-11
28 O 0 7.046819239242552e-10
% O 0 4.082633189850249e-11
of O 0 2.0444533566088552e-10
their O 0 2.987610825400111e-09
familial O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 1.7870419810606109e-07
, O 0 7.123478890092017e-11
but O 0 2.3027866072333758e-11
not O 0 2.091526431213797e-11
in O 0 9.966854425114136e-11
non O 0 4.072140669109103e-08
- O 0 1.3081711358609027e-07
Jews O 0 4.55626860684788e-08
. O 0 1.152972828322163e-07

We O 0 1.4668648873339407e-07
assessed O 0 4.753066207285883e-07
the O 0 2.3030448659255853e-08
I1307K O 0 5.912658025408746e-07
prevalence O 0 1.9720188149108253e-08
in O 0 1.2583482866812545e-10
Israeli O 0 1.3578980162520793e-09
Jews O 0 2.3097025680929306e-10
of O 0 9.613592560908657e-11
differing O 0 3.386281186013029e-11
ethnic O 0 1.0942732137086963e-10
origin O 0 1.4361435651810694e-11
and O 0 5.471217229269243e-11
risk O 0 1.7808739372071614e-08
for O 0 6.04041616725226e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 5.09251958646928e-06

METHODS O 0 3.8734623331038165e-07
DNA O 0 1.0968215669038273e-08
samples O 0 3.6817254800425303e-10
from O 0 3.304407789062047e-11
500 O 0 1.914898378752028e-10
unrelated O 0 4.4351847194867844e-10
Jews O 0 1.7172864519299225e-10
of O 0 3.352172706083678e-10
European O 0 9.571005099573426e-10
or O 0 1.4541072512752606e-10
non O 0 1.4803179793076993e-09
- O 0 7.659177181373877e-10
European O 0 2.8808766483479076e-10
origin O 0 8.404911315540442e-12
, O 0 2.1625529058461046e-12
with O 0 2.4896100805915644e-12
or O 0 4.296546105009291e-11
without O 0 1.463782844934869e-10
a O 0 1.1154684814718152e-10
personal O 0 2.8399982365812093e-09
and O 0 2.5874065112674316e-09
/ O 0 1.567974123872773e-07
or O 0 2.81231837817586e-09
family O 0 9.623321028939813e-10
history O 0 2.393562681390904e-09
of O 0 1.0980712339403453e-08
neoplasia B-Disease 0 1.5820141925360076e-05
, O 0 1.0142484629938053e-09
were O 0 3.2763688984083217e-10
examined O 0 2.8647411109972154e-09
for O 0 2.593354142543802e-10
the O 0 2.7652025114122125e-09
I1307K O 0 8.205093138258235e-08
variant O 0 1.1920262554809824e-09
by O 0 4.353058538630883e-11
the O 0 1.7989845169097407e-09
allele O 0 1.291937112846142e-09
- O 0 2.044747837715022e-08
specific O 0 1.0174226794390506e-08
oligonucleotide O 0 5.512590632861247e-07
( O 0 1.4635078038338634e-08
ASO O 0 0.0017382800579071045
) O 0 2.650030062056885e-08
method O 0 5.277707870732229e-08
. O 0 1.0880311407390764e-07

RESULTS O 0 7.185208232840523e-07
In O 0 1.0260911231796399e-08
persons O 0 4.1100986503117554e-10
at O 0 5.751818465959957e-10
average O 0 7.052909922755646e-10
risk O 0 6.208570546561987e-09
for O 0 1.4951936577745073e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 4.35982059343587e-08
I1307K O 0 2.5116801225522067e-06
was O 0 1.5694380905983962e-08
found O 0 1.207239641587421e-09
in O 0 1.193582344072297e-09
5 O 0 2.1805875860536617e-07
. O 0 1.3631229478505702e-07

0 O 0 1.60069689059128e-07
% O 0 2.651454389379637e-09
of O 0 2.8617703762279234e-09
120 O 0 6.5393721548900885e-09
European O 0 4.4009658139998464e-09
and O 0 1.0286266949321998e-08
1 O 0 8.484494173899293e-07
. O 0 3.9523615669168066e-07

6 O 0 3.769658007968246e-07
% O 0 2.635647255999629e-09
of O 0 1.9947228313554888e-09
188 O 0 3.9956389308315465e-09
non O 0 2.53674361516687e-08
- O 0 5.060703500703312e-08
European O 0 1.7466319945924624e-08
Jews O 0 7.71376207353569e-09
( O 0 9.501740505513112e-10
P O 0 7.91771626040827e-08
= O 0 1.6897832022522152e-09
0 O 0 2.458591774612273e-09
. O 0 1.3195332604354348e-09
08 O 0 1.3233002391643822e-06
) O 0 2.552254407817145e-08
. O 0 2.6217634285785607e-07

It O 0 1.5560466692932096e-07
occurred O 0 5.377933121053502e-08
in O 0 1.546813344077691e-08
15 O 0 4.165609652773128e-07
. O 0 7.197868399089202e-07

4 O 0 2.745093752309913e-07
% O 0 2.9102205090225652e-09
of O 0 3.219404076659771e-09
52 O 0 1.0094665547910608e-08
Ashkenazi O 0 3.3257972376077305e-08
Israelis O 0 1.2142583827312592e-08
with O 0 1.0382279036491582e-08
familial O 1 0.6745770573616028
cancer B-Disease 1 0.9999998807907104
( O 0 6.534771390676042e-09
P O 0 1.517780106041755e-07
= O 0 3.8798611545765027e-10
0 O 0 3.7391909013528846e-10
. O 0 1.2747217170705483e-10
02 O 0 4.858761570858405e-08
) O 0 7.461811724063239e-11
and O 0 5.984973627803925e-10
was O 0 3.525749026067615e-09
not O 0 9.611539342202491e-11
detected O 0 6.48476716769153e-10
in O 0 2.42853848142488e-10
51 O 0 1.588325915236055e-08
non O 0 2.4126313391548138e-08
- O 0 3.113714086566688e-08
European O 0 7.763963694173981e-09
Jews O 0 3.0782880688917658e-09
at O 0 4.739204140236097e-09
increased O 0 4.095117489555378e-08
cancer B-Disease 0 3.2849875424290076e-06
risk O 0 7.962299832797726e-07
. O 0 1.9865575495714438e-07

Colorectal B-Disease 1 1.0
neoplasia I-Disease 1 0.999993085861206
occurred O 0 8.400573960898328e-07
personally O 0 2.575061159859615e-07
or O 0 1.3840305568280087e-09
in O 0 1.210926775518928e-10
the O 0 5.721793594481994e-10
families O 0 1.0432545452521147e-11
of O 0 3.5650629670591627e-10
13 O 0 1.6184507067862342e-09
of O 0 3.760305844480172e-09
20 O 0 7.920583300347062e-09
Ashkenazi O 0 6.724112378009295e-09
I1307K O 0 1.0033052433300327e-07
carriers O 0 3.223322719847488e-10
, O 0 1.0666189459440645e-10
8 O 0 1.1878682482091563e-09
of O 0 2.1771366931488956e-09
whom O 0 1.0528787841579401e-09
also O 0 1.4206620324586083e-09
had O 0 4.140267240160256e-09
a O 0 1.7724319789635956e-09
personal O 0 2.3506910196147146e-08
or O 0 2.8946314234445936e-09
family O 0 1.9090533598387083e-09
history O 0 3.524795744169751e-08
of O 0 4.965045263816137e-07
noncolonic O 1 0.9987188577651978
neoplasia B-Disease 1 0.9994649291038513
. O 0 4.8770339162729215e-06

CONCLUSIONS O 0 9.750936442287639e-06
The O 0 6.334614113256976e-07
I1307K O 0 1.659162990108598e-05
APC O 0 2.1926878162048524e-06
variant O 0 4.375119431188068e-07
may O 0 3.8728980022995074e-09
represent O 0 1.5908961925603649e-09
a O 0 5.88853410476986e-10
susceptibility O 0 1.316326425637726e-08
gene O 0 1.0237622971587257e-09
for O 0 4.7162642680120825e-09
colorectal B-Disease 1 1.0
, I-Disease 0 7.959295800219479e-08
or I-Disease 0 1.5359378213730679e-09
other I-Disease 0 9.672785905578962e-10
, I-Disease 0 6.161545162974846e-10
cancers I-Disease 0 7.715590299994801e-08
in O 0 1.1302782321198634e-10
Ashkenazi O 0 4.7668731184558055e-09
Jews O 0 1.7182013589689404e-09
, O 0 3.706569773331836e-10
and O 0 2.015547284628383e-09
partially O 0 4.3867132148989185e-07
explains O 0 4.4873651461330155e-09
the O 0 3.786176649978046e-10
higher O 0 8.751944169382853e-10
incidence O 0 9.079646190457424e-08
of O 0 2.3239820166054415e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
in O 0 2.19045812599461e-08
European O 0 1.1162150315158215e-07
Israelis O 0 5.25559826769495e-08
. O 0 6.817587916430057e-08

Systematic O 0 4.204177628253092e-07
analysis O 0 1.3657768249686342e-08
of O 0 4.958137012067709e-08
coproporphyrinogen O 0 0.00011570200877031311
oxidase O 0 1.5379077922261786e-06
gene O 0 2.649626367201563e-07
defects O 0 8.250843166024424e-06
in O 0 1.002709915098876e-08
hereditary B-Disease 1 0.9999997615814209
coproporphyria I-Disease 1 1.0
and O 0 3.076759867326473e-06
mutation O 0 5.65174161692994e-07
update O 0 5.730307179874217e-07
. O 0 7.492526492569596e-07

Hereditary B-Disease 1 1.0
coproporphyria I-Disease 1 1.0
( O 0 3.0321663871291094e-05
HC B-Disease 1 1.0
) O 0 1.1779751503127045e-06
is O 0 9.863455829872692e-09
an O 0 3.887300259464155e-09
acute O 1 1.0
hepatic B-Disease 1 1.0
porphyria I-Disease 1 1.0
with O 1 0.9999734163284302
autosomal O 1 1.0
dominant O 1 1.0
inheritance O 0 0.00014617684064432979
caused O 0 5.367460076399766e-08
by O 0 4.119689589465736e-10
deficient B-Disease 0 9.804413991787442e-08
activity I-Disease 0 8.805681517287667e-09
of I-Disease 0 2.907869500745619e-08
coproporphyrinogen I-Disease 0 0.0003415671526454389
III I-Disease 1 1.0
oxidase I-Disease 0 7.927446290523221e-07
( O 0 1.625458700971194e-08
CPO O 1 0.7279993891716003
) O 0 9.123427702206754e-08
. O 0 2.8684723929472966e-07

Clinical O 1 0.6507954001426697
manifestations O 0 0.010449148714542389
of O 0 1.5628774008291657e-06
the O 0 2.7582780148804886e-07
disease O 1 0.9755064249038696
are O 0 1.1568856289612128e-10
characterized O 0 6.266362984064244e-10
by O 0 6.193141832699922e-11
acute O 0 1.3613807823276147e-05
attacks O 0 1.611195088457862e-08
of O 1 0.9999998807907104
neurological B-Disease 1 1.0
dysfunction I-Disease 1 1.0
often O 0 2.3668502713292128e-09
precipitated O 0 1.4375071133443384e-09
by O 0 2.6259751317869728e-11
drugs O 0 1.9969270681485796e-09
, O 0 4.752708226973823e-10
fasting O 0 1.9272851758955767e-08
, O 0 8.317546651426255e-09
cyclical O 1 0.9769850969314575
hormonal O 0 4.2045330701512285e-06
changes O 0 2.027056389408699e-08
, O 0 6.577926647821641e-09
or O 0 5.4982052688501426e-08
infectious B-Disease 0 0.11298494040966034
diseases I-Disease 1 0.7401696443557739
. O 0 8.607837003182794e-07

Skin O 1 1.0
photosensitivity O 1 1.0
may O 0 2.4216635097218386e-07
also O 0 1.887047318405166e-08
be O 0 3.4765867962249786e-09
present O 0 8.792976124993857e-09
. O 0 1.1728507587349668e-07

The O 0 7.917503239696089e-07
seven O 0 6.475849545495294e-08
exons O 0 3.0012918728061777e-07
, O 0 1.2021921236282651e-08
the O 0 4.4742741067693714e-08
exon O 0 1.004308273877541e-06
/ O 0 3.9633454207432806e-07
intron O 0 5.891230330234976e-07
boundaries O 0 2.006285448885592e-08
and O 0 5.206007847036176e-10
part O 0 2.889633643476941e-09
of O 0 3.743274579193212e-09
3 O 0 9.55131440605328e-09
noncoding O 0 7.503840038225462e-08
sequence O 0 1.0885740087118734e-09
of O 0 4.814542986508741e-09
the O 0 9.715984461422522e-09
CPO O 0 0.0001322038733633235
gene O 0 3.6257055135990868e-09
were O 0 1.5773178319022918e-09
systematically O 0 1.0059051369637473e-08
analyzed O 0 1.171340691108469e-09
by O 0 8.123266642678928e-11
an O 0 5.124397017830518e-10
exon O 0 6.304107103005663e-08
- O 0 8.699063158701392e-08
by O 0 6.9525536439130065e-09
- O 0 3.1506092454947066e-06
exon O 0 4.745991191157373e-06
denaturing O 0 1.1795560567406937e-05
gradient O 0 1.571504100184029e-07
gel O 0 3.025777459697565e-07
electrophoresis O 0 3.710648144306106e-08
( O 0 1.4509884405100593e-09
DGGE O 0 0.000462435360532254
) O 0 7.533187407204878e-10
strategy O 0 3.816215787821875e-09
followed O 0 2.658344933070822e-10
by O 0 2.8501319360163535e-11
direct O 0 5.234065403314503e-10
sequencing O 0 1.9201038536920123e-09
in O 0 4.761908645178892e-10
seven O 0 8.153778097153008e-09
unrelated O 0 1.552136694726869e-07
heterozygous O 0 8.934993189768647e-08
HC B-Disease 1 1.0
patients O 0 6.379486272578561e-09
from O 0 2.9723143391002793e-10
France O 0 5.701522809431481e-09
, O 0 4.1541237116859975e-10
Holland O 0 6.18462792090213e-08
, O 0 8.774576065739836e-10
and O 0 3.4381417712836537e-09
Czech O 0 0.0001377951557515189
Republic O 0 1.5207898286462296e-05
. O 0 1.959998826350784e-06

Seven O 0 3.393690803932259e-07
novel O 0 1.157962330466944e-07
mutations O 0 1.966068863268333e-09
and O 0 5.211074349809053e-10
two O 0 2.1791461690678915e-10
new O 0 1.0030595243293305e-09
polymorphisms O 0 9.199821349170634e-09
were O 0 6.6839866974532924e-09
detected O 0 1.1788804954449006e-07
. O 0 1.861171767814085e-07

Among O 0 3.65911674293784e-08
these O 0 1.3655392372413644e-09
mutations O 0 4.3405001814988964e-10
two O 0 1.5763124139311913e-10
are O 0 1.3595766179541613e-10
missense O 0 2.1609205091976946e-08
( O 0 6.243409123030119e-10
G197W O 0 6.805984753555094e-07
, O 0 1.8351835606722489e-09
W427R O 0 1.897214190194063e-07
) O 0 4.694121757964353e-10
, O 0 2.0753619656144195e-10
two O 0 7.765748460952793e-11
are O 0 9.941640566335508e-11
nonsense O 0 1.1263776578118723e-08
( O 0 2.002070870199546e-10
Q306X O 0 2.403675409823336e-07
, O 0 9.62827706452174e-10
Q385X O 0 1.166916376860172e-07
) O 0 1.9965643027752833e-10
, O 0 1.804172089503453e-10
two O 0 4.074737422476993e-11
are O 0 2.8229347678876415e-11
small O 0 5.569795180626613e-10
deletions O 0 1.842469110613365e-08
( O 0 1.338325561484055e-09
662de14bp O 0 3.8134825786073634e-07
; O 0 1.0847106546307828e-09
1168del3bp O 0 7.86563418841979e-07
removing O 0 9.227662189914554e-08
a O 0 1.4566952089012375e-09
glycine O 0 3.7197236402164435e-09
at O 0 7.485953190666805e-09
position O 0 3.2451619169648893e-09
390 O 0 5.579207318362478e-09
) O 0 1.0879300238464396e-10
, O 0 1.2229453560941295e-10
and O 0 2.331932702492878e-10
one O 0 1.9736122458535732e-10
is O 0 1.7143117481133174e-10
a O 0 3.3541555644056587e-10
splicing O 0 1.8778232302452125e-08
mutation O 0 7.207345387172381e-09
( O 0 1.4068398668243276e-09
IVS1 O 1 0.9100583791732788
- O 0 1.1269147535131196e-06
15c O 0 1.566207629366545e-06
- O 0 2.5688311211524706e-07
- O 0 2.3840237872718717e-07
> O 0 2.6303702327368228e-08
g O 0 5.235345490461896e-09
) O 0 1.416518846664161e-10
which O 0 1.6776943723151305e-10
creates O 0 6.9164456384385176e-09
a O 0 1.016035700018847e-09
new O 0 4.079975024495752e-09
acceptor O 0 2.6041113709851516e-09
splice O 0 7.721773158664291e-07
site O 0 5.225113000051351e-07
. O 0 4.1551666640771145e-07

The O 0 3.4330625453549146e-07
pathological O 0 1.221950697072316e-06
significance O 0 1.9430038378231984e-07
of O 0 4.2556909107815954e-08
the O 0 1.4907257650520478e-08
point O 0 9.088760322129019e-08
mutations O 0 1.940319016568992e-09
G197W O 0 1.6680733949669957e-07
, O 0 1.3254762842862533e-09
W427R O 0 2.9615773655677913e-07
, O 0 8.281655361486173e-10
and O 0 5.937129676780728e-10
the O 0 1.0464041855229311e-09
in O 0 6.64321042620486e-10
- O 0 1.2834232165914727e-07
frame O 0 8.889674063539132e-08
deletion O 0 3.7446330480861434e-08
390delGly O 0 5.953851456297343e-08
were O 0 1.3197944126464023e-10
assessed O 0 2.2284682987816495e-09
by O 0 3.0654770388771624e-11
their O 0 1.5936103825442416e-10
respective O 0 2.6245356998799707e-09
expression O 0 4.42108016862619e-10
in O 0 1.2336565102799568e-10
a O 0 7.449869610098858e-10
prokaryotic O 0 3.07263325893814e-09
system O 0 2.2280306488653423e-09
using O 0 1.5951743259634554e-09
site O 0 2.9067493301226932e-08
- O 0 5.999608987394822e-08
directed O 0 7.053185413496976e-08
mutagenesis O 0 3.2252595701720566e-05
. O 0 7.336677754210541e-07

These O 0 5.221526677701149e-08
mutations O 0 3.2495470758675538e-09
resulted O 0 4.440739775901648e-09
in O 0 2.837635959540563e-10
the O 0 3.0602924638856166e-09
absence O 0 1.3320080149981095e-08
or O 0 1.0218056401001263e-09
a O 0 1.0572779318707148e-09
dramatic O 0 2.6881087578090046e-08
decrease O 0 7.217913378099183e-08
of O 0 3.298909518889559e-07
CPO O 1 0.9999947547912598
activity O 0 6.082656227590633e-07
. O 0 4.5864371145398763e-07

The O 0 2.0980306203455257e-07
two O 0 3.143027615948313e-09
polymorphisms O 0 1.9530062012051985e-09
were O 0 6.496850279980038e-10
localized O 0 2.6706819866717524e-08
in O 0 1.1300266278269078e-09
noncoding O 0 2.8600945256584964e-07
part O 0 2.0530015021336112e-08
of O 0 2.3491134371056432e-08
the O 0 2.4216384453268347e-09
gene O 0 2.5396992842097177e-10
1 O 0 3.4815834659696066e-09
) O 0 3.0681518436992405e-10
a O 0 1.201943877759959e-09
C O 0 1.1526649501547581e-07
/ O 0 2.7660583157285146e-08
G O 0 1.793551440698593e-08
polymorphism O 0 1.4576589935089146e-10
in O 0 1.3715892310806055e-10
the O 0 4.312700419006887e-09
promotor O 0 7.035663202259457e-06
region O 0 1.6074264408416639e-07
, O 0 1.2784337144466917e-08
142 O 0 6.215042702706342e-08
bp O 0 2.8432404874934036e-08
upstream O 0 2.638600982152184e-08
from O 0 5.154147109109886e-10
the O 0 1.338601340883372e-09
transcriptional O 0 1.8964565473567063e-09
initiation O 0 4.5250279079311895e-09
site O 0 8.271556772854183e-09
( O 0 3.0801658446044655e-10
- O 0 5.7502781203311315e-08
142C O 0 7.918031883491494e-07
/ O 0 5.893708632243033e-08
G O 0 7.824084491403482e-08
) O 0 1.4833952122206284e-10
, O 0 7.595903073198684e-11
and O 0 1.159523241311966e-10
2 O 0 4.4336818660895005e-09
) O 0 3.9622294334407115e-10
a O 0 1.0636472813629894e-09
6 O 0 9.401602163450207e-09
bp O 0 8.440846244184286e-09
deletion O 0 1.7917042294257612e-09
polymorphism O 0 3.499148887309289e-11
in O 0 8.032702281113302e-11
the O 0 7.146290781356868e-10
3 O 0 3.951770910504138e-09
noncoding O 0 1.67379099025311e-07
part O 0 1.8134267421032746e-08
of O 0 3.047351171403534e-08
the O 0 3.001520454404272e-08
CPO O 0 0.06178387627005577
gene O 0 9.811014223259917e-09
, O 0 4.8594630541742845e-09
574 O 0 8.280920837933081e-08
bp O 0 1.4037233597719023e-08
downstream O 0 1.969845975224871e-08
of O 0 3.350058674911338e-09
the O 0 1.6406828118320504e-09
last O 0 5.10268605147246e-10
base O 0 3.0653806160074737e-09
of O 0 4.946469012168109e-09
the O 0 9.909542519892511e-09
normal O 0 1.8544985991297835e-08
termination O 0 4.4116671205074454e-08
codon O 0 1.3798974407563946e-07
( O 0 6.044079015055104e-09
+ O 0 4.506924256020284e-08
574 O 0 2.669684420197882e-07
delATTCTT O 0 5.9296999097568914e-06
) O 0 4.2175102521468943e-08
. O 0 3.196385307546734e-07

Five O 0 6.103383611844038e-07
intragenic O 0 1.4546973034157418e-05
dimorphisms O 0 8.770584827288985e-06
are O 0 2.1247814618874372e-09
now O 0 1.4458775288161974e-09
well O 0 8.001329043771932e-10
characterized O 0 1.5637987571537337e-09
and O 0 4.3285866557774e-10
the O 0 1.768433732785013e-09
high O 0 2.943808041777629e-08
degree O 0 5.518805856752351e-09
of O 0 7.749258124079006e-09
allelic O 0 5.165815650798322e-07
heterogeneity O 0 1.937872298185539e-07
in O 0 5.603865371739403e-09
HC B-Disease 1 1.0
is O 0 9.167958836542311e-09
demonstrated O 0 5.055219021166124e-10
with O 0 6.706583205451366e-11
seven O 0 1.0159556529387714e-10
new O 0 2.3405317614577648e-11
different O 0 3.9608351320996604e-12
mutations O 0 2.958574010780701e-11
making O 0 1.4429014927319628e-10
a O 0 1.3075220073321958e-10
total O 0 4.352197213730591e-10
of O 0 5.9679576835947046e-09
nineteen O 0 6.458050165747409e-07
CPO O 1 1.0
gene B-Disease 0 1.775141299731331e-06
defects I-Disease 0 1.3939289601694327e-05
reported O 0 3.158532768665623e-09
so O 0 5.517434842339242e-10
far O 0 2.837442503178522e-09
. O 0 7.214965069834989e-09
. O 0 1.866468579692082e-07

Coincidence O 0 7.060399411784601e-07
of O 0 9.510633702802807e-08
two O 0 3.785015856294649e-09
novel O 0 1.4276703552695835e-07
arylsulfatase O 0 3.7849420095881214e-06
A O 0 2.0241978404555994e-07
alleles O 0 2.7582545136795034e-09
and O 0 5.931970914474505e-09
mutation O 0 2.332936155369225e-08
459 O 0 2.460948849147826e-07
+ O 0 1.6641740785416914e-07
1G O 0 8.433440962107852e-05
> O 0 1.7677778885172302e-07
A O 0 1.0395282146191676e-07
within O 0 1.882358713345411e-09
a O 0 8.85926554339278e-10
family O 0 1.1453201720357242e-09
with O 0 7.514779021278173e-09
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
: O 0 1.7495226600772185e-08
molecular O 0 1.7421836417952363e-08
basis O 0 4.940971631839375e-09
of O 0 1.4786481372652815e-08
phenotypic O 0 3.0408248221647227e-06
heterogeneity O 0 5.46730007044971e-06
. O 0 8.508235396220698e-07

In O 0 3.644601065388997e-08
a O 0 5.108073519721756e-09
family O 0 7.634193277539225e-10
with O 0 3.501139933526076e-10
three O 0 1.3363536943700183e-09
siblings O 0 6.297999899373963e-09
, O 0 4.3983375275225e-10
one O 0 2.1743053191247697e-10
developed O 0 7.893041220619068e-10
classical O 0 3.28898224211116e-08
late O 0 8.781381666267407e-08
infantile O 1 0.9999310970306396
metachromatic B-Disease 1 1.0
leukodystrophy I-Disease 1 1.0
( O 0 7.38538972200331e-08
MLD B-Disease 1 1.0
) O 0 8.838122234067214e-09
, O 0 2.6504229921897604e-09
fatal O 0 2.021627487636124e-08
at O 0 2.2730020088346237e-09
age O 0 1.3694307909872805e-09
5 O 0 1.0318607079895514e-09
years O 0 2.2242335750988218e-10
, O 0 1.3160186829175302e-10
with O 0 2.2036267255387543e-10
deficient O 0 8.215113211917924e-07
arylsulfatase O 0 0.0001030268394970335
A O 0 4.908436494588386e-06
( O 0 1.175257580143807e-08
ARSA O 0 0.29083505272865295
) O 0 4.798368924419094e-10
activity O 0 1.972532137628491e-10
and O 0 9.00911290013795e-11
increased O 0 2.8298974275031696e-09
galactosylsulfatide O 0 9.187318028125446e-06
( O 0 4.703725409171966e-08
GS O 1 1.0
) O 0 6.982403988331498e-08
excretion O 0 4.862544074057951e-07
. O 0 1.3004380150505312e-07

The O 0 5.161619398563744e-08
two O 0 4.716504409252309e-10
other O 0 4.838669465101475e-10
siblings O 0 7.627327214265733e-09
, O 0 1.2275731542388257e-09
apparently O 0 4.854109114660332e-09
healthy O 0 3.4463030207376733e-09
at O 0 1.2550793737631238e-09
12 O 0 2.357964490329323e-09
( O 0 4.078111806582463e-11
1 O 0 2.728424153275455e-09
/ O 0 2.001984134025747e-09
2 O 0 1.3127052778116877e-09
) O 0 2.201403469237473e-11
and O 0 8.193726946936764e-11
15 O 0 3.5399921882728336e-10
years O 0 9.173109494220455e-11
, O 0 5.362069468994868e-11
respectively O 0 9.946211215750012e-11
, O 0 3.4371418905498885e-11
and O 0 7.588372985534164e-11
their O 0 6.998127771717932e-11
father O 0 1.1382553788408245e-09
, O 0 7.637193655263275e-10
apparently O 0 1.987803033287605e-09
healthy O 0 1.9783394922257003e-09
as O 0 1.5286627519373042e-10
well O 0 6.552053344321962e-10
, O 0 9.363391173522473e-10
presented O 0 1.0533317151839583e-07
ARSA O 1 0.9999865293502808
and O 0 3.399855188490619e-07
GS O 1 1.0
values O 0 1.6606252373208008e-08
within O 0 1.0625949009579472e-09
the O 0 1.201352461954741e-09
range O 0 1.5692307897552382e-07
of O 0 1.3533200160509296e-07
MLD B-Disease 1 1.0
patients O 0 8.559343882552639e-07
. O 0 1.809937373309367e-07

Mutation O 0 7.284660341611016e-08
screening O 0 2.595524151161044e-08
and O 0 1.3695038436623008e-09
sequence O 0 8.043316013228718e-10
analysis O 0 2.4062407621983084e-10
disclosed O 0 2.607670079868285e-09
the O 0 7.641505761490919e-10
involvement O 0 6.635084481843023e-09
of O 0 1.3982961455383247e-08
three O 0 1.0229327385147258e-09
different O 0 6.439017097292776e-10
ARSA O 1 0.9565554857254028
mutations O 0 7.756844055961665e-09
being O 0 2.0495418695531953e-09
the O 0 1.149171313663544e-09
molecular O 0 3.5353651117731033e-09
basis O 0 2.7526205759187405e-09
of O 0 2.06011314674015e-08
intrafamilial O 0 3.256434138165787e-05
phenotypic O 0 1.831981717259623e-05
heterogeneity O 0 1.3487963769875932e-05
. O 0 1.1687278629324283e-06

The O 0 5.75595606733259e-07
late O 0 3.733155722329684e-07
infantile O 0 7.597362855449319e-05
patient O 0 1.4595417496821028e-07
inherited O 0 1.7674946661827562e-07
from O 0 1.7244788930170785e-09
his O 0 6.477850433839194e-08
mother O 0 8.511885418727161e-09
the O 0 2.6845310419076895e-09
frequent O 0 1.2135591198614293e-08
0 O 0 4.32064766187068e-08
- O 0 2.898114246363548e-07
type O 0 5.66176510119476e-08
mutation O 0 1.0440404096812017e-08
459 O 0 6.48982165785128e-08
+ O 0 8.449447364000662e-09
1G O 0 2.5083600121433847e-06
> O 0 8.199269707631629e-09
A O 0 1.211551747815065e-08
, O 0 1.4679514548365802e-10
and O 0 1.4732529085570434e-10
from O 0 2.48054077278681e-10
his O 0 4.594813862723868e-09
father O 0 4.44653736053624e-09
a O 0 5.70380409570248e-10
novel O 0 1.1824345946820358e-08
, O 0 1.0298532027164242e-09
single O 0 2.633802953511122e-09
basepair O 0 1.4332637192637776e-06
microdeletion O 0 2.1828107037435984e-06
of O 0 8.755259273129923e-08
guanine O 0 2.615092853375245e-08
at O 0 6.413280573269731e-09
nucleotide O 0 2.372373186787513e-09
7 O 0 6.300018284832731e-09
in O 0 1.084301204379301e-09
exon O 0 2.8537979801512847e-07
1 O 0 4.23703056640079e-07
( O 0 1.4505380896423503e-08
7delG O 0 3.50731102116697e-06
) O 0 3.685361704697243e-08
. O 0 2.735090731675882e-07

The O 0 4.907739139525802e-07
two O 0 3.865932995950061e-08
clinically O 0 5.273746410239255e-06
unaffected O 0 1.1819114433819777e-06
siblings O 0 4.731223057774514e-08
carried O 0 9.977724424459211e-09
the O 0 8.962366848663805e-09
maternal O 0 1.7864797996480775e-07
mutation O 0 3.429184403103136e-08
459 O 0 1.1070364536180932e-07
+ O 0 5.1826219760187087e-08
1G O 0 1.5079583135957364e-05
> O 0 3.978272644644676e-08
A O 0 3.1826996149675324e-08
and O 0 8.632313197587393e-10
, O 0 1.5030725275533285e-10
on O 0 1.0543498296655684e-09
their O 0 1.8382025068763852e-10
paternal O 0 6.163852095397715e-09
allele O 0 1.3777041729667872e-09
, O 0 9.115418420080346e-10
a O 0 1.6103677280554507e-09
novel O 0 4.748843451807261e-08
cytosine O 0 4.9719535155645644e-08
to O 0 4.2339420858183985e-09
thymidine O 0 1.0009084405737667e-07
transition O 0 1.0252068527449865e-08
at O 0 1.5182356705167876e-08
nucleotide O 0 1.7327355550378343e-08
2435 O 0 2.601854703243589e-06
in O 0 1.9145376395357516e-09
exon O 0 9.825418345599246e-08
8 O 0 2.4942398368921204e-08
, O 0 8.166396447961688e-10
resulting O 0 9.863507788310244e-10
in O 0 9.025623998182297e-11
substitution O 0 3.0119848837273366e-09
of O 0 1.0753424817266932e-08
alanine O 0 2.283197204633325e-07
464 O 0 1.0785925042000599e-07
by O 0 7.501160581568911e-09
valine O 0 1.7587053662282415e-05
( O 0 4.7066151864783023e-08
A464V O 0 1.4711768017150462e-05
) O 0 1.102352484849689e-07
. O 0 4.491006677653786e-07

The O 0 1.0584739129626541e-06
fathers O 0 1.9919528426726174e-07
genotype O 0 6.189230106201649e-08
thus O 0 2.209984728551717e-08
was O 0 2.721475027556153e-07
7delG O 0 4.912876829621382e-05
/ O 0 6.109193054726347e-05
A464V O 0 0.0003197539481334388
. O 0 4.7144139898591675e-06

Mutation O 0 2.554330194470822e-06
A464V O 0 6.320291959127644e-06
was O 0 4.2512777298497895e-08
not O 0 4.135750630851476e-10
found O 0 1.470810140347112e-10
in O 0 4.1263895078635926e-10
18 O 0 3.80191238491534e-08
unrelated O 0 3.3433375392633025e-06
MLD B-Disease 1 1.0
patients O 0 1.861169920402972e-07
and O 0 1.8551318703430297e-08
50 O 0 1.7586638989541825e-07
controls O 0 6.8422873482631985e-06
. O 0 9.330111652161577e-07

A464V O 0 3.665697659016587e-05
, O 0 5.122037194382756e-08
although O 0 1.1513395570261764e-08
clearly O 0 3.355515332259529e-08
modifying O 0 6.809620458625432e-07
ARSA O 1 1.0
and O 0 7.830413437659445e-07
GS O 1 1.0
levels O 0 1.0634393277086929e-07
, O 0 1.4300086670360201e-09
apparently O 0 2.592742021079175e-09
bears O 0 1.938275175916715e-07
little O 0 3.9884358038477785e-09
significance O 0 2.9505535792395676e-08
for O 0 8.837730547384126e-10
clinical O 0 5.63525155428124e-08
manifestation O 0 1.4807471870881272e-07
of O 0 1.8114154443082953e-07
MLD B-Disease 1 1.0
, O 0 7.36927816546995e-08
mimicking O 0 5.794670414616121e-07
the O 0 1.3143500154910726e-07
frequent O 0 2.446786538712331e-06
ARSA O 1 0.9990304708480835
pseudodeficiency O 0 0.0007126007694751024
allele O 0 4.984163297194755e-06
. O 0 1.0149475428988808e-06

Our O 0 2.4125051822920796e-07
results O 0 2.9871094486821903e-09
demonstrate O 0 1.2614703726043786e-09
that O 0 3.6659363045199456e-11
in O 0 1.0654071375126861e-10
certain O 0 1.330882404282363e-09
genetic O 0 2.658092634888476e-09
conditions O 0 6.160232324248227e-09
MLD B-Disease 1 1.0
- O 0 0.006201239302754402
like O 0 3.165062878451863e-07
ARSA O 1 1.0
and O 0 2.010990698408932e-07
GS O 1 1.0
values O 0 3.5668603626248796e-09
need O 0 3.5515163032684427e-10
not O 0 5.614547368693046e-11
be O 0 7.525299827726428e-11
paralleled O 0 1.1984367942474705e-09
by O 0 7.790865175216766e-11
clinical O 0 9.441205293114763e-06
disease O 0 1.1948810652029351e-06
, O 0 4.0482456276080825e-10
a O 0 3.5697442224424947e-10
finding O 0 6.361863813530988e-10
with O 0 2.3524290848619955e-10
serious O 0 6.949625799279602e-07
diagnostic O 0 5.8987789088860154e-05
and O 0 2.1445380582463258e-07
prognostic O 1 1.0
implications O 0 0.00017111978377215564
. O 0 6.744576239725575e-07

Moreover O 0 1.8175946934206877e-06
, O 0 1.2701498519618326e-07
further O 0 6.511346555271302e-07
ARSA O 0 0.00411657290533185
alleles O 0 3.096969791727133e-08
functionally O 0 4.583603185892571e-08
similar O 0 7.890211262129299e-10
to O 0 1.1155711909793808e-09
A464V O 0 6.125302434156765e-07
might O 0 1.5818009124757282e-09
exist O 0 2.2339485816758042e-10
which O 0 5.555903653808869e-11
, O 0 7.058585660413286e-11
together O 0 1.4604048872990383e-11
with O 0 3.805178741544957e-11
0 O 0 6.767472360280635e-09
- O 0 8.046883692713891e-08
type O 0 3.3141457578267364e-08
mutations O 0 3.5369434048249104e-09
, O 0 4.283709498231758e-10
may O 0 9.244212617609548e-10
cause O 0 1.9393729289163275e-08
pathological O 0 0.04323079437017441
ARSA O 1 1.0
and O 0 1.662334057073167e-06
GS O 1 1.0
levels O 0 5.393938451447866e-08
, O 0 2.6877780556766595e-10
but O 0 7.90714091425393e-11
not O 0 7.3747938311719e-11
clinical O 0 1.411937411432973e-08
outbreak O 0 3.4305038809634425e-09
of O 0 8.408034268825304e-09
the O 0 4.786920015931173e-08
disease O 0 4.549022492028598e-07
. O 0 1.8161406600825103e-08
. O 0 3.3029166957021516e-07

Human O 1 0.9999643564224243
MLH1 O 1 1.0
deficiency O 1 1.0
predisposes O 0 0.00012192227586638182
to O 0 4.853528139392438e-07
hematological B-Disease 1 1.0
malignancy I-Disease 1 1.0
and O 0 1.5074832617756329e-06
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 0.06158506125211716
1 I-Disease 0 0.0006648152484558523
. O 0 4.210276642879762e-07

Heterozygous O 0 7.837324119464029e-06
germ O 0 6.43178327663918e-06
- O 0 1.5853165677981451e-06
line O 0 1.955440041001566e-07
mutations O 0 2.038601953913144e-09
in O 0 1.9439225229511692e-10
the O 0 1.3973434631608939e-09
DNA O 0 1.7611235136882897e-08
mismatch O 0 1.4887673387420364e-06
repair O 0 3.792356721987744e-07
genes O 0 8.329342549018293e-09
lead O 0 1.7436196486642075e-08
to O 0 1.872315635864652e-08
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.2572848390846048e-05

The O 0 4.787481771018065e-07
disease O 0 4.6819971544209693e-07
susceptibility O 0 4.3882028677444396e-08
of O 0 1.5580037882045872e-07
individuals O 0 7.381538713602254e-10
who O 0 4.166218481316264e-09
constitutionally O 0 1.3190273762120341e-07
lack O 0 2.9040228000098978e-08
both O 0 3.000826032106829e-09
wild O 0 5.492869377121679e-07
- O 0 4.93420316161064e-07
type O 0 7.446935512689379e-08
alleles O 0 2.9029580961292822e-09
is O 0 1.577098229788021e-09
unknown O 0 2.7550171921575384e-08
. O 0 6.205921465607389e-08

We O 0 6.03753704808696e-08
have O 0 4.989409996269956e-10
identified O 0 9.008567225521347e-10
three O 0 3.500252032662132e-10
offspring O 0 9.193607541924109e-10
in O 0 9.419093283113966e-11
a O 0 4.109520723716287e-09
hereditary B-Disease 1 1.0
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 1.4867016489006346e-06
who O 0 4.2324965754403365e-09
developed O 0 3.181121854822777e-08
hematological B-Disease 1 0.9999982118606567
malignancy I-Disease 0 0.03777037188410759
at O 0 6.757849835281604e-09
a O 0 1.9435182629923275e-10
very O 0 2.9283696995063835e-11
early O 0 1.6286844095603215e-10
age O 0 4.6437803602472627e-10
, O 0 4.6193611435985105e-11
and O 0 8.397128131720777e-11
at O 0 6.207502289967692e-10
least O 0 1.9485949312447737e-11
two O 0 4.506245203372838e-12
of O 0 1.5536985586983576e-10
them O 0 5.6731182251912315e-11
displayed O 0 6.623628756585731e-09
signs O 0 2.1170929187519505e-07
of O 0 7.179290406611472e-08
neurofibromatosis B-Disease 1 0.9999970197677612
type I-Disease 0 1.9627971141744638e-06
1 I-Disease 0 3.1331946956925094e-06
( O 0 1.3286308053750417e-08
NF1 B-Disease 1 0.8209681510925293
) O 0 5.5415604549580166e-08
. O 0 2.6814268494490534e-07

DNA O 0 4.520984120404137e-08
sequence O 0 7.06610603362634e-10
analysis O 0 4.675702880430066e-11
and O 0 1.1804233979173517e-10
allele O 0 1.0092961189034355e-10
- O 0 6.926448858912693e-10
specific O 0 2.35007902027462e-10
amplification O 0 1.2830255746720809e-09
in O 0 1.5438790523791823e-10
two O 0 4.816386733885736e-10
siblings O 0 5.5696065537347295e-09
revealed O 0 6.38138475395067e-09
a O 0 1.4609921272779047e-08
homozygous O 0 1.0543462849454954e-06
MLH1 O 1 0.9810891151428223
mutation O 0 7.797729750791405e-08
( O 0 3.497777845140604e-09
C676T O 0 2.651916474860627e-06
- O 0 6.984534138609888e-06
- O 0 6.645689154538559e-06
> O 0 6.121454134699889e-07
Arg226Stop O 0 3.4928161767311394e-05
) O 0 4.303245049186444e-08
. O 0 1.440447761069663e-07

Thus O 0 6.610044351873512e-07
, O 0 3.8399768698127446e-08
a O 0 2.573695390140074e-08
homozygous O 0 5.282471988721227e-07
germ O 0 1.0411238690721802e-05
- O 0 2.609368493722286e-05
line O 0 4.052842086821329e-06
MLH1 O 1 0.9999415874481201
mutation O 0 1.0016069751372925e-08
and O 0 1.812741290407871e-09
consequent O 0 5.623983270197641e-06
mismatch O 1 1.0
repair O 1 1.0
deficiency O 1 0.9999983310699463
results O 0 4.868907943489376e-09
in O 0 8.17771239614018e-10
a O 0 6.335083124753282e-09
mutator O 0 1.3362737263378222e-05
phenotype O 0 5.69604496902798e-09
characterized O 0 6.604298219414773e-10
by O 0 1.1040511560533872e-10
leukemia B-Disease 1 1.0
and O 0 1.4590033288186532e-06
/ O 1 1.0
or O 1 0.9490763545036316
lymphoma B-Disease 1 1.0
associated O 0 3.8562788517992885e-07
with O 0 2.0119607313517918e-08
neurofibromatosis B-Disease 1 1.0
type I-Disease 0 1.4175116120895837e-06
1 I-Disease 0 5.602563533102511e-07
. O 0 1.2810772886950872e-08
. O 0 7.64814771514466e-08

Missense O 0 3.339491377118975e-05
mutations O 0 1.1580528536114798e-07
in O 0 2.2953647871304383e-09
the O 0 4.416042642674256e-09
most O 0 8.097066905854433e-10
ancient O 0 4.802537478809654e-09
residues O 0 4.263327824105545e-08
of O 0 1.073358912861977e-08
the O 0 2.8665246176728942e-08
PAX6 O 1 0.9947490096092224
paired O 0 4.887892828264739e-07
domain O 0 9.734425532315072e-08
underlie O 0 4.932584261041484e-07
a O 0 2.8817299657646345e-09
spectrum O 0 1.9955922425651806e-07
of O 0 2.101786776620429e-06
human O 1 1.0
congenital B-Disease 1 1.0
eye I-Disease 1 1.0
malformations I-Disease 1 1.0
. O 0 7.814202399458736e-05

Mutations O 0 3.484990998003923e-07
of O 0 1.0208111689280486e-07
the O 0 1.6475764752499344e-08
human O 0 6.281614872705177e-08
PAX6 O 1 1.0
gene O 0 1.180323124572169e-06
underlie O 1 1.0
aniridia B-Disease 1 1.0
( O 1 0.9999972581863403
congenital B-Disease 1 1.0
absence I-Disease 0 8.12453151866066e-07
of I-Disease 0 1.1696956789819524e-06
the I-Disease 0 5.273049552556586e-08
iris I-Disease 0 1.520173213975795e-06
) O 0 1.2839117546903367e-09
, O 0 7.341535712690472e-10
a O 0 3.5539440279563905e-09
rare O 0 6.741900619999797e-07
dominant O 1 0.9999605417251587
malformation B-Disease 1 1.0
of I-Disease 0 0.005939002148807049
the I-Disease 0 3.38654535880778e-05
eye I-Disease 1 0.9999998807907104
. O 0 2.4714486244192813e-06

The O 0 2.93973556608762e-07
spectrum O 0 9.500531632511411e-07
of O 0 7.884740398367285e-07
PAX6 O 1 1.0
mutations O 0 1.7594707912849117e-07
in O 0 1.136854343997129e-08
aniridia B-Disease 1 1.0
patients O 0 4.875564130202292e-08
is O 0 2.0508154896514696e-10
highly O 0 2.1347255074744e-09
biased O 0 3.626833056102896e-09
, O 0 1.2997344867038407e-10
with O 0 4.4393298065381614e-11
92 O 0 7.385640543589034e-09
% O 0 3.647753279989452e-11
of O 0 2.7834834437356903e-10
all O 0 1.8677696889124462e-10
reported O 0 8.57628468242666e-10
mutations O 0 1.1721452697344148e-09
leading O 0 8.145616625654384e-09
to O 0 3.0911966319990825e-09
premature O 0 1.5229224104018613e-08
truncation O 0 6.56562022527396e-08
of O 0 4.2608000683230784e-08
the O 0 6.690211051818551e-09
protein O 0 3.025256267719101e-09
( O 0 1.2430002860330802e-10
nonsense O 0 9.33441945960567e-09
, O 0 1.4785112023574243e-10
splicing O 0 1.383143932720543e-09
, O 0 2.829226852796296e-10
insertions O 0 4.705679401695306e-09
and O 0 4.1345676882187377e-10
deletions O 0 2.471248095048395e-09
) O 0 1.2829515227963384e-10
and O 0 2.5522373103825657e-10
just O 0 4.744013515356471e-10
2 O 0 2.325333925412565e-09
% O 0 8.491866237969603e-11
leading O 0 2.264268494922561e-10
to O 0 1.587408850201033e-11
substitution O 0 9.3995189409668e-10
of O 0 4.2976897596247454e-09
one O 0 5.877099917839246e-10
amino O 0 6.058248902540697e-10
acid O 0 5.812597625443061e-10
by O 0 6.847603734039254e-11
another O 0 3.4904068524355125e-09
( O 0 5.060661667499744e-09
missense O 0 7.408725650748238e-07
) O 0 6.371536187543825e-08
. O 0 3.00791072049833e-07

The O 0 1.6072148412149545e-07
extraordinary O 0 1.024950702088745e-08
conservation O 0 2.8515717787058747e-08
of O 0 1.7956805820062982e-08
the O 0 1.843432251291688e-08
PAX6 O 0 0.00017952009511645883
protein O 0 9.533041023246369e-09
at O 0 3.5294767108950964e-09
the O 0 2.3243937885553123e-09
amino O 0 9.193927397177504e-09
acid O 0 6.7496057631899475e-09
level O 0 1.1531285259991364e-08
amongst O 0 1.815818606587527e-08
vertebrates O 0 2.202163216225017e-07
predicts O 0 4.430370026398123e-08
that O 0 1.9063537415320297e-09
pathological O 0 3.875097718264442e-06
missense O 0 6.049616985137618e-08
mutations O 0 1.7164850651951724e-09
should O 0 2.363483575518188e-10
in O 0 4.233905934181159e-11
fact O 0 2.7202698427153393e-10
be O 0 4.8630374033242774e-11
common O 0 8.092645997770376e-11
even O 0 5.865663510462582e-11
though O 0 6.288750770133689e-11
they O 0 1.1945337774488252e-10
are O 0 1.3662575237827213e-10
hardly O 0 8.34795077508943e-09
ever O 0 5.302941641360803e-09
seen O 0 1.4363513045623222e-08
in O 0 1.6783552325705386e-08
aniridia B-Disease 1 1.0
patients O 0 6.634073770328541e-07
. O 0 3.5320988445164403e-07

This O 0 1.529702586822168e-08
indicates O 0 4.466384595502859e-09
that O 0 8.233723425288275e-11
there O 0 2.681991295716557e-10
is O 0 1.6542946179587403e-10
a O 0 3.51055517988641e-10
heavy O 0 3.220831388262013e-07
ascertainment O 0 2.4410996957158204e-06
bias O 0 1.5894654481485304e-08
in O 0 2.3351107159008677e-10
the O 0 8.317749267128249e-10
selection O 0 2.2005324229468215e-09
of O 0 3.060525832765393e-09
patients O 0 7.439688309851533e-10
for O 0 2.0189832028449928e-09
PAX6 O 1 0.9971828460693359
mutation O 0 1.771958690888198e-09
analysis O 0 1.3179581037636723e-10
and O 0 1.1492146123615044e-10
that O 0 8.572322712785407e-11
the O 0 7.104056010120985e-09
missing O 0 1.776308664602766e-07
PAX6 O 1 0.999402642250061
missense O 0 7.03943533153506e-06
mutations O 0 1.0500799874080258e-07
frequently O 0 2.1055146959270132e-08
may O 0 4.630039018849175e-09
underlie O 0 7.614392529831093e-07
phenotypes O 0 1.6809575242859864e-07
distinct O 0 1.2467673116134392e-08
from O 0 9.9258672392466e-09
textbook O 0 5.0610531616257504e-05
aniridia B-Disease 1 1.0
. O 0 3.334224629725213e-06

Here O 0 2.779915675432676e-08
we O 0 2.2844326430515594e-09
present O 0 1.1882489436843002e-09
four O 0 1.9427854880404993e-09
novel O 0 3.3233121143894095e-07
PAX6 O 0 0.05330725386738777
missense O 0 1.2497670240918524e-06
mutations O 0 1.8922156286294012e-08
, O 0 1.7265556762069423e-09
two O 0 3.4579752949959186e-10
in O 0 3.7728617452437163e-10
association O 0 6.48909759259908e-10
with O 0 8.899267989193049e-10
atypical O 0 8.276102789750439e-07
phenotypes O 0 9.534969649394043e-07
ectopia B-Disease 0 0.0020196891855448484
pupillae I-Disease 0 6.391063652699813e-05
( O 0 7.98760557696454e-10
displaced B-Disease 0 6.197540813879243e-10
pupils I-Disease 0 1.032912200216174e-09
) O 0 1.0231552272088607e-09
and O 0 1.3705181345358142e-06
congenital B-Disease 1 1.0
nystagmus I-Disease 0 0.002074586460366845
( O 0 1.062667842610665e-09
searching B-Disease 0 3.0934381722858006e-09
gaze I-Disease 0 6.17722406559551e-08
) O 0 1.503433905147844e-10
, O 0 1.9732132594540985e-10
and O 0 6.323972456812044e-10
two O 0 1.7500717541807376e-10
in O 0 2.1831152163809264e-10
association O 0 2.561625356278796e-10
with O 0 3.8820149872442755e-10
more O 0 2.577850377605273e-09
recognizable O 0 4.078972779097967e-05
aniridia B-Disease 1 1.0
phenotypes O 0 1.4428017493628431e-05
. O 0 7.886304729254334e-07

Strikingly O 0 6.589608005924674e-07
, O 0 9.745141582584438e-09
all O 0 9.45816314157355e-10
four O 0 2.154350170480157e-10
mutations O 0 1.910043095909586e-10
are O 0 2.6327707375317644e-11
located O 0 3.1420805957083076e-09
within O 0 1.4302050654890763e-09
the O 0 1.0363839564320187e-08
PAX6 O 1 0.9785760045051575
paired O 0 1.5521634111337335e-07
domain O 0 2.4651388486063297e-08
and O 0 1.5927754670741479e-09
affect O 0 2.056425696395081e-09
amino O 0 4.623126881320161e-10
acids O 0 1.2503287294407528e-10
which O 0 6.8332748313915115e-12
are O 0 2.417831993645203e-12
highly O 0 1.638021246419541e-10
conserved O 0 1.3305929691398433e-09
in O 0 2.2803481325439634e-10
all O 0 7.776335131381984e-10
known O 0 5.750549370020508e-09
paired O 0 1.1878341865667608e-07
domain O 0 1.2295484452806704e-07
proteins O 0 1.8605287976924956e-08
. O 0 1.1616045725304502e-07

Our O 0 3.1944927059157635e-07
results O 0 4.450686486023869e-09
support O 0 4.334890779666978e-10
the O 0 1.7879968616796305e-09
hypothesis O 0 6.781385453180633e-10
that O 0 1.0037780502625271e-11
the O 0 1.0187052590371337e-10
under O 0 2.8328661638710173e-10
- O 0 7.382823685730955e-09
representation O 0 7.641768884347755e-10
of O 0 8.014988672755408e-09
missense O 0 4.905806463284534e-07
mutations O 0 2.3540561500112744e-08
is O 0 1.0597450694760369e-09
caused O 0 2.0703814218592242e-09
by O 0 6.106556371676675e-10
ascertainment O 0 9.213413250108715e-06
bias O 0 5.742825237575744e-08
and O 0 1.8910455423792882e-09
suggest O 0 5.973865291331037e-10
that O 0 2.520111549997317e-11
a O 0 7.408319097068627e-11
substantial O 0 5.955870019391796e-09
burden O 0 2.688401821160369e-07
of O 0 2.39866494666785e-07
PAX6 B-Disease 1 1.0
- I-Disease 1 0.9999988079071045
related I-Disease 1 0.9999634027481079
disease I-Disease 1 0.9999996423721313
remains O 0 9.2227175230164e-08
to O 0 1.1833003465966385e-09
be O 0 1.2619685296755279e-09
uncovered O 0 1.372543749766919e-07
. O 0 1.4751889487740755e-08
. O 0 1.7358424031499453e-07

The O 0 1.6142779202255042e-07
chromosomal O 0 8.105882187692259e-08
order O 0 4.838275113883128e-09
of O 0 8.987565358609118e-09
genes O 0 1.4875921605650433e-09
controlling O 0 6.334940394481237e-07
the O 0 3.269941828420997e-08
major O 0 2.0815978132304735e-06
histocompatibility O 1 0.9995658993721008
complex O 0 2.980864110213588e-06
, O 0 1.0881090473091604e-09
properdin O 0 1.2813160310543026e-07
factor O 0 9.418492652457644e-09
B O 0 6.94465654760279e-07
, O 0 1.2547603234214222e-10
and O 0 4.035994871642856e-10
deficiency B-Disease 0 1.6758225740431953e-07
of I-Disease 0 5.413252424091297e-08
the I-Disease 0 4.29134381363383e-08
second I-Disease 0 2.9743077334387635e-08
component I-Disease 0 2.0555097535179812e-07
of I-Disease 0 1.1738936223082419e-07
complement I-Disease 0 8.508437758791842e-07
. O 0 7.413842695314088e-07

The O 0 1.519751435807848e-07
relationship O 0 2.18785989325454e-09
of O 0 1.1181366055268427e-08
the O 0 2.244815888730045e-09
genes O 0 1.4385925783955145e-10
coding O 0 3.783066748752617e-09
for O 0 1.1539772470925413e-09
HLA O 0 1.4524434277518594e-07
to O 0 9.228041109032858e-10
those O 0 2.1840564079500524e-10
coding O 0 1.6486507714574827e-09
for O 0 3.433179296408184e-10
properdin O 0 1.916387901701455e-07
Factor O 0 1.9300994580362385e-08
B O 0 1.021740345663602e-07
allotypes O 0 2.432495449511407e-08
and O 0 1.1250195219858483e-10
for O 0 2.4890001171229414e-10
deficiency B-Disease 0 2.1222875901116822e-08
of I-Disease 0 3.860355235474344e-08
the I-Disease 0 6.932690421734833e-09
second I-Disease 0 1.1639821329012534e-09
component I-Disease 0 9.765291686392175e-09
of I-Disease 0 4.251680785216649e-09
complement I-Disease 0 3.456448993688355e-08
( O 0 4.806413933522435e-09
C2 O 1 0.8068978190422058
) O 0 4.2650152853873635e-10
was O 0 1.4542134163519904e-09
studied O 0 1.786030101591507e-09
in O 0 5.871506059129672e-11
families O 0 6.0463526546650215e-12
of O 0 1.6220810805656072e-10
patients O 0 7.810166402499874e-10
with O 0 5.346939335737488e-09
connective O 1 1.0
tissue O 1 1.0
disorders O 1 1.0
. O 0 2.984661705340841e-06

Patients O 0 7.443128424711176e-07
were O 0 2.475696980752673e-09
selected O 0 2.0656716337441594e-09
because O 0 1.941262012250533e-10
they O 0 5.834053379283333e-11
were O 0 4.394178354516498e-10
heterozygous O 0 4.862504177083338e-09
or O 0 1.787219483517788e-09
homozygous O 0 1.853590561040619e-07
for O 0 1.1182067964909947e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
. O 0 1.865733338490827e-06

12 O 0 3.622072313191893e-07
families O 0 4.1241710047046354e-10
with O 0 7.747790742307359e-10
15 O 0 1.9293890929361623e-08
matings O 0 7.863218911552394e-07
informative O 0 5.935742706242308e-07
for O 0 2.4511655283276923e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
were O 0 3.9492032755106266e-08
found O 0 2.197731596709218e-08
. O 0 9.225039576676863e-08

Of O 0 2.9343957521632547e-06
57 O 0 6.43892519747169e-07
informative O 0 5.219674790168938e-07
meioses O 0 4.342693046055501e-06
, O 0 2.4834674317020244e-09
two O 0 1.8612156260644497e-10
crossovers O 0 2.7552677916986568e-09
were O 0 1.4710120621597156e-10
noted O 0 6.967949550684693e-10
between O 0 8.992104283400693e-10
the O 0 2.119480768669746e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 1.3185470493226603e-09
and O 0 1.025263096643414e-09
the O 0 3.4735512244310485e-09
HLA O 0 1.5979589989001397e-06
- O 0 1.034666524901695e-06
B O 0 2.0667230273829773e-06
gene O 0 1.1453719223064596e-10
, O 0 2.585006861344219e-11
with O 0 1.3577102116191231e-11
a O 0 1.9331959644208752e-10
recombinant O 0 4.1040978948636564e-10
fraction O 0 1.4361285494146614e-09
of O 0 9.93548976424563e-09
0 O 0 1.0930482119420049e-07
. O 0 9.401838951816899e-08

035 O 0 0.021138528361916542
. O 0 5.7179571740562096e-05

A O 0 1.3431026673060842e-06
lod O 0 5.0858029680966865e-06
score O 0 5.311731143819998e-08
of O 0 1.615444489289075e-08
13 O 0 6.891136550279953e-09
was O 0 1.155783468931304e-09
calculated O 0 5.117500867513058e-10
for O 0 2.757747918913367e-10
linkage O 0 1.3625172812226083e-07
between O 0 1.3067201507510617e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 3.21350377419094e-08
HLA O 0 3.2401896987721557e-06
- O 0 2.546162818362063e-07
B O 0 3.0596169153795927e-07
at O 0 7.235053667287161e-10
a O 0 7.453134637236403e-11
maximum O 0 2.6698948607517536e-10
likelihood O 0 2.487960670816136e-10
value O 0 3.350165700410912e-10
of O 0 6.08446681926722e-10
the O 0 4.5635265011334525e-10
recombinant O 0 5.865498087231913e-10
fraction O 0 2.415595279359195e-09
of O 0 1.556960249615713e-08
0 O 0 1.9040439269701892e-07
. O 0 1.749466917999598e-07

04 O 0 0.013746612705290318
. O 0 5.199469160288572e-05

18 O 0 2.9178764293646964e-07
families O 0 5.759031029839434e-10
with O 0 5.265184954694746e-10
21 O 0 2.769664142476813e-08
informative O 0 5.3141633316045045e-08
matings O 0 5.575976302907293e-08
for O 0 1.2433968299419007e-09
both O 0 1.7658250417440513e-09
properdin O 0 7.225888793982449e-07
Factor O 0 1.0664780347724445e-07
B O 0 1.0999084452123498e-06
allotype O 0 5.380805419008539e-07
and O 0 4.998937708222684e-09
HLA O 0 6.195482910698047e-06
- O 0 1.7913023384608096e-06
B O 0 7.522126452386146e-06
were O 0 2.4167012835363266e-09
found O 0 5.086965515488373e-09
. O 0 5.4990966447121536e-08

Of O 0 3.991279754700372e-06
72 O 0 1.0252184665660025e-06
informative O 0 4.2308406023039424e-07
meioses O 0 8.5855572251603e-06
, O 0 7.808203861259244e-09
three O 0 8.86173301406501e-10
recombinants O 0 4.149962933297502e-07
were O 0 4.1778822068572197e-10
found O 0 3.517217073145673e-10
, O 0 1.9471173284824062e-10
giving O 0 3.7517139395149e-10
a O 0 1.6268711378053524e-10
recombinant O 0 7.740730834093767e-10
fraction O 0 4.060961344976022e-09
of O 0 3.1314804971316335e-08
0 O 0 3.307276017494587e-07
. O 0 2.5033602923940634e-07

042 O 0 0.013931898400187492
. O 0 7.274368545040488e-05

A O 0 7.977660629876482e-07
lod O 0 3.160962023684988e-06
score O 0 5.394524649204868e-08
of O 0 1.7499166560241974e-08
16 O 0 6.956426990001319e-09
between O 0 1.040526997897473e-09
HLA O 0 1.5952670651131484e-07
- O 0 4.940248743423581e-08
B O 0 1.5620190652043675e-07
and O 0 3.2153646412069747e-10
Factor O 0 9.735016348599856e-09
B O 0 2.3464808407425153e-07
allotypes O 0 2.645901986397803e-07
was O 0 2.7792832479889285e-09
calculated O 0 7.228418974492001e-10
at O 0 7.973935955973843e-10
a O 0 1.9035294174241102e-10
maximum O 0 7.914689459376234e-10
likelihood O 0 6.945763408872097e-10
value O 0 9.332901118597192e-10
of O 0 1.3013524702287782e-09
the O 0 9.802852973805898e-10
recombinant O 0 9.931789834993765e-10
fraction O 0 4.641675044325666e-09
of O 0 2.10710560111238e-08
0 O 0 2.5060143116206746e-07
. O 0 2.092260302788418e-07

04 O 0 0.020426291972398758
. O 0 6.93824258632958e-05

A O 0 9.654689847593545e-07
crossover O 0 1.4045969010112458e-07
was O 0 1.5434094891020322e-08
shown O 0 4.82234308041285e-10
to O 0 4.6307785384058775e-10
have O 0 1.1834667967836054e-10
occurred O 0 3.2473518318809624e-10
between O 0 2.7239184866023614e-11
genes O 0 7.001007412688054e-12
for O 0 2.2461584675559365e-11
Factor O 0 1.3624458228278513e-09
B O 0 2.4521956021317237e-08
and O 0 2.801112120032201e-10
HLA O 0 2.0762438168731023e-07
- O 0 3.968602300119528e-07
D O 0 9.913618669088464e-06
, O 0 5.543183134726348e-10
in O 0 1.0021238699975399e-10
which O 0 1.8122425782252094e-10
HLA O 0 6.664575380455062e-07
- O 0 7.331620963668684e-07
D O 0 1.2609735676960554e-05
segregared O 0 1.534725470264675e-06
with O 0 1.6633634469798153e-09
HLA O 0 3.2620732781651895e-06
- O 0 4.09915088539492e-07
A O 0 1.6810119518595457e-07
and O 0 2.7323261875267235e-08
B O 0 1.7820022549130954e-05
. O 0 1.5487404425584828e-07

These O 0 5.617373233235412e-08
studies O 0 5.926870549899377e-09
suggest O 0 4.1958184149315514e-10
that O 0 1.6239530553630033e-11
the O 0 1.1047420617193993e-10
genes O 0 1.4107561473186703e-11
for O 0 1.631326324025295e-11
Factor O 0 5.1418883373344215e-08
B O 1 0.9999992847442627
and O 0 3.507273049763171e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 1.0306229480949725e-10
located O 0 3.1969940583742584e-10
outside O 0 2.1884265233307332e-10
those O 0 4.3966157103891845e-11
for O 0 1.6145618175755772e-10
HLA O 0 8.948739349534662e-08
, O 0 2.5664084746246374e-10
that O 0 1.6690631515769994e-11
the O 0 1.8841321558493718e-10
order O 0 1.846907626834593e-10
of O 0 2.817859501291764e-09
genese O 0 8.696754321135813e-07
is O 0 1.7020296283476455e-09
HLA O 0 1.3937155074472685e-07
- O 0 4.870656411526397e-08
A O 0 3.187620833955407e-08
, O 0 1.6583194539787627e-10
- O 0 2.7227471388613367e-09
B O 0 5.606561970239454e-08
, O 0 1.134459678975297e-10
- O 0 6.723419598841929e-09
D O 0 1.7971441934605537e-07
, O 0 1.7906305604942219e-10
Factor O 0 1.2265393145582948e-08
B O 0 1.3865376786270645e-05
allotype O 0 0.31436920166015625
, O 0 2.4496537207596703e-06
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
, O 0 1.0259888494346114e-09
that O 0 2.591587534850337e-11
the O 0 1.8049363392780293e-10
genes O 0 2.4746810156628385e-10
coding O 0 4.068235526233366e-08
for O 0 3.6276966852710757e-07
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
and O 0 2.208154992189293e-09
Factor O 0 2.4745698823380735e-08
B O 0 8.86348274775628e-08
allotypes O 0 3.140524640343756e-08
are O 0 1.5315483256617135e-11
approximately O 0 2.6211512127449765e-11
3 O 0 1.3546430643884833e-10
- O 0 1.3304001234004659e-09
- O 0 4.29006474789162e-09
5 O 0 2.463586223910852e-09
centimorgans O 0 3.003324167138999e-08
from O 0 8.671749429645104e-11
the O 0 6.394784146657173e-10
HLA O 0 9.639273912398494e-08
- O 0 4.184776969395898e-08
A O 0 3.672359483175569e-08
and O 0 1.1555101320226413e-09
HLA O 0 3.7114733686394175e-07
- O 0 1.1496700835778029e-07
B O 0 2.733839039592567e-07
loci O 0 3.8585479256170174e-10
, O 0 1.6297898794426224e-11
and O 0 1.432480436353023e-11
that O 0 3.928954817739028e-12
the O 0 8.147162111615813e-11
apparent O 0 8.625071212797764e-10
lack O 0 1.4257165448228193e-09
of O 0 9.355612284878134e-09
recombinants O 0 3.827473449291574e-07
between O 0 2.2858392956237594e-10
the O 0 6.716597278355607e-10
Factor O 0 6.333418411941238e-08
B O 1 0.8086499571800232
gene O 0 6.868673807503001e-08
and O 0 0.08585432916879654
C2 B-Disease 1 1.0
deficiency I-Disease 1 1.0
gene O 0 4.546274467998046e-09
suggests O 0 2.4071036830441983e-10
that O 0 6.449999388757899e-12
these O 0 1.5217093210506683e-11
two O 0 2.6177138581773285e-11
genes O 0 1.3785315944314647e-10
lie O 0 5.9275380159817814e-09
in O 0 3.66712021859783e-10
close O 0 6.673846808524786e-09
proximity O 0 4.498284766896177e-08
to O 0 9.462859829056924e-09
one O 0 3.372936419054895e-08
another O 0 9.381866306057418e-08
. O 0 5.647189027513377e-07

Distribution O 0 1.4247800095290586e-07
of O 0 5.1235225839718623e-08
emerin O 0 4.783082658832427e-06
and O 0 2.6624629612115314e-08
lamins O 0 1.2957736998941982e-06
in O 0 1.6275425451794945e-09
the O 0 1.1391724896725464e-08
heart O 0 3.301175581782445e-07
and O 0 3.4091482969955678e-09
implications O 0 6.813063890831472e-08
for O 0 2.736340931619452e-09
Emery B-Disease 1 0.9999922513961792
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 1.3606098036689218e-05

Emerin O 1 0.8716052770614624
is O 0 1.195568017919868e-07
a O 0 6.452420819869076e-09
nuclear O 0 4.9237673493962575e-08
membrane O 0 6.5684484518158115e-09
protein O 0 1.7628433157668155e-09
which O 0 1.5179618673144546e-10
is O 0 5.478822395765803e-10
missing O 0 3.4358473843809634e-09
or O 0 1.0925302884601251e-09
defective O 0 6.06794543500655e-08
in O 0 3.916174495799396e-09
Emery B-Disease 1 1.0
- I-Disease 1 1.0
Dreifuss I-Disease 1 1.0
muscular I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 1.0031203601101879e-05
EDMD B-Disease 1 1.0
) O 0 4.5868262077419786e-07
. O 0 4.262055881554261e-07

It O 0 2.308762425684563e-08
is O 0 1.4930497949094956e-09
one O 0 4.293066735439055e-10
member O 0 3.916292290462309e-10
of O 0 3.6342424625246394e-09
a O 0 1.7962071829913384e-09
family O 0 1.8405188484393875e-09
of O 0 2.5274804471564494e-08
lamina O 1 0.9999817609786987
- O 0 9.350278560305014e-07
associated O 0 3.485018273963192e-09
proteins O 0 1.3361313444537615e-10
which O 0 9.336457301722945e-11
includes O 0 2.300966750468092e-09
LAP1 O 1 0.999976634979248
, O 0 1.1329579940877466e-08
LAP2 O 0 0.0006310034077614546
and O 0 5.369231104168648e-08
lamin O 0 1.9582763343350962e-05
B O 0 9.126595250563696e-05
receptor O 0 4.859725777350832e-07
( O 0 7.952618119588806e-08
LBR O 1 0.999993085861206
) O 0 1.732108501073526e-07
. O 0 5.101426268083742e-07

A O 0 2.7369692361389752e-06
panel O 0 5.508197986614505e-08
of O 0 3.2684951634109893e-08
16 O 0 1.519324754895024e-08
monoclonal O 0 1.2027379092671708e-08
antibodies O 0 4.015288546099782e-09
( O 0 1.1974999880592918e-09
mAbs O 0 6.807283057241875e-07
) O 0 1.8790371481003376e-09
has O 0 1.4331597020245113e-09
been O 0 7.806323920611646e-10
mapped O 0 1.0098208491626792e-08
to O 0 4.4628659101597634e-10
six O 0 4.844847856233514e-10
specific O 0 5.118574453177871e-10
sites O 0 2.5437143502671233e-09
throughout O 0 7.142230140644301e-10
the O 0 5.980343775746633e-09
emerin O 0 5.790405452898995e-07
molecule O 0 5.687074700055916e-10
using O 0 4.135750630851476e-10
phage O 0 3.398632486550923e-08
- O 0 1.4816519566807074e-08
displayed O 0 5.529605662246695e-09
peptide O 0 1.4209006193866003e-09
libraries O 0 1.4466223774434184e-09
and O 0 7.649891275995913e-10
has O 0 2.238427082579264e-10
been O 0 8.459049433140464e-11
used O 0 1.6791669443794177e-10
to O 0 8.388583716545384e-10
localize O 0 1.4838911965853185e-06
emerin O 0 1.4200149962562136e-05
in O 0 1.3487687411384286e-08
human O 0 3.4669401571818526e-08
and O 0 8.202682977298537e-08
rabbit O 0 0.0004773392283823341
heart O 0 0.035688936710357666
. O 0 1.546087105452898e-06

Several O 0 4.253565180079022e-07
mAbs O 0 2.0363895600894466e-06
against O 0 1.389473993640422e-07
different O 0 5.129592306474251e-09
emerin O 0 2.344741005799733e-06
epitopes O 0 1.7393554685440904e-07
did O 0 4.269103293097487e-09
not O 0 6.608204539126916e-10
recognize O 0 7.302324522839854e-09
intercalated O 0 4.0664519929123344e-07
discs O 0 9.30693488498946e-07
in O 0 2.3032105112008594e-09
the O 0 1.3136828513893306e-08
heart O 0 1.7110312455770327e-07
, O 0 2.577091873234849e-10
though O 0 2.5901061850852614e-10
they O 0 1.293798262969048e-10
recognized O 0 3.041392249159003e-09
cardiomyocyte O 0 1.4282572635693214e-07
nuclei O 0 5.754269061242212e-09
strongly O 0 9.18029041674373e-10
, O 0 3.752322341732395e-10
both O 0 2.2189242110393081e-10
at O 0 6.426726262276361e-09
the O 0 1.4319718744104648e-08
rim O 0 8.67620997269114e-07
and O 0 1.2768254009642988e-08
in O 0 1.046800068849052e-08
intranuclear O 0 1.9667317246785387e-05
spots O 0 1.4154812788547133e-06
or O 0 3.062074327431219e-08
channels O 0 1.8373880550370814e-07
. O 0 4.736866117127647e-07

A O 0 1.4579417438653763e-05
polyclonal O 0 1.0154693882213905e-05
rabbit O 0 1.2062032510584686e-06
antiserum O 0 1.1960486290263361e-06
against O 0 1.7383588613029133e-07
emerin O 0 1.6904832591535524e-05
did O 0 1.6187602369654996e-08
recognize O 0 1.0460615484930713e-08
both O 0 1.3625316430676548e-09
nuclear O 0 3.3208657157501875e-08
membrane O 0 2.045300817599127e-09
and O 0 1.998531118374558e-09
intercalated O 0 1.586900140182479e-07
discs O 0 1.5952259957430215e-07
but O 0 5.901002464447913e-10
, O 0 1.815120692638672e-10
after O 0 2.3193306997182361e-10
affinity O 0 4.746167348024244e-10
purification O 0 2.4807984999597466e-08
against O 0 1.9769297310290312e-08
a O 0 7.235222643231509e-09
pure O 0 1.5294260435894103e-07
- O 0 1.815130019622302e-07
emerin O 0 2.201370534749003e-06
band O 0 6.35787884561978e-08
on O 0 1.1143234779353861e-08
a O 0 1.5142669340661996e-09
western O 0 1.2244403713168595e-08
blot O 0 8.597044143243693e-06
, O 0 1.6119166001971053e-09
it O 0 2.5312507645480764e-10
stained O 0 3.249363373925007e-07
only O 0 1.4566201578247728e-09
the O 0 7.019978820466122e-09
nuclear O 0 3.5454834801385005e-07
membrane O 0 2.87780466123877e-07
. O 0 4.269195130746084e-07

These O 0 2.149213784718995e-08
results O 0 9.319809368690812e-10
would O 0 1.5613421666671456e-10
not O 0 4.876663656228075e-11
be O 0 4.174622106334347e-11
expected O 0 3.3685937372851527e-10
if O 0 6.17547568637633e-10
immunostaining O 0 3.197991986780835e-07
at O 0 1.0874580347319807e-08
intercalated O 0 2.2746473860024707e-07
discs O 0 3.4533522352830914e-07
were O 0 9.900206210389229e-10
due O 0 1.7710733990483618e-09
to O 0 2.4767962680805056e-10
a O 0 2.1898460822455945e-10
product O 0 1.8852044370021304e-09
of O 0 3.434687423364835e-09
the O 0 9.11201603059908e-09
emerin O 0 1.1261014378760592e-06
gene O 0 3.026195405375631e-10
and O 0 5.815114501039886e-10
, O 0 3.4013394878407155e-10
therefore O 0 1.5034309908124044e-10
, O 0 6.879467828735386e-11
cast O 0 9.074443418910505e-10
some O 0 9.576715115366952e-11
doubt O 0 1.059765275535085e-09
upon O 0 2.9404603751892466e-10
the O 0 2.276093896691478e-10
hypothesis O 0 3.924307823144346e-10
that O 0 2.7720606365910783e-10
cardiac B-Disease 1 0.999924898147583
defects I-Disease 0 7.714846287854016e-05
in O 0 8.10448685939491e-09
EDMD B-Disease 1 1.0
are O 0 2.5087287802705305e-09
caused O 0 3.06453284970587e-09
by O 0 3.0089802871557936e-10
absence O 0 8.817079333311995e-08
of O 0 4.1270087081102247e-07
emerin O 0 0.0002124195743817836
from O 0 1.6208772990466969e-07
intercalated O 0 5.500271436176263e-05
discs O 0 0.0012277020141482353
. O 0 3.7934198644506978e-06

Although O 0 4.296630606859253e-07
emerin O 0 1.528439315734431e-05
was O 0 8.238275484018232e-08
abundant O 0 1.2716922626054838e-08
in O 0 6.263388141469761e-10
the O 0 3.777702151097628e-09
membranes O 0 1.2338625232644063e-08
of O 0 5.359838439744635e-08
cardiomyocyte O 0 3.1882098028290784e-06
nuclei O 0 2.7698966675870906e-08
, O 0 3.34417743497184e-10
it O 0 1.381927627885915e-10
was O 0 3.862496544826399e-09
absent O 0 4.690642541049783e-09
from O 0 9.478638707260956e-11
many O 0 4.68475702675164e-10
non O 0 3.139769688687011e-08
- O 0 8.540315121763342e-08
myocyte O 0 5.628231178889109e-07
cells O 0 2.876654192629502e-10
in O 0 4.888502380673287e-10
the O 0 4.2683403478349646e-08
heart O 0 6.44397687210585e-06
. O 0 4.742923636058549e-07

This O 0 4.14221057454256e-09
distribution O 0 1.070619060072886e-08
of O 0 1.719769571195684e-08
emerin O 0 4.496167093748227e-06
was O 0 8.67043503660625e-09
similar O 0 2.734064918907819e-10
to O 0 1.4619301602625256e-10
that O 0 5.5570482243583186e-11
of O 0 6.943409402992984e-09
lamin O 0 1.0625193453961401e-06
A O 0 5.368606252886821e-07
, O 0 1.9973651621540967e-09
a O 0 8.993991107431043e-10
candidate O 0 8.174437238217536e-10
gene O 0 2.347677885428112e-10
for O 0 2.31631130942489e-10
an O 0 7.970803461709863e-10
autosomal O 0 5.2119446536380565e-08
form O 0 2.9215343033683894e-08
of O 0 6.578260217793286e-05
EDMD B-Disease 1 1.0
. O 0 1.4731505871168338e-05

In O 0 5.1733874073534025e-08
contrast O 0 3.5388211472309195e-08
, O 0 2.445749736068592e-08
lamin O 0 2.312308606633451e-05
B1 O 1 0.9999879598617554
was O 0 4.0919991306509473e-07
absent O 0 8.86316087189698e-08
from O 0 2.817391875353792e-09
cardiomyocyte O 0 1.1760938605220872e-06
nuclei O 0 4.2249173048958255e-08
, O 0 1.2958092376891273e-09
showing O 0 1.1816568168399044e-08
that O 0 4.070329406857809e-09
lamin O 0 1.2431800314516295e-05
B1 O 0 8.62170199980028e-05
is O 0 1.0019313156917065e-09
not O 0 3.855544356001772e-11
essential O 0 3.9928180206594277e-10
for O 0 6.493625775982892e-11
localization O 0 1.7471885271902465e-08
of O 0 2.9091232534028677e-08
emerin O 0 4.305783932068152e-06
to O 0 1.503573088257326e-08
the O 0 2.831546339621127e-07
nuclear O 0 2.532663529564161e-05
lamina O 1 0.9999520778656006
. O 0 6.98413487043581e-06

Lamin O 1 0.9995753169059753
B1 O 1 1.0
is O 0 6.163359955735359e-08
also O 0 7.2891328528612576e-09
almost O 0 2.9359841224874117e-09
completely O 0 3.0152339292044417e-08
absent O 0 4.703187173049628e-08
from O 0 5.636000999231783e-09
skeletal O 0 4.894376979791559e-05
muscle O 0 1.3295834833115805e-05
nuclei O 0 9.681230039859656e-06
. O 0 4.2591221927068545e-07

In O 0 1.9850197929827118e-07
EDMD B-Disease 1 1.0
, O 0 8.413778118665505e-09
the O 0 8.494818737325716e-10
additional O 0 1.049804798647358e-09
absence O 0 6.702434163230464e-09
of O 0 2.268498633384297e-08
lamin O 0 0.000596956058871001
B1 O 1 1.0
from O 0 8.404639117998158e-08
heart O 1 0.9999996423721313
and O 0 9.09199968646135e-07
skeletal O 1 1.0
muscle O 0 0.44018954038619995
nuclei O 0 6.795166882511694e-07
which O 0 8.282066699116797e-10
already O 0 3.1527904731376566e-09
lack O 0 2.223425532577039e-08
emerin O 0 3.2496002404514e-06
may O 0 5.764371757699394e-10
offer O 0 1.5662128538540543e-10
an O 0 2.6182731330259834e-11
alternative O 0 8.497832992837573e-10
explanation O 0 2.3537305438026124e-10
of O 0 7.493134446256988e-10
why O 0 9.882432649988004e-10
these O 0 3.6267203129547454e-10
tissues O 0 6.328006119105112e-09
are O 0 1.5253104335144485e-10
particularly O 0 9.830265490506918e-10
affected O 0 3.135232073958605e-09
. O 0 4.538477149651499e-09
. O 0 1.2865248777416127e-07

Genetic O 0 3.3318073633381573e-07
mapping O 0 4.057990210526441e-08
of O 0 2.7331299179422786e-07
the O 0 7.71010206790379e-07
copper B-Disease 0 0.00026195196551270783
toxicosis I-Disease 1 0.6353695392608643
locus O 0 6.9590105340466835e-06
in O 0 9.895644836888096e-08
Bedlington O 0 7.073803135426715e-05
terriers O 0 2.5036757506313734e-05
to O 0 2.9746596297286487e-08
dog O 0 2.0357670393877925e-07
chromosome O 0 1.3833609813218573e-08
10 O 0 2.0269161904451494e-09
, O 0 2.894132988817688e-10
in O 0 3.1404973066528896e-10
a O 0 3.076738419593994e-09
region O 0 5.6366918244066255e-08
syntenic O 0 3.731653805516544e-06
to O 0 8.850065569276921e-09
human O 0 1.5285738896864132e-08
chromosome O 0 1.0036459485718296e-07
region O 0 1.860263267872142e-07
2p13 O 0 6.333003693725914e-05
- O 0 2.421709541522432e-05
p16 O 0 1.2191582754894625e-05
. O 0 6.80819198350946e-07

Abnormal O 1 1.0
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9998476505279541
accumulation I-Disease 0 0.0039823888801038265
is O 0 5.724831719788881e-09
recognized O 0 2.9004123547338168e-09
as O 0 3.9265690698897515e-10
an O 0 2.6438087274982536e-09
inherited B-Disease 1 1.0
disorder I-Disease 1 1.0
in O 0 3.4041729435330126e-08
man O 0 4.368802208887246e-08
, O 0 2.8246234240469903e-09
mouse O 0 5.896901598134718e-07
, O 0 4.2148801782104783e-08
rat O 0 9.095161658478901e-05
and O 0 4.982962309441064e-07
dog O 0 3.3271891879849136e-05
. O 0 1.4461562614087597e-06

The O 0 7.945315587676305e-07
major O 0 3.2768402888905257e-06
cause O 0 1.3085832506476436e-06
of O 0 0.0005878969677723944
hepatic B-Disease 1 1.0
copper I-Disease 1 0.9999998807907104
accumulation I-Disease 0 0.0003426607872825116
in O 0 1.1912540287539741e-08
man O 0 3.9618328173673945e-08
is O 0 1.5281125254063e-09
a O 0 3.2930105309247892e-09
dysfunctional O 0 2.0908501596750284e-07
ATP7B O 1 1.0
gene O 0 2.5265020298093077e-08
, O 0 3.2096432178718715e-09
causing O 0 3.3453613923484227e-07
Wilson B-Disease 0 1.9961869838880375e-05
disease I-Disease 0 0.00041751947719603777
( O 0 3.433608597447346e-08
WD B-Disease 1 1.0
) O 0 1.6971362981621496e-07
. O 0 3.824386567430338e-07

Mutations O 0 1.5980872092313803e-07
in O 0 4.462476166366969e-09
the O 0 1.710723651626722e-08
ATP7B O 1 0.9999691247940063
genes O 0 2.0418824409063063e-09
have O 0 1.69105909830769e-10
also O 0 3.7070435610075947e-10
been O 0 9.42229627654001e-10
demonstrated O 0 2.199701532035192e-09
in O 0 3.11611270120693e-09
mouse O 0 8.931344837037614e-07
and O 0 3.2765353807917563e-07
rat O 0 0.0002548549964558333
. O 0 1.9855624486808665e-06

The O 0 2.140224069080432e-06
ATP7B O 1 1.0
gene O 0 2.6037353606511715e-08
has O 0 2.4205579762792695e-09
been O 0 7.837026583246143e-10
excluded O 0 4.811743004040636e-09
in O 0 1.2042011832136268e-10
the O 0 1.3377640106781996e-09
much O 0 5.420627058327909e-09
rarer O 0 2.1473183551279362e-06
human O 0 1.3154651696822839e-06
copper B-Disease 1 0.9999998807907104
overload I-Disease 1 0.9999274015426636
disease O 1 0.9996590614318848
non B-Disease 0 0.00399403041228652
- I-Disease 0 6.996828233241104e-06
Indian I-Disease 0 2.73842015729997e-08
childhood I-Disease 0 6.854578259662958e-06
cirrhosis I-Disease 1 1.0
, O 0 1.0604614075759855e-08
indicating O 0 3.210440624457078e-08
genetic O 0 8.265787698746863e-08
heterogeneity O 0 1.2273793572603608e-06
. O 0 3.1913808129502286e-07

By O 0 8.998542355698191e-09
investigating O 0 5.008340764334207e-08
the O 0 5.39093463203244e-08
common O 0 3.0160276764945593e-06
autosomal O 1 0.999895453453064
recessive O 1 0.9998247027397156
copper B-Disease 1 1.0
toxicosis I-Disease 1 1.0
( O 0 6.819655595791119e-08
CT B-Disease 1 0.9998854398727417
) O 0 4.497561434391173e-09
in O 0 5.0298396558901e-09
Bedlington O 0 1.1914927199541125e-05
terriers O 0 7.521273346355883e-06
, O 0 1.3563552503370602e-09
we O 0 2.136427285082121e-10
have O 0 2.0281283596990107e-11
identified O 0 6.004179098351159e-11
a O 0 3.5284362237542055e-11
new O 0 1.6130936864033885e-10
locus O 0 2.0085904495203977e-08
involved O 0 1.1924674581109684e-09
in O 0 8.218151492656034e-09
progressive O 1 1.0
liver B-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 1.729877908474009e-06

We O 0 1.0589802457161568e-07
examined O 0 6.234157012841024e-08
whether O 0 4.436388589823537e-09
the O 0 1.1413757050604545e-08
WD B-Disease 1 0.9915669560432434
gene O 0 2.810157013755088e-07
ATP7B O 1 1.0
was O 0 1.1484427631103244e-07
also O 0 3.963644967797109e-09
causative O 0 4.089560334818998e-08
for O 0 4.86149120959567e-10
CT B-Disease 0 2.5459569314989494e-06
by O 0 2.5679558479652087e-10
investigating O 0 9.442342907561851e-09
the O 0 9.21896781136411e-09
chromosomal O 0 1.1334144289776305e-07
co O 0 3.3236791097124296e-08
- O 0 7.486498532216501e-08
localization O 0 2.186924916713906e-07
of O 0 2.2352982398388122e-07
ATP7B O 1 1.0
and O 0 2.3826501660551003e-08
C04107 O 0 1.0021823300121468e-06
, O 0 1.2315718445066182e-09
using O 0 4.387846752607061e-10
fluorescence O 0 1.0459936916618062e-08
in O 0 4.941961062598921e-09
situ O 0 2.077492581520346e-06
hybridization O 0 4.333621816954292e-08
( O 0 4.7104742328940574e-09
FISH O 0 6.84099541103933e-06
) O 0 2.2378486619345495e-08
. O 0 1.3137196219759062e-07

C04107 O 0 0.0001287602208321914
is O 0 9.14691540288004e-08
an O 0 5.93547966332153e-09
anonymous O 0 7.035583848846727e-08
microsatellite O 0 3.6629755868489156e-06
marker O 0 3.951926828449359e-06
closely O 0 8.500872894501299e-08
linked O 0 9.088375350074784e-07
to O 0 1.6274354663892154e-07
CT B-Disease 1 1.0
. O 0 2.5198401090165135e-06

However O 0 4.822550181415863e-07
, O 0 1.5023495336663473e-07
BAC O 1 0.9999996423721313
clones O 0 2.557304014771944e-06
containing O 0 4.0490226638212334e-07
ATP7B O 1 0.9999983310699463
and O 0 3.4686404859485265e-08
C04107 O 0 2.3551419872092083e-06
mapped O 0 8.217622848860628e-08
to O 0 5.4540834071303834e-09
the O 0 3.573344642404663e-08
canine O 0 2.370389893258107e-06
chromosome O 0 4.117368490597073e-08
regions O 0 1.5235819716963306e-08
CFA22q11 O 0 0.0001559553056722507
and O 0 1.8302241500123273e-08
CFA10q26 O 0 0.011139453388750553
, O 0 1.85989645906659e-09
respectively O 0 1.2561235385177838e-09
, O 0 3.4495037382065163e-10
demonstrating O 0 2.61634869325178e-09
that O 0 1.1202451188907503e-09
WD B-Disease 0 0.00022808548237662762
cannot O 0 2.1642655667619692e-08
be O 0 1.4229726286174582e-09
homologous O 0 9.183131588486049e-09
to O 0 2.9594362516149886e-08
CT B-Disease 1 0.9411396384239197
. O 0 1.6576227608311456e-06

The O 0 3.3518297186674317e-06
copper O 0 9.90580133475305e-07
transport O 0 6.284466280703782e-08
genes O 0 9.005136192286045e-09
CTR1 O 1 0.9999158382415771
and O 0 3.1561135926949646e-08
CTR2 O 1 1.0
were O 0 7.2546515461624494e-09
also O 0 1.123763304633485e-09
excluded O 0 9.193541927743354e-09
as O 0 3.1478497586334697e-10
candidate O 0 2.8079377711875964e-10
genes O 0 9.112335885852474e-11
for O 0 2.076027127984048e-10
CT B-Disease 1 0.7873136401176453
since O 0 1.6667679458848284e-09
they O 0 4.938123798758909e-10
both O 0 6.176040789895865e-10
mapped O 0 6.315974587778328e-08
to O 0 1.186320108814698e-08
canine O 0 6.627701804973185e-05
chromosome O 0 2.882501348722144e-06
region O 0 2.4266764739877544e-06
CFA11q22 O 1 0.9993822574615479
. O 0 3.34764786202868e-06

2 O 0 1.5745219570817426e-05
- O 0 1.7702721379464492e-05
22 O 0 2.480019020367763e-06
. O 0 5.253859853837639e-07

5 O 0 7.296126568689942e-05
. O 0 8.360306310351007e-06

A O 0 2.2403144157578936e-06
transcribed O 0 6.98193787229684e-08
sequence O 0 2.2249770914584133e-09
identified O 0 4.738560099859512e-10
from O 0 1.5827174293381319e-10
the O 0 1.8117043421028711e-09
C04107 O 0 3.6564313177223084e-07
- O 0 2.275617134728236e-07
containing O 0 1.289557616246384e-07
BAC O 1 0.9999998807907104
was O 0 9.371149189973949e-09
found O 0 1.5513236528708063e-10
to O 0 9.796138900064477e-11
be O 0 6.39109876132693e-11
homologous O 0 8.40526814815945e-11
to O 0 2.640612173365753e-10
a O 0 7.795670220467343e-10
gene O 0 7.717231853554551e-10
expressed O 0 9.385473509482267e-10
from O 0 1.0127214622457359e-09
human O 0 6.03698202539249e-09
chromosome O 0 1.62633000400092e-08
2p13 O 0 5.380928200793278e-07
- O 0 1.2875840127435367e-07
p16 O 0 8.516728655649786e-08
, O 0 7.584903261026454e-10
a O 0 8.777488180733428e-10
region O 0 1.435036889319008e-08
devoid O 0 2.682470494619338e-07
of O 0 9.594771199772367e-09
any O 0 6.85453649396095e-09
positional O 0 5.421145488071488e-07
candidate O 0 2.0719078008824e-07
genes O 0 7.172214822048772e-08
. O 0 1.5537747799498902e-07

Molecular O 0 5.1637758957667756e-08
analysis O 0 2.4778510354650507e-09
of O 0 8.93563711912293e-09
the O 0 1.4143254567500207e-08
APC B-Disease 0 3.119534426332393e-07
gene O 0 9.076936424712301e-10
in O 0 2.982894764524957e-10
205 O 0 3.4172340512839128e-09
families O 0 6.94015817037652e-11
: O 0 9.750653756634975e-11
extended O 0 4.50580461830441e-09
genotype O 0 8.935244544261423e-09
- O 0 1.0624215462939901e-07
phenotype O 0 5.847093031974282e-09
correlations O 0 2.9951763291791167e-09
in O 0 2.0259796618127268e-10
FAP B-Disease 0 8.167352234522696e-07
and O 0 2.2102818186819917e-10
evidence O 0 8.988498834128222e-11
for O 0 5.384966084154286e-11
the O 0 5.489837473504622e-10
role O 0 4.935160280439277e-09
of O 0 1.7082456338357588e-08
APC B-Disease 0 5.38758797574701e-07
amino O 0 1.4089217792445652e-08
acid O 0 6.759035553471904e-09
changes O 0 2.2349639916541264e-09
in O 0 3.02530942519752e-08
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9999997615814209
. O 0 7.468762532880646e-07

BACKGROUND O 0 0.00014591877697966993
/ O 0 9.10885319171939e-06
AIMS O 0 2.8630100132431835e-05
The O 0 1.131303850598897e-08
development O 0 1.2120047188091121e-08
of O 0 2.600961579446448e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
and O 0 3.632470324532733e-08
a O 0 8.640944626492342e-10
variable O 0 7.575043925456271e-10
range O 0 6.340220348732828e-09
of O 0 4.49934667301477e-09
extracolonic O 0 9.529878752800869e-07
manifestations O 0 2.0146724466485466e-07
in O 0 2.4474250182038304e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
( O 0 9.071446811503847e-07
FAP B-Disease 1 1.0
) O 0 1.5822897436734706e-09
is O 0 1.4505006917797658e-10
the O 0 1.7099748006454973e-10
result O 0 8.806008006123633e-11
of O 0 9.621209384746976e-10
the O 0 1.320024201056924e-09
dominant O 0 6.873654001537943e-08
inheritance O 0 2.5917307766576414e-07
of O 0 2.1953660507278983e-06
adenomatous B-Disease 1 1.0
polyposis I-Disease 1 1.0
coli I-Disease 1 1.0
( O 0 1.2301055107855063e-07
APC B-Disease 0 3.5538282645575237e-06
) O 0 2.197551296490019e-08
gene O 0 8.649082161582555e-08
mutations O 0 1.33883858666195e-07
. O 0 2.2655243014924054e-07

In O 0 3.1803210731595755e-08
this O 0 8.123891004352402e-10
study O 0 8.259696815393625e-10
, O 0 1.7609236291349362e-10
direct O 0 2.2064867988280668e-10
mutation O 0 3.175588264570095e-11
analysis O 0 4.356821500794972e-11
of O 0 1.2328621457058375e-09
the O 0 6.990930501160619e-09
APC B-Disease 0 3.3081309425142535e-07
gene O 0 2.456679304430054e-09
was O 0 6.062945256957164e-09
performed O 0 1.486766598723932e-09
to O 0 2.998467307779862e-10
determine O 0 1.4172871765083528e-09
genotype O 0 2.5418567251023205e-09
- O 0 2.0801751432486526e-08
phenotype O 0 7.023296388908307e-10
correlations O 0 1.1532115262724574e-09
for O 0 3.427062522654012e-10
nine O 0 2.569583656963914e-09
extracolonic O 0 1.5326369862123101e-07
manifestations O 0 3.817615734647006e-08
and O 0 6.947963315795391e-10
to O 0 6.078620384819544e-10
investigate O 0 4.7235562128378206e-09
the O 0 1.3142484878159166e-09
incidence O 0 8.86688127366142e-08
of O 0 7.24480955227591e-08
APC B-Disease 0 1.9286258066131268e-06
mutations O 0 3.480222332541416e-09
in O 0 1.5280308129916875e-09
non O 1 0.9994003772735596
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 3.1062218113220297e-06

METHODS O 0 4.148773768974934e-06
The O 0 3.6349308629723964e-07
APC B-Disease 0 2.2278122742136475e-06
gene O 0 1.2065243915060364e-08
was O 0 1.9709320397964802e-08
analysed O 0 1.2064163001923589e-08
in O 0 7.044009819878738e-10
190 O 0 1.9902547165884243e-08
unrelated O 0 6.131304530754278e-08
FAP B-Disease 0 0.00012663206143770367
and O 0 4.336993431053315e-09
15 O 0 4.014433230281611e-08
non O 0 0.0002970762725453824
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 1.711169943519053e-07
using O 0 6.847767686224415e-09
denaturing O 0 1.711670620352379e-06
gradient O 0 3.780854385126986e-08
gel O 0 5.281554749103634e-08
electrophoresis O 0 6.844163902286482e-09
, O 0 3.037541329575788e-10
the O 0 5.327879248895329e-10
protein O 0 4.322028013259427e-10
truncation O 0 1.1411515288273222e-08
test O 0 1.099862756426262e-09
, O 0 4.815045584471989e-10
and O 0 1.2953915717872633e-09
direct O 0 2.4706933388074503e-08
sequencing O 0 1.988809685826709e-07
. O 0 1.5117635143724328e-07

RESULTS O 0 8.082512977125589e-06
Chain O 0 5.057186740486941e-07
terminating O 0 6.532243901347101e-08
signals O 0 4.443264867148855e-09
were O 0 3.552085292568563e-10
only O 0 1.3053989833533564e-10
identified O 0 1.7624189607712282e-10
in O 0 1.463071053198206e-10
patients O 0 3.802655690332557e-10
belonging O 0 2.478214022882952e-10
to O 0 8.130401352168803e-10
the O 0 2.8442388000371466e-08
FAP B-Disease 1 1.0
group O 0 1.1280632428167792e-08
( O 0 1.2683826211556948e-09
105 O 0 3.410555677874072e-07
patients O 0 1.2043401831363099e-08
) O 0 9.169689896282307e-09
. O 0 2.1802965477490943e-07

Amino O 0 2.1968163821384223e-07
acid O 0 5.559597671123129e-09
changes O 0 6.56244669716699e-10
were O 0 7.070146551546586e-11
identified O 0 2.5479897705626975e-11
in O 0 2.621801213631425e-11
four O 0 9.6355846912477e-11
patients O 0 6.478285963229524e-11
, O 0 2.973304935594001e-11
three O 0 3.954375715764513e-11
of O 0 5.813565184809022e-09
whom O 0 2.463873105540415e-09
belonged O 0 4.914645135301043e-09
to O 0 1.1716445591503089e-09
the O 0 2.4004537024779893e-08
non O 0 6.190368731040508e-05
- O 0 7.378619920928031e-05
FAP O 1 1.0
group O 0 3.587289398865323e-08
of O 0 0.0067001269198954105
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.9029513573041186e-05
. O 0 9.967742897742937e-08

Genotype O 0 3.0795683414908126e-05
- O 0 5.829923793498892e-06
phenotype O 0 4.707046130647541e-08
correlations O 0 7.2510966120376e-09
identified O 0 4.2197345617722704e-10
significant O 0 1.216385658864283e-09
differences O 0 3.425600025863673e-09
in O 0 2.976064117365951e-10
the O 0 1.801813920287998e-09
nature O 0 8.775751680900612e-09
of O 0 5.100829980619892e-09
certain O 0 6.935917618022813e-09
extracolonic O 0 3.4135828173020855e-06
manifestations O 0 3.1401836508848646e-07
in O 0 3.159532857566205e-09
FAP B-Disease 1 0.9999662637710571
patients O 0 6.6921255204022145e-09
belonging O 0 6.750734971028294e-10
to O 0 1.7414218955735805e-09
three O 0 1.6329412488857997e-08
mutation O 0 1.3124987674473232e-07
subgroups O 0 9.752412779562292e-07
. O 0 1.6722449913686432e-07

CONCLUSIONS O 0 1.1802008884842508e-05
Extended O 0 1.1948993687838083e-06
genotype O 0 1.789798034224077e-07
- O 0 2.2438031521687662e-07
phenotype O 0 5.334349406638239e-09
correlations O 0 4.490464444728559e-09
made O 0 1.1156052748262368e-09
in O 0 1.1268277283482675e-10
this O 0 4.713165968617261e-11
study O 0 2.4467924908400107e-10
may O 0 6.905392230249774e-11
have O 0 9.219780321145787e-12
the O 0 1.7023533971372018e-10
potential O 0 3.642887658195093e-10
to O 0 3.672017898082025e-11
determine O 0 1.3984226276964051e-10
the O 0 2.683198940811593e-10
most O 0 8.851120530950496e-11
appropriate O 0 3.833847406209401e-10
surveillance O 0 1.9907938408891823e-08
and O 0 5.639463562800984e-09
prophylactic O 0 1.4649848480985384e-06
treatment O 0 2.76064024973266e-08
regimens O 0 1.4008427307032889e-08
for O 0 7.043281236018828e-11
those O 0 9.176661514009865e-11
patients O 0 4.7485553683612736e-11
with O 0 2.2085867856791452e-11
mutations O 0 5.280169634858112e-10
associated O 0 1.1549372569419347e-09
with O 0 4.730065228386593e-09
life O 0 1.234644599890089e-07
threatening O 0 2.017473207160947e-06
conditions O 0 6.745424911969167e-07
. O 0 3.9262366158254736e-07

This O 0 1.7265827878532036e-08
study O 0 3.976586171461349e-09
also O 0 2.6034346900516425e-10
provided O 0 1.2715843655808357e-10
evidence O 0 3.583087160308196e-10
for O 0 2.857699910041589e-10
the O 0 3.055614428149056e-09
pathological O 0 3.569874706954579e-07
nature O 0 8.518187044614933e-09
of O 0 4.387279872730687e-09
amino O 0 8.695836273275859e-10
acid O 0 7.298170956460126e-10
changes O 0 1.3967325906971695e-10
in O 0 9.227367481212667e-11
APC O 0 1.777175384631846e-08
associated O 0 4.4089371042943526e-10
with O 0 1.986300984802014e-10
both O 0 2.2863331228251127e-09
FAP B-Disease 1 0.9999992847442627
and O 0 5.4468092258730394e-08
non O 1 1.0
- O 1 1.0
FAP O 1 1.0
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 3.08346130850623e-07
. O 0 1.9777584014946115e-09
. O 0 2.915155405958103e-08

Inherited B-Disease 1 1.0
colorectal I-Disease 1 1.0
polyposis I-Disease 1 1.0
and O 1 0.9980402588844299
cancer B-Disease 1 1.0
risk O 0 4.259717115928652e-06
of O 0 3.1073784612090094e-07
the O 0 4.7519515078420227e-07
APC O 0 1.9287401300971396e-05
I1307K O 0 2.2865382561576553e-05
polymorphism O 0 5.243292662271415e-07
. O 0 3.7901622818026226e-07

Germ O 0 9.80464683379978e-05
- O 0 2.9644133974215947e-06
line O 0 8.471783985442016e-07
and O 0 1.8918186128757952e-08
somatic O 0 1.6703035043974523e-07
truncating O 0 2.7674155944623635e-07
mutations O 0 6.957116660544216e-09
of O 0 1.3316193481216487e-08
the O 0 2.1489228174687014e-08
APC B-Disease 0 4.159766149314237e-07
gene O 0 1.3733674197879964e-09
are O 0 9.823680757747866e-11
thought O 0 8.352804559130789e-10
to O 0 4.668095354709578e-10
initiate O 0 3.3023687251443334e-07
colorectal B-Disease 1 1.0
tumor I-Disease 1 1.0
formation O 0 6.5290305428789e-07
in O 0 6.336897939718256e-08
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 3.895268946507713e-06
sporadic O 1 1.0
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 1.0679950719350018e-06
respectively O 0 2.912561001267022e-07
. O 0 3.4025120498881734e-07

Recently O 0 2.1112307422299637e-06
, O 0 4.978121737053698e-08
an O 0 2.718125458045506e-08
isoleucine O 0 4.9944763304665685e-05
- O 0 1.177531885332428e-05
- O 0 2.8083641154807992e-06
> O 0 9.530553768399841e-08
lysine O 0 6.282093778509079e-08
polymorphism O 0 1.1763379159646092e-09
at O 0 6.911776928575364e-09
codon O 0 4.7954369364333616e-08
1307 O 0 8.248399012700247e-07
( O 0 1.7439947264108469e-09
I1307K O 0 3.148712153233646e-07
) O 0 6.552178799523745e-10
of O 0 8.806436468944412e-09
the O 0 1.2751072198113889e-08
APC B-Disease 0 2.1825037777034595e-07
gene O 0 1.6714349904134451e-09
has O 0 5.442358785856527e-10
been O 0 3.000618642445829e-10
identified O 0 6.387076978420225e-11
in O 0 5.232125843690483e-11
6 O 0 3.0075759660519452e-09
% O 0 5.4222137196857645e-11
- O 0 8.353043257081083e-10
7 O 0 1.0507802405967936e-09
% O 0 3.390107292111644e-11
of O 0 2.6574170641779915e-10
the O 0 9.731039307681044e-10
Ashkenazi O 0 3.014980975990511e-08
Jewish O 0 1.3170748047741654e-08
population O 0 5.182863582753328e-10
. O 0 1.6559189575104938e-08

To O 0 3.212149835007949e-08
assess O 0 7.738611884633428e-08
the O 0 9.403414047426395e-09
risk O 0 1.9010713003808632e-08
of O 0 2.333384374608727e-09
this O 0 3.48965967233994e-10
common O 0 4.730065228386593e-09
APC B-Disease 0 6.428151095860812e-07
allelic O 0 3.0374744710570667e-06
variant O 0 1.4007673598825932e-06
in O 0 7.991102535243044e-08
colorectal O 1 1.0
carcinogenesis O 1 1.0
, O 0 9.158191716096553e-08
we O 0 3.0133180395353065e-09
have O 0 1.4791994018548138e-10
analyzed O 0 4.641008966022042e-10
a O 0 1.1493154344899281e-10
large O 0 1.4510327384087418e-09
cohort O 0 1.569797269951323e-08
of O 0 8.74057093369629e-09
unselected O 0 1.1038268894481007e-05
Ashkenazi O 0 2.763664141980371e-08
Jewish O 0 1.0400096783769186e-08
subjects O 0 2.634990181604735e-08
with O 0 1.0113392345800776e-09
adenomatous B-Disease 0 0.0014874152839183807
polyps I-Disease 0 1.6427164155174978e-05
and O 0 4.834400879616396e-09
. O 0 3.4571459028853724e-09
or O 0 3.845881565212039e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, I-Disease 0 2.7802271596044648e-09
for O 0 7.98926647060938e-10
the O 0 2.6070647862752594e-08
APC O 0 1.6684695083313272e-06
I1307K O 0 6.9147595240792725e-06
polymorphism O 0 2.1803796812491782e-07
. O 0 2.634362772369059e-07

The O 0 2.0173076791252242e-06
APC O 0 5.851168225490255e-06
I1307K O 0 4.846252522838768e-06
allele O 0 1.5060471980632428e-08
was O 0 9.114553556344163e-09
identified O 0 1.1134179134231204e-09
in O 0 5.15913367582499e-10
48 O 0 1.3825906641784513e-08
( O 0 1.218005696301816e-10
10 O 0 5.510052414336997e-10
. O 0 1.0293164931507448e-10
1 O 0 4.873674352978696e-09
% O 0 2.935025278372194e-10
) O 0 2.820891020771654e-10
of O 0 1.0345333478767316e-08
476 O 0 3.7789877183058707e-07
patients O 0 5.105124856186194e-08
. O 0 8.808220997025273e-08

Compared O 0 1.0723091747877334e-08
with O 0 3.7387060114468795e-10
the O 0 1.1257927923224997e-09
frequency O 0 7.431334991814253e-10
in O 0 9.604776696203743e-11
two O 0 8.93825360948064e-11
separate O 0 1.782806124950298e-10
population O 0 5.674435313990367e-12
control O 0 2.4364724127146076e-10
groups O 0 1.599962697051982e-11
, O 0 1.9268349416012853e-10
the O 0 3.0140885343143964e-09
APC O 0 3.3647509667389386e-07
I1307K O 0 1.1275683391431812e-06
allele O 0 2.416092881318832e-09
is O 0 1.1931994281511038e-10
associated O 0 8.344742952193229e-11
with O 0 6.815029096607361e-11
an O 0 1.2100608015597203e-10
estimated O 0 4.534632946917583e-10
relative O 0 2.7686171133467496e-09
risk O 0 6.763936521991809e-09
of O 0 1.7489989900809633e-08
1 O 0 1.4019902891959646e-06
. O 0 4.0784334487398155e-07

5 O 0 1.0202256817137823e-05
- O 0 1.2843288459407631e-05
1 O 0 7.222097337944433e-06
. O 0 1.7003681023197714e-06

7 O 0 1.613531253497058e-06
for O 0 1.619421823306766e-07
colorectal B-Disease 1 1.0
neoplasia I-Disease 1 1.0
( O 0 2.9589056538270597e-08
both O 0 4.984839208077574e-08
P O 0 5.626032816508086e-06
= O 0 1.855128495265035e-08
. O 0 6.127654383902836e-09
01 O 0 3.174835001118481e-06
) O 0 3.687506477945135e-08
. O 0 3.126384342522215e-07

Furthermore O 0 9.865093488770071e-07
, O 0 1.5924390694976864e-08
compared O 0 6.6002465715087055e-09
with O 0 3.4288687444927746e-09
noncarriers O 0 0.00013691943604499102
, O 0 1.06918896847219e-07
APC O 0 3.835717052425025e-06
I1307K O 0 8.425989108218346e-06
carriers O 0 8.288676411893903e-09
had O 0 7.370467014489179e-10
increased O 0 2.517192010387248e-10
numbers O 0 2.782379604493457e-10
of O 0 6.080455694501552e-09
adenomas B-Disease 1 0.9999991655349731
and O 0 0.0036224217619746923
colorectal B-Disease 1 1.0
cancers I-Disease 1 1.0
per O 0 9.440794812576314e-09
patient O 0 3.293564887485445e-08
( O 0 3.76227687892694e-10
P O 0 6.09611134905208e-08
= O 0 2.904983753548862e-10
. O 0 9.464583977658592e-11
03 O 0 5.8199582042561815e-08
) O 0 9.352730395706388e-11
, O 0 1.0806626427051214e-10
as O 0 7.884565916826958e-11
well O 0 1.891015954935682e-10
as O 0 3.568546291798924e-10
a O 0 6.843716704452163e-10
younger O 0 5.246541423531426e-09
age O 0 6.81087808374059e-09
at O 0 1.5367914940611627e-08
diagnosis O 0 6.218036787686287e-07
. O 0 2.555655385094724e-07

We O 0 1.6117751044930628e-07
conclude O 0 3.834809447766929e-08
that O 0 6.888478121247488e-10
the O 0 2.1695930385590145e-08
APC O 0 2.2869462554808706e-06
I1307K O 0 1.238651111634681e-05
variant O 0 6.595643071705126e-07
leads O 0 3.4200397180939035e-08
to O 0 1.7573713595453455e-09
increased O 0 9.81410579470321e-08
adenoma B-Disease 1 1.0
formation O 0 4.831370574720495e-07
and O 0 1.7038720656614714e-08
directly O 0 5.555442328386562e-09
contributes O 0 4.504154826889817e-09
to O 0 4.1594358513030727e-10
3 O 0 4.643995410447133e-09
% O 0 7.858248080028218e-11
- O 0 6.94724777705602e-10
4 O 0 9.178258708608666e-10
% O 0 1.7949622690971445e-11
of O 0 8.768615694654258e-11
all O 0 1.6252894863288958e-10
Ashkenazi O 0 5.946950665247641e-08
Jewish O 0 1.704300188976049e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 1.0196955599894864e-06

The O 0 1.511442064838775e-07
estimated O 0 7.922063893772702e-09
relative O 0 4.666183439638871e-09
risk O 0 7.938020907261034e-09
for O 0 2.4205937254606624e-10
carriers O 0 1.6691984461303377e-09
may O 0 2.8614249858449625e-10
justify O 0 2.5144775150920395e-09
specific O 0 5.092438137843658e-10
clinical O 0 1.5282582976894332e-09
screening O 0 6.326409396351096e-10
for O 0 1.3837447854214702e-10
the O 0 1.5497865213376372e-09
360 O 0 8.219546820953383e-09
, O 0 1.1048306020056131e-10
000 O 0 8.427521458465037e-10
Americans O 0 2.255280684426708e-11
expected O 0 9.913559556595786e-11
to O 0 8.410528523628003e-11
harbor O 0 2.9285306624160512e-08
this O 0 5.786599324708597e-11
allele O 0 2.9197266826486157e-10
, O 0 1.6964314675238512e-10
and O 0 1.826177542518792e-10
genetic O 0 1.8004252255732212e-10
testing O 0 5.83236237083895e-11
in O 0 1.8042952548702473e-11
the O 0 4.834315170398895e-10
setting O 0 3.940961779136387e-09
of O 0 3.123962200035635e-09
long O 0 4.162342470692693e-09
- O 0 4.580238766038747e-08
term O 0 7.982766447867107e-09
- O 0 1.8512190891328828e-08
outcome O 0 7.233001309003839e-09
studies O 0 1.2976345553639135e-09
may O 0 1.4253297153654643e-10
impact O 0 4.34373248481279e-09
significantly O 0 6.1349521018883024e-09
on O 0 1.38782945668936e-06
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 1.9543023881851695e-05
in O 0 5.303080752305789e-10
this O 0 3.0039457032948746e-10
population O 0 5.396299518345415e-10
. O 0 1.94415790133462e-08

Localization O 0 3.7843576592422323e-06
of O 0 3.432290043292596e-07
human O 0 1.6011801662330072e-08
BRCA1 O 0 1.8735230256083923e-08
and O 0 6.529572438296327e-10
its O 0 1.6995512774897747e-09
loss O 0 1.4868298592318752e-08
in O 0 1.7180465383681565e-10
high O 0 5.251720267551718e-07
- O 0 1.831076872349513e-07
grade O 0 6.46355886146921e-07
, O 0 1.61615254512526e-09
non B-Disease 0 1.5149183809626265e-06
- I-Disease 0 0.0017416467890143394
inherited I-Disease 1 0.9999189376831055
breast I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 1.0845646102097817e-05

Although O 0 5.077952636156624e-08
the O 0 1.1414388545460952e-08
link O 0 1.4505464385194955e-08
between O 0 2.33675145899781e-09
the O 0 5.7984077983519455e-08
BRCA1 O 0 1.0850053513422608e-05
tumour B-Disease 1 1.0
- O 0 0.00027505980688147247
suppressor O 0 9.397870599059388e-05
gene O 0 2.7262149870921348e-08
and O 0 3.842350793092919e-08
hereditary B-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
is O 0 5.234613853488668e-10
established O 0 1.1296209107003463e-10
, O 0 2.53951859541246e-11
the O 0 1.2396571269501777e-10
role O 0 6.819012021708204e-10
, O 0 9.046254023648004e-11
if O 0 5.7587649926471585e-11
any O 0 2.5272658965569406e-10
, O 0 1.5405493547504534e-10
of O 0 4.9094173171226885e-09
BRCA1 O 0 3.774182388838199e-08
in O 0 1.597445731249536e-09
non B-Disease 1 0.9998412132263184
- I-Disease 1 0.9999804496765137
familial I-Disease 1 0.9999688863754272
cancers I-Disease 1 1.0
is O 0 4.32691535934282e-08
unclear O 0 5.636713495960066e-08
. O 0 8.804224194136623e-08

BRCA1 O 0 2.5236484361812472e-05
mutations O 0 9.142449641785788e-08
are O 0 2.467225979074783e-09
rare O 0 1.2137836513659295e-08
in O 0 2.0689681079488764e-09
sporadic B-Disease 0 3.172476135659963e-05
cancers I-Disease 1 1.0
, O 0 3.567738326992753e-09
but O 0 9.091769004321293e-10
loss O 0 9.694015545846923e-08
of O 0 1.3789950514819793e-07
BRCA1 O 0 5.914124656669628e-08
resulting O 0 1.1277743183768507e-09
from O 0 1.033104782277583e-10
reduced O 0 6.721624590255715e-09
expression O 0 6.309852085273349e-10
or O 0 1.5107119721857742e-10
incorrect O 0 2.727055914419907e-09
subcellular O 0 2.5112768753388082e-08
localization O 0 4.3987444797721764e-08
is O 0 7.87625797915581e-10
postulated O 0 1.5510935869045284e-09
to O 0 7.19658221903785e-11
be O 0 5.6281750093756244e-11
important O 0 2.8049615408143325e-10
in O 0 3.1254387966583863e-10
non B-Disease 0 7.736287443549372e-06
- I-Disease 0 0.011379988864064217
familial I-Disease 1 1.0
breast I-Disease 1 1.0
and I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 3.343691332702292e-06

Epigenetic O 0 0.00015262275701388717
loss O 0 0.00846267119050026
, O 0 2.6167295885670683e-08
however O 0 3.6435010564161985e-09
, O 0 1.5960994748098756e-09
has O 0 4.478478976555067e-10
not O 0 4.6033267475653616e-11
received O 0 3.8345715491772125e-10
general O 0 5.319613638476994e-10
acceptance O 0 3.0968621000937446e-09
due O 0 3.731391640116044e-09
to O 0 1.1769528684979491e-09
controversy O 0 2.1720692799931385e-08
regarding O 0 1.580272801504634e-08
the O 0 5.966625860054364e-09
subcellular O 0 9.284119784069844e-08
localization O 0 1.3955309441371355e-07
of O 0 9.930586486461834e-08
BRCA1 O 0 1.492464107855085e-08
proteins O 0 7.102802374037154e-11
, O 0 6.477989672459827e-11
reports O 0 1.7402655705378578e-10
of O 0 8.972676490692777e-10
which O 0 6.027506271877314e-11
have O 0 2.2892675602403934e-11
ranged O 0 1.364003354709098e-09
from O 0 2.280955806177598e-11
exclusively O 0 1.2579552954861128e-09
nuclear O 0 9.951174106959115e-09
, O 0 2.5992916152794976e-10
to O 0 5.658445378919907e-10
conditionally O 0 1.0780207304605938e-07
nuclear O 0 3.2530959259702286e-08
, O 0 4.4533082776965216e-10
to O 0 5.740037334334147e-10
the O 0 1.4073451737317555e-08
ER O 1 0.9999220371246338
/ O 0 9.504619242761692e-07
golgi O 0 9.14082534109184e-07
, O 0 6.064564850305487e-09
to O 0 8.127459594220454e-09
cytoplasmic O 0 6.314793949968589e-07
invaginations O 0 1.0181467587244697e-05
into O 0 4.070967918323731e-08
the O 0 6.134767005505637e-08
nucleus O 0 5.514168037734635e-07
. O 0 2.6782581130646577e-07

In O 0 4.7939920477801934e-08
an O 0 2.8752402680964906e-09
attempt O 0 1.1587263593071384e-08
to O 0 1.729934417937784e-09
resolve O 0 1.8606176155344656e-08
this O 0 2.4531568443286744e-10
issue O 0 6.383844119994819e-09
, O 0 1.0691940666163191e-09
we O 0 8.32568514130827e-10
have O 0 7.38970884484047e-10
comprehensively O 0 1.7261438642890425e-06
characterized O 0 7.081439434841741e-08
19 O 0 1.3256290287699812e-07
anti O 0 1.9664882984216092e-06
- O 0 2.834165934473276e-05
BRCA1 O 0 9.492634376329079e-07
antibodies O 0 1.642603990603675e-07
. O 0 1.6631999244509643e-07

These O 0 6.86680664330197e-07
reagents O 0 1.2078251074854052e-06
detect O 0 6.88220666233974e-07
a O 0 2.7482782272159056e-08
220 O 0 5.0560334585725286e-08
- O 0 2.2572039881652017e-07
kD O 0 1.2536761460069101e-05
protein O 0 1.1778607422741061e-08
localized O 0 4.009413245853466e-08
in O 0 4.952073751063324e-10
discrete O 0 6.337258273703128e-09
nuclear O 0 3.521489588820259e-08
foci O 0 3.681532589894232e-08
in O 0 1.152058934361655e-10
all O 0 2.2594970339184783e-10
epithelial O 0 4.770565720235709e-09
cell O 0 5.49022782792008e-09
lines O 0 8.482971658452243e-09
, O 0 3.1342919926125035e-10
including O 0 3.9502240367639274e-10
those O 0 3.3209637817499527e-10
derived O 0 1.433361984659598e-09
from O 0 3.3780018782181287e-09
breast B-Disease 0 2.605365079944022e-05
malignancies I-Disease 0 6.20845821686089e-05
. O 0 8.418467132287333e-07

Immunohistochemical O 0 0.00011989340418949723
staining O 0 5.332517503120471e-06
of O 0 1.8227572127216263e-06
human O 0 3.1779870823811507e-07
breast O 0 0.00012415240053087473
specimens O 0 3.249852795761399e-07
also O 0 8.725280942201152e-09
revealed O 0 9.903650521891905e-08
BRCA1 O 0 8.338532211382699e-07
nuclear O 0 9.826765108300606e-07
foci O 0 2.355135165998945e-06
in O 0 1.6639321032130283e-08
benign O 1 1.0
breast O 1 1.0
, O 0 1.1475989367681905e-06
invasive B-Disease 1 1.0
lobular I-Disease 1 1.0
cancers I-Disease 1 1.0
and O 0 2.0844663595198654e-06
low B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
grade I-Disease 1 0.9999758005142212
ductal I-Disease 1 1.0
carcinomas I-Disease 1 1.0
. O 0 3.749426105059683e-05

Conversely O 0 3.910727173206396e-06
, O 0 1.5594633850923856e-07
BRCA1 O 0 2.269771641749685e-07
expression O 0 6.796733398317656e-09
was O 0 2.9307305471348855e-09
reduced O 0 3.0763629421670657e-09
or O 0 2.445149915875078e-10
undetectable O 0 5.765474764274359e-09
in O 0 1.7811295840997055e-11
the O 0 2.1019815055201008e-10
majority O 0 3.196700196217428e-11
of O 0 9.99976323967644e-10
high O 0 5.777750970992201e-07
- O 0 3.2773525617812993e-06
grade O 0 0.00011453273327788338
, O 0 2.566264178938127e-08
ductal B-Disease 1 1.0
carcinomas I-Disease 1 1.0
, O 0 4.3649791336974886e-08
suggesting O 0 5.747292863844677e-09
that O 0 2.6455074242370813e-10
absence O 0 1.1435439262186264e-08
of O 0 3.910541224172448e-08
BRCA1 O 0 7.622458753075989e-08
may O 0 1.2874963595255196e-10
contribute O 0 2.510057994786763e-10
to O 0 9.751416341075014e-11
the O 0 1.865346099805265e-09
pathogenesis O 0 2.3605920773661637e-07
of O 0 2.4555468769449362e-08
a O 0 1.248194325675911e-09
significant O 0 4.344792969845912e-09
percentage O 0 2.6621938431503622e-08
of O 0 3.7555910381570357e-08
sporadic B-Disease 0 0.053297534584999084
breast I-Disease 1 1.0
cancers I-Disease 1 1.0
. O 0 3.9307245458530815e-08
. O 0 2.5551850058036507e-07

